23.11.2014 Views

Download Full Volume - United States Renal Data System

Download Full Volume - United States Renal Data System

Download Full Volume - United States Renal Data System

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Reference<br />

A<br />

Section<br />

Incidence of<br />

reported ESRD


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

284<br />

A.1 . 285<br />

Incident counts of reported ESRD: all patients<br />

by demographic characteristics & primary diagnosis<br />

A.2 . 289<br />

Incident rates of reported ESRD<br />

per million population, by demographic characteristics & primary diagnosis<br />

A.3 . 293<br />

Incident rates of reported diabetic ESRD<br />

per million population, by demographic characteristics<br />

A.4 . 295<br />

Incident counts of reported ESRD patients, 2001-2003<br />

by age, gender, & race<br />

A.5 . 296<br />

Incident rates of reported ESRD, 2001-2003<br />

per million population, by age, gender, & race<br />

A.6 . 297<br />

Mean age at start of ESRD therapy<br />

by demographic characteristics & primary diagnosis<br />

A.7 . 299<br />

Incidence of reported ESRD, by primary diagnosis: all patients<br />

1999-2003 combined, by detailed primary diagnosis<br />

A.8 . 301<br />

Incident counts of reported ESRD patients, by diabetic status & state/territory<br />

A.9 . 307<br />

Incident rates of reported ESRD, by diabetic status & state, adjusted<br />

per million population<br />

A.10 . 313<br />

Incident counts of reported ESRD patients, by diabetic status & ESRD network<br />

A.11 . 315<br />

Incident rates of reported ESRD, by diabetic status & ESRD network, adjusted<br />

per million population


ON OUR WEBSITE & CD<br />

Incident counts of reported ESRD, by primary diagnosis, (A.1.1-4), patients residing<br />

in Puerto Rico & U.S. territories (A.a).<br />

INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

Table A.1<br />

Incident counts of reported ESRD: all patients<br />

by demographic characteristics & primary diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 47 69 101 106 112 139 136 148 145 158 151 182<br />

5-9 97 97 105 88 110 103 122 115 106 131 154 129<br />

10-14 179 188 224 211 230 217 213 220 225 208 249 248<br />

15-19 433 476 456 444 431 442 457 484 522 526 548 490<br />

20-29 1,540 1,689 1,902 1,857 2,007 2,088 2,159 2,186 2,420 2,584 2,637 2,651<br />

30-39 2,222 2,484 2,768 2,851 3,077 3,313 3,673 3,834 4,297 4,652 4,893 5,149<br />

40-49 2,447 2,741 2,890 3,250 3,389 3,703 4,002 4,523 5,018 5,690 6,280 7,003<br />

50-59 3,759 4,375 4,690 4,853 5,129 5,510 5,813 6,290 7,206 7,733 8,362 9,016<br />

60-64 2,139 2,464 2,791 3,223 3,533 3,959 4,146 4,621 5,072 5,527 6,145 6,702<br />

65-69 2,187 2,273 2,602 3,335 3,522 3,934 4,460 5,117 5,670 6,544 7,254 8,034<br />

70-79 2,533 2,754 3,404 4,690 4,933 5,796 6,607 7,463 8,317 9,792 10,886 12,697<br />

80+ 434 491 646 1,017 1,099 1,383 1,669 1,944 2,289 2,907 3,359 3,869<br />

Unknown . * * * * 17 14 * * * * *<br />

0-19 756 830 886 849 883 901 928 967 998 1,023 1,102 1,049<br />

20-44 4,877 5,471 6,024 6,226 6,654 7,151 7,736 8,209 9,137 9,905 10,651 11,215<br />

45-64 7,230 8,282 9,017 9,808 10,481 11,422 12,057 13,245 14,876 16,281 17,666 19,306<br />

65-74 3,795 4,024 4,764 6,208 6,462 7,427 8,291 9,488 10,451 12,067 13,528 15,322<br />

75+ 1,359 1,494 1,888 2,834 3,092 3,686 4,445 5,036 5,825 7,176 7,971 9,278<br />

Unknown . * * * * 17 14 * * * * *<br />

285<br />

Male 10,041 11,124 12,437 14,222 15,220 16,590 18,267 20,004 22,154 25,026 27,344 29,991<br />

Female 7,976 8,977 10,150 11,711 12,360 14,010 15,203 16,946 19,137 21,436 23,582 26,180<br />

Unknown . * . * * * * * * . . *<br />

White 12,593 14,004 15,753 17,675 18,829 20,857 22,909 25,003 27,483 30,886 33,876 37,231<br />

Black 4,876 5,508 6,203 7,476 7,892 8,744 9,415 10,664 12,175 13,913 15,016 16,697<br />

Native American 122 144 186 275 286 300 372 424 507 545 596 641<br />

Asian 110 179 357 373 466 591 631 736 911 1,009 1,279 1,449<br />

Other/unknown 316 267 88 136 108 112 144 124 216 109 159 155<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 2,690 4,043 5,308 6,218 7,513 8,708 10,092 11,477 13,072 15,770 18,138 20,720<br />

Hypertension 3,141 4,528 5,838 6,349 7,152 8,241 8,924 10,342 11,937 13,878 15,301 16,982<br />

Glomerulonephritis 2,802 3,633 4,265 4,493 4,816 5,089 5,353 5,854 6,234 6,610 7,053 7,262<br />

Cystic kidney 765 944 1,081 1,105 1,148 1,228 1,311 1,362 1,400 1,417 1,573 1,624<br />

Other urologic 483 679 874 968 985 1,184 1,214 1,341 1,389 1,405 1,331 1,494<br />

Other cause 1,781 2,227 2,827 3,134 3,343 3,608 3,708 3,729 3,890 4,455 4,646 5,009<br />

Unknown cause 1,625 1,679 1,414 1,457 1,495 1,588 1,832 2,021 2,242 2,149 2,287 2,554<br />

Missing disease 4,730 2,369 980 2,211 1,129 958 1,037 825 1,128 778 597 528<br />

U.S. 17,555 19,638 22,055 25,379 26,948 29,904 32,728 36,179 40,283 45,431 49,863 55,119<br />

U.S territories * 16 18 19 14 30 28 35 47 51 59 69<br />

Puerto Rico 235 245 299 300 377 387 403 425 489 576 583 665<br />

Foreign * 14 * 13 13 20 13 15 19 20 43 38<br />

Unknown 209 189 207 224 229 263 299 297 454 384 378 282<br />

All 18,017 20,102 22,587 25,935 27,581 30,604 33,471 36,951 41,292 46,462 50,926 56,173<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.1 A.1 (continued)<br />

Incident counts of of reported ESRD: all patients<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

286<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 153 187 146 168 186 176 175 182 197 205 184 207<br />

5-9 125 135 162 146 146 133 138 157 155 152 182 153<br />

10-14 248 243 260 281 270 281 270 300 311 312 345 340<br />

15-19 533 528 529 570 581 534 542 609 576 585 582 637<br />

20-29 2,795 2,827 2,826 2,705 2,715 2,660 2,741 2,656 2,701 2,712 2,604 2,545<br />

30-39 5,505 5,602 5,928 5,796 5,892 5,803 5,836 5,968 5,821 5,755 5,817 5,760<br />

40-49 7,543 8,020 8,477 9,036 9,727 9,728 10,523 10,746 10,991 11,018 11,360 11,638<br />

50-59 9,984 10,591 11,876 12,066 12,771 13,848 15,093 16,296 16,802 17,696 18,289 19,133<br />

60-64 7,033 7,398 7,844 8,121 8,540 8,992 9,515 9,734 10,055 10,428 10,669 11,263<br />

65-69 8,654 8,984 9,636 9,635 10,467 10,874 11,148 11,253 11,435 11,666 11,937 12,180<br />

70-79 14,198 15,013 16,635 17,142 19,344 20,795 21,895 23,246 23,721 24,014 25,146 24,872<br />

80+ 4,545 4,963 5,643 6,121 7,221 8,378 9,243 10,412 11,201 11,737 13,510 13,839<br />

Unknown * * * * . * * * . . . .<br />

0-19 1,059 1,093 1,097 1,165 1,183 1,124 1,125 1,248 1,239 1,254 1,293 1,337<br />

20-44 11,919 12,150 12,546 12,614 12,979 12,734 13,212 13,241 13,267 13,163 13,175 13,172<br />

45-64 20,941 22,288 24,405 25,110 26,666 28,297 30,496 32,159 33,103 34,446 35,564 37,167<br />

65-74 16,820 17,625 19,163 19,337 21,305 22,231 22,854 23,326 23,733 24,122 24,765 24,599<br />

75+ 10,577 11,335 12,751 13,561 15,727 17,816 19,432 21,585 22,624 23,295 25,828 26,292<br />

Unknown * * * * . * * * . . . .<br />

Male 32,447 34,359 37,056 37,852 41,561 43,792 46,397 48,954 50,268 51,805 54,628 55,584<br />

Female 28,870 30,129 32,911 33,932 36,298 38,411 40,724 42,604 43,697 44,475 45,995 46,955<br />

Unknown * * * * * . . * * . * 28<br />

White 40,340 42,004 45,263 45,686 49,936 53,151 55,992 59,568 61,387 62,667 65,451 66,287<br />

Black 18,377 19,565 21,250 21,907 23,253 24,193 25,868 26,380 26,640 27,560 28,812 29,357<br />

Native American 760 753 823 877 927 960 1,064 1,126 1,144 1,131 1,134 1,097<br />

Asian 1,633 1,936 2,177 2,319 2,514 2,652 2,938 3,195 3,180 3,386 3,581 3,608<br />

Other/unknown 208 234 455 1,002 1,230 1,247 1,259 1,291 1,615 1,536 1,647 2,218<br />

†Hispanic 8,829 9,094 9,722 10,516 11,347 11,706 12,579 13,258<br />

†Non-Hispanic 69,031 73,109 77,399 81,044 82,619 84,574 88,046 89,309<br />

Diabetes 22,971 24,585 27,384 29,912 33,450 35,971 38,351 40,371 42,070 43,265 44,700 45,330<br />

Hypertension 18,963 19,681 21,350 19,174 20,342 21,857 23,041 24,420 24,853 25,779 27,335 28,319<br />

Glomerulonephritis 7,450 7,712 8,311 8,370 8,795 8,721 8,905 8,923 8,636 8,519 8,724 8,384<br />

Cystic kidney 1,738 1,807 1,863 1,941 1,895 1,985 2,157 2,192 2,188 2,248 2,250 2,291<br />

Other urologic 1,536 1,351 1,406 2,113 2,364 2,437 2,449 2,847 2,716 2,737 2,978 2,827<br />

Other cause 5,414 5,730 6,277 7,147 7,557 7,761 8,390 8,667 9,058 9,266 10,057 10,192<br />

Unknown cause 2,784 3,027 2,986 2,801 3,104 3,179 3,398 3,611 3,849 4,028 4,062 4,209<br />

Missing disease 462 599 391 333 353 292 430 529 596 438 519 1,015<br />

U.S. 60,225 63,424 68,806 70,766 76,736 81,030 85,854 90,234 92,647 94,915 99,163 100,786<br />

U.S territories 97 76 89 103 119 139 139 144 137 150 174 175<br />

Puerto Rico 785 800 858 853 938 963 1,040 1,115 1,108 1,154 1,224 1,295<br />

Foreign 32 42 43 33 31 31 39 26 39 28 27 16<br />

Unknown 179 150 172 36 36 40 49 41 35 33 37 295<br />

All 61,318 64,492 69,968 71,791 77,860 82,203 87,121 91,560 93,966 96,280 100,625 102,567<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

Table A.1 A.1 (continued)<br />

Incident counts of of reported ESRD patients: U.S. only, with unknowns dropped<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 46 67 100 105 107 132 131 140 138 149 142 173<br />

5-9 92 94 103 86 107 101 121 111 100 126 148 122<br />

10-14 174 180 217 207 220 208 204 214 215 197 241 238<br />

15-19 425 464 447 437 422 428 448 458 492 512 528 474<br />

20-29 1,480 1,646 1,851 1,790 1,939 2,029 2,091 2,117 2,310 2,501 2,559 2,564<br />

30-39 2,144 2,403 2,698 2,773 2,978 3,225 3,584 3,708 4,147 4,503 4,749 5,044<br />

40-49 2,353 2,652 2,790 3,148 3,298 3,589 3,864 4,383 4,814 5,523 6,081 6,793<br />

50-59 3,609 4,240 4,550 4,728 4,977 5,344 5,640 6,114 6,960 7,515 8,099 8,750<br />

60-64 2,029 2,377 2,711 3,125 3,448 3,850 4,037 4,528 4,955 5,373 5,986 6,554<br />

65-69 2,101 2,182 2,547 3,267 3,449 3,852 4,366 5,023 5,575 6,441 7,158 7,903<br />

70-79 2,405 2,627 3,329 4,602 4,828 5,686 6,488 7,363 8,167 9,657 10,743 12,542<br />

80+ 417 467 630 989 1,073 1,355 1,636 1,917 2,253 2,858 3,315 3,835<br />

0-19 737 805 867 835 856 869 904 923 945 984 1,059 1,007<br />

20-44 4,694 5,311 5,861 6,031 6,448 6,937 7,506 7,945 8,774 9,597 10,332 10,927<br />

45-64 6,921 8,007 8,739 9,533 10,192 11,100 11,710 12,905 14,412 15,818 17,142 18,778<br />

65-74 3,624 3,850 4,663 6,083 6,329 7,280 8,124 9,332 10,277 11,894 13,348 15,093<br />

75+ 1,299 1,426 1,843 2,775 3,021 3,613 4,366 4,971 5,718 7,062 7,868 9,187<br />

287<br />

Male 9,636 10,726 12,093 13,848 14,792 16,164 17,787 19,490 21,520 24,375 26,674 29,316<br />

Female 7,639 8,673 9,880 11,409 12,054 13,635 14,823 16,586 18,606 20,980 23,075 25,676<br />

White 12,256 13,661 15,373 17,268 18,372 20,365 22,394 24,477 26,798 30,160 33,152 36,452<br />

Black 4,793 5,424 6,082 7,364 7,754 8,577 9,250 10,483 11,993 13,721 14,824 16,548<br />

Native American 121 143 181 271 280 297 366 423 503 543 593 639<br />

Asian 105 171 337 354 440 560 600 693 832 931 1,180 1,353<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 2,569 3,901 5,164 6,057 7,303 8,473 9,794 11,175 12,695 15,342 17,675 20,196<br />

Hypertension 3,059 4,408 5,731 6,250 7,041 8,071 8,774 10,198 11,763 13,703 15,094 16,787<br />

Glomerulonephritis 2,710 3,528 4,146 4,352 4,660 4,946 5,213 5,712 6,062 6,421 6,866 7,090<br />

Cystic kidney 753 932 1,070 1,092 1,131 1,204 1,294 1,340 1,379 1,399 1,544 1,605<br />

Other urologic 462 653 839 938 947 1,149 1,181 1,316 1,334 1,352 1,278 1,455<br />

Other cause 1,732 2,191 2,778 3,090 3,297 3,554 3,646 3,674 3,813 4,378 4,579 4,913<br />

Unknown cause 1,511 1,575 1,351 1,370 1,425 1,520 1,757 1,935 2,162 2,089 2,206 2,473<br />

Missing disease 4,479 2,211 894 2,108 1,042 882 951 726 918 671 507 473<br />

All 17,275 19,399 21,973 25,257 26,846 29,799 32,610 36,076 40,126 45,355 49,749 54,992<br />

Patients dropped 742 703 614 678 735 805 861 875 1,166 1,107 1,177 1,181<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.1 A.1 (continued)<br />

Incident counts of reported ESRD patients: U.S. only, with unknowns dropped<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

288<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 149 181 140 160 172 166 165 175 190 186 166 185<br />

5-9 119 128 154 145 140 130 131 145 149 143 175 132<br />

10-14 242 239 249 266 265 269 263 292 298 297 328 303<br />

15-19 526 507 513 551 564 516 522 590 543 559 541 579<br />

20-29 2,719 2,770 2,737 2,624 2,625 2,569 2,642 2,567 2,558 2,586 2,439 2,367<br />

30-39 5,391 5,488 5,773 5,657 5,731 5,653 5,656 5,779 5,621 5,533 5,601 5,440<br />

40-49 7,358 7,842 8,266 8,779 9,416 9,455 10,237 10,458 10,643 10,712 10,992 11,158<br />

50-59 9,682 10,301 11,549 11,666 12,353 13,368 14,562 15,755 16,204 17,097 17,693 18,304<br />

60-64 6,875 7,216 7,649 7,890 8,261 8,703 9,219 9,442 9,698 10,094 10,321 10,800<br />

65-69 8,501 8,841 9,484 9,384 10,227 10,600 10,878 10,958 11,127 11,357 11,619 11,812<br />

70-79 14,003 14,817 16,432 16,875 18,999 20,422 21,505 22,863 23,274 23,557 24,674 24,334<br />

80+ 4,503 4,903 5,560 6,030 7,120 8,259 9,154 10,251 11,060 11,594 13,326 13,620<br />

0-19 1,036 1,055 1,056 1,122 1,141 1,081 1,081 1,202 1,180 1,185 1,210 1,199<br />

20-44 11,651 11,889 12,209 12,283 12,600 12,393 12,801 12,844 12,764 12,685 12,638 12,472<br />

45-64 20,374 21,728 23,765 24,333 25,786 27,355 29,515 31,157 31,960 33,337 34,408 35,597<br />

65-74 16,540 17,366 18,886 18,933 20,872 21,749 22,348 22,812 23,160 23,561 24,171 23,935<br />

75+ 10,467 11,195 12,590 13,356 15,474 17,532 19,189 21,260 22,301 22,947 25,448 25,831<br />

Male 31,768 33,649 36,199 36,842 40,443 42,626 45,122 47,645 48,745 50,270 52,986 53,566<br />

Female 28,300 29,584 32,307 33,185 35,430 37,484 39,812 41,630 42,620 43,445 44,889 45,468<br />

White 39,566 41,233 44,462 45,113 49,390 52,516 55,301 58,816 60,610 61,877 64,623 65,266<br />

Black 18,216 19,409 21,116 21,796 23,137 24,085 25,735 26,249 26,538 27,434 28,664 29,202<br />

Native American 759 749 821 876 927 956 1,063 1,124 1,144 1,131 1,134 1,097<br />

Asian 1,527 1,842 2,107 2,242 2,419 2,553 2,835 3,086 3,073 3,273 3,454 3,469<br />

†Hispanic 7,346 7,529 8,149 8,824 9,514 9,844 10,548 10,956<br />

†Non-Hispanic 68,527 72,581 76,785 80,451 81,851 83,871 87,327 88,078<br />

Diabetes 22,378 24,035 26,701 29,019 32,367 34,831 37,190 39,111 40,703 41,864 43,219 43,589<br />

Hypertension 18,732 19,416 21,074 18,857 20,029 21,500 22,676 24,063 24,446 25,350 26,871 27,706<br />

Glomeruloneph. 7,299 7,560 8,132 8,169 8,595 8,492 8,659 8,694 8,373 8,262 8,444 8,076<br />

Cystic kidney 1,710 1,771 1,822 1,909 1,854 1,946 2,119 2,160 2,133 2,195 2,195 2,216<br />

Other urologic 1,497 1,330 1,384 2,038 2,313 2,375 2,395 2,763 2,641 2,678 2,898 2,765<br />

Other cause 5,321 5,617 6,136 7,021 7,399 7,621 8,232 8,507 8,837 9,079 9,833 9,957<br />

Unknown cause 2,713 2,950 2,909 2,716 3,018 3,087 3,302 3,518 3,725 3,913 3,958 4,050<br />

Missing disease 418 554 348 298 298 258 361 459 507 374 457 675<br />

All 60,068 63,233 68,506 70,027 75,873 80,110 84,934 89,275 91,365 93,715 97,875 99,034<br />

Patients dropped 1,250 1,259 1,462 1,764 1,987 2,093 2,187 2,285 2,601 2,565 2,750 3,533<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


ON OUR WEBSITE & CD<br />

Incident rates of reported ESRD: diabetes, hypertension, glomerulonephritis,<br />

& cystic kidney disease (A.2.1-4).<br />

INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

Table A.2 A.2<br />

Incident rates of of reported ESRD<br />

per<br />

per<br />

million<br />

million<br />

population,<br />

population,<br />

by<br />

by<br />

demographic<br />

demographic characteristics<br />

characteristics<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 2.8 4.0 5.8 6.0 6.1 7.4 7.3 7.8 7.6 8.1 7.5 9.0<br />

5-9 5.5 5.9 6.5 5.4 6.6 6.1 7.1 6.4 5.6 7.0 8.2 6.7<br />

10-14 9.5 9.8 12.0 11.6 12.6 12.2 12.4 13.1 13.0 11.7 14.0 13.4<br />

15-19 20.1 22.6 22.4 22.5 22.3 22.9 23.8 24.5 26.6 28.2 29.7 27.5<br />

20-29 36.0 39.4 43.7 41.9 45.1 47.3 49.0 50.4 55.8 61.3 63.3 63.9<br />

30-39 67.4 72.6 78.7 78.8 81.9 85.7 91.7 93.6 102.7 109.5 113.3 117.6<br />

40-49 103.3 115.2 118.9 129.3 131.6 139.7 147.1 157.1 165.2 181.8 192.3 206.6<br />

50-59 154.8 183.2 198.9 209.1 223.1 242.0 257.3 280.9 320.5 345.6 370.6 395.3<br />

60-64 200.0 229.5 256.6 293.3 319.2 353.0 371.8 419.9 459.2 501.8 563.5 618.1<br />

65-69 238.5 245.2 282.9 358.0 374.3 412.3 457.5 516.0 567.7 646.5 710.2 787.3<br />

70-79 206.1 219.8 271.9 367.5 377.6 436.5 490.1 546.5 595.6 693.3 758.0 862.7<br />

80+ 79.8 86.9 113.7 173.2 182.6 224.1 262.8 298.7 341.9 420.9 473.8 530.0<br />

0-19 10.2 11.2 12.2 11.8 12.2 12.4 12.9 13.1 13.3 13.8 14.7 13.9<br />

20-44 55.5 61.1 65.8 66.2 69.3 73.3 78.1 81.7 89.6 97.0 103.2 107.4<br />

45-64 155.5 180.0 196.6 214.4 228.8 248.9 262.3 287.8 317.0 344.8 370.2 400.7<br />

65-74 231.6 242.3 288.8 370.6 380.7 431.8 474.1 535.5 583.1 665.8 737.3 825.0<br />

75+ 129.3 138.0 173.2 253.5 268.5 312.6 367.8 407.5 457.5 551.0 598.6 679.6<br />

289<br />

Male 87.3 96.2 107.4 121.9 129.0 139.7 152.2 165.2 180.7 202.7 219.2 237.5<br />

Female 65.4 73.5 83.0 95.0 99.5 111.6 120.3 133.4 148.4 165.8 180.4 198.2<br />

White 62.8 69.5 77.6 86.6 91.5 100.8 110.1 119.5 130.0 145.3 158.3 172.3<br />

Black 179.0 199.9 221.1 264.3 274.8 300.2 319.6 357.5 403.5 455.2 483.7 528.9<br />

Native American 84.6 96.4 117.7 169.8 169.1 172.9 205.2 228.5 261.6 271.3 288.0 300.4<br />

Asian 27.4 40.6 73.6 72.1 83.8 99.9 100.4 109.3 123.7 130.5 156.3 170.0<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 11.3 17.0 22.3 25.9 31.0 35.6 40.8 46.1 51.9 62.2 70.8 79.8<br />

Hypertension 13.5 19.2 24.7 26.7 29.9 33.9 36.5 42.1 48.1 55.5 60.5 66.4<br />

Glomerulonephritis 11.9 15.4 17.9 18.6 19.8 20.8 21.7 23.6 24.8 26.0 27.5 28.0<br />

Cystic kidney 3.3 4.1 4.6 4.7 4.8 5.1 5.4 5.5 5.6 5.7 6.2 6.3<br />

Other urologic 2.0 2.9 3.6 4.0 4.0 4.8 4.9 5.4 5.5 5.5 5.1 5.8<br />

Other cause 7.6 9.6 12.0 13.2 14.0 14.9 15.2 15.2 15.6 17.7 18.3 19.4<br />

Unknown cause 6.7 6.9 5.8 5.9 6.0 6.4 7.3 8.0 8.8 8.5 8.8 9.8<br />

Missing disease 19.7 9.6 3.9 9.0 4.4 3.7 4.0 3.0 3.8 2.7 2.0 1.9<br />

All 76.0 84.5 94.9 108.0 113.8 125.3 135.8 148.9 164.1 183.8 199.3 217.4<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.2 A.2 (continued)<br />

Incident rates of of reported ESRD<br />

per<br />

per<br />

million<br />

million<br />

population,<br />

population,<br />

by<br />

by<br />

demographic<br />

demographic characteristics<br />

characteristics<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

290<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 7.6 9.2 7.1 8.2 8.9 8.6 8.6 9.2 9.9 9.6 8.5 9.4<br />

5-9 6.5 6.9 8.1 7.5 7.1 6.4 6.4 7.0 7.3 7.1 8.8 6.7<br />

10-14 13.3 12.8 13.1 13.9 13.6 13.7 13.3 14.5 14.5 14.2 15.6 14.3<br />

15-19 30.5 29.0 28.7 30.0 29.8 26.6 26.3 29.4 26.9 27.6 26.6 28.3<br />

20-29 68.5 70.9 71.3 69.1 69.6 68.0 69.6 67.3 66.6 66.7 62.2 59.3<br />

30-39 123.4 123.9 129.1 126.1 128.1 127.5 128.9 132.9 130.2 128.8 131.4 129.2<br />

40-49 215.1 222.8 226.6 232.0 239.1 236.3 250.1 249.9 248.9 245.9 248.7 249.5<br />

50-59 427.4 436.7 473.9 465.9 481.2 488.0 507.3 525.0 516.3 524.3 524.4 525.4<br />

60-64 656.2 701.1 753.6 778.3 817.2 853.7 884.6 883.0 892.5 908.4 890.1 892.1<br />

65-69 850.5 880.3 947.7 940.6 1026.4 1076.2 1124.1 1148.5 1167.8 1190.4 1212.2 1212.0<br />

70-79 940.4 978.9 1068.8 1081.9 1205.2 1281.8 1334.0 1409.6 1429.6 1452.4 1528.6 1516.8<br />

80+ 602.9 634.9 699.4 735.8 846.1 958.3 1037.8 1134.4 1192.8 1210.6 1348.7 1344.6<br />

0-19 14.1 14.2 14.0 14.6 14.7 13.8 13.6 15.0 14.7 14.7 14.9 14.8<br />

20-44 114.1 115.9 118.8 119.2 122.1 119.8 123.5 123.7 122.6 121.4 120.6 118.8<br />

45-64 419.7 435.5 463.2 460.9 474.1 486.1 506.8 516.2 511.5 516.9 516.7 518.1<br />

65-74 894.7 929.0 1005.1 1003.6 1108.8 1164.1 1203.4 1238.5 1260.5 1285.4 1321.3 1305.3<br />

75+ 754.7 787.9 865.8 896.2 1010.2 1115.4 1195.7 1298.0 1334.7 1349.1 1469.8 1469.2<br />

Male 253.6 265.0 281.5 282.9 306.8 319.4 333.9 348.3 352.1 359.1 374.4 374.5<br />

Female 215.6 222.5 240.2 243.9 257.5 269.3 282.9 292.7 296.6 299.4 306.5 307.7<br />

White 184.9 190.7 203.7 204.7 222.1 233.9 244.0 257.2 262.8 266.1 275.6 276.1<br />

Black 569.6 594.7 634.9 644.0 672.3 688.0 723.0 725.7 722.9 737.5 760.8 765.5<br />

Native American 344.7 328.2 347.7 358.8 365.7 364.0 389.9 396.8 381.9 372.8 369.3 352.6<br />

Asian 182.1 209.0 229.0 233.4 241.3 244.1 260.4 272.0 258.9 265.7 270.7 262.8<br />

†Hispanic 249.3 243.7 251.7 260.0 266.9 265.6 274.1 274.6<br />

†Non-Hispanic 285.6 300.2 315.4 328.2 332.0 338.2 350.0 351.0<br />

Diabetes 87.2 92.5 101.5 109.0 120.2 127.8 134.8 140.2 144.3 146.8 150.1 149.9<br />

Hypertension 73.0 74.7 80.1 70.8 74.4 78.9 82.2 86.2 86.6 88.9 93.3 95.3<br />

Glomerulonephritis 28.5 29.1 30.9 30.7 31.9 31.2 31.4 31.2 29.7 29.0 29.3 27.8<br />

Cystic kidney 6.7 6.8 6.9 7.2 6.9 7.1 7.7 7.7 7.6 7.7 7.6 7.6<br />

Other urologic 5.8 5.1 5.3 7.7 8.6 8.7 8.7 9.9 9.4 9.4 10.1 9.5<br />

Other cause 20.7 21.6 23.3 26.4 27.5 28.0 29.8 30.5 31.3 31.9 34.2 34.2<br />

Unknown cause 10.6 11.4 11.1 10.2 11.2 11.3 12.0 12.6 13.2 13.7 13.7 13.9<br />

Missing disease 1.6 2.1 1.3 1.1 1.1 1.0 1.3 1.6 1.8 1.3 1.6 2.3<br />

All 234.2 243.3 260.4 263.0 281.6 293.8 307.9 319.9 323.8 328.7 339.9 340.5<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

Table A.2 A.2 (continued)<br />

Incident rates of of reported ESRD<br />

per<br />

per<br />

million<br />

million<br />

population,<br />

population,<br />

by<br />

by<br />

demographic<br />

demographic characteristics<br />

characteristics<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

ADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 2.7 3.9 5.7 5.9 5.9 7.3 7.2 7.6 7.4 7.9 7.4 8.8<br />

5-9 5.4 5.7 6.5 5.3 6.5 6.0 7.1 6.2 5.6 6.9 8.0 6.6<br />

10-14 9.2 9.6 12.2 11.6 12.5 12.2 12.3 12.8 12.9 11.6 13.8 13.3<br />

15-19 19.8 22.5 22.6 22.1 21.8 22.6 23.6 24.1 25.9 27.5 28.9 26.8<br />

20-29 36.6 39.7 44.2 42.4 45.5 47.4 48.9 49.9 55.2 60.4 62.3 62.5<br />

30-39 71.4 77.3 83.7 83.5 86.2 90.4 95.9 97.9 107.3 113.6 117.0 121.4<br />

40-49 110.8 123.3 128.2 141.5 144.3 152.4 160.8 173.1 183.1 202.7 211.9 229.3<br />

50-59 170.6 203.0 221.7 233.1 248.0 268.8 284.2 311.5 356.3 381.7 410.2 439.4<br />

60-64 223.0 255.3 289.7 338.5 364.3 406.2 419.9 474.5 518.8 569.1 632.4 687.7<br />

65-69 261.6 270.9 317.3 402.1 424.2 467.5 521.2 590.8 641.7 727.6 812.8 892.8<br />

70-79 224.0 243.3 306.9 426.3 439.0 500.1 566.1 624.5 690.2 805.7 880.2 999.0<br />

80+ 92.6 103.0 141.3 216.4 232.9 289.0 325.3 365.1 429.1 521.9 590.8 672.4<br />

0-19 9.3 10.4 11.7 11.2 11.7 12.0 12.5 12.7 13.0 13.5 14.5 13.9<br />

20-44 62.4 68.8 73.6 74.5 77.0 80.8 85.2 88.6 96.1 102.8 108.2 111.4<br />

45-64 172.4 199.5 219.3 241.8 256.7 280.0 293.4 324.1 360.5 393.0 423.6 459.0<br />

65-74 253.0 268.8 323.8 421.9 434.4 494.3 542.8 614.9 666.0 761.0 848.5 943.6<br />

75+ 129.6 141.9 188.7 281.2 299.7 352.4 406.2 446.8 516.1 620.3 685.9 782.7<br />

291<br />

Male 102.4 113.0 126.7 145.3 152.9 165.5 179.5 194.9 213.3 238.4 257.6 278.6<br />

Female 68.2 76.9 86.8 98.0 102.2 113.9 122.3 134.4 149.2 165.4 179.2 195.9<br />

White 65.5 72.2 80.0 89.0 93.5 102.4 111.5 120.3 130.4 145.1 157.6 170.4<br />

Black 242.0 270.0 297.4 360.8 371.0 406.6 432.8 482.0 542.3 611.5 649.2 716.4<br />

Native American 129.4 150.8 185.6 274.4 267.5 272.7 327.7 363.2 418.6 446.5 471.2 494.2<br />

Asian 30.7 51.3 97.7 101.7 121.5 146.7 144.3 156.2 182.8 189.4 233.0 256.4<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 12.5 18.8 24.8 28.9 34.1 39.3 44.7 50.3 56.4 67.2 76.6 85.9<br />

Hypertension 15.8 22.3 28.4 30.5 33.7 38.1 40.7 46.5 53.1 60.4 65.5 71.4<br />

Glomerulonephritis 12.9 16.7 19.4 20.5 21.7 22.6 23.4 25.3 26.5 27.8 29.2 29.7<br />

Cystic kidney 3.8 4.6 5.3 5.3 5.5 5.8 6.1 6.2 6.4 6.4 6.9 7.0<br />

Other urologic 2.2 3.1 3.9 4.3 4.4 5.1 5.3 5.8 5.8 5.7 5.4 6.0<br />

Other cause 7.8 9.9 12.6 13.8 14.6 15.5 15.9 15.6 16.2 18.5 18.9 20.1<br />

Unknown cause 7.3 7.4 6.4 6.4 6.6 6.9 7.9 8.7 9.4 9.1 9.4 10.4<br />

Missing disease 21.7 10.8 4.4 9.7 4.7 3.9 4.2 3.2 4.1 3.0 2.2 2.0<br />

All 84.0 93.6 105.1 119.5 125.2 137.3 148.1 161.7 177.8 197.9 214.0 232.5<br />

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race,<br />

rates by race & ethnicity are adjusted for gender & age.<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.2 A.2 (continued)<br />

Incident rates of of reported ESRD<br />

per<br />

per<br />

million<br />

million<br />

population,<br />

population,<br />

by<br />

by<br />

demographic<br />

demographic characteristics<br />

characteristics<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

292<br />

ADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 7.6 9.1 7.0 7.9 8.8 8.5 8.5 9.1 9.8 9.6 8.3 9.3<br />

5-9 6.3 6.8 7.9 7.3 7.0 6.4 6.2 6.9 7.1 7.0 8.7 6.6<br />

10-14 13.2 12.6 12.9 13.5 13.3 13.5 12.9 14.2 14.1 13.8 15.1 14.1<br />

15-19 29.6 27.8 27.7 28.8 28.5 25.7 25.3 28.5 26.1 26.6 25.9 27.2<br />

20-29 67.2 69.2 69.4 67.0 67.3 65.5 67.2 64.9 64.7 65.1 60.5 58.0<br />

30-39 126.8 126.5 131.4 127.6 128.9 127.5 128.3 131.8 128.9 127.2 129.9 127.6<br />

40-49 236.3 244.0 247.8 250.8 255.7 250.9 263.7 262.2 259.3 254.9 257.0 256.2<br />

50-59 474.9 488.2 529.5 522.0 538.2 547.1 569.1 586.3 574.0 578.9 575.9 572.7<br />

60-64 734.3 778.2 828.3 855.7 892.0 932.7 966.1 960.3 960.8 986.5 966.7 971.0<br />

65-69 959.3 998.7 1,061.0 1,044.8 1,137.3 1,187.6 1,232.0 1,254.9 1,271.1 1,289.7 1,310.4 1,312.6<br />

70-79 1,085.5 1,131.8 1,244.1 1,262.5 1,390.6 1,473.5 1,542.4 1,611.4 1,617.3 1,637.4 1,728.0 1,703.6<br />

80+ 750.2 789.7 871.6 914.7 1,059.3 1,174.3 1,287.9 1,398.9 1,455.5 1,460.6 1,614.1 1,605.6<br />

0-19 14.2 14.1 13.9 14.4 14.4 13.5 13.2 14.7 14.3 14.2 14.5 14.3<br />

20-44 117.4 118.1 119.8 119.1 120.9 117.5 120.5 120.0 118.8 117.6 116.8 115.3<br />

45-64 489.4 510.9 546.3 548.8 566.9 581.7 605.0 612.7 605.1 612.7 607.4 605.9<br />

65-74 1,019.2 1,066.2 1,144.9 1,142.2 1,252.1 1,311.2 1,349.3 1,376.3 1,390.6 1,413.0 1,457.5 1,435.3<br />

75+ 864.0 903.1 1,000.8 1,038.3 1,177.6 1,287.0 1,398.0 1,507.6 1,545.2 1,553.2 1,693.2 1,686.8<br />

Male 296.1 308.0 327.6 327.2 353.4 366.2 381.6 396.1 397.1 402.0 416.9 413.4<br />

Female 212.4 218.8 234.4 237.2 248.5 257.3 268.6 276.1 277.2 278.0 281.6 280.4<br />

White 182.3 187.5 199.7 199.9 215.8 226.3 235.1 246.6 250.9 252.8 259.8 258.6<br />

Black 771.2 803.1 858.8 867.5 905.7 928.7 972.2 969.5 961.4 974.6 999.6 995.7<br />

Native American 560.8 548.0 553.9 582.0 581.7 591.6 633.6 636.8 599.9 549.8 541.7 503.9<br />

Asian 272.7 306.2 342.0 351.9 362.9 354.0 378.1 390.1 362.1 360.2 366.1 346.1<br />

†Hispanic 464.8 456.3 479.8 496.4 503.5 491.7 503.9 495.9<br />

†Non-Hispanic 280.1 292.1 304.9 315.2 316.5 320.3 328.6 326.9<br />

Diabetes 93.5 98.8 108.1 115.6 126.5 133.4 139.7 144.1 146.8 148.3 150.1 148.3<br />

Hypertension 78.1 79.6 85.0 74.6 77.6 81.8 84.7 88.4 88.1 89.7 93.3 94.5<br />

Glomerulonephritis 30.0 30.6 32.5 32.1 33.1 32.1 32.2 31.8 30.1 29.2 29.3 27.6<br />

Cystic kidney 7.4 7.5 7.5 7.7 7.3 7.5 8.0 8.0 7.7 7.8 7.6 7.6<br />

Other urologic 6.1 5.3 5.5 7.9 8.8 8.9 8.9 10.1 9.5 9.5 10.1 9.5<br />

Other cause 21.4 22.4 24.0 27.2 28.2 28.5 30.4 30.9 31.6 32.0 34.2 34.0<br />

Unknown cause 11.2 11.9 11.6 10.7 11.7 11.7 12.3 12.9 13.4 13.8 13.7 13.8<br />

Missing disease 1.7 2.2 1.4 1.2 1.1 1.0 1.3 1.7 1.8 1.3 1.6 2.3<br />

All 249.4 258.3 275.5 276.9 294.3 304.9 317.5 327.7 328.9 331.5 339.9 337.6<br />

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race,<br />

rates by race & ethnicity are adjusted for gender & age.<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

Table A.3 A.3<br />

Incident rates of of reported diabetic ESRD<br />

per<br />

per<br />

million<br />

million<br />

population,<br />

population,<br />

by<br />

by<br />

demographic<br />

demographic characteristics<br />

characteristics<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 . * . * * * * * * * * *<br />

5-9 . * . . . . . . * * * .<br />

10-14 . * * * * * * * * * . *<br />

15-19 0.5 0.6 * * * * * 0.6 0.6 0.8 0.8 0.7<br />

20-29 5.2 7.6 9.8 10.1 10.6 12.5 12.7 13.0 13.2 15.7 15.3 16.1<br />

30-39 16.3 20.0 23.4 24.2 28.3 30.0 32.0 31.5 33.5 37.2 37.3 38.1<br />

40-49 17.7 26.3 31.5 36.5 41.0 46.2 51.6 56.6 57.9 69.4 74.4 80.8<br />

50-59 26.7 42.7 56.3 65.7 77.8 89.2 100.1 113.1 132.7 153.0 176.0 191.2<br />

60-64 31.8 49.4 71.3 86.0 106.8 118.9 136.3 163.4 182.7 218.5 262.8 300.1<br />

65-69 29.4 49.7 63.6 79.2 99.0 121.7 147.3 175.0 207.1 245.0 283.2 338.5<br />

70-79 17.7 28.1 43.7 54.5 68.4 82.2 104.0 122.8 141.4 183.1 220.5 262.6<br />

80+ * 4.1 9.2 11.9 16.7 22.2 27.0 31.8 40.1 57.0 71.9 85.3<br />

0-19 . . * * . . . . . . . .<br />

20-44 10.9 14.6 17.3 18.6 21.4 23.3 25.3 26.0 27.3 31.6 32.6 34.2<br />

45-64 26.1 40.7 55.2 64.7 76.6 87.8 98.5 112.9 126.9 148.6 170.8 189.2<br />

65-74 25.5 43.9 58.4 73.9 90.8 109.3 136.0 159.1 188.4 226.9 269.3 319.2<br />

75+ 7.6 10.0 20.3 23.8 33.4 43.2 52.3 64.8 73.4 103.3 122.2 147.5<br />

293<br />

Male 12.2 17.0 22.3 25.5 30.9 35.9 40.2 44.7 50.2 59.5 67.6 75.5<br />

Female 10.5 17.1 22.3 26.3 31.1 35.4 41.4 47.5 53.6 64.7 73.9 84.0<br />

White 9.6 14.0 18.3 20.9 25.0 28.4 33.0 36.7 41.4 49.8 56.1 63.3<br />

Black 24.1 38.6 50.0 59.6 72.0 83.6 92.9 108.2 120.9 144.4 167.6 188.4<br />

Native American 35.0 53.3 59.2 88.4 95.4 105.4 127.9 144.8 175.2 184.9 189.4 213.9<br />

Asian * 5.7 14.6 17.5 17.5 28.7 28.3 33.1 34.1 40.9 54.8 56.7<br />

†Hispanic<br />

†Non-Hispanic<br />

All 11.3 17.0 22.3 25.9 31.0 35.6 40.8 46.1 51.9 62.2 70.8 79.8<br />

ADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 . * . * * * * * * * * *<br />

5-9 . * . . . . . . * * * .<br />

10-14 . * * * * * * * * * . *<br />

15-19 0.5 0.6 * * * * * 0.6 0.6 0.7 0.8 0.6<br />

20-29 5.2 7.6 9.7 10.0 10.5 12.3 12.4 12.6 12.7 15.1 14.7 15.6<br />

30-39 16.1 20.0 23.5 24.2 28.2 30.1 32.0 31.6 33.8 37.3 37.5 38.3<br />

40-49 18.8 27.4 33.7 39.3 43.7 49.7 55.1 61.1 62.9 75.8 81.2 88.8<br />

50-59 30.2 48.3 63.5 75.0 87.4 100.4 112.3 126.9 148.3 169.6 195.0 212.5<br />

60-64 36.3 57.3 85.3 102.2 124.3 140.7 155.8 188.1 210.2 250.3 297.3 337.6<br />

65-69 34.0 59.5 72.6 94.1 113.9 143.9 172.7 208.9 238.7 278.4 330.7 388.2<br />

70-79 18.8 32.3 50.3 62.9 82.3 99.0 124.9 142.4 165.0 213.6 256.3 306.1<br />

80+ * 3.8 12.5 14.5 22.6 31.3 32.9 36.1 48.9 69.9 90.0 105.5<br />

0-19 0.1 0.2 * * 0.2 0.2 0.3 0.2 0.2 0.3 0.3 0.2<br />

20-44 11.8 15.9 18.6 20.2 23.2 25.0 26.8 27.4 28.5 32.7 33.5 34.8<br />

45-64 29.5 46.1 63.2 74.5 87.0 100.2 111.3 128.9 145.8 170.6 196.7 218.5<br />

65-74 28.5 51.8 66.1 87.4 105.5 128.9 159.4 187.0 215.3 259.3 312.9 366.8<br />

75+ 6.0 9.4 21.9 24.7 37.7 48.9 56.5 63.9 78.6 108.9 132.5 159.2<br />

Male 14.0 19.5 25.9 30.0 35.7 41.8 46.4 51.7 58.2 68.4 78.4 87.1<br />

Female 11.1 18.1 23.6 27.6 32.3 36.8 42.8 48.6 54.5 65.6 74.5 84.4<br />

White 10.1 14.7 19.0 21.5 25.6 28.9 33.4 37.0 41.5 49.6 55.9 62.8<br />

Black 32.3 51.8 68.0 81.0 97.5 114.1 127.7 147.7 165.1 198.9 231.4 261.5<br />

Native American 57.1 88.2 97.9 149.5 162.5 174.8 209.5 241.4 291.0 307.4 314.8 359.5<br />

Asian * 8.5 22.2 27.5 28.7 48.0 46.1 50.8 54.3 64.7 85.7 89.1<br />

†Hispanic<br />

†Non-Hispanic<br />

All 12.5 18.8 24.8 28.9 34.1 39.3 44.7 50.3 56.4 67.2 76.6 85.9<br />

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race,<br />

rates by race & ethnicity are adjusted for gender and age.<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.3 A.3 (continued)<br />

Incident rates of of reported diabetic ESRD<br />

per<br />

per<br />

million<br />

million<br />

population,<br />

population,<br />

by<br />

by<br />

demographic<br />

demographic characteristics<br />

characteristics<br />

294<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 * * * * * . * * * * * *<br />

5-9 . * * . . . . . . . * .<br />

10-14 * * . * * * * . . * * .<br />

15-19 0.8 0.7 0.6 * * * * 0.7 * * * *<br />

20-29 15.4 14.5 15.2 13.8 13.0 13.3 11.8 12.0 12.8 12.0 10.4 10.2<br />

30-39 40.2 40.0 41.8 40.9 41.5 40.4 40.6 41.7 42.1 40.1 41.0 40.7<br />

40-49 84.2 87.9 90.4 94.1 95.8 99.1 102.7 100.4 101.9 99.9 101.6 101.2<br />

50-59 207.9 216.6 238.8 248.5 268.3 272.3 280.0 289.4 288.5 289.5 285.9 283.9<br />

60-64 320.3 349.8 390.8 426.4 464.5 488.2 521.5 515.6 518.0 535.8 513.9 503.7<br />

65-69 384.8 397.7 439.8 472.6 540.7 571.2 601.7 627.0 638.5 657.5 655.4 654.6<br />

70-79 298.2 332.8 370.5 419.6 482.1 531.1 564.8 607.2 632.9 642.0 676.1 674.9<br />

80+ 101.6 108.8 132.3 156.9 197.9 236.6 265.5 287.3 318.1 337.6 379.9 368.6<br />

0-19 * * * * * * * * * * * *<br />

20-44 35.6 35.4 36.6 36.9 37.2 37.5 37.5 37.3 38.4 37.3 36.2 36.7<br />

45-64 199.5 210.6 229.4 239.8 254.9 263.3 275.1 278.2 277.7 279.7 277.2 273.4<br />

65-74 363.8 388.0 427.6 468.5 537.9 571.4 599.7 630.6 646.3 661.0 672.6 666.2<br />

75+ 167.2 184.3 214.2 248.7 295.5 346.9 382.1 416.0 446.7 458.8 499.3 496.3<br />

Male 82.5 88.8 96.5 104.4 116.5 125.7 132.9 139.8 145.0 149.5 155.4 155.7<br />

Female 91.8 96.0 106.2 113.3 123.6 129.7 136.7 140.5 143.5 144.3 145.0 144.3<br />

White 69.1 72.9 80.2 84.8 94.0 101.0 105.7 112.2 117.1 118.2 120.8 121.1<br />

Black 203.0 216.2 234.6 257.5 282.4 293.9 313.8 309.6 310.3 322.7 331.1 328.4<br />

Native American 238.4 234.4 241.4 260.5 265.1 270.7 285.8 290.9 285.8 271.6 268.7 261.0<br />

Asian 68.0 76.8 88.9 101.4 106.8 110.0 118.8 126.3 121.9 126.3 125.7 122.8<br />

†Hispanic 144.0 147.3 150.5 157.6 163.2 160.5 163.7 166.5<br />

†Non-Hispanic 117.2 125.3 132.7 137.8 141.5 144.8 148.0 147.2<br />

All 87.2 92.5 101.5 109.0 120.2 127.8 134.8 140.2 144.3 146.8 150.1 149.9<br />

ADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 * * * * * . * * * * * *<br />

5-9 . * * . . . . . . . * .<br />

10-14 * * . * * * * . . * * .<br />

15-19 0.8 0.7 0.6 * * * * 0.7 * * * *<br />

20-29 15.1 14.2 14.8 13.4 12.5 12.9 11.4 11.6 12.7 12.0 10.4 10.2<br />

30-39 40.4 40.0 41.9 40.8 41.4 40.1 40.3 41.3 41.8 39.8 40.8 40.6<br />

40-49 91.7 95.4 98.1 100.7 101.7 104.6 108.1 105.1 106.0 103.2 104.9 103.7<br />

50-59 232.0 243.4 266.3 279.1 301.0 305.8 315.3 324.2 320.8 320.2 314.8 309.4<br />

60-64 360.4 388.6 430.4 471.4 508.2 535.0 571.1 561.3 556.5 581.5 558.2 548.1<br />

65-69 437.8 453.5 493.5 530.5 606.7 635.9 662.5 689.7 697.2 714.8 709.0 709.2<br />

70-79 342.9 385.0 430.9 493.3 558.1 612.6 659.0 693.5 716.3 725.1 767.1 760.0<br />

80+ 123.9 137.4 163.7 197.6 252.1 293.4 330.5 360.7 389.4 404.3 455.2 435.8<br />

0-19 0.2 0.3 0.2 0.1 0.2 0.2 0.1 0.2 0.2 * 0.2 0.1<br />

20-44 36.0 35.6 36.4 36.3 36.2 36.3 36.1 35.8 37.0 35.8 34.9 35.5<br />

45-64 234.7 249.2 272.6 289.5 310.1 320.1 335.2 336.7 333.5 338.2 331.4 324.5<br />

65-74 416.1 447.5 489.3 536.4 612.3 648.0 675.5 703.5 714.4 728.0 742.9 731.8<br />

75+ 179.7 201.1 234.7 279.8 334.2 383.9 430.2 463.7 493.3 505.9 555.9 545.7<br />

Male 94.9 101.8 110.7 119.5 132.7 142.2 149.7 156.4 160.6 164.5 169.8 168.4<br />

Female 91.9 95.8 105.3 112.0 121.0 125.6 131.3 134.1 135.5 135.0 134.1 132.2<br />

White 68.2 71.9 79.0 83.2 91.8 98.3 102.2 107.9 112.2 112.6 114.1 113.6<br />

Black 281.9 301.1 326.3 358.4 393.7 408.7 434.7 425.1 422.3 436.0 444.6 434.6<br />

Native American 392.9 401.9 394.0 434.5 429.1 447.9 470.3 474.4 443.8 408.3 396.7 375.0<br />

Asian 108.4 118.0 138.6 158.2 168.4 165.4 175.5 184.7 175.4 175.3 172.1 162.2<br />

†Hispanic 282.1 290.0 298.8 312.1 319.9 309.8 315.1 312.3<br />

†Non-Hispanic 115.3 122.1 128.4 132.2 134.7 136.9 138.5 136.5<br />

All 93.5 98.8 108.1 115.6 126.5 133.4 139.7 144.1 146.8 148.3 150.1 148.3<br />

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race,<br />

rates by race & ethnicity are adjusted for gender and age.<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


ON OUR WEBSITE & CD<br />

Incident counts of reported ESRD patients, 1998-2000 (A.4.1).<br />

Incident counts of reported ESRD: by primary diagnosis, 2000-2003 (A.4.2).<br />

INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

Table A.4 A.4<br />

Incident counts of of reported ESRD patients, 2001-2003<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender, &<br />

race<br />

race<br />

Male Female All<br />

White Black N Am Asian All White Black N Am Asian All White Black N Am Asian All<br />

0-4 261 60 * 11 337 162 28 * * 200 423 88 * 17 537<br />

5-9 187 55 * * 249 165 34 . * 201 352 89 * * 450<br />

10-14 355 121 * 21 504 287 118 * * 424 642 239 16 31 928<br />

15-19 623 264 * 41 938 437 253 15 36 741 1,060 517 25 77 1,679<br />

20-29 2,252 1,519 61 207 4,039 1,689 1,438 60 166 3,353 3,941 2,957 121 373 7,392<br />

30-39 5,061 4,179 111 339 9,690 3,406 3,051 117 310 6,884 8,467 7,230 228 649 16,574<br />

40-49 10,647 7,844 287 561 19,339 6,926 5,849 261 487 13,523 17,573 13,693 548 1,048 32,862<br />

50-59 18,050 10,063 428 1,083 29,624 13,519 8,734 418 799 23,470 31,569 18,797 846 1,882 53,094<br />

60-64 10,943 4,631 197 642 16,413 8,972 5,119 252 459 14,802 19,915 9,750 449 1,101 31,215<br />

65-69 12,677 4,293 185 634 17,789 10,687 5,482 274 556 16,999 23,364 9,775 459 1,190 34,788<br />

70-79 30,061 6,414 213 1,212 37,900 23,924 9,118 326 1,297 34,665 53,985 15,532 539 2,509 72,565<br />

80+ 16,863 2,431 44 662 20,000 13,612 4,202 77 649 18,540 30,475 6,633 121 1,311 38,540<br />

0-19 1,426 500 23 79 2,028 1,051 433 28 54 1,566 2,477 933 51 133 3,594<br />

20-44 11,768 9,119 313 754 21,954 7,902 6,958 292 689 15,841 19,670 16,077 605 1,443 37,795<br />

45-64 35,185 19,117 771 2,078 57,151 26,610 17,233 816 1,532 46,191 61,795 36,350 1,587 3,610 103,342<br />

65-74 27,508 7,871 312 1,265 36,956 22,542 10,453 464 1,252 34,711 50,050 18,324 776 2,517 71,667<br />

75+ 32,093 5,267 130 1,243 38,733 25,681 8,349 213 1,250 35,493 57,774 13,616 343 2,493 74,226<br />

295<br />

Diabetes 45,232 16,338 1,086 2,529 65,185 39,192 20,669 1,375 2,251 63,487 84,424 37,007 2,461 4,780 128,672<br />

Hypertension 27,865 15,369 153 1,440 44,827 19,932 13,858 133 1,177 35,100 47,797 29,227 286 2,617 79,927<br />

Glomerulonephritis 10,417 3,580 143 743 14,883 6,446 2,680 137 636 9,899 16,863 6,260 280 1,379 24,782<br />

Other cause 24,466 6,587 167 707 31,927 18,216 6,219 168 713 25,316 42,682 12,806 335 1,420 57,243<br />

All 107,980 41,874 1,549 5,419 156,822 83,786 43,426 1,813 4,777 133,802 191,766 85,300 3,362 10,196 290,624<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.5 A.5<br />

Incident rates of of reported ESRD, 2001-2003<br />

per<br />

per<br />

million<br />

million<br />

population,<br />

population,<br />

by<br />

by<br />

age,<br />

age, gender,<br />

gender,<br />

& race<br />

race<br />

ON OUR WEBSITE & CD<br />

Incident rates of reported ESRD, 1998-2000 (A.5.1).<br />

Incident rates of reported ESRD: by primary diagnosis (A.5.2).<br />

296<br />

Unadjusted rates<br />

Rates adjusted for:<br />

Male Female Gender Race Gender &<br />

White Black N Am Asian White Black N Am Asian White Black N Am Asian Male Female race<br />

0-4 11 12 * 8 7 6 * * 9 9 * 6 11 7 9<br />

5-9 8 11 * * 7 7 . * 8 9 * * 8 7 7<br />

10-14 14 23 * 15 12 23 * * 13 23 18 12 15 13 14<br />

15-19 25 55 * 30 19 54 35 28 22 54 29 29 29 24 27<br />

20-29 47 183 79 64 38 164 84 51 43 177 83 57 67 56 61<br />

30-39 97 520 159 99 68 340 171 87 82 427 164 94 153 105 128<br />

40-49 195 1,029 447 203 127 672 388 159 162 859 420 183 311 204 256<br />

50-59 429 2,054 1,019 575 311 1,493 934 368 377 1,815 1,007 486 668 488 576<br />

60-64 764 3,060 1,566 1,075 579 2,647 1,852 682 670 2,851 1,719 877 1,087 868 975<br />

65-69 1,089 3,574 2,086 1,405 809 3,382 2,689 1,004 947 3,476 2,394 1,202 1,439 1,174 1,304<br />

70-79 1,618 4,125 2,021 2,087 988 3,740 2,423 1,627 1,309 3,946 2,226 1,884 1,994 1,395 1,690<br />

80+ 1,839 3,631 1,087 2,696 776 2,836 1,059 1,773 1,273 3,175 1,000 2,188 2,048 1,087 1,560<br />

0-19 15 25 13 15 11 22 17 10 13 24 15 12 16 13 14<br />

20-44 92 447 172 93 64 312 166 82 75 379 172 88 138 96 117<br />

45-64 425 1,919 913 550 312 1,451 907 355 405 1,878 1,052 520 699 523 609<br />

65-74 1,255 3,742 2,052 1,605 872 3,525 2,589 1,237 1,067 3,652 2,315 1,448 1,618 1,258 1,435<br />

75+ 1,837 3,983 1,576 2,539 882 3,242 1,639 1,774 1,326 3,471 1,405 2,150 2,095 1,208 1,644<br />

Diabetes 130 303 236 136 110 349 298 114 113 438 393 170 281 229 254<br />

Hypertension 80 285 33 77 56 234 29 60 63 349 51 101 255 150 201<br />

Glomerulonephritis 30 66 31 40 18 45 30 32 23 64 36 41 53 29 41<br />

Other cause 70 122 36 38 51 105 36 36 12 28 10 9 28 16 22<br />

All 311 778 337 291 235 734 393 243 273 755 365 266 369 305 336<br />

All (age adjusted) 325 1,108 508 427 207 887 550 304 257 990 532 357 411 280 336<br />

Rates by age are adjusted for gender & race.<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


ON OUR WEBSITE & CD<br />

Median age at start of ESRD therapy; incident patients by demographic<br />

characteristics & primary diagnosis (A.c).<br />

INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

Table A.6 A.6<br />

Mean age at start of ESRD therapy<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics & primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992<br />

0-4 2.4 2.4 2.1 2.1 2.0 1.8 1.8 1.8 1.6 2.0 1.7 1.6 1.6<br />

5-9 7.9 7.9 7.5 7.9 7.8 7.6 7.7 7.7 7.8 7.8 7.8 7.6 7.6<br />

10-14 12.6 12.9 12.9 12.7 12.8 12.9 12.7 12.6 12.7 13.0 12.7 12.8 12.8<br />

15-19 17.7 17.8 17.7 17.8 17.8 17.7 17.8 17.7 17.7 17.8 17.8 17.9 17.9<br />

20-29 25.5 25.6 25.6 25.8 25.7 25.7 25.9 25.8 25.8 26.0 25.9 25.9 25.8<br />

30-39 34.9 35.0 34.9 35.0 35.0 35.2 35.2 35.2 35.3 35.2 35.3 35.3 35.4<br />

40-49 45.3 45.2 45.2 45.3 45.3 45.2 45.2 45.2 45.1 45.2 45.1 45.2 45.2<br />

50-59 55.3 55.4 55.3 55.4 55.4 55.5 55.4 55.4 55.4 55.4 55.4 55.4 55.3<br />

60-64 62.5 62.5 62.5 62.5 62.5 62.6 62.6 62.6 62.6 62.6 62.6 62.6 62.6<br />

65-69 67.4 67.5 67.5 67.5 67.5 67.4 67.4 67.4 67.5 67.5 67.5 67.5 67.5<br />

70-79 74.1 74.1 74.1 74.2 74.3 74.3 74.5 74.4 74.5 74.6 74.5 74.5 74.5<br />

80+ 83.4 83.5 84.1 83.6 83.6 83.6 83.7 83.5 83.6 83.7 83.8 83.8 83.8<br />

0-19 14.3 14.2 13.5 13.6 13.2 13.0 13.0 12.9 13.2 13.1 13.0 12.6 13.1<br />

20-44 33.7 33.9 33.7 34.1 34.0 34.2 34.4 34.7 34.7 34.8 35.1 35.3 35.3<br />

45-64 56.0 56.1 56.2 56.4 56.5 56.6 56.5 56.5 56.5 56.4 56.5 56.5 56.3<br />

65-74 69.5 69.6 69.7 69.7 69.7 69.8 69.8 69.7 69.8 69.7 69.8 69.8 69.9<br />

75+ 79.2 79.3 79.5 79.5 79.5 79.6 79.7 79.7 79.8 79.9 80.0 80.0 80.1<br />

297<br />

Male 52.4 52.2 52.8 54.7 54.6 55.3 55.8 56.2 56.5 57.1 57.5 58.1 58.5<br />

Female 53.3 53.4 53.9 56.1 56.2 56.9 57.4 58.1 58.1 58.8 59.2 59.9 60.2<br />

Unknown . 33.1 . 46.4 30.6 34.9 45.9 35.7 42.3 . . 59.3 62.2<br />

White 53.1 53.1 53.8 55.8 56.0 56.8 57.4 58.1 58.6 59.4 59.7 60.5 61.0<br />

Black 52.2 52.0 52.5 54.4 54.1 54.6 54.9 54.9 54.7 55.0 55.4 55.9 56.0<br />

Native American 49.4 50.8 50.8 53.0 52.2 53.0 53.5 54.5 55.2 56.4 55.4 56.2 56.2<br />

Asian 42.2 45.8 48.0 51.3 52.3 52.7 52.4 53.5 53.6 54.0 55.8 56.9 56.7<br />

Other/unknown 55.6 56.4 51.0 53.2 52.2 50.0 53.1 50.7 49.8 52.0 47.3 47.8 51.0<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 51.1 52.1 53.0 54.0 54.5 54.9 55.6 56.5 57.1 57.5 58.4 59.1 59.5<br />

Hypertension 56.4 58.3 59.4 60.9 61.0 61.9 62.6 63.2 63.0 63.7 64.1 64.4 64.5<br />

Glomerulonephritis 44.9 46.6 47.2 48.5 49.2 50.2 50.3 50.5 50.5 51.3 51.3 52.3 52.0<br />

Cystic kidney 51.7 52.6 52.9 53.6 53.6 53.7 53.6 54.1 53.9 53.3 54.3 53.7 54.6<br />

Other urologic 51.3 55.3 54.0 57.4 58.1 58.4 58.7 59.5 59.8 60.3 58.8 59.6 59.9<br />

Other cause 46.5 48.3 49.0 49.4 49.6 50.8 51.6 51.2 51.1 51.9 51.3 51.6 52.3<br />

Unknown cause 55.0 56.8 56.3 58.6 59.5 58.7 59.3 59.6 59.4 58.9 58.5 58.9 59.1<br />

Missing disease 58.0 53.3 53.1 63.2 62.0 61.1 58.8 55.0 52.9 53.6 51.5 53.6 52.3<br />

U.S. 52.8 52.7 53.3 55.4 55.4 56.1 56.6 57.2 57.4 58.0 58.4 59.0 59.4<br />

U.S. territories 48.2 44.2 54.7 52.5 51.6 53.0 55.0 53.8 51.2 53.4 53.7 56.3 52.9<br />

Puerto Rico 54.4 54.7 52.1 55.0 55.0 56.1 55.9 55.5 57.3 58.7 57.6 56.8 58.8<br />

Foreign 52.3 47.9 52.0 51.0 55.9 50.5 54.7 58.9 45.6 49.7 49.5 45.1 48.9<br />

Unknown 53.0 55.3 53.0 50.3 48.8 49.8 51.1 44.1 44.1 44.9 47.7 49.3 49.3<br />

All 52.8 52.8 53.3 55.3 55.3 56.0 56.5 57.1 57.2 57.9 58.3 59.0 59.3<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients with unknown age are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.6 A.6 (continued)<br />

Mean age at start of ESRD therapy<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics & primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

298<br />

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 1.8 1.6 1.7 1.9 1.9 1.4 1.6 1.6 1.7 1.7 1.7<br />

5-9 7.6 7.8 7.6 7.6 7.9 8.0 7.9 7.6 7.6 7.7 7.6<br />

10-14 12.8 13.0 12.8 12.9 12.8 12.7 12.8 12.6 12.8 12.8 12.8<br />

15-19 17.7 17.7 17.7 17.8 17.7 17.7 17.8 17.8 17.8 17.8 17.7<br />

20-29 25.8 25.8 25.8 25.8 25.9 25.9 25.8 25.9 25.8 25.7 25.6<br />

30-39 35.4 35.4 35.5 35.5 35.5 35.5 35.6 35.5 35.5 35.6 35.5<br />

40-49 45.2 45.3 45.3 45.4 45.4 45.4 45.5 45.5 45.5 45.6 45.5<br />

50-59 55.3 55.3 55.3 55.3 55.3 55.2 55.2 55.2 55.2 55.3 55.2<br />

60-64 62.6 62.6 62.6 62.6 62.6 62.6 62.6 62.6 62.6 62.5 62.5<br />

65-69 67.5 67.5 67.5 67.5 67.5 67.5 67.6 67.5 67.5 67.6 67.5<br />

70-79 74.5 74.5 74.6 74.6 74.7 74.8 74.9 74.9 74.9 74.9 75.0<br />

80+ 83.8 83.8 83.9 84.0 84.1 84.2 84.3 84.3 84.3 84.3 84.4<br />

0-19 12.7 13.0 12.9 12.9 12.9 12.8 13.0 12.7 12.7 12.7 12.8<br />

20-44 35.4 35.4 35.7 35.9 35.9 36.0 36.1 36.1 36.1 36.2 36.2<br />

45-64 56.2 56.1 56.1 56.1 56.1 56.0 56.0 56.0 56.0 56.0 56.0<br />

65-74 69.9 70.0 70.0 70.1 70.1 70.1 70.1 70.1 70.1 70.1 70.1<br />

75+ 80.2 80.2 80.3 80.4 80.5 80.6 80.7 80.8 80.9 81.0 81.1<br />

Male 58.6 59.1 59.2 60.1 60.7 60.9 61.4 61.4 61.6 62.1 62.1<br />

Female 60.5 60.9 61.2 61.6 62.3 62.4 62.6 63.0 63.1 63.6 63.5<br />

Unknown 53.0 58.5 58.7 67.3 . . 42.7 39.8 . 57.9 64.7<br />

White 61.3 61.9 62.2 62.8 63.4 63.6 64.0 64.2 64.4 64.9 64.9<br />

Black 56.0 56.2 56.2 56.8 57.5 57.8 57.7 58.2 58.4 58.6 58.6<br />

Native American 57.2 55.8 56.1 56.1 57.6 57.1 57.6 58.0 56.4 57.4 58.0<br />

Asian 57.5 59.2 60.1 61.0 60.3 61.2 61.8 61.4 61.3 62.2 62.5<br />

Other/unknown 52.7 51.1 56.9 57.2 57.7 56.2 56.9 55.5 55.1 54.7 53.8<br />

†Hispanic 57.9 58.1 58.4 58.8 58.4 58.4 58.7 58.7<br />

†Non-Hispanic 61.2 61.9 62.0 62.4 62.7 62.8 63.3 63.3<br />

Diabetes 59.9 60.3 60.9 61.6 62.0 62.3 62.6 62.8 63.0 63.3 63.2<br />

Hypertension 65.0 65.1 65.4 65.8 66.5 66.6 66.9 67.1 67.1 67.6 67.5<br />

Glomerulonephritis 52.1 53.2 53.0 53.8 53.8 53.7 54.3 53.8 53.5 54.1 53.8<br />

Cystic kidney 54.3 55.1 54.2 54.8 55.0 54.6 55.1 55.1 54.9 55.3 54.4<br />

Other urologic 57.5 58.2 59.4 61.1 60.7 61.4 61.5 62.2 62.1 61.6 63.0<br />

Other cause 52.2 52.8 53.2 53.7 54.8 55.1 55.0 55.7 55.9 56.9 56.9<br />

Unknown cause 57.6 58.8 61.1 61.4 62.9 62.4 63.4 63.2 63.1 63.0 63.2<br />

Missing disease 59.8 49.8 50.6 49.6 51.2 50.1 49.1 49.7 48.7 55.7 55.4<br />

U.S. 59.6 60.0 60.2 60.8 61.5 61.7 62.0 62.2 62.3 62.8 62.8<br />

U.S. territories 56.4 55.5 54.9 55.7 55.9 57.4 58.8 58.6 58.8 56.9 58.0<br />

Puerto Rico 58.8 58.4 58.0 59.5 60.5 59.6 60.9 60.1 60.6 60.7 61.1<br />

Foreign 45.1 48.4 48.5 48.9 51.1 53.0 61.0 54.9 63.9 58.0 71.8<br />

Unknown 48.4 48.2 47.0 36.6 41.7 44.1 36.2 44.1 40.7 38.1 41.1<br />

All 59.5 59.9 60.1 60.8 61.4 61.6 62.0 62.2 62.3 62.8 62.7<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients with unknown age are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


ON OUR WEBSITE & CD<br />

Incidence of reported ESRD, by primary diagnosis: Hispanics & non-Hispanic<br />

(A.7.1-2). Incidence of reported ESRD: by detailed primary diagnosis, age


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.7 A.7 (continued)<br />

Incidence of of reported ESRD, by by primary diagnosis: all patients<br />

1999-2003<br />

1999-2003<br />

combined,<br />

combined,<br />

by<br />

by<br />

detailed<br />

detailed<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

300<br />

Total Counts<br />

Percent<br />

COLUMN PERCENT Patients White Black N Am Asian White Black N Am Asian<br />

All ESRD (reference) 484,998 315,360 138,749 5,632 16,950 100.0 100.0 100.0 100.0<br />

Diabetes 215,733 139,620 59,957 4,142 8,057 44.6 43.4 73.6 47.7<br />

Type I, juvenile type 20,518 15,269 4,403 214 369 4.9 3.2 3.8 2.2<br />

Type II, adult-onset or unspecified type 195,215 124,351 55,554 3,928 7,688 39.7 40.2 69.8 45.5<br />

Glomerulonephritis 41,097 27,370 10,147 425 2,314 8.7 7.4 7.6 13.7<br />

Focal glomerulosclerosis, focal GN 11,037 6,422 4,088 68 313 2.0 3.0 1.2 1.9<br />

Membranous nephropathy 2,181 1,555 521 18 56 0.5 0.4 0.3 0.3<br />

Membranoproliferative GN, types I & II 1,665 1,218 320 25 72 0.4 0.2 0.4 0.4<br />

IgA nephropathy, Berger's disease 3,661 2,751 263 64 500 0.9 0.2 1.1 3.0<br />

IgM nephropathy 423 314 44 * 57 0.1 . 0.1 0.3<br />

Rapidly progressive GN 1,642 1,326 220 20 49 0.4 0.2 0.4 0.3<br />

Goodpasture's Syndrome 579 528 36 * * 0.2 . 0.1 .<br />

Post infectious GN, SBE 443 363 61 * * 0.1 . 0.1 0.1<br />

Glomerulonephritis (GN) 18,170 11,945 4,331 203 1,207 3.8 3.1 3.6 7.2<br />

Other proliferative GN 1,296 948 263 12 44 0.3 0.2 0.2 0.3<br />

Secondary GN/vasculitis 10,412 6,449 3,339 102 337 2.1 2.4 1.8 2.0<br />

Lupus erythematosus (SLE nephritis) 5,301 2,316 2,551 50 256 0.7 1.8 0.9 1.5<br />

Polyarteritis 253 205 39 * * 0.1 . 0.1 .<br />

Wegeners granulomatosis 1,261 1,160 68 * 12 0.4 . 0.1 0.1<br />

Henoch-Schonlein syndrome 164 139 17 * * . . 0.1 .<br />

Vasculitis and its derivatives 1,097 947 96 20 21 0.3 0.1 0.4 0.1<br />

Scleroderma 840 662 147 * 14 0.2 0.1 0.1 0.1<br />

Hemolytic uremic syndrome 755 580 144 * 11 0.2 0.1 0.1 0.1<br />

Nephropathy from heroin /related abuse 213 81 127 . * . 0.1 . .<br />

Secondary GN, other 528 359 150 * 12 0.1 0.1 0.1 0.1<br />

Interstitial nephritis/pyelonephritis 17,582 14,319 2,438 108 466 4.6 1.8 1.9 2.8<br />

Chronic pyelonephritis, reflux neph. 2,231 1,913 187 23 64 0.6 0.1 0.4 0.4<br />

Analgesic abuse 955 785 130 * 23 0.3 0.1 0.1 0.1<br />

Nephropathy caused by other agents 2,954 2,437 425 16 43 0.8 0.3 0.3 0.3<br />

Nephrolithiasis, obstruction, gouty 6,116 4,839 958 29 188 1.5 0.7 0.5 1.1<br />

Nephrocalcinosis 316 260 36 * 11 0.1 . . 0.1<br />

Chronic interstitial nephritis 4,074 3,295 588 30 118 1.1 0.4 0.5 0.7<br />

Acute interstitial nephritis 936 790 114 * 19 0.3 0.1 0.1 0.1<br />

Hypertensive/large vessel disease 130,704 77,174 47,283 488 4,229 24.6 34.3 8.7 25.1<br />

Hypertension (no primary renal disease) 117,439 64,883 46,587 441 4,066 20.7 33.7 7.8 24.1<br />

<strong>Renal</strong> artery stenosis or occlusion 9,213 8,450 578 29 110 2.7 0.4 0.5 0.7<br />

Cholesterol emboli, renal emboli 4,052 3,841 118 18 53 1.2 0.1 0.3 0.3<br />

Cystic/hereditary/congenital diseases 15,206 12,508 1,966 85 370 4.0 1.4 1.5 2.2<br />

Polycystic kidneys, adult (dominant) 10,722 8,913 1,352 40 267 2.8 1.0 0.7 1.6<br />

Polycystic kidneys, infantile (recessive) 225 179 26 * * 0.1 . 0.1 .<br />

Medullary cystic, including nephronophthisis 222 187 19 * 10 0.1 . . 0.1<br />

Alport's, other hereditary/familial disease 1,048 912 84 * 31 0.3 0.1 0.1 0.2<br />

Tuberous sclerosis 167 130 29 * * . . . .<br />

Cystinosis 81 66 * * * . . . .<br />

Primary oxalosis 38 32 * * * . . . .<br />

Fabrys disease 83 78 * . . . . . .<br />

Congenital nephrotic syndrome 289 209 56 * 12 0.1 . . 0.1<br />

Drash syndrome, mesangial sclerosis 42 30 * . * . . . .<br />

Congenital obstructive uropathy 1,245 971 201 15 19 0.3 0.1 0.3 0.1<br />

<strong>Renal</strong> hypoplasia, dysplasia 914 707 143 11 19 0.2 0.1 0.2 0.1<br />

Prune belly syndrome 130 94 33 * * . . . .<br />

Neoplasms/tumors 10,094 7,894 1,901 50 143 2.5 1.4 0.9 0.8<br />

<strong>Renal</strong> or urological neoplasms 2,846 2,282 494 12 24 0.7 0.4 0.2 0.1<br />

Multiple myeloma 5,390 4,077 1,149 25 90 1.3 0.8 0.4 0.5<br />

Light chain nephropathy 631 514 98 * 10 0.2 0.1 0.1 0.1<br />

Amyloidosis 1,227 1,021 160 * 19 0.3 0.1 0.2 0.1<br />

Miscellaneous conditions 21,301 13,772 6,803 100 310 4.4 4.9 1.8 1.8<br />

Complication post bone marrow/other txp 684 599 63 * * 0.2 . 0.1 0.1<br />

Sickle cell disease/anemia or trait 521 31 485 * * . 0.4 . .<br />

AIDS nephropathy 4,258 336 3,837 * * 0.1 2.8 0.1 .<br />

Traumatic/surgical loss of kidney(s) 527 427 85 . * 0.1 0.1 . .<br />

Hepatorenal syndrome 1,205 987 148 25 24 0.3 0.1 0.4 0.1<br />

Tubular necrosis (no recovery) 8,124 6,607 1,243 44 115 2.1 0.9 0.8 0.7<br />

Post-partum failure, other renal disorders 5,982 4,785 942 23 145 1.5 0.7 0.4 0.9<br />

Etiology uncertain 19,646 14,206 4,213 127 654 4.5 3.1 2.3 3.9<br />

Missing 3,223 2,048 702 * 70 0.7 0.5 0.1 0.4<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


ON OUR WEBSITE & CD<br />

Incident counts of reported ESRD patients, by diabetic status & state: U.S.<br />

only, with unknowns dropped (A.8.1).<br />

INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

Table A.8 A.8<br />

Incident counts of reported ESRD patients, by diabetic status & state/territory: all patients<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992<br />

Alabama 332 372 401 526 505 546 573 674 793 1,022 939 1,053 1,186<br />

Alaska * * 13 17 13 14 34 24 32 46 34 48 50<br />

Arizona 268 300 342 416 425 472 557 656 655 768 789 881 1,100<br />

Arkansas 140 162 176 236 261 275 296 372 386 420 419 519 551<br />

California 1,866 2,267 2,440 2,905 3,009 3,324 3,794 4,041 4,521 5,061 5,670 6,186 6,463<br />

Colorado 186 200 209 208 246 266 329 340 358 429 434 490 535<br />

Connecticut 226 232 283 371 351 484 457 488 502 578 624 704 707<br />

Delaware 45 57 83 64 67 95 92 107 133 142 145 193 203<br />

District of Columbia 120 128 175 169 164 206 170 196 191 283 274 329 352<br />

Florida 1,141 1,226 1,309 1,481 1,676 1,818 2,116 2,414 2,579 2,949 3,111 3,512 3,881<br />

Georgia 484 641 633 773 797 815 954 1,084 1,319 1,413 1,497 1,776 1,961<br />

Hawaii 85 101 101 115 125 177 176 206 217 235 279 273 293<br />

Idaho 51 45 59 63 69 83 87 96 101 138 142 135 128<br />

Illinois 827 969 1,121 1,271 1,315 1,520 1,619 1,730 1,789 1,972 2,304 2,729 2,766<br />

Indiana 336 412 451 551 538 598 609 719 826 865 1,003 1,102 1,234<br />

Iowa 176 189 203 240 227 266 317 283 325 380 439 457 526<br />

Kansas 127 142 198 187 213 219 252 276 297 367 403 412 449<br />

Kentucky 235 249 272 281 323 371 406 460 483 542 668 762 836<br />

Louisiana 324 403 425 478 555 603 687 774 1,058 1,058 1,107 1,240 1,414<br />

Maine 40 83 63 76 110 94 109 120 120 108 146 146 158<br />

Maryland 314 391 439 465 541 588 576 751 771 959 1,063 1,247 1,329<br />

Massachusetts 398 343 483 589 579 586 641 688 788 870 933 1,053 1,206<br />

Michigan 765 803 884 946 1,096 1,127 1,231 1,321 1,510 1,743 1,804 1,991 2,225<br />

Minnesota 259 294 312 317 400 436 462 557 549 596 690 743 804<br />

Mississippi 212 198 244 342 329 356 384 423 486 610 652 671 785<br />

Missouri 334 361 441 469 551 614 664 764 832 893 1,017 1,098 1,207<br />

Montana 30 59 41 68 73 64 66 79 76 112 122 138 126<br />

Nebraska 88 115 102 110 118 141 146 176 198 221 220 260 300<br />

Nevada 89 82 83 102 106 126 175 166 184 185 211 248 251<br />

New Hampshire 52 72 62 70 70 86 84 101 113 130 125 139 151<br />

New Jersey 781 769 883 1,034 966 1,176 1,219 1,353 1,414 1,655 1,786 1,990 2,177<br />

New Mexico 124 104 132 155 162 177 191 214 269 267 288 351 355<br />

New York 1,466 1,623 1,789 2,058 2,245 2,395 2,697 2,826 3,174 3,418 3,869 4,028 4,546<br />

North Carolina 504 519 608 698 722 903 937 1,061 1,160 1,357 1,451 1,689 1,867<br />

North Dakota 26 42 40 40 51 57 74 65 79 103 99 99 128<br />

Ohio 708 809 952 1,060 1,117 1,258 1,350 1,468 1,711 1,851 2,246 2,324 2,546<br />

Oklahoma 203 222 242 263 301 303 371 404 485 506 596 580 675<br />

Oregon 127 153 179 221 214 250 305 312 359 400 415 509 482<br />

Pennsylvania 945 1,009 1,142 1,302 1,492 1,714 1,793 1,853 2,065 2,292 2,693 2,791 3,028<br />

Rhode Island 76 79 75 103 119 124 101 118 133 167 182 208 206<br />

South Carolina 270 336 365 425 460 548 564 625 763 829 934 1,008 1,089<br />

South Dakota 42 58 55 55 73 75 62 92 96 97 92 101 119<br />

Tennessee 335 350 415 534 469 561 582 744 748 1,118 1,077 1,169 1,269<br />

Texas 1,072 1,271 1,517 1,737 1,710 1,943 2,174 2,407 2,754 3,170 3,584 3,925 4,429<br />

Utah 92 116 99 96 148 120 140 146 193 184 194 192 211<br />

Vermont 36 27 36 37 36 45 36 47 53 61 66 83 64<br />

Virginia 503 518 593 730 736 764 818 935 1,042 1,110 1,221 1,488 1,642<br />

Washington 241 243 281 330 371 407 455 493 523 651 688 747 793<br />

West Virginia 118 122 154 190 217 196 236 241 298 278 302 365 392<br />

Wisconsin 311 337 418 381 460 474 532 647 726 773 782 892 984<br />

Wyoming 15 28 32 24 27 44 28 42 46 49 34 45 46<br />

301<br />

American Samoa * * * * * * * * * 13 * * 13<br />

Guam * * * * * * 12 * 19 19 28 36 43<br />

Puerto Rico 235 245 299 300 377 387 403 425 489 576 583 665 785<br />

Saipan . . . . * * . * * * * * 11<br />

Virgin Islands * * 11 * * 13 * 17 15 14 19 20 30<br />

Foreign * 14 * 13 13 20 13 15 19 20 43 38 32<br />

Unknown 209 189 207 224 229 263 299 297 454 384 378 282 179<br />

All 18,017 20,102 22,587 25,935 27,581 30,604 33,471 36,951 41,292 46,462 50,926 56,173 61,318<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.8 A.8 (continued)<br />

Incident counts of reported ESRD patients, by diabetic status & state/territory: all patients<br />

302<br />

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Alabama 1,197 1,297 1,374 1,501 1,659 1,596 1,700 1,754 1,791 1,816 1,859<br />

Alaska 45 136 219 69 81 66 72 87 91 80 98<br />

Arizona 1,144 1,125 1,226 1,302 1,391 1,535 1,634 1,697 1,760 1,795 1,886<br />

Arkansas 593 695 731 724 825 763 830 849 875 938 917<br />

California 6,985 7,938 8,037 8,540 9,109 9,854 10,418 10,773 11,125 11,897 12,089<br />

Colorado 558 576 556 672 689 781 762 783 783 848 828<br />

Connecticut 748 863 847 901 916 942 991 1,018 958 994 962<br />

Delaware 192 219 236 229 230 246 279 291 273 310 349<br />

District of Columbia 374 357 394 392 404 407 417 455 432 445 451<br />

Florida 3,934 4,256 4,343 4,881 5,101 5,177 5,549 5,748 5,970 6,250 6,344<br />

Georgia 1,981 2,178 2,293 2,504 2,511 2,682 2,977 3,151 3,209 3,302 3,359<br />

Hawaii 328 407 391 386 424 450 481 508 467 507 489<br />

Idaho 141 174 191 213 226 218 259 253 282 259 267<br />

Illinois 3,101 3,386 3,551 3,903 3,850 4,108 4,331 4,372 4,502 4,890 4,698<br />

Indiana 1,308 1,333 1,402 1,542 1,615 1,829 1,802 1,898 1,920 2,026 2,001<br />

Iowa 546 576 542 612 616 662 788 707 739 787 750<br />

Kansas 438 501 494 575 657 660 676 688 658 720 724<br />

Kentucky 831 881 903 971 1,044 1,143 1,231 1,229 1,274 1,270 1,330<br />

Louisiana 1,400 1,525 1,602 1,620 1,847 2,007 2,133 2,015 2,181 2,323 2,385<br />

Maine 177 194 226 215 265 268 258 297 296 312 326<br />

Maryland 1,422 1,544 1,720 1,828 1,903 2,090 2,117 2,206 2,252 2,340 2,380<br />

Massachusetts 1,345 1,396 1,372 1,509 1,572 1,629 1,599 1,696 1,621 1,698 1,777<br />

Michigan 2,395 2,452 2,543 2,923 2,917 3,131 3,208 3,330 3,489 3,655 3,616<br />

Minnesota 830 882 847 940 1,000 1,055 1,053 1,092 1,212 1,232 1,183<br />

Mississippi 854 941 915 1,025 1,091 1,135 1,196 1,144 1,230 1,336 1,323<br />

Missouri 1,296 1,383 1,439 1,522 1,634 1,797 1,820 1,877 1,918 1,839 1,981<br />

Montana 147 141 162 157 145 154 194 165 208 172 190<br />

Nebraska 296 315 330 357 409 428 466 490 529 483 490<br />

Nevada 303 374 356 377 413 455 565 548 616 621 728<br />

New Hampshire 156 183 182 167 206 222 253 271 246 273 282<br />

New Jersey 2,333 2,502 2,627 2,642 2,874 3,046 3,256 3,137 3,277 3,334 3,390<br />

New Mexico 377 373 428 476 488 474 555 571 561 547 600<br />

New York 4,936 5,001 5,113 5,507 5,844 6,081 6,272 6,535 6,623 6,798 6,913<br />

North Carolina 2,009 2,195 2,135 2,420 2,640 2,826 2,814 3,039 3,091 3,138 3,207<br />

North Dakota 127 148 118 140 136 137 136 161 187 182 164<br />

Ohio 2,603 2,911 3,003 3,440 3,441 3,749 3,985 4,264 4,184 4,361 4,482<br />

Oklahoma 729 755 781 827 948 1,037 1,035 1,073 1,124 1,137 1,259<br />

Oregon 552 568 571 604 641 672 718 740 786 855 902<br />

Pennsylvania 3,077 3,495 3,589 3,951 4,136 4,213 4,424 4,547 4,460 4,781 4,492<br />

Rhode Island 238 266 232 275 270 285 310 328 315 324 338<br />

South Carolina 1,130 1,324 1,235 1,385 1,459 1,596 1,656 1,600 1,678 1,641 1,826<br />

South Dakota 138 145 181 197 200 208 215 244 217 253 253<br />

Tennessee 1,263 1,453 1,504 1,569 1,709 1,784 1,973 1,897 1,850 2,000 2,055<br />

Texas 4,546 4,816 4,974 5,532 5,805 6,249 6,632 6,889 7,100 7,411 7,771<br />

Utah 261 254 270 263 270 347 345 335 403 373 365<br />

Vermont 83 80 101 111 111 117 128 122 101 132 139<br />

Virginia 1,684 1,796 1,902 2,071 2,343 2,341 2,440 2,272 2,472 2,685 2,675<br />

Washington 837 938 952 999 1,050 1,109 1,230 1,323 1,301 1,419 1,462<br />

West Virginia 420 461 492 532 616 659 649 701 725 703 709<br />

Wisconsin 965 1,053 1,068 1,168 1,229 1,359 1,320 1,390 1,468 1,591 1,633<br />

Wyoming 51 44 66 70 70 75 82 87 85 80 89<br />

American Samoa * 14 * 12 * * 20 21 18 15 20<br />

Guam 40 44 50 63 69 67 73 67 83 96 93<br />

Puerto Rico 800 858 853 938 963 1,040 1,115 1,108 1,154 1,224 1,295<br />

Saipan * * 14 14 18 22 14 18 * 17 19<br />

Virgin Islands 22 23 32 30 43 41 37 31 39 46 43<br />

Foreign 42 43 33 31 31 39 26 39 28 27 16<br />

Unknown 150 172 36 36 40 49 41 35 33 37 295<br />

All 64,492 69,968 71,791 77,860 82,203 87,121 91,560 93,966 96,280 100,625 102,567<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


Table A.8 A.8 (continued)<br />

Incident counts of reported ESRD patients, by diabetic status & state/territory: diabetic patients<br />

INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

Alabama 26 42 62 89 104 120 143 183 190 288 298 350<br />

Alaska * * * * * * 11 * * 21 11 14<br />

Arizona 64 85 116 144 167 181 236 296 287 363 354 439<br />

Arkansas * 25 31 53 62 74 84 120 105 134 130 186<br />

California 211 463 597 723 814 1,040 1,216 1,259 1,433 1,880 2,080 2,388<br />

Colorado 38 42 51 69 81 96 137 135 156 183 189 213<br />

Connecticut 29 60 64 93 112 150 138 148 147 185 212 245<br />

Delaware * 12 16 * 17 25 29 29 51 59 52 70<br />

District of Columbia * 24 43 35 48 70 57 53 48 70 86 95<br />

Florida 126 203 267 298 368 427 585 657 682 810 929 1,047<br />

Georgia 53 127 154 150 191 222 268 340 359 440 503 558<br />

Hawaii 23 36 32 34 28 58 75 106 99 107 145 144<br />

Idaho * * 16 22 19 16 28 36 36 50 49 41<br />

Illinois 141 191 254 294 335 446 464 517 523 620 767 925<br />

Indiana 43 83 78 130 131 154 159 225 252 259 361 413<br />

Iowa 27 52 54 69 68 85 105 67 104 130 134 147<br />

Kansas 24 32 53 52 67 63 59 78 99 106 135 162<br />

Kentucky 38 46 49 80 105 95 112 146 143 176 237 281<br />

Louisiana 31 60 77 76 133 131 186 211 312 357 365 467<br />

Maine * 11 15 17 21 24 25 40 35 33 42 47<br />

Maryland 37 76 93 115 137 181 159 213 215 313 382 454<br />

Massachusetts 62 85 100 105 116 122 154 160 189 264 302 359<br />

Michigan 176 209 230 255 291 336 417 403 504 612 703 790<br />

Minnesota 71 84 99 121 158 144 168 202 192 241 264 286<br />

Mississippi 25 36 44 52 79 80 98 108 148 178 229 256<br />

Missouri 19 74 121 103 137 181 177 216 240 281 327 382<br />

Montana * 12 * 15 24 22 17 27 33 52 59 62<br />

Nebraska 16 33 28 35 32 38 46 58 66 83 80 103<br />

Nevada 19 17 22 17 23 26 44 60 54 70 81 91<br />

New Hampshire * * 11 15 16 20 20 28 35 42 41 45<br />

New Jersey 114 159 198 241 240 311 350 378 442 497 641 692<br />

New Mexico 27 33 43 69 67 61 88 108 135 135 130 202<br />

New York 202 315 392 485 595 627 795 851 996 1,038 1,252 1,367<br />

North Carolina 68 78 127 150 179 242 240 323 332 419 509 610<br />

North Dakota * * * 17 21 18 25 24 36 52 43 39<br />

Ohio 143 203 262 283 333 396 435 509 591 670 817 874<br />

Oklahoma 25 40 66 82 91 101 132 145 210 194 257 265<br />

Oregon 20 27 55 57 50 69 88 101 118 132 142 165<br />

Pennsylvania 174 191 258 304 432 448 518 569 647 740 917 1,026<br />

Rhode Island * 14 14 15 20 24 21 36 47 45 57 56<br />

South Carolina 41 51 78 89 127 167 156 198 224 267 308 372<br />

South Dakota * 23 12 19 29 32 26 37 47 36 32 52<br />

Tennessee 34 47 76 98 116 132 135 201 215 333 349 379<br />

Texas 158 267 398 422 545 633 697 812 1,006 1,333 1,541 1,683<br />

Utah 33 35 32 38 59 53 66 67 84 66 91 87<br />

Vermont * * 14 * * 16 * 15 * 25 21 32<br />

Virginia 59 73 124 169 184 172 223 248 310 342 374 477<br />

Washington 43 41 62 71 100 140 120 133 191 227 239 289<br />

West Virginia 19 22 32 54 56 53 82 77 92 94 112 131<br />

Wisconsin 77 84 126 118 159 147 185 226 237 281 305 359<br />

Wyoming * * 11 * * 21 * 16 15 23 12 14<br />

303<br />

American Samoa . * * . . * * * * * * *<br />

Guam * . * * * * * * * 11 13 20<br />

Puerto Rico 39 54 83 101 140 137 166 197 212 288 282 352<br />

Saipan . . . . * . . * * * * *<br />

Virgin Islands . * * * * * * * * * * *<br />

Foreign . . * . * * * * . * * *<br />

Unknown 23 21 45 48 55 66 94 68 108 98 129 96<br />

All 2,690 4,043 5,308 6,218 7,513 8,708 10,092 11,477 13,072 15,770 18,138 20,720<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.8 A.8 (continued)<br />

Incident counts of reported ESRD patients, by diabetic status & state/territory: diabetic patients<br />

304<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Alabama 410 437 484 537 598 721 673 760 779 819 779 816<br />

Alaska 15 23 44 85 33 44 31 38 37 46 37 41<br />

Arizona 537 573 557 637 646 740 797 843 903 924 948 973<br />

Arkansas 178 205 230 281 302 318 303 336 356 370 405 402<br />

California 2,553 2,690 3,262 3,443 3,771 4,285 4,551 4,851 5,168 5,156 5,535 5,583<br />

Colorado 230 256 233 262 333 316 382 360 386 372 408 393<br />

Connecticut 246 267 331 334 349 417 381 425 451 384 415 449<br />

Delaware 58 73 76 78 82 89 98 123 128 109 128 150<br />

District of Columbia 123 116 116 142 164 148 148 153 162 163 164 171<br />

Florida 1,203 1,275 1,426 1,543 1,793 1,961 1,961 2,202 2,328 2,485 2,504 2,603<br />

Georgia 683 685 785 925 1,082 1,052 1,126 1,242 1,343 1,354 1,445 1,430<br />

Hawaii 151 194 231 231 239 248 266 270 311 291 306 292<br />

Idaho 61 57 76 75 85 102 104 118 112 108 113 102<br />

Illinois 906 1,016 1,201 1,359 1,533 1,496 1,594 1,803 1,777 1,830 1,938 1,863<br />

Indiana 465 466 531 607 673 673 825 779 797 813 862 871<br />

Iowa 192 216 224 230 262 252 272 318 293 302 317 294<br />

Kansas 153 172 204 187 235 268 314 308 331 301 327 295<br />

Kentucky 298 330 346 375 432 460 504 551 546 585 588 610<br />

Louisiana 540 490 571 620 720 806 906 939 870 970 1,008 1,026<br />

Maine 55 71 64 78 77 103 97 106 129 124 133 140<br />

Maryland 504 527 582 655 746 796 849 854 832 937 985 884<br />

Massachusetts 417 455 530 529 600 599 639 594 644 697 660 689<br />

Michigan 878 931 1,005 1,068 1,310 1,311 1,419 1,401 1,491 1,602 1,603 1,564<br />

Minnesota 296 336 347 338 361 391 402 382 414 444 469 427<br />

Mississippi 287 306 358 382 461 454 505 539 491 537 594 570<br />

Missouri 438 495 514 590 667 743 791 771 825 809 813 863<br />

Montana 66 58 64 86 69 70 78 93 81 112 86 98<br />

Nebraska 116 123 121 165 160 177 180 215 210 235 204 208<br />

Nevada 86 100 128 165 138 189 208 259 252 294 309 361<br />

New Hampshire 45 52 55 71 59 77 82 96 103 88 108 106<br />

New Jersey 703 821 909 1,054 1,090 1,170 1,319 1,358 1,311 1,335 1,386 1,352<br />

New Mexico 205 227 203 250 287 279 284 340 359 352 316 341<br />

New York 1,518 1,727 1,740 1,946 2,235 2,365 2,435 2,545 2,691 2,832 2,862 2,894<br />

North Carolina 668 774 879 877 1,043 1,150 1,282 1,217 1,354 1,344 1,329 1,422<br />

North Dakota 63 52 64 52 53 58 64 40 63 79 87 71<br />

Ohio 1,029 1,047 1,223 1,324 1,549 1,597 1,758 1,868 2,003 1,970 1,992 1,992<br />

Oklahoma 324 337 338 387 392 455 552 531 545 553 565 591<br />

Oregon 176 199 209 232 240 264 248 304 302 321 311 341<br />

Pennsylvania 1,135 1,123 1,337 1,478 1,593 1,672 1,760 1,827 1,949 1,970 2,013 1,908<br />

Rhode Island 70 75 85 86 108 107 114 119 105 117 121 112<br />

South Carolina 389 417 502 485 599 607 740 727 722 772 743 851<br />

South Dakota 61 67 64 94 91 91 96 119 109 98 115 120<br />

Tennessee 453 465 532 600 634 688 706 798 823 801 825 928<br />

Texas 1,885 2,085 2,189 2,440 2,780 3,031 3,208 3,377 3,651 3,719 3,995 4,139<br />

Utah 91 117 116 147 129 133 160 161 166 206 167 185<br />

Vermont 16 35 40 49 44 52 51 62 48 41 54 50<br />

Virginia 556 623 710 724 821 992 1,014 1,020 996 1,111 1,173 1,124<br />

Washington 322 329 361 380 407 456 473 528 566 550 561 617<br />

West Virginia 162 157 185 216 237 289 294 325 377 370 362 369<br />

Wisconsin 392 389 399 443 479 533 553 536 548 582 611 635<br />

Wyoming 12 25 22 39 31 37 31 39 44 34 37 45<br />

American Samoa * * * * * * * * 18 14 12 16<br />

Guam 25 22 27 34 46 47 44 54 39 57 63 64<br />

Puerto Rico 441 417 471 452 539 551 628 698 691 736 766 834<br />

Saipan * * * * * 13 17 * 14 * 12 13<br />

Virgin Islands * * * 20 19 20 21 21 19 20 18 24<br />

Foreign * * 13 * * * * * * * 11 *<br />

Unknown 61 42 48 * * * * . * * * 13<br />

All 22,971 24,585 27,384 29,912 33,450 35,971 38,351 40,371 42,070 43,265 44,700 45,330<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


Table A.8 A.8 (continued)<br />

Incident counts of reported ESRD patients, by diabetic status & state/territory: non-diabetic patients<br />

INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

Alabama 306 330 339 437 401 426 430 491 603 734 641 703<br />

Alaska * * * 14 * 11 23 16 24 25 23 34<br />

Arizona 204 215 226 272 258 291 321 360 368 405 435 442<br />

Arkansas 131 137 145 183 199 201 212 252 281 286 289 333<br />

California 1,655 1,804 1,843 2,182 2,195 2,284 2,578 2,782 3,088 3,181 3,590 3,798<br />

Colorado 148 158 158 139 165 170 192 205 202 246 245 277<br />

Connecticut 197 172 219 278 239 334 319 340 355 393 412 459<br />

Delaware 38 45 67 54 50 70 63 78 82 83 93 123<br />

District of Columbia 110 104 132 134 116 136 113 143 143 213 188 234<br />

Florida 1,015 1,023 1,042 1,183 1,308 1,391 1,531 1,757 1,897 2,139 2,182 2,465<br />

Georgia 431 514 479 623 606 593 686 744 960 973 994 1,218<br />

Hawaii 62 65 69 81 97 119 101 100 118 128 134 129<br />

Idaho 41 36 43 41 50 67 59 60 65 88 93 94<br />

Illinois 686 778 867 977 980 1,074 1,155 1,213 1,266 1,352 1,537 1,804<br />

Indiana 293 329 373 421 407 444 450 494 574 606 642 689<br />

Iowa 149 137 149 171 159 181 212 216 221 250 305 310<br />

Kansas 103 110 145 135 146 156 193 198 198 261 268 250<br />

Kentucky 197 203 223 201 218 276 294 314 340 366 431 481<br />

Louisiana 293 343 348 402 422 472 501 563 746 701 742 773<br />

Maine 33 72 48 59 89 70 84 80 85 75 104 99<br />

Maryland 277 315 346 350 404 407 417 538 556 646 681 793<br />

Massachusetts 336 258 383 484 463 464 487 528 599 606 631 694<br />

Michigan 589 594 654 691 805 791 814 918 1,006 1,131 1,101 1,201<br />

Minnesota 188 210 213 196 242 292 294 355 357 355 426 457<br />

Mississippi 187 162 200 290 250 276 286 315 338 432 423 415<br />

Missouri 315 287 320 366 414 433 487 548 592 612 690 716<br />

Montana 25 47 35 53 49 42 49 52 43 60 63 76<br />

Nebraska 72 82 74 75 86 103 100 118 132 138 140 157<br />

Nevada 70 65 61 85 83 100 131 106 130 115 130 157<br />

New Hampshire 46 62 51 55 54 66 64 73 78 88 84 94<br />

New Jersey 667 610 685 793 726 865 869 975 972 1,158 1,145 1,298<br />

New Mexico 97 71 89 86 95 116 103 106 134 132 158 149<br />

New York 1,264 1,308 1,397 1,573 1,650 1,768 1,902 1,975 2,178 2,380 2,617 2,661<br />

North Carolina 436 441 481 548 543 661 697 738 828 938 942 1,079<br />

North Dakota 19 34 31 23 30 39 49 41 43 51 56 60<br />

Ohio 565 606 690 777 784 862 915 959 1,120 1,181 1,429 1,450<br />

Oklahoma 178 182 176 181 210 202 239 259 275 312 339 315<br />

Oregon 107 126 124 164 164 181 217 211 241 268 273 344<br />

Pennsylvania 771 818 884 998 1,060 1,266 1,275 1,284 1,418 1,552 1,776 1,765<br />

Rhode Island 67 65 61 88 99 100 80 82 86 122 125 152<br />

South Carolina 229 285 287 336 333 381 408 427 539 562 626 636<br />

South Dakota 32 35 43 36 44 43 36 55 49 61 60 49<br />

Tennessee 301 303 339 436 353 429 447 543 533 785 728 790<br />

Texas 914 1,004 1,119 1,315 1,165 1,310 1,477 1,595 1,748 1,837 2,043 2,242<br />

Utah 59 81 67 58 89 67 74 79 109 118 103 105<br />

Vermont 30 20 22 33 26 29 26 32 43 36 45 51<br />

Virginia 444 445 469 561 552 592 595 687 732 768 847 1,011<br />

Washington 198 202 219 259 271 267 335 360 332 424 449 458<br />

West Virginia 99 100 122 136 161 143 154 164 206 184 190 234<br />

Wisconsin 234 253 292 263 301 327 347 421 489 492 477 533<br />

Wyoming 12 21 21 19 19 23 18 26 31 26 22 31<br />

305<br />

American Samoa * * * * * * * * * * * *<br />

Guam * * * * * . * * * * 15 16<br />

Puerto Rico 196 191 216 199 237 250 237 228 277 288 301 313<br />

Saipan . . . . . * . * * * . *<br />

Virgin Islands * * * * * 12 * 15 11 11 17 14<br />

Foreign * 14 * 13 11 18 * 13 19 14 36 30<br />

Unknown 186 168 162 176 174 197 205 229 346 286 249 186<br />

All 15,327 16,059 17,279 19,717 20,068 21,896 23,379 25,474 28,220 30,692 32,788 35,453<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.8 A.8 (continued)<br />

Incident counts of reported ESRD patients, by diabetic status & state/territory: non-diabetic patients<br />

306<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Alabama 776 760 813 837 903 938 923 940 975 972 1,037 1,043<br />

Alaska 35 22 92 134 36 37 35 34 50 45 43 57<br />

Arizona 563 571 568 589 656 651 738 791 794 836 847 913<br />

Arkansas 373 388 465 450 422 507 460 494 493 505 533 515<br />

California 3,910 4,295 4,676 4,594 4,769 4,824 5,303 5,567 5,605 5,969 6,362 6,506<br />

Colorado 305 302 343 294 339 373 399 402 397 411 440 435<br />

Connecticut 461 481 532 513 552 499 561 566 567 574 579 513<br />

Delaware 145 119 143 158 147 141 148 156 163 164 182 199<br />

District of Columbia 229 258 241 252 228 256 259 264 293 269 281 280<br />

Florida 2,678 2,659 2,830 2,800 3,088 3,140 3,216 3,347 3,420 3,485 3,746 3,741<br />

Georgia 1,278 1,296 1,393 1,368 1,422 1,459 1,556 1,735 1,808 1,855 1,857 1,929<br />

Hawaii 142 134 176 160 147 176 184 211 197 176 201 197<br />

Idaho 67 84 98 116 128 124 114 141 141 174 146 165<br />

Illinois 1,860 2,085 2,185 2,192 2,370 2,354 2,514 2,528 2,595 2,672 2,952 2,835<br />

Indiana 769 842 802 795 869 942 1,004 1,023 1,101 1,107 1,164 1,130<br />

Iowa 334 330 352 312 350 364 390 470 414 437 470 456<br />

Kansas 296 266 297 307 340 389 346 368 357 357 393 429<br />

Kentucky 538 501 535 528 539 584 639 680 683 689 682 720<br />

Louisiana 874 910 954 982 900 1,041 1,101 1,194 1,145 1,211 1,315 1,359<br />

Maine 103 106 130 148 138 162 171 152 168 172 179 186<br />

Maryland 825 895 962 1,065 1,082 1,107 1,241 1,263 1,374 1,315 1,355 1,496<br />

Massachusetts 789 890 866 843 909 973 990 1,005 1,052 924 1,038 1,088<br />

Michigan 1,347 1,464 1,447 1,475 1,613 1,606 1,712 1,807 1,839 1,887 2,052 2,052<br />

Minnesota 508 494 535 509 579 609 653 671 678 768 763 756<br />

Mississippi 498 548 583 533 564 637 630 657 653 693 742 753<br />

Missouri 769 801 869 849 855 891 1,006 1,049 1,052 1,109 1,026 1,118<br />

Montana 60 89 77 76 88 75 76 101 84 96 86 92<br />

Nebraska 184 173 194 165 197 232 248 251 280 294 279 282<br />

Nevada 165 203 246 191 239 224 247 306 296 322 312 367<br />

New Hampshire 106 104 128 111 108 129 140 157 168 158 165 176<br />

New Jersey 1,474 1,512 1,593 1,573 1,552 1,704 1,727 1,898 1,826 1,942 1,948 2,038<br />

New Mexico 150 150 170 178 189 209 190 215 212 209 231 259<br />

New York 3,028 3,209 3,261 3,167 3,272 3,479 3,646 3,727 3,844 3,791 3,936 4,019<br />

North Carolina 1,199 1,235 1,316 1,258 1,377 1,490 1,544 1,597 1,685 1,747 1,809 1,785<br />

North Dakota 65 75 84 66 87 78 73 96 98 108 95 93<br />

Ohio 1,517 1,556 1,688 1,679 1,891 1,844 1,991 2,117 2,261 2,214 2,369 2,490<br />

Oklahoma 351 392 417 394 435 493 485 504 528 571 572 668<br />

Oregon 306 353 359 339 364 377 424 414 438 465 544 561<br />

Pennsylvania 1,893 1,954 2,158 2,111 2,358 2,464 2,453 2,597 2,598 2,490 2,768 2,584<br />

Rhode Island 136 163 181 146 167 163 171 191 223 198 203 226<br />

South Carolina 700 713 822 750 786 852 856 929 878 906 898 975<br />

South Dakota 58 71 81 87 106 109 112 96 135 119 138 133<br />

Tennessee 816 798 921 904 935 1,021 1,078 1,175 1,074 1,049 1,175 1,127<br />

Texas 2,544 2,461 2,627 2,534 2,752 2,774 3,041 3,255 3,238 3,381 3,416 3,632<br />

Utah 120 144 138 123 134 137 187 184 169 197 206 180<br />

Vermont 48 48 40 52 67 59 66 66 74 60 78 89<br />

Virginia 1,086 1,061 1,086 1,178 1,250 1,351 1,327 1,420 1,276 1,361 1,512 1,551<br />

Washington 471 508 577 572 592 594 636 702 757 751 858 845<br />

West Virginia 230 263 276 276 295 327 365 324 324 355 341 340<br />

Wisconsin 592 576 654 625 689 696 806 784 842 886 980 998<br />

Wyoming 34 26 22 27 39 33 44 43 43 51 43 44<br />

American Samoa * * * * * * * 12 * * * *<br />

Guam 18 18 17 16 17 22 23 19 28 26 33 29<br />

Puerto Rico 344 383 387 401 399 412 412 417 417 418 458 461<br />

Saipan * * * * * * * * * . * *<br />

Virgin Islands 24 15 16 12 11 23 20 16 12 19 28 19<br />

Foreign 26 39 30 26 25 28 33 16 33 19 16 11<br />

Unknown 118 108 124 33 34 39 47 41 34 32 35 282<br />

All 38,347 39,907 42,584 41,879 44,410 46,232 48,770 51,189 51,896 53,015 55,925 57,237<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

Table A.9<br />

Incident rates of reported ESRD, by diabetic status & state, adjusted: all patients<br />

per million population<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

Alabama 74.8 82.3 82.4 110.8 107.9 112.1 118.5 136.9 166.7 212.6 184.6 206.8<br />

Alaska * * * 90.8 27.4 47.9 128.0 119.2 102.2 198.4 152.0 170.5<br />

Arizona 111.5 144.0 146.8 186.3 168.5 180.8 201.3 230.7 234.1 260.1 257.0 294.3<br />

Arkansas 61.9 74.7 81.3 101.9 110.8 116.4 121.5 155.0 165.2 175.2 167.2 212.6<br />

California 89.0 108.2 116.9 139.1 141.0 153.6 170.4 177.5 192.4 213.1 235.2 250.3<br />

Colorado 85.6 89.4 89.5 98.4 101.7 118.4 137.5 149.0 145.3 180.7 174.1 199.3<br />

Connecticut 82.2 83.4 103.5 135.1 119.6 171.2 164.2 172.2 172.3 203.1 204.1 235.0<br />

Delaware 73.9 101.2 138.9 109.8 110.7 146.7 149.4 159.5 193.5 206.5 225.2 271.1<br />

District of Columbia 118.8 88.1 121.8 105.0 117.7 131.4 97.8 114.5 194.0 177.0 196.7 199.4<br />

Florida 107.8 113.6 118.0 127.7 140.1 150.4 166.6 182.9 191.9 214.2 219.8 238.9<br />

Georgia 78.4 102.0 97.2 120.5 115.1 122.2 139.4 149.7 181.2 191.4 196.4 233.6<br />

Hawaii 130.7 112.9 66.4 89.8 127.0 120.0 163.2 145.6 107.5 154.3 247.9 211.2<br />

Idaho 131.5 105.8 62.0 58.7 137.2 88.0 348.0 92.5 101.1 199.0 151.0 204.8<br />

Illinois 76.2 88.4 103.2 114.4 119.8 139.6 146.3 156.1 161.2 174.8 204.6 239.6<br />

Indiana 73.1 87.5 100.8 121.2 115.5 128.3 123.1 162.4 173.5 182.6 208.3 225.2<br />

Iowa 91.6 117.3 96.3 122.1 93.5 110.3 167.2 137.3 165.7 203.1 229.4 244.8<br />

Kansas 63.4 77.5 97.8 102.0 114.4 104.9 126.3 139.9 148.4 185.0 202.7 203.7<br />

Kentucky 76.4 87.6 85.4 90.0 113.6 122.6 132.8 148.6 154.3 165.1 197.4 233.6<br />

Louisiana 71.2 86.1 89.2 104.0 114.9 123.3 141.8 159.3 218.6 207.5 224.7 259.7<br />

Maine 33.0 69.2 51.6 100.2 227.3 72.5 90.4 102.1 282.0 138.7 172.4 216.6<br />

Maryland 70.6 85.1 96.1 99.2 113.7 120.2 111.3 143.7 145.9 172.7 196.6 223.1<br />

Massachusetts 85.3 73.2 101.7 126.2 125.0 114.6 130.0 134.5 160.9 166.9 181.1 199.8<br />

Michigan 90.3 98.8 108.6 113.4 134.3 134.8 142.2 154.1 172.7 200.7 200.1 221.4<br />

Minnesota 98.7 93.7 124.6 112.8 139.7 144.7 170.0 202.4 217.2 204.1 242.3 261.9<br />

Mississippi 72.1 69.9 89.1 111.7 117.2 108.9 125.5 139.0 158.4 179.1 202.6 214.2<br />

Missouri 73.1 77.5 102.2 102.1 119.7 131.5 142.5 162.5 176.2 185.0 207.4 219.8<br />

Montana 39.4 71.9 50.5 485.7 428.6 76.9 82.2 95.2 177.9 129.8 477.9 295.6<br />

Nebraska 84.4 114.3 86.2 104.6 118.1 110.4 132.6 192.0 194.9 188.1 186.2 241.4<br />

Nevada 148.5 114.0 124.9 156.8 147.7 189.3 232.6 204.2 211.2 219.1 218.6 237.2<br />

New Hampshire 170.9 74.5 97.3 97.5 65.4 106.7 146.0 140.6 259.7 202.6 161.7 162.5<br />

New Jersey 111.6 106.9 121.6 144.0 129.7 158.4 160.6 175.0 180.6 212.8 225.8 249.0<br />

New Mexico 116.0 101.1 133.8 123.6 120.4 169.2 163.9 178.6 219.9 212.4 233.6 261.0<br />

New York 83.6 91.0 100.2 113.6 123.1 131.3 145.9 152.7 169.5 181.6 202.8 210.1<br />

North Carolina 76.4 80.2 94.5 105.1 109.1 131.2 132.9 146.6 155.0 179.9 188.2 219.7<br />

North Dakota 42.5 69.7 59.2 70.6 82.6 136.7 1,381.0 107.1 135.1 475.9 158.5 151.6<br />

Ohio 71.2 84.8 94.7 107.3 115.6 126.5 136.0 143.7 165.6 179.9 218.4 223.7<br />

Oklahoma 80.5 89.0 93.0 95.4 109.9 109.2 130.5 140.4 173.0 181.0 208.9 200.7<br />

Oregon 95.9 80.0 112.5 117.9 138.7 130.0 141.2 158.6 168.1 209.7 175.3 250.5<br />

Pennsylvania 83.2 89.2 100.2 115.2 129.8 147.7 151.9 158.2 173.0 191.9 226.2 229.4<br />

Rhode Island 96.0 109.0 110.1 121.4 142.4 158.5 110.7 139.2 151.3 220.8 230.2 218.6<br />

South Carolina 72.9 89.8 100.8 105.9 123.5 136.6 141.3 146.8 184.3 187.3 210.2 225.0<br />

South Dakota 63.2 83.9 77.3 382.6 113.6 111.5 91.4 131.3 138.4 134.1 511.7 449.5<br />

Tennessee 71.7 82.5 94.4 114.1 98.5 115.7 123.2 150.4 154.9 233.1 219.4 239.5<br />

Texas 87.1 101.4 115.2 131.7 129.4 140.7 159.4 174.8 197.9 221.5 248.3 272.2<br />

Utah 120.4 144.9 105.7 110.9 167.2 112.7 121.9 112.3 220.8 133.8 167.9 178.1<br />

Vermont 63.6 45.1 66.8 66.9 59.9 78.7 64.4 166.6 95.5 610.9 147.6 245.5<br />

Virginia 86.0 95.1 104.2 126.6 126.5 129.1 134.9 152.2 161.8 174.2 187.6 225.1<br />

Washington 84.5 72.0 82.3 90.4 106.9 133.9 138.8 143.8 148.0 178.2 192.0 201.6<br />

West Virginia 77.2 80.2 109.3 121.1 133.2 127.9 163.4 153.9 186.7 175.2 191.7 233.8<br />

Wisconsin 96.2 100.4 115.0 101.6 141.2 135.4 165.3 194.3 202.0 213.1 222.7 243.1<br />

Wyoming 105.9 63.3 62.9 91.3 68.3 240.4 165.7 149.6 231.7 182.0 121.8 362.8<br />

307<br />

All 84.0 93.6 105.1 119.5 125.2 137.3 148.1 161.7 177.8 197.9 214.0 232.5<br />

Rates are adjusted by age, gender, & race.<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

*Values for cells with 10 or fewer patients are suppressed.


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.9 A.9 (continued)<br />

Incident rates of of reported ESRD, by by diabetic status & state, adjusted: all all patients<br />

per<br />

per<br />

million<br />

million<br />

population<br />

population<br />

308<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Alabama 227.7 225.6 251.1 256.7 276.6 295.4 292.2 297.5 308.3 304.2 301.8 305.4<br />

Alaska 169.2 177.8 433.0 704.4 227.2 285.1 188.7 168.1 236.2 206.4 216.8 258.2<br />

Arizona 341.7 333.8 302.1 319.4 330.2 342.5 359.6 358.8 360.0 378.3 358.8 379.1<br />

Arkansas 226.2 225.8 262.8 285.4 274.6 304.1 268.2 296.2 287.5 297.6 314.8 308.2<br />

California 256.2 271.2 305.7 301.7 314.6 329.2 352.4 357.3 364.2 366.3 382.5 377.1<br />

Colorado 208.7 204.1 211.3 199.3 228.1 235.1 260.7 241.7 251.0 230.5 242.6 236.0<br />

Connecticut 237.7 250.7 283.0 268.1 285.7 281.0 289.2 295.0 305.5 276.0 282.0 268.2<br />

Delaware 287.2 250.7 280.5 297.0 284.1 270.0 283.8 308.4 320.1 296.4 332.4 352.7<br />

District of Columbia 252.8 226.5 232.4 246.1 233.5 232.5 223.5 275.6 309.3 236.7 246.9 290.1<br />

Florida 257.4 258.6 266.1 262.7 284.5 284.8 285.5 295.5 297.5 305.9 307.6 298.9<br />

Georgia 250.1 249.0 267.1 277.8 293.2 278.4 294.3 320.9 331.0 329.0 337.5 327.9<br />

Hawaii 206.8 196.8 204.7 219.1 236.5 271.1 214.6 318.3 258.9 225.6 218.9 170.1<br />

Idaho 337.8 377.4 503.3 346.5 244.3 633.3 272.8 410.5 217.5 425.5 265.8 242.5<br />

Illinois 237.4 263.2 285.5 294.2 321.4 315.1 330.6 347.6 345.5 352.5 376.6 357.0<br />

Indiana 246.9 263.4 262.8 268.8 297.3 302.0 341.5 333.6 343.5 341.2 356.4 341.5<br />

Iowa 264.0 265.7 289.3 263.3 360.9 269.3 323.4 348.8 305.6 292.0 342.1 304.7<br />

Kansas 219.8 221.0 236.1 237.9 278.4 299.7 304.1 308.2 303.6 297.5 319.7 308.4<br />

Kentucky 267.9 250.0 267.3 270.3 282.3 301.2 322.3 343.1 328.1 332.5 333.3 340.0<br />

Louisiana 280.4 277.5 292.0 297.3 296.1 334.2 351.0 388.5 357.9 381.9 403.1 410.3<br />

Maine 163.4 267.5 192.8 396.4 359.0 220.4 293.5 289.8 269.4 193.9 300.1 304.0<br />

Maryland 235.7 241.7 254.8 279.9 286.9 297.9 316.9 331.1 326.5 335.6 334.6 329.4<br />

Massachusetts 234.0 255.6 261.0 260.0 276.5 278.8 289.1 270.2 281.2 261.4 277.3 282.2<br />

Michigan 240.7 256.8 265.0 267.9 301.2 299.8 319.7 320.9 330.0 338.5 349.2 337.0<br />

Minnesota 250.0 278.7 284.6 282.8 279.2 288.1 306.2 291.4 290.1 316.7 312.0 302.7<br />

Mississippi 235.1 243.4 284.3 274.1 291.0 306.5 308.7 341.0 312.0 333.0 351.6 335.2<br />

Missouri 248.0 268.6 274.5 281.9 293.2 306.1 333.5 333.2 337.5 340.7 319.6 337.9<br />

Montana 216.9 259.0 417.2 806.1 165.7 149.4 225.4 387.0 161.3 319.8 320.4 211.4<br />

Nebraska 266.0 262.9 281.5 264.5 298.0 313.4 344.8 362.9 333.5 394.0 349.0 327.2<br />

Nevada 219.9 263.4 308.8 277.8 245.6 258.6 277.8 329.9 302.9 331.4 317.1 359.5<br />

New Hampshire 196.4 201.6 322.0 210.2 179.8 220.9 280.8 280.3 304.6 407.3 376.6 371.9<br />

New Jersey 269.9 283.5 297.5 309.2 305.8 327.4 340.8 359.8 340.1 349.5 352.7 351.9<br />

New Mexico 250.5 261.6 279.1 288.0 306.2 316.9 281.9 324.9 324.1 319.1 313.6 343.8<br />

New York 234.4 252.6 251.5 250.1 271.0 285.7 293.2 298.3 303.5 305.2 307.5 305.6<br />

North Carolina 235.4 244.9 260.6 249.4 273.9 293.8 303.6 293.3 316.8 315.3 314.1 311.4<br />

North Dakota 205.3 357.6 801.9 357.1 203.2 202.5 199.8 194.2 313.1 255.8 334.1 221.2<br />

Ohio 243.6 241.3 265.6 271.6 312.5 309.1 331.7 350.9 363.9 357.1 367.5 371.2<br />

Oklahoma 226.8 254.7 251.2 256.7 268.3 297.0 325.2 316.8 312.8 327.6 331.1 359.8<br />

Oregon 196.7 232.5 246.0 239.6 253.4 213.4 311.6 273.6 267.1 305.3 304.4 293.4<br />

Pennsylvania 249.6 250.6 283.5 286.8 307.3 318.9 322.2 338.1 342.5 329.7 349.9 324.5<br />

Rhode Island 221.4 257.3 307.4 269.4 313.5 293.4 291.0 327.5 325.6 310.6 313.4 321.2<br />

South Carolina 241.6 242.1 283.1 249.1 269.5 289.5 299.2 307.5 291.9 307.5 296.3 307.3<br />

South Dakota 534.8 202.6 208.2 255.5 301.7 550.6 401.4 250.9 309.4 432.5 279.1 411.4<br />

Tennessee 251.8 239.2 272.3 275.0 277.1 297.2 309.6 332.6 317.4 303.0 319.1 315.8<br />

Texas 295.6 297.0 308.5 303.2 328.5 338.8 360.3 373.8 373.3 379.4 388.7 391.0<br />

Utah 205.0 278.2 222.7 246.6 278.1 218.5 311.2 290.1 240.1 241.7 248.7 246.6<br />

Vermont 104.8 128.8 160.5 166.8 365.4 599.6 397.5 209.9 170.0 278.5 313.2 341.8<br />

Virginia 241.9 244.1 253.5 265.9 285.0 309.3 306.2 313.6 287.8 301.7 322.7 310.6<br />

Washington 219.8 223.7 235.4 231.2 242.5 244.7 251.2 261.9 290.1 262.5 292.1 290.1<br />

West Virginia 243.5 256.4 312.3 303.2 311.8 354.0 396.1 375.9 378.4 400.9 393.2 363.0<br />

Wisconsin 270.3 263.4 261.6 278.3 288.5 294.0 321.5 314.0 321.0 336.2 349.5 356.1<br />

Wyoming 183.0 226.5 148.0 205.8 237.7 213.8 193.4 255.9 228.2 285.6 143.8 166.0<br />

All 249.4 258.3 275.5 276.9 294.3 304.9 317.5 327.7 328.9 331.5 339.9 337.6<br />

Rates are adjusted by age, gender, & race.<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.


Table A.9 A.9 (continued)<br />

Incident rates of of reported ESRD, by by diabetic status & state, adjusted: diabetic patients<br />

per<br />

per<br />

million<br />

million<br />

population<br />

population<br />

INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992<br />

Alabama * * 11.0 18.9 23.8 24.4 28.0 35.9 42.1 62.6 57.3 65.2 79.4<br />

Alaska * * * * * * 38.1 * * 117.4 41.3 40.5 46.3<br />

Arizona 24.5 44.3 55.9 62.8 64.3 73.1 89.3 102.1 103.5 124.3 110.5 148.8 170.6<br />

Arkansas * 11.9 17.3 23.8 28.8 32.7 34.3 52.7 45.4 54.9 51.3 76.0 74.1<br />

California * 21.6 28.3 34.7 38.5 47.5 54.4 54.8 61.3 79.1 87.3 96.9 101.5<br />

Colorado 14.6 18.3 24.6 34.3 32.2 37.1 57.6 60.1 63.6 83.7 75.6 87.5 89.6<br />

Connecticut * 20.7 23.5 32.7 38.8 54.6 48.8 50.4 49.3 65.0 71.8 82.4 84.6<br />

Delaware * 21.4 27.4 * 26.6 34.8 48.9 43.6 70.9 87.0 77.9 94.8 85.5<br />

District of Columbia * * 23.6 22.0 24.7 38.6 31.1 22.0 38.7 40.5 36.0 45.5 75.6<br />

Florida 13.1 18.8 24.9 27.4 32.5 37.7 49.8 52.7 52.7 62.8 70.5 74.7 84.0<br />

Georgia * 19.8 23.4 21.9 27.7 32.1 39.6 46.0 46.9 60.0 67.7 76.0 87.9<br />

Hawaii * 23.1 26.0 21.6 18.7 33.6 53.3 44.7 44.8 81.7 161.3 64.5 83.2<br />

Idaho * * 19.0 19.7 21.3 19.6 140.3 32.9 40.8 106.0 57.3 46.5 70.4<br />

Illinois 13.2 17.6 23.0 27.0 30.4 40.8 41.6 46.9 45.7 55.1 68.2 80.9 77.4<br />

Indiana * 18.4 17.4 28.8 28.3 32.1 32.1 48.6 52.0 52.7 72.9 81.5 96.1<br />

Iowa 23.8 26.1 23.4 41.8 28.7 31.8 65.9 37.9 60.9 67.4 65.9 79.3 86.5<br />

Kansas 14.3 17.3 28.9 26.5 34.8 36.6 33.1 46.7 52.5 55.8 67.5 86.4 78.6<br />

Kentucky 14.3 17.9 15.4 26.9 35.3 36.4 40.1 49.5 46.0 53.8 72.7 85.7 99.3<br />

Louisiana * 12.9 15.1 15.0 27.3 27.4 37.6 40.0 59.5 68.2 74.2 90.6 101.4<br />

Maine * * 11.1 13.4 26.0 16.3 19.3 30.5 96.5 24.1 64.5 131.0 41.6<br />

Maryland * 15.1 20.1 24.5 27.4 36.9 30.2 41.0 40.3 57.7 68.2 78.7 88.9<br />

Massachusetts 14.1 17.7 20.6 23.3 27.8 24.0 33.5 30.4 43.5 50.5 59.6 67.4 82.2<br />

Michigan 20.0 27.3 26.2 30.0 34.5 40.1 46.9 46.8 57.6 68.1 77.4 88.4 94.7<br />

Minnesota 27.8 30.4 36.4 48.9 62.8 47.2 66.5 87.0 86.7 92.2 105.4 98.7 95.6<br />

Mississippi * * 16.7 19.7 29.7 28.8 41.8 40.4 57.9 55.8 83.8 84.9 96.1<br />

Missouri * 17.1 27.7 22.7 30.6 39.5 38.5 45.8 50.5 58.5 67.8 77.2 95.1<br />

Montana * 15.6 * 172.7 31.1 28.8 22.8 36.3 128.5 63.7 333.7 210.7 78.8<br />

Nebraska 18.3 38.7 22.6 32.6 46.3 37.0 37.7 79.5 83.3 77.9 68.2 106.2 126.0<br />

Nevada 31.0 22.0 32.4 24.2 30.4 43.1 55.8 72.4 61.3 85.0 78.5 81.4 73.4<br />

New Hampshire * * 41.7 14.1 13.5 18.3 16.4 48.1 50.9 69.2 60.1 43.9 58.8<br />

New Jersey 15.8 21.6 27.3 33.3 30.9 41.6 44.9 48.1 55.9 63.4 81.0 86.1 87.0<br />

New Mexico 19.8 32.1 35.5 55.5 53.9 59.7 75.1 86.8 97.2 96.7 100.9 138.1 135.8<br />

New York 11.4 17.5 21.5 26.3 32.7 34.2 42.7 45.5 53.1 55.0 65.5 71.2 78.8<br />

North Carolina * 12.4 19.6 22.6 25.0 34.1 35.0 45.3 43.3 57.2 67.5 81.5 85.3<br />

North Dakota * * * 39.0 38.9 40.7 1,171.8 44.3 67.5 403.6 80.0 71.0 111.4<br />

Ohio 13.9 21.4 26.0 28.4 33.3 41.3 44.1 48.4 55.1 63.9 78.7 82.1 97.7<br />

Oklahoma * 15.5 25.3 29.8 35.1 36.2 45.7 51.8 73.7 66.0 85.1 91.7 104.7<br />

Oregon 14.2 19.8 40.2 36.3 36.0 44.7 41.2 63.1 53.5 85.8 61.4 83.3 70.5<br />

Pennsylvania 14.9 16.4 22.4 26.5 37.1 37.8 43.5 48.1 54.5 60.6 73.9 83.8 93.4<br />

Rhode Island * 13.4 16.8 16.7 23.6 37.3 19.0 54.8 46.2 68.0 81.6 56.3 84.7<br />

South Carolina * 12.8 21.6 20.8 32.9 41.5 38.0 44.5 52.5 56.2 70.0 83.4 81.5<br />

South Dakota * 36.7 17.4 29.3 46.9 49.7 42.4 59.2 74.2 55.4 49.3 388.5 460.3<br />

Tennessee * 12.7 16.2 21.0 23.8 27.6 28.1 40.2 47.5 72.6 70.5 79.5 89.4<br />

Texas 12.8 21.8 30.6 31.4 41.2 45.2 51.2 58.2 72.6 93.3 108.0 117.0 126.3<br />

Utah 27.8 32.3 27.9 67.5 47.9 46.1 45.8 47.0 128.4 49.4 67.9 79.0 106.5<br />

Vermont * * 27.7 * * 27.3 * 27.2 * 309.0 33.5 165.2 27.8<br />

Virginia * 13.2 22.5 27.0 31.3 27.5 35.8 38.2 47.3 50.2 54.6 69.1 80.3<br />

Washington 17.2 12.1 18.1 18.3 27.2 51.2 36.1 39.4 51.8 67.3 75.7 87.8 97.2<br />

West Virginia 12.7 20.3 16.8 44.4 35.7 30.1 61.6 51.7 63.5 73.1 72.4 91.6 97.7<br />

Wisconsin 23.0 30.6 36.8 33.7 49.4 42.5 63.6 73.7 69.4 81.3 90.7 99.0 103.3<br />

Wyoming * * 22.0 * * 189.7 * 87.7 97.8 68.2 77.2 27.8 50.2<br />

309<br />

All 12.5 18.8 24.8 28.9 34.1 39.3 44.7 50.3 56.4 67.2 76.6 85.9 93.5<br />

Rates are adjusted by age, gender, & race.<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

*Values for cells with 10 or fewer patients are suppressed.


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.9 A.9 (continued)<br />

Incident rates of of reported ESRD, by by diabetic status & state, adjusted: diabetic patients<br />

per<br />

per<br />

million<br />

million<br />

population<br />

population<br />

310<br />

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Alabama 79.7 96.1 98.6 110.6 126.0 115.0 128.1 135.1 132.4 125.5 132.1<br />

Alaska 96.5 177.8 226.5 105.6 183.2 107.6 68.7 113.7 101.2 110.2 112.4<br />

Arizona 165.8 151.1 169.8 162.6 187.5 186.4 184.1 187.9 198.4 195.9 192.4<br />

Arkansas 80.7 88.7 110.4 118.1 118.1 109.6 119.8 123.9 125.2 135.7 136.1<br />

California 105.3 126.0 129.9 138.6 154.7 162.5 165.0 174.7 169.7 176.8 173.1<br />

Colorado 90.2 82.0 98.0 115.7 102.2 128.4 115.2 124.3 109.8 120.8 113.6<br />

Connecticut 91.9 112.8 107.2 113.3 132.7 118.9 128.6 135.8 110.2 121.8 126.8<br />

Delaware 94.1 98.0 97.2 104.2 101.2 112.9 134.8 136.0 118.6 134.2 147.8<br />

District of Columbia 49.7 65.9 74.1 101.1 78.2 67.9 76.4 94.4 90.5 91.4 113.9<br />

Florida 87.4 93.7 98.0 108.2 112.9 111.9 119.2 122.3 129.4 124.3 123.3<br />

Georgia 86.9 96.9 109.0 125.7 117.0 120.2 134.3 140.9 138.6 148.4 138.0<br />

Hawaii 116.8 97.7 115.6 127.6 128.4 122.7 149.7 135.2 136.1 118.6 87.5<br />

Idaho 233.9 78.6 74.9 103.7 349.4 136.0 108.6 95.5 194.8 90.1 80.2<br />

Illinois 85.6 101.0 112.0 125.3 121.9 128.3 144.8 141.7 143.8 149.8 142.1<br />

Indiana 97.1 104.7 114.8 127.7 126.8 154.1 147.3 142.5 144.0 154.0 148.9<br />

Iowa 108.3 129.6 131.3 170.1 132.5 167.5 153.9 131.5 129.9 142.6 132.2<br />

Kansas 94.0 97.9 95.9 114.6 128.4 147.4 147.3 152.2 143.7 152.2 132.9<br />

Kentucky 101.1 105.2 114.2 123.8 133.2 143.3 160.8 145.1 150.7 154.3 155.0<br />

Louisiana 97.8 104.7 116.5 129.0 141.2 155.5 173.6 146.2 166.0 167.4 171.3<br />

Maine 48.2 65.2 173.6 134.5 107.9 161.5 68.2 165.4 84.6 134.0 156.3<br />

Maryland 88.4 96.2 105.2 116.3 122.3 125.9 134.4 122.0 139.7 140.5 120.7<br />

Massachusetts 89.6 101.9 103.8 110.6 108.8 122.3 105.5 107.7 114.1 108.8 109.5<br />

Michigan 100.5 108.5 113.1 136.1 136.1 146.3 140.7 147.9 155.5 153.9 146.1<br />

Minnesota 136.9 116.8 114.4 112.0 125.2 129.9 114.5 120.9 126.5 131.2 118.2<br />

Mississippi 84.9 121.1 128.6 133.8 135.4 146.7 161.5 139.4 150.2 166.0 154.4<br />

Missouri 99.6 101.4 118.1 129.3 141.2 147.9 142.8 148.5 143.6 141.8 146.7<br />

Montana 125.8 236.0 521.5 74.7 74.7 81.5 290.4 80.2 107.0 242.1 89.0<br />

Nebraska 122.6 114.4 154.1 135.9 159.1 163.4 188.0 158.4 187.7 147.8 142.1<br />

Nevada 86.6 96.3 128.4 81.3 113.7 127.0 146.0 139.7 154.0 150.2 167.3<br />

New Hampshire 111.1 91.4 113.2 59.7 71.9 140.8 125.4 115.9 120.4 183.8 134.1<br />

New Jersey 100.4 108.2 124.4 125.2 132.7 146.3 147.7 141.6 140.7 145.6 139.3<br />

New Mexico 148.1 142.8 161.6 172.3 173.5 156.8 194.3 190.8 188.7 166.9 185.3<br />

New York 88.1 88.4 94.2 108.8 114.0 116.7 119.7 123.0 128.7 128.0 125.9<br />

North Carolina 94.9 105.8 103.3 116.7 124.9 135.8 125.7 137.9 135.7 130.3 136.1<br />

North Dakota 87.2 408.0 88.7 85.9 95.9 101.3 66.7 185.7 120.5 129.4 100.0<br />

Ohio 97.1 111.3 117.6 139.0 144.8 154.8 160.8 169.4 168.4 167.6 163.9<br />

Oklahoma 116.1 108.0 126.9 124.7 135.0 167.5 158.8 155.5 156.0 160.8 163.8<br />

Oregon 82.1 97.5 103.4 113.4 92.0 102.0 119.0 106.1 147.3 100.3 108.4<br />

Pennsylvania 90.0 107.4 118.6 123.6 128.0 134.0 137.7 144.4 145.6 146.6 137.4<br />

Rhode Island 85.4 103.1 107.2 133.9 117.8 121.2 134.0 115.5 125.4 127.7 115.2<br />

South Carolina 86.4 111.6 93.5 113.1 115.4 138.2 135.3 128.6 133.9 129.9 139.3<br />

South Dakota 96.7 89.4 126.7 118.7 189.9 251.1 143.9 127.9 288.2 131.3 172.1<br />

Tennessee 87.3 100.9 108.3 112.8 119.9 120.5 137.5 135.9 131.7 129.7 141.8<br />

Texas 137.3 140.2 148.5 165.4 177.3 185.1 190.2 198.5 199.2 209.4 208.2<br />

Utah 153.3 98.5 142.6 129.8 122.7 206.6 164.1 127.3 135.7 107.4 138.8<br />

Vermont 54.4 61.8 71.9 154.3 199.0 176.5 86.6 66.1 55.2 172.0 93.7<br />

Virginia 87.6 98.1 99.2 111.0 129.1 130.7 128.2 125.5 134.4 139.0 126.6<br />

Washington 98.7 91.8 98.4 102.2 111.2 109.4 115.4 128.4 118.6 119.3 130.4<br />

West Virginia 99.2 118.0 139.5 140.3 157.4 165.2 205.4 199.8 201.2 197.6 186.3<br />

Wisconsin 111.7 101.2 120.4 127.4 135.0 135.8 138.7 134.8 143.8 145.1 146.4<br />

Wyoming 56.8 97.3 86.1 78.4 137.7 99.4 86.9 98.3 154.4 67.5 86.2<br />

All 98.8 108.1 115.6 126.5 133.4 139.7 144.1 146.8 148.3 150.1 148.3<br />

Rates are adjusted by age, gender, & race.<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.


Table A.9 A.9 (continued)<br />

Incident rates of of reported ESRD, by by diabetic status & state, adjusted: non-diabetic patients<br />

per<br />

per<br />

million<br />

million<br />

population<br />

population<br />

INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992<br />

Alabama 69.5 73.9 71.4 91.9 84.0 87.7 90.5 101.0 124.6 150.0 127.4 141.6 148.3<br />

Alaska * * * 87.3 * 35.1 89.9 60.2 81.3 81.1 110.7 130.0 122.9<br />

Arizona 86.9 99.7 90.9 123.6 104.2 107.7 112.0 128.6 130.6 135.8 146.4 145.4 171.2<br />

Arkansas 57.5 62.9 64.0 78.1 82.0 83.8 87.2 102.3 119.8 120.3 116.0 136.6 152.2<br />

California 79.4 86.6 88.6 104.4 102.5 106.1 116.0 122.7 131.1 134.0 147.9 153.4 154.7<br />

Colorado 71.1 71.1 64.9 64.1 69.5 81.3 79.9 88.9 81.7 97.0 98.5 111.8 119.1<br />

Connecticut 72.6 62.6 80.0 102.4 80.8 116.6 115.4 121.8 123.0 138.1 132.3 152.6 153.2<br />

Delaware 63.0 79.8 111.5 93.8 84.1 111.9 100.5 115.9 122.6 119.5 147.4 176.3 201.7<br />

District of Columbia 111.8 82.5 98.2 83.1 93.0 92.9 66.7 92.6 155.2 136.5 160.7 154.0 177.2<br />

Florida 94.6 94.8 93.1 100.2 107.5 112.7 116.8 130.2 139.2 151.4 149.3 164.2 173.4<br />

Georgia 70.2 82.2 73.8 98.6 87.4 90.1 99.8 103.7 134.4 131.4 128.7 157.6 162.2<br />

Hawaii 104.1 89.8 40.4 68.2 108.4 86.3 109.9 100.9 62.7 72.6 86.5 146.7 123.6<br />

Idaho 121.3 96.2 43.0 39.1 116.0 68.4 207.7 59.6 60.3 93.0 93.6 158.3 267.4<br />

Illinois 63.0 70.8 80.2 87.3 89.4 98.8 104.6 109.3 115.5 119.8 136.4 158.7 160.0<br />

Indiana 63.3 69.1 83.5 92.4 87.3 96.2 90.9 113.8 121.5 129.9 135.3 143.7 150.8<br />

Iowa 67.7 91.2 72.9 80.3 64.8 78.5 101.3 99.4 104.8 135.7 163.5 165.6 177.6<br />

Kansas 49.1 60.2 68.9 75.5 79.6 68.4 93.3 93.2 95.9 129.2 135.2 117.2 141.2<br />

Kentucky 62.1 69.7 70.0 63.2 78.3 86.1 92.7 99.2 108.3 111.3 124.7 147.9 168.6<br />

Louisiana 64.9 73.2 74.1 89.0 87.6 96.0 104.2 119.4 159.1 139.3 150.5 169.1 179.0<br />

Maine 26.8 61.1 40.5 86.8 201.3 56.1 71.1 71.7 185.5 114.6 107.9 85.6 121.8<br />

Maryland 63.4 70.0 76.0 74.6 86.3 83.3 81.1 102.6 105.6 115.0 128.4 144.3 146.8<br />

Massachusetts 71.2 55.5 81.1 103.0 97.2 90.6 96.6 104.1 117.4 116.4 121.5 132.4 151.8<br />

Michigan 70.3 71.5 82.4 83.3 99.8 94.7 95.3 107.3 115.1 132.6 122.8 133.0 146.0<br />

Minnesota 70.9 63.3 88.2 63.8 76.9 97.4 103.5 115.3 130.5 111.9 137.0 163.3 154.3<br />

Mississippi 65.4 61.3 72.4 92.0 87.4 80.1 83.7 98.6 100.5 123.3 118.8 129.3 139.0<br />

Missouri 68.7 60.4 74.5 79.4 89.1 92.0 104.0 116.7 125.7 126.5 139.6 142.6 152.9<br />

Montana 31.4 56.3 42.4 313.0 397.5 48.1 59.5 58.9 49.4 66.2 144.2 84.9 138.2<br />

Nebraska 66.1 75.6 63.6 72.0 71.7 73.4 94.9 112.5 111.6 110.2 118.0 135.2 140.0<br />

Nevada 117.5 92.0 92.6 132.5 117.4 146.2 176.9 131.8 150.0 134.1 140.1 155.7 146.5<br />

New Hampshire 164.8 64.6 55.6 83.5 51.9 88.4 129.6 92.6 208.8 133.4 101.7 118.6 137.6<br />

New Jersey 95.8 85.3 94.3 110.6 98.8 116.8 115.7 126.9 124.6 149.4 144.8 162.8 182.9<br />

New Mexico 96.2 69.1 98.3 68.1 66.5 109.6 88.8 91.8 122.7 115.7 132.7 122.9 114.7<br />

New York 72.2 73.5 78.7 87.3 90.4 97.1 103.2 107.2 116.4 126.6 137.3 138.9 155.6<br />

North Carolina 66.7 67.7 74.9 82.4 84.1 97.1 97.9 101.4 111.8 122.6 120.7 138.2 150.2<br />

North Dakota 30.9 53.7 44.4 31.6 43.7 96.0 209.3 62.8 67.6 72.3 78.6 80.5 93.9<br />

Ohio 57.3 63.4 68.7 78.9 82.3 85.2 91.9 95.4 110.6 116.1 139.7 141.5 146.0<br />

Oklahoma 71.3 73.5 67.7 65.5 74.9 73.0 84.8 88.7 99.3 115.0 123.8 109.0 122.1<br />

Oregon 81.7 60.2 72.3 81.6 102.7 85.3 100.0 95.5 114.6 123.9 113.9 167.2 126.3<br />

Pennsylvania 68.3 72.7 77.8 88.7 92.7 109.9 108.3 110.1 118.6 131.2 152.3 145.5 156.2<br />

Rhode Island 88.2 95.6 93.3 104.8 118.8 121.2 91.7 84.4 105.1 152.8 148.5 162.3 136.6<br />

South Carolina 62.7 77.0 79.2 85.1 90.6 95.1 103.4 102.2 131.8 131.1 140.2 141.6 160.1<br />

South Dakota 47.3 47.2 59.9 353.2 66.7 61.8 49.0 72.1 64.3 78.7 462.3 61.0 74.5<br />

Tennessee 64.0 69.8 78.2 93.1 74.6 88.1 95.2 110.2 107.4 160.5 148.8 160.0 162.4<br />

Texas 74.3 79.6 84.7 100.3 88.2 95.5 108.2 116.7 125.4 128.2 140.3 155.2 169.3<br />

Utah 92.6 112.7 77.8 43.4 119.3 66.5 76.1 65.3 92.4 84.4 100.1 99.1 98.5<br />

Vermont 52.6 34.9 39.1 59.6 43.4 51.4 48.7 139.4 79.0 301.9 114.1 80.3 77.0<br />

Virginia 76.6 81.9 81.7 99.6 95.1 101.6 99.1 114.0 114.5 124.0 133.0 156.0 161.6<br />

Washington 67.3 60.0 64.2 72.1 79.7 82.8 102.8 104.4 96.2 110.9 116.3 113.9 122.6<br />

West Virginia 64.5 59.9 92.5 76.7 97.5 97.9 101.8 102.2 123.2 102.1 119.3 142.2 145.8<br />

Wisconsin 73.2 69.7 78.3 67.8 91.9 92.9 101.7 120.7 132.6 131.8 132.0 144.1 167.0<br />

Wyoming 90.1 49.6 40.9 83.0 47.0 50.7 104.6 61.9 133.9 113.8 44.6 335.0 132.8<br />

311<br />

All 71.5 74.8 80.3 90.7 91.1 97.9 103.4 111.3 121.4 130.8 137.4 146.6 155.9<br />

Rates are adjusted by age, gender, & race.<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

*Values for cells with 10 or fewer patients are suppressed.


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.9 A.9 (continued)<br />

Incident rates of of reported ESRD, by by diabetic status & state, adjusted: non-diabetic patients<br />

per<br />

per<br />

million<br />

million<br />

population<br />

population<br />

312<br />

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Alabama 145.9 155.0 158.1 165.9 169.4 177.2 169.5 173.2 171.8 176.3 173.4<br />

Alaska 81.2 255.2 477.9 121.6 101.8 81.1 99.4 122.5 105.2 106.5 145.8<br />

Arizona 168.1 151.0 149.6 167.6 155.0 173.2 174.7 172.1 180.0 162.9 186.7<br />

Arkansas 145.0 174.0 175.0 156.6 186.0 158.6 176.5 163.5 172.4 179.1 172.1<br />

California 165.9 179.6 171.8 176.0 174.5 190.0 192.3 189.4 196.6 205.7 204.1<br />

Colorado 113.9 129.3 101.3 112.4 133.0 132.2 126.5 126.7 120.7 121.7 122.4<br />

Connecticut 158.8 170.2 160.9 172.4 148.3 170.4 166.4 169.6 165.8 160.2 141.4<br />

Delaware 156.5 182.5 199.8 179.9 168.8 171.0 173.6 184.1 177.8 198.3 204.8<br />

District of Columbia 176.8 166.5 171.9 132.3 154.3 155.7 199.1 214.9 146.2 155.5 176.1<br />

Florida 171.2 172.5 164.7 176.3 171.9 173.5 176.3 175.1 176.5 183.3 175.6<br />

Georgia 162.2 170.2 168.8 167.5 161.4 174.1 186.7 190.1 190.5 189.0 189.9<br />

Hawaii 80.0 107.0 103.5 109.0 142.7 91.9 168.6 123.8 89.5 100.3 82.6<br />

Idaho 143.5 424.6 271.6 140.6 283.9 136.8 301.9 122.0 230.8 175.8 162.3<br />

Illinois 177.6 184.5 182.2 196.1 193.2 202.4 202.8 203.8 208.7 226.9 215.0<br />

Indiana 166.3 158.1 154.0 169.5 175.2 187.4 186.3 201.0 197.3 202.4 192.6<br />

Iowa 157.4 159.7 131.9 190.7 136.8 155.9 194.9 174.1 162.2 199.4 172.5<br />

Kansas 127.0 138.3 142.0 163.8 171.3 156.7 160.9 151.4 153.8 167.5 175.4<br />

Kentucky 148.9 162.0 156.1 158.5 168.0 179.0 182.3 183.0 181.9 179.0 185.0<br />

Louisiana 179.7 187.2 180.8 167.1 193.0 195.5 215.0 211.7 215.9 235.7 239.0<br />

Maine 219.3 127.5 222.8 224.5 112.4 132.0 221.6 104.0 109.3 166.1 147.8<br />

Maryland 153.3 158.7 174.8 170.6 175.7 191.0 196.6 204.6 195.9 194.0 208.6<br />

Massachusetts 166.1 159.2 156.2 165.8 170.0 166.8 164.7 173.5 147.4 168.5 172.8<br />

Michigan 156.2 156.5 154.9 165.1 163.7 173.3 180.2 182.1 183.1 195.3 190.9<br />

Minnesota 141.9 167.8 168.4 167.2 162.9 176.3 176.9 169.1 190.3 180.8 184.6<br />

Mississippi 158.5 163.2 145.5 157.3 171.1 162.1 179.5 172.6 182.7 185.6 180.8<br />

Missouri 169.1 173.2 163.8 163.8 165.0 185.6 190.5 188.9 197.0 177.8 191.1<br />

Montana 133.3 181.2 284.6 91.0 74.7 143.9 96.6 81.1 212.8 78.3 122.4<br />

Nebraska 140.3 167.1 110.4 162.0 154.3 181.4 174.9 175.1 206.3 201.2 185.1<br />

Nevada 176.8 212.5 149.4 164.3 144.8 150.9 183.9 163.2 177.4 166.9 192.2<br />

New Hampshire 90.5 230.5 97.0 120.1 149.0 140.0 154.9 188.7 286.9 192.9 237.9<br />

New Jersey 183.1 189.3 184.8 180.6 194.7 194.5 212.1 198.4 208.8 207.1 212.6<br />

New Mexico 113.5 136.3 126.4 133.9 143.5 125.1 130.7 133.3 130.4 146.7 158.4<br />

New York 164.5 163.1 156.0 162.1 171.7 176.5 178.6 180.5 176.6 179.5 179.7<br />

North Carolina 150.0 154.8 146.1 157.2 169.0 167.8 167.7 179.0 179.6 183.8 175.3<br />

North Dakota 270.4 394.0 268.4 117.3 106.6 98.5 127.5 127.4 135.3 204.8 121.2<br />

Ohio 144.2 154.4 154.0 173.5 164.4 177.0 190.0 194.6 188.7 200.0 207.3<br />

Oklahoma 138.6 143.2 129.8 143.6 161.9 157.7 158.0 157.3 171.6 170.3 195.9<br />

Oregon 150.4 148.6 136.3 140.0 121.4 209.6 154.6 161.0 158.0 204.1 184.9<br />

Pennsylvania 160.6 176.1 168.2 183.7 190.9 188.2 200.4 198.1 184.1 203.3 187.1<br />

Rhode Island 171.9 204.3 162.2 179.6 175.6 169.8 193.4 210.1 185.1 185.7 206.0<br />

South Carolina 155.7 171.5 155.5 156.5 174.2 160.9 172.2 163.3 173.6 166.5 168.1<br />

South Dakota 105.9 118.8 128.8 183.0 360.6 150.3 107.0 181.5 144.4 147.9 239.4<br />

Tennessee 151.9 171.4 166.7 164.3 177.3 189.2 195.1 181.5 171.3 189.4 174.0<br />

Texas 159.6 168.3 154.7 163.1 161.5 175.3 183.6 174.8 180.1 179.3 182.8<br />

Utah 124.9 124.2 103.9 148.2 95.8 104.6 126.0 112.9 106.0 141.4 107.9<br />

Vermont 74.4 98.7 94.9 211.1 400.6 221.0 123.3 103.9 223.3 141.2 248.0<br />

Virginia 156.5 155.4 166.7 173.9 180.2 175.5 185.3 162.3 167.3 183.7 184.1<br />

Washington 125.0 143.6 132.8 140.3 133.6 141.8 146.5 161.7 143.9 172.8 159.7<br />

West Virginia 157.2 194.4 163.7 171.4 196.6 230.9 170.4 178.5 199.7 195.6 176.7<br />

Wisconsin 151.7 160.4 158.0 161.1 159.1 185.6 175.3 186.2 192.4 204.4 209.7<br />

Wyoming 169.7 50.6 119.7 159.3 76.1 94.0 168.9 129.9 131.2 76.2 79.8<br />

All 159.6 167.4 161.3 167.8 171.5 177.8 183.6 182.1 183.2 189.8 189.2<br />

Rates are adjusted by age, gender, & race.<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.


ON OUR WEBSITE & CD<br />

Incident counts of reported ESRD patients: U.S. only, with unknowns dropped<br />

(A.10.1).<br />

INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

Table A.10 A.10<br />

Incident counts of reported ESRD patients, by diabetic status & ESRD network<br />

ALL 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992<br />

1 CT, MA, ME, NH, RI, VT 827 842 1,003 1,255 1,271 1,421 1,429 1,565 1,726 1,925 2,080 2,350 2,494<br />

2 NY 1,479 1,629 1,810 2,096 2,279 2,430 2,734 2,858 3,199 3,428 3,906 4,034 4,558<br />

3 NJ, PR, VI 1,123 1,126 1,293 1,437 1,455 1,701 1,753 1,868 2,040 2,341 2,468 2,721 2,996<br />

4 DE, PA 990 1,072 1,229 1,374 1,563 1,810 1,887 1,961 2,205 2,439 2,853 2,987 3,241<br />

5 MD, DC, VA, WV 1,054 1,160 1,369 1,558 1,662 1,759 1,802 2,130 2,323 2,644 2,868 3,432 3,710<br />

6 NC, SC, GA 1,259 1,497 1,606 1,898 1,974 2,262 2,453 2,765 3,248 3,595 3,878 4,470 4,914<br />

7 FL 1,172 1,246 1,319 1,480 1,671 1,814 2,116 2,414 2,587 2,949 3,101 3,509 3,874<br />

8 AL, MS, TN 883 924 1,059 1,402 1,306 1,459 1,542 1,842 2,030 2,761 2,674 2,909 3,241<br />

9 IN, KY, OH 1,282 1,468 1,674 1,896 1,977 2,237 2,371 2,657 3,040 3,270 3,922 4,185 4,612<br />

10 IL 830 974 1,119 1,275 1,313 1,521 1,617 1,734 1,788 1,982 2,302 2,722 2,763<br />

11 MI, MN, ND, SD, WI 1,414 1,540 1,715 1,748 2,093 2,181 2,370 2,692 2,963 3,316 3,480 3,823 4,266<br />

12 IA, KS, MO, NE 721 805 946 1,008 1,112 1,242 1,386 1,503 1,655 1,865 2,091 2,247 2,506<br />

13 AR, LA, OK 669 787 847 979 1,121 1,184 1,358 1,562 1,928 1,981 2,122 2,342 2,631<br />

14 TX 1,078 1,277 1,525 1,754 1,714 1,964 2,189 2,444 2,794 3,201 3,595 3,937 4,444<br />

15 AZ, CO, NV, NM, UT, WY 775 832 903 1,009 1,123 1,213 1,426 1,578 1,718 1,882 1,946 2,209 2,506<br />

16 AK, ID, MT, OR, WA 459 509 576 699 742 814 943 1,001 1,092 1,349 1,397 1,581 1,573<br />

17 N. CA, HI, Guam, AS 871 885 1,001 1,197 1,298 1,429 1,599 1,776 2,100 2,263 2,631 2,772 2,822<br />

18 S. CA 1,124 1,525 1,584 1,862 1,895 2,153 2,476 2,579 2,821 3,242 3,595 3,929 4,140<br />

Unknown * * * * 12 * 20 22 35 29 17 14 27<br />

313<br />

All 18,017 20,102 22,587 25,935 27,581 30,604 33,471 36,951 41,292 46,462 50,926 56,173 61,318<br />

DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 119 187 219 251 296 356 368 428 463 594 673 785 849<br />

2 NY 202 316 392 489 598 629 798 855 997 1,041 1,263 1,367 1,519<br />

3 NJ, PR, VI 170 223 309 373 421 492 565 603 709 826 960 1,069 1,150<br />

4 DE, PA 181 204 274 316 448 473 547 598 698 801 969 1,095 1,195<br />

5 MD, DC, VA, WV 126 195 294 374 426 478 521 592 665 816 956 1,158 1,341<br />

6 NC, SC, GA 161 258 359 391 495 631 667 860 915 1,126 1,317 1,538 1,740<br />

7 FL 129 205 268 298 369 427 585 656 684 811 929 1,049 1,203<br />

8 AL, MS, TN 85 126 183 239 301 329 377 492 552 802 879 986 1,151<br />

9 IN, KY, OH 225 332 389 494 569 646 707 883 984 1,105 1,416 1,566 1,793<br />

10 IL 139 192 255 294 335 447 463 517 522 622 763 923 904<br />

11 MI, MN, ND, SD, WI 345 411 478 533 659 677 822 895 1,016 1,225 1,353 1,527 1,691<br />

12 IA, KS, MO, NE 86 189 256 259 303 368 390 421 512 601 677 796 906<br />

13 AR, LA, OK 65 126 174 210 288 306 402 476 627 683 750 917 1,042<br />

14 TX 158 268 402 423 547 642 704 827 1,024 1,341 1,541 1,683 1,885<br />

15 AZ, CO, NV, NM, UT, WY 184 220 277 343 409 440 582 683 735 840 854 1,048 1,164<br />

16 AK, ID, MT, OR, WA 80 90 141 167 198 249 264 304 386 483 502 573 639<br />

17 N. CA, HI, Guam, AS 89 189 232 263 300 434 490 591 684 868 1,006 1,065 1,144<br />

18 S. CA 146 312 406 500 549 683 839 795 899 1,184 1,329 1,573 1,649<br />

Unknown . . . * * * * * . * * * *<br />

All 2,690 4,043 5,308 6,218 7,513 8,708 10,092 11,477 13,072 15,770 18,138 20,720 22,971<br />

NON-DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 708 655 784 1,004 975 1,065 1,061 1,137 1,263 1,331 1,407 1,565 1,645<br />

2 NY 1,277 1,313 1,418 1,607 1,681 1,801 1,936 2,003 2,202 2,387 2,643 2,667 3,039<br />

3 NJ, PR, VI 953 903 984 1,064 1,034 1,209 1,188 1,265 1,331 1,515 1,508 1,652 1,846<br />

4 DE, PA 809 868 955 1,058 1,115 1,337 1,340 1,363 1,507 1,638 1,884 1,892 2,046<br />

5 MD, DC, VA, WV 928 965 1,075 1,184 1,236 1,281 1,281 1,538 1,658 1,828 1,912 2,274 2,369<br />

6 NC, SC, GA 1,098 1,239 1,247 1,507 1,479 1,631 1,786 1,905 2,333 2,469 2,561 2,932 3,174<br />

7 FL 1,043 1,041 1,051 1,182 1,302 1,387 1,531 1,758 1,903 2,138 2,172 2,460 2,671<br />

8 AL, MS, TN 798 798 876 1,163 1,005 1,130 1,165 1,350 1,478 1,959 1,795 1,923 2,090<br />

9 IN, KY, OH 1,057 1,136 1,285 1,402 1,408 1,591 1,664 1,774 2,056 2,165 2,506 2,619 2,819<br />

10 IL 691 782 864 981 978 1,074 1,154 1,217 1,266 1,360 1,539 1,799 1,859<br />

11 MI, MN, ND, SD, WI 1,069 1,129 1,237 1,215 1,434 1,504 1,548 1,797 1,947 2,091 2,127 2,296 2,575<br />

12 IA, KS, MO, NE 635 616 690 749 809 874 996 1,082 1,143 1,264 1,414 1,451 1,600<br />

13 AR, LA, OK 604 661 673 769 833 878 956 1,086 1,301 1,298 1,372 1,425 1,589<br />

14 TX 920 1,009 1,123 1,331 1,167 1,322 1,485 1,617 1,770 1,860 2,054 2,254 2,559<br />

15 AZ, CO, NV, NM, UT, WY 591 612 626 666 714 773 844 895 983 1,042 1,092 1,161 1,342<br />

16 AK, ID, MT, OR, WA 379 419 435 532 544 565 679 697 706 866 895 1,008 934<br />

17 N. CA, HI, Guam, AS 782 696 769 934 998 995 1,109 1,185 1,416 1,395 1,625 1,707 1,678<br />

18 S. CA 978 1,213 1,178 1,362 1,346 1,470 1,637 1,784 1,922 2,058 2,266 2,356 2,491<br />

Unknown * * * * * * 19 21 35 28 16 12 21<br />

All 15,327 16,059 17,279 19,717 20,068 21,896 23,379 25,474 28,220 30,692 32,788 35,453 38,347<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


AINCIDENCE OF REPORTED ESRD<br />

Reference section A<br />

Table A.10 A.10 (continued)<br />

Incident counts of reported ESRD patients, by diabetic status & ESRD network<br />

314<br />

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

1 CT, MA, ME, NH, RI, VT 2,761 2,990 2,963 3,188 3,354 3,472 3,536 3,728 3,544 3,757 3,839<br />

2 NY 4,948 5,028 5,128 5,523 5,870 6,113 6,311 6,567 6,660 6,883 6,963<br />

3 NJ, PR, VI 3,150 3,374 3,506 3,605 3,880 4,126 4,417 4,299 4,490 4,619 4,786<br />

4 DE, PA 3,284 3,721 3,830 4,184 4,371 4,466 4,702 4,826 4,721 5,096 4,858<br />

5 MD, DC, VA, WV 3,898 4,151 4,517 4,835 5,269 5,512 5,641 5,651 5,868 6,164 6,225<br />

6 NC, SC, GA 5,109 5,691 5,656 6,310 6,606 7,081 7,418 7,762 7,980 8,017 8,367<br />

7 FL 3,935 4,261 4,334 4,881 5,089 5,176 5,543 5,721 5,934 6,224 6,282<br />

8 AL, MS, TN 3,312 3,688 3,794 4,095 4,463 4,517 4,866 4,784 4,870 5,154 5,248<br />

9 IN, KY, OH 4,728 5,122 5,310 5,955 6,105 6,732 7,024 7,403 7,373 7,654 7,843<br />

10 IL 3,103 3,382 3,553 3,899 3,860 4,123 4,339 4,398 4,509 4,911 4,738<br />

11 MI, MN, ND, SD, WI 4,466 4,696 4,758 5,380 5,495 5,909 5,941 6,216 6,573 6,920 6,890<br />

12 IA, KS, MO, NE 2,591 2,791 2,808 3,071 3,315 3,541 3,746 3,780 3,848 3,830 3,946<br />

13 AR, LA, OK 2,722 2,970 3,121 3,172 3,617 3,802 3,994 3,951 4,188 4,387 4,579<br />

14 TX 4,555 4,829 4,979 5,527 5,801 6,242 6,641 6,889 7,085 7,392 7,746<br />

15 AZ, CO, NV, NM, UT, WY 2,700 2,746 2,894 3,148 3,307 3,663 3,940 3,991 4,196 4,234 4,443<br />

16 AK, ID, MT, OR, WA 1,723 1,961 2,108 2,044 2,141 2,211 2,472 2,566 2,657 2,794 2,935<br />

17 N. CA, HI, Guam, AS 3,035 3,361 3,359 3,545 3,789 4,072 4,342 4,464 4,485 4,674 4,772<br />

18 S. CA 4,455 5,097 5,142 5,484 5,861 6,343 6,660 6,952 7,269 7,896 7,958<br />

Unknown 17 109 31 14 * 20 27 18 30 19 149<br />

All 64,492 69,968 71,791 77,860 82,203 87,121 91,560 93,966 96,280 100,625 102,567<br />

DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 958 1,106 1,144 1,240 1,357 1,368 1,404 1,474 1,454 1,497 1,546<br />

2 NY 1,728 1,751 1,948 2,241 2,372 2,447 2,554 2,699 2,858 2,911 2,907<br />

3 NJ, PR, VI 1,241 1,384 1,523 1,648 1,743 1,966 2,078 2,035 2,097 2,171 2,245<br />

4 DE, PA 1,198 1,418 1,560 1,672 1,757 1,859 1,956 2,077 2,077 2,141 2,060<br />

5 MD, DC, VA, WV 1,424 1,592 1,738 1,969 2,226 2,305 2,360 2,364 2,572 2,680 2,533<br />

6 NC, SC, GA 1,873 2,161 2,286 2,722 2,805 3,140 3,168 3,408 3,459 3,486 3,690<br />

7 FL 1,274 1,427 1,544 1,788 1,949 1,957 2,196 2,310 2,459 2,504 2,587<br />

8 AL, MS, TN 1,210 1,369 1,521 1,694 1,865 1,886 2,095 2,096 2,163 2,200 2,315<br />

9 IN, KY, OH 1,845 2,100 2,308 2,657 2,735 3,091 3,195 3,350 3,367 3,441 3,479<br />

10 IL 1,015 1,199 1,357 1,533 1,498 1,601 1,812 1,783 1,833 1,942 1,871<br />

11 MI, MN, ND, SD, WI 1,774 1,885 1,996 2,303 2,391 2,540 2,475 2,621 2,806 2,883 2,828<br />

12 IA, KS, MO, NE 1,007 1,065 1,174 1,327 1,439 1,557 1,610 1,669 1,644 1,665 1,660<br />

13 AR, LA, OK 1,033 1,139 1,289 1,413 1,575 1,761 1,806 1,769 1,895 1,964 2,023<br />

14 TX 2,086 2,191 2,442 2,778 3,032 3,202 3,380 3,664 3,712 3,986 4,124<br />

15 AZ, CO, NV, NM, UT, WY 1,301 1,256 1,496 1,555 1,690 1,859 2,004 2,099 2,175 2,169 2,280<br />

16 AK, ID, MT, OR, WA 665 755 862 835 933 930 1,082 1,098 1,136 1,115 1,200<br />

17 N. CA, HI, Guam, AS 1,240 1,451 1,516 1,657 1,830 1,922 2,017 2,154 2,128 2,251 2,268<br />

18 S. CA 1,709 2,105 2,204 2,417 2,774 2,960 3,179 3,400 3,430 3,693 3,709<br />

Unknown * 30 * * . . . . . * *<br />

All 24,585 27,384 29,912 33,450 35,971 38,351 40,371 42,070 43,265 44,700 45,330<br />

NON-DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 1,803 1,884 1,819 1,948 1,997 2,104 2,132 2,254 2,090 2,260 2,293<br />

2 NY 3,220 3,277 3,180 3,282 3,498 3,666 3,757 3,868 3,802 3,972 4,056<br />

3 NJ, PR, VI 1,909 1,990 1,983 1,957 2,137 2,160 2,339 2,264 2,393 2,448 2,541<br />

4 DE, PA 2,086 2,303 2,270 2,512 2,614 2,607 2,746 2,749 2,644 2,955 2,798<br />

5 MD, DC, VA, WV 2,474 2,559 2,779 2,866 3,043 3,207 3,281 3,287 3,296 3,484 3,692<br />

6 NC, SC, GA 3,236 3,530 3,370 3,588 3,801 3,941 4,250 4,354 4,521 4,531 4,677<br />

7 FL 2,661 2,834 2,790 3,093 3,140 3,219 3,347 3,411 3,475 3,720 3,695<br />

8 AL, MS, TN 2,102 2,319 2,273 2,401 2,598 2,631 2,771 2,688 2,707 2,954 2,933<br />

9 IN, KY, OH 2,883 3,022 3,002 3,298 3,370 3,641 3,829 4,053 4,006 4,213 4,364<br />

10 IL 2,088 2,183 2,196 2,366 2,362 2,522 2,527 2,615 2,676 2,969 2,867<br />

11 MI, MN, ND, SD, WI 2,692 2,811 2,762 3,077 3,104 3,369 3,466 3,595 3,767 4,037 4,062<br />

12 IA, KS, MO, NE 1,584 1,726 1,634 1,744 1,876 1,984 2,136 2,111 2,204 2,165 2,286<br />

13 AR, LA, OK 1,689 1,831 1,832 1,759 2,042 2,041 2,188 2,182 2,293 2,423 2,556<br />

14 TX 2,469 2,638 2,537 2,749 2,769 3,040 3,261 3,225 3,373 3,406 3,622<br />

15 AZ, CO, NV, NM, UT, WY 1,399 1,490 1,398 1,593 1,617 1,804 1,936 1,892 2,021 2,065 2,163<br />

16 AK, ID, MT, OR, WA 1,058 1,206 1,246 1,209 1,208 1,281 1,390 1,468 1,521 1,679 1,735<br />

17 N. CA, HI, Guam, AS 1,795 1,910 1,843 1,888 1,959 2,150 2,325 2,310 2,357 2,423 2,504<br />

18 S. CA 2,746 2,992 2,938 3,067 3,087 3,383 3,481 3,552 3,839 4,203 4,249<br />

Unknown 13 79 27 13 * 20 27 18 30 18 144<br />

All 39,907 42,584 41,879 44,410 46,232 48,770 51,189 51,896 53,015 55,925 57,237<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


INCIDENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportA<br />

Table A.11<br />

Incident rates of reported ESRD, by diabetic status & ESRD network, adjusted<br />

per per million population<br />

ALL 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992<br />

1 CT, MA, ME, NH, RI, VT 82.4 82.2 99.6 124.9 122.9 134.8 137.0 148.0 162.2 182.5 188.1 209.8 225.6<br />

2 NY 83.6 91.0 100.5 114.0 123.2 131.5 146.6 153.1 169.6 181.2 203.4 210.0 234.5<br />

3 NJ 112.3 107.2 121.6 143.4 129.9 158.5 160.2 174.8 181.3 212.7 225.4 249.6 270.7<br />

4 DE, PA 82.5 90.1 102.5 115.3 129.4 147.8 152.4 158.1 174.6 192.8 226.7 232.3 253.1<br />

5 MD, DC, VA, WV 79.4 88.1 102.9 115.5 121.4 125.6 126.3 146.8 156.6 174.8 189.9 223.4 239.7<br />

6 NC, SC, GA 77.0 90.0 96.8 111.5 114.1 128.9 136.2 148.1 170.6 185.5 195.4 225.7 241.2<br />

7 FL 108.3 113.6 117.7 127.2 139.4 149.6 166.2 182.9 191.5 213.9 218.7 237.3 256.6<br />

8 AL, MS, TN 73.2 80.8 88.5 111.9 106.4 112.3 122.3 142.9 160.2 213.4 204.0 222.2 238.4<br />

9 IN, KY, OH 72.4 85.3 94.5 107.8 115.2 126.3 132.1 148.6 164.9 178.2 213.2 225.7 247.8<br />

10 IL 76.1 88.6 103.0 114.2 120.1 139.2 145.8 156.0 160.6 174.9 203.8 238.8 236.9<br />

11 MI, MN, ND, SD, WI 93.8 100.9 109.9 115.7 139.6 141.3 154.7 170.7 187.7 209.3 214.4 231.0 254.9<br />

12 IA, KS, MO, NE 74.8 83.7 100.7 105.4 115.3 124.6 143.0 156.9 169.1 187.4 206.5 222.4 250.2<br />

13 AR, LA, OK 71.0 85.6 90.7 103.7 113.4 120.9 136.0 158.0 196.4 196.9 212.5 229.2 253.7<br />

14 TX 86.9 101.3 115.1 131.5 129.0 140.9 159.3 174.7 197.9 221.6 248.3 272.3 295.8<br />

15 AZ, CO, NV, NM, UT, WY 109.5 115.2 119.5 143.1 139.9 160.4 176.4 189.6 202.8 222.0 215.4 246.3 262.1<br />

16 AK, ID, MT, OR, WA 83.6 73.1 84.7 96.4 112.6 126.5 137.5 143.9 151.5 187.2 185.8 213.7 208.4<br />

17 N. CA, HI 96.1 94.8 108.8 125.1 135.2 144.2 155.0 170.4 190.8 204.2 228.7 238.3 237.3<br />

18 S. CA 83.8 116.7 122.4 147.3 144.9 161.2 180.3 182.2 192.2 218.5 240.6 257.8 268.3<br />

315<br />

All 84.0 93.6 105.1 119.5 125.2 137.3 148.1 161.7 177.8 197.9 214.0 232.5 249.3<br />

DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 11.7 17.8 21.8 25.4 30.9 34.9 37.1 40.6 45.6 57.4 64.3 72.3 79.8<br />

2 NY 11.4 17.5 21.4 26.4 32.8 34.2 42.8 45.7 53.1 54.9 65.5 71.1 78.8<br />

3 NJ 15.8 21.6 27.3 33.2 31.2 42.1 44.9 48.0 55.9 63.2 81.1 86.7 87.0<br />

4 DE, PA 14.7 16.9 22.7 25.9 36.5 37.5 44.4 48.2 55.6 62.3 74.2 85.0 93.3<br />

5 MD, DC, VA, WV * 13.9 22.1 26.9 30.3 32.8 36.0 39.8 44.7 53.3 61.4 73.2 85.8<br />

6 NC, SC, GA * 15.3 21.4 22.2 27.7 34.9 37.5 46.0 46.5 58.3 68.4 80.0 85.7<br />

7 FL 13.1 18.8 24.9 27.4 32.5 37.6 49.7 52.6 52.9 62.9 70.5 74.8 84.0<br />

8 AL, MS, TN * 10.9 14.7 19.7 25.8 26.0 31.4 38.2 47.8 65.0 69.0 75.8 87.1<br />

9 IN, KY, OH 12.9 19.8 21.9 28.3 32.2 37.9 40.2 48.2 52.4 59.1 76.2 82.8 96.9<br />

10 IL 12.9 17.7 23.0 26.9 30.4 40.9 41.6 46.6 45.6 55.1 67.8 80.7 77.1<br />

11 MI, MN, ND, SD, WI 23.6 30.5 30.4 37.5 44.8 46.9 56.1 58.6 69.0 80.1 87.7 94.7 105.1<br />

12 IA, KS, MO, NE * 22.1 28.4 27.2 33.5 40.0 42.0 48.9 54.0 61.9 67.5 81.7 98.2<br />

13 AR, LA, OK * 15.1 20.9 24.4 31.1 33.4 42.0 51.3 66.8 69.7 78.3 91.5 103.0<br />

14 TX 12.8 21.8 30.6 31.4 41.0 45.2 51.2 58.0 72.6 93.4 108.0 117.0 126.4<br />

15 AZ, CO, NV, NM, UT, WY 23.4 31.6 39.2 48.5 51.1 58.3 73.2 81.6 87.6 102.2 93.4 116.3 123.8<br />

16 AK, ID, MT, OR, WA 15.4 14.6 22.4 23.7 29.0 45.6 38.4 47.0 51.2 76.3 73.2 84.9 88.5<br />

17 N. CA, HI * 19.2 24.5 28.1 32.2 43.9 44.5 53.9 60.9 77.8 86.2 86.3 92.3<br />

18 S. CA * 23.4 31.1 39.1 42.2 50.6 61.3 56.2 62.1 80.8 90.0 104.3 107.7<br />

All 12.5 18.8 24.8 28.9 34.1 39.3 44.7 50.3 56.4 67.2 76.6 85.9 93.5<br />

NON-DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 70.7 64.4 77.8 99.5 92.0 99.9 99.8 107.5 116.6 125.1 123.9 137.4 145.8<br />

2 NY 72.3 73.5 79.1 87.6 90.4 97.4 103.9 107.5 116.6 126.4 137.9 138.9 155.7<br />

3 NJ 96.6 85.6 94.3 110.3 98.7 116.5 115.3 126.8 125.3 149.5 144.3 162.9 183.7<br />

4 DE, PA 67.8 73.3 79.8 89.5 92.9 110.3 107.9 109.9 119.0 130.5 152.5 147.3 159.8<br />

5 MD, DC, VA, WV 70.5 74.1 80.8 88.6 91.1 92.8 90.3 107.0 111.8 121.5 128.6 150.2 153.9<br />

6 NC, SC, GA 67.8 74.7 75.4 89.3 86.4 94.1 98.7 102.1 124.1 127.2 127.0 145.7 155.5<br />

7 FL 95.2 94.8 92.9 99.7 106.9 112.0 116.6 130.3 138.6 150.9 148.2 162.5 172.6<br />

8 AL, MS, TN 66.5 69.9 73.9 92.1 80.6 86.3 90.9 104.7 112.5 148.3 135.0 146.4 151.3<br />

9 IN, KY, OH 59.6 65.5 72.5 79.5 83.0 88.4 91.9 100.4 112.5 119.1 137.0 142.9 150.9<br />

10 IL 63.1 70.8 80.0 87.3 89.7 98.3 104.2 109.4 115.0 119.8 136.0 158.1 159.8<br />

11 MI, MN, ND, SD, WI 70.3 70.4 79.5 78.2 94.8 94.4 98.6 112.1 118.8 129.2 126.7 136.3 149.9<br />

12 IA, KS, MO, NE 64.8 61.6 72.3 78.3 81.8 84.5 101.1 108.0 115.1 125.5 138.9 140.7 152.0<br />

13 AR, LA, OK 63.7 70.5 69.8 79.3 82.3 87.6 93.9 106.8 129.6 127.2 134.2 137.7 150.7<br />

14 TX 74.1 79.5 84.5 100.1 88.0 95.7 108.0 116.7 125.4 128.2 140.4 155.3 169.5<br />

15 AZ, CO, NV, NM, UT, WY 86.1 83.6 80.3 94.5 88.8 102.1 103.2 108.0 115.2 119.8 122.0 130.0 138.3<br />

16 AK, ID, MT, OR, WA 68.3 58.5 62.3 72.8 83.6 80.8 99.1 97.0 100.3 111.0 112.6 128.8 119.9<br />

17 N. CA, HI 87.4 75.6 84.3 97.0 103.0 100.3 110.5 116.5 129.8 126.4 142.4 152.0 145.0<br />

18 S. CA 73.5 93.4 91.2 108.2 102.7 110.7 119.0 126.0 130.1 137.7 150.6 153.4 160.5<br />

All 71.5 74.8 80.3 90.7 91.1 97.9 103.4 111.3 121.4 130.8 137.4 146.6 155.9<br />

Rates are adjusted by age, race, & gender.<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

*Values for cells with 10 or fewer patients are suppressed.


AINCIDENCE OF REPORTED ESRD<br />

AReference section A<br />

Table A.11 A.11 (continued) (continued)<br />

Incident rates of of reported ESRD: by diabetic status & ESRD network, adjusted<br />

per<br />

per<br />

million<br />

million<br />

population<br />

population<br />

316<br />

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

1 CT, MA, ME, NH, RI, VT 247 267 260 274 277 285 281 289 268 282 282<br />

2 NY 253 252 251 272 287 294 300 305 307 311 307<br />

3 NJ 283 296 308 305 328 341 362 344 353 355 360<br />

4 DE, PA 251 285 288 306 316 321 336 340 327 349 328<br />

5 MD, DC, VA, WV 245 257 277 290 311 320 327 321 327 336 330<br />

6 NC, SC, GA 245 266 259 280 287 298 304 315 318 315 314<br />

7 FL 258 266 262 284 283 284 294 296 303 306 295<br />

8 AL, MS, TN 234 265 265 279 297 303 318 310 308 317 315<br />

9 IN, KY, OH 247 264 271 303 305 332 344 353 349 358 358<br />

10 IL 263 285 294 321 315 331 348 347 353 378 357<br />

11 MI, MN, ND, SD, WI 264 270 274 297 299 321 318 326 336 346 339<br />

12 IA, KS, MO, NE 254 268 266 291 297 324 332 325 329 322 326<br />

13 AR, LA, OK 258 276 284 286 320 328 344 335 351 361 373<br />

14 TX 297 309 303 328 338 360 374 373 378 387 389<br />

15 AZ, CO, NV, NM, UT, WY 274 269 270 275 283 303 310 305 315 303 314<br />

16 AK, ID, MT, OR, WA 226 251 269 244 240 260 261 275 271 285 285<br />

17 N. CA, HI 255 282 271 282 298 317 318 327 321 323 315<br />

18 S. CA 282 321 321 335 350 376 381 389 397 422 415<br />

All 258 275 277 294 305 318 328 329 331 340 338<br />

DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 89 103 103 110 117 120 116 116 113 115 116<br />

2 NY 88 89 94 109 114 117 120 123 130 130 126<br />

3 NJ 100 108 124 125 133 146 148 144 142 146 144<br />

4 DE, PA 90 108 118 122 126 134 138 145 144 146 139<br />

5 MD, DC, VA, WV 88 98 105 117 131 132 136 135 143 146 133<br />

6 NC, SC, GA 90 103 104 119 120 130 129 136 136 135 137<br />

7 FL 87 94 98 108 112 111 118 121 128 124 122<br />

8 AL, MS, TN 85 101 107 116 125 124 139 137 136 135 140<br />

9 IN, KY, OH 98 108 116 134 138 152 156 158 159 162 159<br />

10 IL 85 101 112 125 122 129 146 142 144 150 143<br />

11 MI, MN, ND, SD, WI 109 112 119 131 134 143 138 142 147 150 143<br />

12 IA, KS, MO, NE 101 104 117 129 135 148 148 148 144 144 140<br />

13 AR, LA, OK 102 109 121 130 142 154 158 151 159 162 164<br />

14 TX 137 140 149 165 177 185 190 199 199 209 207<br />

15 AZ, CO, NV, NM, UT, WY 131 120 142 133 143 154 157 159 162 155 158<br />

16 AK, ID, MT, OR, WA 96 99 110 104 111 109 116 119 126 114 122<br />

17 N. CA, HI 101 117 116 123 138 145 138 149 144 147 140<br />

18 S. CA 110 133 140 150 167 176 183 192 188 198 194<br />

All 99 108 116 127 133 140 144 147 148 150 148<br />

NON-DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 158 163 157 163 160 165 165 173 156 166 167<br />

2 NY 165 164 156 163 172 177 180 181 177 181 181<br />

3 NJ 183 188 184 180 195 195 213 200 211 208 216<br />

4 DE, PA 161 177 170 184 190 188 198 196 183 203 189<br />

5 MD, DC, VA, WV 157 159 172 174 181 188 191 186 184 190 197<br />

6 NC, SC, GA 155 163 156 161 167 168 175 179 182 180 177<br />

7 FL 171 173 164 176 171 173 176 175 175 182 173<br />

8 AL, MS, TN 150 163 158 163 172 179 180 173 171 183 175<br />

9 IN, KY, OH 150 156 155 170 167 180 189 195 190 197 199<br />

10 IL 177 184 182 196 193 202 202 205 209 228 215<br />

11 MI, MN, ND, SD, WI 155 158 155 166 165 178 180 184 189 196 196<br />

12 IA, KS, MO, NE 153 164 149 162 162 176 184 178 185 178 186<br />

13 AR, LA, OK 156 167 163 156 178 174 186 184 191 199 209<br />

14 TX 160 168 155 163 161 175 184 174 180 179 182<br />

15 AZ, CO, NV, NM, UT, WY 143 149 128 141 140 149 153 146 153 148 156<br />

16 AK, ID, MT, OR, WA 130 152 159 140 129 151 144 155 146 171 164<br />

17 N. CA, HI 154 165 155 159 160 172 180 178 177 176 175<br />

18 S. CA 172 188 181 186 183 200 199 197 209 225 221<br />

All 160 167 161 168 171 178 184 182 183 190 189<br />

Rates are adjusted by age, race, & gender.<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.


Reference<br />

B<br />

Section<br />

Prevalence of<br />

reported ESRD


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

318<br />

B.1 . 319<br />

Point prevalent counts of reported ESRD: all patients<br />

patients alive on December 31 of each year, by demographic characteristics<br />

& primary diagnosis<br />

B.2 . 323<br />

Point prevalent rates of reported ESRD<br />

patients alive on December 31 of each year, per million population, by<br />

demographic characteristics & primary diagnosis<br />

B.3 . 327<br />

Point prevalent rates of reported diabetic ESRD<br />

patients alive on December 31 of each year, per million population, by<br />

demographic characteristics<br />

B.4 . 329<br />

Point prevalent counts of reported ESRD patients, 2001-2003<br />

patients alive on December 31 of each year, by age, gender, & race<br />

B.5 . 330<br />

Point prevalent rates of reported ESRD, 2001-2003<br />

patients alive on December 31 of each year, per million population, by age,<br />

gender, & race<br />

B.6 . 331<br />

Mean age at start of ESRD therapy<br />

patients alive on December 31 of each year, by demographic characteristics<br />

& primary diagnosis<br />

B.7 . 333<br />

Prevalence of reported ESRD, by primary diagnosis: all patients<br />

1999-2003 combined, patients alive on December 31 of each year, by detailed<br />

primary diagnosis<br />

B.8 . 335<br />

Point prevalent counts of reported ESRD patients, by diabetic status & state/<br />

territory<br />

B.9 . 341<br />

Point prevalent rates of reported ESRD, by diabetic status & state, adjusted<br />

patients alive on December 31 of each year, per million population<br />

B.10 . 347<br />

Point prevalent counts of reported ESRD patients, by diabetic status & ESRD<br />

network<br />

patients alive on December 31 of each year<br />

B.11 . 349<br />

Point prevalent rates of reported ESRD: by diabetic status & ESRD network,<br />

adjusted<br />

patients alive on December 31 of each year, per million population<br />

B.12 . 351<br />

Period prevalent counts of reported ESRD: all patients<br />

by demographic characteristics & primary diagnosis


ON OUR WEBSITE & CD<br />

Point prevalent counts of reported ESRD: diabetes, hypertension,<br />

glomerulonephritis, & cystic kidney disease (B.1.1-4).<br />

Point prevalent counts of reported ESRD patients (B.a).<br />

Percent decrease in point prevalent counts of ESRD patients (B.b).<br />

PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

Table B.1 B.1<br />

Point prevalent counts of of reported ESRD: all patients<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 73 112 168 208 233 290 315 347 348 357 343 380<br />

5-9 226 237 290 327 387 427 502 544 581 658 711 743<br />

10-14 574 632 715 797 845 864 889 960 1,027 1,073 1,166 1,221<br />

15-19 1,547 1,649 1,743 1,785 1,850 1,982 2,076 2,207 2,302 2,376 2,388 2,430<br />

20-29 6,714 7,514 8,388 9,245 9,969 10,634 11,291 11,796 12,426 13,051 13,726 14,203<br />

30-39 9,269 10,910 12,608 14,452 16,500 18,483 20,434 22,131 24,027 26,146 28,160 30,282<br />

40-49 9,854 11,054 12,453 14,636 16,339 18,082 20,090 22,566 25,504 28,910 32,287 36,427<br />

50-59 13,056 14,814 16,570 18,366 20,121 21,711 23,520 25,336 27,759 30,498 33,617 37,148<br />

60-64 6,271 7,511 8,616 10,180 11,473 12,661 13,572 15,079 16,462 18,085 19,987 21,807<br />

65-69 5,592 6,289 7,141 8,734 9,928 11,120 12,644 14,462 16,139 18,190 20,320 22,670<br />

70-79 5,977 7,043 8,356 10,681 12,474 14,209 16,322 18,477 20,785 23,937 27,398 32,094<br />

80+ 882 1,112 1,409 2,029 2,445 3,039 3,733 4,568 5,388 6,476 7,864 9,316<br />

Unknown * * 14 22 29 29 28 16 12 * 11 *<br />

0-19 2,420 2,630 2,916 3,117 3,315 3,563 3,782 4,058 4,258 4,464 4,608 4,774<br />

20-44 20,727 23,721 27,042 30,876 34,467 38,001 41,867 45,256 49,288 53,816 58,582 63,058<br />

45-64 24,437 28,082 31,593 36,003 39,935 43,570 47,040 51,652 56,890 62,874 69,195 76,809<br />

65-74 9,534 10,846 12,533 15,452 17,629 19,772 22,491 25,453 28,407 32,214 36,553 41,775<br />

75+ 2,917 3,598 4,373 5,992 7,218 8,596 10,208 12,054 13,905 16,389 19,029 22,305<br />

Unknown * * 14 22 29 29 28 16 12 * 11 *<br />

319<br />

Male 33,219 37,886 43,195 50,173 56,377 62,187 68,451 75,307 82,715 91,801 101,588 112,738<br />

Female 26,822 30,997 35,274 41,285 46,211 51,336 56,956 63,172 70,034 77,955 86,379 95,980<br />

Unknown * * * * * * * * 11 11 11 12<br />

White 41,752 47,543 53,845 62,190 69,244 76,265 83,948 92,162 100,702 111,124 122,228 134,853<br />

Black 16,581 19,330 22,338 26,545 30,188 33,597 37,239 41,453 46,337 52,101 58,170 65,063<br />

Native American 351 469 581 762 924 1,069 1,238 1,436 1,663 1,914 2,160 2,450<br />

Asian 413 577 864 1,162 1,483 1,880 2,272 2,716 3,291 3,940 4,695 5,583<br />

Other/unknown 945 966 843 803 754 720 719 722 767 688 725 781<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 5,756 8,039 10,850 13,850 17,360 20,943 24,956 29,330 34,231 40,808 48,017 56,244<br />

Hypertension 9,506 12,236 15,571 19,033 22,266 25,481 28,985 32,771 37,055 42,373 47,756 53,799<br />

Glomerulonephritis 13,537 15,798 18,351 21,320 24,105 26,709 29,275 31,926 34,544 37,413 40,288 43,403<br />

Cystic kidney 3,635 4,212 4,870 5,620 6,236 6,838 7,423 8,090 8,680 9,273 9,970 10,751<br />

Other urologic 1,626 2,065 2,587 3,149 3,679 4,242 4,667 5,177 5,641 6,048 6,356 6,858<br />

Other cause 6,614 7,970 9,676 11,559 13,217 14,829 16,338 17,602 18,913 20,609 22,120 23,735<br />

Unknown cause 6,254 6,748 6,810 7,295 7,675 7,777 8,136 8,627 9,038 9,175 9,603 10,273<br />

Missing disease 13,114 11,817 9,756 9,636 8,055 6,712 5,636 4,966 4,658 4,068 3,868 3,667<br />

U.S. 58,913 67,618 77,048 89,808 100,651 111,322 122,985 135,841 149,706 166,325 184,271 204,828<br />

U.S territories 37 44 58 56 56 69 88 113 126 141 168 203<br />

Puerto Rico 615 710 821 974 1,181 1,336 1,467 1,608 1,753 1,981 2,191 2,407<br />

Foreign 41 51 51 66 69 82 89 92 98 108 143 164<br />

Unknown 436 462 493 558 636 722 787 835 1,077 1,212 1,205 1,128<br />

All 60,042 68,885 78,471 91,462 102,593 113,531 125,416 138,489 152,760 169,767 187,978 208,730<br />

Total lost-to-followup 3,433 4,093 4,964 3,708 3,702 4,136 4,344 4,799 5,292 5,634 5,995 6,210<br />

All with lost-to-followup 63,475 72,978 83,435 95,170 106,295 117,667 129,760 143,288 158,052 175,401 193,973 214,940<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

*Values for cells with 10 or fewer patients are suppressed.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table B.1 B.1 (continued)<br />

Point prevalent counts of of reported ESRD: all patients<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

320<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 394 424 418 420 446 414 430 450 492 495 497 502<br />

5-9 746 777 806 822 842 913 896 918 903 938 952 982<br />

10-14 1,294 1,353 1,457 1,537 1,591 1,586 1,683 1,711 1,799 1,826 1,924 1,902<br />

15-19 2,496 2,598 2,724 2,877 2,964 3,073 3,138 3,268 3,309 3,396 3,473 3,647<br />

20-29 14,716 15,074 15,380 15,624 16,015 16,296 16,620 16,726 16,817 16,847 16,831 16,948<br />

30-39 32,312 34,229 36,123 37,338 38,435 39,233 40,106 40,976 41,721 42,127 42,515 42,832<br />

40-49 40,238 44,246 48,351 52,673 56,557 59,624 63,207 66,264 69,316 71,737 73,998 76,325<br />

50-59 41,332 45,439 50,123 53,972 58,858 64,564 70,767 77,102 83,126 89,328 94,767 100,559<br />

60-64 23,604 25,384 27,419 29,463 31,578 33,786 36,384 38,585 40,793 43,165 46,277 49,560<br />

65-69 25,216 27,479 29,764 31,509 33,749 35,516 37,301 39,231 41,008 42,993 44,813 46,843<br />

70-79 36,476 40,227 45,209 49,131 53,891 58,793 62,866 66,530 69,942 72,239 75,423 77,579<br />

80+ 11,047 12,718 14,501 16,198 18,202 20,335 22,545 24,852 27,714 30,069 32,837 35,277<br />

Unknown * * * * * * * * * * * *<br />

0-19 4,930 5,152 5,405 5,656 5,843 5,986 6,147 6,347 6,503 6,655 6,846 7,033<br />

20-44 67,241 71,167 74,787 77,984 80,952 83,477 86,143 88,380 90,122 91,459 92,428 93,605<br />

45-64 84,961 93,205 102,609 111,086 120,491 130,026 140,941 151,273 161,651 171,745 181,960 192,619<br />

65-74 46,966 51,586 56,680 60,310 64,780 68,950 72,554 75,997 79,423 82,620 85,969 89,105<br />

75+ 25,773 28,838 32,794 36,528 41,062 45,694 50,158 54,616 59,241 62,681 67,104 70,594<br />

Unknown * * * * * * * * * * * *<br />

Male 123,871 134,852 146,834 157,167 169,140 181,135 193,447 205,449 217,217 227,955 239,615 250,523<br />

Female 105,993 115,088 125,436 134,386 143,976 152,985 162,485 171,152 179,710 187,192 194,677 202,400<br />

Unknown 13 12 * 13 14 14 12 13 14 14 16 34<br />

White 147,243 158,626 171,580 181,966 194,293 206,486 218,833 231,476 244,098 255,176 266,451 277,048<br />

Black 72,426 79,577 87,176 93,977 101,167 108,207 115,703 121,844 127,561 132,792 138,624 144,245<br />

Native American 2,798 3,107 3,427 3,752 4,040 4,323 4,710 5,047 5,307 5,591 5,796 5,943<br />

Asian 6,538 7,689 8,851 9,935 10,961 11,992 13,144 14,347 15,551 16,733 17,993 19,129<br />

Other/unknown 872 953 1,246 1,936 2,669 3,126 3,554 3,900 4,424 4,869 5,444 6,592<br />

†Hispanic 31,720 35,417 39,086 42,929 47,126 51,052 55,233 59,608<br />

†Non-Hispanic 281,410 298,717 316,858 333,685 349,815 364,109 379,075 393,349<br />

Diabetes 64,645 72,594 81,832 91,178 101,605 111,989 121,955 130,942 140,532 148,949 157,406 165,113<br />

Hypertension 60,308 65,988 72,260 75,208 79,172 83,197 87,645 92,129 96,268 100,287 104,843 109,642<br />

Glomerulonephritis 46,370 49,419 52,713 55,571 58,599 61,336 64,164 66,706 68,812 70,778 72,771 74,444<br />

Cystic kidney 11,561 12,332 13,165 13,932 14,628 15,335 16,247 17,108 17,968 18,732 19,555 20,409<br />

Other urologic 7,281 7,469 7,817 8,669 9,491 10,241 10,904 11,757 12,338 12,818 13,421 13,861<br />

Other cause 25,468 27,172 28,947 31,067 33,022 34,834 37,024 38,913 40,875 42,477 44,221 46,022<br />

Unknown cause 10,879 11,644 12,383 12,759 13,390 13,960 14,626 15,445 16,264 17,068 17,807 18,656<br />

Missing disease 3,365 3,334 3,163 3,182 3,223 3,242 3,379 3,614 3,884 4,052 4,284 4,810<br />

U.S. 225,716 245,595 267,613 286,830 308,171 329,058 350,651 371,105 391,232 409,298 428,198 446,401<br />

U.S territories 252 275 310 351 404 449 490 548 582 614 674 708<br />

Puerto Rico 2,666 2,858 3,077 3,192 3,397 3,571 3,734 3,878 4,016 4,134 4,304 4,471<br />

Foreign 182 203 230 246 258 269 284 292 304 302 300 286<br />

Unknown 1,061 1,021 1,050 947 900 787 785 791 807 813 832 1,091<br />

All 229,877 249,952 272,280 291,566 313,130 334,134 355,944 376,614 396,941 415,161 434,308 452,957<br />

Total lost-to-followup 6,900 7,596 8,260 9,014 9,691 11,597 13,002 14,239 15,564 17,044 19,230 21,137<br />

All with lost-to-followup 236,777 257,548 280,540 300,580 322,821 345,731 368,946 390,853 412,505 432,205 453,538 474,094<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

*Values for cells with 10 or fewer patients are suppressed.


Table B.1 B.1 (continued)<br />

Point prevalent counts of of reported ESRD patients: U.S. only, with unknowns dropped<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992<br />

0-4 66 104 162 205 227 280 304 332 333 339 329 361 380<br />

5-9 219 231 281 318 374 416 489 534 568 644 692 722 717<br />

10-14 562 615 701 781 823 839 866 934 1,000 1,039 1,137 1,187 1,261<br />

15-19 1,506 1,614 1,707 1,749 1,819 1,946 2,029 2,146 2,225 2,303 2,308 2,364 2,438<br />

20-29 6,534 7,341 8,211 9,040 9,736 10,393 11,036 11,532 12,113 12,728 13,397 13,855 14,360<br />

30-39 8,961 10,557 12,229 14,059 16,053 18,004 19,930 21,577 23,428 25,473 27,475 29,627 31,654<br />

40-49 9,514 10,692 12,085 14,216 15,887 17,575 19,529 21,935 24,757 28,120 31,419 35,474 39,232<br />

50-59 12,621 14,375 16,101 17,859 19,583 21,111 22,883 24,676 26,990 29,674 32,721 36,157 40,239<br />

60-64 6,068 7,282 8,389 9,937 11,212 12,392 13,282 14,768 16,124 17,671 19,533 21,339 23,105<br />

65-69 5,393 6,061 6,936 8,532 9,703 10,881 12,383 14,196 15,863 17,894 20,002 22,318 24,824<br />

70-79 5,753 6,786 8,111 10,420 12,174 13,897 15,998 18,155 20,425 23,579 27,015 31,688 35,978<br />

80+ 850 1,071 1,369 1,971 2,382 2,964 3,650 4,477 5,310 6,388 7,742 9,184 10,909<br />

0-19 2,353 2,564 2,851 3,053 3,243 3,481 3,688 3,946 4,126 4,325 4,466 4,634 4,796<br />

20-44 20,081 23,028 26,311 30,069 33,561 37,009 40,808 44,112 48,000 52,428 57,141 61,591 65,741<br />

45-64 23,617 27,219 30,704 35,042 38,910 42,466 45,852 50,376 55,412 61,238 67,404 74,861 82,849<br />

65-74 9,200 10,450 12,169 15,090 17,217 19,346 22,027 24,983 27,913 31,712 36,011 41,180 46,251<br />

75+ 2,796 3,468 4,247 5,833 7,042 8,396 10,004 11,845 13,685 16,149 18,748 22,010 25,460<br />

321<br />

Male 32,098 36,679 41,950 48,825 54,863 60,598 66,739 73,448 80,661 89,536 99,141 110,146 121,105<br />

Female 25,949 30,050 34,332 40,262 45,110 50,100 55,640 61,814 68,475 76,316 84,629 94,130 103,992<br />

White 40,925 46,615 52,824 61,005 67,846 74,705 82,255 90,354 98,637 108,785 119,676 132,108 144,316<br />

Black 16,375 19,092 22,053 26,215 29,800 33,148 36,741 40,903 45,746 51,463 57,543 64,467 71,803<br />

Native American 349 466 573 750 908 1,054 1,219 1,418 1,642 1,892 2,138 2,430 2,780<br />

Asian 398 556 832 1,117 1,419 1,791 2,164 2,587 3,111 3,712 4,413 5,271 6,198<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 5,534 7,773 10,565 13,527 16,960 20,471 24,359 28,656 33,437 39,874 46,942 55,045 63,278<br />

Hypertension 9,309 11,974 15,276 18,700 21,890 25,032 28,497 32,234 36,462 41,736 47,072 53,080 59,508<br />

Glomerulonephritis 13,203 15,406 17,921 20,810 23,498 26,055 28,593 31,202 33,761 36,550 39,389 42,464 45,403<br />

Cystic kidney 3,590 4,163 4,816 5,563 6,165 6,757 7,339 8,000 8,588 9,180 9,862 10,636 11,425<br />

Other urologic 1,567 1,995 2,505 3,056 3,572 4,115 4,541 5,052 5,488 5,885 6,178 6,686 7,101<br />

Other cause 6,496 7,839 9,527 11,398 13,045 14,640 16,127 17,387 18,675 20,355 21,856 23,445 25,156<br />

Unknown cause 5,922 6,409 6,504 6,960 7,309 7,395 7,745 8,232 8,641 8,808 9,246 9,911 10,520<br />

Missing disease 12,426 11,170 9,168 9,073 7,534 6,233 5,178 4,499 4,084 3,464 3,225 3,009 2,706<br />

All 58,047 66,729 76,282 89,087 99,973 110,698 122,379 135,262 149,136 165,852 183,770 204,276 225,097<br />

Patients dropped 1,995 2,156 2,189 2,375 2,620 2,833 3,037 3,227 3,624 3,915 4,208 4,454 4,780<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table Table B.1 B.1 (continued)<br />

Point prevalent counts of of reported ESRD patients: U.S. only, with unknowns dropped<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

322<br />

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 409 402 402 422 392 410 431 476 474 465 455<br />

5-9 744 769 791 810 881 860 879 867 894 915 938<br />

10-14 1,320 1,417 1,491 1,545 1,533 1,633 1,663 1,742 1,768 1,855 1,808<br />

15-19 2,537 2,649 2,788 2,876 2,987 3,047 3,172 3,206 3,289 3,335 3,483<br />

20-29 14,731 15,029 15,256 15,623 15,871 16,162 16,262 16,290 16,308 16,219 16,246<br />

30-39 33,571 35,400 36,589 37,649 38,422 39,243 40,059 40,737 41,057 41,349 41,479<br />

40-49 43,228 47,268 51,511 55,287 58,286 61,799 64,803 67,761 70,135 72,317 74,421<br />

50-59 44,275 48,853 52,552 57,244 62,789 68,858 75,025 80,903 86,962 92,269 97,688<br />

60-64 24,811 26,746 28,705 30,739 32,882 35,402 37,546 39,631 41,921 44,951 48,070<br />

65-69 27,031 29,292 30,931 33,055 34,762 36,450 38,317 40,040 41,966 43,708 45,627<br />

70-79 39,708 44,639 48,479 53,097 57,864 61,846 65,450 68,728 70,932 74,006 76,017<br />

80+ 12,553 14,314 15,990 17,961 20,099 22,298 24,538 27,378 29,704 32,426 34,819<br />

0-19 5,010 5,237 5,472 5,653 5,793 5,950 6,145 6,291 6,425 6,570 6,684<br />

20-44 69,672 73,198 76,324 79,207 81,686 84,235 86,384 87,939 89,147 89,886 90,691<br />

45-64 90,944 100,098 108,289 117,335 126,564 137,229 147,311 157,383 167,236 177,219 187,213<br />

65-74 50,800 55,844 59,316 63,601 67,630 71,079 74,420 77,711 80,823 83,991 86,964<br />

75+ 28,492 32,401 36,084 40,512 45,095 49,515 53,885 58,435 61,779 66,149 69,499<br />

Male 131,949 143,610 153,598 165,158 176,813 188,776 200,418 211,726 222,097 233,252 243,340<br />

Female 112,969 123,168 131,887 141,150 149,955 159,232 167,727 176,033 183,313 190,563 197,711<br />

White 155,560 168,342 178,829 191,179 203,304 215,560 228,072 240,527 251,506 262,669 273,057<br />

Black 78,951 86,555 93,384 100,570 107,614 115,079 121,209 126,945 132,171 137,981 143,584<br />

Native American 3,086 3,408 3,734 4,022 4,302 4,688 5,025 5,288 5,574 5,779 5,926<br />

Asian 7,321 8,473 9,538 10,537 11,548 12,681 13,839 14,999 16,159 17,386 18,484<br />

†Hispanic 28,226 31,219 34,351 37,712 41,387 44,868 48,463 52,078<br />

†Non-Hispanic 278,082 295,549 313,657 330,433 346,372 360,542 375,352 388,973<br />

Diabetes 71,141 80,193 89,221 99,211 109,277 118,995 127,702 137,002 145,158 153,311 160,453<br />

Hypertension 65,111 71,286 74,154 78,021 81,964 86,312 90,752 94,788 98,707 103,124 107,654<br />

Glomerulonephritis 48,413 51,637 54,400 57,347 59,991 62,720 65,176 67,178 69,063 70,953 72,498<br />

Cystic kidney 12,174 12,981 13,743 14,413 15,113 16,012 16,871 17,708 18,456 19,260 20,068<br />

Other urologic 7,288 7,632 8,455 9,265 10,010 10,673 11,490 12,054 12,523 13,093 13,531<br />

Other cause 26,820 28,534 30,631 32,538 34,334 36,473 38,332 40,219 41,781 43,456 45,205<br />

Unknown cause 11,290 12,019 12,362 12,976 13,519 14,154 14,950 15,725 16,490 17,189 17,949<br />

Missing disease 2,681 2,496 2,519 2,537 2,560 2,669 2,872 3,085 3,232 3,429 3,693<br />

All 244,918 266,778 285,485 306,308 326,768 348,008 368,145 387,759 405,410 423,815 441,051<br />

Patients dropped 5,034 5,502 6,081 6,822 7,366 7,936 8,469 9,182 9,751 10,493 11,906<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


ON OUR WEBSITE & CD<br />

Point prevalent rates of reported ESRD: diabetes, hypertension, glomerulonephritis,<br />

cystic kidney disease, adjusted (B.2.1-4).<br />

PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

Table B.2 B.2<br />

Point prevalent rates of of reported ESRD<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population,<br />

population,<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992<br />

0-4 4.0 6.1 9.3 11.6 12.8 15.6 16.9 18.3 18.2 18.2 17.3 18.6 19.4<br />

5-9 13.1 14.4 17.6 19.6 22.7 24.6 28.3 30.4 31.8 35.8 38.1 39.3 38.7<br />

10-14 30.9 33.8 38.9 44.2 47.7 50.1 52.7 56.8 60.1 61.1 65.0 65.9 68.2<br />

15-19 71.9 79.7 86.8 91.3 96.6 103.7 108.2 115.4 121.5 128.4 131.7 137.0 140.4<br />

20-29 159.1 174.3 192.8 210.8 226.6 242.9 260.6 276.4 294.7 313.6 332.5 347.0 364.7<br />

30-39 277.1 313.4 352.1 393.0 433.9 469.4 506.5 539.5 574.8 613.7 647.9 684.6 719.5<br />

40-49 409.9 460.0 505.4 575.4 626.0 676.4 720.9 769.1 831.8 907.2 974.2 1,057.6 1,130.6<br />

50-59 542.9 624.7 707.9 795.2 882.3 959.6 1,047.6 1,134.9 1,242.0 1,361.6 1,487.7 1,614.5 1,740.3<br />

60-64 596.4 696.0 790.6 926.2 1,032.9 1,138.7 1,227.5 1,369.1 1,500.0 1,657.3 1,840.4 2,024.6 2,224.9<br />

65-69 607.4 677.1 765.1 930.4 1,045.7 1,152.2 1,284.6 1,451.8 1,603.7 1,786.0 1,988.5 2,228.0 2,477.5<br />

70-79 487.7 561.0 655.0 823.4 943.3 1,058.2 1,197.8 1,335.6 1,477.8 1,678.3 1,881.9 2,153.5 2,396.4<br />

80+ 160.0 196.2 243.3 340.2 399.5 483.1 577.4 688.4 793.7 927.6 1,088.0 1,249.1 1,436.2<br />

0-19 32.5 35.8 40.1 43.2 46.1 49.5 52.4 55.8 58.0 60.4 61.8 63.5 64.8<br />

20-44 235.1 261.6 292.0 326.7 357.7 388.0 422.0 451.9 487.6 527.1 565.9 604.0 642.3<br />

45-64 529.4 612.0 690.6 787.4 873.1 951.6 1,024.6 1,115.6 1,213.3 1,329.0 1,446.8 1,569.2 1,683.3<br />

65-74 583.0 652.4 747.4 913.4 1,028.3 1,138.1 1,274.5 1,425.4 1,573.0 1,763.6 1,978.7 2,239.3 2,488.0<br />

75+ 274.0 330.7 393.5 525.5 617.5 716.7 831.2 959.2 1,081.2 1,244.8 1,406.4 1,607.3 1,813.4<br />

323<br />

Male 289.1 327.4 370.9 427.7 476.2 521.1 568.4 619.7 674.0 740.4 808.9 885.9 960.3<br />

Female 221.0 253.5 287.0 333.7 370.7 408.2 449.4 495.0 543.6 600.1 657.4 721.8 787.2<br />

White 208.8 236.2 265.8 304.9 336.9 368.5 403.0 439.8 476.9 522.0 568.6 620.9 671.0<br />

Black 606.9 698.8 796.5 934.9 1,049.6 1,152.8 1,261.1 1,385.4 1,528.3 1,695.8 1,858.1 2,037.8 2,222.5<br />

Native American 238.6 308.5 365.7 461.2 538.2 601.9 670.6 751.2 836.6 929.0 1,021.6 1,122.6 1,239.9<br />

Asian 99.1 126.4 175.3 219.9 261.4 309.2 351.2 395.9 448.9 507.9 569.2 645.0 720.7<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 24.2 33.7 45.4 57.6 71.6 85.6 101.0 117.7 136.1 160.7 186.8 216.1 245.1<br />

Hypertension 40.8 51.9 65.6 79.6 92.4 104.7 118.1 132.4 148.4 168.2 187.3 208.4 230.5<br />

Glomerulonephritis 57.8 66.8 77.0 88.6 99.2 109.0 118.5 128.2 137.4 147.3 156.7 166.7 175.8<br />

Cystic kidney 15.7 18.1 20.7 23.7 26.0 28.3 30.4 32.9 35.0 37.0 39.2 41.8 44.3<br />

Other urologic 6.9 8.7 10.8 13.0 15.1 17.2 18.8 20.8 22.3 23.7 24.6 26.3 27.5<br />

Other cause 28.4 34.0 40.9 48.5 55.1 61.3 66.9 71.4 76.0 82.0 87.0 92.0 97.4<br />

Unknown cause 25.9 27.8 28.0 29.6 30.9 30.9 32.1 33.8 35.2 35.5 36.8 38.9 40.7<br />

Missing disease 54.4 48.5 39.4 38.6 31.8 26.1 21.5 18.5 16.6 14.0 12.8 11.8 10.5<br />

All 254.1 289.4 327.8 379.4 422.1 463.1 507.4 555.7 607.1 668.5 731.3 801.9 871.7<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

*Values for cells with 10 or fewer patients are suppressed.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table B.2 B.2 (continued)<br />

Point prevalent rates of of reported ESRD<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population,<br />

population,<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

324<br />

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 20.7 20.4 20.6 21.8 20.4 21.4 22.5 24.7 24.4 23.6 22.9<br />

5-9 39.5 40.0 40.3 40.4 43.2 41.8 42.6 42.6 44.5 46.1 47.7<br />

10-14 70.0 74.2 77.2 79.2 77.8 81.6 81.5 84.0 84.2 87.7 85.1<br />

15-19 143.5 146.2 149.5 150.1 152.3 152.6 157.0 158.4 162.0 163.4 169.5<br />

20-29 380.4 393.6 403.0 413.6 418.9 424.6 425.0 422.3 418.3 410.0 403.9<br />

30-39 754.1 790.3 816.8 845.3 871.0 898.4 925.4 945.7 959.4 976.0 990.9<br />

40-49 1,206.3 1,272.1 1,334.2 1,392.8 1,440.1 1,493.0 1,531.8 1,569.9 1,598.1 1,626.4 1,654.4<br />

50-59 1,846.4 1,977.5 2,072.7 2,157.5 2,238.3 2,345.5 2,447.1 2,528.4 2,621.5 2,691.1 2,760.5<br />

60-64 2,427.4 2,636.7 2,835.5 3,028.0 3,190.0 3,353.3 3,467.2 3,606.4 3,692.2 3,793.1 3,888.9<br />

65-69 2,696.2 2,931.5 3,102.3 3,336.5 3,560.4 3,793.2 4,044.6 4,199.6 4,388.4 4,522.0 4,643.2<br />

70-79 2,603.0 2,882.6 3,091.6 3,350.3 3,610.4 3,824.6 4,022.9 4,229.4 4,383.7 4,598.7 4,752.7<br />

80+ 1,602.0 1,773.2 1,925.3 2,108.9 2,305.0 2,497.4 2,683.5 2,904.8 3,053.2 3,241.0 3,395.6<br />

0-19 66.7 68.8 70.9 72.4 73.4 74.7 76.4 78.0 79.5 81.0 82.2<br />

20-44 678.5 711.1 739.9 766.3 788.6 811.8 831.1 843.0 851.9 857.0 863.2<br />

45-64 1,797.2 1,922.9 2,020.5 2,120.5 2,210.4 2,314.2 2,398.7 2,478.9 2,551.3 2,619.6 2,683.8<br />

65-74 2,710.6 2,966.0 3,147.5 3,391.3 3,630.7 3,843.2 4,057.1 4,234.7 4,413.8 4,585.9 4,736.9<br />

75+ 1,982.0 2,200.8 2,388.0 2,610.6 2,839.2 3,053.9 3,257.1 3,466.2 3,599.9 3,791.2 3,922.9<br />

Male 1,032.6 1,109.8 1,172.4 1,245.2 1,316.5 1,388.4 1,456.1 1,520.7 1,577.7 1,639.3 1,692.3<br />

Female 844.7 910.4 963.9 1,020.0 1,071.5 1,125.5 1,173.0 1,219.0 1,257.6 1,295.4 1,331.9<br />

White 716.1 767.5 807.7 855.4 901.2 946.8 992.9 1,038.7 1,077.1 1,115.8 1,150.7<br />

Black 2,396.3 2,579.6 2,736.0 2,897.3 3,048.5 3,207.0 3,324.2 3,435.1 3,530.5 3,639.5 3,740.7<br />

Native American 1,329.3 1,419.2 1,500.6 1,558.5 1,607.5 1,686.7 1,741.1 1,754.1 1,826.1 1,869.7 1,892.6<br />

Asian 812.7 901.1 971.9 1,028.8 1,082.0 1,140.8 1,195.4 1,240.2 1,288.8 1,339.4 1,377.0<br />

†Hispanic 935.3 986.7 1,035.9 1,086.3 1,138.4 1,187.8 1,236.5 1,282.6<br />

†Non-Hispanic 1,154.6 1,218.2 1,284.0 1,343.7 1,400.7 1,449.4 1,500.2 1,545.9<br />

Diabetes 272.0 303.0 333.1 366.1 398.5 428.9 455.1 483.0 506.6 529.8 549.1<br />

Hypertension 249.0 269.3 276.9 287.9 298.9 311.1 323.4 334.2 344.5 356.4 368.4<br />

Glomerulonephritis 185.1 195.1 203.1 211.6 218.8 226.1 232.3 236.9 241.0 245.2 248.1<br />

Cystic kidney 46.6 49.0 51.3 53.2 55.1 57.7 60.1 62.4 64.4 66.6 68.7<br />

Other urologic 27.9 28.8 31.6 34.2 36.5 38.5 40.9 42.5 43.7 45.2 46.3<br />

Other cause 102.6 107.8 114.4 120.1 125.2 131.5 136.6 141.8 145.8 150.2 154.7<br />

Unknown cause 43.2 45.4 46.2 47.9 49.3 51.0 53.3 55.4 57.6 59.4 61.4<br />

Missing disease 10.3 9.4 9.4 9.4 9.3 9.6 10.2 10.9 11.3 11.9 12.6<br />

All 936.5 1,007.8 1,065.9 1,130.2 1,191.5 1,254.3 1,311.8 1,367.1 1,414.9 1,464.5 1,509.3<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

*Values for cells with 10 or fewer patients are suppressed.


Table B.2 B.2 (continued)<br />

Point prevalent rates of of reported ESRD<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population,<br />

population,<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

ADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992<br />

0-4 3.9 6.1 9.2 11.5 12.4 15.3 16.5 18.0 17.7 17.8 17.1 18.3 19.0<br />

5-9 12.9 14.1 17.3 19.3 22.4 24.4 28.1 30.0 31.6 35.2 37.2 38.5 37.9<br />

10-14 30.5 33.1 38.7 44.1 47.3 49.8 52.3 56.1 59.3 60.5 64.3 65.3 67.5<br />

15-19 70.7 78.6 85.8 90.0 95.2 102.3 107.0 114.1 119.9 126.3 129.6 134.9 138.3<br />

20-29 160.1 174.8 192.9 210.7 225.9 241.3 257.8 272.3 289.6 307.8 326.4 340.9 358.4<br />

30-39 291.2 330.3 369.4 411.0 452.4 487.1 523.6 556.8 591.6 629.5 662.9 697.8 730.9<br />

40-49 436.6 490.3 541.6 620.9 678.2 732.2 781.1 836.1 904.7 989.0 1,058.1 1,145.8 1,217.0<br />

50-59 596.6 689.5 782.6 879.2 976.2 1,062.4 1,158.3 1,255.9 1,376.6 1,509.7 1,648.4 1,792.7 1,936.0<br />

60-64 665.6 783.8 900.6 1,060.1 1,185.3 1,314.7 1,410.5 1,566.3 1,716.9 1,897.7 2,102.7 2,300.6 2,525.2<br />

65-69 665.1 754.9 860.0 1,056.4 1,200.1 1,330.0 1,489.9 1,695.1 1,870.9 2,073.5 2,315.8 2,592.1 2,866.1<br />

70-79 534.6 623.2 737.1 945.3 1,091.9 1,228.0 1,396.2 1,562.9 1,746.5 1,995.7 2,238.5 2,563.3 2,857.7<br />

80+ 185.2 227.9 291.1 413.0 491.8 605.8 720.9 857.2 988.7 1,161.2 1,381.8 1,607.3 1,855.6<br />

0-19 29.5 33.0 37.7 41.2 44.3 47.9 51.0 54.6 57.1 60.0 62.0 64.2 65.7<br />

20-44 261.1 290.4 322.2 359.8 391.3 420.8 453.2 479.7 512.8 549.2 584.0 617.9 652.1<br />

45-64 582.3 675.5 765.7 876.3 973.5 1,064.1 1,146.5 1,252.5 1,369.5 1,505.9 1,643.6 1,791.4 1,937.3<br />

65-74 641.3 728.8 839.8 1,040.8 1,184.7 1,315.7 1,482.5 1,662.5 1,840.1 2,065.1 2,327.9 2,633.6 2,921.8<br />

75+ 274.1 333.2 412.3 563.8 666.1 788.7 919.8 1,070.1 1,220.4 1,419.0 1,633.6 1,888.7 2,149.7<br />

325<br />

Male 336.6 382.0 432.1 500.1 556.3 607.9 660.9 718.3 780.1 856.1 934.0 1,020.4 1,102.3<br />

Female 234.6 268.6 303.2 350.2 387.5 425.0 465.4 509.6 557.9 613.8 669.8 731.8 794.0<br />

White 219.4 247.4 276.9 316.4 348.3 379.6 413.3 448.9 485.2 529.2 575.0 625.4 673.0<br />

Black 823.7 948.8 1,078.0 1,266.9 1,418.7 1,556.7 1,698.3 1,861.4 2,051.3 2,274.1 2,493.5 2,738.8 2,989.4<br />

Native American 343.1 450.0 539.9 696.3 809.7 905.5 1,009.6 1,133.0 1,265.8 1,425.0 1,583.1 1,747.1 1,928.1<br />

Asian 111.2 148.9 214.8 279.0 339.4 405.9 464.5 526.4 603.6 691.2 778.9 885.3 985.7<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 27.2 37.9 50.8 64.3 79.6 95.1 111.6 129.4 149.0 175.4 203.5 234.5 264.7<br />

Hypertension 49.4 62.5 78.1 94.0 108.2 121.7 136.1 151.2 168.4 189.6 209.3 230.9 253.2<br />

Glomerulonephritis 62.7 72.5 83.4 96.3 107.9 118.3 128.0 137.8 147.6 157.8 167.2 177.1 186.1<br />

Cystic kidney 17.5 20.1 23.1 26.5 29.2 31.6 34.0 36.6 38.8 41.1 43.6 46.2 48.7<br />

Other urologic 7.2 9.2 11.4 13.8 16.0 18.2 19.8 21.8 23.4 24.8 25.8 27.4 28.7<br />

Other cause 29.1 34.9 42.2 50.1 56.7 62.9 68.6 73.0 77.8 84.1 89.0 94.1 99.5<br />

Unknown cause 29.1 31.0 31.0 32.9 34.2 34.0 35.1 36.9 38.1 38.3 39.6 41.6 43.4<br />

Missing disease 60.5 54.0 43.9 42.6 34.9 28.6 23.4 20.0 17.9 15.0 13.7 12.5 11.1<br />

All 282.6 322.0 363.8 420.5 466.5 510.4 556.6 606.8 661.1 726.1 791.6 864.4 935.2<br />

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race/ethnicity<br />

are adjusted for gender & age, rates by primary diagnosis are adusted for age, gender, & race.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table Table B.2 B.2 (continued)<br />

Point prevalent rates of of reported ESRD<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population,<br />

population,<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

&<br />

&<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

326<br />

ADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 20.5 20.1 20.2 21.6 20.3 21.2 22.4 24.5 24.2 23.4 22.6<br />

5-9 38.7 39.4 39.7 39.7 42.5 41.3 42.0 41.9 44.1 45.8 47.4<br />

10-14 69.4 73.2 76.0 77.8 76.6 80.2 80.2 82.7 82.5 85.9 83.8<br />

15-19 140.9 143.2 146.6 146.8 148.9 149.2 153.5 155.0 158.5 160.0 165.8<br />

20-29 373.3 385.3 392.9 401.9 406.8 413.1 414.5 414.8 412.8 405.3 399.0<br />

30-39 763.2 797.1 820.7 846.0 868.0 892.1 916.4 936.4 950.4 966.7 981.2<br />

40-49 1,292.4 1,357.0 1,414.5 1,467.1 1,507.8 1,555.3 1,587.0 1,621.1 1,643.3 1,665.8 1,686.7<br />

50-59 2,060.0 2,203.4 2,308.0 2,408.5 2,503.8 2,617.4 2,720.4 2,790.7 2,879.6 2,937.4 2,991.6<br />

60-64 2,739.8 2,960.3 3,169.9 3,374.2 3,544.1 3,717.8 3,837.7 3,973.3 4,077.8 4,202.4 4,321.8<br />

65-69 3,123.9 3,375.2 3,552.4 3,798.4 4,033.8 4,280.3 4,541.1 4,685.1 4,870.1 5,002.1 5,129.3<br />

70-79 3,115.5 3,463.5 3,720.9 4,003.0 4,296.5 4,547.6 4,754.1 4,954.9 5,102.9 5,326.0 5,469.4<br />

80+ 2,063.6 2,284.7 2,475.5 2,722.3 2,948.1 3,203.7 3,431.4 3,664.6 3,813.1 4,021.7 4,193.1<br />

0-19 67.4 69.0 70.6 71.5 72.1 73.0 74.5 76.0 77.3 78.8 79.9<br />

20-44 682.6 708.9 731.6 752.1 769.4 788.7 804.7 816.6 826.1 832.9 841.2<br />

45-64 2,076.1 2,225.3 2,346.1 2,465.2 2,567.4 2,682.6 2,772.7 2,854.1 2,929.8 2,997.1 3,058.3<br />

65-74 3,194.3 3,490.9 3,700.1 3,956.4 4,210.7 4,432.4 4,638.1 4,807.3 4,984.0 5,164.3 5,312.9<br />

75+ 2,364.5 2,629.9 2,848.3 3,112.0 3,367.2 3,639.3 3,878.7 4,103.2 4,244.7 4,456.3 4,609.5<br />

Male 1,180.0 1,262.6 1,326.6 1,400.2 1,469.5 1,540.3 1,604.8 1,662.1 1,711.2 1,763.9 1,805.6<br />

Female 848.8 909.3 957.4 1,006.0 1,048.0 1,093.2 1,131.8 1,165.7 1,193.4 1,218.4 1,242.1<br />

White 715.8 764.4 801.7 844.9 885.6 926.5 967.1 1,006.7 1,038.3 1,068.9 1,095.6<br />

Black 3,216.1 3,454.6 3,645.6 3,838.1 4,017.1 4,200.4 4,323.6 4,430.1 4,518.1 4,622.9 4,712.3<br />

Native American 2,076.9 2,210.9 2,335.8 2,416.1 2,482.8 2,598.7 2,672.0 2,575.9 2,608.4 2,601.6 2,573.5<br />

Asian 1,104.1 1,224.5 1,317.8 1,386.3 1,439.6 1,504.4 1,559.5 1,587.1 1,616.6 1,654.0 1,671.4<br />

†Hispanic 1,592.2 1,693.5 1,791.1 1,888.0 1,957.3 2,018.9 2,079.6 2,129.0<br />

†Non-Hispanic 1,144.6 1,198.6 1,254.8 1,304.5 1,350.3 1,387.6 1,425.3 1,457.6<br />

Diabetes 292.5 324.1 354.4 386.7 417.4 445.6 469.0 492.6 512.0 529.8 543.2<br />

Hypertension 271.5 291.2 296.9 305.7 314.0 323.7 333.4 340.9 348.0 356.4 364.8<br />

Glomerulonephritis 195.2 204.8 212.2 219.7 225.7 232.0 236.8 239.8 242.5 245.2 246.6<br />

Cystic kidney 50.9 53.3 55.4 56.8 58.2 60.2 62.2 63.8 65.2 66.6 67.9<br />

Other urologic 28.9 29.8 32.5 35.1 37.3 39.2 41.5 42.9 43.9 45.2 46.1<br />

Other cause 104.8 109.9 116.6 122.1 126.9 133.1 137.9 142.8 146.3 150.2 154.1<br />

Unknown cause 45.7 47.7 48.3 49.8 50.9 52.4 54.4 56.2 57.9 59.4 61.0<br />

Missing disease 10.8 9.9 9.8 9.7 9.6 9.8 10.4 11.0 11.4 11.9 12.6<br />

All 1,000.3 1,070.8 1,126.1 1,185.5 1,240.1 1,296.1 1,345.7 1,390.0 1,427.2 1,464.5 1,496.2<br />

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race/ethnicity<br />

are adjusted for gender & age, rates by primary diagnosis are adusted for age, gender, & race.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

Table B.3 B.3<br />

Point prevalent rates of of reported diabetic ESRD<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population,<br />

population,<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992<br />

0-4 * * * * * 1 1 1 1 1 1 * *<br />

5-9 * * * * * * * * * * * * *<br />

10-14 * * * * * * * * * * * * *<br />

15-19 1 1 1 1 1 1 1 1 1 1 1 2 2<br />

20-29 11 14 18 21 24 28 30 33 34 38 40 42 43<br />

30-39 37 49 60 73 87 100 111 121 131 143 154 163 173<br />

40-49 43 57 73 90 107 128 148 170 194 223 247 276 303<br />

50-59 56 81 111 139 176 208 244 280 327 386 453 524 586<br />

60-64 66 93 131 175 219 263 306 375 440 523 626 731 835<br />

65-69 57 82 115 153 196 243 304 369 443 533 629 764 916<br />

70-79 31 49 71 98 132 161 203 247 299 380 472 581 686<br />

80+ 6 7 15 21 28 38 53 69 81 108 147 181 227<br />

0-19 . . . . . 1 1 1 1 1 1 1 1<br />

20-44 25 33 41 51 60 70 80 89 98 110 121 131 140<br />

45-64 55 79 108 137 171 204 238 277 322 378 441 505 562<br />

65-74 48 73 103 139 180 218 277 331 401 492 594 724 860<br />

75+ 15 19 30 43 59 80 100 131 153 198 251 308 372<br />

327<br />

Male 26 35 47 59 73 88 102 118 135 158 182 210 238<br />

Female 22 32 44 57 70 84 100 117 138 164 191 221 252<br />

White 20 27 37 46 57 67 79 91 105 124 144 165 187<br />

Black 56 79 108 139 177 213 251 296 342 402 471 546 619<br />

Native American 65 109 136 184 223 271 315 373 434 499 560 635 718<br />

Asian 3 8 17 26 33 48 58 71 81 98 123 148 175<br />

†Hispanic<br />

†Non-Hispanic<br />

All 24 34 45 58 72 86 101 118 136 161 187 216 245<br />

ADJUSTED<br />

0-4 * * * * * 1 1 1 1 1 1 * *<br />

5-9 * * * * * * * * * * * * *<br />

10-14 * * * * * * * * * * * * *<br />

15-19 1 1 1 1 1 1 1 1 1 1 1 2 2<br />

20-29 11 14 18 21 23 27 29 31 33 36 39 41 42<br />

30-39 37 48 60 73 87 100 111 121 131 144 155 164 173<br />

40-49 45 60 76 95 113 135 157 180 206 238 262 294 320<br />

50-59 63 92 126 158 199 237 277 318 370 435 510 590 661<br />

60-64 78 110 159 213 265 316 365 444 521 617 734 851 970<br />

65-69 67 101 138 185 238 299 372 455 537 635 756 913 1,082<br />

70-79 35 57 84 116 157 198 251 305 366 465 572 704 828<br />

80+ 7 8 19 25 37 55 72 87 100 136 192 235 293<br />

0-19 . . . . . . 1 1 1 1 1 1 1<br />

20-44 27 36 45 55 65 75 84 93 101 113 123 132 140<br />

45-64 63 90 124 158 197 235 273 320 374 440 513 592 665<br />

65-74 55 87 122 166 217 265 336 405 483 591 716 871 1,026<br />

75+ 14 19 34 45 64 92 115 143 168 218 283 350 424<br />

Male 31 41 55 69 85 102 119 136 155 182 211 242 273<br />

Female 24 34 47 60 74 88 104 122 142 168 195 225 255<br />

White 22 29 39 48 59 69 81 93 107 126 145 166 187<br />

Black 76 107 147 190 241 292 346 407 471 556 654 762 864<br />

Native American 109 183 227 308 374 452 518 616 715 823 935 1,057 1,187<br />

Asian 4 11 26 39 51 77 94 111 126 154 192 229 270<br />

†Hispanic<br />

†Non-Hispanic<br />

All 27 38 51 64 80 95 112 129 149 175 204 235 265<br />

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race/ethnicity are adjusted for gender & age.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table B.3 B.3 (continued)<br />

Point prevalent rates of of reported diabetic ESRD<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population,<br />

population,<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

328<br />

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 * * * * * . * * * * *<br />

5-9 * * * . * * * * * * *<br />

10-14 * * * * * * * * * * *<br />

15-19 2 2 1 1 1 1 1 1 1 1 1<br />

20-29 41 40 40 38 37 35 33 33 32 30 27<br />

30-39 184 193 197 202 206 208 210 212 208 206 205<br />

40-49 331 356 382 403 417 435 444 458 468 479 488<br />

50-59 638 707 764 824 877 930 979 1,019 1,057 1,090 1,116<br />

60-64 947 1,070 1,201 1,332 1,450 1,573 1,650 1,722 1,793 1,849 1,874<br />

65-69 1,028 1,169 1,296 1,465 1,617 1,769 1,933 2,044 2,164 2,237 2,312<br />

70-79 791 915 1,056 1,211 1,371 1,504 1,619 1,763 1,867 1,987 2,086<br />

80+ 266 314 367 435 522 596 657 758 831 923 981<br />

0-19 1 1 . . . . . . . . .<br />

20-44 149 157 164 169 173 177 178 180 180 178 178<br />

45-64 618 683 740 802 856 910 952 992 1,027 1,061 1,084<br />

65-74 976 1,113 1,250 1,419 1,574 1,711 1,852 1,977 2,090 2,190 2,283<br />

75+ 429 505 595 696 819 925 1,009 1,127 1,206 1,302 1,368<br />

Male 265 295 325 358 395 428 458 490 518 548 573<br />

Female 279 311 341 373 402 430 453 477 495 512 526<br />

White 206 229 250 274 299 321 342 366 385 403 419<br />

Black 692 767 846 934 1,010 1,088 1,140 1,189 1,233 1,286 1,326<br />

Native American 787 845 909 955 1,000 1,062 1,103 1,129 1,181 1,211 1,231<br />

Asian 209 242 275 300 325 351 377 402 430 451 467<br />

†Hispanic 408 445 476 510 545 574 602 627<br />

†Non-Hispanic 361 392 423 447 474 496 518 536<br />

All 272 303 333 366 398 429 455 483 507 530 549<br />

ADJUSTED<br />

0-4 * * * * * . * * * * *<br />

5-9 * * * . * * * * * * *<br />

10-14 * * * * * * * * * * *<br />

15-19 2 2 1 1 1 1 1 1 1 1 1<br />

20-29 40 39 38 36 35 34 32 33 33 30 28<br />

30-39 184 193 196 200 204 205 207 209 207 205 205<br />

40-49 349 375 399 419 432 449 456 470 479 488 495<br />

50-59 723 798 862 933 994 1,050 1,100 1,136 1,172 1,199 1,215<br />

60-64 1,090 1,220 1,360 1,500 1,624 1,758 1,842 1,909 1,994 2,059 2,094<br />

65-69 1,217 1,368 1,509 1,696 1,858 2,021 2,196 2,298 2,416 2,486 2,567<br />

70-79 959 1,113 1,287 1,463 1,649 1,810 1,935 2,086 2,194 2,325 2,420<br />

80+ 349 413 484 573 677 777 851 963 1,044 1,150 1,215<br />

0-19 1 1 . . . . . . . . .<br />

20-44 147 154 159 162 165 168 169 171 172 171 172<br />

45-64 736 815 889 967 1,033 1,099 1,147 1,188 1,229 1,262 1,281<br />

65-74 1,170 1,330 1,490 1,678 1,850 1,998 2,141 2,265 2,377 2,482 2,573<br />

75+ 498 587 690 805 937 1,067 1,162 1,289 1,380 1,490 1,564<br />

Male 303 336 369 404 442 476 505 536 563 589 610<br />

Female 281 311 339 369 393 417 436 454 467 477 485<br />

White 205 228 248 271 294 314 332 354 370 384 396<br />

Black 966 1,070 1,178 1,296 1,397 1,497 1,560 1,612 1,660 1,715 1,749<br />

Native American 1,312 1,402 1,506 1,574 1,642 1,735 1,795 1,745 1,771 1,761 1,745<br />

Asian 318 367 415 450 479 507 538 562 587 602 609<br />

†Hispanic 783 862 926 995 1,048 1,090 1,131 1,159<br />

†Non-Hispanic 357 385 411 432 454 471 487 499<br />

All 293 324 354 387 417 446 469 493 512 530 543<br />

Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race/ethnicity are adjusted for gender & age.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


ON OUR WEBSITE & CD<br />

Point prevalent counts of reported ESRD patients, 1998-2000 (B.4.1).<br />

Point prevalent counts of reported ESRD: by primary diagnosis, 2000-2003<br />

combined (B.4.2).<br />

PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

Table B.4 B.4<br />

Point prevalent counts of of reported ESRD patients, 2001-2003<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

& race<br />

race<br />

Male Female All<br />

White Black N Am Asian All White Black N Am Asian All White Black N Am Asian All<br />

0-4 753 155 * 21 939 370 61 * 16 455 1,123 216 18 37 1,394<br />

5-9 1,315 309 16 45 1,685 878 155 * 25 1,062 2,193 464 20 70 2,747<br />

10-14 2,391 659 53 76 3,179 1,658 490 38 66 2,252 4,049 1,149 91 142 5,431<br />

15-19 4,177 1,346 76 191 5,790 2,994 1,073 59 191 4,317 7,171 2,419 135 382 10,107<br />

20-29 17,071 8,579 299 1,214 27,163 12,931 7,204 343 1,132 21,610 30,002 15,783 642 2,346 48,773<br />

30-39 41,879 25,759 674 2,671 70,983 30,508 19,224 811 2,359 52,902 72,387 44,983 1,485 5,030 123,885<br />

40-49 76,095 46,245 1,575 4,202 128,117 50,944 32,478 1,244 4,090 88,756 127,039 78,723 2,819 8,292 216,873<br />

50-59 94,475 56,425 2,451 5,910 159,261 66,966 43,243 2,299 5,150 117,658 161,441 99,668 4,750 11,060 276,919<br />

60-64 45,051 23,201 1,097 3,135 72,484 35,143 23,396 1,382 2,537 62,458 80,194 46,597 2,479 5,672 134,942<br />

65-69 43,780 19,671 856 2,763 67,070 36,614 23,755 1,254 2,608 64,231 80,394 43,426 2,110 5,371 131,301<br />

70-79 82,059 24,669 823 4,465 112,016 67,576 35,017 1,391 4,955 108,939 149,635 59,686 2,214 9,420 220,955<br />

80+ 39,936 7,811 199 2,056 50,002 31,668 12,811 317 2,151 46,947 71,604 20,622 516 4,207 96,949<br />

0-19 8,636 2,469 155 333 11,593 5,900 1,779 109 298 8,086 14,536 4,248 264 631 19,679<br />

20-44 93,441 54,213 1,634 5,754 155,042 66,903 40,761 1,701 5,317 114,682 160,344 94,974 3,335 11,071 269,724<br />

45-64 181,130 105,996 4,462 11,378 302,966 129,589 84,784 4,378 9,951 228,702 310,719 190,780 8,840 21,329 531,668<br />

65-74 86,846 34,385 1,391 5,192 127,814 72,564 43,995 2,102 5,303 123,964 159,410 78,380 3,493 10,495 251,778<br />

75+ 78,929 17,766 487 4,092 101,274 63,294 27,588 860 4,411 96,153 142,223 45,354 1,347 8,503 197,427<br />

329<br />

Diabetes 154,948 64,443 4,935 9,021 233,347 129,463 81,356 6,269 8,487 225,575 284,411 145,799 11,204 17,508 458,922<br />

Hypertension 88,042 86,692 797 6,476 182,007 57,762 63,632 600 5,484 127,478 145,804 150,324 1,397 11,960 309,485<br />

Glomerulonephritis 87,139 32,516 1,326 7,030 128,011 53,571 23,304 1,289 6,339 84,503 140,710 55,820 2,615 13,369 212,514<br />

Other cause 118,853 31,178 1,071 4,222 155,324 97,454 30,615 992 4,970 134,031 216,307 61,793 2,063 9,192 289,355<br />

All 448,982 214,829 8,129 26,749 698,689 338,250 198,907 9,150 25,280 571,587 787,232 413,736 17,279 52,029 1,270,276<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

*Values for cells with 10 or fewer patients are suppressed.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table B.5 B.5<br />

Point prevalent rates of of reported ESRD, 2001-2003<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population,<br />

population,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

& race<br />

race<br />

ON OUR WEBSITE & CD<br />

Point prevalent rates of reported ESRD, 1998-2000 (B.5.1).<br />

Point prevalent rates of reported ESRD: by primary diagnosis (B.5.2).<br />

330<br />

Unadjusted rates<br />

Rates adjusted for:<br />

Male Female Gender Race Gender &<br />

White Black N Am Asian White Black N Am Asian White Black N Am Asian Male Female race<br />

0-4 32 32 * 15 16 13 * 12 24 22 25 14 31 16 23<br />

5-9 55 62 38 33 39 32 * 19 47 47 24 26 55 37 46<br />

10-14 95 123 114 55 69 94 84 51 82 108 99 53 97 72 84<br />

15-19 168 277 169 139 128 228 137 147 148 252 153 143 181 142 161<br />

20-29 353 1,020 381 371 286 819 472 344 322 943 439 352 449 365 406<br />

30-39 811 3,215 964 763 611 2,149 1,190 645 707 2,668 1,078 710 1,123 818 966<br />

40-49 1,388 6,006 2,421 1,487 930 3,696 1,828 1,311 1,159 4,885 2,147 1,410 2,024 1,326 1,665<br />

50-59 2,211 11,274 5,694 3,044 1,520 7,229 5,012 2,299 1,879 9,410 5,510 2,729 3,524 2,381 2,936<br />

60-64 3,075 15,119 8,496 5,109 2,219 11,912 9,867 3,665 2,637 13,482 9,203 4,370 4,797 3,634 4,201<br />

65-69 3,738 16,260 9,404 5,936 2,758 14,562 12,053 4,614 3,239 15,394 10,749 5,264 5,536 4,486 5,001<br />

70-79 4,429 15,785 7,610 7,512 2,808 14,299 10,118 6,061 3,616 14,945 8,751 6,841 6,099 4,526 5,299<br />

80+ 4,280 11,456 4,707 8,001 1,787 8,547 4,203 5,599 2,944 9,713 4,241 6,623 5,208 2,850 4,009<br />

0-19 89 123 92 61 64 91 66 57 75 107 75 59 91 67 79<br />

20-44 729 2,644 892 696 543 1,822 963 620 617 2,238 949 662 970 704 833<br />

45-64 2,158 10,437 5,167 2,933 1,495 7,005 4,759 2,248 1,922 9,526 5,702 2,866 3,546 2,473 2,995<br />

65-74 3,962 16,238 8,923 6,408 2,814 14,760 11,488 5,134 3,388 15,491 10,128 5,825 5,747 4,582 5,154<br />

75+ 4,472 13,290 5,692 8,078 2,162 10,617 6,420 6,010 3,194 11,242 5,492 6,847 5,552 3,359 4,437<br />

Diabetes 444 1,189 1,066 476 363 1,367 1,350 424 384 1,708 1,759 599 916 783 849<br />

Hypertension 252 1,599 172 342 162 1,069 129 274 194 1,712 220 412 848 486 662<br />

Glomerulonephritis 250 600 286 371 150 392 277 317 194 561 332 370 367 209 286<br />

Other cause 340 575 231 223 273 514 214 248 59 127 57 53 102 70 86<br />

All 1,286 3,963 1,756 1,413 947 3,342 1,970 1,263 1,115 3,638 1,863 1,336 1,637 1,295 1,463<br />

All (age adjusted) 1,309 5,344 2,510 1,872 871 3,954 2,656 1,468 1,068 4,618 2,594 1,647 1,760 1,218 1,463<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

*Values for cells with 10 or fewer patients are suppressed.


ON OUR WEBSITE & CD<br />

Median age at start of ESRD therapy: Prevalent patients by demographic<br />

characteristics & primary diagnosis (B.c).<br />

PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

Table B.6 B.6<br />

Mean age at start of ESRD therapy<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992<br />

0-4 2.4 2.5 2.4 2.4 2.3 2.3 2.3 2.4 2.4 2.4 2.4 2.2 2.3<br />

5-9 7.4 7.4 7.3 7.3 7.2 7.1 7.2 7.2 7.2 7.1 7.2 7.2 7.3<br />

10-14 12.3 12.2 12.4 12.4 12.4 12.3 12.3 12.2 12.2 12.3 12.3 12.2 12.2<br />

15-19 17.4 17.3 17.4 17.4 17.3 17.3 17.3 17.3 17.4 17.4 17.4 17.3 17.3<br />

20-29 25.1 25.1 25.1 25.2 25.2 25.3 25.3 25.4 25.4 25.4 25.5 25.4 25.4<br />

30-39 34.5 34.5 34.5 34.5 34.6 34.6 34.7 34.8 34.8 34.8 34.8 34.8 34.9<br />

40-49 44.6 44.6 44.6 44.5 44.6 44.6 44.5 44.5 44.4 44.4 44.4 44.5 44.5<br />

50-59 54.7 54.7 54.7 54.8 54.7 54.7 54.7 54.7 54.7 54.6 54.6 54.7 54.6<br />

60-64 61.9 61.9 62.0 62.0 62.0 62.0 62.0 62.0 62.0 62.0 62.0 62.1 62.1<br />

65-69 66.9 67.0 66.9 66.9 66.9 66.9 66.9 66.9 67.0 67.0 67.0 67.0 67.0<br />

70-79 73.5 73.5 73.6 73.6 73.7 73.8 73.8 73.9 73.9 73.9 73.9 73.9 73.9<br />

80+ 82.7 82.9 83.0 82.8 82.9 83.0 83.0 83.0 83.1 83.1 83.2 83.3 83.3<br />

0-19 14.8 14.6 14.3 14.0 13.8 13.6 13.5 13.5 13.5 13.4 13.4 13.2 13.3<br />

20-44 33.2 33.2 33.3 33.5 33.6 33.7 33.9 34.1 34.3 34.5 34.7 34.8 35.0<br />

45-64 54.9 55.1 55.1 55.2 55.2 55.2 55.2 55.1 55.1 55.0 55.0 55.0 54.9<br />

65-74 68.9 69.0 69.1 69.1 69.1 69.1 69.1 69.1 69.1 69.1 69.1 69.2 69.2<br />

75+ 78.5 78.6 78.8 78.7 78.8 78.9 79.0 79.1 79.2 79.3 79.5 79.5 79.6<br />

331<br />

Male 48.6 48.7 48.9 49.5 49.7 50.0 50.3 50.6 50.9 51.3 51.8 52.4 52.8<br />

Female 49.9 50.3 50.6 51.4 51.8 52.1 52.5 53.0 53.3 53.7 54.1 54.6 55.1<br />

Unknown 29.0 31.5 32.5 39.8 38.8 34.6 36.7 37.5 43.3 44.3 45.3 48.5 50.5<br />

White 48.9 49.1 49.3 50.0 50.3 50.6 51.0 51.4 51.8 52.4 52.9 53.5 54.0<br />

Black 50.0 50.4 50.6 51.3 51.6 51.9 52.2 52.5 52.7 52.8 53.1 53.5 53.8<br />

Native American 45.3 46.8 47.6 49.0 49.3 49.8 50.1 50.8 51.4 52.1 52.3 52.6 53.0<br />

Asian 41.1 43.1 44.5 46.2 47.3 47.9 48.6 49.4 49.9 50.5 51.3 52.2 52.7<br />

Other/unknown 51.4 52.3 51.5 51.0 50.2 49.3 48.7 48.1 47.0 45.3 45.4 45.6 46.9<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 49.7 50.3 51.0 51.5 52.1 52.4 52.9 53.5 54.0 54.6 55.3 56.0 56.5<br />

Hypertension 52.7 54.0 55.0 56.0 56.5 57.0 57.6 58.2 58.4 58.8 59.2 59.7 59.9<br />

Glomerulonephritis 42.5 43.1 43.6 44.3 44.8 45.3 45.7 46.0 46.2 46.5 46.8 47.2 47.4<br />

Cystic kidney 52.2 52.5 52.8 53.3 53.5 53.7 53.8 54.0 54.1 54.1 54.2 54.2 54.4<br />

Other urologic 46.0 47.7 48.4 49.7 50.6 51.3 51.5 51.8 52.0 52.2 51.9 52.2 52.2<br />

Other cause 42.7 43.2 43.7 44.2 44.3 44.5 44.7 44.7 44.8 45.0 45.1 45.2 45.5<br />

Unknown cause 51.6 52.0 52.0 52.5 53.1 53.1 53.3 53.7 53.8 53.4 53.3 53.5 53.5<br />

Missing disease 54.8 54.4 53.9 55.2 54.9 54.3 52.9 52.2 51.3 50.1 49.6 49.3 48.1<br />

U.S. 49.2 49.4 49.6 50.3 50.7 50.9 51.3 51.7 52.1 52.5 52.9 53.5 53.9<br />

U.S. territories 51.2 48.7 50.9 49.3 49.3 49.7 52.1 52.9 50.9 50.4 51.6 53.2 52.5<br />

Puerto Rico 49.2 49.5 49.3 50.2 50.9 51.4 51.5 51.5 52.0 52.8 53.2 53.4 54.0<br />

Foreign 48.5 48.2 47.9 49.3 51.1 50.7 51.6 52.4 50.6 50.8 50.7 48.9 48.6<br />

Unknown 48.5 49.2 49.3 48.9 47.9 47.4 47.7 45.9 45.2 45.1 45.5 45.5 45.6<br />

All 49.2 49.4 49.6 50.3 50.6 50.9 51.3 51.7 52.0 52.4 52.9 53.4 53.9<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

Patients with unknown age are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table B.6 B.6 (continued)<br />

Mean age at start of ESRD therapy<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

332<br />

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 2.3 2.4 2.4 2.5 2.4 2.3 2.3 2.3 2.4 2.4 2.3<br />

5-9 7.3 7.3 7.2 7.2 7.2 7.2 7.3 7.3 7.3 7.2 7.2<br />

10-14 12.2 12.2 12.2 12.2 12.3 12.2 12.3 12.2 12.3 12.3 12.3<br />

15-19 17.3 17.3 17.3 17.3 17.2 17.3 17.3 17.3 17.2 17.2 17.2<br />

20-29 25.4 25.4 25.4 25.4 25.5 25.5 25.5 25.4 25.4 25.3 25.3<br />

30-39 34.9 34.9 34.9 35.0 35.1 35.1 35.1 35.1 35.1 35.1 35.1<br />

40-49 44.5 44.6 44.7 44.7 44.7 44.7 44.8 44.8 44.8 44.8 44.9<br />

50-59 54.6 54.6 54.6 54.5 54.5 54.5 54.5 54.5 54.5 54.5 54.5<br />

60-64 62.0 62.0 62.0 62.0 62.0 62.0 62.0 62.0 62.0 62.0 62.0<br />

65-69 67.0 67.0 67.0 67.0 67.0 67.0 67.0 67.0 67.0 67.0 67.0<br />

70-79 73.9 73.9 73.9 74.0 74.0 74.1 74.2 74.2 74.2 74.2 74.2<br />

80+ 83.3 83.3 83.4 83.5 83.6 83.6 83.7 83.7 83.7 83.7 83.8<br />

0-19 13.2 13.3 13.3 13.3 13.4 13.4 13.4 13.4 13.4 13.4 13.4<br />

20-44 35.1 35.2 35.3 35.4 35.5 35.6 35.7 35.7 35.8 35.8 35.8<br />

45-64 54.8 54.7 54.7 54.6 54.6 54.6 54.6 54.6 54.7 54.7 54.8<br />

65-74 69.3 69.3 69.4 69.4 69.4 69.4 69.4 69.4 69.4 69.4 69.3<br />

75+ 79.7 79.7 79.7 79.8 79.8 79.9 80.0 80.1 80.1 80.2 80.3<br />

Male 53.2 53.5 53.8 54.2 54.6 55.0 55.3 55.6 55.8 56.1 56.3<br />

Female 55.4 55.8 56.1 56.4 56.8 57.0 57.2 57.4 57.6 57.9 58.0<br />

Unknown 48.0 49.3 53.0 55.0 56.0 59.0 58.2 57.9 58.9 59.6 60.7<br />

White 54.4 54.9 55.2 55.7 56.1 56.5 56.8 57.2 57.4 57.7 57.9<br />

Black 53.9 54.2 54.3 54.4 54.7 54.9 54.9 55.1 55.2 55.4 55.6<br />

Native American 53.5 53.7 53.9 54.0 54.4 54.6 54.9 55.1 55.2 55.5 55.8<br />

Asian 53.4 54.2 54.8 55.4 55.6 56.0 56.4 56.8 57.0 57.3 57.6<br />

Other/unknown 47.8 48.7 52.1 53.8 54.5 54.4 54.5 54.1 53.8 53.3 53.0<br />

†Hispanic 53.0 53.4 53.8 54.1 54.4 54.5 54.7 54.8<br />

†Non-Hispanic 55.5 55.9 56.2 56.4 56.7 56.9 57.2 57.4<br />

Diabetes 57.0 57.4 57.9 58.5 59.0 59.4 59.7 60.0 60.3 60.6 60.8<br />

Hypertension 60.1 60.4 60.4 60.6 60.7 60.9 61.1 61.2 61.3 61.5 61.7<br />

Glomerulonephritis 47.7 48.0 48.2 48.5 48.7 48.9 49.1 49.3 49.4 49.6 49.8<br />

Cystic kidney 54.5 54.7 54.8 55.0 55.1 55.3 55.4 55.6 55.7 55.8 56.0<br />

Other urologic 51.7 51.7 52.0 52.5 52.8 53.0 53.3 53.5 53.7 53.6 53.8<br />

Other cause 45.7 46.1 46.4 46.7 46.9 47.2 47.3 47.6 47.7 48.0 48.1<br />

Unknown cause 53.2 53.3 53.5 53.9 54.2 54.2 54.5 54.7 54.8 54.7 54.7<br />

Missing disease 48.8 47.5 47.4 47.3 47.4 47.4 47.4 47.3 47.5 48.5 49.2<br />

U.S. 54.2 54.6 54.9 55.3 55.6 55.9 56.2 56.4 56.7 56.9 57.1<br />

U.S. territories 53.0 53.0 53.2 53.7 53.8 54.6 55.0 55.8 56.2 56.0 55.7<br />

Puerto Rico 54.6 54.6 54.5 54.7 54.9 55.2 55.7 55.7 55.8 55.9 55.9<br />

Foreign 48.5 48.4 48.3 48.4 48.3 48.5 49.9 50.6 51.0 50.5 50.7<br />

Unknown 46.1 46.7 46.6 46.9 46.6 47.1 47.2 47.8 48.7 49.3 47.8<br />

All 54.2 54.6 54.9 55.2 55.6 55.9 56.2 56.4 56.6 56.9 57.1<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

Patients with unknown age are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


ON OUR WEBSITE & CD<br />

Prevalence of reported ESRD, by primary diagnosis: Hispanics & non-Hispanics<br />

(B.7.1-2). Prevalence of reported ESRD: by detailed primary diagnosis, age<br />


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

334<br />

Table B.7 B.7 (continued)<br />

Prevalence of of reported ESRD, by primary diagnosis: all patients<br />

1999-2003 combined, patients alive on December 31 of each year, by detailed primary diagnosis<br />

1999-2003 combined, patients alive on December 31 of each year, by detailed primary diagnosis<br />

Total counts<br />

Percent<br />

COLUMN PERCENT Patients White Black N Am Asian White Black N Am Asian<br />

All ESRD (reference) 2,075,981 274,249 665,066 27,684 83,753 100.0 100.0 100.0 100.0<br />

Diabetes 742,927 454,428 232,450 17,799 28,111 36.1 35.1 64.5 33.8<br />

Type I, juvenile type 145,994 106,483 34,036 1,875 2,659 8.5 5.1 6.8 3.2<br />

Type II, adult-onset or unspecified type 596,933 347,945 198,414 15,924 25,452 27.6 30.0 57.7 30.6<br />

Glomerulonephritis 341,877 225,384 87,801 4,026 21,272 17.9 13.3 14.6 25.6<br />

Focal glomerulosclerosis, focal GN 73,479 40,701 29,478 523 2,207 3.2 4.5 1.9 2.7<br />

Membranous nephropathy 14,806 10,229 3,953 91 417 0.8 0.6 0.3 0.5<br />

Membranoproliferative GN, types I & II 14,503 10,827 2,597 255 715 0.9 0.4 0.9 0.9<br />

IgA nephropathy, Berger's disease 20,053 15,084 1,423 398 2,848 1.2 0.2 1.4 3.4<br />

IgM nephropathy 2,113 1,579 189 25 298 0.1 . 0.1 0.4<br />

Rapidly progressive GN 10,100 7,747 1,600 194 481 0.6 0.2 0.7 0.6<br />

Goodpasture's Syndrome 3,625 3,244 250 43 60 0.3 . 0.2 0.1<br />

Post infectious GN, SBE 2,000 1,551 311 49 82 0.1 . 0.2 0.1<br />

Glomerulonephritis (GN) 190,950 126,963 45,941 2,350 13,645 10.1 6.9 8.5 16.4<br />

Other proliferative GN 10,248 7,459 2,059 98 519 0.6 0.3 0.4 0.6<br />

Secondary GN/vasculitis 67,336 40,693 22,684 627 2,783 3.2 3.4 2.3 3.3<br />

Lupus erythematosus (SLE nephritis) 39,573 19,300 17,487 311 2,076 1.5 2.6 1.1 2.5<br />

Polyarteritis 1,281 1,008 206 12 49 0.1 . . 0.1<br />

Wegeners granulomatosis 6,163 5,577 411 44 94 0.4 0.1 0.2 0.1<br />

Henoch-Schonlein syndrome 1,871 1,599 137 37 95 0.1 . 0.1 0.1<br />

Vasculitis and its derivatives 5,247 4,401 588 109 119 0.3 0.1 0.4 0.1<br />

Scleroderma 3,045 2,243 704 17 42 0.2 0.1 0.1 0.1<br />

Hemolytic uremic syndrome 4,879 3,858 866 41 93 0.3 0.1 0.1 0.1<br />

Nephropathy from heroin /related abuse 3,197 1,436 1,586 41 132 0.1 0.2 0.1 0.2<br />

Secondary GN, other 2,080 1,271 699 15 83 0.1 0.1 0.1 0.1<br />

Interstitial nephritis/pyelonephritis 96,214 77,015 14,292 806 3,311 6.1 2.2 2.9 4.0<br />

Chronic pyelonephritis, reflux neph. 15,906 13,747 1,373 161 479 1.1 0.2 0.6 0.6<br />

Analgesic abuse 3,712 2,852 700 36 82 0.2 0.1 0.1 0.1<br />

Nephropathy caused by other agents 8,418 6,694 1,469 38 155 0.5 0.2 0.1 0.2<br />

Nephrolithiasis, obstruction, gouty 28,434 22,061 4,744 194 1,108 1.8 0.7 0.7 1.3<br />

Nephrocalcinosis 1,137 907 150 * 49 0.1 . . 0.1<br />

Chronic interstitial nephritis 36,252 28,873 5,473 362 1,382 2.3 0.8 1.3 1.7<br />

Acute interstitial nephritis 2,355 1,881 383 * 56 0.1 0.1 . 0.1<br />

Hypertensive/large vessel disease 503,315 235,322 242,358 2,289 18,934 18.7 36.6 8.3 22.8<br />

Hypertension (no primary renal disease) 469,180 204,156 240,378 2,111 18,261 16.2 36.3 7.6 22.0<br />

<strong>Renal</strong> artery stenosis or occlusion 23,658 21,238 1,669 134 524 1.7 0.3 0.5 0.6<br />

Cholesterol emboli, renal emboli 10,477 9,928 311 44 149 0.8 . 0.2 0.2<br />

Cystic/hereditary/congenital diseases 138,647 116,780 17,014 811 3,075 9.3 2.6 2.9 3.7<br />

Polycystic kidneys, adult (dominant) 90,778 76,822 10,901 415 2,098 6.1 1.6 1.5 2.5<br />

Polycystic kidneys, infantile (recessive) 1,393 1,165 177 14 19 0.1 . 0.1 .<br />

Medullary cystic, including nephronophthisis 1,586 1,365 137 18 56 0.1 . 0.1 0.1<br />

Alport's, other hereditary/familial disease 11,517 10,017 1,089 112 229 0.8 0.2 0.4 0.3<br />

Tuberous sclerosis 768 605 141 * * . . . .<br />

Cystinosis 943 857 67 * * 0.1 . . .<br />

Primary oxalosis 588 522 23 15 * . . 0.1 .<br />

Fabrys disease 704 646 43 * * 0.1 . . .<br />

Congenital nephrotic syndrome 1,713 1,277 316 19 84 0.1 . 0.1 0.1<br />

Drash syndrome, mesangial sclerosis 193 129 51 . * . . . .<br />

Congenital obstructive uropathy 14,521 11,930 2,035 88 336 0.9 0.3 0.3 0.4<br />

<strong>Renal</strong> hypoplasia, dysplasia 12,951 10,670 1,830 116 216 0.8 0.3 0.4 0.3<br />

Prune belly syndrome 992 775 204 * 10 0.1 . . .<br />

Neoplasms/tumors 18,824 14,359 3,911 118 266 1.1 0.6 0.4 0.3<br />

<strong>Renal</strong> or urological neoplasms 7,347 5,677 1,497 50 54 0.5 0.2 0.2 0.1<br />

Multiple myeloma 7,104 5,150 1,746 30 124 0.4 0.3 0.1 0.1<br />

Light chain nephropathy 1,231 992 204 * 25 0.1 . . .<br />

Amyloidosis 3,142 2,540 464 36 63 0.2 0.1 0.1 0.1<br />

Miscellaneous conditions 63,034 39,581 21,068 331 1,334 3.1 3.2 1.2 1.6<br />

Complication post bone marrow/other txp 5,159 3,965 989 17 154 0.3 0.1 0.1 0.2<br />

Sickle cell disease/anemia or trait 2,022 109 1,888 * 14 . 0.3 . .<br />

AIDS nephropathy 11,704 824 10,656 19 20 0.1 1.6 0.1 .<br />

Traumatic/surgical loss of kidney(s) 1,794 1,425 314 * 30 0.1 . . .<br />

Hepatorenal syndrome 1,840 1,508 206 34 60 0.1 . 0.1 0.1<br />

Tubular necrosis (no recovery) 19,377 15,829 2,906 133 314 1.3 0.4 0.5 0.4<br />

Post-partum failure, other renal disorders 21,138 15,921 4,109 122 742 1.3 0.6 0.4 0.9<br />

Etiology uncertain 81,966 55,244 20,437 789 4,015 4.4 3.1 2.9 4.8<br />

Missing 21,841 15,443 3,051 88 652 1.2 0.5 0.3 0.8<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


ON OUR WEBSITE & CD<br />

Point prevalent counts of reported ESRD patients, by diabetic status & state:<br />

U.S. only, with unknowns dropped (B.8.1).<br />

PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

Table B.8 B.8<br />

Point prevalent counts of of reported ESRD patients, by diabetic status & state/territory: all all patients<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on December<br />

December<br />

31<br />

31 of<br />

of<br />

each<br />

each year<br />

year<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

Alabama 1,149 1,295 1,496 1,806 1,996 2,178 2,060 2,348 2,626 3,355 3,821 4,156<br />

Alaska 40 38 58 67 69 70 97 103 119 139 152 175<br />

Arizona 812 975 1,124 1,323 1,488 1,678 1,897 2,160 2,326 2,624 2,923 3,251<br />

Arkansas 472 544 627 767 875 982 1,071 1,224 1,367 1,473 1,604 1,797<br />

California 6,198 7,592 8,560 9,819 10,928 12,031 13,323 14,743 16,165 18,059 20,167 22,599<br />

Colorado 608 684 779 859 960 1,076 1,206 1,337 1,456 1,649 1,819 2,000<br />

Connecticut 827 909 944 1,131 1,198 1,493 1,630 1,779 1,894 2,084 2,297 2,576<br />

Delaware 162 162 201 271 301 340 364 412 474 525 588 683<br />

District of Columbia 415 457 534 596 654 722 755 822 862 948 1,017 1,150<br />

Florida 3,320 3,927 4,474 5,092 5,791 6,413 7,245 8,002 8,779 9,724 10,721 11,972<br />

Georgia 1,621 1,974 2,226 2,630 3,003 3,299 3,642 4,070 4,663 5,249 5,826 6,609<br />

Hawaii 356 381 409 450 490 551 624 693 782 875 967 1,065<br />

Idaho 150 162 194 219 242 294 317 363 386 452 521 571<br />

Illinois 3,140 3,578 4,047 4,630 5,112 5,685 6,287 6,831 7,307 7,845 8,620 9,674<br />

Indiana 1,242 1,446 1,645 1,972 2,126 2,317 2,501 2,786 3,072 3,373 3,757 4,147<br />

Iowa 613 698 766 920 1,028 1,119 1,277 1,348 1,441 1,589 1,764 1,914<br />

Kansas 533 582 674 782 858 939 1,013 1,111 1,202 1,359 1,548 1,701<br />

Kentucky 703 860 1,003 1,105 1,239 1,395 1,545 1,714 1,886 2,052 2,310 2,630<br />

Louisiana 1,079 1,240 1,467 1,650 1,899 2,115 2,405 2,728 3,210 3,565 3,935 4,324<br />

Maine 129 228 260 298 361 387 399 453 532 560 623 671<br />

Maryland 1,125 1,320 1,503 1,761 2,013 2,225 2,385 2,699 3,017 3,385 3,845 4,427<br />

Massachusetts 1,556 1,423 1,564 2,162 2,358 2,501 2,689 2,951 3,239 3,533 3,842 4,226<br />

Michigan 2,519 2,821 3,183 3,510 3,935 4,305 4,639 5,036 5,487 6,157 6,740 7,399<br />

Minnesota 929 1,107 1,277 1,430 1,628 1,813 1,986 2,223 2,401 2,610 2,894 3,190<br />

Mississippi 678 760 874 1,079 1,230 1,410 1,547 1,733 1,965 2,210 2,462 2,688<br />

Missouri 1,094 1,221 1,255 1,706 1,968 2,186 2,452 2,796 3,115 3,479 3,863 4,232<br />

Montana 127 159 177 214 246 273 298 332 347 398 449 496<br />

Nebraska 320 388 422 465 510 573 623 698 767 873 952 1,042<br />

Nevada 243 282 318 370 407 450 542 610 663 709 763 861<br />

New Hampshire 166 212 248 276 307 343 380 418 464 532 563 603<br />

New Jersey 2,418 2,703 3,057 3,470 3,768 4,147 4,451 4,764 5,063 5,582 6,141 6,843<br />

New Mexico 372 412 456 537 596 667 747 828 947 1,039 1,177 1,324<br />

New York 4,920 5,605 6,177 7,213 8,257 9,129 10,047 10,838 11,688 12,592 13,766 15,040<br />

North Carolina 1,534 1,778 2,121 2,521 2,846 3,282 3,681 4,074 4,522 5,025 5,605 6,277<br />

North Dakota 123 155 176 196 219 243 282 292 317 353 387 427<br />

Ohio 2,272 2,602 3,073 3,529 4,012 4,485 4,994 5,548 6,216 6,926 7,865 8,744<br />

Oklahoma 619 720 792 925 1,028 1,130 1,243 1,384 1,552 1,745 1,955 2,135<br />

Oregon 472 549 640 751 870 986 1,131 1,227 1,365 1,525 1,675 1,906<br />

Pennsylvania 3,197 3,581 4,039 4,615 5,157 5,833 6,422 7,038 7,757 8,514 9,451 10,446<br />

Rhode Island 292 306 326 370 432 454 468 495 547 622 668 736<br />

South Carolina 848 1,049 1,240 1,507 1,714 1,582 2,155 2,397 2,738 3,043 3,405 3,771<br />

South Dakota 166 201 215 245 279 306 323 356 391 419 444 474<br />

Tennessee 1,189 1,335 1,530 1,861 2,028 2,251 2,474 2,806 3,074 3,638 4,010 4,419<br />

Texas 3,797 4,374 5,165 6,065 6,684 7,407 8,269 9,220 10,272 11,572 13,004 14,540<br />

Utah 270 326 361 412 496 544 607 657 754 804 850 927<br />

Vermont 109 124 138 152 161 183 182 199 224 243 259 293<br />

Virginia 1,639 1,848 2,090 2,485 2,790 3,014 3,252 3,553 3,989 4,334 4,742 5,350<br />

Washington 877 843 1,131 1,347 1,538 1,707 1,938 2,136 2,339 2,631 2,863 3,162<br />

West Virginia 312 362 442 526 635 700 782 854 958 1,045 1,125 1,255<br />

Wisconsin 1,098 1,246 1,479 1,620 1,812 1,976 2,194 2,495 2,798 3,086 3,316 3,705<br />

Wyoming 63 74 91 101 109 133 144 157 181 202 210 225<br />

335<br />

American Samoa . * * * * 14 18 21 18 23 23 28<br />

Guam 17 18 22 23 24 26 33 38 46 54 66 85<br />

Puerto Rico 615 710 821 974 1,181 1,336 1,467 1,608 1,753 1,981 2,191 2,407<br />

Saipan * * * * * * * * 13 16 21 22<br />

Virgin Islands 18 20 28 22 21 24 32 46 49 48 58 68<br />

Foreign 41 51 51 66 69 82 89 92 98 108 143 164<br />

Unknown 436 462 493 558 636 722 787 835 1,077 1,212 1,205 1,128<br />

All 60,042 68,885 78,471 91,462 102,593 113,531 125,416 138,489 152,760 169,767 187,978 208,730<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table B.8 B.8 (continued)<br />

Point prevalent counts of of reported ESRD patients, by diabetic status & state/territory: all all patients<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on December<br />

December<br />

31<br />

31 of<br />

of<br />

each<br />

each year<br />

year<br />

336<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Alabama 4,548 4,940 5,362 5,748 6,309 6,805 7,120 7,424 7,879 8,194 8,452 8,750<br />

Alaska 203 219 327 496 467 467 452 456 474 511 515 541<br />

Arizona 3,681 4,077 4,383 4,742 5,102 5,513 5,931 6,351 6,759 7,128 7,429 7,857<br />

Arkansas 1,947 2,155 2,426 2,680 2,867 3,085 3,209 3,348 3,456 3,600 3,690 3,762<br />

California 24,944 27,287 30,243 32,327 34,643 36,906 39,489 42,152 45,057 47,943 51,059 53,967<br />

Colorado 2,228 2,443 2,672 2,810 3,022 3,244 3,513 3,710 3,912 4,086 4,295 4,495<br />

Connecticut 2,795 2,997 3,237 3,428 3,651 3,845 4,014 4,219 4,428 4,490 4,613 4,712<br />

Delaware 774 822 883 949 1,022 1,084 1,134 1,212 1,281 1,331 1,422 1,501<br />

District of Columbia 1,299 1,444 1,518 1,597 1,670 1,738 1,782 1,871 1,960 2,024 2,055 2,135<br />

Florida 13,293 14,431 15,611 16,545 17,914 19,027 20,000 21,098 22,225 23,311 24,373 25,272<br />

Georgia 7,390 8,060 8,913 9,645 10,425 11,092 11,837 12,603 13,332 14,033 14,744 15,272<br />

Hawaii 1,156 1,298 1,462 1,568 1,661 1,804 1,908 2,005 2,159 2,248 2,396 2,519<br />

Idaho 617 673 742 788 868 952 1,004 1,114 1,140 1,216 1,261 1,302<br />

Illinois 10,471 11,424 12,472 13,479 14,677 15,600 16,610 17,564 18,450 19,261 20,199 21,002<br />

Indiana 4,603 5,019 5,418 5,782 6,229 6,639 7,157 7,533 7,957 8,309 8,609 8,953<br />

Iowa 2,118 2,263 2,426 2,511 2,688 2,811 2,972 3,201 3,347 3,514 3,661 3,779<br />

Kansas 1,856 1,946 2,098 2,220 2,360 2,569 2,699 2,851 2,977 3,019 3,165 3,263<br />

Kentucky 2,955 3,168 3,365 3,642 3,865 4,121 4,418 4,613 4,864 5,123 5,289 5,533<br />

Louisiana 4,774 5,150 5,579 6,049 6,458 7,049 7,532 8,009 8,350 8,624 9,067 9,419<br />

Maine 724 808 885 974 1,032 1,104 1,191 1,241 1,310 1,381 1,447 1,512<br />

Maryland 4,952 5,484 6,046 6,574 7,121 7,655 8,179 8,653 9,057 9,506 9,985 10,413<br />

Massachusetts 4,664 5,075 5,463 5,742 6,068 6,448 6,836 7,013 7,277 7,431 7,672 7,904<br />

Michigan 8,203 9,002 9,769 10,457 11,453 12,091 12,851 13,363 14,080 14,768 15,403 16,100<br />

Minnesota 3,471 3,756 4,039 4,281 4,584 4,878 5,127 5,365 5,606 5,935 6,241 6,439<br />

Mississippi 2,940 3,268 3,640 3,913 4,252 4,572 4,869 5,141 5,344 5,582 5,838 6,057<br />

Missouri 4,615 5,033 5,422 5,817 6,219 6,586 7,072 7,485 7,840 8,153 8,408 8,670<br />

Montana 530 591 631 701 748 801 830 899 934 1,003 1,044 1,085<br />

Nebraska 1,183 1,266 1,371 1,476 1,545 1,666 1,771 1,888 1,998 2,094 2,176 2,248<br />

Nevada 966 1,096 1,231 1,352 1,492 1,622 1,752 1,924 2,038 2,212 2,357 2,540<br />

New Hampshire 637 678 738 796 818 872 926 1,000 1,087 1,131 1,206 1,261<br />

New Jersey 7,423 7,953 8,628 9,201 9,751 10,352 11,074 11,818 12,240 12,744 13,229 13,751<br />

New Mexico 1,473 1,600 1,702 1,874 2,018 2,177 2,321 2,478 2,684 2,802 2,874 3,005<br />

New York 16,352 17,708 18,879 20,065 21,304 22,789 24,393 25,807 27,149 28,153 29,346 30,504<br />

North Carolina 7,041 7,822 8,605 9,234 9,973 10,789 11,567 12,094 12,851 13,484 14,089 14,635<br />

North Dakota 478 519 556 557 577 607 639 662 689 753 807 822<br />

Ohio 9,601 10,323 11,281 12,073 12,969 13,718 14,646 15,524 16,505 17,166 17,903 18,621<br />

Oklahoma 2,372 2,610 2,849 3,074 3,268 3,541 3,807 4,021 4,235 4,393 4,593 4,832<br />

Oregon 2,033 2,214 2,412 2,558 2,709 2,859 3,032 3,184 3,338 3,556 3,763 3,987<br />

Pennsylvania 11,385 12,102 13,061 13,986 14,987 15,949 16,820 17,609 18,428 18,940 19,663 20,059<br />

Rhode Island 790 855 956 990 1,063 1,099 1,165 1,212 1,274 1,311 1,351 1,383<br />

South Carolina 4,164 4,531 4,998 5,395 5,790 6,217 6,622 7,039 7,293 7,634 7,815 8,221<br />

South Dakota 500 557 609 677 748 810 867 921 985 1,002 1,048 1,112<br />

Tennessee 4,854 5,179 5,742 6,195 6,616 6,998 7,440 7,887 8,256 8,481 8,740 8,988<br />

Texas 16,270 17,805 19,504 20,967 22,759 24,402 26,255 28,193 30,054 31,685 33,363 35,272<br />

Utah 998 1,134 1,226 1,337 1,400 1,464 1,604 1,713 1,839 1,960 2,050 2,138<br />

Vermont 308 335 365 407 450 493 532 563 597 615 627 663<br />

Virginia 6,038 6,652 7,194 7,755 8,381 9,149 9,802 10,388 10,779 11,233 11,789 12,225<br />

Washington 3,422 3,708 4,064 4,343 4,616 4,880 5,215 5,549 5,888 6,229 6,630 6,949<br />

West Virginia 1,369 1,475 1,587 1,711 1,836 2,019 2,180 2,309 2,465 2,586 2,661 2,760<br />

Wisconsin 4,074 4,392 4,757 5,052 5,410 5,758 6,122 6,436 6,674 6,975 7,337 7,744<br />

Wyoming 234 248 266 290 316 342 363 392 431 435 449 467<br />

American Samoa 35 35 40 39 44 44 41 56 67 74 77 84<br />

Guam 109 127 146 172 195 218 233 263 280 298 330 349<br />

Puerto Rico 2,666 2,858 3,077 3,192 3,397 3,571 3,734 3,878 4,016 4,134 4,304 4,471<br />

Saipan 26 27 32 41 52 60 75 81 92 90 94 100<br />

Virgin Islands 82 86 92 99 113 127 141 148 143 152 173 175<br />

Foreign 182 203 230 246 258 269 284 292 304 302 300 286<br />

Unknown 1,061 1,021 1,050 947 900 787 785 791 807 813 832 1,091<br />

All 229,877 249,952 272,280 291,566 313,130 334,134 355,944 376,614 396,941 415,161 434,308 452,957<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.


Table B.8 B.8 (continued)<br />

PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

Point prevalent counts of of reported ESRD patients, by diabetic status & state/territory: diabetic patients<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on December<br />

December<br />

31<br />

31 of<br />

of<br />

each<br />

each year<br />

year<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

Alabama 57 73 107 168 220 274 322 394 465 660 778 919<br />

Alaska * * * * 11 * 16 19 20 30 34 36<br />

Arizona 148 200 257 329 394 463 560 709 783 936 1,069 1,251<br />

Arkansas 23 42 58 90 118 152 162 228 254 305 350 421<br />

California 445 778 1,129 1,512 1,859 2,348 2,783 3,202 3,729 4,594 5,360 6,378<br />

Colorado 81 95 116 148 190 239 309 351 400 485 565 643<br />

Connecticut 91 127 141 190 226 303 349 392 425 500 559 678<br />

Delaware 14 22 28 32 44 54 70 89 120 139 162 196<br />

District of Columbia 39 47 70 91 123 151 166 189 187 213 252 278<br />

Florida 246 392 556 703 873 1,033 1,344 1,573 1,785 2,049 2,421 2,822<br />

Georgia 144 232 317 379 482 574 685 838 983 1,208 1,402 1,646<br />

Hawaii 59 75 77 81 82 107 147 201 241 285 341 394<br />

Idaho 15 19 25 36 42 50 63 86 94 122 150 159<br />

Illinois 320 419 561 678 803 1,014 1,180 1,355 1,513 1,746 2,016 2,398<br />

Indiana 129 179 216 288 336 377 437 533 627 728 881 1,061<br />

Iowa 51 88 114 163 201 227 282 284 320 370 417 464<br />

Kansas 56 71 105 132 169 191 188 229 262 311 385 455<br />

Kentucky 53 86 109 146 203 246 279 338 395 445 545 666<br />

Louisiana 66 103 154 180 273 322 410 519 664 811 953 1,139<br />

Maine * 22 32 36 52 56 64 85 105 111 136 150<br />

Maryland 82 130 169 236 307 389 433 519 607 753 941 1,166<br />

Massachusetts 167 192 227 291 330 363 413 463 536 658 800 950<br />

Michigan 328 409 494 572 685 812 955 1,046 1,224 1,467 1,743 2,035<br />

Minnesota 187 247 298 358 439 501 563 655 720 824 940 1,059<br />

Mississippi 45 68 99 129 174 206 244 303 383 477 576 677<br />

Missouri 55 107 193 247 319 402 457 556 649 757 889 1,045<br />

Montana 14 24 26 39 54 68 72 89 107 127 157 174<br />

Nebraska 51 70 84 99 102 119 135 159 190 237 280 315<br />

Nevada 37 48 57 56 59 68 92 118 139 157 191 230<br />

New Hampshire 14 22 29 38 42 54 66 77 98 116 131 141<br />

New Jersey 246 310 431 542 607 731 815 901 1,033 1,197 1,453 1,744<br />

New Mexico 49 75 91 136 158 177 219 264 334 383 434 529<br />

New York 382 577 765 1,001 1,313 1,556 1,879 2,152 2,470 2,781 3,223 3,646<br />

North Carolina 136 170 242 316 418 539 639 780 913 1,103 1,341 1,597<br />

North Dakota 24 29 36 48 59 65 78 80 94 123 135 150<br />

Ohio 295 390 525 624 779 926 1,105 1,318 1,530 1,803 2,176 2,490<br />

Oklahoma 52 73 109 158 191 231 282 339 436 497 600 698<br />

Oregon 30 49 94 119 146 178 229 268 312 370 431 490<br />

Pennsylvania 349 419 530 668 871 1,048 1,269 1,502 1,723 1,979 2,344 2,741<br />

Rhode Island 19 24 31 36 48 54 58 70 97 120 145 159<br />

South Carolina 78 108 151 200 279 319 415 499 589 702 827 988<br />

South Dakota 23 45 40 50 65 81 85 101 125 130 144 165<br />

Tennessee 62 90 146 207 257 329 375 472 568 759 882 1,036<br />

Texas 386 554 793 972 1,258 1,532 1,844 2,202 2,669 3,355 4,030 4,708<br />

Utah 43 59 70 98 133 158 182 207 252 262 301 325<br />

Vermont 15 20 28 26 30 44 44 49 48 62 70 79<br />

Virginia 134 174 237 330 420 464 553 637 776 915 1,058 1,284<br />

Washington 82 87 129 174 234 314 369 420 512 622 711 842<br />

West Virginia 32 39 61 85 112 118 161 187 218 245 281 329<br />

Wisconsin 177 208 281 333 405 451 533 633 737 838 933 1,111<br />

Wyoming * * 17 19 21 37 37 42 48 62 62 64<br />

337<br />

American Samoa . * * * * * * * * * * 13<br />

Guam * * * * * 11 14 13 14 20 25 35<br />

Puerto Rico 58 89 123 170 239 289 357 425 483 601 705 823<br />

Saipan . . . . * * * * * * 11 11<br />

Virgin Islands * * * * * * * * * * * *<br />

Foreign . . * * * * * * * 11 17 20<br />

Unknown 40 45 56 71 91 110 151 149 201 226 239 212<br />

All 5,756 8,039 10,850 13,850 17,360 20,943 24,956 29,330 34,231 40,808 48,017 56,244<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table B.8 B.8 (continued)<br />

Point prevalent counts of of reported ESRD patients, by diabetic status & state/territory: diabetic patients<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on December<br />

December<br />

31<br />

31 of<br />

of<br />

each<br />

each year<br />

year<br />

338<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Alabama 1,063 1,237 1,419 1,594 1,833 2,089 2,244 2,412 2,692 2,876 2,973 3,095<br />

Alaska 44 56 91 160 155 162 148 157 148 166 167 176<br />

Arizona 1,474 1,662 1,841 2,035 2,210 2,476 2,678 2,874 3,107 3,316 3,466 3,689<br />

Arkansas 472 537 634 753 858 948 992 1,045 1,114 1,203 1,241 1,293<br />

California 7,322 8,218 9,538 10,484 11,575 12,787 13,890 15,097 16,529 17,828 19,156 20,434<br />

Colorado 756 861 932 998 1,107 1,204 1,322 1,416 1,536 1,599 1,699 1,780<br />

Connecticut 752 829 924 1,024 1,110 1,241 1,292 1,365 1,490 1,492 1,559 1,623<br />

Delaware 216 231 260 277 300 337 363 399 446 459 498 532<br />

District of Columbia 341 390 406 441 498 515 516 547 570 598 613 647<br />

Florida 3,286 3,718 4,204 4,631 5,226 5,770 6,174 6,627 7,143 7,733 8,147 8,502<br />

Georgia 1,936 2,173 2,486 2,827 3,260 3,574 3,922 4,274 4,577 4,858 5,203 5,442<br />

Hawaii 432 529 617 683 733 805 862 919 1,034 1,110 1,196 1,241<br />

Idaho 181 206 235 250 288 331 368 413 418 445 465 461<br />

Illinois 2,633 2,933 3,334 3,831 4,356 4,755 5,162 5,632 6,014 6,266 6,653 6,948<br />

Indiana 1,264 1,403 1,569 1,818 2,019 2,151 2,395 2,560 2,719 2,845 2,979 3,142<br />

Iowa 558 626 703 764 851 894 961 1,053 1,113 1,181 1,226 1,257<br />

Kansas 505 550 626 673 739 823 931 1,007 1,074 1,100 1,159 1,182<br />

Kentucky 800 877 931 1,101 1,224 1,328 1,455 1,545 1,671 1,796 1,907 1,979<br />

Louisiana 1,347 1,472 1,621 1,814 2,076 2,365 2,611 2,803 2,971 3,081 3,248 3,391<br />

Maine 166 197 224 262 282 320 356 367 408 451 489 525<br />

Maryland 1,375 1,585 1,769 1,972 2,236 2,490 2,676 2,836 2,891 3,080 3,296 3,410<br />

Massachusetts 1,145 1,275 1,453 1,584 1,739 1,893 2,033 2,080 2,170 2,306 2,400 2,456<br />

Michigan 2,345 2,658 3,022 3,337 3,848 4,170 4,522 4,710 5,076 5,391 5,631 5,909<br />

Minnesota 1,136 1,272 1,353 1,440 1,529 1,632 1,728 1,802 1,897 2,002 2,117 2,160<br />

Mississippi 782 902 1,050 1,189 1,353 1,480 1,622 1,748 1,814 1,918 2,027 2,145<br />

Missouri 1,200 1,382 1,540 1,733 1,908 2,123 2,356 2,497 2,669 2,782 2,897 2,966<br />

Montana 193 214 232 276 296 320 332 361 395 438 460 479<br />

Nebraska 372 426 451 524 564 614 663 719 764 803 818 861<br />

Nevada 263 305 348 419 463 539 613 676 724 812 886 993<br />

New Hampshire 152 167 188 216 224 255 273 296 327 344 373 391<br />

New Jersey 1,915 2,113 2,423 2,742 3,045 3,322 3,692 4,006 4,172 4,345 4,540 4,657<br />

New Mexico 617 706 761 866 971 1,072 1,164 1,264 1,425 1,489 1,514 1,580<br />

New York 4,130 4,651 5,054 5,640 6,314 6,993 7,630 8,178 8,733 9,238 9,739 10,223<br />

North Carolina 1,881 2,166 2,523 2,815 3,228 3,622 3,998 4,227 4,596 4,833 5,094 5,331<br />

North Dakota 179 191 201 204 206 219 239 227 242 265 291 296<br />

Ohio 2,850 3,148 3,605 4,013 4,436 4,851 5,344 5,727 6,168 6,509 6,815 7,051<br />

Oklahoma 807 921 1,019 1,141 1,221 1,381 1,543 1,650 1,737 1,831 1,937 2,046<br />

Oregon 536 595 669 747 835 926 956 1,022 1,080 1,162 1,224 1,306<br />

Pennsylvania 3,168 3,440 3,820 4,257 4,619 5,043 5,450 5,739 6,106 6,356 6,688 6,845<br />

Rhode Island 188 205 231 252 296 324 362 384 392 408 417 417<br />

South Carolina 1,121 1,265 1,449 1,603 1,812 1,974 2,237 2,444 2,586 2,771 2,820 3,006<br />

South Dakota 194 223 243 277 310 338 356 398 417 425 453 497<br />

Tennessee 1,197 1,345 1,567 1,786 1,989 2,159 2,347 2,506 2,676 2,791 2,910 3,019<br />

Texas 5,410 6,122 6,913 7,718 8,704 9,666 10,649 11,580 12,661 13,488 14,513 15,521<br />

Utah 348 409 457 517 544 576 623 669 729 789 817 856<br />

Vermont 84 92 111 132 150 168 187 205 216 217 216 220<br />

Virginia 1,547 1,796 2,020 2,269 2,529 2,903 3,185 3,440 3,640 3,881 4,160 4,305<br />

Washington 975 1,097 1,232 1,323 1,442 1,603 1,743 1,866 1,999 2,140 2,269 2,379<br />

West Virginia 398 418 472 536 602 699 778 867 978 1,035 1,062 1,121<br />

Wisconsin 1,253 1,376 1,498 1,613 1,739 1,906 2,035 2,144 2,185 2,295 2,428 2,573<br />

Wyoming 61 75 88 109 120 136 140 152 171 171 173 184<br />

American Samoa 16 16 19 19 20 18 19 26 37 44 47 54<br />

Guam 46 58 68 88 104 119 127 155 156 171 185 195<br />

Puerto Rico 982 1,058 1,161 1,197 1,313 1,417 1,516 1,642 1,739 1,814 1,929 2,093<br />

Saipan 11 11 15 21 27 31 44 48 58 61 63 64<br />

Virgin Islands 12 16 19 32 43 49 56 63 57 65 68 73<br />

Foreign 21 17 24 22 23 22 21 27 29 29 36 31<br />

Unknown 187 173 169 129 103 61 54 49 46 47 49 61<br />

All 64,645 72,594 81,832 91,178 101,605 111,989 121,955 130,942 140,532 148,949 157,406 165,113<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.


Table B.8 B.8 (continued)<br />

PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

Point prevalent counts of of reported ESRD patients, by diabetic status & state/territory: non-diabetic patients<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on December<br />

December<br />

31<br />

31 of<br />

of<br />

each<br />

each year<br />

year<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

Alabama 1,092 1,222 1,389 1,638 1,776 1,904 1,738 1,954 2,161 2,695 3,043 3,237<br />

Alaska 36 36 53 60 58 62 81 84 99 109 118 139<br />

Arizona 664 775 867 994 1,094 1,215 1,337 1,451 1,543 1,688 1,854 2,000<br />

Arkansas 449 502 569 677 757 830 909 996 1,113 1,168 1,254 1,376<br />

California 5,753 6,814 7,431 8,307 9,069 9,683 10,540 11,541 12,436 13,465 14,807 16,221<br />

Colorado 527 589 663 711 770 837 897 986 1,056 1,164 1,254 1,357<br />

Connecticut 736 782 803 941 972 1,190 1,281 1,387 1,469 1,584 1,738 1,898<br />

Delaware 148 140 173 239 257 286 294 323 354 386 426 487<br />

District of Columbia 376 410 464 505 531 571 589 633 675 735 765 872<br />

Florida 3,074 3,535 3,918 4,389 4,918 5,380 5,901 6,429 6,994 7,675 8,300 9,150<br />

Georgia 1,477 1,742 1,909 2,251 2,521 2,725 2,957 3,232 3,680 4,041 4,424 4,963<br />

Hawaii 297 306 332 369 408 444 477 492 541 590 626 671<br />

Idaho 135 143 169 183 200 244 254 277 292 330 371 412<br />

Illinois 2,820 3,159 3,486 3,952 4,309 4,671 5,107 5,476 5,794 6,099 6,604 7,276<br />

Indiana 1,113 1,267 1,429 1,684 1,790 1,940 2,064 2,253 2,445 2,645 2,876 3,086<br />

Iowa 562 610 652 757 827 892 995 1,064 1,121 1,219 1,347 1,450<br />

Kansas 477 511 569 650 689 748 825 882 940 1,048 1,163 1,246<br />

Kentucky 650 774 894 959 1,036 1,149 1,266 1,376 1,491 1,607 1,765 1,964<br />

Louisiana 1,013 1,137 1,313 1,470 1,626 1,793 1,995 2,209 2,546 2,754 2,982 3,185<br />

Maine 119 206 228 262 309 331 335 368 427 449 487 521<br />

Maryland 1,043 1,190 1,334 1,525 1,706 1,836 1,952 2,180 2,410 2,632 2,904 3,261<br />

Massachusetts 1,389 1,231 1,337 1,871 2,028 2,138 2,276 2,488 2,703 2,875 3,042 3,276<br />

Michigan 2,191 2,412 2,689 2,938 3,250 3,493 3,684 3,990 4,263 4,690 4,997 5,364<br />

Minnesota 742 860 979 1,072 1,189 1,312 1,423 1,568 1,681 1,786 1,954 2,131<br />

Mississippi 633 692 775 950 1,056 1,204 1,303 1,430 1,582 1,733 1,886 2,011<br />

Missouri 1,039 1,114 1,062 1,459 1,649 1,784 1,995 2,240 2,466 2,722 2,974 3,187<br />

Montana 113 135 151 175 192 205 226 243 240 271 292 322<br />

Nebraska 269 318 338 366 408 454 488 539 577 636 672 727<br />

Nevada 206 234 261 314 348 382 450 492 524 552 572 631<br />

New Hampshire 152 190 219 238 265 289 314 341 366 416 432 462<br />

New Jersey 2,172 2,393 2,626 2,928 3,161 3,416 3,636 3,863 4,030 4,385 4,688 5,099<br />

New Mexico 323 337 365 401 438 490 528 564 613 656 743 795<br />

New York 4,538 5,028 5,412 6,212 6,944 7,573 8,168 8,686 9,218 9,811 10,543 11,394<br />

North Carolina 1,398 1,608 1,879 2,205 2,428 2,743 3,042 3,294 3,609 3,922 4,264 4,680<br />

North Dakota 99 126 140 148 160 178 204 212 223 230 252 277<br />

Ohio 1,977 2,212 2,548 2,905 3,233 3,559 3,889 4,230 4,686 5,123 5,689 6,254<br />

Oklahoma 567 647 683 767 837 899 961 1,045 1,116 1,248 1,355 1,437<br />

Oregon 442 500 546 632 724 808 902 959 1,053 1,155 1,244 1,416<br />

Pennsylvania 2,848 3,162 3,509 3,947 4,286 4,785 5,153 5,536 6,034 6,535 7,107 7,705<br />

Rhode Island 273 282 295 334 384 400 410 425 450 502 523 577<br />

South Carolina 770 941 1,089 1,307 1,435 1,263 1,740 1,898 2,149 2,341 2,578 2,783<br />

South Dakota 143 156 175 195 214 225 238 255 266 289 300 309<br />

Tennessee 1,127 1,245 1,384 1,654 1,771 1,922 2,099 2,334 2,506 2,879 3,128 3,383<br />

Texas 3,411 3,820 4,372 5,093 5,426 5,875 6,425 7,018 7,603 8,217 8,974 9,832<br />

Utah 227 267 291 314 363 386 425 450 502 542 549 602<br />

Vermont 94 104 110 126 131 139 138 150 176 181 189 214<br />

Virginia 1,505 1,674 1,853 2,155 2,370 2,550 2,699 2,916 3,213 3,419 3,684 4,066<br />

Washington 795 756 1,002 1,173 1,304 1,393 1,569 1,716 1,827 2,009 2,152 2,320<br />

West Virginia 280 323 381 441 523 582 621 667 740 800 844 926<br />

Wisconsin 921 1,038 1,198 1,287 1,407 1,525 1,661 1,862 2,061 2,248 2,383 2,594<br />

Wyoming 56 64 74 82 88 96 107 115 133 140 148 161<br />

339<br />

American Samoa . * * * * 12 13 16 11 14 13 15<br />

Guam 13 16 19 17 17 15 19 25 32 34 41 50<br />

Puerto Rico 557 621 698 804 942 1,047 1,110 1,183 1,270 1,380 1,486 1,584<br />

Saipan * * * * * * * * * * * 11<br />

Virgin Islands 16 18 25 19 18 21 27 40 43 42 53 59<br />

Foreign 41 51 49 64 67 78 83 84 92 97 126 144<br />

Unknown 396 417 437 487 545 612 636 686 876 986 966 916<br />

All 54,286 60,846 67,621 77,612 85,233 92,588 100,460 109,159 118,529 128,959 139,961 152,486<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table B.8 B.8 (continued)<br />

Point prevalent counts of of reported ESRD patients, by diabetic status & state/territory: non-diabetic patients<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on December<br />

December<br />

31<br />

31 of<br />

of<br />

each<br />

each year<br />

year<br />

340<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Alabama 3,485 3,703 3,943 4,154 4,476 4,716 4,876 5,012 5,187 5,318 5,479 5,655<br />

Alaska 159 163 236 336 312 305 304 299 326 345 348 365<br />

Arizona 2,207 2,415 2,542 2,707 2,892 3,037 3,253 3,477 3,652 3,812 3,963 4,168<br />

Arkansas 1,475 1,618 1,792 1,927 2,009 2,137 2,217 2,303 2,342 2,397 2,449 2,469<br />

California 17,622 19,069 20,705 21,843 23,068 24,119 25,599 27,055 28,528 30,115 31,903 33,533<br />

Colorado 1,472 1,582 1,740 1,812 1,915 2,040 2,191 2,294 2,376 2,487 2,596 2,715<br />

Connecticut 2,043 2,168 2,313 2,404 2,541 2,604 2,722 2,854 2,938 2,998 3,054 3,089<br />

Delaware 558 591 623 672 722 747 771 813 835 872 924 969<br />

District of Columbia 958 1,054 1,112 1,156 1,172 1,223 1,266 1,324 1,390 1,426 1,442 1,488<br />

Florida 10,007 10,713 11,407 11,914 12,688 13,257 13,826 14,471 15,082 15,578 16,226 16,770<br />

Georgia 5,454 5,887 6,427 6,818 7,165 7,518 7,915 8,329 8,755 9,175 9,541 9,830<br />

Hawaii 724 769 845 885 928 999 1,046 1,086 1,125 1,138 1,200 1,278<br />

Idaho 436 467 507 538 580 621 636 701 722 771 796 841<br />

Illinois 7,838 8,491 9,138 9,648 10,321 10,845 11,448 11,932 12,436 12,995 13,546 14,054<br />

Indiana 3,339 3,616 3,849 3,964 4,210 4,488 4,762 4,973 5,238 5,464 5,630 5,811<br />

Iowa 1,560 1,637 1,723 1,747 1,837 1,917 2,011 2,148 2,234 2,333 2,435 2,522<br />

Kansas 1,351 1,396 1,472 1,547 1,621 1,746 1,768 1,844 1,903 1,919 2,006 2,081<br />

Kentucky 2,155 2,291 2,434 2,541 2,641 2,793 2,963 3,068 3,193 3,327 3,382 3,554<br />

Louisiana 3,427 3,678 3,958 4,235 4,382 4,684 4,921 5,206 5,379 5,543 5,819 6,028<br />

Maine 558 611 661 712 750 784 835 874 902 930 958 987<br />

Maryland 3,577 3,899 4,277 4,602 4,885 5,165 5,503 5,817 6,166 6,426 6,689 7,003<br />

Massachusetts 3,519 3,800 4,010 4,158 4,329 4,555 4,803 4,933 5,107 5,125 5,272 5,448<br />

Michigan 5,858 6,344 6,747 7,120 7,605 7,921 8,329 8,653 9,004 9,377 9,772 10,191<br />

Minnesota 2,335 2,484 2,686 2,841 3,055 3,246 3,399 3,563 3,709 3,933 4,124 4,279<br />

Mississippi 2,158 2,366 2,590 2,724 2,899 3,092 3,247 3,393 3,530 3,664 3,811 3,912<br />

Missouri 3,415 3,651 3,882 4,084 4,311 4,463 4,716 4,988 5,171 5,371 5,511 5,704<br />

Montana 337 377 399 425 452 481 498 538 539 565 584 606<br />

Nebraska 811 840 920 952 981 1,052 1,108 1,169 1,234 1,291 1,358 1,387<br />

Nevada 703 791 883 933 1,029 1,083 1,139 1,248 1,314 1,400 1,471 1,547<br />

New Hampshire 485 511 550 580 594 617 653 704 760 787 833 870<br />

New Jersey 5,508 5,840 6,205 6,459 6,706 7,030 7,382 7,812 8,068 8,399 8,689 9,094<br />

New Mexico 856 894 941 1,008 1,047 1,105 1,157 1,214 1,259 1,313 1,360 1,425<br />

New York 12,222 13,057 13,825 14,425 14,990 15,796 16,763 17,629 18,416 18,915 19,607 20,281<br />

North Carolina 5,160 5,656 6,082 6,419 6,745 7,167 7,569 7,867 8,255 8,651 8,995 9,304<br />

North Dakota 299 328 355 353 371 388 400 435 447 488 516 526<br />

Ohio 6,751 7,175 7,676 8,060 8,533 8,867 9,302 9,797 10,337 10,657 11,088 11,570<br />

Oklahoma 1,565 1,689 1,830 1,933 2,047 2,160 2,264 2,371 2,498 2,562 2,656 2,786<br />

Oregon 1,497 1,619 1,743 1,811 1,874 1,933 2,076 2,162 2,258 2,394 2,539 2,681<br />

Pennsylvania 8,217 8,662 9,241 9,729 10,368 10,906 11,370 11,870 12,322 12,584 12,975 13,214<br />

Rhode Island 602 650 725 738 767 775 803 828 882 903 934 966<br />

South Carolina 3,043 3,266 3,549 3,792 3,978 4,243 4,385 4,595 4,707 4,863 4,995 5,215<br />

South Dakota 306 334 366 400 438 472 511 523 568 577 595 615<br />

Tennessee 3,657 3,834 4,175 4,409 4,627 4,839 5,093 5,381 5,580 5,690 5,830 5,969<br />

Texas 10,860 11,683 12,591 13,249 14,055 14,736 15,606 16,613 17,393 18,197 18,850 19,751<br />

Utah 650 725 769 820 856 888 981 1,044 1,110 1,171 1,233 1,282<br />

Vermont 224 243 254 275 300 325 345 358 381 398 411 443<br />

Virginia 4,491 4,856 5,174 5,486 5,852 6,246 6,617 6,948 7,139 7,352 7,629 7,920<br />

Washington 2,447 2,611 2,832 3,020 3,174 3,277 3,472 3,683 3,889 4,089 4,361 4,570<br />

West Virginia 971 1,057 1,115 1,175 1,234 1,320 1,402 1,442 1,487 1,551 1,599 1,639<br />

Wisconsin 2,821 3,016 3,259 3,439 3,671 3,852 4,087 4,292 4,489 4,680 4,909 5,171<br />

Wyoming 173 173 178 181 196 206 223 240 260 264 276 283<br />

American Samoa 19 19 21 20 24 26 22 30 30 30 30 30<br />

Guam 63 69 78 84 91 99 106 108 124 127 145 154<br />

Puerto Rico 1,684 1,800 1,916 1,995 2,084 2,154 2,218 2,236 2,277 2,320 2,375 2,378<br />

Saipan 15 16 17 20 25 29 31 33 34 29 31 36<br />

Virgin Islands 70 70 73 67 70 78 85 85 86 87 105 102<br />

Foreign 161 186 206 224 235 247 263 265 275 273 264 255<br />

Unknown 874 848 881 818 797 726 731 742 761 766 783 1,030<br />

All 165,232 177,358 190,448 200,388 211,525 222,145 233,989 245,672 256,409 266,212 276,902 287,844<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.


Table B.9 B.9<br />

Point prevalent rates of of reported ESRD, by by diabetic status & state, adjusted: all all patients<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population<br />

population<br />

PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

Alabama 343 383 439 525 578 626 586 658 732 932 1,035 1,106<br />

Alaska 116 105 148 156 155 152 224 234 265 317 334 367<br />

Arizona 320 380 424 488 530 570 618 675 710 781 849 910<br />

Arkansas 230 264 302 363 410 462 502 563 627 671 723 798<br />

California 248 301 340 391 430 467 508 551 593 651 718 791<br />

Colorado 233 254 279 302 329 364 405 446 480 535 578 615<br />

Connecticut 297 324 336 400 414 515 561 609 639 701 765 852<br />

Delaware 332 328 410 548 602 658 693 758 843 915 1,005 1,138<br />

District of Columbia 661 732 859 965 1,034 1,131 1,173 1,265 1,348 1,484 1,635 1,861<br />

Florida 356 411 456 506 561 607 667 718 770 831 894 968<br />

Georgia 341 406 447 517 576 617 665 728 825 911 984 1,083<br />

Hawaii 217 251 345 419 484 575 670 731 825 911 985 1,059<br />

Idaho 176 185 218 241 269 327 350 392 409 477 539 568<br />

Illinois 299 339 383 435 480 533 585 633 674 717 780 864<br />

Indiana 249 287 327 395 423 458 487 541 591 644 705 765<br />

Iowa 232 267 293 354 392 430 495 522 559 612 674 722<br />

Kansas 242 260 304 353 385 421 447 488 525 587 661 711<br />

Kentucky 218 265 307 335 377 423 463 510 555 602 666 750<br />

Louisiana 304 347 407 452 516 570 646 736 874 969 1,054 1,141<br />

Maine 125 222 250 283 349 373 377 420 480 504 554 595<br />

Maryland 332 382 430 492 549 596 630 690 754 829 923 1,041<br />

Massachusetts 306 277 299 415 450 472 500 542 594 640 694 760<br />

Michigan 313 351 398 437 487 526 557 599 649 723 777 842<br />

Minnesota 267 313 361 400 447 491 531 586 627 674 738 797<br />

Mississippi 325 363 411 505 572 644 696 777 876 978 1,068 1,149<br />

Missouri 245 271 281 375 429 475 528 597 659 730 801 866<br />

Montana 183 227 252 289 346 376 415 462 479 538 615 662<br />

Nebraska 223 272 299 328 366 402 436 491 538 608 651 700<br />

Nevada 344 376 416 467 494 530 622 659 669 674 674 707<br />

New Hampshire 207 261 304 326 349 379 408 436 474 537 563 596<br />

New Jersey 364 402 449 509 545 597 633 667 700 771 837 924<br />

New Mexico 344 373 395 462 500 554 613 675 761 824 910 989<br />

New York 316 357 390 453 514 564 615 659 705 756 821 889<br />

North Carolina 293 336 393 458 509 577 635 688 749 820 891 977<br />

North Dakota 207 261 294 330 367 413 502 525 574 637 688 755<br />

Ohio 235 269 316 362 411 459 508 558 620 688 774 849<br />

Oklahoma 229 262 281 327 363 397 437 487 544 609 678 728<br />

Oregon 190 217 261 302 351 392 442 470 516 566 605 671<br />

Pennsylvania 293 327 368 423 473 534 581 634 695 761 837 915<br />

Rhode Island 349 367 392 440 505 527 537 551 597 677 717 780<br />

South Carolina 318 387 452 541 606 552 739 814 917 1,000 1,086 1,182<br />

South Dakota 278 332 349 402 466 507 534 582 638 675 707 771<br />

Tennessee 296 329 374 451 484 527 573 639 692 817 882 954<br />

Texas 282 314 357 410 445 484 536 593 654 725 799 874<br />

Utah 208 242 261 293 342 362 399 420 482 503 512 538<br />

Vermont 232 257 299 321 330 372 366 401 445 496 519 578<br />

Virginia 350 387 431 501 553 584 619 662 729 783 840 924<br />

Washington 224 216 288 342 387 427 476 512 544 598 634 675<br />

West Virginia 189 216 264 313 367 408 457 506 568 622 664 736<br />

Wisconsin 272 302 354 385 431 467 518 583 645 703 745 815<br />

Wyoming 161 173 203 225 245 307 327 369 434 496 503 529<br />

341<br />

All 283 322 364 420 467 510 557 607 661 726 792 864<br />

Rates are adjusted by age, gender, & race.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table B.9 B.9 (continued)<br />

Point prevalent rates of of reported ESRD, by by diabetic status & state, adjusted: all all patients<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population<br />

population<br />

342<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Alabama 1,184 1,264 1,353 1,427 1,539 1,627 1,672 1,716 1,796 1,846 1,879 1,918<br />

Alaska 410 420 611 900 836 828 782 766 774 812 794 809<br />

Arizona 984 1,035 1,055 1,091 1,121 1,166 1,213 1,257 1,296 1,325 1,335 1,364<br />

Arkansas 848 919 1,017 1,102 1,159 1,227 1,252 1,281 1,299 1,337 1,351 1,356<br />

California 861 931 1,021 1,075 1,128 1,170 1,221 1,272 1,326 1,376 1,429 1,471<br />

Colorado 659 696 735 749 783 816 859 880 903 918 945 968<br />

Connecticut 915 974 1,045 1,093 1,148 1,189 1,223 1,263 1,304 1,300 1,309 1,312<br />

Delaware 1,260 1,291 1,342 1,400 1,474 1,512 1,537 1,596 1,640 1,663 1,740 1,797<br />

District of Columbia 2,126 2,387 2,552 2,738 2,878 2,991 3,044 3,186 3,327 3,437 3,527 3,733<br />

Florida 1,046 1,107 1,163 1,194 1,250 1,286 1,315 1,350 1,385 1,413 1,433 1,442<br />

Georgia 1,168 1,232 1,317 1,378 1,438 1,476 1,524 1,569 1,613 1,655 1,694 1,711<br />

Hawaii 1,128 1,236 1,369 1,444 1,499 1,586 1,659 1,720 1,801 1,828 1,898 1,946<br />

Idaho 594 629 671 698 744 798 819 891 885 921 930 935<br />

Illinois 921 992 1,072 1,148 1,236 1,296 1,364 1,427 1,481 1,528 1,584 1,626<br />

Indiana 836 902 960 1,010 1,074 1,132 1,208 1,257 1,311 1,354 1,386 1,422<br />

Iowa 792 839 888 913 972 1,008 1,056 1,128 1,157 1,204 1,243 1,270<br />

Kansas 764 794 844 881 927 994 1,033 1,079 1,112 1,116 1,158 1,180<br />

Kentucky 830 879 918 982 1,028 1,081 1,139 1,173 1,216 1,264 1,287 1,326<br />

Louisiana 1,238 1,313 1,398 1,489 1,565 1,677 1,763 1,847 1,901 1,941 2,015 2,065<br />

Maine 639 707 769 839 876 924 985 1,008 1,041 1,080 1,111 1,138<br />

Maryland 1,141 1,232 1,326 1,403 1,483 1,556 1,622 1,671 1,710 1,756 1,806 1,845<br />

Massachusetts 835 898 954 988 1,026 1,072 1,117 1,126 1,146 1,153 1,175 1,194<br />

Michigan 922 998 1,072 1,132 1,224 1,277 1,342 1,379 1,431 1,481 1,524 1,571<br />

Minnesota 848 899 948 984 1,032 1,076 1,108 1,136 1,153 1,193 1,228 1,241<br />

Mississippi 1,235 1,346 1,468 1,545 1,644 1,726 1,805 1,874 1,910 1,968 2,030 2,075<br />

Missouri 932 1,003 1,065 1,128 1,188 1,240 1,314 1,372 1,412 1,449 1,476 1,501<br />

Montana 694 755 797 871 913 964 982 1,053 1,056 1,116 1,141 1,162<br />

Nebraska 780 826 880 934 959 1,017 1,071 1,127 1,175 1,219 1,252 1,274<br />

Nevada 749 800 842 867 897 912 933 981 990 1,034 1,060 1,101<br />

New Hampshire 621 651 699 733 737 766 792 832 883 899 938 960<br />

New Jersey 993 1,050 1,122 1,178 1,227 1,280 1,345 1,414 1,441 1,475 1,505 1,538<br />

New Mexico 1,061 1,120 1,155 1,230 1,285 1,338 1,383 1,431 1,498 1,526 1,523 1,551<br />

New York 957 1,029 1,084 1,135 1,189 1,253 1,320 1,375 1,419 1,445 1,481 1,511<br />

North Carolina 1,069 1,156 1,237 1,293 1,359 1,430 1,494 1,526 1,589 1,634 1,672 1,702<br />

North Dakota 838 909 967 954 969 1,014 1,063 1,131 1,105 1,197 1,273 1,282<br />

Ohio 921 980 1,059 1,124 1,196 1,254 1,327 1,395 1,466 1,511 1,560 1,607<br />

Oklahoma 792 857 923 981 1,026 1,095 1,156 1,195 1,237 1,264 1,300 1,340<br />

Oregon 699 741 793 825 857 887 923 953 980 1,025 1,061 1,101<br />

Pennsylvania 990 1,046 1,120 1,191 1,265 1,338 1,399 1,453 1,506 1,536 1,578 1,592<br />

Rhode Island 835 891 993 1,019 1,082 1,107 1,151 1,178 1,212 1,230 1,245 1,250<br />

South Carolina 1,280 1,363 1,470 1,550 1,623 1,694 1,756 1,821 1,845 1,889 1,890 1,945<br />

South Dakota 809 870 920 1,008 1,091 1,165 1,226 1,276 1,327 1,334 1,375 1,433<br />

Tennessee 1,025 1,068 1,162 1,224 1,275 1,317 1,375 1,431 1,471 1,485 1,500 1,511<br />

Texas 950 1,013 1,081 1,128 1,189 1,240 1,302 1,365 1,420 1,463 1,504 1,547<br />

Utah 563 615 642 676 690 703 753 790 824 855 873 888<br />

Vermont 599 629 674 748 816 887 937 973 1,000 1,012 1,012 1,050<br />

Virginia 1,017 1,097 1,161 1,224 1,294 1,382 1,445 1,494 1,517 1,549 1,589 1,609<br />

Washington 713 753 803 840 872 901 940 979 1,013 1,045 1,084 1,109<br />

West Virginia 796 856 919 989 1,057 1,155 1,241 1,309 1,385 1,444 1,470 1,510<br />

Wisconsin 878 931 989 1,031 1,087 1,142 1,198 1,242 1,259 1,295 1,339 1,391<br />

Wyoming 549 573 610 651 709 753 790 841 888 882 896 917<br />

All 935 1,000 1,071 1,126 1,186 1,240 1,296 1,346 1,390 1,427 1,465 1,496<br />

Rates are adjusted by age, gender, & race.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.


Table B.9 B.9 (continued)<br />

Point prevalent rates of of reported ESRD, by by diabetic status & state, adjusted: diabetic patients<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population<br />

population<br />

PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

Alabama 15 19 30 48 63 78 91 110 131 184 212 247<br />

Alaska * * * * 21 * 42 48 46 70 77 74<br />

Arizona 61 86 106 130 150 167 195 235 254 295 325 368<br />

Arkansas 12 21 30 45 57 75 78 108 118 138 154 183<br />

California 18 31 46 62 75 93 108 121 137 166 192 225<br />

Colorado 30 33 40 51 64 79 103 118 132 158 181 198<br />

Connecticut 32 46 50 67 78 104 121 134 142 168 187 225<br />

Delaware 30 51 67 71 92 102 132 167 215 244 276 328<br />

District of Columbia 57 69 108 142 195 238 256 290 291 332 403 451<br />

Florida 28 42 58 72 87 100 127 145 161 180 207 233<br />

Georgia 30 47 63 74 93 108 125 149 174 210 239 274<br />

Hawaii 22 32 60 73 83 126 181 231 268 311 360 398<br />

Idaho 16 22 29 37 48 55 70 91 100 128 156 160<br />

Illinois 31 41 54 65 76 96 111 127 140 160 183 216<br />

Indiana 27 37 44 60 68 75 85 103 119 137 162 194<br />

Iowa 20 35 45 66 79 88 111 112 125 144 159 174<br />

Kansas 27 32 48 61 77 88 84 103 116 136 164 190<br />

Kentucky 17 28 34 45 62 76 85 102 117 130 156 191<br />

Louisiana 19 30 44 49 75 88 110 140 181 221 256 303<br />

Maine * 21 30 33 51 53 59 79 94 100 122 135<br />

Maryland 24 36 49 66 84 105 117 136 154 186 234 281<br />

Massachusetts 33 37 42 55 62 68 77 84 98 120 144 171<br />

Michigan 41 52 62 70 84 99 112 122 143 170 200 230<br />

Minnesota 57 73 88 104 123 137 153 178 193 221 250 271<br />

Mississippi 19 30 44 59 80 93 111 136 173 214 255 296<br />

Missouri 13 25 45 56 70 88 99 119 138 160 186 216<br />

Montana 23 37 40 57 81 99 107 135 157 180 226 237<br />

Nebraska 37 53 64 71 77 85 95 117 139 171 199 221<br />

Nevada 60 71 86 81 80 89 114 139 147 155 174 195<br />

New Hampshire 22 31 41 47 47 60 69 80 102 117 133 143<br />

New Jersey 37 46 64 81 87 105 115 125 143 166 200 236<br />

New Mexico 51 72 83 127 143 160 195 230 282 321 353 416<br />

New York 24 37 48 62 83 98 116 132 150 168 194 217<br />

North Carolina 25 31 44 57 74 95 110 132 151 181 213 249<br />

North Dakota 39 46 57 85 101 117 160 164 185 237 252 281<br />

Ohio 31 41 54 65 80 96 113 133 152 178 214 242<br />

Oklahoma 18 27 42 62 74 87 105 127 162 180 214 245<br />

Oregon 14 21 43 50 60 72 90 103 117 135 156 171<br />

Pennsylvania 31 38 48 60 79 94 113 134 153 175 204 236<br />

Rhode Island 21 28 34 39 51 58 62 74 100 122 152 165<br />

South Carolina 27 38 53 69 97 112 143 170 199 232 266 315<br />

South Dakota 42 80 68 82 110 139 151 174 219 217 239 274<br />

Tennessee 16 22 35 49 60 76 86 106 127 171 196 226<br />

Texas 29 40 55 66 84 100 119 142 170 211 249 285<br />

Utah 34 46 51 71 93 104 117 129 163 166 184 191<br />

Vermont 31 39 63 56 63 90 88 104 96 132 150 168<br />

Virginia 28 37 49 65 82 89 104 118 141 165 186 220<br />

Washington 23 24 35 47 61 80 93 101 119 141 158 178<br />

West Virginia 19 24 37 54 65 67 94 112 129 146 165 193<br />

Wisconsin 45 52 69 80 97 107 129 151 175 194 213 248<br />

Wyoming * * 38 38 47 88 84 100 116 151 148 151<br />

343<br />

All 27 38 51 64 80 95 112 129 149 175 204 235<br />

Rates are adjusted by age, gender, & race.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.<br />

*Values for cells with 10 or fewer patients are suppressed.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table B.9 B.9 (continued)<br />

Point prevalent rates of of reported ESRD, by by diabetic status & state, adjusted: diabetic patients<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population<br />

population<br />

344<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Alabama 279 320 362 398 449 502 530 559 615 649 661 677<br />

Alaska 90 112 181 303 288 296 257 264 240 262 257 261<br />

Arizona 411 438 456 479 496 533 557 577 601 619 623 638<br />

Arkansas 204 229 267 310 348 378 388 400 419 447 454 465<br />

California 254 282 324 351 379 407 431 457 488 512 535 555<br />

Colorado 224 246 255 267 288 304 324 336 355 360 374 383<br />

Connecticut 247 272 300 327 349 385 393 409 438 430 440 449<br />

Delaware 352 364 393 408 435 471 493 526 573 576 611 635<br />

District of Columbia 563 654 694 766 868 901 896 944 984 1,032 1,071 1,147<br />

Florida 263 290 318 340 369 394 409 427 446 469 477 483<br />

Georgia 310 335 371 407 454 480 508 536 556 575 599 609<br />

Hawaii 433 521 597 647 676 718 758 796 868 905 946 953<br />

Idaho 177 196 216 224 250 281 303 334 326 338 343 331<br />

Illinois 232 255 287 327 367 395 424 459 484 498 523 538<br />

Indiana 229 252 278 318 348 367 405 428 448 463 479 498<br />

Iowa 206 229 255 277 309 321 342 372 385 405 416 422<br />

Kansas 207 225 252 266 289 315 355 379 400 406 424 426<br />

Kentucky 225 245 255 298 328 351 378 396 419 444 464 474<br />

Louisiana 353 379 411 452 510 569 617 652 680 695 722 742<br />

Maine 150 175 198 233 243 270 297 300 325 353 376 395<br />

Maryland 325 363 395 428 472 512 536 551 549 571 597 604<br />

Massachusetts 205 226 255 274 294 315 332 334 341 357 367 369<br />

Michigan 263 294 331 361 412 441 473 487 517 541 557 576<br />

Minnesota 283 311 324 335 347 362 376 384 391 402 416 415<br />

Mississippi 335 380 430 476 528 565 608 643 651 678 705 733<br />

Missouri 244 277 304 340 368 403 440 459 482 495 509 513<br />

Montana 259 278 302 355 372 394 397 429 448 488 502 510<br />

Nebraska 258 290 297 339 356 381 406 429 448 466 470 486<br />

Nevada 207 227 239 271 281 304 327 345 353 380 397 430<br />

New Hampshire 152 170 188 204 206 226 238 250 268 274 290 297<br />

New Jersey 256 280 316 353 383 410 447 476 489 501 513 517<br />

New Mexico 467 519 544 596 647 685 715 747 807 817 802 811<br />

New York 244 273 293 320 353 384 412 434 454 471 488 501<br />

North Carolina 288 323 365 398 444 483 519 537 571 588 606 620<br />

North Dakota 330 347 364 357 352 372 405 395 391 423 459 459<br />

Ohio 274 298 339 374 409 444 483 514 548 573 594 609<br />

Oklahoma 276 309 336 370 391 433 473 494 509 528 548 564<br />

Oregon 183 197 219 242 267 288 292 307 317 335 345 361<br />

Pennsylvania 272 295 326 361 388 420 451 472 498 515 537 543<br />

Rhode Island 195 206 235 256 299 326 358 370 371 380 381 373<br />

South Carolina 351 386 435 467 514 543 598 637 659 689 683 710<br />

South Dakota 322 362 385 431 470 504 520 566 567 569 594 637<br />

Tennessee 254 279 318 354 386 408 435 457 478 489 500 507<br />

Texas 318 350 385 416 454 490 527 560 598 622 653 677<br />

Utah 202 227 242 264 271 279 296 311 329 347 349 356<br />

Vermont 177 183 212 249 277 306 336 360 364 359 348 347<br />

Virginia 261 297 329 360 393 441 472 497 515 537 562 567<br />

Washington 202 222 243 255 273 297 315 331 345 360 371 379<br />

West Virginia 231 244 273 310 348 399 442 493 550 578 587 613<br />

Wisconsin 272 295 314 330 349 379 399 415 413 426 444 462<br />

Wyoming 150 180 209 250 271 302 309 329 353 345 344 360<br />

All 265 293 324 354 387 417 446 469 493 512 530 543<br />

Rates are adjusted by age, gender, & race.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.


Table B.9 B.9 (continued)<br />

Point prevalent rates of of reported ESRD, by by diabetic status & state, adjusted: non-diabetic patients<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population<br />

population<br />

PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

Alabama 328 364 409 477 514 548 495 548 601 748 823 860<br />

Alaska 108 100 136 143 134 135 182 186 219 247 257 293<br />

Arizona 259 294 319 359 380 403 423 440 457 486 524 542<br />

Arkansas 218 243 272 318 353 387 424 455 510 533 568 615<br />

California 230 270 294 329 355 374 400 430 456 485 526 566<br />

Colorado 203 221 239 251 265 285 302 328 349 377 397 417<br />

Connecticut 265 279 285 333 336 410 440 474 497 533 578 627<br />

Delaware 301 276 343 477 509 556 561 591 627 671 729 810<br />

District of Columbia 604 663 751 822 839 893 917 976 1,057 1,153 1,232 1,410<br />

Florida 327 368 397 434 474 507 541 573 610 652 687 735<br />

Georgia 311 359 383 443 483 510 540 579 651 700 745 809<br />

Hawaii 196 219 284 346 401 449 489 500 557 600 625 660<br />

Idaho 159 163 189 204 221 272 280 302 309 349 383 408<br />

Illinois 267 298 329 370 404 437 474 506 534 557 597 649<br />

Indiana 222 250 283 335 355 383 402 439 472 508 543 572<br />

Iowa 212 232 248 288 313 342 385 410 434 468 514 548<br />

Kansas 215 228 256 293 308 333 362 384 409 450 497 521<br />

Kentucky 201 237 273 289 315 347 379 408 438 472 510 559<br />

Louisiana 285 317 364 403 441 482 536 596 692 749 798 838<br />

Maine 115 201 220 250 299 320 318 341 386 405 433 460<br />

Maryland 308 345 381 426 466 492 513 554 600 642 689 759<br />

Massachusetts 273 240 257 361 388 404 424 458 496 520 549 589<br />

Michigan 272 299 336 367 403 427 445 477 506 553 578 612<br />

Minnesota 210 240 273 296 324 354 378 408 434 452 488 527<br />

Mississippi 305 332 367 445 492 552 585 641 703 764 813 853<br />

Missouri 232 246 236 320 358 387 429 478 521 570 616 650<br />

Montana 159 190 211 232 265 277 308 327 322 358 389 425<br />

Nebraska 187 219 235 257 289 317 341 374 399 436 452 479<br />

Nevada 284 305 330 387 414 442 508 521 522 519 500 512<br />

New Hampshire 185 230 263 278 302 319 339 355 372 420 430 452<br />

New Jersey 327 355 385 429 458 492 519 541 558 605 638 688<br />

New Mexico 293 300 311 335 358 394 418 446 478 503 557 573<br />

New York 292 320 342 390 431 466 499 527 555 588 627 671<br />

North Carolina 269 304 348 401 435 482 525 556 598 640 678 727<br />

North Dakota 167 215 237 245 265 296 342 361 389 401 436 474<br />

Ohio 204 229 262 298 331 363 395 426 469 510 560 608<br />

Oklahoma 211 235 239 265 289 310 332 359 381 429 464 483<br />

Oregon 176 196 218 252 291 320 352 367 399 431 450 500<br />

Pennsylvania 262 290 320 363 394 439 468 501 542 586 632 679<br />

Rhode Island 328 339 358 400 453 469 475 477 497 555 565 615<br />

South Carolina 291 349 399 472 509 440 596 644 718 768 820 867<br />

South Dakota 236 252 280 320 356 368 383 408 419 458 468 498<br />

Tennessee 281 307 339 402 424 451 487 533 565 645 686 727<br />

Texas 254 274 302 344 361 384 416 451 483 514 549 589<br />

Utah 175 196 211 222 249 259 282 291 320 337 327 347<br />

Vermont 201 218 236 265 268 282 278 298 348 363 369 410<br />

Virginia 322 351 382 436 470 495 515 544 588 618 654 704<br />

Washington 202 192 253 295 326 346 383 411 425 457 477 497<br />

West Virginia 170 192 227 259 302 341 363 394 439 476 498 543<br />

Wisconsin 227 250 285 304 334 360 389 432 471 509 532 567<br />

Wyoming 140 148 164 187 198 219 243 269 317 345 355 378<br />

345<br />

All 255 284 313 356 387 415 445 477 512 551 588 630<br />

Rates are adjusted by age, gender, & race.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table B.9 B.9 (continued)<br />

Point prevalent rates of of reported ESRD, by by diabetic status & state, adjusted: non-diabetic patients<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population<br />

population<br />

346<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Alabama 905 944 991 1,029 1,091 1,125 1,142 1,156 1,181 1,196 1,218 1,240<br />

Alaska 320 308 431 597 548 533 525 502 534 549 536 549<br />

Arizona 573 597 599 612 626 633 656 681 695 705 712 726<br />

Arkansas 644 690 750 792 810 849 864 881 880 890 897 891<br />

California 606 649 697 724 748 763 790 815 838 864 893 916<br />

Colorado 435 450 480 482 495 512 535 544 548 559 571 586<br />

Connecticut 668 703 745 766 800 804 829 855 866 870 869 863<br />

Delaware 908 927 949 992 1,039 1,041 1,044 1,071 1,067 1,087 1,128 1,162<br />

District of Columbia 1,563 1,733 1,858 1,972 2,011 2,089 2,147 2,242 2,343 2,405 2,456 2,586<br />

Florida 783 817 845 855 881 892 906 924 939 944 956 960<br />

Georgia 859 897 946 971 984 996 1,016 1,033 1,057 1,080 1,095 1,102<br />

Hawaii 695 715 772 797 823 868 901 924 934 922 952 993<br />

Idaho 418 433 454 474 494 517 516 557 559 584 588 604<br />

Illinois 689 737 785 821 869 901 939 968 997 1,029 1,061 1,087<br />

Indiana 607 650 682 692 726 765 803 829 863 892 908 924<br />

Iowa 586 611 633 636 663 687 714 756 772 799 826 848<br />

Kansas 557 570 592 615 638 679 678 700 711 710 735 754<br />

Kentucky 606 634 663 684 700 729 762 778 796 819 822 853<br />

Louisiana 885 934 987 1,037 1,054 1,108 1,146 1,195 1,221 1,246 1,293 1,323<br />

Maine 489 531 570 606 633 655 688 708 715 727 734 743<br />

Maryland 816 869 931 975 1,011 1,044 1,086 1,120 1,162 1,184 1,209 1,241<br />

Massachusetts 630 671 699 714 732 758 785 792 804 796 809 825<br />

Michigan 659 704 742 771 812 837 869 892 914 940 967 995<br />

Minnesota 565 588 625 649 684 714 732 752 762 791 812 826<br />

Mississippi 900 967 1,038 1,069 1,116 1,161 1,197 1,230 1,258 1,290 1,325 1,342<br />

Missouri 687 727 761 788 820 837 874 912 930 954 967 988<br />

Montana 435 477 495 516 541 570 585 623 608 628 639 651<br />

Nebraska 522 537 583 595 603 636 665 698 728 752 782 788<br />

Nevada 543 573 603 596 616 607 606 636 637 655 663 671<br />

New Hampshire 469 481 511 529 531 540 555 583 615 625 647 662<br />

New Jersey 737 770 805 826 843 870 898 938 952 975 992 1,021<br />

New Mexico 594 601 611 634 638 653 668 684 691 709 721 740<br />

New York 713 757 791 815 837 869 908 941 965 974 993 1,010<br />

North Carolina 781 833 872 896 916 947 975 989 1,018 1,046 1,066 1,082<br />

North Dakota 508 561 603 597 618 642 658 736 714 774 814 823<br />

Ohio 648 682 720 750 786 810 844 881 918 938 966 999<br />

Oklahoma 516 548 587 610 636 662 682 701 728 736 752 776<br />

Oregon 515 544 574 583 590 598 632 647 663 690 716 740<br />

Pennsylvania 717 751 795 830 878 917 948 981 1,008 1,021 1,042 1,049<br />

Rhode Island 641 684 758 763 782 781 793 808 841 849 864 877<br />

South Carolina 930 977 1,035 1,082 1,109 1,150 1,158 1,184 1,187 1,200 1,207 1,236<br />

South Dakota 487 508 535 577 622 661 706 710 760 765 780 796<br />

Tennessee 772 790 843 869 889 909 940 974 993 995 1,001 1,004<br />

Texas 632 663 696 713 735 750 775 804 822 840 852 869<br />

Utah 361 388 400 412 420 423 457 478 495 509 524 533<br />

Vermont 421 446 461 499 539 580 601 613 635 653 664 702<br />

Virginia 757 800 833 864 901 940 973 997 1,002 1,012 1,027 1,042<br />

Washington 511 531 560 585 600 604 625 648 668 685 713 730<br />

West Virginia 565 611 647 680 710 756 799 816 835 866 883 897<br />

Wisconsin 606 636 675 702 737 763 799 827 846 868 896 929<br />

Wyoming 400 392 401 402 438 451 481 513 535 537 552 558<br />

All 671 708 747 772 799 823 850 877 897 915 935 953<br />

Rates are adjusted by age, gender, & race.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.


ON OUR WEBSITE & CD<br />

Point prevalent counts of reported ESRD patients: U.S. only, with unknowns<br />

dropped (B.10.1).<br />

PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

Table B.10 B.10<br />

Point prevalent counts of of reported ESRD patients, by by diabetic status & ESRD network<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December 31<br />

31 of<br />

of<br />

each<br />

each<br />

year<br />

year<br />

ALL 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

1 CT, MA, ME, NH, RI, VT 3,083 3,208 3,484 4,401 4,829 5,372 5,757 6,304 6,923 7,607 8,289 9,156<br />

2 NY 4,944 5,633 6,217 7,287 8,360 9,254 10,185 10,980 11,833 12,715 13,897 15,158<br />

3 NJ, PR, VI 3,243 3,653 4,133 4,698 5,217 5,756 6,178 6,582 7,057 7,764 8,469 9,312<br />

4 DE, PA 3,362 3,748 4,246 4,895 5,465 6,181 6,794 7,458 8,244 9,054 10,066 11,159<br />

5 MD, DC, VA, WV 3,494 3,991 4,579 5,378 6,106 6,678 7,192 7,951 8,865 9,761 10,785 12,240<br />

6 NC, SC, GA 4,000 4,799 5,583 6,656 7,553 8,151 9,462 10,522 11,907 13,298 14,813 16,635<br />

7 FL 3,363 3,968 4,508 5,108 5,792 6,406 7,231 7,982 8,762 9,704 10,693 11,939<br />

8 AL, MS, TN 3,022 3,401 3,908 4,751 5,259 5,838 6,080 6,887 7,667 9,215 10,309 11,282<br />

9 IN, KY, OH 4,220 4,907 5,718 6,608 7,377 8,205 9,053 10,070 11,214 12,401 13,980 15,561<br />

10 IL 3,143 3,588 4,055 4,644 5,121 5,698 6,299 6,848 7,316 7,861 8,637 9,684<br />

11 MI, MN, ND, SD, WI 4,866 5,555 6,360 7,038 7,918 8,695 9,479 10,462 11,455 12,687 13,853 15,261<br />

12 IA, KS, MO, NE 2,563 2,893 3,119 3,876 4,375 4,829 5,384 5,976 6,548 7,325 8,161 8,943<br />

13 AR, LA, OK 2,168 2,502 2,888 3,344 3,807 4,231 4,724 5,341 6,132 6,784 7,497 8,262<br />

14 TX 3,828 4,408 5,208 6,124 6,746 7,490 8,360 9,325 10,398 11,717 13,119 14,647<br />

15 AZ, CO, NV, NM, UT, WY 2,369 2,754 3,134 3,609 4,063 4,556 5,146 5,760 6,337 7,035 7,742 8,583<br />

16 AK, ID, MT, OR, WA 1,659 1,747 2,198 2,596 2,967 3,327 3,774 4,151 4,548 5,140 5,648 6,303<br />

17 N. CA, HI, Guam, AS 2,935 3,272 3,700 4,217 4,752 5,247 5,847 6,546 7,334 8,232 9,168 10,163<br />

18 S. CA 3,737 4,812 5,378 6,169 6,813 7,535 8,370 9,223 10,071 11,305 12,688 14,281<br />

Unknown 43 46 55 63 73 82 101 121 149 162 164 161<br />

347<br />

All 60,042 68,885 78,471 91,462 102,593 113,531 125,416 138,489 152,760 169,767 187,978 208,730<br />

DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 317 408 489 619 729 874 994 1,137 1,310 1,568 1,840 2,158<br />

2 NY 382 577 764 1,003 1,317 1,561 1,886 2,162 2,479 2,787 3,234 3,657<br />

3 NJ, PR, VI 333 431 595 759 906 1,088 1,248 1,382 1,586 1,848 2,196 2,576<br />

4 DE, PA 364 442 557 701 914 1,100 1,337 1,589 1,841 2,118 2,506 2,936<br />

5 MD, DC, VA, WV 287 390 538 743 964 1,125 1,316 1,536 1,792 2,126 2,536 3,063<br />

6 NC, SC, GA 357 511 710 896 1,176 1,430 1,738 2,113 2,481 3,011 3,564 4,223<br />

7 FL 250 397 560 706 877 1,037 1,343 1,570 1,783 2,048 2,422 2,825<br />

8 AL, MS, TN 164 232 353 504 652 806 939 1,166 1,412 1,895 2,237 2,632<br />

9 IN, KY, OH 478 655 850 1,058 1,318 1,550 1,824 2,196 2,555 2,979 3,605 4,219<br />

10 IL 317 418 560 678 802 1,014 1,179 1,354 1,511 1,746 2,013 2,393<br />

11 MI, MN, ND, SD, WI 746 946 1,158 1,372 1,663 1,920 2,222 2,526 2,911 3,394 3,911 4,535<br />

12 IA, KS, MO, NE 212 333 493 638 790 939 1,066 1,234 1,430 1,684 1,979 2,289<br />

13 AR, LA, OK 141 218 321 427 583 706 854 1,085 1,352 1,609 1,898 2,254<br />

14 TX 387 556 799 979 1,267 1,549 1,870 2,236 2,719 3,412 4,064 4,734<br />

15 AZ, CO, NV, NM, UT, WY 366 490 612 790 959 1,146 1,401 1,692 1,957 2,284 2,618 3,038<br />

16 AK, ID, MT, OR, WA 145 181 278 373 486 616 746 878 1,041 1,270 1,482 1,702<br />

17 N. CA, HI, Guam, AS 206 337 460 585 701 935 1,145 1,414 1,714 2,159 2,526 2,900<br />

18 S. CA 304 517 753 1,018 1,253 1,544 1,844 2,056 2,354 2,867 3,384 4,107<br />

Unknown . . . * * * * * * * * *<br />

All 5,756 8,039 10,850 13,850 17,360 20,943 24,956 29,330 34,231 40,808 48,017 56,244<br />

NON-DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 2,766 2,800 2,995 3,782 4,100 4,498 4,763 5,167 5,613 6,039 6,449 6,998<br />

2 NY 4,562 5,056 5,453 6,284 7,043 7,693 8,299 8,818 9,354 9,928 10,663 11,501<br />

3 NJ, PR, VI 2,910 3,222 3,538 3,939 4,311 4,668 4,930 5,200 5,471 5,916 6,273 6,736<br />

4 DE, PA 2,998 3,306 3,689 4,194 4,551 5,081 5,457 5,869 6,403 6,936 7,560 8,223<br />

5 MD, DC, VA, WV 3,207 3,601 4,041 4,635 5,142 5,553 5,876 6,415 7,073 7,635 8,249 9,177<br />

6 NC, SC, GA 3,643 4,288 4,873 5,760 6,377 6,721 7,724 8,409 9,426 10,287 11,249 12,412<br />

7 FL 3,113 3,571 3,948 4,402 4,915 5,369 5,888 6,412 6,979 7,656 8,271 9,114<br />

8 AL, MS, TN 2,858 3,169 3,555 4,247 4,607 5,032 5,141 5,721 6,255 7,320 8,072 8,650<br />

9 IN, KY, OH 3,742 4,252 4,868 5,550 6,059 6,655 7,229 7,874 8,659 9,422 10,375 11,342<br />

10 IL 2,826 3,170 3,495 3,966 4,319 4,684 5,120 5,494 5,805 6,115 6,624 7,291<br />

11 MI, MN, ND, SD, WI 4,120 4,609 5,202 5,666 6,255 6,775 7,257 7,936 8,544 9,293 9,942 10,726<br />

12 IA, KS, MO, NE 2,351 2,560 2,626 3,238 3,585 3,890 4,318 4,742 5,118 5,641 6,182 6,654<br />

13 AR, LA, OK 2,027 2,284 2,567 2,917 3,224 3,525 3,870 4,256 4,780 5,175 5,599 6,008<br />

14 TX 3,441 3,852 4,409 5,145 5,479 5,941 6,490 7,089 7,679 8,305 9,055 9,913<br />

15 AZ, CO, NV, NM, UT, WY 2,003 2,264 2,522 2,819 3,104 3,410 3,745 4,068 4,380 4,751 5,124 5,545<br />

16 AK, ID, MT, OR, WA 1,514 1,566 1,920 2,223 2,481 2,711 3,028 3,273 3,507 3,870 4,166 4,601<br />

17 N. CA, HI, Guam, AS 2,729 2,935 3,240 3,632 4,051 4,312 4,702 5,132 5,620 6,073 6,642 7,263<br />

18 S. CA 3,433 4,295 4,625 5,151 5,560 5,991 6,526 7,167 7,717 8,438 9,304 10,174<br />

Unknown 43 46 55 62 70 79 97 117 146 159 162 158<br />

All 54,286 60,846 67,621 77,612 85,233 92,588 100,460 109,159 118,529 128,959 139,961 152,486<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table B.10 B.10 (continued)<br />

Point prevalent counts of of reported ESRD patients, by by diabetic status & ESRD network<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December 31<br />

31 of<br />

of<br />

each<br />

each<br />

year<br />

year<br />

ON OUR WEBSITE & CD<br />

Point prevalent counts of reported ESRD patients: U.S. only, with unknowns<br />

dropped (B.10.1).<br />

348<br />

ALL 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

1 CT, MA, ME, NH, RI, VT 9,970 10,815 11,712 12,407 13,159 13,949 14,756 15,329 16,050 16,440 17,018 17,540<br />

2 NY 16,475 17,835 19,022 20,208 21,454 22,955 24,584 26,039 27,400 28,437 29,704 30,911<br />

3 NJ, PR, VI 10,168 10,894 11,796 12,494 13,262 14,052 14,956 15,863 16,443 17,093 17,786 18,524<br />

4 DE, PA 12,198 12,969 13,992 14,980 16,058 17,078 18,002 18,868 19,742 20,288 21,104 21,601<br />

5 MD, DC, VA, WV 13,714 15,108 16,392 17,690 19,071 20,621 22,018 23,315 24,363 25,435 26,565 27,608<br />

6 NC, SC, GA 18,568 20,380 22,479 24,234 26,151 28,057 29,957 31,634 33,344 35,021 36,456 37,917<br />

7 FL 13,251 14,385 15,570 16,496 17,859 18,955 19,923 21,011 22,105 23,156 24,193 25,029<br />

8 AL, MS, TN 12,355 13,392 14,742 15,851 17,166 18,367 19,424 20,443 21,457 22,231 23,003 23,769<br />

9 IN, KY, OH 17,193 18,531 20,079 21,512 23,082 24,501 26,257 27,715 29,380 30,643 31,839 33,178<br />

10 IL 10,482 11,441 12,489 13,501 14,702 15,636 16,655 17,616 18,526 19,344 20,298 21,134<br />

11 MI, MN, ND, SD, WI 16,794 18,300 19,817 21,107 22,864 24,246 25,722 26,868 28,154 29,549 30,961 32,362<br />

12 IA, KS, MO, NE 9,843 10,584 11,399 12,103 12,892 13,711 14,588 15,492 16,245 16,866 17,497 18,053<br />

13 AR, LA, OK 9,091 9,913 10,844 11,801 12,590 13,669 14,539 15,367 16,045 16,619 17,340 18,019<br />

14 TX 16,367 17,885 19,585 21,039 22,820 24,455 26,298 28,241 30,098 31,711 33,368 35,252<br />

15 AZ, CO, NV, NM, UT, WY 9,581 10,603 11,486 12,403 13,339 14,336 15,450 16,531 17,593 18,539 19,337 20,342<br />

16 AK, ID, MT, OR, WA 6,790 7,394 8,169 8,892 9,415 9,963 10,523 11,191 11,760 12,488 13,193 13,859<br />

17 N. CA, HI, Guam, AS 11,009 11,982 13,075 13,870 14,722 15,747 16,809 17,983 19,232 20,431 21,581 22,715<br />

18 S. CA 15,854 17,362 19,360 20,705 22,250 23,649 25,296 26,903 28,785 30,629 32,809 34,747<br />

Unknown 174 179 272 273 274 187 187 205 219 241 256 397<br />

All 229,877 249,952 272,280 291,566 313,130 334,134 355,944 376,614 396,941 415,161 434,308 452,957<br />

DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 2,488 2,769 3,133 3,468 3,802 4,204 4,509 4,702 5,003 5,221 5,463 5,639<br />

2 NY 4,139 4,660 5,071 5,655 6,333 7,015 7,660 8,218 8,780 9,311 9,862 10,358<br />

3 NJ, PR, VI 2,910 3,185 3,602 3,968 4,399 4,788 5,264 5,712 5,982 6,244 6,558 6,877<br />

4 DE, PA 3,385 3,670 4,083 4,540 4,923 5,379 5,811 6,143 6,555 6,816 7,185 7,382<br />

5 MD, DC, VA, WV 3,664 4,193 4,670 5,224 5,872 6,614 7,162 7,705 8,088 8,594 9,127 9,460<br />

6 NC, SC, GA 4,930 5,596 6,446 7,232 8,286 9,152 10,131 10,899 11,702 12,395 13,022 13,670<br />

7 FL 3,287 3,715 4,202 4,630 5,220 5,752 6,151 6,599 7,097 7,658 8,073 8,410<br />

8 AL, MS, TN 3,044 3,486 4,031 4,565 5,170 5,725 6,213 6,663 7,182 7,590 7,917 8,266<br />

9 IN, KY, OH 4,915 5,430 6,108 6,933 7,683 8,339 9,209 9,844 10,574 11,164 11,711 12,192<br />

10 IL 2,628 2,929 3,327 3,822 4,349 4,751 5,163 5,641 6,027 6,285 6,675 6,980<br />

11 MI, MN, ND, SD, WI 5,120 5,731 6,333 6,887 7,655 8,294 8,912 9,309 9,842 10,403 10,943 11,463<br />

12 IA, KS, MO, NE 2,652 3,001 3,340 3,716 4,085 4,476 4,933 5,297 5,649 5,892 6,129 6,298<br />

13 AR, LA, OK 2,622 2,927 3,271 3,706 4,150 4,684 5,137 5,490 5,812 6,104 6,401 6,710<br />

14 TX 5,426 6,132 6,919 7,723 8,704 9,666 10,643 11,577 12,671 13,490 14,506 15,501<br />

15 AZ, CO, NV, NM, UT, WY 3,517 4,020 4,425 4,939 5,404 5,987 6,519 7,033 7,665 8,139 8,503 9,009<br />

16 AK, ID, MT, OR, WA 1,926 2,165 2,456 2,757 3,018 3,341 3,542 3,815 4,036 4,344 4,586 4,802<br />

17 N. CA, HI, Guam, AS 3,220 3,645 4,133 4,531 4,955 5,516 6,001 6,574 7,191 7,749 8,272 8,794<br />

18 S. CA 4,763 5,327 6,242 6,844 7,561 8,300 8,993 9,720 10,675 11,549 12,471 13,295<br />

Unknown * 13 40 38 36 * * * * * * *<br />

All 64,645 72,594 81,832 91,178 101,605 111,989 121,955 130,942 140,532 148,949 157,406 165,113<br />

NON-DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 7,482 8,046 8,579 8,939 9,357 9,745 10,247 10,627 11,047 11,219 11,555 11,901<br />

2 NY 12,336 13,175 13,951 14,553 15,121 15,940 16,924 17,821 18,620 19,126 19,842 20,553<br />

3 NJ, PR, VI 7,258 7,709 8,194 8,526 8,863 9,264 9,692 10,151 10,461 10,849 11,228 11,647<br />

4 DE, PA 8,813 9,299 9,909 10,440 11,135 11,699 12,191 12,725 13,187 13,472 13,919 14,219<br />

5 MD, DC, VA, WV 10,050 10,915 11,722 12,466 13,199 14,007 14,856 15,610 16,275 16,841 17,438 18,148<br />

6 NC, SC, GA 13,638 14,784 16,033 17,002 17,865 18,905 19,826 20,735 21,642 22,626 23,434 24,247<br />

7 FL 9,964 10,670 11,368 11,866 12,639 13,203 13,772 14,412 15,008 15,498 16,120 16,619<br />

8 AL, MS, TN 9,311 9,906 10,711 11,286 11,996 12,642 13,211 13,780 14,275 14,641 15,086 15,503<br />

9 IN, KY, OH 12,278 13,101 13,971 14,579 15,399 16,162 17,048 17,871 18,806 19,479 20,128 20,986<br />

10 IL 7,854 8,512 9,162 9,679 10,353 10,885 11,492 11,975 12,499 13,059 13,623 14,154<br />

11 MI, MN, ND, SD, WI 11,674 12,569 13,484 14,220 15,209 15,952 16,810 17,559 18,312 19,146 20,018 20,899<br />

12 IA, KS, MO, NE 7,191 7,583 8,059 8,387 8,807 9,235 9,655 10,195 10,596 10,974 11,368 11,755<br />

13 AR, LA, OK 6,469 6,986 7,573 8,095 8,440 8,985 9,402 9,877 10,233 10,515 10,939 11,309<br />

14 TX 10,941 11,753 12,666 13,316 14,116 14,789 15,655 16,664 17,427 18,221 18,862 19,751<br />

15 AZ, CO, NV, NM, UT, WY 6,064 6,583 7,061 7,464 7,935 8,349 8,931 9,498 9,928 10,400 10,834 11,333<br />

16 AK, ID, MT, OR, WA 4,864 5,229 5,713 6,135 6,397 6,622 6,981 7,376 7,724 8,144 8,607 9,057<br />

17 N. CA, HI, Guam, AS 7,789 8,337 8,942 9,339 9,767 10,231 10,808 11,409 12,041 12,682 13,309 13,921<br />

18 S. CA 11,091 12,035 13,118 13,861 14,689 15,349 16,303 17,183 18,110 19,080 20,338 21,452<br />

Unknown 165 166 232 235 238 181 185 204 218 240 254 390<br />

All 165,232 177,358 190,448 200,388 211,525 222,145 233,989 245,672 256,409 266,212 276,902 287,844<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.


Table B.11 B.11<br />

Point prevalent rates of of reported ESRD, by by diabetic status & ESRD network, adjusted<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population<br />

population<br />

PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

ALL 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992<br />

1 CT, MA, ME, NH, RI, VT 281 289 311 390 423 467 494 534 579 631 682 749 810<br />

2 NY 317 357 391 453 515 565 617 661 707 758 823 891 960<br />

3 NJ 365 403 450 510 546 598 634 667 701 772 838 925 995<br />

4 DE, PA 296 328 371 429 479 541 588 641 703 769 846 928 1,007<br />

5 MD, DC, VA, WV 334 376 427 493 549 590 626 678 742 806 878 979 1,079<br />

6 NC, SC, GA 317 374 426 498 555 587 667 728 811 891 965 1,058 1,149<br />

7 FL 356 411 455 504 559 605 665 716 768 829 891 964 1,041<br />

8 AL, MS, TN 318 355 404 487 534 585 603 674 745 892 975 1,048 1,125<br />

9 IN, KY, OH 235 273 316 365 407 451 493 543 599 658 733 806 879<br />

10 IL 298 339 383 435 480 533 585 633 673 716 779 862 920<br />

11 MI, MN, ND, SD, WI 290 329 375 413 462 502 541 590 641 704 757 819 888<br />

12 IA, KS, MO, NE 239 269 292 360 404 446 493 545 593 659 725 783 851<br />

13 AR, LA, OK 260 297 339 388 438 486 542 612 704 776 848 919 992<br />

14 TX 282 314 357 409 445 484 535 592 653 725 799 874 950<br />

15 AZ, CO, NV, NM, UT, WY 280 318 348 394 432 472 521 568 612 664 708 756 809<br />

16 AK, ID, MT, OR, WA 200 208 262 304 348 387 433 467 501 556 596 643 675<br />

17 N. CA, HI 263 294 344 395 441 484 532 586 645 707 769 836 892<br />

18 S. CA 235 302 338 390 425 464 503 540 574 630 701 778 856<br />

349<br />

All 283 322 364 420 467 510 557 607 661 726 792 864 935<br />

DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 29 37 43 54 64 76 85 96 110 131 153 178 204<br />

2 NY 24 37 48 62 83 98 116 132 150 168 194 217 244<br />

3 NJ 37 47 64 81 87 106 116 126 143 166 200 237 257<br />

4 DE, PA 32 38 49 60 79 95 114 135 156 179 208 241 277<br />

5 MD, DC, VA, WV 27 36 50 68 87 100 115 132 151 177 209 248 292<br />

6 NC, SC, GA 27 39 53 66 86 103 122 146 169 203 234 272 309<br />

7 FL 28 42 58 72 87 100 126 144 161 180 207 233 263<br />

8 AL, MS, TN 16 23 35 51 65 80 93 113 138 185 214 248 280<br />

9 IN, KY, OH 27 37 48 60 74 86 100 118 136 157 189 219 252<br />

10 IL 31 40 54 65 76 96 111 127 140 160 183 215 232<br />

11 MI, MN, ND, SD, WI 46 58 70 82 98 113 129 145 166 192 218 247 274<br />

12 IA, KS, MO, NE 21 32 48 61 75 88 99 114 131 153 177 202 231<br />

13 AR, LA, OK 17 27 40 53 71 85 101 129 160 188 218 255 291<br />

14 TX 29 40 55 66 84 100 119 141 170 211 249 285 318<br />

15 AZ, CO, NV, NM, UT, WY 46 61 73 92 109 125 150 176 199 226 250 279 309<br />

16 AK, ID, MT, OR, WA 19 23 36 46 59 74 88 101 116 138 158 173 192<br />

17 N. CA, HI 16 28 44 56 67 90 107 130 152 186 213 239 262<br />

18 S. CA 19 33 48 66 80 98 114 122 136 162 189 227 261<br />

All 27 38 51 64 80 95 112 129 149 175 204 235 265<br />

NON-DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 252 252 267 336 359 391 409 438 469 500 530 570 605<br />

2 NY 292 321 343 391 432 467 501 529 557 589 629 674 716<br />

3 NJ 328 357 386 430 459 492 518 541 558 606 639 688 738<br />

4 DE, PA 264 290 322 369 400 446 474 506 547 591 638 687 729<br />

5 MD, DC, VA, WV 307 339 377 425 462 490 511 546 591 629 669 731 786<br />

6 NC, SC, GA 289 335 372 432 469 484 545 581 642 688 731 786 840<br />

7 FL 328 368 397 433 472 505 539 571 607 649 683 730 778<br />

8 AL, MS, TN 302 332 369 436 469 506 510 560 607 707 761 801 845<br />

9 IN, KY, OH 208 235 269 305 334 365 393 425 463 501 545 587 627<br />

10 IL 267 299 329 370 405 437 474 506 533 557 596 648 688<br />

11 MI, MN, ND, SD, WI 244 271 305 331 364 389 412 445 475 512 539 573 613<br />

12 IA, KS, MO, NE 219 237 244 299 330 358 395 431 463 506 548 581 620<br />

13 AR, LA, OK 243 270 299 335 368 401 441 483 544 589 630 664 701<br />

14 TX 253 274 302 344 361 383 416 451 483 513 549 589 632<br />

15 AZ, CO, NV, NM, UT, WY 234 257 275 302 323 346 371 392 413 437 459 477 500<br />

16 AK, ID, MT, OR, WA 181 185 226 259 289 313 345 367 385 418 439 470 484<br />

17 N. CA, HI 247 266 301 338 374 394 426 457 493 521 556 597 631<br />

18 S. CA 216 269 290 324 345 366 389 417 438 468 512 552 596<br />

All 255 284 313 356 387 415 445 477 512 551 588 630 671<br />

Rates are adjusted by age, race, & gender.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.


BPREVALENCE OF REPORTED ESRD<br />

Reference section B<br />

Table B.11 B.11 (continued)<br />

Point prevalent rates of of reported ESRD, by by diabetic status & ESRD network, adjusted<br />

patients<br />

patients<br />

alive<br />

alive<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

of<br />

of<br />

each<br />

each<br />

year,<br />

year,<br />

per<br />

per<br />

million<br />

million<br />

population<br />

population<br />

350<br />

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

1 CT, MA, ME, NH, RI, VT 868 930 971 1,013 1,056 1,097 1,120 1,150 1,158 1,179 1,195<br />

2 NY 1,032 1,087 1,139 1,194 1,258 1,326 1,383 1,428 1,456 1,495 1,527<br />

3 NJ 1,052 1,123 1,179 1,228 1,283 1,349 1,420 1,452 1,490 1,522 1,562<br />

4 DE, PA 1,062 1,135 1,205 1,279 1,350 1,409 1,463 1,514 1,542 1,587 1,604<br />

5 MD, DC, VA, WV 1,166 1,244 1,318 1,394 1,479 1,545 1,601 1,641 1,682 1,725 1,760<br />

6 NC, SC, GA 1,225 1,313 1,376 1,441 1,498 1,554 1,596 1,642 1,686 1,714 1,743<br />

7 FL 1,101 1,158 1,189 1,244 1,278 1,307 1,341 1,374 1,399 1,419 1,424<br />

8 AL, MS, TN 1,195 1,292 1,362 1,444 1,510 1,568 1,623 1,675 1,710 1,742 1,768<br />

9 IN, KY, OH 937 1,002 1,063 1,128 1,185 1,257 1,313 1,374 1,419 1,458 1,501<br />

10 IL 990 1,071 1,147 1,234 1,295 1,363 1,426 1,482 1,530 1,586 1,628<br />

11 MI, MN, ND, SD, WI 953 1,016 1,065 1,136 1,189 1,244 1,281 1,316 1,359 1,401 1,441<br />

12 IA, KS, MO, NE 904 959 1,007 1,059 1,111 1,169 1,227 1,266 1,299 1,333 1,358<br />

13 AR, LA, OK 1,063 1,145 1,224 1,285 1,372 1,434 1,490 1,531 1,566 1,611 1,647<br />

14 TX 1,013 1,081 1,128 1,188 1,239 1,300 1,364 1,418 1,461 1,501 1,543<br />

15 AZ, CO, NV, NM, UT, WY 856 887 919 950 982 1,024 1,060 1,090 1,116 1,130 1,155<br />

16 AK, ID, MT, OR, WA 717 774 825 854 885 916 955 979 1,016 1,048 1,075<br />

17 N. CA, HI 962 1,041 1,085 1,126 1,172 1,224 1,282 1,337 1,387 1,429 1,463<br />

18 S. CA 931 1,030 1,092 1,152 1,195 1,248 1,294 1,350 1,400 1,463 1,510<br />

All 1,000 1,071 1,126 1,185 1,240 1,296 1,346 1,390 1,427 1,464 1,496<br />

DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 225 252 274 295 320 337 345 360 369 379 383<br />

2 NY 273 293 320 353 385 414 436 456 475 493 507<br />

3 NJ 280 317 352 383 410 448 478 492 505 518 527<br />

4 DE, PA 299 330 364 391 423 454 476 503 518 541 549<br />

5 MD, DC, VA, WV 328 359 394 435 479 508 534 549 573 596 605<br />

6 NC, SC, GA 340 381 415 461 493 529 554 579 599 614 628<br />

7 FL 289 318 339 369 392 407 424 443 464 472 477<br />

8 AL, MS, TN 315 357 395 438 474 505 532 562 585 600 615<br />

9 IN, KY, OH 275 306 344 377 405 442 468 496 518 537 552<br />

10 IL 255 286 326 366 395 424 459 485 500 525 541<br />

11 MI, MN, ND, SD, WI 302 328 350 383 409 434 447 462 480 496 510<br />

12 IA, KS, MO, NE 258 282 311 338 364 397 420 441 454 467 473<br />

13 AR, LA, OK 319 351 390 431 476 512 537 557 577 595 611<br />

14 TX 350 385 416 453 490 526 560 598 622 652 676<br />

15 AZ, CO, NV, NM, UT, WY 337 352 376 394 418 439 457 479 493 497 510<br />

16 AK, ID, MT, OR, WA 210 234 257 276 298 309 327 337 354 364 372<br />

17 N. CA, HI 294 332 357 381 410 434 465 496 520 540 557<br />

18 S. CA 289 337 366 397 425 449 472 506 532 559 579<br />

All 293 324 354 387 417 446 469 493 512 530 543<br />

NON-DIABETIC<br />

1 CT, MA, ME, NH, RI, VT 643 678 697 718 735 760 775 790 790 800 812<br />

2 NY 759 794 819 840 874 913 947 972 981 1,002 1,020<br />

3 NJ 771 806 827 845 872 901 943 959 984 1,003 1,034<br />

4 DE, PA 763 805 841 888 926 955 987 1,012 1,024 1,046 1,055<br />

5 MD, DC, VA, WV 838 884 924 959 999 1,037 1,067 1,092 1,110 1,129 1,154<br />

6 NC, SC, GA 885 932 961 980 1,005 1,025 1,042 1,063 1,087 1,100 1,115<br />

7 FL 812 840 849 875 886 899 917 931 936 946 948<br />

8 AL, MS, TN 880 935 966 1,006 1,037 1,064 1,091 1,112 1,125 1,142 1,154<br />

9 IN, KY, OH 662 696 719 751 780 815 846 879 901 921 949<br />

10 IL 736 784 820 868 901 939 967 997 1,030 1,062 1,088<br />

11 MI, MN, ND, SD, WI 650 688 715 753 779 810 834 854 879 905 931<br />

12 IA, KS, MO, NE 646 677 695 721 747 772 806 825 845 866 885<br />

13 AR, LA, OK 744 794 834 855 896 922 953 974 989 1,016 1,036<br />

14 TX 662 696 713 735 749 774 804 821 839 850 867<br />

15 AZ, CO, NV, NM, UT, WY 519 535 543 556 563 584 603 611 624 633 645<br />

16 AK, ID, MT, OR, WA 507 540 568 578 587 607 628 642 662 684 703<br />

17 N. CA, HI 668 709 729 745 762 790 817 841 866 889 906<br />

18 S. CA 642 693 725 755 770 799 822 845 869 904 931<br />

All 708 747 772 799 823 850 877 897 915 935 953<br />

Rates are adjusted by age, race, & gender.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.


PREVALENCE OF REPORTED ESRD<br />

2005 Annual <strong>Data</strong> ReportB<br />

Table B.12 B.12<br />

Period prevalent counts of of reported ESRD: all patients<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 108 142 213 274 320 372 426 463 492 506 508 525<br />

5-9 285 323 342 378 437 490 549 617 650 712 812 840<br />

10-14 704 762 856 926 1,027 1,062 1,077 1,109 1,185 1,235 1,322 1,414<br />

15-19 1,861 2,023 2,105 2,187 2,216 2,292 2,439 2,560 2,729 2,828 2,924 2,878<br />

20-29 7,490 8,403 9,416 10,245 11,252 12,057 12,793 13,477 14,216 15,010 15,688 16,377<br />

30-39 10,165 11,753 13,678 15,459 17,529 19,813 22,156 24,268 26,428 28,679 31,039 33,309<br />

40-49 11,193 12,595 13,944 15,703 18,025 20,042 22,084 24,613 27,584 31,194 35,190 39,290<br />

50-59 15,319 17,431 19,504 21,423 23,495 25,631 27,524 29,810 32,542 35,492 38,860 42,633<br />

60-64 7,575 8,735 10,302 11,839 13,713 15,432 16,807 18,193 20,151 21,989 24,230 26,689<br />

65-69 7,114 7,865 8,891 10,476 12,256 13,862 15,580 17,761 20,132 22,683 25,444 28,354<br />

70-79 7,404 8,731 10,447 13,046 15,614 18,270 20,816 23,785 26,794 30,577 34,823 40,095<br />

80+ 1,103 1,373 1,758 2,426 3,128 3,828 4,708 5,677 6,857 8,295 9,835 11,733<br />

Unknown * * 16 24 31 46 43 34 21 22 18 14<br />

0-19 2,958 3,250 3,516 3,765 4,000 4,216 4,491 4,749 5,056 5,281 5,566 5,657<br />

20-44 22,954 26,198 29,745 33,268 37,530 41,618 45,737 50,076 54,393 59,193 64,467 69,797<br />

45-64 28,788 32,719 37,099 41,401 46,484 51,357 55,627 60,285 66,528 73,171 80,540 88,501<br />

65-74 11,953 13,558 15,610 18,741 21,914 25,056 28,063 31,979 35,904 40,474 45,742 51,875<br />

75+ 3,668 4,411 5,486 7,207 9,084 10,904 13,041 15,244 17,879 21,081 24,360 28,307<br />

Unknown * * 16 24 31 46 43 34 21 22 18 14<br />

351<br />

Male 38,916 44,343 50,323 57,417 65,393 72,967 80,454 88,455 97,461 107,741 119,145 131,579<br />

Female 31,411 35,799 41,147 46,985 53,645 60,221 66,539 73,902 82,309 91,470 101,537 112,559<br />

Unknown * * * * * * * * 11 11 11 13<br />

White 49,130 55,756 63,296 71,520 81,019 90,101 99,174 108,951 119,645 131,588 145,000 159,459<br />

Black 19,171 22,089 25,533 29,814 34,437 38,932 43,012 47,903 53,628 60,250 67,117 74,867<br />

Native American 382 495 655 856 1,048 1,224 1,441 1,662 1,943 2,208 2,510 2,801<br />

Asian 439 592 934 1,237 1,628 2,074 2,511 3,008 3,627 4,300 5,219 6,144<br />

Other/unknown 1,206 1,212 1,054 979 911 866 864 843 938 876 847 880<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 7,050 9,799 13,347 17,068 21,363 26,068 31,035 36,433 42,402 50,001 58,946 68,737<br />

Hypertension 10,835 14,034 18,074 21,920 26,185 30,507 34,405 39,327 44,708 50,933 57,674 64,738<br />

Glomerulonephritis 14,673 17,170 20,063 22,844 26,136 29,194 32,062 35,129 38,160 41,154 44,466 47,550<br />

Cystic kidney 3,939 4,579 5,293 5,975 6,768 7,464 8,149 8,785 9,490 10,097 10,846 11,594<br />

Other urologic 1,778 2,305 2,939 3,555 4,134 4,863 5,456 6,008 6,566 7,046 7,379 7,850<br />

Other cause 7,332 8,841 10,797 12,810 14,902 16,825 18,537 20,067 21,492 23,368 25,255 27,129<br />

Unknown cause 7,347 7,933 8,162 8,267 8,790 9,263 9,609 10,157 10,869 11,187 11,462 12,157<br />

Missing disease 17,374 15,483 12,797 11,967 10,765 9,013 7,749 6,461 6,094 5,436 4,665 4,396<br />

All 70,328 80,144 91,472 104,406 119,043 133,197 147,002 162,367 179,781 199,222 220,693 244,151<br />

Patients alive on ESRD therapy and not lost to followup at any time during each year.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

*Values for cells with 10 or fewer patients are suppressed.


BPREVALENCE OF REPORTED ESRD<br />

BReference section B<br />

Table B.12 B.12 (continued)<br />

Period prevalent counts of of reported ESRD: all patients<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

352<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 533 581 570 586 606 622 589 612 647 697 679 704<br />

5-9 868 881 939 952 968 975 1,051 1,053 1,073 1,055 1,120 1,105<br />

10-14 1,469 1,537 1,613 1,738 1,807 1,872 1,856 1,983 2,022 2,111 2,171 2,264<br />

15-19 2,963 3,024 3,127 3,294 3,458 3,498 3,615 3,747 3,844 3,894 3,978 4,110<br />

20-29 16,998 17,543 17,900 18,085 18,339 18,675 19,037 19,276 19,427 19,529 19,451 19,376<br />

30-39 35,787 37,914 40,157 41,919 43,230 44,238 45,069 46,074 46,797 47,476 47,944 48,275<br />

40-49 43,970 48,258 52,723 57,387 62,400 66,285 70,147 73,953 77,255 80,334 83,097 85,636<br />

50-59 47,132 51,923 57,315 62,189 66,743 72,706 79,657 87,063 93,904 100,822 107,617 113,900<br />

60-64 28,840 31,002 33,228 35,540 38,003 40,570 43,301 46,118 48,640 51,221 53,834 57,540<br />

65-69 31,324 34,200 37,115 39,399 41,976 44,623 46,664 48,554 50,666 52,674 54,930 56,993<br />

70-79 46,292 51,489 56,862 62,351 68,475 74,686 80,688 86,112 90,251 93,956 97,385 100,295<br />

80+ 13,861 16,010 18,361 20,622 23,419 26,580 29,578 32,957 36,053 39,451 43,579 46,676<br />

Unknown 11 * * * * * * * * * * *<br />

0-19 5,833 6,023 6,249 6,570 6,839 6,967 7,111 7,395 7,586 7,757 7,948 8,183<br />

20-44 74,977 79,391 83,713 87,401 90,963 93,686 96,689 99,384 101,647 103,285 104,634 105,600<br />

45-64 97,750 107,249 117,610 127,719 137,752 148,788 160,522 173,100 184,376 196,097 207,309 219,127<br />

65-74 58,595 64,591 70,749 76,017 81,615 87,011 91,804 95,880 99,730 103,545 107,385 110,568<br />

75+ 32,882 37,108 41,589 46,355 52,255 58,878 65,126 71,743 77,240 82,536 88,509 93,396<br />

Unknown 11 * * * * * * * * * * *<br />

Male 145,185 158,230 171,908 184,686 198,728 212,932 227,532 242,401 255,717 269,022 282,583 295,199<br />

Female 124,850 136,122 147,999 159,368 170,684 182,387 193,709 205,089 214,849 224,185 233,187 241,632<br />

Unknown 13 17 13 17 14 14 14 14 14 14 16 44<br />

White 175,193 189,247 203,889 217,266 231,902 247,444 262,478 278,401 292,863 306,765 320,627 332,738<br />

Black 83,440 91,991 100,827 109,083 117,230 125,360 134,075 142,083 148,484 155,121 161,604 167,981<br />

Native American 3,210 3,551 3,930 4,304 4,679 5,000 5,387 5,836 6,191 6,438 6,725 6,893<br />

Asian 7,216 8,474 9,866 11,170 12,449 13,613 14,930 16,339 17,527 18,937 20,314 21,601<br />

Other/unknown 989 1,106 1,408 2,248 3,166 3,916 4,385 4,845 5,515 5,960 6,516 7,662<br />

†Hispanic 36,210 40,814 45,139 49,602 54,276 58,832 63,631 68,491<br />

†Non-Hispanic 333,216 354,519 376,116 397,902 416,304 434,389 452,155 468,384<br />

Diabetes 79,215 89,230 99,978 111,744 124,628 137,576 150,340 162,326 173,012 183,797 193,649 202,736<br />

Hypertension 72,762 79,989 87,338 91,434 95,550 101,029 106,238 112,065 116,982 122,047 127,622 133,162<br />

Glomerulonephritis 50,853 54,082 57,730 61,083 64,366 67,320 70,241 73,087 75,342 77,331 79,502 81,155<br />

Cystic kidney 12,489 13,368 14,195 15,106 15,827 16,613 17,492 18,439 19,296 20,216 20,982 21,846<br />

Other urologic 8,394 8,632 8,875 9,930 11,033 11,928 12,690 13,751 14,473 15,075 15,796 16,248<br />

Other cause 29,149 31,198 33,449 36,094 38,624 40,783 43,224 45,691 47,971 50,141 52,534 54,413<br />

Unknown cause 13,057 13,906 14,630 15,184 15,863 16,569 17,358 18,237 19,294 20,292 21,130 22,016<br />

Missing disease 4,129 3,964 3,725 3,496 3,535 3,515 3,672 3,908 4,210 4,322 4,571 5,299<br />

All 270,048 294,369 319,920 344,071 369,426 395,333 421,255 447,504 470,580 493,221 515,786 536,875<br />

Patients alive on ESRD therapy and not lost to followup at any time during each year.<br />

The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

Age is calculated as of December 31.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

*Values for cells with 10 or fewer patients are suppressed.


Reference<br />

C<br />

Section<br />

Patient<br />

characteristics


CPATIENT CHARACTERISTICS<br />

Reference section C<br />

354<br />

C.1 . 355<br />

Counts of new ESRD patients with Medical Evidence forms<br />

by demographic characteristics & primary diagnosis<br />

C.2 . 356<br />

Mean lab values<br />

by demographic characteristics & diabetic status; incident patients with<br />

completed Medical Evidence forms, May 1995-June 2004 combined<br />

C.3 . 357<br />

Mean serum albumin (g/dl): by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

C.4 . 358<br />

Mean blood urea nitrogen (mg/dl): by demographic characteristics & diabetic<br />

status<br />

incident patients with completed Medical Evidence forms, by demographic<br />

characteristics<br />

C.5 . 359<br />

Mean creatinine (mg/dl): by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

C.6 . 360<br />

Mean hematocrit (%): by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

C.7 . 361<br />

Mean hemoglobin (g/dl): by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

C.8 . 632<br />

Mean height (cm): by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

C.9 . 363<br />

Mean weight (kg): by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

C.10 . 364<br />

Mean body mass index (kg/m 2 ): by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

C.11 . 365<br />

Mean eGFR (ml/min 1.73m 2 ): by MDRD formula, demographic characteristics, &<br />

diabetic status<br />

incident patients with completed Medical Evidence forms<br />

C.12 . 366<br />

Counts of new ESRD patients, with or without a Medical Evidence form: by race<br />

incident patients with completed Medical Evidence forms<br />

C.13 . 366<br />

Percent distribution of patients, by race & Hispanic ethnicity: column percent<br />

incident patients with completed Medical Evidence forms<br />

C.14 . 367<br />

Percent distribution of diabetic patients, by race & Hispanic ethnicity<br />

incident patients with completed Medical Evidence forms<br />

C.15 . 367<br />

Percent distribution of patients, by employment status<br />

incident patients with completed Medical Evidence forms<br />

C.16 . 368<br />

Insurance coverage in the incident population<br />

incident patients with completed Medical Evidence forms; percent with<br />

coverage in each year<br />

C.17 . 368<br />

Incident patient comorbidity<br />

incident patients with completed Medical Evidence forms; percent with<br />

comorbidity in each year


PATIENT CHARACTERISTICS<br />

2005 Annual <strong>Data</strong> ReportC<br />

Table C.1 C.1<br />

Counts of new ESRD patients with Medical Evidence forms<br />

by demographic characteristics & primary diagnosis<br />

by demographic characteristics primary diagnosis<br />

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^ All<br />

0-4 95 173 175 170 180 192 199 174 200 90 1,648<br />

5-9 89 128 117 124 140 141 136 159 135 53 1,222<br />

10-14 154 244 257 253 265 281 286 325 310 131 2,506<br />

15-19 352 526 482 504 561 533 547 558 584 255 4,902<br />

20-29 1,619 2,560 2,516 2,607 2,512 2,583 2,615 2,507 2,465 1,074 23,058<br />

30-39 3,543 5,498 5,434 5,568 5,674 5,572 5,572 5,661 5,553 2,473 50,548<br />

40-49 5,643 9,115 9,235 10,082 10,259 10,576 10,709 11,106 11,352 5,009 93,086<br />

50-59 7,551 12,065 13,124 14,538 15,577 16,296 17,269 17,855 18,648 8,269 141,192<br />

60-64 5,085 8,079 8,521 9,240 9,394 9,757 10,207 10,435 11,017 4,816 86,551<br />

65-69 5,929 9,667 10,276 10,730 10,780 11,065 11,436 11,650 11,904 5,109 98,546<br />

70-79 10,537 17,958 19,576 21,116 22,258 23,064 23,585 24,589 24,326 10,346 197,355<br />

80+ 3,840 6,735 7,906 8,949 9,979 10,858 11,516 13,164 13,515 5,972 92,434<br />

Unknown * . * . * . * . . . *<br />

0-19 690 1,071 1,031 1,051 1,146 1,147 1,168 1,216 1,229 529 10,278<br />

20-44 7,711 12,133 12,004 12,603 12,600 12,723 12,762 12,806 12,768 5,615 113,725<br />

45-64 15,730 25,184 26,826 29,432 30,816 32,061 33,610 34,758 36,267 16,026 280,710<br />

65-74 11,852 19,718 20,986 22,003 22,308 23,027 23,702 24,173 24,044 10,386 202,199<br />

75+ 8,454 14,642 16,772 18,792 20,709 21,960 22,835 25,230 25,701 11,041 186,136<br />

Unknown * . * . * . * . . . *<br />

355<br />

Male 23,321 38,785 41,329 44,615 46,805 48,602 50,583 53,309 54,123 24,092 425,564<br />

Female 21,118 33,963 36,291 39,266 40,775 42,313 43,495 44,874 45,886 19,505 367,486<br />

Unknown . . . . . * . . . . *<br />

White 27,151 44,793 48,208 52,108 55,032 56,563 60,026 62,752 63,491 27,919 498,043<br />

Black 13,363 21,309 22,743 24,677 25,001 25,266 26,595 27,760 28,352 12,186 227,252<br />

Native American/Alaskan Native 680 1,219 896 1,110 1,373 2,058 1,091 1,071 1,059 453 11,010<br />

Asian 1,024 1,774 1,726 2,170 2,272 2,348 2,242 2,346 2,404 1,043 19,349<br />

Pacific Islander 380 681 683 788 725 784 860 924 968 430 7,223<br />

Middle-eastern/Arabian 176 172 228 274 291 372 338 388 359 161 2,759<br />

Indian Subcontinent 120 184 203 235 254 292 329 295 392 168 2,472<br />

Other/multiracial 1,245 2,215 2,592 2,239 2,309 2,751 2,342 2,366 2,769 1,135 21,963<br />

Unknown 300 401 341 280 323 484 255 281 215 102 2,982<br />

Hispanic-Mexican 3,271 5,315 5,305 5,643 6,326 7,952 6,841 7,464 7,895 3,499 59,511<br />

Hispanic-other 1,939 3,153 3,487 3,765 4,024 4,200 4,629 4,926 5,228 2,252 37,603<br />

Non-Hispanic 38,599 63,585 68,179 73,724 76,687 78,447 82,450 85,581 86,658 37,733 691,643<br />

Unknown 630 695 649 749 543 319 158 212 228 113 4,296<br />

Diabetes 18,855 31,547 34,137 37,186 38,968 41,102 42,601 43,942 44,810 19,797 352,945<br />

Hypertension 11,457 19,022 20,689 22,246 23,461 24,101 25,250 26,782 27,922 11,983 212,913<br />

Glomerulonephritis 5,062 7,901 7,915 8,202 8,199 8,018 7,942 8,166 7,877 3,461 72,743<br />

Cystic kidney 1,199 1,783 1,888 2,081 2,122 2,126 2,202 2,212 2,271 966 18,850<br />

Other urologic 863 1,483 1,411 1,523 1,612 1,597 1,589 1,674 1,594 659 14,005<br />

Other cause 5,257 8,081 8,501 9,238 9,775 10,215 10,621 11,486 11,606 5,118 89,898<br />

Unknown cause 1,661 2,836 2,977 3,333 3,370 3,721 3,868 3,921 3,928 1,613 31,228<br />

Missing 85 95 102 72 73 38 * . * . 471<br />

All 44,439 72,748 77,620 83,881 87,580 90,918 94,078 98,183 100,009 43,597 793,053<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

<strong>Data</strong> are based on first & new Medical Evidence forms filed between May 1995 & June 2004.<br />

^Incomplete data.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


CPATIENT CHARACTERISTICS<br />

Reference section C<br />

356<br />

Table C.2 C.2<br />

Mean lab values<br />

by demographic characteristics & diabetic status; incident patients with completed Medical Evidence forms, May 1995-June 2004 combined<br />

by demographic characteristics diabetic status; incident patients with completed Medical Evidence forms, May 1995-June 2004 combined<br />

Serum Body mass eGFR (ml/min 1.73m 2 )<br />

albumin BUN Creat. Hct Hgb Height Weight index by MDRD<br />

Patients (g/dl) (mg/dl) (mg/dl) % (g/dl) (cm) (kg) (kg/m 2 ) formula<br />

0-4 1,648 3.1 72.7 4.9 29.3 9.9 98.7 20.4 19.2 10.9<br />

5-9 1,222 3.3 88.0 7.0 28.1 9.5 117.5 25.2 18.0 10.8<br />

10-14 2,506 3.4 89.0 9.0 28.0 9.5 146.0 43.9 20.6 11.3<br />

15-19 4,902 3.3 91.6 10.8 27.4 9.3 164.5 63.9 23.9 9.7<br />

20-29 23,058 3.2 90.8 11.0 27.2 9.2 168.0 71.4 25.9 7.3<br />

30-39 50,548 3.1 88.1 10.1 28.1 9.4 169.2 75.0 26.8 7.6<br />

40-49 93,086 3.1 88.5 9.1 28.6 9.6 169.5 78.4 27.8 7.9<br />

50-59 141,192 3.1 88.4 8.0 29.1 9.7 168.5 79.3 28.5 8.5<br />

60-64 86,551 3.1 88.4 7.4 29.2 9.7 167.4 76.6 27.9 8.9<br />

65-69 98,546 3.2 88.3 7.0 29.5 9.8 166.9 73.8 27.1 9.1<br />

70-79 197,355 3.2 88.4 6.6 29.8 9.9 166.3 69.8 25.8 9.6<br />

80+ 92,434 3.2 88.3 6.1 30.1 10.0 164.9 64.4 24.1 10.1<br />

Unknown * 3.1 78.2 6.8 28.9 9.5 170.8 65.4 25.6 9.1<br />

0-19 10,278 3.3 87.7 8.9 27.9 9.5 146.0 47.5 21.8 10.4<br />

20-44 113,725 3.1 88.8 10.0 28.1 9.4 169.1 75.2 26.9 7.6<br />

45-64 280,710 3.1 88.4 8.0 29.1 9.7 168.3 78.4 28.2 8.5<br />

65-74 202,199 3.2 88.3 6.9 29.6 9.9 166.7 72.4 26.6 9.3<br />

75+ 186,136 3.2 88.4 6.3 30.0 10.0 165.5 66.4 24.7 9.9<br />

Unknown * 3.1 78.2 6.8 28.9 9.5 170.8 65.4 25.6 9.1<br />

Male 425,564 3.2 92.4 8.2 29.4 9.8 173.2 77.0 26.2 9.3<br />

Female 367,486 3.1 83.8 6.9 29.1 9.7 160.1 68.8 27.3 8.5<br />

Unknown * 2.5 59.7 4.5 29.3 9.6 180.2 79.2 24.6 15.4<br />

White 498,043 3.2 89.1 7.0 29.8 10.0 167.4 73.0 26.6 9.2<br />

Black 227,252 3.1 86.7 8.8 28.3 9.4 167.9 75.7 27.4 8.6<br />

Native American/Alaskan Native 11,010 2.9 84.6 7.7 28.8 9.6 165.9 74.0 27.4 8.3<br />

Asian 19,349 3.2 90.3 8.1 29.1 9.8 160.0 58.8 23.4 7.9<br />

Pacific Islander 7,223 3.0 94.2 8.6 29.1 9.7 161.8 66.4 25.7 7.4<br />

Middle-eastern/Arabian 2,759 3.3 90.4 7.8 29.7 9.8 163.9 68.8 25.8 8.7<br />

Indian Subcontinent 2,472 3.2 85.1 7.7 29.3 9.8 163.3 63.3 24.1 8.7<br />

Other/multiracial 21,963 3.1 89.6 8.3 28.5 9.5 162.2 68.0 26.1 7.9<br />

Unknown 2,982 3.1 92.1 8.1 28.5 9.6 163.8 69.6 26.1 8.2<br />

Hispanic-Mexican 59,511 3.1 86.6 7.6 28.8 9.6 162.3 67.6 26.5 8.7<br />

Hispanic-Other 37,603 3.1 88.7 8.0 28.9 9.6 163.0 69.0 26.2 8.2<br />

Non-Hispanic 691,643 3.2 88.5 7.6 29.3 9.8 167.8 73.9 26.8 9.0<br />

Unknown 4,296 3.1 99.1 8.7 28.8 9.6 164.3 67.7 25.6 7.5<br />

Diabetic 352,945 3.1 86.9 6.8 29.4 9.8 166.7 76.7 28.1 9.6<br />

Non-diabetic 440,108 3.2 89.7 8.3 29.2 9.8 167.4 70.4 25.6 8.4<br />

All 793,053 3.2 88.5 7.6 29.3 9.8 167.1 73.2 26.7 8.9<br />

Completed forms 793,053 590,791 732,542 789,314 731,512 696,743 781,193 790,431 746,908 783,455<br />

<strong>Data</strong> are based on first & new Medical Evidence forms filed between May 1995 & June 2004.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

*Values for cells with 10 or fewer patients are suppressed.


PATIENT CHARACTERISTICS<br />

2005 Annual <strong>Data</strong> ReportC<br />

Table C.3 C.3<br />

Mean serum albumin (g/dl): by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

incident patients with completed Medical Evidence forms<br />

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^<br />

0-4 3.2 3.1 3.2 3.1 3.1 3.0 3.2 3.2 3.2 3.2<br />

5-9 3.6 3.3 3.3 3.2 3.4 3.1 3.2 3.2 3.3 3.3<br />

10-14 3.6 3.5 3.4 3.5 3.4 3.4 3.3 3.2 3.3 3.2<br />

15-19 3.4 3.4 3.3 3.3 3.2 3.3 3.3 3.3 3.3 3.2<br />

20-29 3.3 3.3 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1<br />

30-39 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1<br />

40-49 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1<br />

50-59 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1<br />

60-64 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1<br />

65-69 3.3 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1<br />

70-79 3.3 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.2 3.1<br />

80+ 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.2 3.1<br />

0-19 3.4 3.4 3.3 3.3 3.3 3.2 3.2 3.2 3.3 3.2<br />

20-44 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1<br />

45-64 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1<br />

65-74 3.3 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.2 3.1<br />

75+ 3.3 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.2 3.1<br />

Unknown 3.6 . 1.8 . 3.5 . . . . .<br />

357<br />

Male 3.3 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.1<br />

Female 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1 3.1 3.1<br />

Unknown . . . . . 2.5 . . . .<br />

White 3.3 3.2 3.2 3.2 3.2 3.2 3.2 3.1 3.2 3.1<br />

Black 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1 3.1 3.0<br />

Native American/Alaskan Native 3.1 3.1 3.0 3.0 2.9 3.0 2.8 2.9 2.9 2.8<br />

Asian 3.3 3.2 3.2 3.2 3.2 3.1 3.1 3.2 3.2 3.2<br />

Pacific Islander 3.0 3.1 3.1 3.1 3.0 3.0 3.0 3.1 3.1 3.1<br />

Middle-eastern/Arabian 3.3 3.4 3.5 3.3 3.2 3.3 3.3 3.3 3.2 3.2<br />

Indian Subcontinent 3.4 3.3 3.2 3.3 3.1 3.2 3.2 3.2 3.2 3.3<br />

Other/multiracial 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.0<br />

Unknown 3.2 3.1 3.1 3.1 3.1 3.0 3.2 3.1 3.1 3.0<br />

Hispanic-Mexican 3.1 3.1 3.1 3.1 3.0 3.0 3.0 3.0 3.1 3.0<br />

Hispanic-Other 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1<br />

Non-Hispanic 3.3 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1<br />

Unknown 3.1 3.0 3.0 3.1 3.1 3.2 3.1 3.2 3.2 3.1<br />

Diabetic 3.1 3.1 3.1 3.1 3.1 3.0 3.0 3.0 3.1 3.0<br />

Non-diabetic 3.3 3.3 3.3 3.3 3.2 3.2 3.2 3.2 3.2 3.2<br />

All 3.2 3.2 3.2 3.2 3.1 3.1 3.1 3.1 3.1 3.1<br />

Completed forms 35,397 57,494 60,074 61,311 63,227 66,912 68,808 72,149 73,507 31,912<br />

<strong>Data</strong> are based on first & new Medical Evidence forms filed between May 1995 & June 2004.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

^Incomplete data.<br />

"." Zero values in this cell.


CPATIENT CHARACTERISTICS<br />

Reference section C<br />

358<br />

Table C.4 C.4<br />

Mean blood urea nitrogen (mg/dl): by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

incident patients with completed Medical Evidence forms<br />

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^<br />

0-4 . . . 31.0 10.6 10.5 12.5 . 23.0 .<br />

5-9 . . . . . 50.7 86.0 10.0 55.1 59.0<br />

10-14 43.7 15.1 39.0 10.0 60.0 72.9 47.7 . . 12.0<br />

15-19 48.3 22.8 54.3 46.4 83.0 . 46.6 37.8 33.2 52.6<br />

20-29 31.3 39.7 35.6 46.1 44.9 45.1 40.8 51.4 37.0 21.2<br />

30-39 36.0 38.0 37.6 39.4 35.4 31.0 44.4 41.5 39.9 44.9<br />

40-49 39.3 37.7 40.1 34.7 39.0 43.1 37.2 37.4 37.8 40.5<br />

50-59 35.8 36.0 42.9 39.1 36.4 40.5 39.2 35.7 41.9 45.0<br />

60-64 37.6 35.6 37.5 39.5 46.3 42.6 36.0 43.9 36.8 34.5<br />

65-69 34.1 41.8 36.6 39.3 32.5 36.7 37.0 40.5 38.4 37.0<br />

70-79 33.8 36.0 38.3 41.0 40.6 40.6 36.4 39.3 40.0 38.2<br />

80+ 39.2 40.4 36.7 46.7 42.3 42.5 38.5 42.2 43.2 36.7<br />

0-19 45.5 19.0 51.2 36.0 51.2 44.7 47.5 30.8 38.0 44.0<br />

20-44 35.4 42.2 37.5 41.2 39.3 38.7 40.2 41.7 36.4 42.1<br />

45-64 36.9 34.8 40.9 37.7 40.3 41.6 37.9 38.5 40.0 40.0<br />

65-74 34.8 38.1 36.2 37.9 37.3 38.9 35.8 40.5 39.8 35.4<br />

75+ 35.3 39.1 39.0 46.6 40.3 41.2 38.4 40.0 40.9 39.9<br />

Unknown . . . . . . . . . .<br />

Male 35.9 36.2 38.8 37.1 37.2 41.2 39.1 38.8 38.9 38.3<br />

Female 35.9 38.9 39.3 43.2 42.0 39.6 36.8 40.9 40.8 39.7<br />

Unknown . . . . . . . . . .<br />

White 36.3 35.4 36.5 37.7 38.9 37.7 36.2 36.8 39.1 35.8<br />

Black 35.0 41.1 43.0 43.0 39.7 43.0 40.7 44.4 40.5 43.4<br />

Native American/Alaskan Native 66.3 35.4 44.5 40.8 32.1 40.9 55.8 34.8 37.9 .<br />

Asian 30.5 30.3 35.5 46.3 26.8 45.6 40.0 35.8 36.6 .<br />

Pacific Islander 25.0 . 32.2 75.6 52.6 65.2 45.7 68.9 42.0 58.5<br />

Middle-eastern/Arabian 42.5 11.0 . 75.9 40.0 38.5 31.0 42.0 38.2 67.5<br />

Indian Subcontinent . 13.5 49.5 . 10.4 10.0 44.3 11.0 53.8 .<br />

Other/multiracial 32.9 46.8 39.6 45.6 48.8 61.6 39.0 51.1 49.5 13.0<br />

Unknown 53.5 36.0 74.0 53.7 . 40.0 . 72.7 . .<br />

Hispanic-Mexican 31.6 40.7 33.7 43.3 43.1 39.4 44.5 49.7 48.1 39.8<br />

Hispanic-Other 43.8 34.1 43.4 52.5 47.8 46.7 34.5 35.1 43.0 39.5<br />

Non-Hispanic 36.2 37.5 39.1 39.0 38.7 40.3 37.4 39.2 38.7 38.9<br />

Unknown 16.0 25.1 32.0 29.7 54.0 29.5 34.2 31.0 80.0 15.0<br />

Diabetic 36.9 33.8 36.8 39.6 36.2 39.0 34.9 37.4 35.0 36.8<br />

Non-diabetic 35.2 40.8 41.0 40.4 42.0 41.8 40.9 42.2 44.3 40.6<br />

All 35.9 37.5 39.0 40.0 39.4 40.4 37.9 39.8 39.8 38.9<br />

Completed forms 369 415 453 580 668 676 651 627 742 331<br />

<strong>Data</strong> are based on first & new Medical Evidence forms filed between May 1995 & June 2004.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

^Incomplete data.<br />

"." Zero values in this cell.


PATIENT CHARACTERISTICS<br />

2005 Annual <strong>Data</strong> ReportC<br />

Table C.5 C.5<br />

Mean creatinine (mg/dl): by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

incident patients with completed Medical Evidence forms<br />

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^<br />

0-4 5.3 5.0 5.2 5.1 5.2 4.5 4.9 4.7 4.6 4.9<br />

5-9 7.1 7.1 7.4 7.1 6.9 7.0 7.3 6.3 6.7 6.8<br />

10-14 9.3 9.7 9.4 9.0 9.0 9.0 8.6 8.6 8.7 8.6<br />

15-19 12.1 11.7 11.3 11.4 10.3 10.7 10.2 10.5 10.2 9.9<br />

20-29 12.1 11.8 11.4 11.5 11.0 10.8 10.7 10.6 10.3 10.0<br />

30-39 10.9 10.8 10.5 10.3 10.1 9.9 9.7 9.6 9.5 9.3<br />

40-49 10.1 10.0 9.7 9.4 9.1 9.0 8.8 8.6 8.5 8.4<br />

50-59 9.0 8.8 8.5 8.3 8.1 7.9 7.8 7.6 7.5 7.4<br />

60-64 8.3 8.2 7.9 7.7 7.4 7.2 7.1 7.0 6.9 6.7<br />

65-69 7.9 7.8 7.5 7.3 7.0 6.8 6.7 6.6 6.5 6.4<br />

70-79 7.5 7.4 7.1 6.9 6.6 6.4 6.3 6.2 6.0 5.9<br />

80+ 7.1 7.0 6.7 6.4 6.2 6.0 5.8 5.7 5.6 5.5<br />

0-19 9.9 9.6 9.3 9.3 8.8 8.8 8.6 8.6 8.5 8.4<br />

20-44 11.0 10.8 10.5 10.4 10.1 9.8 9.7 9.5 9.4 9.2<br />

45-64 8.9 8.8 8.5 8.3 8.1 7.8 7.7 7.6 7.5 7.3<br />

65-74 7.8 7.6 7.3 7.1 6.9 6.7 6.6 6.4 6.3 6.2<br />

75+ 7.3 7.2 6.8 6.6 6.4 6.2 6.0 5.8 5.7 5.6<br />

Unknown 7.3 . 5.8 . 9.6 . 4.1 . . .<br />

359<br />

Male 9.4 9.1 8.8 8.5 8.3 8.0 7.8 7.7 7.6 7.4<br />

Female 7.9 7.7 7.5 7.2 7.0 6.7 6.6 6.4 6.3 6.2<br />

Unknown . . . . . 4.5 . . . .<br />

White 8.0 7.8 7.5 7.3 7.0 6.8 6.7 6.5 6.4 6.4<br />

Black 10.0 9.8 9.4 9.1 8.9 8.7 8.4 8.2 8.1 8.0<br />

Native American/Alaskan Native 8.5 8.8 8.0 8.1 7.6 7.0 7.4 7.5 7.2 6.6<br />

Asian 9.1 8.8 8.9 8.3 8.0 8.0 7.8 7.6 7.5 7.1<br />

Pacific Islander 10.1 9.4 9.3 8.9 8.7 8.5 8.1 8.2 7.9 7.9<br />

Middle-eastern/Arabian 8.8 8.6 8.0 8.1 8.0 8.0 7.7 7.3 7.0 6.9<br />

Indian Subcontinent 8.7 8.7 8.8 8.3 7.6 8.0 7.4 7.3 7.1 6.7<br />

Other/multiracial 9.1 9.0 8.6 8.5 8.2 8.1 8.1 8.0 8.0 7.5<br />

Unknown 8.8 8.4 8.7 8.5 7.9 7.6 7.9 7.7 7.1 7.0<br />

Hispanic-Mexican 8.6 8.4 8.0 7.9 7.7 7.4 7.4 7.3 7.2 7.1<br />

Hispanic-Other 9.1 9.0 8.7 8.3 8.0 7.9 7.8 7.6 7.5 7.4<br />

Non-Hispanic 8.6 8.5 8.1 7.9 7.6 7.4 7.2 7.1 7.0 6.8<br />

Unknown 9.7 9.3 9.3 9.1 8.6 7.4 7.4 7.2 6.8 6.5<br />

Diabetic 7.7 7.5 7.2 7.0 6.8 6.6 6.5 6.4 6.4 6.2<br />

Non-diabetic 9.4 9.3 8.9 8.6 8.3 8.1 7.9 7.7 7.5 7.4<br />

All 8.7 8.5 8.2 7.9 7.7 7.4 7.3 7.1 7.0 6.9<br />

Completed forms 44,218 72,390 77,250 83,472 87,151 90,427 93,596 97,730 99,594 43,486<br />

<strong>Data</strong> are based on first & new Medical Evidence forms filed between May 1995 & June 2004.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

^Incomplete data.<br />

"." Zero values in this cell.


CPATIENT CHARACTERISTICS<br />

Reference section C<br />

360<br />

Table C.6 C.6<br />

Mean hematocrit (%): by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

incident patients with completed Medical Evidence forms<br />

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^<br />

0-4 28.6 28.3 28.5 28.2 28.9 29.3 29.7 30.1 30.8 30.0<br />

5-9 26.7 26.9 27.4 27.6 28.5 28.5 28.3 28.5 29.3 28.4<br />

10-14 26.6 26.8 27.2 27.0 28.1 28.7 28.5 28.9 28.7 28.8<br />

15-19 26.5 25.6 26.6 26.9 27.4 27.6 28.1 28.0 28.3 29.4<br />

20-29 25.9 26.1 26.7 26.8 27.2 27.5 27.8 27.9 28.0 28.0<br />

30-39 26.9 27.0 27.3 27.6 27.9 28.4 28.7 28.7 29.1 29.2<br />

40-49 27.4 27.5 27.8 28.1 28.5 28.8 29.1 29.3 29.6 29.7<br />

50-59 27.6 27.7 28.2 28.5 28.9 29.2 29.5 29.8 30.0 30.0<br />

60-64 27.8 28.1 28.4 28.6 29.2 29.4 29.5 29.9 30.2 30.5<br />

65-69 28.2 28.3 28.8 28.9 29.4 29.7 30.0 30.2 30.5 30.7<br />

70-79 28.4 28.7 29.0 29.3 29.8 30.0 30.2 30.5 30.8 30.9<br />

80+ 28.6 28.7 29.1 29.4 29.9 30.2 30.5 30.7 31.0 31.2<br />

0-19 26.9 26.5 27.2 27.2 27.9 28.2 28.5 28.6 28.9 29.3<br />

20-44 26.8 26.9 27.3 27.6 28.0 28.3 28.6 28.7 29.0 29.1<br />

45-64 27.6 27.8 28.2 28.5 29.0 29.2 29.5 29.7 30.0 30.1<br />

65-74 28.2 28.4 28.9 29.1 29.6 29.8 30.0 30.3 30.6 30.8<br />

75+ 28.6 28.8 29.1 29.4 29.9 30.1 30.4 30.7 30.9 31.1<br />

Unknown 30.6 . 21.1 . 29.4 . 33.0 . . .<br />

Male 28.0 28.2 28.6 28.9 29.3 29.6 29.8 30.1 30.3 30.5<br />

Female 27.6 27.8 28.2 28.5 29.0 29.3 29.6 29.9 30.1 30.3<br />

Unknown . . . . . 29.3 . . . .<br />

White 28.5 28.6 29.0 29.3 29.7 29.9 30.2 30.4 30.6 30.8<br />

Black 26.7 26.9 27.4 27.7 28.1 28.5 28.9 29.1 29.4 29.5<br />

Native American/Alaskan Native 27.1 26.9 28.0 28.0 28.7 29.4 29.0 29.3 29.7 30.0<br />

Asian 27.4 27.7 27.9 28.5 29.3 29.1 29.6 30.0 30.3 30.5<br />

Pacific Islander 27.3 27.7 28.1 28.7 29.2 29.3 29.4 29.7 29.9 30.5<br />

Middle-eastern/Arabian 27.5 28.6 29.1 29.6 29.2 30.2 29.9 30.4 30.4 30.1<br />

Indian Subcontinent 28.4 27.6 27.9 28.4 29.1 29.6 29.6 30.1 30.2 30.8<br />

Other/multiracial 27.1 27.5 27.7 28.1 28.4 28.8 28.9 29.2 29.4 29.8<br />

Unknown 27.5 27.5 27.8 27.8 28.6 29.2 29.0 29.4 29.9 29.2<br />

Hispanic-Mexican 27.3 27.3 27.9 28.1 28.7 29.0 28.9 29.5 29.7 29.6<br />

Hispanic-Other 27.2 27.6 27.9 28.3 28.9 28.8 29.2 29.6 29.8 30.1<br />

Non-Hispanic 27.9 28.1 28.5 28.8 29.2 29.5 29.8 30.0 30.3 30.5<br />

Unknown 27.7 28.3 28.6 28.8 28.8 29.6 30.2 30.4 29.8 30.5<br />

Diabetic 27.9 28.2 28.5 28.8 29.3 29.5 29.8 30.1 30.3 30.5<br />

Non-diabetic 27.7 27.9 28.3 28.6 29.1 29.4 29.7 29.9 30.2 30.3<br />

All 27.8 28.0 28.4 28.7 29.2 29.5 29.7 30.0 30.2 30.4<br />

Completed forms 40,002 65,779 70,115 75,843 80,814 84,723 87,496 91,870 93,763 41,107<br />

<strong>Data</strong> are based on first & new Medical Evidence forms filed between May 1995 & June 2004.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

^Incomplete data.<br />

"." Zero values in this cell.


PATIENT CHARACTERISTICS<br />

2005 Annual <strong>Data</strong> ReportC<br />

Table C.7 C.7<br />

Mean hemoglobin (g/dl): by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

incident patients with completed Medical Evidence forms<br />

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^<br />

0-4 9.6 9.8 9.7 9.6 9.8 9.9 10.1 10.3 10.3 10.0<br />

5-9 9.3 8.9 9.2 9.5 9.6 9.7 9.5 9.7 10.0 9.5<br />

10-14 9.1 9.2 9.2 9.3 9.5 9.8 9.7 9.8 9.7 9.7<br />

15-19 9.1 8.7 9.0 9.1 9.3 9.3 9.5 9.5 9.6 9.9<br />

20-29 8.8 8.9 9.0 9.0 9.2 9.3 9.4 9.4 9.5 9.5<br />

30-39 9.1 9.1 9.2 9.3 9.4 9.6 9.6 9.7 9.7 9.8<br />

40-49 9.2 9.2 9.3 9.4 9.5 9.6 9.7 9.8 9.9 9.9<br />

50-59 9.3 9.3 9.4 9.5 9.6 9.7 9.8 9.9 10.0 10.0<br />

60-64 9.3 9.4 9.4 9.5 9.7 9.8 9.8 10.0 10.0 10.1<br />

65-69 9.4 9.5 9.6 9.6 9.8 9.9 10.0 10.0 10.1 10.1<br />

70-79 9.5 9.6 9.7 9.7 9.9 10.0 10.0 10.1 10.2 10.2<br />

80+ 9.6 9.6 9.7 9.8 9.9 10.0 10.1 10.2 10.3 10.3<br />

0-19 9.2 9.0 9.2 9.3 9.5 9.6 9.7 9.7 9.8 9.8<br />

20-44 9.1 9.1 9.2 9.2 9.4 9.5 9.6 9.7 9.7 9.7<br />

45-64 9.3 9.3 9.4 9.5 9.6 9.7 9.8 9.9 10.0 10.0<br />

65-74 9.5 9.5 9.6 9.7 9.8 9.9 10.0 10.1 10.1 10.2<br />

75+ 9.6 9.6 9.7 9.8 9.9 10.0 10.1 10.2 10.2 10.3<br />

Unknown 9.9 . 7.1 . 9.9 . 10.9 . . .<br />

361<br />

Male 9.5 9.5 9.6 9.6 9.8 9.9 10.0 10.1 10.1 10.1<br />

Female 9.2 9.3 9.4 9.5 9.6 9.7 9.8 9.9 10.0 10.0<br />

Unknown . . . . . 9.6 . . . .<br />

White 9.6 9.6 9.7 9.8 9.9 10.0 10.1 10.2 10.2 10.2<br />

Black 8.9 9.0 9.1 9.2 9.3 9.4 9.5 9.6 9.7 9.7<br />

Native American/Alaskan Native 9.0 9.0 9.3 9.2 9.6 9.8 9.7 9.8 9.9 9.9<br />

Asian 9.3 9.3 9.3 9.5 9.8 9.8 9.9 10.0 10.1 10.1<br />

Pacific Islander 9.2 9.3 9.3 9.5 9.7 9.8 9.8 9.9 10.0 10.1<br />

Middle-eastern/Arabian 9.3 9.5 9.7 9.8 9.7 10.0 9.9 10.0 10.1 9.9<br />

Indian Subcontinent 9.5 9.2 9.3 9.4 9.7 9.8 9.9 10.0 10.0 10.2<br />

Other/multiracial 9.1 9.3 9.3 9.4 9.5 9.6 9.7 9.8 9.8 9.9<br />

Unknown 9.3 9.3 9.3 9.4 9.5 9.7 9.7 9.8 10.0 9.7<br />

Hispanic-Mexican 9.2 9.2 9.3 9.4 9.6 9.7 9.7 9.9 9.9 9.9<br />

Hispanic-Other 9.2 9.3 9.3 9.4 9.6 9.6 9.7 9.9 9.9 10.0<br />

Non-Hispanic 9.4 9.4 9.5 9.6 9.7 9.8 9.9 10.0 10.1 10.1<br />

Unknown 9.4 9.5 9.5 9.6 9.6 9.8 10.3 10.1 10.1 10.1<br />

Diabetic 9.4 9.4 9.5 9.6 9.7 9.8 9.9 10.0 10.0 10.1<br />

Non-diabetic 9.3 9.4 9.5 9.6 9.7 9.8 9.9 10.0 10.0 10.1<br />

All 9.3 9.4 9.5 9.6 9.7 9.8 9.9 10.0 10.0 10.1<br />

Completed forms 36,422 60,456 65,200 70,961 76,091 80,947 84,513 89,455 92,088 40,610<br />

<strong>Data</strong> are based on first & new Medical Evidence forms filed between May 1995 & June 2004.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

^Incomplete data.<br />

"." Zero values in this cell.


CPATIENT CHARACTERISTICS<br />

Reference section C<br />

362<br />

Table C.8 C.8<br />

Mean height (cm): by by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

incident patients with completed Medical Evidence forms<br />

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^<br />

0-4 92.3 93.5 104.3 99.1 104.8 96.1 96.8 95.9 100.5 102.2<br />

5-9 113.5 116.3 118.3 119.0 118.2 117.9 117.1 117.5 117.3 121.1<br />

10-14 145.0 146.3 145.3 145.7 147.2 144.7 146.4 144.9 146.6 149.6<br />

15-19 164.7 165.3 164.3 164.6 164.2 163.1 165.1 163.5 165.3 165.8<br />

20-29 167.6 168.1 167.7 167.9 167.8 167.7 168.6 168.1 167.8 168.5<br />

30-39 169.5 169.2 169.1 169.1 168.9 168.6 169.1 169.5 169.7 170.0<br />

40-49 169.6 169.3 169.6 169.5 169.0 169.1 169.5 169.7 169.8 170.0<br />

50-59 168.0 168.3 168.3 168.3 168.1 168.0 168.6 168.7 169.0 169.3<br />

60-64 167.1 167.2 167.4 167.0 167.0 167.0 167.6 167.9 167.9 168.3<br />

65-69 166.5 167.0 166.9 166.7 166.6 166.7 167.0 167.1 167.4 167.7<br />

70-79 165.8 166.2 166.4 166.2 166.0 165.9 166.4 166.6 166.9 167.1<br />

80+ 164.0 164.5 164.4 164.6 164.6 164.7 165.1 165.2 165.5 165.8<br />

0-19 146.2 145.9 146.1 146.8 147.1 143.9 145.3 145.1 146.9 148.1<br />

20-44 169.2 169.2 169.1 169.0 168.7 168.6 169.1 169.4 169.4 169.6<br />

45-64 168.0 168.1 168.2 168.1 167.9 167.9 168.5 168.6 168.8 169.1<br />

65-74 166.3 166.7 166.7 166.5 166.4 166.4 166.8 166.9 167.3 167.6<br />

75+ 164.8 165.3 165.4 165.3 165.2 165.3 165.6 165.8 166.0 166.2<br />

Unknown 178.0 . 170.0 . 168.0 . 160.0 . . .<br />

Male 173.1 173.1 173.2 173.1 172.8 172.7 173.2 173.2 173.5 173.7<br />

Female 159.9 160.0 160.1 160.0 159.8 159.7 160.1 160.2 160.5 160.6<br />

Unknown . . . . . 180.2 . . . .<br />

White 167.1 167.4 167.4 167.3 167.0 167.0 167.4 167.5 167.8 168.0<br />

Black 167.7 167.8 168.0 167.7 167.4 167.4 167.9 168.2 168.4 169.0<br />

Native American/Alaskan Native 164.6 165.9 165.0 165.9 165.9 166.7 165.7 165.6 166.0 166.0<br />

Asian 159.3 160.1 159.2 160.0 159.7 160.3 160.2 160.0 160.0 160.1<br />

Pacific Islander 161.9 160.7 161.3 160.9 161.6 161.6 162.3 161.9 162.9 163.3<br />

Middle-eastern/Arabian 162.6 164.5 163.0 162.4 164.2 163.0 162.7 164.3 165.5 167.5<br />

Indian Subcontinent 165.1 162.9 162.3 163.3 162.1 163.1 163.3 164.6 163.5 163.9<br />

Other/multiracial 161.9 161.0 161.5 161.5 161.9 162.2 163.0 162.7 163.1 163.2<br />

Unknown 164.4 163.9 164.3 164.2 163.7 163.1 164.0 163.0 163.6 163.6<br />

Hispanic-Mexican 162.1 161.9 161.6 162.0 162.0 162.6 162.3 162.6 162.6 162.8<br />

Hispanic-Other 162.1 162.1 162.1 162.2 162.3 163.1 163.8 163.3 163.6 164.0<br />

Non-Hispanic 167.5 167.7 167.8 167.6 167.4 167.3 167.8 167.9 168.2 168.5<br />

Unknown 165.1 164.1 163.0 162.8 163.9 166.6 164.6 164.9 166.3 166.9<br />

Diabetic 166.4 166.5 166.6 166.5 166.3 166.3 166.9 167.1 167.3 167.6<br />

Non-diabetic 167.1 167.4 167.4 167.3 167.1 167.0 167.4 167.5 167.8 168.0<br />

All 166.8 167.0 167.0 166.9 166.7 166.7 167.2 167.3 167.5 167.8<br />

Completed forms 43,035 70,426 75,178 81,299 85,727 90,475 93,793 97,965 99,786 43,509<br />

<strong>Data</strong> are based on first & new Medical Evidence forms filed between May 1995 & June 2004.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

^Incomplete data.<br />

"." Zero values in this cell.


PATIENT CHARACTERISTICS<br />

2005 Annual <strong>Data</strong> ReportC<br />

Table C.9 C.9<br />

Mean weight (kg): by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

incident patients with completed Medical Evidence forms<br />

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^<br />

0-4 19.3 19.0 17.2 20.6 23.8 20.7 20.0 19.1 22.1 22.0<br />

5-9 23.9 25.5 24.4 25.3 26.0 27.0 24.2 24.9 25.1 25.7<br />

10-14 41.6 40.3 40.3 42.8 44.1 44.2 46.7 44.6 46.2 48.5<br />

15-19 58.5 60.6 61.6 62.9 62.6 65.3 66.9 65.4 67.5 66.3<br />

20-29 65.5 66.6 67.2 68.5 70.9 74.5 74.9 75.0 75.1 76.5<br />

30-39 67.0 68.9 69.4 70.5 74.6 77.9 79.5 80.1 80.9 81.4<br />

40-49 71.6 72.5 73.1 74.4 76.9 81.4 82.0 82.6 83.2 83.5<br />

50-59 71.3 72.8 73.5 74.8 77.8 82.0 82.8 83.7 83.8 84.6<br />

60-64 68.8 70.1 71.0 72.3 75.5 79.1 80.5 81.0 81.4 82.2<br />

65-69 66.4 67.7 68.5 69.8 72.5 76.8 77.4 78.1 79.2 79.1<br />

70-79 63.2 64.1 64.7 66.0 68.6 71.9 72.9 73.5 74.3 74.7<br />

80+ 57.8 59.0 59.9 60.7 63.0 65.9 66.4 67.2 67.9 68.3<br />

0-19 44.8 45.1 44.5 46.8 47.8 47.9 49.0 47.9 50.1 50.3<br />

20-44 68.0 69.4 69.9 71.3 74.3 78.1 79.3 79.8 80.6 80.7<br />

45-64 70.7 72.0 72.7 74.0 77.1 81.1 82.0 82.8 83.0 83.9<br />

65-74 65.3 66.5 67.1 68.5 71.2 75.1 75.8 76.6 77.5 77.7<br />

75+ 59.9 60.9 61.8 62.7 65.1 68.0 68.9 69.4 70.1 70.4<br />

Unknown 57.4 . 87.0 . 71.0 . 54.0 . . .<br />

363<br />

Male 70.1 71.1 71.8 73.0 75.7 79.5 80.4 80.7 81.5 82.0<br />

Female 62.2 63.2 63.8 65.1 67.7 71.1 71.9 72.5 73.1 73.5<br />

Unknown . . . . . 79.2 . . . .<br />

White 66.0 66.8 67.6 69.1 71.7 75.5 76.3 76.8 77.6 77.9<br />

Black 68.7 70.0 70.5 71.3 74.6 78.4 79.3 79.8 80.3 81.2<br />

Native American/Alaskan Native 66.5 72.2 71.1 71.9 73.3 72.7 77.4 78.2 78.7 79.8<br />

Asian 54.4 56.8 55.0 56.1 58.5 61.3 60.7 60.8 60.7 61.4<br />

Pacific Islander 61.9 61.5 63.3 63.8 63.7 68.5 68.0 68.1 71.2 71.2<br />

Middle-eastern/Arabian 64.0 63.1 65.1 66.5 66.8 71.2 70.2 70.5 71.9 73.6<br />

Indian Subcontinent 58.4 58.3 58.5 60.7 61.8 64.2 64.3 66.4 66.1 67.8<br />

Other/multiracial 61.8 63.5 64.3 65.8 68.0 69.8 70.6 71.0 71.8 71.8<br />

Unknown 65.6 66.3 66.9 68.9 70.0 72.2 71.5 71.8 72.3 73.7<br />

Hispanic-Mexican 59.5 61.4 61.2 62.5 65.8 70.8 70.9 71.9 71.9 72.3<br />

Hispanic-Other 64.0 64.4 64.5 66.2 68.1 70.6 71.0 71.2 72.4 72.7<br />

Non-Hispanic 67.1 68.1 68.8 70.0 72.7 76.3 77.2 77.8 78.5 79.1<br />

Unknown 62.7 65.7 66.6 67.4 65.3 73.7 74.8 72.7 75.6 74.8<br />

Diabetic 69.2 70.3 70.9 72.3 75.2 79.3 80.3 80.9 81.8 82.2<br />

Non-diabetic 64.2 65.2 65.8 66.9 69.4 72.6 73.3 73.8 74.3 74.9<br />

All 66.3 67.4 68.0 69.3 72.0 75.6 76.5 77.0 77.7 78.2<br />

Completed forms 44,352 72,610 77,464 83,690 87,247 90,190 93,784 97,926 99,710 43,458<br />

<strong>Data</strong> are based on first & new Medical Evidence forms filed between May 1995 & June 2004.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

^Incomplete data.<br />

"." Zero values in this cell.


CPATIENT CHARACTERISTICS<br />

Reference section C<br />

364<br />

Table C.10 C.10<br />

Mean body mass index (kg/m 2 ): 2 ): by by demographic characteristics & diabetic status<br />

incident patients with completed Medical Evidence forms<br />

incident patients with completed Medical Evidence forms<br />

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^<br />

0-4 17.7 18.7 18.9 18.2 19.8 19.2 18.8 19.7 20.1 19.7<br />

5-9 17.6 17.7 17.4 19.2 18.5 18.8 17.8 17.9 17.6 17.6<br />

10-14 20.0 19.3 19.9 20.2 20.5 20.6 21.4 21.0 21.1 21.3<br />

15-19 22.5 23.0 24.1 23.9 23.9 24.1 24.3 24.3 24.5 23.8<br />

20-29 24.7 25.0 25.2 25.5 25.8 26.3 26.3 26.4 26.5 26.8<br />

30-39 24.9 25.5 25.6 26.0 26.9 27.3 27.6 27.8 28.0 28.2<br />

40-49 26.2 26.6 26.8 27.1 27.5 28.3 28.4 28.7 28.9 28.9<br />

50-59 26.8 27.0 27.2 27.6 28.2 28.9 29.0 29.4 29.4 29.6<br />

60-64 26.0 26.4 26.7 27.1 27.8 28.2 28.6 28.8 28.9 29.1<br />

65-69 25.4 25.6 25.8 26.3 26.8 27.6 27.7 27.9 28.3 28.2<br />

70-79 24.4 24.5 24.7 25.1 25.5 26.0 26.2 26.5 26.7 26.8<br />

80+ 22.9 23.1 23.4 23.6 23.9 24.2 24.3 24.7 24.8 24.9<br />

0-19 20.8 21.0 21.6 21.9 21.9 21.9 22.1 22.1 22.3 22.0<br />

20-44 25.2 25.6 25.9 26.2 26.8 27.4 27.5 27.7 28.0 28.0<br />

45-64 26.5 26.8 27.0 27.3 28.0 28.6 28.8 29.1 29.2 29.3<br />

65-74 25.1 25.2 25.4 25.9 26.4 27.1 27.2 27.5 27.7 27.7<br />

75+ 23.5 23.6 23.9 24.2 24.5 24.8 25.1 25.3 25.5 25.5<br />

Unknown 25.9 . 30.1 . 25.2 . 21.1 . . .<br />

Male 24.8 25.0 25.2 25.5 26.0 26.5 26.7 26.9 27.0 27.2<br />

Female 25.7 25.9 26.1 26.6 27.1 27.7 27.9 28.2 28.4 28.4<br />

Unknown . . . . . 24.6 . . . .<br />

White 25.1 25.2 25.5 25.9 26.3 26.9 27.1 27.3 27.5 27.6<br />

Black 25.8 26.1 26.3 26.6 27.3 27.8 28.0 28.2 28.3 28.5<br />

Native American/Alaskan Native 25.8 26.6 26.8 26.9 27.2 27.2 28.0 28.5 28.6 28.9<br />

Asian 22.6 23.0 22.7 23.0 23.4 23.9 23.5 23.7 23.6 23.9<br />

Pacific Islander 24.5 24.7 25.0 25.6 25.3 26.0 25.5 25.9 26.6 26.5<br />

Middle-eastern/Arabian 24.8 24.3 25.1 25.4 25.1 26.4 26.1 26.2 26.2 26.4<br />

Indian Subcontinent 22.9 23.0 22.8 23.5 24.4 24.1 24.1 24.5 24.8 25.1<br />

Other/multiracial 24.6 25.3 25.3 25.7 26.1 26.3 26.4 26.7 26.9 26.9<br />

Unknown 25.0 25.0 25.7 26.1 25.9 26.9 26.2 26.9 27.2 27.3<br />

Hispanic-Mexican 24.9 25.4 25.5 25.7 26.3 26.9 26.8 27.1 27.1 27.3<br />

Hispanic-Other 25.0 25.2 25.2 25.8 26.2 26.4 26.4 26.6 27.0 27.0<br />

Non-Hispanic 25.3 25.5 25.7 26.0 26.6 27.1 27.3 27.5 27.7 27.8<br />

Unknown 24.2 25.7 25.0 25.9 25.0 26.4 27.6 26.4 27.4 26.8<br />

Diabetic 26.4 26.6 26.8 27.2 27.8 28.5 28.7 29.0 29.2 29.3<br />

Non-diabetic 24.4 24.5 24.7 25.1 25.4 25.8 26.0 26.2 26.3 26.4<br />

All 25.2 25.4 25.6 26.0 26.5 27.1 27.2 27.5 27.6 27.7<br />

Completed forms 38,445 63,555 68,052 74,492 81,171 88,718 92,770 97,254 99,187 43,264<br />

<strong>Data</strong> are based on first & new Medical Evidence forms filed between May 1995 & June 2004.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

^Incomplete data.<br />

"." Zero values in this cell.


ON OUR WEBSITE & CD<br />

Mean eGFR by MDRD formula, demographic characteristics, & diabetic status<br />

(C.a). Counts of new ESRD patients, with or without a Medical Evidence form:<br />

by data source (C.b).<br />

PATIENT CHARACTERISTICS<br />

2005 Annual <strong>Data</strong> ReportC<br />

Table C.11 C.11<br />

Mean eGFR (ml/min/1.73 m 2 ): 2 ): by by MDRD MDRD formula, formula, demographic characteristics, && diabetic diabetic status status<br />

incident patients with completed Medical Evidence forms<br />

incident patients with completed Medical Evidence forms<br />

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^<br />

0-4 9.9 9.9 10.2 10.2 10.5 11.2 11.2 10.7 12.3 11.7<br />

5-9 10.6 10.9 10.2 10.5 10.5 10.9 10.2 11.7 11.4 11.3<br />

10-14 10.7 10.4 10.7 10.9 11.2 11.3 11.6 11.9 12.0 12.1<br />

15-19 8.7 9.1 9.1 9.0 9.9 9.7 10.4 10.0 10.6 10.7<br />

20-29 6.5 6.6 6.9 6.9 7.3 7.5 7.6 7.8 8.0 8.2<br />

30-39 6.7 6.8 7.1 7.3 7.5 7.7 7.9 8.1 8.2 8.4<br />

40-49 6.9 7.0 7.3 7.6 7.8 8.0 8.3 8.6 8.6 8.8<br />

50-59 7.2 7.4 7.8 8.1 8.3 8.7 8.8 9.2 9.3 9.5<br />

60-64 7.5 7.7 8.1 8.4 8.8 9.0 9.3 9.5 9.7 9.9<br />

65-69 7.7 7.9 8.4 8.7 9.0 9.4 9.6 9.9 10.0 10.3<br />

70-79 8.0 8.2 8.6 9.0 9.4 9.8 10.1 10.4 10.6 10.8<br />

80+ 8.2 8.5 8.9 9.4 9.8 10.2 10.6 10.9 11.1 11.3<br />

0-19 9.5 9.7 9.8 9.8 10.4 10.5 10.8 10.9 11.2 11.3<br />

20-44 6.7 6.8 7.1 7.3 7.5 7.7 7.9 8.1 8.3 8.4<br />

45-64 7.3 7.5 7.8 8.1 8.4 8.7 8.9 9.2 9.3 9.5<br />

65-74 7.8 8.0 8.5 8.8 9.2 9.6 9.8 10.1 10.2 10.4<br />

75+ 8.1 8.4 8.8 9.3 9.7 10.1 10.4 10.7 10.9 11.2<br />

Unknown 8.1 . 13.2 . 5.1 . 11.0 . . .<br />

365<br />

Male 7.9 8.1 8.5 8.8 9.2 9.5 9.7 10.0 10.2 10.4<br />

Female 7.1 7.4 7.7 8.1 8.4 8.7 9.0 9.3 9.4 9.6<br />

Unknown . . . . . 15.4 . . . .<br />

White 7.7 7.9 8.4 8.7 9.1 9.4 9.7 10.0 10.1 10.3<br />

Black 7.3 7.5 7.8 8.2 8.5 8.8 9.0 9.4 9.5 9.7<br />

Native American/Alaskan Native 7.1 7.3 7.8 7.8 8.4 9.0 8.6 8.5 8.9 9.4<br />

Asian 6.7 6.9 7.0 7.6 7.9 8.1 8.1 8.5 8.7 9.1<br />

Pacific Islander 6.0 6.3 6.4 7.0 7.2 7.4 8.0 7.7 8.2 8.4<br />

Middle-eastern/Arabian 7.2 7.5 8.3 8.1 8.3 8.4 9.0 9.6 9.4 10.1<br />

Indian Subcontinent 7.6 7.4 7.4 8.1 8.5 8.3 9.0 9.6 9.3 10.1<br />

Other/multiracial 6.9 7.1 7.5 7.7 7.9 8.1 8.1 8.4 8.4 8.9<br />

Unknown 7.4 7.7 7.6 7.9 8.3 8.8 8.5 8.7 9.5 9.2<br />

Hispanic-Mexican 7.4 7.6 8.1 8.2 8.5 8.9 9.0 9.2 9.3 9.5<br />

Hispanic-Other 6.9 7.1 7.4 7.7 8.1 8.3 8.4 8.8 8.9 9.1<br />

Non-Hispanic 7.6 7.8 8.2 8.5 8.9 9.2 9.5 9.8 9.9 10.1<br />

Unknown 6.6 6.6 6.6 7.0 7.7 9.0 9.1 9.3 9.9 10.1<br />

Diabetic 8.2 8.4 8.8 9.1 9.5 9.8 10.1 10.3 10.4 10.7<br />

Non-diabetic 7.0 7.2 7.6 7.9 8.2 8.6 8.8 9.2 9.4 9.5<br />

All 7.5 7.7 8.1 8.5 8.8 9.1 9.4 9.7 9.8 10.0<br />

Completed forms 44,034 72,123 76,887 82,997 86,590 89,727 92,767 96,806 98,520 43,004<br />

<strong>Data</strong> are based on first & new Medical Evidence forms filed between May 1995 & June 2004.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

^Incomplete data.<br />

"." Zero values in this cell.


CPATIENT CHARACTERISTICS<br />

Reference section C<br />

366<br />

Table Table<br />

C.12 C.12 C.13<br />

Counts Percent of distribution new ESRD patients, of patients, with by or or race without & Hispanic a Medical ethnicity: Evidence column form: percent by race<br />

incident patients with completed Medical Evidence forms<br />

incident patients with completed Medical Evidence forms<br />

1995^ Nat. Am/ 1996 1997Pacific 1998 Mid-East/ 1999 Indian 2000 Sub- 2001 Other/ 2002 2003 2004^ No CMS-<br />

White White Black Alas. 61.1 Native 61.6Asian 62.1 Islander62.1 Arabian 62.8 continent 62.2 63.8 Multiracial 63.9 Unknown 63.5 64.0 2728 All<br />

1960-1972 Black 828 211 30.1 18 29.3 14 29.3 29.4 * 28.5 . 27.8 . 28.3 28.3* 28.3 135 28.0 1,242 2,455<br />

1973 Native American/Alaskan 517 Native171 1.5 * 1.7 * 1.2 * 1.3 1.6 . 2.3 . 1.2 1.1* 2,739 1.1 1.0 437 3,880<br />

1974 Asian 653 206 2.3 13 2.4 14 2.2 * 2.6 2.6 . 2.6 * 2.4 2.4. 3,345 2.4 2.4 401 4,635<br />

1975 Pacific Islander 767 266 0.9 11 0.9 * 0.9 * 0.9 0.8 . 0.9 * 0.9 0.9* 4,210 1.0 1.0 426 5,703<br />

1976 Mid-East/Arabian 880 305 0.4 15 0.2 14 0.3 * 0.3 0.3 . 0.4 . 0.4 0.4* 4,823 0.4 0.4 516 6,562<br />

1977 Indian Subcontinent 1,666 590 0.3 30 0.3 28 0.3 * 0.3 0.3* 0.3 . 0.3 0.3* 6,409 0.4 0.412,187 20,930<br />

1978 Other/multiracial 1,744 646 2.8 43 3.0 37 3.3 132.7 2.6 . 3.0 . 2.5 2.4* 6,365 2.8 2.6 5,873 14,722<br />

1979 Unknown 2,178 803 0.7 49 0.6 38 0.4 210.3 0.4 . 0.5 . 0.3 0.3* 6,835 0.2 0.2 6,586 16,520<br />

1980 2,818 1,045 94 54 19 * * * 7,575 6,423 18,037<br />

1981 Hispanic-Mexican 6,209 2,494 7.4 162 7.3 129 6.8 246.7 7.2 . 8.7 . 7.3 7.6* 7,444 7.9 8.0 3,668 20,136<br />

1982 Hispanic-Other 14,017 5,587 4.4 213 4.3 314 4.5 274.5 4.6* 4.6 . 4.9 5.0 13 5.2 609 5.2 1,829 22,612<br />

1983 Non-Hispanic 15,111 6,467 86.9 280 87.4 329 87.8 15987.9 87.6* 86.3 * 87.6 87.2* 86.7 443 86.5 3,166 25,965<br />

1984 Unknown 16,840 7,176 1.4 294 1.0 385 0.8 3170.9 0.6 . 0.4 * 0.2 0.2 16 0.2 475 0.3 2,096 27,600<br />

1985 18,761 7,977 303 505 294 * * 13 596 2,185 30,639<br />

1986 20,200 8,364 385 523 383 * * 17 970 2,642 33,487<br />

1987 Total N 22,073 9,349 44,439 448 72,748 573 77,620 483 83,881 87,580* 90,918 94,078 * 98,183 15 100,009 1,245 43,597 2,776 36,969<br />

1988 23,940 10,244 520 698 329 * * 33 1,756 3,789 41,314<br />

1989 27,718 12,094 596 844 * * * 42 1,856 3,335 46,500<br />

1990 30,404 12,835 641 1,066 * * * 50 1,830 4,128 50,972<br />

1991 33,852 14,703 711 1,161 * * * 61 2,049 3,653 56,207<br />

1992 36,800 16,354 866 1,327 * * * 83 2,247 3,642 61,342<br />

1993 36,540 16,341 765 1,464 12 15 11 91 2,794 6,475 64,508<br />

1994 41,141 18,787 868 1,908 12 16 11 121 2,712 4,411 69,987<br />

1995 42,646 20,592 1,019 1,684 470 221 159 1,579 910 2,538 71,818<br />

1996 47,541 22,136 1,234 1,848 691 185 192 2,312 507 1,225 77,871<br />

1997 50,645 23,579 911 1,803 691 230 212 2,658 437 1,045 82,211<br />

1998 53,545 25,194 1,128 2,234 795 283 240 2,291 387 1,029 87,126<br />

1999 56,545 25,570 1,397 2,333 747 301 262 2,363 826 1,223 91,567<br />

2000 57,712 25,811 2,096 2,397 799 375 297 2,792 604 1,102 93,985<br />

2001 60,713 26,965 1,101 2,273 870 349 332 2,365 294 1,026 96,288<br />

2002 63,485 28,200 1,089 2,371 935 390 300 2,392 310 1,165 100,637<br />

2003 63,826 28,564 1,062 2,416 972 361 394 2,788 219 1,967 102,569<br />

2004^ 44,503 19,331 777 1,626 715 257 261 1,810 175 2,564 72,019<br />

All 896,818 398,957 19,146 32,424 9,845 3,020 2,702 23,960 74,131 96,770 1,557,773<br />

Table C.13 C.13<br />

Percent distribution of of patients, by race & Hispanic ethnicity: column percent<br />

incident patients with completed Medical Evidence forms<br />

incident patients with completed Medical Evidence forms<br />

ON OUR WEBSITE & CD<br />

Patient counts, by ESRD network (C.c).<br />

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^<br />

White 61.1 61.6 62.1 62.1 62.8 62.2 63.8 63.9 63.5 64.0<br />

Black 30.1 29.3 29.3 29.4 28.5 27.8 28.3 28.3 28.3 28.0<br />

Native American/Alaskan Native 1.5 1.7 1.2 1.3 1.6 2.3 1.2 1.1 1.1 1.0<br />

Asian 2.3 2.4 2.2 2.6 2.6 2.6 2.4 2.4 2.4 2.4<br />

Pacific Islander 0.9 0.9 0.9 0.9 0.8 0.9 0.9 0.9 1.0 1.0<br />

Mid-East/Arabian 0.4 0.2 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4<br />

Indian Subcontinent 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4<br />

Other/multiracial 2.8 3.0 3.3 2.7 2.6 3.0 2.5 2.4 2.8 2.6<br />

Unknown 0.7 0.6 0.4 0.3 0.4 0.5 0.3 0.3 0.2 0.2<br />

Hispanic-Mexican 7.4 7.3 6.8 6.7 7.2 8.7 7.3 7.6 7.9 8.0<br />

Hispanic-Other 4.4 4.3 4.5 4.5 4.6 4.6 4.9 5.0 5.2 5.2<br />

Non-Hispanic 86.9 87.4 87.8 87.9 87.6 86.3 87.6 87.2 86.7 86.5<br />

Unknown 1.4 1.0 0.8 0.9 0.6 0.4 0.2 0.2 0.2 0.3<br />

Total N 44,439 72,748 77,620 83,881 87,580 90,918 94,078 98,183 100,009 43,597<br />

<strong>Data</strong> are based on first & new Medical Evidence forms filed between May 1995 & June 2004.<br />

^Incomplete data.<br />

*Values for cells with 10 or fewer are suppressed.<br />

"." Zero values in this cell.


Table C.14 C.14<br />

Percent distribution of of diabetic patients, by race & Hispanic ethnicity<br />

incident patients with completed Medical Evidence forms<br />

incident patients with completed Medical Evidence forms<br />

All diabetes 1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^<br />

White 48.8 49.4 50.1 50.5 51.6 52.9 53.4 53.7 54.1 54.9<br />

Black 48.8 50.3 50.5 51.4 51.7 52.9 54.2 54.3 54.6 55.1<br />

Native American/Alaskan Native 70.0 67.8 77.9 75.0 73.1 67.2 78.3 77.1 80.6 84.3<br />

Asian 45.0 47.8 49.4 49.4 51.1 51.3 51.8 51.6 52.6 56.9<br />

Pacific Islander 65.0 58.1 61.8 63.5 63.4 66.7 67.7 63.6 66.8 67.0<br />

Mid-East/Arabian 47.7 38.4 48.7 43.8 50.2 43.5 46.2 52.8 51.0 52.2<br />

Indian Subcontinent 45.8 47.8 53.7 55.3 53.5 52.7 59.6 60.3 55.1 66.1<br />

Other/multiracial 57.3 60.5 60.7 60.2 62.2 62.6 61.5 59.8 63.3 63.1<br />

Unknown 53.3 51.6 54.8 52.5 59.8 64.3 56.9 53.7 63.3 60.8<br />

PATIENT CHARACTERISTICS<br />

2005 Annual <strong>Data</strong> ReportC<br />

Hispanic-Mexican 66.2 66.3 70.1 67.7 69.0 67.4 70.1 69.6 70.3 71.2<br />

Hispanic-Other 54.7 57.3 58.0 59.7 60.9 61.3 62.2 61.0 62.8 62.6<br />

Non-Hispanic 47.6 48.6 49.0 49.7 50.5 51.8 52.5 52.6 53.0 53.8<br />

Unknown 57.0 60.7 61.5 60.9 54.3 45.1 57.6 43.4 55.3 51.3<br />

367<br />

All 49.4 50.3 51.0 51.4 52.3 53.6 54.2 54.3 54.9 55.7<br />

Diabetes as primary diagnosis<br />

White 41.8 42.4 43.2 43.5 43.8 44.7 44.7 44.2 44.3 44.8<br />

Black 41.2 42.6 42.7 43.5 42.9 43.3 44.1 43.7 43.2 43.7<br />

Native American/Alaskan Native 64.1 63.7 74.1 71.4 67.8 60.4 72.3 72.1 74.0 77.0<br />

Asian 38.7 43.2 43.5 44.2 45.5 44.8 44.4 43.9 44.3 46.3<br />

Pacific Islander 61.1 53.9 56.2 58.1 57.5 59.8 62.4 57.6 58.4 60.0<br />

Mid-East/Arabian 41.5 31.4 42.1 39.4 43.3 37.4 39.1 42.8 42.3 41.0<br />

Indian Subcontinent 38.3 43.5 45.3 47.7 45.3 46.2 51.7 54.2 47.2 54.8<br />

Other/multiracial 52.9 56.9 55.9 55.2 57.3 56.8 56.2 54.6 56.6 57.3<br />

Unknown 49.7 44.6 47.5 43.2 52.6 54.1 47.8 47.0 53.5 49.0<br />

Hispanic-Mexican 61.0 61.7 65.0 63.3 63.3 61.6 64.0 62.9 63.2 64.3<br />

Hispanic-Other 50.1 52.6 53.2 54.2 56.2 55.6 55.7 54.5 56.1 55.8<br />

Non-Hispanic 40.3 41.2 41.8 42.3 42.3 43.0 43.1 42.6 42.4 43.0<br />

Unknown 51.0 56.3 55.6 54.3 48.8 36.7 45.6 35.4 44.7 42.5<br />

All 42.4 43.4 44.0 44.3 44.5 45.2 45.3 44.8 44.8 45.4<br />

Table C.15 C.15<br />

Percent distribution of of patients, by employment status<br />

*All diabetes: diabetes listed on Medical Evidence form as either the cause of ESRD or a comorbidity.<br />

incident patients with completed Medical Evidence forms<br />

incident patients with completed Medical Evidence forms<br />

1995^ 1996 1997 1998 1999 2000 2001 2002 2003 2004^<br />

Current employment status<br />

Employed full-time 8.2 8.2 8.6 8.6 8.8 8.6 8.7 8.4 8.2 8.4<br />

Employed part-time 1.9 1.8 1.8 1.9 1.8 1.7 1.7 1.7 1.7 1.7<br />

Homemaker 6.1 6.0 5.8 5.7 5.4 5.4 5.1 4.9 4.5 4.6<br />

Retired due to age/preference 31.6 33.9 36.7 38.0 38.7 38.5 38.8 39.7 39.5 38.8<br />

Retired due to disability 16.7 17.2 17.7 18.5 18.2 18.4 18.3 18.5 18.7 19.3<br />

Medical leave of absence 3.1 2.7 2.6 2.7 2.8 3.2 3.2 3.2 3.1 3.2<br />

Student 1.2 1.2 1.1 1.1 1.1 1.0 1.0 1.1 1.0 1.0<br />

Unemployed 21.8 20.7 19.9 19.2 19.1 19.0 19.1 18.2 19.1 19.2<br />

Missing 9.4 8.3 5.9 4.5 4.3 4.2 4.1 4.4 4.1 3.9<br />

Previous employment status<br />

Employed full-time 15.1 14.2 14.3 14.5 14.6 14.5 14.6 13.3 12.6 13.0<br />

Employed part-time 2.7 2.5 2.3 2.5 2.3 2.2 2.2 2.1 2.1 2.2<br />

Homemaker 6.1 6.0 5.8 5.7 5.4 5.4 5.1 4.7 4.3 4.4<br />

Retired due to age/preference 29.1 31.6 34.4 36.0 36.4 36.5 36.8 36.7 35.3 35.1<br />

Retired due to disability 13.6 14.6 15.2 16.0 15.8 16.1 15.9 15.7 15.6 16.3<br />

Medical leave of absence 0.6 0.6 0.5 0.5 0.5 0.6 0.5 0.5 0.5 0.5<br />

Student 1.2 1.2 1.1 1.0 1.1 1.0 1.0 1.0 1.0 0.9<br />

Unemployed 16.8 16.3 15.8 15.1 15.5 15.2 15.3 14.0 14.4 14.7<br />

Missing 14.9 13.2 10.6 8.7 8.4 8.6 8.7 12.0 14.2 12.9<br />

Total N 44,439 72,748 77,620 83,881 87,580 90,918 94,078 98,183 100,009 43,597<br />

All diabetes: diabetes listed on Medical Evidence form as either the cause of ESRD or a comorbidity.<br />

<strong>Data</strong> are based on first & new Medical Evidence forms filed between May 1995 & June 2004.<br />

^Incomplete data.


PATIENT CHARACTERISTICS<br />

CReference section C<br />

368<br />

Table C.16 C.16 C.17<br />

Insurance Incident patient coverage comorbidity<br />

in in the incident population<br />

ON OUR WEBSITE & CD<br />

Patient employment status: current & previous (C.15.1-2).<br />

Patient comorbidity: ESRD, transplant, & dialysis patients (C.17.1-11).<br />

Denominators obtained from counts by network in Table C.c.<br />

incident incident<br />

patients patients<br />

with with<br />

completed completed<br />

Medical Medical<br />

Evidence Evidence<br />

forms; forms;<br />

percent percent<br />

with with<br />

coverage<br />

coverage comorbidity<br />

in each<br />

in each in each<br />

year<br />

year year<br />

1995^ 1995^19961996199719971998199819991999200020002001200120022002 2003 2003 2004^ 2004^<br />

Congestive Medicaid coverage heart failure 25.0 30.7 23.9 32.4 23.7 33.4 23.5 32.4 22.8 31.6 23.9 32.1 23.6 31.5 24.4 31.1 24.8 31.7 24.8 32.2<br />

Ischemic Medicare heart coverage disease/CAD 48.0 21.2 49.4 22.6 50.5 23.8 49.9 23.7 50.2 23.8 54.5 24.6 55.1 24.9 56.0 24.9 55.8 25.1 55.8 25.2<br />

Myocardial DVA coverage infarction 1.8 8.4 1.3 8.8 1.1 9.0 1.1 8.8 1.6 8.8 1.2 9.0 1.3 8.9 1.3 8.7 1.4 8.3 1.3 8.1<br />

Cardiac Employer arrest group health insurance 25.3 1.0 24.1 1.1 23.9 0.9 23.3 0.8 23.0 0.8 22.9 0.8 23.5 0.7 23.4 0.7 22.5 0.8 22.4 0.7<br />

Cardiac Other medical dysrhythmia insurance 29.0 5.3 31.2 5.6 32.0 5.9 32.1 5.7 31.9 5.8 32.1 6.0 32.7 6.0 32.1 6.2 31.6 6.3 31.4 6.4<br />

No Pericarditis medical insurance 7.6 1.5 7.3 1.2 7.2 1.1 6.9 0.9 7.9 0.8 8.0 0.7 7.7 0.6 7.5 0.5 7.9 0.5 7.9 0.4<br />

Cerebrovascular Patient applying disease, for Medicare CVA/TIA 79.8 8.0 80.2 8.8 79.8 9.2 77.9 9.1 80.2 9.1 79.3 9.1 78.4 9.4 77.4 9.4 76.6 9.2 76.0 9.0<br />

Peripheral vascular disease 13.8 14.3 14.9 14.6 14.2 14.4 14.2 13.9 14.1 13.7<br />

All History of hypertension 44,439 67.5 72,748 71.4 77,620 73.7 83,881 74.0 87,580 75.3 90,918 76.7 94,078 78.3 98,183 79.3 100,009 80.3 43,597 81.0<br />

Diabetes: primary/contributing 36.0 38.5 40.0 40.4 41.5 43.3 44.7 45.3 46.5 46.9<br />

Diabetes: on insulin 22.2 23.4 23.9 23.4 23.2 23.2 22.6 22.3 22.7 22.9<br />

Chronic obstructive pulmonary disease 6.6 6.8 7.1 6.9 7.1 7.3 7.5 7.6 7.9 8.0<br />

Table C.17<br />

Current C.17 smoker/tobacco use 5.9 5.8 5.6 5.2 5.0 5.0 5.0 5.0 5.0 5.0<br />

Incident Malignant neoplasm/cancer patient comorbidity<br />

4.7 4.8 5.0 5.1 5.3 5.6 5.9 6.2 6.2 6.2<br />

incident Alcohol dependence patients with completed Medical Evidence 1.8 forms; 1.9 percent with 1.6 comorbidity 1.4 in 1.4each year 1.4 1.3 1.3 1.3 1.4<br />

incident Drug dependence patients with completed Medical Evidence 1.1 forms; 1.1 percent with 1.1 comorbidity 1.0 in 1.0each year 1.0 1.0 0.9 1.0 1.0<br />

AIDS 1995^ 4.4 1996 4.4 1997 2.6 1998 0.5 1999 1.7 2000 1.8 2001 0.4 2002 0.4 2003 0.4 2004^ 0.3<br />

Congestive HIV heart failure 30.7 4.7 32.4 4.8 33.4 2.9 32.4 0.9 31.6 2.1 32.1 2.2 31.5 0.7 31.1 0.8 31.7 0.8 32.2 0.8<br />

Ischemic Inability to heart ambulate disease/CAD 21.2 4.9 22.6 4.6 23.8 4.3 23.7 3.9 23.8 3.9 24.6 4.1 24.9 3.9 24.9 4.2 25.1 4.2 25.2 4.2<br />

Myocardial Inability to transfer infarction 1.7 8.4 1.6 8.8 1.6 9.0 8.8 1.5 8.8 1.3 9.0 1.5 8.9 1.5 8.7 1.5 8.3 1.5 8.1 1.6<br />

Cardiac arrest 1.0 1.1 0.9 0.8 0.8 0.8 0.7 0.7 0.8 0.7<br />

Cardiac All dysrhythmia 44,439 5.3 72,748 5.6 77,620 5.9 83,881 5.7 87,580 5.8 90,918 6.0 94,078 6.0 98,183 6.2 100,009 6.3 43,597 6.4<br />

Pericarditis 1.5 1.2 1.1 0.9 0.8 0.7 0.6 0.5 0.5 0.4<br />

Cerebrovascular disease, CVA/TIA 8.0 8.8 9.2 9.1 9.1 9.1 9.4 9.4 9.2 9.0<br />

Peripheral vascular disease 13.8 14.3 14.9 14.6 14.2 14.4 14.2 13.9 14.1 13.7<br />

History of hypertension 67.5 71.4 73.7 74.0 75.3 76.7 78.3 79.3 80.3 81.0<br />

Diabetes: primary/contributing 36.0 38.5 40.0 40.4 41.5 43.3 44.7 45.3 46.5 46.9<br />

Diabetes: on insulin 22.2 23.4 23.9 23.4 23.2 23.2 22.6 22.3 22.7 22.9<br />

Chronic obstructive pulmonary disease 6.6 6.8 7.1 6.9 7.1 7.3 7.5 7.6 7.9 8.0<br />

Current smoker/tobacco use 5.9 5.8 5.6 5.2 5.0 5.0 5.0 5.0 5.0 5.0<br />

Malignant neoplasm/cancer 4.7 4.8 5.0 5.1 5.3 5.6 5.9 6.2 6.2 6.2<br />

Alcohol dependence 1.8 1.9 1.6 1.4 1.4 1.4 1.3 1.3 1.3 1.4<br />

Drug dependence 1.1 1.1 1.1 1.0 1.0 1.0 1.0 0.9 1.0 1.0<br />

AIDS 4.4 4.4 2.6 0.5 1.7 1.8 0.4 0.4 0.4 0.3<br />

HIV 4.7 4.8 2.9 0.9 2.1 2.2 0.7 0.8 0.8 0.8<br />

Inability to ambulate 4.9 4.6 4.3 3.9 3.9 4.1 3.9 4.2 4.2 4.2<br />

Inability to transfer 1.7 1.6 1.6 1.5 1.3 1.5 1.5 1.5 1.5 1.6<br />

All 44,439 72,748 77,620 83,881 87,580 90,918 94,078 98,183 100,009 43,597<br />

<strong>Data</strong> are based on first & new Medical Evidence forms filed between May 1995 & June 2004.<br />

^Incomplete data.


Reference<br />

D<br />

Section<br />

Treatment<br />

modalities


DTREATMENT MODALITIES<br />

Reference section D<br />

370<br />

D.1 . 371<br />

Percentages & counts of reported ESRD patients: by treatment modality<br />

incident & point prevalent patients<br />

D.2 . 373<br />

Counts of incident ESRD patients, by initial mode of therapy: all dialysis<br />

by demographic characteristics & primary diagnosis<br />

D.3 . 375<br />

Counts of incident ESRD patients, by initial mode of therapy: hemodialysis<br />

by demographic characteristics & primary diagnosis<br />

D.4 . 377<br />

Counts of incident ESRD patients, by initial mode of therapy: peritoneal dialysis<br />

by demographic characteristics & primary diagnosis<br />

D.5 . 379<br />

Counts of incident ESRD patients, by initial mode of therapy: transplant<br />

by demographic characteristics & primary diagnosis<br />

D.6 . 381<br />

Counts of prevalent ESRD patients, by mode of therapy: all dialysis<br />

point prevalent patients on December 31<br />

D.7 . 383<br />

Counts of prevalent ESRD patients, by mode of therapy: hemodialysis<br />

point prevalent patients on December 31<br />

D.8 . 385<br />

Counts of prevalent ESRD patients, by mode of therapy: peritoneal dialysis<br />

point prevalent patients on December 31<br />

D.9. 387<br />

Counts of prevalent ESRD patients, by mode of therapy: functioning transplant<br />

point prevalent patients on December 31<br />

D.10 . 389<br />

Incident ESRD patients, 2003: by age, gender, race/ethnicity, primary diagnosis, &<br />

modality<br />

D.11 . 390<br />

Prevalent ESRD patients, 2003: by age, gender, race/ethnicity, primary diagnosis,<br />

& modality<br />

D.12 . 391<br />

Treatment status two years after first ESRD service, 1999-2001<br />

incident patients with Medicare coverage, 1999-2001 combined<br />

D.13 . 392<br />

Prevalent ESRD patients, 2003: by patient vintage<br />

point prevalent patients on December 31, by year-end treatment modality &<br />

number of years patient has had ESRD (vintage)<br />

D.14 . 393<br />

Prevalent ESRD patients, 2003: by number of years on modality<br />

point prevalent patients on December 31, by year-end treatment modality<br />

D.15 . 394<br />

Incident ESRD patients, 2003: by modality & state/territory<br />

incident ESRD patients<br />

D.16 . 395<br />

Prevalent ESRD patients, 2003: by modality & state/territory<br />

point prevalent ESRD patients on December 31


TREATMENT MODALITIES<br />

2005 Annual <strong>Data</strong> ReportD<br />

Table D.1 D.1<br />

Percentages & counts of of reported ESRD patients: by treatment modality<br />

incident<br />

incident &<br />

point<br />

point<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

INCIDENT COUNTS 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

Modality<br />

Dialysis 17,678 19,777 22,168 25,528 27,109 30,060 32,745 36,040 40,244 45,413 49,820 55,079<br />

Started with a tx 339 325 419 407 472 544 726 911 1,048 1,049 1,106 1,094<br />

Dialysis type<br />

Center hemodialysis 15,537 16,886 18,322 21,145 22,375 24,118 26,466 29,285 33,386 37,943 41,326 45,887<br />

Center self hemodialysis . . . . . . . . . . . 61<br />

Home hemodialysis 71 26 21 32 54 208 208 140 121 75 88 69<br />

CAPD 982 1,880 3,144 3,735 3,912 4,035 4,093 4,410 4,672 5,125 5,914 6,129<br />

CCPD * * * 16 37 136 223 336 310 460 610 834<br />

Other PD 681 439 267 286 273 587 733 663 719 773 663 771<br />

Uncertain dialysis 404 540 407 314 458 976 1,022 1,206 1,036 1,037 1,219 1,328<br />

All 18,017 20,102 22,587 25,935 27,581 30,604 33,471 36,951 41,292 46,462 50,926 56,173<br />

PERCENTAGES<br />

Modality<br />

Dialysis 98.1 98.4 98.1 98.4 98.3 98.2 97.8 97.5 97.5 97.7 97.8 98.1<br />

Started with a tx 1.9 1.6 1.9 1.6 1.7 1.8 2.2 2.5 2.5 2.3 2.2 1.9<br />

Dialysis type<br />

Center hemodialysis 87.9 85.4 82.7 82.8 82.5 80.2 80.8 81.3 83.0 83.6 83.0 83.3<br />

Center self hemodialysis . . . . . . . . . . . 0.1<br />

Home hemodialysis 0.4 0.1 0.1 0.1 0.2 0.7 0.6 0.4 0.3 0.2 0.2 0.1<br />

CAPD 5.6 9.5 14.2 14.6 14.4 13.4 12.5 12.2 11.6 11.3 11.9 11.1<br />

CCPD 0.0 . . 0.1 0.1 0.5 0.7 0.9 0.8 1.0 1.2 1.5<br />

Other PD 3.9 2.2 1.2 1.1 1.0 2.0 2.2 1.8 1.8 1.7 1.3 1.4<br />

Uncertain dialysis 2.3 2.7 1.8 1.2 1.7 3.2 3.1 3.3 2.6 2.3 2.4 2.4<br />

371<br />

All 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0<br />

POINT PREVALENT COUNTS<br />

Modality<br />

Dialysis 49,949 56,237 63,047 72,963 80,414 87,003 93,716 101,937 111,619 124,159 137,437 152,927<br />

Functioning graft 10,093 12,648 15,424 18,499 22,179 26,528 31,700 36,552 41,141 45,608 50,541 55,803<br />

Dialysis type<br />

Center hemodialysis 44,423 50,661 55,886 62,960 66,831 68,157 73,948 81,743 91,747 102,608 113,462 125,468<br />

Center self hemodialysis . * * * . . . * . . . 680<br />

Home hemodialysis 1,838 704 509 1,229 2,476 5,557 5,290 4,456 2,772 2,597 2,268 2,082<br />

CAPD 893 2,603 4,343 6,726 8,762 10,591 11,519 12,449 13,466 15,072 17,004 18,953<br />

CCPD * 17 46 72 202 540 789 1,007 1,118 1,347 1,992 2,903<br />

Other PD 1,428 1,096 1,022 874 785 876 787 700 657 612 495 445<br />

Uncertain dialysis 1,363 1,155 1,240 1,101 1,358 1,282 1,383 1,581 1,859 1,923 2,216 2,396<br />

All 60,042 68,885 78,471 91,462 102,593 113,531 125,416 138,489 152,760 169,767 187,978 208,730<br />

PERCENTAGES<br />

Modality<br />

Dialysis 83.2 81.6 80.3 79.8 78.4 76.6 74.7 73.6 73.1 73.1 73.1 73.3<br />

Functioning graft 16.8 18.4 19.7 20.2 21.6 23.4 25.3 26.4 26.9 26.9 26.9 26.7<br />

Dialysis type<br />

Center hemodialysis 88.9 90.1 88.6 86.3 83.1 78.3 78.9 80.2 82.2 82.6 82.6 82.0<br />

Center self hemodialysis . . . . . . . . . . . 0.4<br />

Home hemodialysis 3.7 1.3 0.8 1.7 3.1 6.4 5.6 4.4 2.5 2.1 1.7 1.4<br />

CAPD 1.8 4.6 6.9 9.2 10.9 12.2 12.3 12.2 12.1 12.1 12.4 12.4<br />

CCPD . . 0.1 0.1 0.3 0.6 0.8 1.0 1.0 1.1 1.4 1.9<br />

Other PD 2.9 1.9 1.6 1.2 1.0 1.0 0.8 0.7 0.6 0.5 0.4 0.3<br />

Uncertain dialysis 2.7 2.1 2.0 1.5 1.7 1.5 1.5 1.6 1.7 1.5 1.6 1.6<br />

All 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0<br />

The incident cohorts & associated modalities are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The point prevalent cohorts & associated modalities are determined on<br />

Dec. 31 of each calendar year without applying the 60-day stable modality rule.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


DTREATMENT MODALITIES<br />

Reference section D<br />

Table D.1 D.1 (continued)<br />

Percentages & counts of reported ESRD patients: by treatment modality<br />

incident<br />

incident &<br />

point<br />

point<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

INCIDENT COUNTS 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Modality<br />

Dialysis 60,214 63,405 68,864 70,569 76,550 80,876 85,715 89,957 92,228 94,429 98,666 100,499<br />

Started with a tx 1,104 1,087 1,104 1,222 1,310 1,327 1,406 1,603 1,738 1,851 1,959 2,068<br />

Dialysis type<br />

Center hemodialysis 50,564 53,373 58,539 60,396 66,073 71,811 76,813 80,754 83,696 86,626 91,178 93,042<br />

Center self hemo. 56 40 24 53 57 48 46 42 30 37 44 39<br />

Home hemodialysis 63 92 47 231 488 201 485 646 249 234 170 195<br />

CAPD 6,298 6,710 6,735 6,573 6,149 5,638 5,153 4,971 4,644 4,681 4,425 4,561<br />

CCPD 1,084 1,029 1,278 1,957 2,258 2,141 2,239 2,261 2,259 2,306 2,184 2,129<br />

Other PD 732 662 630 472 447 417 389 256 302 277 415 289<br />

Uncertain dialysis 1,417 1,499 1,611 887 1,078 620 590 1,027 1,048 268 250 244<br />

372<br />

All 61,318 64,492 69,968 71,791 77,860 82,203 87,121 91,560 93,966 96,280 100,625 102,567<br />

PERCENTAGES<br />

Modality<br />

Dialysis 98.2 98.3 98.4 98.3 98.3 98.4 98.4 98.2 98.2 98.1 98.1 98.0<br />

Started with a tx 1.8 1.7 1.6 1.7 1.7 1.6 1.6 1.8 1.8 1.9 1.9 2.0<br />

Dialysis type<br />

Center hemodialysis 84.0 84.2 85.0 85.6 86.3 88.8 89.6 89.8 90.7 91.7 92.4 92.6<br />

Center self hemo. 0.1 0.1 . 0.1 0.1 0.1 0.1 . . . . .<br />

Home hemodialysis 0.1 0.1 0.1 0.3 0.6 0.2 0.6 0.7 0.3 0.2 0.2 0.2<br />

CAPD 10.5 10.6 9.8 9.3 8.0 7.0 6.0 5.5 5.0 5.0 4.5 4.5<br />

CCPD 1.8 1.6 1.9 2.8 2.9 2.6 2.6 2.5 2.4 2.4 2.2 2.1<br />

Other PD 1.2 1.0 0.9 0.7 0.6 0.5 0.5 0.3 0.3 0.3 0.4 0.3<br />

Uncertain dialysis 2.4 2.4 2.3 1.3 1.4 0.8 0.7 1.1 1.1 0.3 0.3 0.2<br />

All 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0<br />

POINT PREVALENT COUNTS<br />

Modality<br />

Dialysis 168,845 183,424 200,367 213,987 229,776 244,915 260,404 274,993 288,967 300,708 313,023 324,826<br />

Functioning graft 61,032 66,528 71,913 77,579 83,354 89,219 95,540 101,621 107,974 114,453 121,285 128,131<br />

Dialysis type<br />

Center hemodialysis 138,590 153,164 167,510 179,205 195,360 212,598 230,180 245,318 260,230 272,887 285,273 296,583<br />

Center self hemo. 764 133 196 513 527 463 359 339 268 320 272 193<br />

Home hemodialysis 2,114 559 829 1,844 1,944 1,649 1,641 1,550 1,450 1,192 1,149 1,325<br />

CAPD 20,846 22,624 23,778 22,454 20,203 18,081 16,076 14,573 13,325 12,464 11,555 11,281<br />

CCPD 3,701 4,319 5,418 7,840 9,586 10,431 10,606 11,312 11,948 12,763 13,724 14,544<br />

Other PD 378 296 287 235 179 138 116 86 73 66 84 67<br />

Uncertain dialysis 2,452 2,329 2,349 1,896 1,977 1,555 1,426 1,815 1,673 1,016 966 833<br />

All 229,877 249,952 272,280 291,566 313,130 334,134 355,944 376,614 396,941 415,161 434,308 452,957<br />

PERCENTAGES<br />

Modality<br />

Dialysis 73.5 73.4 73.6 73.4 73.4 73.3 73.2 73.0 72.8 72.4 72.1 71.7<br />

Functioning graft 26.5 26.6 26.4 26.6 26.6 26.7 26.8 27.0 27.2 27.6 27.9 28.3<br />

Dialysis type<br />

Center hemodialysis 82.1 83.5 83.6 83.7 85.0 86.8 88.4 89.2 90.1 90.7 91.1 91.3<br />

Center self hemo. 0.5 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.1<br />

Home hemodialysis 1.3 0.3 0.4 0.9 0.8 0.7 0.6 0.6 0.5 0.4 0.4 0.4<br />

CAPD 12.3 12.3 11.9 10.5 8.8 7.4 6.2 5.3 4.6 4.1 3.7 3.5<br />

CCPD 2.2 2.4 2.7 3.7 4.2 4.3 4.1 4.1 4.1 4.2 4.4 4.5<br />

Other PD 0.2 0.2 0.1 0.1 0.1 0.1 . . . . . .<br />

Uncertain dialysis 1.5 1.3 1.2 0.9 0.9 0.6 0.5 0.7 0.6 0.3 0.3 0.3<br />

All 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0<br />

The incident cohorts & associated modalities are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The point prevalent cohorts & associated modalities are determined on<br />

Dec. 31 of each calendar year without applying the 60-day stable modality rule.<br />

"." Zero values in this cell.


TREATMENT MODALITIES<br />

2005 Annual <strong>Data</strong> ReportD<br />

Table D.2 D.2<br />

Counts of of incident ESRD patients, by initial mode of of therapy: all all dialysis<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 41 58 83 94 98 123 125 123 117 133 126 161<br />

5-9 86 80 87 79 95 80 103 92 83 94 122 86<br />

10-14 161 174 210 192 199 187 169 169 178 159 195 199<br />

15-19 409 451 425 415 395 405 403 420 456 463 480 436<br />

20-29 1,456 1,617 1,811 1,770 1,919 1,962 2,029 2,033 2,207 2,371 2,459 2,488<br />

30-39 2,133 2,386 2,661 2,735 2,944 3,178 3,453 3,590 4,019 4,383 4,602 4,849<br />

40-49 2,376 2,691 2,809 3,166 3,305 3,605 3,867 4,345 4,819 5,470 6,018 6,723<br />

50-59 3,730 4,344 4,635 4,813 5,074 5,456 5,735 6,162 7,059 7,608 8,220 8,884<br />

60-64 2,136 2,460 2,788 3,215 3,530 3,951 4,128 4,592 5,041 5,497 6,112 6,666<br />

65-69 2,185 2,272 2,602 3,333 3,517 3,925 4,452 5,107 5,661 6,532 7,240 8,021<br />

70-79 2,533 2,753 3,404 4,689 4,926 5,791 6,601 7,458 8,310 9,787 10,880 12,694<br />

80+ 432 490 645 1,017 1,098 1,381 1,666 1,943 2,289 2,906 3,358 3,869<br />

Unknown . * * * * 16 14 * * * * *<br />

0-19 697 763 805 780 787 795 800 804 834 849 923 882<br />

20-44 4,672 5,274 5,781 5,980 6,385 6,828 7,313 7,715 8,531 9,301 10,021 10,581<br />

45-64 7,159 8,224 8,923 9,719 10,387 11,324 11,899 13,007 14,614 16,028 17,390 19,029<br />

65-74 3,793 4,022 4,764 6,205 6,452 7,416 8,278 9,476 10,436 12,051 13,509 15,307<br />

75+ 1,357 1,493 1,887 2,834 3,089 3,681 4,441 5,032 5,824 7,174 7,969 9,277<br />

Unknown . * * * * 16 14 * * * * *<br />

373<br />

Male 9,819 10,904 12,165 13,964 14,919 16,277 17,834 19,469 21,529 24,410 26,706 29,348<br />

Female 7,859 8,873 10,003 11,562 12,190 13,780 14,910 16,570 18,715 21,003 23,114 25,729<br />

Unknown . . . * . * * * . . . *<br />

White 12,332 13,747 15,435 17,378 18,463 20,422 22,305 24,281 26,683 30,005 32,973 36,281<br />

Black 4,824 5,457 6,135 7,421 7,832 8,687 9,340 10,548 12,036 13,802 14,896 16,606<br />

Native American 122 142 185 267 282 291 367 419 496 543 586 631<br />

Asian 108 177 345 360 456 581 622 710 880 983 1,245 1,429<br />

Other/unknown 292 254 68 102 76 79 111 82 149 80 120 132<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 2,652 3,984 5,221 6,149 7,414 8,594 9,914 11,287 12,864 15,516 17,905 20,456<br />

Hypertension 3,116 4,503 5,800 6,316 7,129 8,211 8,880 10,269 11,858 13,823 15,233 16,914<br />

Glomerulonephritis 2,747 3,577 4,191 4,412 4,726 4,967 5,233 5,675 6,078 6,421 6,842 7,070<br />

Cystic kidney 763 931 1,072 1,086 1,130 1,204 1,266 1,291 1,333 1,344 1,478 1,525<br />

Other urologic 459 655 860 950 959 1,157 1,172 1,298 1,349 1,345 1,277 1,432<br />

Other cause 1,734 2,189 2,772 3,085 3,268 3,540 3,609 3,612 3,783 4,319 4,504 4,874<br />

Unknown cause 1,608 1,664 1,371 1,411 1,452 1,526 1,775 1,952 2,162 2,080 2,194 2,461<br />

Missing cause 4,599 2,274 881 2,119 1,031 861 896 656 817 565 387 347<br />

All 17,678 19,777 22,168 25,528 27,109 30,060 32,745 36,040 40,244 45,413 49,820 55,079<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


DTREATMENT MODALITIES<br />

Reference section D<br />

Table D.2 D.2 (continued)<br />

Counts of incident ESRD patients, by initial mode of of therapy: all dialysis<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

374<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 127 155 131 149 147 145 154 147 170 170 164 168<br />

5-9 88 107 127 111 111 96 105 121 121 120 130 102<br />

10-14 198 199 223 217 224 231 215 240 247 248 294 289<br />

15-19 492 469 458 495 504 466 489 527 505 500 505 549<br />

20-29 2,641 2,683 2,672 2,570 2,575 2,519 2,591 2,485 2,545 2,541 2,453 2,379<br />

30-39 5,214 5,330 5,648 5,485 5,613 5,532 5,522 5,684 5,502 5,455 5,487 5,473<br />

40-49 7,273 7,772 8,204 8,751 9,366 9,402 10,154 10,325 10,547 10,552 10,884 11,158<br />

50-59 9,816 10,415 11,715 11,868 12,544 13,583 14,803 15,962 16,402 17,250 17,795 18,587<br />

60-64 6,991 7,347 7,796 8,064 8,466 8,909 9,449 9,643 9,939 10,295 10,505 11,089<br />

65-69 8,636 8,963 9,616 9,605 10,441 10,827 11,103 11,196 11,366 11,583 11,841 12,049<br />

70-79 14,192 15,002 16,625 17,129 19,338 20,787 21,887 23,216 23,684 23,979 25,098 24,819<br />

80+ 4,544 4,963 5,643 6,121 7,221 8,378 9,241 10,411 11,200 11,736 13,510 13,837<br />

Unknown * . * * . * * . . . . .<br />

0-19 905 930 939 972 986 938 963 1,035 1,043 1,038 1,093 1,108<br />

20-44 11,320 11,597 11,971 12,028 12,368 12,153 12,564 12,579 12,566 12,471 12,474 12,515<br />

45-64 20,615 21,950 24,064 24,710 26,196 27,792 29,955 31,520 32,369 33,622 34,650 36,171<br />

65-74 16,797 17,596 19,135 19,296 21,274 22,179 22,803 23,240 23,629 24,011 24,630 24,424<br />

75+ 10,575 11,332 12,749 13,559 15,726 17,813 19,428 21,583 22,621 23,287 25,819 26,281<br />

Unknown * . * * . * * . . . . .<br />

Male 31,834 33,728 36,440 37,164 40,777 43,000 45,596 48,035 49,277 50,743 53,516 54,392<br />

Female 28,379 29,675 32,424 33,400 35,772 37,876 40,119 41,920 42,950 43,686 45,148 46,081<br />

Unknown * * . * * . . * * . * 26<br />

White 39,401 41,048 44,381 44,741 48,916 52,012 54,746 58,163 59,891 61,063 63,771 64,575<br />

Black 18,262 19,475 21,078 21,688 23,028 24,065 25,768 26,246 26,497 27,417 28,631 29,170<br />

Native American 751 749 817 868 915 950 1,051 1,118 1,133 1,121 1,125 1,084<br />

Asian 1,604 1,914 2,147 2,290 2,474 2,622 2,906 3,165 3,129 3,333 3,517 3,550<br />

Other/unknown 196 219 441 982 1,217 1,227 1,244 1,265 1,578 1,495 1,622 2,120<br />

†Hispanic 8,752 9,018 9,629 10,420 11,231 11,589 12,444 13,116<br />

†Non-Hispanic 67,798 71,858 76,086 79,537 80,997 82,840 86,222 87,383<br />

Diabetes 22,739 24,330 27,137 29,636 33,137 35,677 38,069 40,061 41,785 42,900 44,308 44,963<br />

Hypertension 18,873 19,611 21,271 19,109 20,277 21,772 22,962 24,336 24,745 25,644 27,159 28,151<br />

Glomerulonephritis 7,235 7,519 8,120 8,121 8,536 8,481 8,639 8,632 8,312 8,179 8,348 8,025<br />

Cystic kidney 1,642 1,709 1,783 1,816 1,750 1,862 1,967 2,023 1,971 2,000 1,981 1,986<br />

Other urologic 1,497 1,298 1,348 1,999 2,281 2,328 2,371 2,773 2,600 2,632 2,834 2,703<br />

Other cause 5,259 5,588 6,132 6,964 7,362 7,552 8,193 8,460 8,832 8,977 9,767 9,909<br />

Unknown cause 2,684 2,883 2,867 2,734 3,027 3,069 3,328 3,472 3,749 3,913 3,925 4,107<br />

Missing cause 285 467 206 190 180 135 186 200 234 184 344 655<br />

All 60,214 63,405 68,864 70,569 76,550 80,876 85,715 89,957 92,228 94,429 98,666 100,499<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


TREATMENT MODALITIES<br />

2005 Annual <strong>Data</strong> ReportD<br />

Table D.3 D.3<br />

Counts of of incident ESRD patients, by initial mode of of therapy: hemodialysis<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 22 18 22 26 19 30 38 20 24 36 35 35<br />

5-9 58 47 49 32 35 29 29 33 27 30 50 31<br />

10-14 134 127 117 110 97 100 86 88 86 85 92 81<br />

15-19 375 394 342 325 299 299 296 293 337 344 336 328<br />

20-29 1,299 1,394 1,529 1,470 1,559 1,611 1,619 1,595 1,728 1,888 1,890 1,967<br />

30-39 1,848 2,015 2,155 2,161 2,369 2,472 2,685 2,779 3,145 3,398 3,529 3,683<br />

40-49 2,103 2,354 2,286 2,567 2,673 2,855 3,049 3,441 3,875 4,317 4,749 5,229<br />

50-59 3,280 3,731 3,877 3,966 4,167 4,433 4,697 5,032 5,900 6,259 6,707 7,292<br />

60-64 1,925 2,085 2,340 2,695 2,966 3,236 3,426 3,818 4,257 4,665 5,111 5,569<br />

65-69 1,970 1,949 2,205 2,902 2,996 3,228 3,722 4,285 4,870 5,671 6,225 6,969<br />

70-79 2,223 2,390 2,872 4,045 4,302 4,862 5,608 6,347 7,235 8,684 9,648 11,285<br />

80+ 371 407 542 869 940 1,157 1,407 1,689 2,018 2,633 3,034 3,546<br />

Unknown . * * * * 14 12 * * * * *<br />

0-19 589 586 530 493 450 458 449 434 474 495 513 475<br />

20-44 4,110 4,513 4,738 4,817 5,157 5,418 5,730 5,996 6,714 7,283 7,736 8,118<br />

45-64 6,345 7,066 7,449 8,042 8,577 9,189 9,746 10,669 12,191 13,244 14,250 15,622<br />

65-74 3,380 3,454 4,027 5,373 5,531 6,166 6,965 7,976 9,000 10,558 11,734 13,409<br />

75+ 1,184 1,292 1,592 2,443 2,707 3,081 3,772 4,345 5,123 6,430 7,173 8,391<br />

Unknown . * * * * 14 12 * * * * *<br />

375<br />

Male 8,746 9,443 10,161 11,660 12,342 13,238 14,558 15,885 17,940 20,377 22,206 24,374<br />

Female 6,862 7,469 8,182 9,515 10,087 11,086 12,115 13,539 15,567 17,641 19,208 21,641<br />

Unknown . . . * . * * * . . . *<br />

White 10,753 11,564 12,573 14,177 15,030 16,123 17,813 19,399 21,732 24,622 26,822 29,628<br />

Black 4,391 4,829 5,238 6,372 6,719 7,387 7,923 8,976 10,441 12,016 12,907 14,493<br />

Native American 108 130 161 223 227 247 304 357 422 469 500 541<br />

Asian 100 160 307 320 393 512 552 630 795 845 1,108 1,260<br />

Other/unknown 256 229 64 85 60 57 82 63 117 66 77 95<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 2,199 3,265 4,109 4,875 5,952 6,813 7,969 9,106 10,660 12,907 14,827 16,977<br />

Hypertension 2,746 3,927 4,886 5,366 6,132 6,888 7,509 8,770 10,228 12,010 13,163 14,755<br />

Glomerulonephritis 2,397 3,098 3,490 3,673 3,884 3,986 4,209 4,515 4,877 5,166 5,443 5,640<br />

Cystic kidney 691 789 914 918 926 987 1,020 1,029 1,066 1,057 1,133 1,142<br />

Other urologic 402 567 719 798 803 946 997 1,102 1,174 1,182 1,096 1,262<br />

Other cause 1,524 1,895 2,329 2,526 2,678 2,828 2,911 2,855 3,112 3,550 3,657 3,937<br />

Unknown cause 1,419 1,354 1,124 1,136 1,176 1,217 1,379 1,567 1,778 1,718 1,808 2,047<br />

Missing cause 4,230 2,017 772 1,885 878 661 680 481 612 428 287 257<br />

All 15,608 16,912 18,343 21,177 22,429 24,326 26,674 29,425 33,507 38,018 41,414 46,017<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


DTREATMENT MODALITIES<br />

Reference section D<br />

Table D.3 D.3 (continued)<br />

Counts of of incident ESRD patients, by initial mode of of therapy: hemodialysis<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

376<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 21 38 27 40 24 37 30 33 42 46 39 44<br />

5-9 36 35 50 50 39 33 44 45 51 55 59 43<br />

10-14 106 99 112 112 103 117 113 129 135 145 174 161<br />

15-19 335 334 336 358 373 343 379 421 390 393 413 442<br />

20-29 2,096 2,116 2,149 2,109 2,126 2,124 2,235 2,167 2,223 2,250 2,219 2,140<br />

30-39 4,035 4,137 4,433 4,401 4,624 4,680 4,716 4,912 4,833 4,815 4,849 4,886<br />

40-49 5,750 6,121 6,629 7,086 7,813 8,050 8,883 9,068 9,362 9,434 9,908 10,118<br />

50-59 8,016 8,627 9,704 9,974 10,704 11,781 13,057 14,274 14,776 15,542 16,217 17,002<br />

60-64 5,866 6,230 6,595 6,898 7,443 7,973 8,573 8,743 9,062 9,492 9,702 10,290<br />

65-69 7,600 7,803 8,481 8,438 9,276 9,856 10,162 10,256 10,401 10,807 11,034 11,231<br />

70-79 12,654 13,427 14,916 15,530 17,424 19,176 20,361 21,541 22,057 22,667 23,777 23,582<br />

80+ 4,167 4,538 5,174 5,681 6,669 7,889 8,789 9,853 10,643 11,251 13,001 13,337<br />

Unknown * . * * . * * . . . . .<br />

0-19 498 506 525 560 539 530 566 628 618 639 685 690<br />

20-44 8,852 9,034 9,511 9,752 10,221 10,277 10,855 10,938 11,045 11,037 11,209 11,249<br />

45-64 16,911 18,197 19,999 20,716 22,489 24,331 26,609 28,226 29,211 30,496 31,686 33,187<br />

65-74 14,827 15,468 16,947 17,190 18,949 20,284 20,982 21,334 21,774 22,502 23,117 22,920<br />

75+ 9,594 10,300 11,624 12,459 14,420 16,637 18,330 20,316 21,327 22,223 24,695 25,230<br />

Unknown * . * * . * * . . . . .<br />

Male 26,704 28,426 30,961 31,878 35,501 38,356 41,238 43,558 44,955 46,788 49,632 50,536<br />

Female 23,978 25,077 27,649 28,798 31,117 33,704 36,106 37,882 39,020 40,109 41,758 42,720<br />

Unknown * * . * . . . * . . * 20<br />

White 32,469 33,980 37,046 37,745 41,659 45,556 48,668 51,842 53,828 55,601 58,557 59,457<br />

Black 16,023 17,053 18,650 19,377 20,933 22,228 24,015 24,533 24,863 25,859 27,101 27,617<br />

Native American 630 652 702 747 807 855 945 1,039 1,022 1,033 1,034 1,016<br />

Asian 1,404 1,647 1,829 1,947 2,141 2,313 2,589 2,877 2,819 3,030 3,197 3,224<br />

Other/unknown 157 173 383 864 1,078 1,108 1,127 1,151 1,443 1,374 1,503 1,962<br />

†Hispanic 7,761 8,180 8,796 9,579 10,380 10,810 11,579 12,282<br />

†Non-Hispanic 58,857 63,880 68,548 71,863 73,595 76,087 79,813 80,994<br />

Diabetes 18,987 20,529 23,031 25,412 28,732 31,815 34,380 36,303 38,142 39,717 41,164 41,940<br />

Hypertension 16,626 17,178 18,815 17,041 18,326 19,986 21,271 22,568 23,024 24,100 25,605 26,553<br />

Glomerulonephritis 5,752 6,034 6,510 6,573 6,994 7,127 7,356 7,461 7,135 7,096 7,364 7,023<br />

Cystic kidney 1,248 1,282 1,350 1,385 1,349 1,471 1,607 1,630 1,609 1,616 1,649 1,622<br />

Other urologic 1,278 1,109 1,144 1,725 2,013 2,078 2,158 2,534 2,356 2,415 2,617 2,503<br />

Other cause 4,303 4,594 5,150 5,994 6,399 6,730 7,368 7,617 8,066 8,174 9,035 9,186<br />

Unknown cause 2,280 2,429 2,467 2,407 2,664 2,750 3,065 3,167 3,465 3,624 3,682 3,874<br />

Missing cause 209 350 143 143 141 103 139 162 178 155 276 575<br />

All 50,683 53,505 58,610 60,680 66,618 72,060 77,344 81,442 83,975 86,897 91,392 93,276<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


TREATMENT MODALITIES<br />

2005 Annual <strong>Data</strong> ReportD<br />

Table D.4 D.4<br />

Counts of of incident ESRD patients, by initial mode of of therapy: peritoneal dialysis<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 * 28 50 58 66 84 77 87 82 71 73 100<br />

5-9 15 22 33 42 54 44 60 49 45 54 53 44<br />

10-14 13 29 75 73 91 72 73 72 81 56 85 87<br />

15-19 15 30 63 73 76 84 82 100 81 103 110 85<br />

20-29 73 142 223 249 302 274 330 323 377 358 440 408<br />

30-39 139 240 414 501 485 558 590 627 685 788 852 967<br />

40-49 152 232 431 531 543 591 641 696 760 895 1,031 1,230<br />

50-59 240 438 628 748 791 793 810 884 889 1,059 1,191 1,266<br />

60-64 107 240 367 456 475 547 513 570 607 621 790 830<br />

65-69 84 212 327 372 424 431 458 526 512 608 762 760<br />

70-79 119 224 451 531 517 572 542 660 696 774 911 987<br />

80+ 19 49 88 116 123 121 139 151 167 196 226 199<br />

Unknown . . * * * . * * . * . .<br />

0-19 52 109 221 246 287 284 292 308 289 284 321 316<br />

20-44 282 499 848 1,004 1,037 1,101 1,234 1,308 1,437 1,571 1,812 2,021<br />

45-64 429 793 1,215 1,481 1,559 1,662 1,650 1,792 1,881 2,150 2,492 2,680<br />

65-74 162 367 611 702 753 779 784 940 942 1,053 1,333 1,359<br />

75+ 60 118 255 317 311 345 355 397 433 525 566 587<br />

Unknown . . * * * . * * . * . .<br />

377<br />

Male 515 940 1,654 1,996 2,160 2,209 2,371 2,535 2,677 3,016 3,508 3,818<br />

Female 470 946 1,497 1,755 1,789 1,961 1,945 2,211 2,305 2,569 3,016 3,145<br />

Unknown . . . . . * . . . . . .<br />

White 792 1,459 2,353 2,771 2,934 3,200 3,267 3,575 3,754 4,112 4,853 5,120<br />

Black 159 401 753 905 918 876 935 1,066 1,086 1,307 1,480 1,617<br />

Native American 11 * 17 41 46 40 55 51 68 61 74 75<br />

Asian * * 27 26 46 47 50 51 66 100 104 134<br />

Other/unknown 16 * * * * * * * * * 13 17<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 255 525 950 1,131 1,247 1,347 1,453 1,650 1,671 2,047 2,416 2,719<br />

Hypertension 215 402 792 842 844 916 917 993 1,178 1,310 1,613 1,618<br />

Glomerulonephritis 206 344 577 646 722 770 791 865 943 997 1,115 1,186<br />

Cystic kidney 46 101 132 147 178 170 194 206 211 231 281 318<br />

Other urologic 23 63 112 128 123 135 112 124 122 105 127 121<br />

Other cause 129 211 365 496 515 544 513 580 511 580 657 676<br />

Unknown cause 89 188 190 206 208 185 231 211 213 226 263 280<br />

Missing cause 22 52 33 155 112 104 105 117 133 89 52 45<br />

All 985 1,886 3,151 3,751 3,949 4,171 4,316 4,746 4,982 5,585 6,524 6,963<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


DTREATMENT MODALITIES<br />

Reference section D<br />

Table D.4 D.4 (continued)<br />

Counts of incident ESRD patients, by initial mode of therapy: peritoneal dialysis<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

378<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 88 100 84 98 115 104 121 111 122 120 118 120<br />

5-9 44 54 70 60 68 60 56 73 65 63 66 54<br />

10-14 80 83 97 98 112 108 98 105 106 98 119 125<br />

15-19 129 109 103 124 125 118 106 102 106 101 87 104<br />

20-29 429 459 428 420 420 367 339 298 295 270 221 233<br />

30-39 979 965 1,006 995 932 805 757 733 643 604 604 571<br />

40-49 1,242 1,351 1,307 1,537 1,475 1,262 1,193 1,171 1,110 1,061 938 992<br />

50-59 1,437 1,481 1,631 1,725 1,689 1,713 1,623 1,563 1,485 1,634 1,503 1,507<br />

60-64 872 861 928 1,015 938 871 805 811 794 765 755 760<br />

65-69 744 864 828 930 858 776 777 726 725 706 697 746<br />

70-79 1,083 1,130 1,211 1,208 1,334 1,246 1,180 1,178 1,119 1,148 1,098 1,067<br />

80+ 254 282 319 319 341 349 337 361 333 417 403 411<br />

Unknown * . * * . . . . . . . .<br />

0-19 341 346 354 380 420 390 381 391 399 382 390 403<br />

20-44 2,023 2,065 2,039 2,086 2,027 1,764 1,603 1,545 1,441 1,355 1,201 1,219<br />

45-64 2,936 3,052 3,261 3,606 3,427 3,254 3,114 3,031 2,886 2,979 2,820 2,844<br />

65-74 1,401 1,560 1,591 1,654 1,695 1,499 1,475 1,412 1,353 1,358 1,298 1,351<br />

75+ 680 716 767 803 838 872 819 853 824 913 900 873<br />

Unknown * . * * . . . . . . . .<br />

Male 3,958 4,094 4,236 4,532 4,449 4,088 3,848 3,782 3,665 3,650 3,522 3,562<br />

Female 3,424 3,645 3,777 3,998 3,957 3,691 3,544 3,450 3,238 3,337 3,087 3,126<br />

Unknown . . . . * . . . . . . *<br />

White 5,398 5,563 5,696 6,041 6,054 5,705 5,375 5,367 5,051 5,063 4,729 4,704<br />

Black 1,706 1,857 1,901 1,979 1,821 1,602 1,547 1,464 1,388 1,440 1,395 1,466<br />

Native American 91 80 95 105 99 83 84 70 90 81 71 63<br />

Asian 167 222 288 313 311 282 286 240 266 295 310 316<br />

Other/unknown 20 17 33 92 122 107 100 91 108 108 104 141<br />

†Hispanic 889 784 761 780 763 740 816 776<br />

†Non-Hispanic 7,518 6,995 6,631 6,452 6,140 6,247 5,793 5,914<br />

Diabetes 2,972 3,039 3,247 3,670 3,767 3,443 3,253 3,214 3,042 2,990 2,869 2,808<br />

Hypertension 1,678 1,858 1,870 1,708 1,529 1,492 1,452 1,404 1,362 1,407 1,393 1,468<br />

Glomerulonephritis 1,231 1,219 1,330 1,424 1,397 1,274 1,198 1,084 1,076 1,041 928 961<br />

Cystic kidney 333 376 376 388 366 358 337 366 331 358 321 350<br />

Other urologic 142 144 132 213 204 209 181 194 196 200 198 178<br />

Other cause 712 730 745 831 822 727 734 723 662 731 662 664<br />

Unknown cause 288 336 289 277 306 265 228 237 225 252 210 219<br />

Missing cause 26 37 24 19 16 11 * * * * 28 42<br />

All 7,382 7,739 8,013 8,530 8,407 7,779 7,392 7,232 6,903 6,987 6,609 6,690<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


TREATMENT MODALITIES<br />

2005 Annual <strong>Data</strong> ReportD<br />

Table D.5 D.5<br />

Counts of of incident ESRD patients, by initial mode of of therapy: transplant<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 * 11 18 12 14 16 11 25 28 25 25 21<br />

5-9 11 17 18 * 15 23 19 23 23 37 32 43<br />

10-14 18 14 14 19 31 30 44 51 47 49 54 49<br />

15-19 24 25 31 29 36 37 54 64 66 63 68 54<br />

20-29 84 72 91 87 88 126 130 153 213 213 178 163<br />

30-39 89 98 107 116 133 135 220 244 278 269 291 300<br />

40-49 71 50 81 84 84 98 135 178 199 220 262 280<br />

50-59 29 31 55 40 55 54 78 128 147 125 142 132<br />

60-64 * * * * * * 18 29 31 30 33 36<br />

65-69 * * . * * * * * * 12 14 13<br />

70-79 . * . * * * * * * * * *<br />

80+ * * * . * * * * . * * .<br />

Unknown . . . . . * . . . . . .<br />

0-19 59 67 81 69 96 106 128 163 164 174 179 167<br />

20-44 205 197 243 246 269 323 423 494 606 604 630 634<br />

45-64 71 58 94 89 94 98 158 238 262 253 276 277<br />

65-74 * * . * * 11 13 12 15 16 19 15<br />

75+ * * * . * * * * * * * *<br />

Unknown . . . . . * . . . . . .<br />

379<br />

Male 222 220 272 258 301 313 433 535 625 616 638 643<br />

Female 117 104 147 149 170 230 293 376 422 433 468 451<br />

Unknown . * . . * * . . * . . .<br />

White 261 257 318 297 366 435 604 722 800 881 903 950<br />

Black 52 51 68 55 60 57 75 116 139 111 120 91<br />

Native American . * * * * * * * 11 * * *<br />

Asian * * 12 13 * * * 26 31 26 34 20<br />

Other/unknown 24 13 20 34 32 33 33 42 67 29 39 23<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 38 59 87 69 99 114 178 190 208 254 233 264<br />

Hypertension 25 25 38 33 23 30 44 73 79 55 68 68<br />

Glomerulonephritis 55 56 74 81 90 122 120 179 156 189 211 192<br />

Cystic kidney * 13 * 19 18 24 45 71 67 73 95 99<br />

Other urologic 24 24 14 18 26 27 42 43 40 60 54 62<br />

Other cause 47 38 55 49 75 68 99 117 107 136 142 135<br />

Unknown cause 17 15 43 46 43 62 57 69 80 69 93 93<br />

Missing cause 131 95 99 92 98 97 141 169 311 213 210 181<br />

All 339 325 419 407 472 544 726 911 1,048 1,049 1,106 1,094<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


DTREATMENT MODALITIES<br />

Reference section D<br />

Table D.5 D.5 (continued)<br />

Counts of of incident ESRD patients, by initial mode of of therapy: transplant<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

380<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 26 32 15 19 39 31 21 35 27 35 20 39<br />

5-9 37 28 35 35 35 37 33 36 34 32 52 51<br />

10-14 50 44 37 64 46 50 55 60 64 64 51 51<br />

15-19 41 59 71 75 77 68 53 82 71 85 77 88<br />

20-29 154 144 154 135 140 141 150 171 156 171 151 166<br />

30-39 291 272 280 311 279 271 314 284 319 300 330 287<br />

40-49 270 248 273 285 361 326 369 421 444 466 476 480<br />

50-59 168 176 161 198 227 265 290 334 400 446 494 546<br />

60-64 42 51 48 57 74 83 66 91 116 133 164 174<br />

65-69 18 21 20 30 26 47 45 57 69 83 96 131<br />

70-79 * 11 * 13 * * * 30 37 35 48 53<br />

80+ * . . . . . * * * * . *<br />

Unknown . * . . . . . * . . . .<br />

0-19 154 163 158 193 197 186 162 213 196 216 200 229<br />

20-44 599 553 575 586 611 581 648 662 701 692 701 657<br />

45-64 326 338 341 400 470 505 541 639 734 824 914 996<br />

65-74 23 29 28 41 31 52 51 86 104 111 135 175<br />

75+ * * * * * * * * * * * 11<br />

Unknown . * . . . . . * . . . .<br />

Male 613 631 616 688 784 792 801 919 991 1,062 1,112 1,192<br />

Female 491 454 487 532 526 535 605 684 747 789 847 874<br />

Unknown . * * * . . . . . . . *<br />

White 939 956 882 945 1,020 1,139 1,246 1,405 1,496 1,604 1,680 1,712<br />

Black 115 90 172 219 225 128 100 134 143 143 181 187<br />

Native American * * * * 12 * 13 * 11 * * 13<br />

Asian 29 22 30 29 40 30 32 30 51 53 64 58<br />

Other/unknown 12 15 14 20 13 20 15 26 37 41 25 98<br />

†Hispanic 77 76 93 96 116 117 135 142<br />

†Non-Hispanic 1,233 1,251 1,313 1,507 1,622 1,734 1,824 1,926<br />

Diabetes 232 255 247 276 313 294 282 310 285 365 392 367<br />

Hypertension 90 70 79 65 65 85 79 84 108 135 176 168<br />

Glomerulonephritis 215 193 191 249 259 240 266 291 324 340 376 359<br />

Cystic kidney 96 98 80 125 145 123 190 169 217 248 269 305<br />

Other urologic 39 53 58 114 83 109 78 74 116 105 144 124<br />

Other cause 155 142 145 183 195 209 197 207 226 289 290 283<br />

Unknown cause 100 144 119 67 77 110 70 139 100 115 137 102<br />

Missing cause 177 132 185 143 173 157 244 329 362 254 175 360<br />

All 1,104 1,087 1,104 1,222 1,310 1,327 1,406 1,603 1,738 1,851 1,959 2,068<br />

The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


TREATMENT MODALITIES<br />

2005 Annual <strong>Data</strong> ReportD<br />

Table D.6 D.6<br />

Counts of prevalent ESRD patients, by mode of of therapy: all dialysis<br />

point<br />

point<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 42 65 93 119 133 164 180 174 171 182 179 205<br />

5-9 112 106 131 154 165 137 161 167 174 193 208 182<br />

10-14 271 295 332 368 354 328 324 344 365 349 393 408<br />

15-19 843 858 901 848 845 887 855 889 957 1,028 1,024 1,047<br />

20-29 4,044 4,289 4,624 4,980 5,222 5,348 5,413 5,569 5,966 6,425 6,759 6,986<br />

30-39 6,421 7,155 7,968 8,771 9,584 10,230 10,773 11,376 12,243 13,415 14,365 15,502<br />

40-49 7,877 8,571 9,311 10,757 11,605 12,184 12,808 13,812 15,315 17,274 19,266 21,648<br />

50-59 11,862 13,272 14,596 15,911 16,989 17,854 18,591 19,370 20,803 22,553 24,554 27,020<br />

60-64 6,101 7,276 8,301 9,754 10,871 11,826 12,396 13,499 14,390 15,558 16,986 18,305<br />

65-69 5,533 6,217 7,047 8,613 9,760 10,863 12,266 13,873 15,313 17,105 18,927 20,913<br />

70-79 5,960 7,018 8,327 10,642 12,420 14,129 16,208 18,298 20,540 23,609 26,928 31,420<br />

80+ 879 1,110 1,405 2,027 2,440 3,027 3,716 4,552 5,371 6,459 7,839 9,284<br />

Unknown * * 11 19 26 26 25 14 11 * * *<br />

0-19 1,268 1,324 1,457 1,489 1,497 1,516 1,520 1,574 1,667 1,752 1,804 1,842<br />

20-44 14,143 15,377 16,898 18,801 20,207 21,262 22,322 23,505 25,531 28,108 30,616 32,969<br />

45-64 22,162 25,186 27,902 31,372 34,064 36,180 37,659 40,121 43,186 47,117 51,314 56,492<br />

65-74 9,461 10,757 12,417 15,300 17,416 19,450 22,021 24,724 27,389 30,871 34,781 39,459<br />

75+ 2,911 3,588 4,362 5,982 7,204 8,569 10,169 11,999 13,835 16,302 18,913 22,158<br />

Unknown * * 11 19 26 26 25 14 11 * * *<br />

381<br />

Male 27,188 30,229 33,787 38,874 42,810 45,911 49,016 52,933 57,693 64,180 71,102 79,229<br />

Female 22,761 26,008 29,260 34,088 37,603 41,089 44,696 49,000 53,926 59,979 66,334 73,696<br />

Unknown . . . * * * * * . . * *<br />

White 33,581 37,277 41,370 47,300 51,429 55,057 58,665 63,044 68,040 74,833 82,054 90,541<br />

Black 15,039 17,393 19,925 23,596 26,644 29,249 32,013 35,456 39,595 44,759 50,081 56,129<br />

Native American 280 376 465 626 748 850 979 1,139 1,305 1,487 1,688 1,910<br />

Asian 324 454 680 904 1,127 1,440 1,682 1,964 2,356 2,845 3,373 4,068<br />

Other/unknown 725 737 607 537 466 407 377 334 323 235 241 279<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 4,909 6,814 9,145 11,582 14,429 17,099 19,978 23,347 27,273 32,756 38,807 45,769<br />

Hypertension 8,502 10,928 13,892 16,880 19,643 22,209 25,003 28,095 31,692 36,393 40,995 46,328<br />

Glomerulonephritis 10,146 11,562 13,172 15,158 16,702 17,948 19,009 20,209 21,449 23,035 24,470 26,025<br />

Cystic kidney 3,207 3,636 4,129 4,688 5,026 5,326 5,478 5,667 5,793 5,959 6,173 6,474<br />

Other urologic 1,217 1,521 1,934 2,349 2,738 3,124 3,366 3,693 3,986 4,216 4,346 4,643<br />

Other cause 4,916 5,837 7,084 8,416 9,406 10,307 10,926 11,489 12,282 13,399 14,317 15,190<br />

Unknown cause 5,401 5,699 5,596 5,938 6,146 6,053 6,195 6,453 6,663 6,580 6,804 7,256<br />

Missing cause 11,651 10,240 8,095 7,952 6,324 4,937 3,761 2,984 2,481 1,821 1,525 1,242<br />

All 49,949 56,237 63,047 72,963 80,414 87,003 93,716 101,937 111,619 124,159 137,437 152,927<br />

The point prevalent cohorts are determined on December 31 of each calendar year without applying the 60-day stable modality rule.<br />

The age of the point prevalent patient is determined as of December 31 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


DTREATMENT MODALITIES<br />

Reference section D<br />

Table D.6 D.6 (continued)<br />

Counts of prevalent ESRD patients, by mode of of therapy: all dialysis<br />

point<br />

point<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

382<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 202 223 220 235 231 204 217 214 248 233 232 244<br />

5-9 181 187 223 214 219 228 217 217 246 241 244 223<br />

10-14 415 422 450 445 432 430 457 433 495 521 567 529<br />

15-19 1,095 1,125 1,081 1,110 1,161 1,176 1,205 1,196 1,147 1,197 1,246 1,275<br />

20-29 7,409 7,679 8,016 8,196 8,435 8,621 8,893 8,972 9,075 9,083 8,989 8,985<br />

30-39 16,685 17,767 18,884 19,383 19,929 20,404 20,787 21,466 21,897 22,126 22,397 22,814<br />

40-49 23,779 25,994 28,375 30,884 33,247 34,999 37,087 38,777 40,321 41,513 42,668 43,899<br />

50-59 29,836 32,508 35,785 38,210 41,353 44,793 48,733 52,818 56,599 60,309 63,318 66,734<br />

60-64 19,634 20,968 22,514 23,969 25,377 26,910 28,697 30,099 31,517 32,947 34,873 36,910<br />

65-69 23,015 24,775 26,602 27,860 29,560 30,806 32,064 33,362 34,493 35,717 36,748 37,854<br />

70-79 35,575 39,094 43,762 47,341 51,715 56,106 59,631 62,766 65,446 67,043 69,276 70,540<br />

80+ 11,015 12,681 14,452 16,140 18,117 20,238 22,416 24,673 27,483 29,778 32,465 34,819<br />

Unknown * * * . . . . . . . . .<br />

0-19 1,893 1,957 1,974 2,004 2,043 2,038 2,096 2,060 2,136 2,192 2,289 2,271<br />

20-44 35,467 37,669 39,894 41,528 43,266 44,770 46,226 47,556 48,531 49,211 49,593 50,399<br />

45-64 61,876 67,247 73,680 79,114 85,075 90,957 97,971 104,576 110,878 116,767 122,652 128,943<br />

65-74 44,000 47,927 52,307 55,206 58,843 62,110 64,788 67,234 69,461 71,396 73,303 74,933<br />

75+ 25,605 28,623 32,509 36,135 40,549 45,040 49,323 53,567 57,961 61,142 65,186 68,280<br />

Unknown * * * . . . . . . . . .<br />

Male 87,317 95,100 103,917 110,853 119,491 127,980 136,679 145,108 153,131 160,065 167,682 174,554<br />

Female 81,525 88,322 96,448 103,131 110,281 116,931 123,723 129,881 135,832 140,639 145,335 150,250<br />

Unknown * * * * * * * * * * * 22<br />

White 98,893 106,007 115,139 121,470 129,633 137,580 145,248 153,445 161,421 167,856 174,110 180,041<br />

Black 62,629 68,863 75,274 80,812 86,742 92,565 98,875 103,855 108,377 112,283 116,799 120,974<br />

Native American 2,208 2,467 2,705 2,967 3,204 3,430 3,753 3,997 4,193 4,429 4,577 4,674<br />

Asian 4,749 5,654 6,528 7,337 8,078 8,790 9,584 10,449 11,271 12,068 12,941 13,601<br />

Other/unknown 366 433 721 1,401 2,119 2,550 2,944 3,247 3,705 4,072 4,596 5,536<br />

†Hispanic 24,459 27,410 30,115 33,057 36,284 39,161 42,126 45,299<br />

†Non-Hispanic 205,317 217,505 230,289 241,936 252,683 261,547 270,897 279,527<br />

Diabetes 53,023 59,448 67,289 75,157 84,007 92,897 101,241 108,715 116,720 123,476 130,111 136,173<br />

Hypertension 51,985 56,821 62,117 64,106 67,135 70,301 73,873 77,580 80,879 83,899 87,412 91,251<br />

Glomerulonephritis 27,519 29,194 31,146 32,554 34,155 35,387 36,573 37,529 38,005 38,486 38,819 38,863<br />

Cystic kidney 6,730 7,016 7,392 7,591 7,746 7,813 8,069 8,334 8,550 8,628 8,729 8,746<br />

Other urologic 4,882 4,843 5,033 5,645 6,251 6,760 7,179 7,822 8,189 8,409 8,743 8,912<br />

Other cause 16,209 17,150 18,220 19,623 20,788 21,837 23,196 24,259 25,362 26,134 27,027 27,998<br />

Unknown cause 7,638 8,153 8,633 8,821 9,245 9,543 9,944 10,430 10,941 11,352 11,720 12,167<br />

Missing cause 859 799 537 490 449 377 329 324 321 324 462 716<br />

All 168,845 183,424 200,367 213,987 229,776 244,915 260,404 274,993 288,967 300,708 313,023 324,826<br />

The point prevalent cohorts are determined on December 31 of each calendar year without applying the 60-day stable modality rule.<br />

The age of the point prevalent patient is determined as of December 31 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


TREATMENT MODALITIES<br />

2005 Annual <strong>Data</strong> ReportD<br />

Table D.7 D.7<br />

Counts of of prevalent ESRD patients, by by mode of of therapy: hemodialysis<br />

point<br />

point<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 25 22 23 32 33 41 47 45 45 47 44 45<br />

5-9 83 67 73 64 57 40 50 57 60 53 59 58<br />

10-14 224 233 228 223 179 163 138 152 160 150 169 159<br />

15-19 789 788 762 685 649 614 588 606 655 684 657 653<br />

20-29 3,780 3,948 4,158 4,301 4,376 4,412 4,401 4,467 4,722 5,104 5,301 5,429<br />

30-39 5,898 6,476 6,991 7,466 7,930 8,281 8,725 9,171 9,807 10,701 11,260 12,062<br />

40-49 7,267 7,824 8,285 9,280 9,811 10,074 10,530 11,342 12,551 14,115 15,584 17,279<br />

50-59 10,962 12,091 13,174 14,041 14,641 15,170 15,739 16,365 17,664 19,042 20,536 22,501<br />

60-64 5,742 6,674 7,510 8,667 9,507 10,151 10,607 11,525 12,303 13,343 14,452 15,635<br />

65-69 5,175 5,772 6,411 7,841 8,673 9,457 10,633 12,069 13,345 14,914 16,453 18,018<br />

70-79 5,519 6,472 7,520 9,721 11,222 12,553 14,389 16,241 18,291 21,129 24,007 27,879<br />

80+ 793 994 1,250 1,851 2,205 2,735 3,370 4,149 4,906 5,914 7,199 8,505<br />

Unknown * * 11 18 24 23 21 11 * * * *<br />

0-19 1,121 1,110 1,086 1,004 918 858 823 860 920 934 929 915<br />

20-44 13,072 13,993 14,968 16,119 16,838 17,365 18,115 18,942 20,486 22,529 24,197 25,785<br />

45-64 20,577 23,020 25,150 27,636 29,427 30,723 31,887 33,928 36,561 39,776 42,936 47,121<br />

65-74 8,822 9,966 11,255 13,933 15,547 17,040 19,241 21,640 23,989 27,148 30,506 34,352<br />

75+ 2,665 3,272 3,926 5,480 6,553 7,705 9,151 10,819 12,553 14,809 17,153 20,050<br />

Unknown * * 11 18 24 23 21 11 * * * *<br />

383<br />

Male 25,258 27,692 30,278 34,113 36,832 38,796 41,370 44,600 48,704 54,174 59,713 66,153<br />

Female 21,003 23,674 26,118 30,076 32,474 34,915 37,866 41,598 45,815 51,031 56,017 62,075<br />

Unknown . . . * * * * * . . . *<br />

White 30,745 33,523 36,330 40,606 43,060 45,035 47,905 51,435 55,527 61,159 66,506 72,958<br />

Black 14,278 16,379 18,457 21,743 24,214 26,342 28,711 31,816 35,523 40,112 44,658 49,900<br />

Native American 259 351 421 555 625 723 820 942 1,114 1,280 1,442 1,632<br />

Asian 315 427 622 816 998 1,271 1,486 1,728 2,093 2,478 2,946 3,526<br />

Other/unknown 664 686 566 470 410 343 316 279 262 176 178 214<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 4,299 5,918 7,762 9,787 12,025 14,146 16,651 19,540 22,983 27,726 32,751 38,479<br />

Hypertension 7,953 10,094 12,584 15,250 17,518 19,550 21,924 24,722 27,901 32,059 35,803 40,234<br />

Glomerulonephritis 9,318 10,444 11,648 13,067 14,003 14,759 15,589 16,491 17,411 18,675 19,717 20,829<br />

Cystic kidney 3,009 3,332 3,709 4,141 4,346 4,512 4,578 4,734 4,858 4,969 5,038 5,244<br />

Other urologic 1,132 1,390 1,722 2,084 2,392 2,710 2,926 3,232 3,483 3,687 3,756 4,015<br />

Other cause 4,544 5,309 6,284 7,286 7,958 8,523 9,052 9,466 10,149 10,994 11,691 12,283<br />

Unknown cause 4,946 5,135 4,966 5,189 5,292 5,141 5,228 5,477 5,665 5,579 5,732 6,150<br />

Missing cause 11,060 9,744 7,721 7,386 5,773 4,373 3,290 2,538 2,069 1,516 1,242 996<br />

All 46,261 51,366 56,396 64,190 69,307 73,714 79,238 86,200 94,519 105,205 115,730 128,230<br />

The point prevalent cohorts are determined on December 31 of each calendar year without applying the 60-day stable modality rule.<br />

The age of the point prevalent patient is determined as of December 31 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


DTREATMENT MODALITIES<br />

Reference section D<br />

Table D.7 D.7 (continued)<br />

Counts of of prevalent ESRD patients, by by mode of of therapy: hemodialysis<br />

point<br />

point<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

384<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 29 46 51 57 50 45 46 48 58 55 49 50<br />

5-9 59 64 68 71 79 84 88 85 104 95 92 76<br />

10-14 176 177 205 203 190 184 214 211 242 262 286 266<br />

15-19 684 698 676 731 745 777 819 828 795 830 898 922<br />

20-29 5,732 5,895 6,185 6,392 6,699 6,932 7,288 7,464 7,594 7,635 7,638 7,656<br />

30-39 12,949 13,688 14,575 15,282 16,031 16,814 17,428 18,143 18,769 19,052 19,390 19,870<br />

40-49 18,953 20,743 22,667 24,911 27,478 29,459 31,915 33,775 35,430 36,806 38,044 39,242<br />

50-59 24,761 27,060 29,707 31,941 35,019 38,643 42,794 46,840 50,720 54,393 57,383 60,660<br />

60-64 16,629 17,898 19,211 20,530 22,111 23,822 25,861 27,365 28,847 30,348 32,188 34,027<br />

65-69 19,857 21,295 22,954 24,145 25,936 27,581 29,165 30,525 31,742 33,069 34,106 35,216<br />

70-79 31,487 34,595 38,894 42,341 46,631 51,341 55,217 58,434 61,305 63,186 65,336 66,549<br />

80+ 10,148 11,696 13,341 14,958 16,862 19,028 21,345 23,489 26,342 28,668 31,284 33,567<br />

Unknown * * * . . . . . . . . .<br />

0-19 948 985 1,000 1,062 1,064 1,090 1,167 1,172 1,199 1,242 1,325 1,314<br />

20-44 27,686 29,252 31,032 32,807 34,955 36,886 38,913 40,408 41,705 42,533 43,213 44,052<br />

45-64 51,338 56,032 61,313 66,249 72,383 78,784 86,373 93,179 99,655 105,701 111,430 117,403<br />

65-74 38,282 41,555 45,556 48,382 52,110 56,039 59,223 61,805 64,292 66,523 68,402 69,935<br />

75+ 23,210 26,031 29,633 33,062 37,319 41,911 46,504 50,643 55,097 58,400 62,324 65,397<br />

Unknown * * * . . . . . . . . .<br />

Male 72,934 79,589 87,253 93,985 103,060 112,551 122,282 130,934 139,283 146,681 154,168 160,865<br />

Female 68,531 74,265 81,280 87,575 94,768 102,156 109,896 116,269 122,662 127,715 132,521 137,217<br />

Unknown * * * * * * * * * * * 19<br />

White 79,590 85,513 93,310 99,396 107,943 117,184 126,401 134,872 143,451 150,467 156,777 162,538<br />

Black 55,658 61,098 66,835 72,311 78,461 84,733 91,449 96,614 101,363 105,430 109,958 114,006<br />

Native American 1,864 2,113 2,323 2,573 2,830 3,055 3,402 3,682 3,852 4,080 4,226 4,326<br />

Asian 4,063 4,781 5,464 6,093 6,792 7,529 8,318 9,153 9,942 10,730 11,545 12,139<br />

Other/unknown 293 351 603 1,189 1,805 2,209 2,610 2,886 3,340 3,692 4,188 5,092<br />

†Hispanic 21,348 24,300 27,073 29,897 33,109 35,992 38,760 41,859<br />

†Non-Hispanic 176,483 190,410 205,107 217,310 228,839 238,407 247,934 256,242<br />

Diabetes 44,594 50,389 57,205 64,557 73,253 82,648 91,679 99,259 107,482 114,486 121,056 126,961<br />

Hypertension 45,235 49,360 54,086 56,233 59,706 63,441 67,553 71,261 74,706 78,065 81,407 85,082<br />

Glomerulonephritis 21,948 23,182 24,699 25,923 27,566 29,088 30,675 31,930 32,592 33,243 33,688 33,769<br />

Cystic kidney 5,359 5,558 5,869 6,040 6,225 6,423 6,797 7,078 7,326 7,412 7,588 7,529<br />

Other urologic 4,170 4,116 4,265 4,820 5,411 5,931 6,381 6,997 7,366 7,592 7,900 8,076<br />

Other cause 13,007 13,742 14,711 16,088 17,351 18,578 20,056 21,116 22,389 23,067 23,979 24,927<br />

Unknown cause 6,489 6,872 7,284 7,513 7,968 8,311 8,792 9,327 9,876 10,301 10,720 11,165<br />

Missing cause 666 637 416 388 351 290 247 239 211 233 356 592<br />

All 141,468 153,856 168,535 181,562 197,831 214,710 232,180 247,207 261,948 274,399 286,694 298,101<br />

The point prevalent cohorts are determined on December 31 of each calendar year without applying the 60-day stable modality rule.<br />

The age of the point prevalent patient is determined as of December 31 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


TREATMENT MODALITIES<br />

2005 Annual <strong>Data</strong> ReportD<br />

Table D.8 D.8<br />

Counts of of prevalent ESRD patients, by by mode of of therapy: peritoneal dialysis<br />

point<br />

point<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 11 32 54 70 78 106 118 102 102 105 109 140<br />

5-9 * 20 44 70 86 72 90 89 87 114 118 107<br />

10-14 17 33 67 120 144 139 159 166 171 163 191 214<br />

15-19 11 39 91 126 158 231 216 239 242 291 300 328<br />

20-29 65 193 301 528 681 769 840 925 1,042 1,091 1,262 1,376<br />

30-39 146 378 620 1,010 1,328 1,647 1,722 1,880 2,084 2,332 2,731 3,072<br />

40-49 138 388 662 1,162 1,437 1,769 1,933 2,086 2,359 2,747 3,245 3,889<br />

50-59 227 651 956 1,488 1,945 2,268 2,469 2,625 2,726 3,096 3,562 4,009<br />

60-64 79 338 547 864 1,130 1,437 1,567 1,736 1,825 1,982 2,250 2,357<br />

65-69 89 253 434 608 889 1,198 1,441 1,569 1,714 1,928 2,196 2,613<br />

70-79 92 246 518 639 931 1,285 1,496 1,726 1,877 2,137 2,516 3,124<br />

80+ 13 49 95 112 155 208 255 310 355 433 516 627<br />

Unknown . . . * * * * * . . . .<br />

0-19 48 124 256 386 466 548 583 596 602 673 718 789<br />

20-44 275 760 1,229 2,080 2,694 3,245 3,530 3,856 4,299 4,762 5,612 6,396<br />

45-64 380 1,188 1,857 2,972 3,827 4,645 5,001 5,396 5,737 6,486 7,438 8,307<br />

65-74 148 417 787 1,021 1,507 2,050 2,400 2,648 2,931 3,275 3,782 4,582<br />

75+ 46 131 260 338 468 641 792 957 1,015 1,223 1,446 1,782<br />

Unknown . . . * * * * * . . . .<br />

385<br />

Male 466 1,351 2,298 3,707 4,797 5,934 6,458 7,070 7,640 8,641 9,950 11,560<br />

Female 431 1,269 2,091 3,091 4,167 5,197 5,850 6,385 6,944 7,778 9,046 10,296<br />

Unknown . . . . . . . * . . . .<br />

White 733 2,065 3,379 5,255 6,819 8,492 9,262 10,049 10,835 11,956 13,694 15,574<br />

Black 138 502 920 1,378 1,902 2,366 2,716 3,006 3,332 3,946 4,695 5,538<br />

Native American 13 19 36 63 111 113 149 182 176 191 229 265<br />

Asian * 20 43 67 106 133 156 200 221 309 359 455<br />

Other/unknown * 14 11 35 26 27 25 19 20 17 19 24<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 203 544 1,014 1,416 2,009 2,530 2,920 3,333 3,737 4,479 5,370 6,460<br />

Hypertension 169 496 929 1,295 1,720 2,224 2,626 2,892 3,240 3,765 4,601 5,429<br />

Glomerulonephritis 220 607 949 1,612 2,187 2,706 2,919 3,206 3,492 3,814 4,215 4,689<br />

Cystic kidney 64 177 302 454 583 718 803 828 822 877 1,007 1,129<br />

Other urologic 24 85 143 204 286 351 361 382 421 467 509 548<br />

Other cause 105 304 555 916 1,200 1,527 1,625 1,765 1,873 2,075 2,311 2,565<br />

Unknown cause 80 228 325 466 556 617 674 699 700 735 817 899<br />

Missing cause 32 179 172 435 423 458 380 351 299 207 166 137<br />

All 897 2,620 4,389 6,798 8,964 11,131 12,308 13,456 14,584 16,419 18,996 21,856<br />

The point prevalent cohorts are determined on December 31 of each calendar year without applying the 60-day stable modality rule.<br />

The age of the point prevalent patient is determined as of December 31 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


DTREATMENT MODALITIES<br />

Reference section D<br />

Table D.8 D.8 (continued)<br />

Counts of prevalent ESRD patients, by mode of of therapy: peritoneal dialysis<br />

point<br />

point<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

386<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 149 148 153 161 169 151 167 162 181 167 176 187<br />

5-9 98 105 135 132 131 135 113 120 133 137 140 140<br />

10-14 208 208 217 210 219 228 225 205 231 237 269 246<br />

15-19 349 362 354 345 373 356 334 329 317 319 303 319<br />

20-29 1,489 1,619 1,670 1,658 1,616 1,579 1,477 1,366 1,345 1,335 1,251 1,250<br />

30-39 3,383 3,697 3,903 3,850 3,679 3,394 3,158 3,104 2,928 2,891 2,843 2,801<br />

40-49 4,343 4,797 5,224 5,585 5,500 5,273 4,909 4,735 4,613 4,470 4,409 4,473<br />

50-59 4,573 5,022 5,627 5,973 6,060 5,925 5,686 5,675 5,614 5,722 5,739 5,900<br />

60-64 2,705 2,807 3,033 3,238 3,129 2,989 2,742 2,614 2,570 2,521 2,596 2,799<br />

65-69 2,890 3,218 3,383 3,466 3,337 3,053 2,763 2,669 2,588 2,589 2,592 2,588<br />

70-79 3,633 4,115 4,510 4,631 4,539 4,380 4,139 3,919 3,775 3,772 3,836 3,911<br />

80+ 727 845 986 1,045 1,037 1,049 969 987 978 1,067 1,125 1,211<br />

Unknown . . * . . . . . . . . .<br />

0-19 804 823 859 848 892 870 839 816 862 860 888 892<br />

20-44 7,007 7,633 8,039 8,130 7,846 7,446 6,850 6,645 6,361 6,254 6,018 6,047<br />

45-64 9,486 10,309 11,418 12,174 12,138 11,714 11,122 10,849 10,709 10,685 10,820 11,176<br />

65-74 5,181 5,871 6,280 6,358 6,142 5,685 5,284 5,039 4,811 4,770 4,799 4,899<br />

75+ 2,069 2,307 2,599 2,784 2,771 2,797 2,587 2,536 2,530 2,658 2,754 2,811<br />

Unknown . . * . . . . . . . . .<br />

Male 12,879 14,121 15,209 15,716 15,295 14,553 13,567 13,135 12,913 12,792 12,938 13,189<br />

Female 11,668 12,822 13,987 14,578 14,494 13,959 13,115 12,750 12,360 12,435 12,341 12,635<br />

Unknown . . . . . . . . . . . *<br />

White 17,371 18,720 20,019 20,610 20,103 19,169 17,756 17,201 16,708 16,678 16,630 16,896<br />

Black 6,217 7,052 7,738 7,950 7,820 7,454 7,066 6,842 6,646 6,561 6,582 6,749<br />

Native American 328 336 370 385 364 366 343 304 326 337 346 339<br />

Asian 602 798 1,003 1,187 1,234 1,217 1,212 1,216 1,269 1,303 1,347 1,429<br />

Other/unknown 29 37 66 162 268 306 305 322 324 348 374 412<br />

†Hispanic 2,950 2,964 2,897 2,992 3,033 3,040 3,237 3,336<br />

†Non-Hispanic 26,839 25,548 23,785 22,893 22,240 22,187 22,042 22,489<br />

Diabetes 7,640 8,336 9,330 9,995 10,117 9,788 9,167 8,899 8,751 8,788 8,836 9,006<br />

Hypertension 6,095 6,825 7,430 7,389 6,902 6,476 6,000 5,909 5,778 5,633 5,786 6,013<br />

Glomerulonephritis 5,097 5,541 5,955 6,214 6,207 5,945 5,548 5,219 5,084 4,959 4,864 4,882<br />

Cystic kidney 1,251 1,353 1,412 1,463 1,444 1,332 1,228 1,199 1,148 1,173 1,097 1,168<br />

Other urologic 611 661 688 747 748 758 733 739 744 766 794 794<br />

Other cause 2,794 3,044 3,158 3,268 3,185 3,056 2,919 2,903 2,775 2,898 2,914 2,942<br />

Unknown cause 966 1,105 1,173 1,173 1,152 1,128 1,061 988 968 993 956 958<br />

Missing cause 93 78 50 45 34 29 26 29 25 17 32 62<br />

All 24,547 26,943 29,196 30,294 29,789 28,512 26,682 25,885 25,273 25,227 25,279 25,825<br />

The point prevalent cohorts are determined on December 31 of each calendar year without applying the 60-day stable modality rule.<br />

The age of the point prevalent patient is determined as of December 31 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


TREATMENT MODALITIES<br />

2005 Annual <strong>Data</strong> ReportD<br />

Table D.9 D.9<br />

Counts of prevalent ESRD patients, by mode of of therapy: functioning transplant<br />

point<br />

point<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 31 47 75 89 100 126 135 173 177 175 164 175<br />

5-9 114 131 159 173 222 290 341 377 407 465 503 561<br />

10-14 303 337 383 429 491 536 565 616 662 724 773 813<br />

15-19 704 791 842 937 1,005 1,095 1,221 1,318 1,345 1,348 1,364 1,383<br />

20-29 2,670 3,225 3,764 4,265 4,747 5,286 5,878 6,227 6,460 6,626 6,967 7,217<br />

30-39 2,848 3,755 4,640 5,681 6,916 8,253 9,661 10,755 11,784 12,731 13,795 14,780<br />

40-49 1,977 2,483 3,142 3,879 4,734 5,898 7,282 8,754 10,189 11,636 13,021 14,779<br />

50-59 1,194 1,542 1,974 2,455 3,132 3,857 4,929 5,966 6,956 7,945 9,063 10,128<br />

60-64 170 235 315 426 602 835 1,176 1,580 2,072 2,527 3,001 3,502<br />

65-69 59 72 94 121 168 257 378 589 826 1,085 1,393 1,757<br />

70-79 17 25 29 39 54 80 114 179 245 328 470 674<br />

80+ * * * * * 12 17 16 17 17 25 32<br />

Unknown * * * * * * * * * * * *<br />

0-19 1,152 1,306 1,459 1,628 1,818 2,047 2,262 2,484 2,591 2,712 2,804 2,932<br />

20-44 6,584 8,344 10,144 12,075 14,260 16,739 19,545 21,751 23,757 25,708 27,966 30,089<br />

45-64 2,275 2,896 3,691 4,631 5,871 7,390 9,381 11,531 13,704 15,757 17,881 20,317<br />

65-74 73 89 116 152 213 322 470 729 1,018 1,343 1,772 2,316<br />

75+ * * 11 * 14 27 39 55 70 87 116 147<br />

Unknown * * * * * * * * * * * *<br />

387<br />

Male 6,031 7,657 9,408 11,299 13,567 16,276 19,435 22,374 25,022 27,621 30,486 33,509<br />

Female 4,061 4,989 6,014 7,197 8,608 10,247 12,260 14,172 16,108 17,976 20,045 22,284<br />

Unknown * * * * * * * * 11 11 * *<br />

White 8,171 10,266 12,475 14,890 17,815 21,208 25,283 29,118 32,662 36,291 40,174 44,312<br />

Black 1,542 1,937 2,413 2,949 3,544 4,348 5,226 5,997 6,742 7,342 8,089 8,934<br />

Native American 71 93 116 136 176 219 259 297 358 427 472 540<br />

Asian 89 123 184 258 356 440 590 752 935 1,095 1,322 1,515<br />

Other/unknown 220 229 236 266 288 313 342 388 444 453 484 502<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 847 1,225 1,705 2,268 2,931 3,844 4,978 5,983 6,958 8,052 9,210 10,475<br />

Hypertension 1,004 1,308 1,679 2,153 2,623 3,272 3,982 4,676 5,363 5,980 6,761 7,471<br />

Glomerulonephritis 3,391 4,236 5,179 6,162 7,403 8,761 10,266 11,717 13,095 14,378 15,818 17,378<br />

Cystic kidney 428 576 741 932 1,210 1,512 1,945 2,423 2,887 3,314 3,797 4,277<br />

Other urologic 409 544 653 800 941 1,118 1,301 1,484 1,655 1,832 2,010 2,215<br />

Other cause 1,698 2,133 2,592 3,143 3,811 4,522 5,412 6,113 6,631 7,210 7,803 8,545<br />

Unknown cause 853 1,049 1,214 1,357 1,529 1,724 1,941 2,174 2,375 2,595 2,799 3,017<br />

Missing cause 1,463 1,577 1,661 1,684 1,731 1,775 1,875 1,982 2,177 2,247 2,343 2,425<br />

All 10,093 12,648 15,424 18,499 22,179 26,528 31,700 36,552 41,141 45,608 50,541 55,803<br />

The point prevalent cohorts are determined on December 31 of each calendar year without applying the 60-day stable modality rule.<br />

The age of the point prevalent patient is determined as of December 31 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


DTREATMENT MODALITIES<br />

Reference section D<br />

Table D.9 D.9 (continued)<br />

Counts of prevalent ESRD patients, by mode of of therapy: functioning transplant<br />

point<br />

point<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

388<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 192 201 198 185 215 210 213 236 244 262 265 258<br />

5-9 565 590 583 608 623 685 679 701 657 697 708 759<br />

10-14 879 931 1,007 1,092 1,159 1,156 1,226 1,278 1,304 1,305 1,357 1,373<br />

15-19 1,401 1,473 1,643 1,767 1,803 1,897 1,933 2,072 2,162 2,199 2,227 2,372<br />

20-29 7,307 7,395 7,364 7,428 7,580 7,675 7,727 7,754 7,742 7,764 7,842 7,963<br />

30-39 15,627 16,462 17,239 17,955 18,506 18,829 19,319 19,510 19,824 20,001 20,118 20,018<br />

40-49 16,459 18,252 19,976 21,789 23,310 24,625 26,120 27,487 28,995 30,224 31,330 32,426<br />

50-59 11,496 12,931 14,338 15,762 17,505 19,771 22,034 24,284 26,527 29,019 31,449 33,825<br />

60-64 3,970 4,416 4,905 5,494 6,201 6,876 7,687 8,486 9,276 10,218 11,404 12,650<br />

65-69 2,201 2,704 3,162 3,649 4,189 4,710 5,237 5,869 6,515 7,276 8,065 8,989<br />

70-79 901 1,133 1,447 1,790 2,176 2,687 3,235 3,764 4,496 5,196 6,147 7,039<br />

80+ 32 37 49 58 85 97 129 179 231 291 372 458<br />

Unknown * * * * * * * * * * * *<br />

0-19 3,037 3,195 3,431 3,652 3,800 3,948 4,051 4,287 4,367 4,463 4,557 4,762<br />

20-44 31,774 33,498 34,893 36,456 37,686 38,707 39,917 40,824 41,591 42,248 42,835 43,206<br />

45-64 23,085 25,958 28,929 31,972 35,416 39,069 42,970 46,697 50,773 54,978 59,308 63,676<br />

65-74 2,966 3,659 4,373 5,104 5,937 6,840 7,766 8,763 9,962 11,224 12,666 14,172<br />

75+ 168 215 285 393 513 654 835 1,049 1,280 1,539 1,918 2,314<br />

Unknown * * * * * * * * * * * *<br />

Male 36,554 39,752 42,917 46,314 49,649 53,155 56,768 60,341 64,086 67,890 71,933 75,969<br />

Female 24,468 26,766 28,988 31,255 33,695 36,054 38,762 41,271 43,878 46,553 49,342 52,150<br />

Unknown * * * * * * * * * * * 12<br />

White 48,350 52,619 56,441 60,496 64,660 68,906 73,585 78,031 82,677 87,320 92,341 97,007<br />

Black 9,797 10,714 11,902 13,165 14,425 15,642 16,828 17,989 19,184 20,509 21,825 23,271<br />

Native American 590 640 722 785 836 893 957 1,050 1,114 1,162 1,219 1,269<br />

Asian 1,789 2,035 2,323 2,598 2,883 3,202 3,560 3,898 4,280 4,665 5,052 5,528<br />

Other/unknown 506 520 525 535 550 576 610 653 719 797 848 1,056<br />

†Hispanic 7,261 8,007 8,971 9,872 10,842 11,891 13,107 14,309<br />

†Non-Hispanic 76,093 81,212 86,569 91,749 97,132 102,562 108,178 113,822<br />

Diabetes 11,622 13,146 14,543 16,021 17,598 19,092 20,714 22,227 23,812 25,473 27,295 28,940<br />

Hypertension 8,323 9,167 10,143 11,102 12,037 12,896 13,772 14,549 15,389 16,388 17,431 18,391<br />

Glomerulonephritis 18,851 20,225 21,567 23,017 24,444 25,949 27,591 29,177 30,807 32,292 33,952 35,581<br />

Cystic kidney 4,831 5,316 5,773 6,341 6,882 7,522 8,178 8,774 9,418 10,104 10,826 11,663<br />

Other urologic 2,399 2,626 2,784 3,024 3,240 3,481 3,725 3,935 4,149 4,409 4,678 4,949<br />

Other cause 9,259 10,022 10,727 11,444 12,234 12,997 13,828 14,654 15,513 16,343 17,194 18,024<br />

Unknown cause 3,241 3,491 3,750 3,938 4,145 4,417 4,682 5,015 5,323 5,716 6,087 6,489<br />

Missing cause 2,506 2,535 2,626 2,692 2,774 2,865 3,050 3,290 3,563 3,728 3,822 4,094<br />

All 61,032 66,528 71,913 77,579 83,354 89,219 95,540 101,621 107,974 114,453 121,285 128,131<br />

The point prevalent cohorts are determined on December 31 of each calendar year without applying the 60-day stable modality rule.<br />

The age of the point prevalent patient is determined as of December 31 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


ON OUR WEBSITE & CD<br />

Incident ESRD patients, 1995 & 1999: by age, gender, race/ethnicity, primary<br />

diagnosis, & modality (Table D.10.1).<br />

TREATMENT MODALITIES<br />

2005 Annual <strong>Data</strong> ReportD<br />

Table D.10 D.10<br />

Incident ESRD patients, 2003: by by age, gender, race/ethnicity, primary diagnosis, & modality<br />

Center Center Home Uncertain<br />

hemo self hemo hemo CAPD CCPD Other PD dialysis Transplant All<br />

0-4 44 . . * 110 . * 39 207<br />

5-9 43 . . 13 41 * * 51 153<br />

10-14 161 . . 14 111 * * 51 340<br />

15-19 441 * . 23 81 * * 88 637<br />

20-29 2,137 * * 160 73 * * 166 2,545<br />

30-39 4,877 . * 404 167 * * 287 5,760<br />

40-49 10,089 * 25 668 324 22 26 480 11,638<br />

50-59 16,964 * 33 1,055 452 31 47 546 19,133<br />

60-64 10,271 * 18 550 210 24 15 174 11,263<br />

65-69 11,204 * 22 551 195 41 31 131 12,180<br />

70-79 23,523 13 46 802 265 96 74 53 24,872<br />

80+ 13,288 * 40 311 100 62 27 * 13,839<br />

Unknown<br />

389<br />

0-19 689 * . 60 343 * * 229 1,337<br />

20-44 11,224 * 22 845 374 19 28 657 13,172<br />

45-64 33,114 * 65 1,992 852 65 75 996 37,167<br />

65-74 22,862 13 45 1,021 330 82 71 175 24,599<br />

75+ 25,153 14 63 643 230 117 61 11 26,292<br />

Unknown<br />

Male 50,415 23 98 2,408 1,154 163 131 1,192 55,584<br />

Female 42,607 16 97 2,152 974 126 109 874 46,955<br />

Unknown 20 . . * * . * * 28<br />

White 59,305 28 124 3,229 1,475 227 187 1,712 66,287<br />

Black 27,545 * 64 973 493 52 35 187 29,357<br />

Native American 1,016 . . 47 16 * * 13 1,097<br />

Asian 3,217 * * 245 71 * * 58 3,608<br />

Other/unknown 1,959 . * 67 74 * 14 98 2,218<br />

Hispanic 12,255 * 24 464 312 36 22 142 13,258<br />

Non-Hispanic 80,787 36 171 4,097 1,817 253 222 1,926 89,309<br />

Diabetes 41,844 17 79 2,016 792 114 101 367 45,330<br />

Hypertension 26,474 12 67 1,081 387 91 39 168 28,319<br />

Glomerulonephritis 7,010 * 11 596 365 24 17 359 8,384<br />

Cystic kidney 1,619 * * 226 124 * 11 305 2,291<br />

Other urologic 2,502 . * 117 61 12 * 124 2,827<br />

Other cause 9,160 * 20 374 290 32 27 283 10,192<br />

Unknown cause 3,859 . 15 125 94 * * 102 4,209<br />

Missing cause 574 . * 26 16 * 34 360 1,015<br />

All 93,042 39 195 4,561 2,129 289 244 2,068 102,567<br />

The incident cohorts and associated modalities are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


DTREATMENT MODALITIES<br />

Reference section D<br />

ON OUR WEBSITE & CD<br />

Prevalent ESRD patients, 1995 & 1999 (Table D.11.1). Counts of incident ESRD patients<br />

for selected years (Table D.a). Living ESRD patients on December 31 for selected<br />

years (D.b). Incident ESRD patients for selected years (D.c). Living ESRD patients on<br />

December 31 for selected years, by age & ESRD network of residence (D.d).<br />

Table D.11 D.11<br />

Prevalent ESRD patients, 2003: by by age, gender, race/ethnicity, primary diagnosis, && modality<br />

390<br />

Center Center Home Uncertain<br />

hemo self hemo hemo CAPD CCPD Other PD dialysis Transplant All<br />

0-4 49 . * 16 171 * * 258 502<br />

5-9 75 . * 24 116 * * 759 982<br />

10-14 259 . * 18 228 . 17 1,373 1,902<br />

15-19 915 . * 45 274 * 33 2,372 3,647<br />

20-29 7,623 * 32 470 780 * 76 7,963 16,948<br />

30-39 19,744 25 101 1,224 1,577 * 141 20,018 42,832<br />

40-49 38,982 52 208 2,027 2,446 * 178 32,426 76,325<br />

50-59 60,327 43 290 2,832 3,068 11 163 33,825 100,559<br />

60-64 33,864 22 141 1,383 1,416 13 71 12,650 49,560<br />

65-69 35,077 16 123 1,092 1,496 * 43 8,989 46,843<br />

70-79 66,253 25 271 1,650 2,261 12 68 7,039 77,579<br />

80+ 33,415 * 143 500 711 * 31 458 35,277<br />

Unknown . . . . . . . * *<br />

0-19 1,298 . 16 103 789 * 62 4,762 7,033<br />

20-44 43,792 44 216 2,586 3,461 * 293 43,206 93,605<br />

45-64 116,748 99 556 5,350 5,826 28 336 63,676 192,619<br />

65-74 69,647 33 255 2,071 2,828 15 84 14,172 89,105<br />

75+ 65,098 17 282 1,171 1,640 14 58 2,314 70,594<br />

Unknown . . . . . . . * *<br />

Male 159,959 119 787 5,504 7,685 36 464 75,969 250,523<br />

Female 136,605 74 538 5,777 6,858 31 367 52,150 202,400<br />

Unknown 19 . . . * . * 12 34<br />

White 161,522 112 904 7,251 9,645 42 565 97,007 277,048<br />

Black 113,568 73 365 2,958 3,791 12 207 23,271 144,245<br />

Native American 4,316 * * 170 169 * * 1,269 5,943<br />

Asian 12,094 * 40 737 692 * 32 5,528 19,129<br />

Other/unknown 5,083 * * 165 247 11 21 1,056 6,592<br />

Hispanic 41,753 11 95 1,345 1,991 18 86 14,309 59,608<br />

Non-Hispanic 254,830 182 1,230 9,936 12,553 49 747 113,822 393,349<br />

Diabetes 126,489 50 422 4,161 4,845 16 190 28,940 165,113<br />

Hypertension 84,698 52 332 2,695 3,318 18 138 18,391 109,642<br />

Glomerulonephritis 33,450 51 268 2,031 2,851 * 206 35,581 74,444<br />

Cystic kidney 7,466 14 49 534 634 * 48 11,663 20,409<br />

Other urologic 8,028 * 46 319 475 * 38 4,949 13,861<br />

Other cause 24,764 21 142 1,092 1,850 17 112 18,024 46,022<br />

Unknown cause 11,100 * 62 416 542 * 39 6,489 18,656<br />

Missing cause 588 . * 33 29 . 62 4,094 4,810<br />

All 296,583 193 1,325 11,281 14,544 67 833 128,131 452,957<br />

The point prevalent cohorts are determined on December 31 of each calendar year without applying the 60-day stable modality rule.<br />

The age of point prevalent patients determined as of December 31 of each cohort year.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


ON OUR WEBSITE & CD<br />

Treatment status two years after first ESRD service, 1999-2001<br />

(Tables D.12.1-18).<br />

TREATMENT MODALITIES<br />

2005 Annual <strong>Data</strong> ReportD<br />

Table D.12 D.12<br />

Treatment status two years after first ESRD service, 1999-2001<br />

incident<br />

incident<br />

patients<br />

patients<br />

with<br />

with<br />

Medicare<br />

Medicare<br />

coverage,<br />

coverage,<br />

1999-2001<br />

1999-2001<br />

combined<br />

combined<br />

Treatment status two years after first ESRD service (percent of patients)<br />

Center Home CAPD & Oth/unk Lost to<br />

ALL % on Day 90 Count hemo hemo CCPD dialysis Transplant Death Followup<br />

Age at first service<br />

0-19 1,397 29.5 0.1 16.6 0.8 45.8 5.6 1.6<br />

20-44 19,478 58.9 0.1 9.2 0.1 14.7 15.2 1.8<br />

45-64 49,796 61.1 0.2 5.8 . 5.3 26.2 1.3<br />

65-74 48,482 52.4 0.2 4.3 . 1.9 39.4 1.7<br />

75+ 44,950 42.6 0.1 1.9 . 0.1 53.9 1.2<br />

Modality on day 90<br />

Center hemodialysis 145,971 56.9 0.1 1.5 . 2.9 36.9 1.6<br />

Home hemodialysis 494 29.8 14.6 2.4 . 3.0 49.0 1.2<br />

CAPD/CCPD 13,839 19.1 0.2 39.8 0.1 8.5 31.8 0.5<br />

Other/unknown dialysis 2,086 49.6 0.1 5.7 1.0 1.9 39.1 2.5<br />

Transplant 1,713 1.5 . 0.3 0.2 94.0 3.9 0.1<br />

391<br />

Interaction of age at first service & modality on day 90<br />

0-19 Center hemodialysis 715 49.5 0.1 6.2 0.7 35.2 6.3 2.0<br />

Home hemodialysis * 25.0 . 25.0 . 25.0 25.0 .<br />

CAPD/CCPD 480 10.8 0.2 38.5 0.6 42.1 6.0 1.7<br />

Other/unknown dialysis * 22.2 . 22.2 11.1 22.2 22.2 .<br />

Transplant 189 1.6 . . 1.1 96.8 0.5 .<br />

20-44 Center hemodialysis 16,326 66.7 0.1 3.8 . 11.0 16.3 2.0<br />

Home hemodialysis 47 44.7 19.1 8.5 . 12.8 10.6 4.3<br />

CAPD/CCPD 2,443 21.9 0.2 47.3 0.2 19.1 10.8 0.5<br />

Other/unknown dialysis 54 38.9 . 9.3 11.1 18.5 22.2 .<br />

Transplant 608 1.5 . 0.7 0.2 94.7 2.8 0.2<br />

45-64 Center hemodialysis 44,037 66.4 0.1 1.9 . 3.7 26.5 1.4<br />

Home hemodialysis 160 38.1 21.9 2.5 . 4.4 31.9 1.3<br />

CAPD/CCPD 4,637 21.3 0.3 43.8 . 8.3 26.0 0.3<br />

Other/unknown dialysis 329 50.8 0.3 6.4 1.8 3.3 31.6 5.8<br />

Transplant 633 1.4 . 0.2 . 93.4 5.1 .<br />

65-74 Center hemodialysis 43,265 55.9 0.1 1.3 . 1.3 39.5 1.8<br />

Home hemodialysis 115 25.2 12.2 1.7 . 0.9 60.0 .<br />

CAPD/CCPD 3,950 18.3 0.3 37.3 . 3.0 40.6 0.5<br />

Other/unknown dialysis 882 53.2 0.2 6.7 0.6 1.7 34.5 3.2<br />

Transplant 270 1.9 . . . 92.6 5.6 .<br />

75+ Center hemodialysis 41,628 44.2 0.1 0.4 . 0.1 53.9 1.3<br />

Home hemodialysis 168 20.8 8.3 0.6 . . 69.0 1.2<br />

CAPD/CCPD 2,329 14.9 0.1 28.4 . 0.3 55.8 0.4<br />

Other/unknown dialysis 812 46.3 . 3.8 0.4 0.2 48.5 0.7<br />

Transplant 13 . . . . 84.6 15.4 .<br />

All 164,103 53.0 0.2 4.8 . 4.3 36.2 1.5<br />

The incident cohorts and associated modalities are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Includes only incident patients with known age & patients who have Medicare as their primary payor,<br />

are receiving their first ESRD service, & survive the first 90 days.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


DTREATMENT MODALITIES<br />

Reference section D<br />

Table D.13 D.13<br />

Prevalent ESRD patients, 2003: by by patient vintage<br />

point<br />

point<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

on<br />

on<br />

December<br />

December<br />

31,<br />

31,<br />

by<br />

by<br />

year-end<br />

year-end<br />

treatment<br />

treatment<br />

modality<br />

modality &<br />

number<br />

number<br />

of<br />

of<br />

years<br />

years<br />

patient<br />

patient<br />

has<br />

has<br />

had<br />

had<br />

ESRD<br />

ESRD<br />

(vintage)<br />

(vintage)<br />

392<br />

Functioning Center Center Home Uncertain<br />

Dialysis graft hemo self hemo hemo CAPD CCPD Other PD dialysis All<br />

0 84,834 3,367 77,061 26 272 3,884 3,389 32 170 88,201<br />

1 62,008 5,962 56,135 14 147 2,428 3,178 17 89 67,970<br />

2 44,734 7,864 40,498 21 137 1,607 2,372 * 98 52,598<br />

3 32,865 9,164 30,133 20 138 860 1,666 * 44 42,029<br />

4 24,428 9,875 22,669 11 95 571 1,042 * 38 34,303<br />

5 17,536 9,926 16,308 17 60 425 677 * 45 27,462<br />

6 12,666 9,402 11,833 14 58 288 435 . 38 22,068<br />

7 9,358 8,793 8,717 * 54 211 312 * 54 18,151<br />

8 6,983 8,052 6,503 * 34 170 241 . 26 15,035<br />

9 5,475 7,313 5,050 * 29 144 211 * 33 12,788<br />

10 4,294 6,553 3,937 * 29 124 166 * 34 10,847<br />

11 3,460 5,891 3,169 * 25 96 136 . 28 9,351<br />

12 2,691 5,054 2,452 * 23 88 103 . 23 7,745<br />

13 2,279 4,466 2,075 * 19 62 101 . 18 6,745<br />

14 1,944 3,783 1,765 * 12 54 87 . 25 5,727<br />

15 1,629 3,331 1,477 * * 45 80 * 11 4,960<br />

16 1,245 2,881 1,114 * 21 41 59 . * 4,126<br />

17 1,063 2,499 941 * 13 39 59 . * 3,562<br />

18 879 2,143 779 * 14 22 53 * * 3,022<br />

19 789 1,929 701 * 20 18 40 * * 2,718<br />

20 666 1,717 609 * 14 17 21 . * 2,383<br />

21 580 1,580 526 * 16 13 20 . * 2,160<br />

22 447 1,288 391 * 14 18 17 . * 1,735<br />

23 388 1,122 354 * * * 15 . * 1,510<br />

24 377 918 334 . 17 * 19 . * 1,295<br />

25 286 862 255 * * * 12 . * 1,148<br />

26 312 832 272 * 15 12 11 . * 1,144<br />

27 146 402 136 . . * * . * 548<br />

28 146 314 123 * * * * . * 460<br />

29 128 269 105 . * * * . * 397<br />

30 86 243 71 . * * * . * 329<br />

31 42 110 35 . * * * . * 152<br />

32 23 86 21 . * . . . * 109<br />

33 * 38 * . . * * . . 48<br />

34 15 53 14 . . . * . . 68<br />

35 * 23 * . * . * . . 32<br />

36 * 26 * . . . . . . 31<br />

All 324,826 128,131 296,583 193 1,325 11,281 14,544 67 833 452,957<br />

The point prevalent cohorts & associated modalities are determined on December 31 of each calendar year<br />

without applying the 60-day stable modality rule.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


TREATMENT MODALITIES<br />

2005 Annual <strong>Data</strong> ReportD<br />

Table D.14 D.14<br />

Prevalent ESRD patients, 2003: by by number of of years on on modality<br />

point<br />

point<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

on<br />

on<br />

December<br />

December<br />

31,<br />

31,<br />

by<br />

by<br />

year-end<br />

year-end<br />

treatment<br />

treatment<br />

modality<br />

modality<br />

Functioning Center Center Home Uncertain<br />

Dialysis graft hemo self hemo hemo CAPD CCPD Other PD dialysis All<br />

0 205,057 15,068 186,796 139 970 6,980 9,449 36 687 220,125<br />

1 62,106 13,949 56,167 36 198 2,406 3,211 18 70 76,055<br />

2 28,272 12,783 25,877 11 77 1,111 1,152 * 40 41,055<br />

3 12,678 11,403 11,910 * 30 328 403 * * 24,081<br />

4 7,128 10,211 6,707 . 23 202 189 * * 17,339<br />

5 3,737 9,339 3,576 * * 75 71 . * 13,076<br />

6 2,275 7,924 2,176 * * 52 34 * * 10,199<br />

7 1,314 6,948 1,248 . * 42 20 * * 8,262<br />

8 1,144 6,160 1,094 . * 35 * * * 7,304<br />

9 359 5,091 347 . . * * . . 5,450<br />

10 186 4,536 169 . . 15 * . * 4,722<br />

11 128 3,667 125 . . * . . . 3,795<br />

12 108 3,441 98 . * * * . * 3,549<br />

13 73 2,858 71 . . * . . . 2,931<br />

14 58 2,447 51 . . * . . * 2,505<br />

15 36 2,063 31 . . * * * . 2,099<br />

16 34 1,805 32 . . * . . . 1,839<br />

17 22 1,665 22 . . . . . . 1,687<br />

18 17 1,249 15 . . * . . . 1,266<br />

19 * 1,092 * . * . . * . 1,102<br />

20 15 982 13 . . * . . . 997<br />

21 11 795 * . * . . . . 806<br />

22 * 657 * . * * . . . 667<br />

23 * 530 * . . . . . . 535<br />

24 * 455 * . . . . . . 465<br />

25 * 380 * . * . . . . 386<br />

26 * 267 * . . . . . . 274<br />

27 * 78 * . . . . . . 79<br />

28 * 85 * . . . . . * 90<br />

29 * 56 . . . . . . * 61<br />

30 * 55 * . . . . . * 62<br />

31 * 39 . . . . . . * 40<br />

32 * 24 . . . . . . * 25<br />

33 . 11 . . . . . . . 11<br />

34 . 18 . . . . . . . 18<br />

393<br />

All 324,826 128,131 296,583 193 1,325 11,281 14,544 67 833 452,957<br />

The point prevalent cohorts and associated modalities are determined on December 31 of each calendar year<br />

without applying the 60-day stable modality rule.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


DTREATMENT MODALITIES<br />

Reference section D<br />

Table D.15 D.15<br />

Incident ESRD patients, 2003: by by modality & state/territory<br />

incident<br />

incident<br />

ESRD<br />

ESRD<br />

patients<br />

patients<br />

ON OUR WEBSITE & CD<br />

Incident ESRD patients for selected years: by state (Table D.e).<br />

394<br />

Center Center Home Uncertain<br />

hemo self hemo hemo CAPD CCPD Other PD dialysis Transplant All<br />

Alabama 1,693 * . 107 21 * * 33 1,859<br />

Alaska 81 . . 11 * . . * 98<br />

Arizona 1,759 * . 78 15 * * 28 1,886<br />

Arkansas 799 * . 73 25 * * 11 917<br />

California 11,090 * * 637 161 11 42 143 12,089<br />

Colorado 760 . . 40 * . . 23 828<br />

Connecticut 779 . . 109 50 . * 22 962<br />

Delaware 331 . . 11 * . . * 349<br />

District of Columbia 425 . . 14 * * . * 451<br />

Florida 5,779 * 74 249 117 32 18 74 6,344<br />

Georgia 3,056 . * 186 73 * * 34 3,359<br />

Hawaii 449 . * 32 * . . * 489<br />

Idaho 227 . . 28 * * * * 267<br />

Illinois 4,184 . 47 248 95 14 * 103 4,698<br />

Indiana 1,787 * * 149 15 * * 36 2,001<br />

Iowa 666 . . 37 13 . * 30 750<br />

Kansas 634 * . 58 * * * 17 724<br />

Kentucky 1,188 . * 79 28 15 . 19 1,330<br />

Louisiana 2,265 . . 70 19 * * 25 2,385<br />

Maine 301 . . 14 * * . * 326<br />

Maryland 2,157 * . 90 60 * 19 52 2,380<br />

Massachusetts 1,594 . . 72 55 * * 50 1,777<br />

Michigan 3,225 . * 256 37 * * 86 3,616<br />

Minnesota 1,013 . . 47 21 * * 98 1,183<br />

Mississippi 1,184 . * 59 52 * . 19 1,323<br />

Missouri 1,781 . * 111 52 * * 23 1,981<br />

Montana 156 . . 23 * * . * 190<br />

Nebraska 430 . . 32 * . . 23 490<br />

Nevada 660 . . 43 * * * * 728<br />

New Hampshire 247 . . 19 * . * * 282<br />

New Jersey 3,145 . . 74 80 11 * 74 3,390<br />

New Mexico 534 . . 40 20 . . * 600<br />

New York 6,436 . * 188 93 55 * 125 6,913<br />

North Carolina 2,967 * * 96 98 * * 35 3,207<br />

North Dakota 132 . . 11 * * . 15 164<br />

Ohio 4,054 * 11 232 79 * 11 86 4,482<br />

Oklahoma 1,135 * . 53 29 23 . 18 1,259<br />

Oregon 790 . * 65 16 . * 29 902<br />

Pennsylvania 4,194 * * 95 128 * * 61 4,492<br />

Rhode Island 305 . * 13 . * * 11 338<br />

South Carolina 1,675 * . 65 63 . * 20 1,826<br />

South Dakota 227 . . 11 * . * * 253<br />

Tennessee 1,869 . . 59 94 * * 27 2,055<br />

Texas 7,158 . 17 237 219 38 14 88 7,771<br />

Utah 309 . * 22 * * * 19 365<br />

Vermont 127 . . * * . * * 139<br />

Virginia 2,450 . * 109 34 12 * 63 2,675<br />

Washington 1,311 19 * 75 11 * * 33 1,462<br />

West Virginia 627 . * 31 33 * * 15 709<br />

Wisconsin 1,423 . . 75 50 * * 73 1,633<br />

Wyoming 75 . . * * * . * 89<br />

American Samoa 20 . . . . . . . 20<br />

Guam 89 . . * . . * . 93<br />

Puerto Rico 1,185 . . * 91 * . * 1,295<br />

Saipan 19 . . . . . . . 19<br />

Virgin Islands 39 . . * * . . . 43<br />

Foreign 16 . . . . . . . 16<br />

Unknown 31 . . * * . 12 248 295<br />

All 93,042 39 195 4,561 2,129 289 244 2,068 102,567<br />

The incident cohorts and associated modalities are determined at the time of ESRD initiation without applying the 60-day stable modality rule.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


ON OUR WEBSITE & CD<br />

Living ESRD patients on December 31 for selected years: by state (Table D.f).<br />

TREATMENT MODALITIES<br />

2005 Annual <strong>Data</strong> ReportD<br />

Table D.16 D.16<br />

Prevalent ESRD patients, 2003: by by modality & state/territory<br />

point<br />

point<br />

prevalent<br />

prevalent<br />

ESRD<br />

ESRD<br />

patients<br />

patients<br />

on<br />

on<br />

December<br />

December<br />

31<br />

31<br />

Center Center Home Uncertain<br />

hemo self hemo hemo CAPD CCPD Other PD dialysis Transplant All<br />

Alabama 5,972 * * 236 312 * * 2,212 8,750<br />

Alaska 234 . * 41 34 . * 225 541<br />

Arizona 5,321 * * 163 237 . 11 2,114 7,857<br />

Arkansas 2,347 * * 230 142 . * 1,031 3,762<br />

California 36,135 21 42 1,659 1,730 * 121 14,253 53,967<br />

Colorado 2,648 * * 95 109 . * 1,626 4,495<br />

Connecticut 2,792 . * 185 346 . 15 1,369 4,712<br />

Delaware 958 . * 18 38 . * 485 1,501<br />

District of Columbia 1,725 . * 30 29 . * 344 2,135<br />

Florida 17,278 * 145 431 868 * 34 6,509 25,272<br />

Georgia 11,161 . 44 449 514 * 15 3,088 15,272<br />

Hawaii 1,874 . . 74 44 . * 525 2,519<br />

Idaho 617 * * 95 47 . * 533 1,302<br />

Illinois 12,947 * 232 572 673 * 38 6,530 21,002<br />

Indiana 5,565 * 19 349 264 * 20 2,733 8,953<br />

Iowa 2,008 . 19 94 68 . 16 1,574 3,779<br />

Kansas 1,997 . 16 141 105 * * 997 3,263<br />

Kentucky 3,501 * 11 145 191 * * 1,673 5,533<br />

Louisiana 7,211 * 12 158 217 . * 1,811 9,419<br />

Maine 872 * * 20 49 . * 560 1,512<br />

Maryland 6,630 * 11 250 349 . 27 3,143 10,413<br />

Massachusetts 4,590 . 20 151 233 * 19 2,890 7,904<br />

Michigan 10,079 . 22 628 387 . 38 4,946 16,100<br />

Minnesota 3,049 . * 92 116 . 13 3,163 6,439<br />

Mississippi 4,542 * 31 158 264 * * 1,054 6,057<br />

Missouri 5,539 * 47 271 345 * * 2,457 8,670<br />

Montana 548 . * 32 38 . * 459 1,085<br />

Nebraska 1,265 . * 97 64 . * 816 2,248<br />

Nevada 1,590 . * 105 88 * * 747 2,540<br />

New Hampshire 682 . . 32 48 . * 498 1,261<br />

New Jersey 9,377 11 20 223 400 * 24 3,694 13,751<br />

New Mexico 2,017 * * 96 131 . * 756 3,005<br />

New York 21,410 111 93 618 623 16 45 7,588 30,504<br />

North Carolina 10,562 * 28 287 598 * 18 3,136 14,635<br />

North Dakota 376 * . 31 * . . 404 822<br />

Ohio 12,044 * 69 547 571 * 32 5,356 18,621<br />

Oklahoma 3,131 . * 143 241 * * 1,305 4,832<br />

Oregon 2,107 . 11 130 154 . * 1,577 3,987<br />

Pennsylvania 12,596 * 27 311 476 * 52 6,593 20,059<br />

Rhode Island 813 . * 25 22 * * 511 1,383<br />

South Carolina 5,899 * 13 164 379 . 11 1,754 8,221<br />

South Dakota 636 . * 26 34 . * 409 1,112<br />

Tennessee 5,931 . 19 161 394 . 13 2,470 8,988<br />

Texas 24,810 * 100 644 1,238 . 53 8,425 35,272<br />

Utah 926 * * 73 33 . 11 1,089 2,138<br />

Vermont 379 . * * 14 . * 258 663<br />

Virginia 8,257 * 65 272 398 * 22 3,208 12,225<br />

Washington 3,890 * 83 162 162 * 23 2,619 6,949<br />

West Virginia 1,619 * * 79 146 * * 907 2,760<br />

Wisconsin 3,916 . 16 170 213 . 21 3,408 7,744<br />

Wyoming 236 . * 22 11 . . 195 467<br />

395<br />

American Samoa 82 . * . . . . * 84<br />

Guam 316 . . 17 * . . 15 349<br />

Puerto Rico 3,168 . * 65 337 * . 886 4,471<br />

Saipan 84 . . * . . . 13 100<br />

Virgin Islands 147 . . * * . . 21 175<br />

Foreign 46 . . * * . . 237 286<br />

Unknown 131 . . * * . 24 931 1,091<br />

All 296,583 193 1,325 11,281 14,544 67 833 128,131 452,957<br />

The point prevalent cohorts & associated modalities are determined on December 31 of each calendar year<br />

without applying the 60-day stable modality rule.<br />

* Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


DTREATMENT MODALITIES<br />

DReference section D<br />

396


Reference<br />

E<br />

Section<br />

Transplantation:<br />

process


TRANSPLANTATION: PROCESS<br />

EReference section E<br />

398<br />

E.1 . 399<br />

Total patients wait-listed for a kidney<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

E.2 . 403<br />

Total ESRD patients wait-listed for a kidney<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

E.3 . 405<br />

Rate of wait-listing: ESRD patients<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

E.4 . 407<br />

Percent of patients either wait-listed or receiving a deceased-donor kidney within<br />

one year of their ESRD initiation date<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

E.5 . 409<br />

<strong>Renal</strong> transplants, by donor type<br />

E.6 . 410<br />

<strong>Renal</strong> transplants: recipients age


TRANSPLANTATION:<br />

2005 Annual <strong>Data</strong><br />

PROCESSE<br />

Report<br />

Table E.1 E.1<br />

by Table Total<br />

age, E.1patients wait-listed for a kidney<br />

by age, gender, gender, race/ethnicity, race/ethnicity, & primary primary diagnosis diagnosis<br />

Total patients wait-listed for a kidney<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />


TRANSPLANTATION: PROCESS<br />

Reference section E ETable E.1 (continued)<br />

400<br />

Table E.1 (continued)<br />

by Table<br />

Total<br />

age, E.1<br />

patients<br />

gender, (continued)<br />

wait-listed for a kidney<br />

by age, gender, race/ethnicity, race/ethnicity, & primary primary diagnosis diagnosis<br />

Total patients wait-listed for a kidney<br />

by age, gender, race/ethnicity, 1992 & primary 1993diagnosis<br />

1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />


TRANSPLANTATION:<br />

2005 Annual <strong>Data</strong><br />

PROCESSE<br />

Report<br />

Table E.1 E.1 (continued)<br />

Total patients wait-listed for a kidney, with unknowns dropped<br />

by Table age, E.1 gender, (continued)<br />

by age, gender, race/ethnicity, race/ethnicity, & primary primary diagnosis diagnosis<br />

Total patients wait-listed for a kidney, with unknowns dropped<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />


TRANSPLANTATION: PROCESS<br />

Reference section E ETable E.1 (continued)<br />

402<br />

Table E.1 (continued)<br />

Total patients wait-listed for a kidney, with unknowns dropped<br />

by Table age, E.1 gender, (continued)<br />

by age, gender, race/ethnicity, race/ethnicity, & primary primary diagnosis diagnosis<br />

Total patients wait-listed for a kidney, with unknowns dropped<br />

by age, gender, race/ethnicity, 1992 & primary 1993diagnosis<br />

1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />


TRANSPLANTATION:<br />

2005 Annual <strong>Data</strong><br />

PROCESSE<br />

Report<br />

Table E.2 E.2<br />

by Table<br />

Total<br />

age, E.2ESRD patients wait-listed for a kidney<br />

by age, gender, gender, race/ethnicity, race/ethnicity, & primary primary diagnosis diagnosis<br />

Total ESRD patients wait-listed for a kidney<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />


TRANSPLANTATION: PROCESS<br />

Reference section E ETable E.2 (continued)<br />

404<br />

Table E.2 (continued)<br />

by Table<br />

Total<br />

age, E.2<br />

ESRD<br />

gender, (continued)<br />

patients wait-listed for a kidney<br />

by age, gender, race/ethnicity, race/ethnicity, & primary primary diagnosis diagnosis<br />

Total ESRD patients wait-listed for a kidney<br />

by age, gender, race/ethnicity, 1992& primary 1993 diagnosis 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />


ON OUR WEBSITE & CD<br />

Median time in days to first renal transplant from first ESRD service day, by<br />

age, gender, race, ethnicity, blood type, HLA mismatches, & peak PRA (E.a).<br />

Table E.3 E.3<br />

Rate of wait-listing: ESRD patients, per 100 dialysis patient-years<br />

by by Table age, age, E.3 gender, gender, race/ethnicity, race/ethnicity, & primary primary diagnosis diagnosis<br />

Rate of wait-listing: ESRD patients, per 100 dialysis patient-years<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />


TRANSPLANTATION: PROCESS<br />

Reference section E ETable E.3 (continued)<br />

406<br />

Table E.3 (continued)<br />

Rate of wait-listing: ESRD patients, per 100 dialysis patient-years<br />

by by Table age, age, E.3 gender, gender, (continued) race/ethnicity, race/ethnicity, & primary primary diagnosis diagnosis<br />

Rate of wait-listing: ESRD patients, per 100 dialysis patient-years<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

by age, gender, race/ethnicity, & primary diagnosis<br />


TRANSPLANTATION:<br />

2005 Annual <strong>Data</strong><br />

PROCESSE<br />

Report<br />

Table E.4 E.4<br />

Percent % of patients of patients wait-listed wait-listed or receiving or receiving a deceased-donor a deceased-donor kidney kidney within within one year one of year their of their ESRD ESRD initiation initiation date date<br />

by by age, age, gender, gender, race/ethnicity, race/ethnicity, & primary primary diagnosis diagnosis<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />


TRANSPLANTATION: PROCESS<br />

Reference section E ETable E.4 (continued)<br />

Table E.4 (continued)<br />

Percent % of patients of patients wait-listed wait-listed or receiving or receiving a deceased-donor a deceased-donor kidney kidney within within one year one of year their of their ESRD ESRD initiation initiation date date<br />

by by age, age, gender, gender, race/ethnicity, race/ethnicity, & primary primary diagnosis diagnosis<br />

408<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />


TRANSPLANTATION:<br />

2005 Annual <strong>Data</strong><br />

PROCESSE<br />

Report<br />

Table E.5 E.5<br />

Table <strong>Renal</strong> E.5<br />

transplants: by donor type<br />

<strong>Renal</strong> transplants: by donor type<br />

Living Donor Relation<br />

Living Distantly Spouse/ Paired Living Donor Unrelated Relation Nondirected Living-Deceased<br />

Deceased (Total) Living Related Distantly Related Life Spouse/ Partner Exchange Paired Unrelated Directed Nondirected Donation Living-Deceased<br />

Exchange Unknown Unknown Total<br />

1980 Deceased 2,578 (Total) 914 Related. Related. Life Partner. Exchange. Directed. Donation. Exchange. Unknown 914 Unknown 290 Total 3,782<br />

1981 1980 2,867 2,578 1,134 914 . . . . . . . 1,134 914 290 224 3,782 4,225<br />

1982 1981 2,867 3,402 1,550 1,134 . . . . . . . 1,550 1,134 158 224 5,110 4,225<br />

1983 1982 3,968 3,402 1,710 1,550 . . . . . . . 1,710 1,550 199 158 5,877 5,110<br />

1984 1983 4,614 3,968 1,927 1,710 *. . . . . . . 1,926 1,710 195 199 6,736 5,877<br />

1985 1984 4,947 4,614 2,326 1,927 *. . . . *. . . 2,325 1,926 228 195 7,501 6,736<br />

1986 1985 5,773 4,947 2,859 2,326 . *. . . *. . . 2,858 2,325 244 228 8,876 7,501<br />

1987 1986 6,055 5,773 2,692 2,859 361 . * 12 . . *. . . 2,310 2,858 184 244 8,931 8,876<br />

1987 1988 6,055 7,281 2,692 1,837 1,631 361 36* 12 38 . 25 * . . 2,310 107 112 184 9,230 8,931<br />

1988 1989 7,113 7,281 1,921 1,837 1,706 1,631 31 36 53 38 . 30 25 . . 101 107 118 112 9,152 9,230<br />

1990 1989 7,798 7,113 2,087 1,921 1,722 1,706 45 31 59 53 . 29 30 . . 232 101 127 118 10,012 9,152<br />

1991 1990 7,735 7,798 2,392 2,087 2,167 1,722 47 45 59 . 47 29 . . 232 72 127 110 10,012 10,237<br />

1992 1991 7,681 7,735 2,542 2,392 2,233 2,167 70 47 78 59 . 75 47 . . 86 72 162 110 10,385 10,237<br />

1993 1992 8,181 7,681 2,874 2,542 2,397 2,233 96 70 114 78 . 67 75 . . 200 86 102 162 11,157 10,385<br />

1993 1994 8,181 8,286 2,874 2,955 2,397 2,276 121 96 127 114 . 73 67 . . 358 200 157 102 11,398 11,157<br />

1995 1994 8,460 8,286 3,375 2,955 2,276 2,773 178 121 254 127 . 157 73 . . 358 13 186 157 12,021 11,398<br />

1995 1996 8,440 8,460 3,653 3,375 2,817 2,773 213 178 351 254 . 213 157 . *. 13 58 186 168 12,021 12,261<br />

1997 1996 8,440 8,598 3,929 3,653 2,817 2,992 236 213 380 351 . 270 213 . * 48 58 113 168 12,640 12,261<br />

1998 1997 8,975 8,598 4,407 3,929 3,142 2,992 295 236 544 380 . 359 270 *. * 64 48 160 113 13,542 12,640<br />

1999 1998 8,951 8,975 4,709 4,407 3,270 3,142 346 295 573 544 . 470 359 * *. 45 64 125 160 13,785 13,542<br />

2000 1999 9,023 8,951 5,478 4,709 3,483 3,270 393 346 653 573 . 741 470 18 * *. 189 45 125 56 14,557 13,785<br />

2000 2001 9,023 9,099 5,478 6,030 3,483 3,674 393 439 653 670 *. 741 854 18 23 * 358 189 49 56 15,178 14,557<br />

2002 2001 9,422 9,099 6,233 6,030 3,663 3,674 467 439 683 670 * 1,028 854 23 53 * 358 331 49 52 15,178 15,707<br />

2002 2003 9,422 8,705 6,233 6,466 3,667 3,663 467 448 683 697 15* 1,028 1,213 73 53 * 346 331 872 52 16,043 15,707<br />

2003 8,705 6,466 3,667 448 697 15 1,213 73 * 346 872 16,043<br />

409<br />

Age is calculated as of the day of transplantation.<br />

USRDS Age is calculated counts include as of the non-Medicare day of transplantation.<br />

patients.<br />

*Values USRDS counts for cells include with 10 non-Medicare or fewer patients patients. are suppressed.<br />

"." *Values Zero values for cells in with this cell. 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


TRANSPLANTATION: PROCESS<br />

Reference section E ETable E.6<br />

410<br />

Table E.6<br />

Table <strong>Renal</strong> E.6<br />

transplants: recipients age


ON OUR WEBSITE & CD<br />

<strong>Renal</strong> transplants, 1999-2003 (Table E.7.1-E.7.6)<br />

TRANSPLANTATION:<br />

2005 Annual <strong>Data</strong><br />

PROCESSE<br />

Report<br />

Table E.7 E.7<br />

Counts of renal transplants, by donor type: all<br />

by by age, age, gender, gender, race, race, ethnicity, ethnicity, & primary primary diagnosis diagnosis<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 All<br />


TRANSPLANTATION: PROCESS<br />

Reference section E ETable E.7 (continued)<br />

Table E.7 (continued)<br />

Counts of renal transplants, by donor type: deceased donor<br />

by by age, age, gender, gender, race, race, ethnicity, ethnicity, & primary primary diagnosis diagnosis<br />

412<br />


TRANSPLANTATION:<br />

2005 Annual <strong>Data</strong><br />

PROCESSE<br />

Report<br />

Table E.7 E.7 (continued)<br />

Counts of renal transplants, transplants: by donor type: living related<br />

by by age, age, gender, gender, race, race, ethnicity, ethnicity, & primary primary diagnosis diagnosis<br />

LIVING RELATED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 All<br />


TRANSPLANTATION: PROCESS<br />

Reference section E ETable E.7 (continued)<br />

Table E.7 (continued)<br />

Counts of renal transplants, transplants: by donor type: living distant/unrelated<br />

by by age, age, gender, gender, race, race, ethnicity, ethnicity, & primary primary diagnosis diagnosis<br />

414<br />

LIVING DISTANT/UNRELATED<br />


TRANSPLANTATION:<br />

2005 Annual <strong>Data</strong><br />

PROCESSE<br />

Report<br />

Table E.8 E.8<br />

Counts of renal transplants: by donor type & number of transplants<br />

ALL 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 All<br />

1st transplant 8,897 9,074 9,883 10,031 10,540 10,832 11,171 11,925 12,227 12,849 13,437 13,891 14,186 148,943<br />

2nd transplant 1,156 1,108 1,112 1,188 1,284 1,208 1,261 1,375 1,328 1,474 1,479 1,556 1,595 17,124<br />

3rd transplant 165 181 141 157 163 190 185 207 197 201 224 222 230 2,463<br />

4+ transplants* 19 22 21 22 34 31 23 35 33 33 38 38 32 381<br />

DECEASED DONOR<br />

1st transplant 6,637 6,608 7,183 7,234 7,346 7,388 7,498 7,823 7,846 7,826 7,971 8,269 7,629 97,258<br />

2nd transplant 945 898 871 913 951 888 935 974 935 1,026 957 983 906 12,182<br />

3rd transplant 136 156 111 119 133 139 144 152 146 144 145 144 149 1,818<br />

4+ transplants* 17 19 16 20 30 25 21 26 24 27 26 26 21 298<br />

LIVING RELATED<br />

1st transplant 2,008 2,074 2,220 2,094 2,536 2,585 2,758 2,887 3,002 3,189 3,348 3,327 3,301 35,329<br />

2nd transplant 141 141 156 156 215 198 206 220 231 257 277 290 327 2,815<br />

3rd transplant 17 15 17 25 19 31 26 29 30 34 41 44 33 361<br />

4+ transplants* * * * * * * * * * * * * * 49<br />

415<br />

LIVING DISTANT/UNRELATED<br />

1st transplant 135 204 244 285 530 700 813 1,075 1,271 1,630 1,762 1,974 2,140 12,763<br />

2nd transplant 17 19 27 33 56 69 71 110 109 154 202 230 272 1,369<br />

3rd transplant * . * * * * * 14 12 19 30 26 37 164<br />

4+ transplants* . . . * . . . * * * * * * 25<br />

Table E.9 E.9<br />

<strong>Renal</strong> transplant rates, rates: by donor type: all<br />

by by age, age, gender, gender, race, race, ethnicity, ethnicity, & primary primary diagnosis diagnosis<br />

ALL 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />


TRANSPLANTATION: PROCESS<br />

Reference section E ETable E.9 (continued)<br />

Table E.9 (continued)<br />

<strong>Renal</strong> transplant rates, rates: by donor type: deceased donor<br />

by by age, age, gender, gender, race, race, ethnicity, ethnicity, & primary primary diagnosis diagnosis<br />

416<br />

DECEASED DONOR<br />


TRANSPLANTATION:<br />

2005 Annual <strong>Data</strong><br />

PROCESSE<br />

Report<br />

Table E.9 E.9 (continued)<br />

<strong>Renal</strong> transplant rates, rates: by donor type: living related<br />

by by age, age, gender, gender, race, race, ethnicity, ethnicity, & primary primary diagnosis diagnosis<br />

LIVING RELATED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />


TRANSPLANTATION: PROCESS<br />

Reference section E ETable E.9 (continued)<br />

Table E.9 (continued)<br />

<strong>Renal</strong> transplant rates, rates: by donor type: living distant/unrelated<br />

by by age, age, gender, gender, race, race, ethnicity, ethnicity, & primary primary diagnosis diagnosis<br />

418<br />

LIVING DISTANT/UNRELATED<br />


TRANSPLANTATION:<br />

2005 Annual <strong>Data</strong><br />

PROCESSE<br />

Report<br />

Table E.10<br />

Treatment status two years after first transplant, 1999-2001*<br />

Treatment status two years after first transplant (percent of patients)<br />

Functioning CAPD & Oth/unk<br />

ALL Count Graft Retransplanted Hemo CCPD dialysis Death<br />

Age at first transplant<br />

0-19 2,362 88.2 1.9 4.1 1.7 1.8 2.3<br />

20-44 14,936 88.4 1.2 4.7 0.8 1.1 3.9<br />

45-64 17,854 85.7 0.8 3.7 0.4 0.6 8.8<br />

65-74 3,147 79.7 0.6 3.7 0.5 0.3 15.2<br />

75+ 213 69.5 0.5 3.3 . 0.5 26.3<br />

All 38,513 86.3 1.0 4.1 0.6 0.9 7.1<br />

Table E.11<br />

Percent panel reactive antibodies (PRA) for selected years^<br />

by donor type, percent of transplant events within year<br />

419<br />

DECEASED DONOR 1996 1997 1998 1999 2000 2001 2002 2003 All<br />

Peak PRA<br />


ETRANSPLANTATION: PROCESS<br />

Reference section E<br />

Table E.13<br />

Hepatitus C (HCVAb) antibody status for selected years^<br />

by<br />

by<br />

recipient<br />

recipient<br />

& donor<br />

donor<br />

HCVAb<br />

HCVAb status,<br />

status,<br />

percent<br />

percent<br />

of<br />

of<br />

transplant<br />

transplant<br />

events<br />

events within<br />

within<br />

year<br />

year<br />

ON OUR WEBSITE<br />

Bayesian first renal transplant ratios: by state/territory (E.b).<br />

DECEASED DONOR<br />

Recipient HCVAb Donor HCVAb 1996 1997 1998 1999 2000 2001 2002 2003 All<br />

Positive Positive 1.4 1.3 1.3 1.5 1.5 1.5 1.7 2.1 1.5<br />

Negative 4.8 4.8 4.6 4.7 4.7 4.8 4.8 4.7 4.7<br />

Unknown . 0.1 0.1 0.1 . . . . 0.1<br />

Negative Positive 0.5 0.6 0.6 0.5 0.6 0.3 0.5 0.2 0.5<br />

Negative 83.1 81.7 82.5 79.8 81.7 84.7 84.0 84.1 82.7<br />

Unknown 1.5 1.1 1.1 1.0 0.3 0.2 0.3 0.3 0.7<br />

Unknown Positive 0.2 0.1 0.3 0.3 0.2 0.3 0.2 0.3 0.2<br />

Negative 8.4 10.2 9.4 12.0 10.9 8.1 8.6 8.1 9.5<br />

Unknown 0.2 0.2 0.1 0.1 0.1 . . . 0.1<br />

420<br />

LIVING DONOR<br />

Positive Positive 0.1 0.1 0.2 0.1 0.1 0.1 0.1 . 0.1<br />

Negative 2.9 3.1 2.9 2.7 2.7 2.9 2.6 2.8 2.8<br />

Unknown 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2<br />

Negative Positive 0.4 0.5 0.5 0.3 0.4 0.5 0.5 0.6 0.5<br />

Negative 82.5 83.4 83.4 81.0 80.5 85.1 85.7 85.8 83.6<br />

Unknown 4.7 3.4 4.4 5.1 6.5 5.4 4.7 4.3 4.9<br />

Unknown Positive 0.1 0.1 . . 0.1 . . . .<br />

Negative 5.8 6.0 5.7 6.8 6.0 3.3 2.9 2.0 4.5<br />

Unknown 3.3 3.3 2.6 3.7 3.4 2.4 3.2 4.3 3.3<br />

Table E.14<br />

Cold ischemia time (hours): deceased donor transplants for selected years<br />

COUNTS 1996 1997 1998 1999 2000 2001 2002 2003 All<br />

0-12 1,480 1,637 1,736 1,748 1,817 1,950 2,230 2,084 14,682<br />

13-24 4,394 4,530 4,464 4,215 4,124 4,011 4,327 3,937 34,002<br />

25-36 1,979 1,815 1,860 1,615 1,467 1,372 1,288 1,254 12,650<br />

37+ 326 257 275 225 205 205 200 175 1,868<br />

Unknown 261 359 640 1,148 1,410 1,561 1,377 1,255 8,011<br />

PERCENTAGES<br />

0-12 17.5 19.0 19.3 19.5 20.1 21.4 23.7 23.9 20.6<br />

13-24 52.1 52.7 49.7 47.1 45.7 44.1 45.9 45.2 47.7<br />

25-36 23.4 21.1 20.7 18.0 16.3 15.1 13.7 14.4 17.8<br />

37+ 3.9 3.0 3.1 2.5 2.3 2.3 2.1 2.0 2.6<br />

Unknown 3.1 4.2 7.1 12.8 15.6 17.2 14.6 14.4 11.2<br />

*One ^1,595 patient transplant with events unknown were age excluded is not included from the in table the age-specific due to unknown rows. donor type.<br />

"." Zero values in this cell.


Reference<br />

F<br />

Section<br />

Transplantation:<br />

outcomes


F<br />

TRANSPLANTATION:<br />

OUTCOMES<br />

Reference section F<br />

422<br />

For survival probabilities, first transplant, see Section I: Patient Survival<br />

F.1 . 423<br />

90-day graft survival probabilities: all transplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.2 . 425<br />

One-year graft survival probabilities: all transplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.3 . 427<br />

Two-year graft survival probabilities: all transplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.4 . 429<br />

Three-year graft survival probabilities: all transplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.5 . 431<br />

Five-year graft survival probabilities: all transplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.6 . 433<br />

Ten-year graft survival probabilities: all transplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.7 . 434<br />

90-day graft survival probabilities: all transplants, living donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.8 . 436<br />

One-year graft survival probabilities: all transplants, living donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.9 . 438<br />

Two-year graft survival probabilities: all transplants, living donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.10 . 440<br />

Three-year graft survival probabilities: all transplants, living donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.11 . 442<br />

Five-year graft survival probabilities: all transplants, living donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.12 . 444<br />

Ten-year graft survival probabilities: all transplants, living donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.13 . 445<br />

90-day survival with functioning graft probabilities: all transplants, deceased<br />

donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.14 . 447<br />

One-year survival with functioning graft probabilities: all transplants, deceased<br />

donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.15 . 449<br />

Two-year survival with functioning graft probabilities: all transplants, deceased<br />

donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.16 . 451<br />

Three-year survival with functioning graft probabilities: all transplants, deceased<br />

donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.17 . 453<br />

Five-year survival with functioning graft probabilities: all transplants, deceased<br />

donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.18 . 455<br />

Ten-year survival with functioning graft probabilities: all transplants, deceased<br />

donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.19 . 456<br />

90-day survival with functioning graft probabilities: all transplants, living donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.20 . 458<br />

One-year survival with functioning graft probabilities: all transplants, living<br />

donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.21 . 460<br />

Two-year survival with functioning graft probabilities: all transplants, living<br />

donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.22 . 462<br />

Three-year survival with functioning graft probabilities: all transplants, living<br />

donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.23 . 464<br />

Five-year survival with functioning graft probabilities: all transplants, living<br />

donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.24 . 466<br />

Ten-year survival with functioning graft probabilities: all transplants, living<br />

donors<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

F.25 . 467<br />

Risk factors for graft failure: deceased donor transplants, 1998-2003<br />

F.26 . 471<br />

Risk factors for graft failure: living donor transplants, 1998-2003


ON OUR WEBSITE & CD<br />

90-day death-censored graft survival probabilities: all transplants, deceased<br />

donors (F.1.1).<br />

TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table F.1 F.1<br />

90-day graft survival probabilities: all transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


F<br />

TRANSPLANTATION:<br />

424<br />

OUTCOMES<br />

Reference section F<br />

Table F.1 F.1 (continued)<br />

90-day graft survival probabilities: all transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />


ON OUR WEBSITE & CD<br />

One-year death-censored graft survival probabilities: all transplants, deceased<br />

donors (F.2.1).<br />

TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table F.2 F.2<br />

One-year graft survival probabilities: all transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


F<br />

TRANSPLANTATION:<br />

426<br />

OUTCOMES<br />

Reference section F<br />

Table F.2 F.2 (continued)<br />

One-year graft survival probabilities: all transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />


ON OUR WEBSITE & CD<br />

Two-year death-censored graft survival probabilities: all transplants, deceased<br />

donors (F.3.1).<br />

TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table Table F.3 F.3<br />

Two-year graft survival probabilities: all all transplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, transplant number<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


F<br />

TRANSPLANTATION:<br />

428<br />

OUTCOMES<br />

Reference section F<br />

Table Table F.3 F.3 (continued)<br />

(continued)<br />

Two-year graft survival probabilities: all all transplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, transplant number<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />


ON OUR WEBSITE & CD<br />

Three-year death-censored graft survival probabilities: all transplants, deceased<br />

donors (F.4.1).<br />

TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table Table F.4 F.4<br />

Three-year graft survival probabilities: all all transplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, transplant number<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


F<br />

TRANSPLANTATION:<br />

430<br />

OUTCOMES<br />

Reference section F<br />

Table Table F.4 F.4 (continued)<br />

(continued)<br />

Three-year graft survival probabilities: all all transplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, transplant number<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />


ON OUR WEBSITE & CD<br />

Five-year death-censored graft survival probabilities: all transplants, deceased<br />

donors (F.5.1<br />

TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table F.5 F.5<br />

Five-year graft survival probabilities: all transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


F<br />

TRANSPLANTATION:<br />

432<br />

OUTCOMES<br />

Reference section F<br />

Table F.5 F.5 (continued)<br />

Five-year graft survival probabilities: all transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998<br />


ON OUR WEBSITE & CD<br />

Ten-year graft survival probabilities: all transplants, deceased donors (F.6.1).<br />

TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table F.6 F.6<br />

Ten-year graft survival probabilities: all all transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<br />


F<br />

TRANSPLANTATION:<br />

434<br />

OUTCOMES<br />

Reference section F<br />

Table Table F.7 F.7<br />

90-day graft survival probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table Table F.7 F.7 (continued)<br />

(continued)<br />

90-day graft survival probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />


F<br />

TRANSPLANTATION:<br />

436<br />

OUTCOMES<br />

Reference section F<br />

Table F.8 F.8<br />

One-year graft survival probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table F.8 F.8 (continued)<br />

One-year graft survival probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />


F<br />

TRANSPLANTATION:<br />

438<br />

OUTCOMES<br />

Reference section F<br />

Table Table F.9 F.9<br />

Two-year graft survival probabilities: all all transplants, living donors<br />

by age, gender, race/ethnicity, primary diagnosis, transplant number<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table Table F.9 F.9 (continued)<br />

(continued)<br />

Two-year graft survival probabilities: all all transplants, living donors<br />

by age, gender, race/ethnicity, primary diagnosis, transplant number<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />


F<br />

TRANSPLANTATION:<br />

440<br />

OUTCOMES<br />

Reference section F<br />

Table F.10 F.10<br />

Three-year graft survival probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

ON OUR WEBSITE & CD<br />

Three-year death-censored graft survival probabilities: all transplants, living<br />

donors (F.10.1).<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table Table F.10 F.10 (continued)<br />

(continued)<br />

Three-year graft survival probabilities: all all transplants, living donors<br />

by age, gender, race/ethnicity, primary diagnosis, transplant number<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />


F<br />

TRANSPLANTATION:<br />

442<br />

OUTCOMES<br />

Reference section F<br />

Table F.11 F.11<br />

Five-year graft survival probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table F.11 F.11 (continued) (continued)<br />

Five-year graft survival probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998<br />


F<br />

TRANSPLANTATION:<br />

444<br />

OUTCOMES<br />

Reference section F<br />

Table F.12 F.12<br />

Ten-year graft survival probabilities: all all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

ON OUR WEBSITE & CD<br />

Ten-year death-censored graft survival probabilities: all transplants, living<br />

donors (F.12.1).<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<br />


Table F.13 F.13<br />

90-day survival with functioning graft probabilities: all transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


F<br />

TRANSPLANTATION:<br />

446<br />

OUTCOMES<br />

Reference section F<br />

Table Table F.13 F.13 (continued) (continued)<br />

90-day survival with functioning graft probabilities: all transplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, transplant number<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />


Table Table F.14 F.14<br />

One-year survival with functioning graft probabilities: all tranplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, transplant number<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


F<br />

TRANSPLANTATION:<br />

448<br />

OUTCOMES<br />

Reference section F<br />

Table F.14 F.14 (continued)<br />

One-year survival with functioning graft probabilities: all tranplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />


TRANSPLANTATION: 2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> ReportF<br />

Table F.15 F.15<br />

Two-year survival with functioning graft probabilities: all transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


F<br />

TRANSPLANTATION:<br />

450<br />

OUTCOMES<br />

Reference section F<br />

Table F.15 F.15 (continued) (continued)<br />

Two-year survival with functioning graft probabilities: all transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />


Table F.16 F.16<br />

Three-year survival with functioning graft probabilities: all transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

TRANSPLANTATION: OUTCOMES<br />

2005 Annual <strong>Data</strong> ReportF<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


F<br />

TRANSPLANTATION:<br />

452<br />

OUTCOMES<br />

Reference section F<br />

Table Table F.16 F.16 (continued)<br />

(continued)<br />

Three-year survival with functioning graft probabilities: all transplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, transplant number<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />


Table Table F.17 F.17<br />

Five-year survival with functioning graft probabilities: all all transplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, transplant number<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


F<br />

TRANSPLANTATION:<br />

454<br />

OUTCOMES<br />

Reference section F<br />

Table Table F.17 F.17 (continued) (continued)<br />

Five-year survival with functioning graft probabilities: all all transplants, deceased donors<br />

by age, gender, race/ethnicity, primary diagnosis, transplant number<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998<br />


Table F.18 F.18<br />

Ten-year survival with functioning graft probabilities: all transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<br />


F<br />

TRANSPLANTATION:<br />

456<br />

OUTCOMES<br />

Reference section F<br />

Table F.19 F.19<br />

90-day survival with functioning graft probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table F.19 F.19 (continued)<br />

90-day survival with functioning graft probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />


F<br />

TRANSPLANTATION:<br />

458<br />

OUTCOMES<br />

Reference section F<br />

Table F.20 F.20<br />

One-year survival with functioning graft probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


Table F.20 F.20 (continued)<br />

One-year survival with functioning graft probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />


F<br />

TRANSPLANTATION:<br />

460<br />

OUTCOMES<br />

Reference section F<br />

Table F.21 F.21<br />

Two-year survival with functioning graft probabilities: all transplants, living donors<br />

by by age, age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


Table F.21 F.21 (continued)<br />

Two-year survival with functioning graft probabilities: all transplants, living donors<br />

by by age, age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />


F<br />

TRANSPLANTATION:<br />

462<br />

OUTCOMES<br />

Reference section F<br />

Table F.22 F.22<br />

Three-year survival with functioning graft probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


Table<br />

Table<br />

F.22<br />

F.22<br />

(continued)<br />

(continued)<br />

Three-year survival with functioning graft probabilities: all all transplants, living donors<br />

by age, gender, race/ethnicity, primary diagnosis, transplant number<br />

by age, gender, race/ethnicity, primary diagnosis, & transplant number<br />

TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />


F<br />

TRANSPLANTATION:<br />

464<br />

OUTCOMES<br />

Reference section F<br />

Table F.23 F.23<br />

Five-year survival with functioning graft probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />


Table F.23 F.23 (continued)<br />

Five-year survival with functioning graft probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998<br />


F<br />

TRANSPLANTATION:<br />

466<br />

OUTCOMES<br />

Reference section F<br />

Table F.24 F.24<br />

Ten-year survival with functioning graft probabilities: all transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

transplant<br />

transplant<br />

number<br />

number<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<br />


TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table F.25 F.25<br />

Risk factors for graft failure: deceased donor transplants, 1998-2003 (n=42,979)<br />

All-cause graft failure<br />

Percent of patients Haz. ratio 95% CI P-value<br />

Transplant era (reference: 1998-2000, 48.5% of patients)<br />

2001-2003 51.5 0.97 (0.92-1.02) 0.2269<br />

Recipient age (years) (reference: 18-34, 13.7% of patients)<br />

0-17 3.7 1.27 (1.11-1.46) 0.0006<br />

35-49 30.8 0.87 (0.81-0.94) 0.0001<br />

50-64 39.7 1.05 (0.98-1.13) 0.1341<br />

65+ 12.1 1.42 (1.31-1.55)


F<br />

TRANSPLANTATION:<br />

OUTCOMES<br />

Reference section F<br />

Table F.25 F.25 (continued)<br />

Risk factors for graft failure: deceased donor transplants, 1998-2003 (n=42,979)<br />

468<br />

All-cause graft failure<br />

Percent of patients Haz. ratio 95% CI P-value<br />

HLA mismatches (reference: 3, 18.1% of patients)<br />

0 12.4 0.85 (0.78-0.92)


TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table F.25 F.25 (continued)<br />

Risk factors for graft failure: deceased donor transplants, 1998-2003 (n=42,979)<br />

Return to dialysis / preemptive retransplant<br />

Death with function<br />

Haz. ratio 95% CI P-value Haz. ratio 95% CI P-value<br />

Transplant era (reference: 1998-2000, 48.5% of patients)<br />

2001-2003 0.97 (0.90-1.03) 0.3258 0.98 (0.91-1.05) 0.5480<br />

Recipient age (years) (reference: 18-34, 13.7% of patients)<br />

0-17 1.37 (1.18-1.60)


F<br />

TRANSPLANTATION:<br />

OUTCOMES<br />

Reference section F<br />

Table F.25 F.25 (continued)<br />

Risk factors for graft failure: deceased donor transplants, 1998-2003 (n=42,979)<br />

470<br />

Return to dialysis / preemptive retransplant Death with function<br />

Haz. ratio 95% CI P-value Haz. ratio 95% CI P-value<br />

HLA mismatches (reference: 3, 18.1% of patients)<br />

0 0.80 (0.71-0.90) 0.0002 0.89 (0.79-1.00) 0.0489<br />

1 0.89 (0.75-1.06) 0.1845 1.10 (0.93-1.29) 0.2686<br />

2 1.06 (0.95-1.19) 0.3173 0.89 (0.78-1.01) 0.0658<br />

4 1.05 (0.97-1.15) 0.2330 1.02 (0.92-1.12) 0.7616<br />

5 1.23 (1.13-1.34)


TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table F.26 F.26<br />

Risk factors for graft failure: living donor transplants, 1998-2003 (n=30,068)<br />

All-cause graft failure<br />

Percent of patiHaz. ratio 95% CI P-value<br />

Transplant era (reference: 1998-2000, 44.3% of patients)<br />

2001-2002 55.8 0.93 (0.86-1.02) 0.1350<br />

Donor relationship (reference: related, 63.3% of patients)<br />

Distant/unrelated 32.8 1.05 (0.95-1.15) 0.3493<br />

Unknown 3.9 1.12 (0.72-1.76) 0.6108<br />

Recipient age (years) (reference: 18-34, 23.1% of patients)<br />

0-17 7.6 1.02 (0.87-1.20) 0.8238<br />

35-49 32.3 0.76 (0.69-0.84)


F<br />

TRANSPLANTATION:<br />

OUTCOMES<br />

Reference section F<br />

Table F.26 F.26 (continued)<br />

Risk factors for graft failure: living donor transplants, 1998-2003 (n=30,068)<br />

472<br />

All-cause graft failure<br />

Percent of paHaz. ratio 95% CI P-value<br />

HLA mismatches (reference: 3, 29.7% of patients)<br />

0 10.6 0.58 (0.50-0.67)


TRANSPLANTATION:<br />

2005 Annual<br />

OUTCOMESF<br />

<strong>Data</strong> Report<br />

Table F.26 (continued)<br />

Table F.26 (continued)<br />

Risk factors for graft failure: living donor transplants, 1998-2003 (n=30,068)<br />

Risk factors for graft failure: living donor transplants, 1998-2003 (n=30,068)<br />

Return to dialysis / preemptive retransplant Death with function<br />

Haz. ratio 95% CI P-value Haz. ratio 95% CI P-value<br />

Transplant era (reference: 1998-2000, 44.3% of patients)<br />

2001-2002 0.96 (0.85-1.07) 0.4432 0.90 (0.79-1.04) 0.1567<br />

Donor relationship (reference: related, 63.3% of patients)<br />

Distant/unrelated 1.01 (0.90-1.14) 0.8456 1.09 (0.95-1.26) 0.2343<br />

Unknown 0.79 (0.41-1.53) 0.4901 1.63 (0.89-3.01) 0.1150<br />

Recipient age (years) (reference: 18-34, 23.1% of patients)<br />

0-17 1.15 (0.96-1.38) 0.1252 0.67 (0.45-1.00) 0.0487<br />

35-49 0.60 (0.53-0.67)


F<br />

TRANSPLANTATION:<br />

OUTCOMES<br />

Reference section F<br />

Table F.26 F.26 (continued)<br />

Risk factors for graft failure: living donor transplants, 1998-2003 (n=30,068)<br />

474<br />

All-cause graft failure<br />

Death with function<br />

Haz. ratio 95% CI P-value Haz. ratio 95% CI P-value<br />

HLA mismatches (reference: 3, 29.7% of patients)<br />

0 0.48 (0.40-0.58)


Reference<br />

G<br />

Section<br />

Morbidity &<br />

hospitalization


MORBIDITY & HOSPITALIZATION<br />

GReference section G<br />

476<br />

G.1 . 477<br />

Total admission rates per 1,000 patient years: ESRD patients<br />

period prevalent patients, including all hospitalizations from Part A<br />

institutional inpatient claims<br />

G.2 . 478<br />

Total admission rates per 1,000 patient years: dialysis patients<br />

period prevalent patients, including all hospitalizations from Part A<br />

institutional inpatient claims<br />

G.3 . 479<br />

Total admission rates per 1,000 patient years: hemodialysis patients<br />

period prevalent patients, including all hospitalizations from Part A<br />

institutional inpatient claims<br />

G.4 . 480<br />

Total admission rates per 1,000 patient years: CAPD/CCPD patients<br />

period prevalent patients, including all hospitalizations from Part A<br />

institutional inpatient claims<br />

G.5. 481<br />

Total admission rates per 1,000 patient years: transplant patients<br />

period prevalent patients, including all hospitalizations from Part A<br />

institutional inpatient claims<br />

G.6 . 482<br />

Hospital days per patient year: ESRD patients<br />

period prevalent patients, including all hospitalizations from Part A<br />

institutional inpatient claims<br />

G.7. 483<br />

Hospital days per patient year: dialysis patients<br />

period prevalent patients, including all hospitalizations from Part A<br />

institutional inpatient claims<br />

G.8 . 484<br />

Hospital days per patient year: hemodialysis patients<br />

period prevalent patients, including all hospitalizations from Part A<br />

institutional inpatient claims<br />

G.9 . 485<br />

Hospital days per patient year: CAPD/CCPD patients<br />

period prevalent patients, including all hospitalizations from Part A<br />

institutional inpatient claims<br />

G.10 . 486<br />

Hospital days per patient year: transplant patients<br />

period prevalent patients, including all hospitalizations from Part A<br />

institutional inpatient claims<br />

G.11 . 487<br />

Inpatient utilization by principal diagnosis of hospitalization: ESRD patients,<br />

2001-2003<br />

period prevalent patients, by age, gender, race/ethnicity, & primary<br />

diagnosis; hospitalizations per 100 patient years<br />

G.12 . 488<br />

Inpatient utilization by principal diagnosis of hospitalization: dialysis patients,<br />

2001-2003<br />

period prevalent patients, by age, gender, race/ethnicity, & primary<br />

diagnosis; hospitalizations per 100 patient years<br />

G.13 . 489<br />

Inpatient utilization by principal diagnosis of hospitalization: hemodialysis<br />

patients, 2001-2003<br />

period prevalent patients, by age, gender, race/ethnicity, & primary<br />

diagnosis; hospitalizations per 100 patient years<br />

G.14 . 490<br />

Inpatient utilization by principal diagnosis of hospitalization: CAPD/CCPD<br />

patients, 2001-2003<br />

period prevalent patients, by age, gender, race/ethnicity, & primary<br />

diagnosis; hospitalizations per 100 patient years<br />

G.15 . 491<br />

Inpatient utilization by principal diagnosis of hospitalization: transplant patients,<br />

2001-2003<br />

period prevalent patients, by age, gender, race/ethnicity, & primary<br />

diagnosis; hospitalizations per 100 patient years<br />

G.16 . 492<br />

Total hospital discharges, by general Diagnostic Related Group<br />

period prevalent patients


ON OUR WEBSITE & CD<br />

jkfj Total admission rates per 1,000 patient years: ESRD patients, by primary diagnosis, adjusted<br />

(G.1.1). Total admission rates per 1,000 patients: ESRD patients, adjusted (G.1.2). ESRD patients:<br />

counts of total admissions (G.1.3). Total admission rates per 1,000 patient years: ESRD patients,<br />

adjusted (G.1.4). ESRD patients: counts of total admissions, years at risk, & patients<br />

used to compute total admissions per 1,000 patient years in G.1.4 (G.1.5).<br />

MORBIDITY &<br />

2005<br />

HOSPITALIZATIONG<br />

Annual <strong>Data</strong> Report<br />

Table G.1 G.1<br />

Total admission rates per 1,000 patient years: ESRD patients<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

including<br />

including<br />

all<br />

all<br />

hospitalizations<br />

hospitalizations<br />

from<br />

from<br />

Part<br />

Part A<br />

institutional<br />

institutional<br />

inpatient<br />

inpatient<br />

claims<br />

claims<br />

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 2,219 2,146 2,545 2,273 2,374 2,199 2,142 2,161 2,131 2,219 1,969<br />

5-9 1,557 1,831 1,575 1,734 1,794 1,750 1,946 1,531 2,179 1,428 1,601<br />

10-14 1,537 1,604 1,800 1,408 1,414 1,725 1,414 1,338 1,445 1,652 1,568<br />

15-19 1,641 1,652 1,651 1,560 1,343 1,557 1,602 1,671 1,674 1,760 1,660<br />

20-29 1,723 1,654 1,667 1,631 1,597 1,578 1,605 1,581 1,609 1,652 1,638<br />

30-39 1,732 1,780 1,764 1,761 1,705 1,715 1,749 1,738 1,752 1,783 1,727<br />

40-49 1,706 1,702 1,718 1,747 1,692 1,696 1,753 1,777 1,838 1,847 1,789<br />

50-59 1,836 1,881 1,848 1,881 1,848 1,836 1,889 1,863 1,908 1,899 1,862<br />

60-64 1,909 1,940 1,977 2,000 1,943 1,977 2,007 1,986 1,998 2,030 1,946<br />

65-69 2,052 2,049 2,040 2,052 2,033 2,054 2,083 2,042 2,063 2,063 2,013<br />

70-79 2,096 2,094 2,105 2,138 2,112 2,109 2,148 2,140 2,147 2,117 2,061<br />

80+ 2,237 2,240 2,209 2,239 2,253 2,200 2,285 2,231 2,261 2,201 2,151<br />

Male 1,793 1,812 1,792 1,806 1,776 1,789 1,831 1,809 1,840 1,838 1,805<br />

Female 2,033 2,044 2,071 2,105 2,069 2,070 2,125 2,118 2,151 2,149 2,079<br />

477<br />

White 1,933 1,933 1,954 1,966 1,938 1,955 1,998 1,984 1,999 1,996 1,944<br />

Black 1,923 1,963 1,936 1,979 1,933 1,925 1,983 1,968 2,031 2,026 1,977<br />

Native American 1,871 1,944 2,071 2,008 1,941 1,981 2,044 1,977 1,964 2,006 1,980<br />

Asian 1,196 1,216 1,205 1,251 1,300 1,311 1,366 1,358 1,332 1,349 1,305<br />

†Hispanic 1,859 1,906 1,856 1,896 1,925 1,880<br />

†Non-Hispanic 1,931 1,980 1,969 1,999 1,993 1,940<br />

Diabetes 2,357 2,352 2,320 2,361 2,297 2,302 2,351 2,323 2,331 2,299 2,229<br />

Hypertension 1,872 1,893 1,870 1,872 1,837 1,827 1,874 1,855 1,900 1,902 1,856<br />

Glomerulonephritis 1,535 1,538 1,574 1,549 1,518 1,514 1,526 1,526 1,545 1,546 1,516<br />

Other cause 1,659 1,661 1,683 1,705 1,682 1,693 1,738 1,717 1,751 1,774 1,718<br />

All 1,910 1,925 1,927 1,950 1,916 1,923 1,972 1,956 1,987 1,984 1,933<br />

ADJUSTED<br />

0-19 1,850 2,068 1,841 1,687 1,569 2,083 2,162 2,512 1,957 1,410 1,511<br />

20-44 1,926 1,930 1,928 1,930 1,866 1,864 1,911 1,900 1,947 1,989 1,931<br />

45-64 1,873 1,885 1,869 1,888 1,839 1,837 1,880 1,871 1,898 1,898 1,843<br />

65-74 2,046 2,043 2,028 2,051 2,029 2,031 2,065 2,026 2,038 2,022 1,986<br />

75+ 2,205 2,206 2,196 2,226 2,199 2,172 2,221 2,209 2,222 2,183 2,114<br />

Male 1,902 1,912 1,869 1,883 1,845 1,846 1,883 1,856 1,876 1,864 1,825<br />

Female 2,081 2,080 2,094 2,120 2,077 2,068 2,112 2,104 2,131 2,129 2,058<br />

White 2,029 2,012 2,009 2,012 1,972 1,975 2,005 1,986 1,991 1,983 1,926<br />

Black 2,004 2,038 2,003 2,050 2,001 1,984 2,040 2,025 2,075 2,065 2,016<br />

Native American 1,778 1,843 1,993 1,958 1,926 2,009 2,028 1,875 1,926 1,956 1,892<br />

Asian 1,282 1,295 1,280 1,321 1,363 1,358 1,410 1,397 1,354 1,363 1,314<br />

†Hispanic 1,863 1,898 1,839 1,871 1,903 1,848<br />

†Non-Hispanic 1,960 2,003 1,989 2,014 2,002 1,947<br />

Diabetes 2,369 2,372 2,326 2,368 2,307 2,317 2,369 2,351 2,351 2,317 2,253<br />

Hypertension 1,852 1,864 1,849 1,840 1,812 1,801 1,840 1,825 1,863 1,864 1,819<br />

Glomerulonephritis 1,648 1,636 1,680 1,655 1,632 1,626 1,633 1,640 1,659 1,646 1,617<br />

Other cause 1,714 1,723 1,726 1,767 1,746 1,745 1,787 1,760 1,793 1,817 1,774<br />

All 1,982 1,987 1,972 1,992 1,952 1,949 1,989 1,970 1,995 1,987 1,933<br />

Overall rates are adjusted for age, gender, race, & primary diagnosis;<br />

rates presented by one of these variables are adjusted for the remaining three.<br />

ESRD cohort from 2003 used as reference.<br />

Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.<br />

Age is determined as of January 1 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995. Because the model-based adjustment method<br />

uses data from the current & previous two years, cells for years prior to 1998 have been left blank.


MORBIDITY & HOSPITALIZATION<br />

GReference section G<br />

Table G.2 G.2<br />

Total admission rates per 1,000 patient years: dialysis patients<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

including<br />

including<br />

all<br />

all<br />

hospitalizations<br />

hospitalizations<br />

from<br />

from<br />

Part<br />

Part A<br />

institutional<br />

institutional<br />

inpatient<br />

inpatient<br />

claims<br />

claims<br />

ON OUR WEBSITE & CD<br />

Total admission rates per 1,000 patient years: dialysis patients, by primary diagnosis, adjusted<br />

(G.2.1). Total admission rates per 1,000 patients: dialysis patients, adjusted (G.2.2). Dialysis<br />

patients: counts of total admissions (G.2.3). Total admission rates per 1,000 patient years: dialysis<br />

patients, adjusted (G.2.4). Dialysis patients: counts of total admissions, years at risk, &<br />

patients used to compute total admissions per 1,000 patient years in G.2.4 (G.2.5).<br />

478<br />

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 3,061 3,128 3,765 2,883 2,940 3,040 3,071 2,566 2,774 2,945 2,671<br />

5-9 2,233 2,904 2,579 2,520 2,542 2,413 3,167 2,517 3,745 1,625 2,169<br />

10-14 1,959 1,942 2,570 1,707 1,755 2,120 1,891 1,683 1,871 2,109 1,840<br />

15-19 1,897 1,910 1,865 1,898 1,567 1,734 1,632 1,865 1,871 2,155 1,803<br />

20-29 1,945 1,817 1,793 1,799 1,729 1,684 1,699 1,654 1,714 1,779 1,793<br />

30-39 1,912 1,914 1,918 1,923 1,863 1,860 1,881 1,868 1,890 1,917 1,881<br />

40-49 1,814 1,801 1,837 1,872 1,788 1,794 1,860 1,882 1,944 1,956 1,921<br />

50-59 1,917 1,973 1,930 1,974 1,927 1,919 1,982 1,952 1,997 1,983 1,962<br />

60-64 1,966 1,998 2,033 2,057 2,000 2,042 2,073 2,045 2,065 2,102 2,012<br />

65-69 2,078 2,075 2,063 2,080 2,060 2,085 2,120 2,082 2,103 2,098 2,059<br />

70-79 2,102 2,101 2,112 2,148 2,120 2,117 2,157 2,149 2,158 2,129 2,075<br />

80+ 2,237 2,240 2,210 2,239 2,254 2,201 2,285 2,231 2,261 2,201 2,153<br />

Male 1,886 1,895 1,872 1,898 1,856 1,867 1,908 1,881 1,911 1,910 1,884<br />

Female 2,113 2,120 2,148 2,182 2,141 2,139 2,197 2,190 2,225 2,218 2,156<br />

White 2,067 2,057 2,077 2,094 2,058 2,071 2,110 2,091 2,105 2,097 2,055<br />

Black 1,950 1,986 1,963 2,012 1,959 1,951 2,016 1,999 2,065 2,060 2,016<br />

Native American 1,930 1,971 2,111 2,062 2,004 2,036 2,084 2,020 2,009 2,064 2,026<br />

Asian 1,254 1,255 1,255 1,322 1,352 1,350 1,416 1,417 1,379 1,398 1,357<br />

†Hispanic 1,929 1,984 1,924 1,972 2,003 1,965<br />

†Non-Hispanic 2,008 2,056 2,043 2,074 2,064 2,020<br />

Diabetes 2,413 2,402 2,374 2,418 2,351 2,351 2,404 2,372 2,379 2,340 2,276<br />

Hypertension 1,912 1,934 1,918 1,924 1,878 1,868 1,916 1,896 1,940 1,938 1,903<br />

Glomerulonephritis 1,664 1,629 1,670 1,655 1,613 1,611 1,620 1,613 1,636 1,640 1,623<br />

Other cause 1,780 1,789 1,799 1,832 1,797 1,798 1,838 1,821 1,864 1,896 1,848<br />

All 1,999 2,007 2,009 2,038 1,996 2,000 2,049 2,030 2,062 2,057 2,014<br />

ADJUSTED<br />

0-19 2,313 2,589 2,184 2,091 1,896 2,598 2,477 3,160 2,382 1,677 1,523<br />

20-44 2,113 2,088 2,104 2,124 2,032 2,020 2,064 2,048 2,103 2,137 2,099<br />

45-64 1,941 1,956 1,946 1,970 1,911 1,912 1,963 1,947 1,974 1,977 1,934<br />

65-74 2,060 2,055 2,041 2,068 2,044 2,048 2,085 2,047 2,061 2,046 2,018<br />

75+ 2,205 2,206 2,196 2,227 2,198 2,171 2,222 2,210 2,221 2,183 2,115<br />

Male 1,955 1,959 1,920 1,944 1,895 1,898 1,937 1,906 1,927 1,918 1,887<br />

Female 2,136 2,134 2,155 2,181 2,130 2,120 2,168 2,161 2,194 2,188 2,127<br />

White 2,115 2,095 2,098 2,106 2,056 2,060 2,090 2,067 2,075 2,065 2,021<br />

Black 2,024 2,053 2,022 2,072 2,017 2,000 2,062 2,046 2,099 2,090 2,045<br />

Native American 1,806 1,864 2,030 2,008 1,975 2,048 2,049 1,905 1,969 2,017 1,938<br />

Asian 1,311 1,314 1,309 1,366 1,382 1,370 1,433 1,424 1,370 1,381 1,335<br />

†Hispanic 1,896 1,936 1,868 1,914 1,947 1,902<br />

†Non-Hispanic 2,018 2,063 2,049 2,075 2,064 2,017<br />

Diabetes 2,440 2,438 2,396 2,446 2,376 2,388 2,444 2,426 2,418 2,377 2,317<br />

Hypertension 1,890 1,903 1,896 1,893 1,853 1,844 1,881 1,868 1,908 1,905 1,872<br />

Glomerulonephritis 1,716 1,678 1,731 1,713 1,680 1,681 1,689 1,690 1,711 1,708 1,690<br />

Other cause 1,777 1,793 1,791 1,839 1,812 1,805 1,851 1,826 1,867 1,900 1,866<br />

All 2,036 2,037 2,027 2,052 2,004 2,001 2,045 2,023 2,051 2,043 1,998<br />

Overall rates are adjusted for age, gender, race, & primary diagnosis;<br />

rates presented by one of these variables are adjusted for the remaining three.<br />

ESRD cohort from 2003 used as reference.<br />

Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.<br />

Age is determined as of January 1 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995. Because the model-based adjustment method<br />

uses data from the current & previous two years, cells for years prior to 1998 have been left blank.


ON OUR WEBSITE & CD<br />

Total admission rates per 1,000 patient years: hemodialysis patients, by primary diagnosis, adjusted<br />

(G.3.1). Total admission rates per 1,000 patients: hemodialysis patients, adjusted (G.3.2). Hemodialysis<br />

patients: counts of total admissions (G.3.3). Total admission rates per 1,000 patient years: hemodialysis<br />

patients, adjusted (G.3.4). Hemodialysis patients: counts of total admissions, years at risk, &<br />

patients used to compute total admissions per 1,000 patient years in G.3.4 (G.3.5).<br />

MORBIDITY &<br />

2005<br />

HOSPITALIZATIONG<br />

Annual <strong>Data</strong> Report<br />

Table G.3 G.3<br />

Total admission rates per 1,000 patient years: hemodialysis patients<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

including<br />

including<br />

all<br />

all<br />

hospitalizations<br />

hospitalizations<br />

from<br />

from<br />

Part<br />

Part A<br />

institutional<br />

institutional<br />

inpatient<br />

inpatient<br />

claims<br />

claims<br />

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 1,885 3,015 4,537 3,444 3,809 * 4,340 2,908 * 4,636 3,065<br />

5-9 3,163 2,676 3,833 2,660 3,238 2,877 3,055 2,280 6,916 2,238 2,271<br />

10-14 2,156 1,976 2,754 2,173 1,992 2,436 1,991 2,034 1,999 2,461 2,151<br />

15-19 1,990 1,800 1,938 2,007 1,608 1,616 1,542 1,958 1,876 2,157 1,802<br />

20-29 1,949 1,801 1,745 1,778 1,725 1,659 1,678 1,635 1,722 1,779 1,819<br />

30-39 1,885 1,914 1,885 1,896 1,845 1,831 1,889 1,844 1,896 1,909 1,889<br />

40-49 1,776 1,773 1,808 1,853 1,788 1,804 1,864 1,891 1,947 1,963 1,921<br />

50-59 1,890 1,958 1,890 1,938 1,910 1,895 1,974 1,947 1,994 1,982 1,966<br />

60-64 1,956 1,993 2,011 2,032 1,982 2,019 2,061 2,028 2,069 2,105 2,023<br />

65-69 2,078 2,077 2,046 2,070 2,044 2,079 2,122 2,092 2,101 2,099 2,062<br />

70-79 2,111 2,105 2,112 2,141 2,113 2,109 2,158 2,148 2,161 2,140 2,089<br />

80+ 2,238 2,246 2,206 2,247 2,262 2,208 2,293 2,230 2,266 2,207 2,160<br />

Male 1,876 1,887 1,846 1,880 1,845 1,853 1,902 1,878 1,912 1,911 1,888<br />

Female 2,111 2,124 2,143 2,179 2,147 2,144 2,212 2,199 2,239 2,233 2,175<br />

479<br />

White 2,079 2,070 2,073 2,096 2,062 2,074 2,120 2,099 2,118 2,114 2,073<br />

Black 1,927 1,970 1,939 1,988 1,947 1,937 2,012 1,994 2,061 2,053 2,015<br />

Native American 1,936 1,962 2,056 2,023 1,995 2,024 2,075 2,014 2,004 2,065 2,024<br />

Asian 1,259 1,285 1,268 1,333 1,385 1,373 1,446 1,432 1,397 1,420 1,378<br />

†Hispanic 1,929 1,993 1,941 1,977 2,017 1,977<br />

†Non-Hispanic 2,002 2,060 2,044 2,081 2,071 2,031<br />

Diabetes 2,368 2,372 2,328 2,375 2,315 2,322 2,386 2,353 2,368 2,329 2,268<br />

Hypertension 1,910 1,934 1,912 1,919 1,876 1,869 1,921 1,900 1,942 1,948 1,915<br />

Glomerulonephritis 1,689 1,644 1,664 1,661 1,627 1,610 1,634 1,625 1,648 1,658 1,639<br />

Other cause 1,785 1,792 1,789 1,833 1,813 1,798 1,849 1,827 1,881 1,908 1,869<br />

All 1,994 2,006 1,994 2,028 1,993 1,995 2,053 2,032 2,069 2,064 2,024<br />

ADJUSTED<br />

0-19 2,672 2,490 2,252 2,299 1,980 2,810 2,017 4,580 2,540 1,663 1,528<br />

20-44 2,107 2,103 2,105 2,126 2,034 2,017 2,072 2,044 2,116 2,144 2,117<br />

45-64 1,921 1,940 1,913 1,941 1,900 1,900 1,960 1,942 1,975 1,980 1,940<br />

65-74 2,064 2,055 2,029 2,057 2,030 2,038 2,084 2,051 2,061 2,051 2,026<br />

75+ 2,200 2,209 2,189 2,220 2,196 2,165 2,223 2,204 2,221 2,185 2,122<br />

Male 1,944 1,951 1,896 1,924 1,882 1,882 1,929 1,902 1,926 1,919 1,889<br />

Female 2,130 2,131 2,146 2,172 2,127 2,115 2,174 2,163 2,202 2,199 2,141<br />

White 2,115 2,096 2,085 2,098 2,050 2,054 2,091 2,069 2,084 2,079 2,036<br />

Black 1,999 2,033 1,997 2,047 2,003 1,980 2,052 2,038 2,091 2,081 2,041<br />

Native American 1,811 1,849 1,994 1,972 1,980 2,048 2,042 1,892 1,975 2,026 1,949<br />

Asian 1,301 1,334 1,312 1,358 1,395 1,375 1,449 1,420 1,375 1,388 1,344<br />

†Hispanic 1,891 1,932 1,878 1,916 1,955 1,911<br />

†Non-Hispanic 2,006 2,060 2,045 2,078 2,068 2,025<br />

Diabetes 2,415 2,426 2,371 2,421 2,353 2,372 2,424 2,441 2,413 2,368 2,316<br />

Hypertension 1,892 1,904 1,890 1,888 1,850 1,847 1,885 1,874 1,916 1,917 1,884<br />

Glomerulonephritis 1,737 1,692 1,722 1,714 1,691 1,680 1,701 1,699 1,720 1,723 1,706<br />

Other cause 1,778 1,790 1,777 1,830 1,822 1,801 1,858 1,829 1,882 1,912 1,884<br />

All 2,027 2,031 2,009 2,036 1,994 1,990 2,042 2,021 2,053 2,048 2,005<br />

Overall rates are adjusted for age, gender, race, & primary diagnosis;<br />

rates presented by one of these variables are adjusted for the remaining three.<br />

ESRD cohort from 2003 used as reference.<br />

Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.<br />

Age is determined as of January 1 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995. Because the model-based adjustment method<br />

uses data from the current & previous two years, cells for years prior to 1998 have been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.


MORBIDITY & HOSPITALIZATION<br />

GReference section G<br />

Table G.4 G.4<br />

Total admission rates per 1,000 patient years: CAPD/CCPD patients<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

including<br />

including<br />

all<br />

all<br />

hospitalizations<br />

hospitalizations<br />

from<br />

from<br />

Part<br />

Part A<br />

institutional<br />

institutional<br />

inpatient<br />

inpatient<br />

claims<br />

claims<br />

ON OUR WEBSITE & CD<br />

Total admission rates per 1,000 patient years: CAPD/CCPD patients, by primary diagnosis, adjusted<br />

(G.4.1). Total admission rates per 1,000 patients: CAPD/CCPD patients, adjusted (G.4.2). CAPD/<br />

CCPD patients: counts of total admissions (G.4.3). Total admission rates per 1,000 patient years:<br />

CAPD/CCPD patients, adjusted (G.4.4). CAPD/CCPD patients: counts of total admissions, years at<br />

risk, & patients used to compute total admissions per 1,000 patient years in G.4.4 (G.4.5).<br />

480<br />

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 3,224 2,971 3,497 2,699 2,684 2,744 2,688 2,334 2,762 2,641 2,604<br />

5-9 1,515 3,095 2,068 2,266 2,174 2,015 3,275 2,639 1,687 1,287 2,138<br />

10-14 1,879 1,739 2,398 1,342 1,541 1,895 1,794 1,236 1,772 1,722 1,614<br />

15-19 1,721 2,091 1,714 1,726 1,491 1,959 1,895 1,628 1,792 1,995 1,814<br />

20-29 1,918 1,820 1,957 1,839 1,729 1,767 1,797 1,712 1,669 1,770 1,640<br />

30-39 1,999 1,896 2,010 2,018 1,923 1,996 1,837 1,983 1,848 1,948 1,808<br />

40-49 1,941 1,908 1,949 1,952 1,771 1,726 1,829 1,798 1,907 1,886 1,897<br />

50-59 2,047 2,044 2,133 2,163 2,024 2,087 2,040 1,992 2,011 1,972 1,913<br />

60-64 1,996 2,023 2,167 2,209 2,120 2,240 2,193 2,232 1,995 2,063 1,858<br />

65-69 2,049 2,035 2,168 2,141 2,166 2,132 2,095 1,947 2,116 2,100 2,004<br />

70-79 2,012 2,043 2,095 2,204 2,176 2,205 2,136 2,129 2,099 1,940 1,854<br />

80+ 2,210 2,126 2,242 2,127 2,111 2,050 2,114 2,238 2,148 2,068 1,999<br />

Male 1,918 1,919 2,010 1,997 1,923 1,971 1,958 1,886 1,892 1,881 1,823<br />

Female 2,098 2,068 2,155 2,191 2,086 2,095 2,055 2,086 2,078 2,048 1,942<br />

White 1,988 1,980 2,083 2,072 2,020 2,044 2,031 1,999 1,975 1,929 1,868<br />

Black 2,141 2,115 2,165 2,240 2,076 2,119 2,061 2,065 2,127 2,177 2,030<br />

Native American 1,862 2,023 2,430 2,312 2,109 2,138 2,169 2,003 2,073 2,048 2,050<br />

Asian 1,209 1,088 1,178 1,271 1,150 1,217 1,189 1,279 1,236 1,201 1,164<br />

†Hispanic 1,916 1,902 1,715 1,903 1,825 1,822<br />

†Non-Hispanic 2,045 2,019 2,021 1,996 1,982 1,891<br />

Diabetes 2,648 2,565 2,657 2,700 2,615 2,625 2,613 2,591 2,519 2,502 2,383<br />

Hypertension 1,904 1,918 1,947 1,963 1,884 1,851 1,848 1,809 1,898 1,797 1,722<br />

Glomerulonephritis 1,535 1,551 1,683 1,622 1,539 1,605 1,528 1,513 1,552 1,501 1,499<br />

Other cause 1,735 1,751 1,825 1,819 1,700 1,781 1,758 1,752 1,708 1,776 1,658<br />

All 2,006 1,992 2,081 2,092 2,003 2,032 2,007 1,987 1,985 1,964 1,883<br />

ADJUSTED<br />

0-19 1,402 3,381 2,079 1,640 1,254 2,050 3,017 2,260 2,129 2,008 1,931<br />

20-44 2,162 2,051 2,149 2,154 2,054 2,060 2,042 2,066 2,061 2,141 2,017<br />

45-64 2,050 2,054 2,128 2,155 2,002 2,047 2,043 2,032 2,012 2,015 1,919<br />

65-74 2,079 2,091 2,192 2,248 2,240 2,212 2,146 2,046 2,119 2,060 1,957<br />

75+ 2,357 2,200 2,327 2,397 2,258 2,381 2,292 2,398 2,322 2,342 2,070<br />

Male 2,040 2,014 2,079 2,091 1,997 2,059 2,037 1,962 1,966 1,983 1,893<br />

Female 2,213 2,176 2,267 2,339 2,226 2,232 2,180 2,234 2,237 2,187 2,036<br />

White 2,107 2,078 2,165 2,164 2,097 2,104 2,090 2,060 2,039 1,969 1,902<br />

Black 2,275 2,215 2,293 2,399 2,228 2,324 2,248 2,246 2,283 2,393 2,147<br />

Native American 1,938 2,040 2,382 2,280 2,027 2,119 2,166 2,070 2,081 1,787 1,800<br />

Asian 1,341 1,221 1,286 1,422 1,319 1,399 1,337 1,479 1,385 1,336 1,293<br />

†Hispanic 1,924 1,978 1,746 1,909 1,874 1,828<br />

†Non-Hispanic 2,135 2,110 2,120 2,090 2,047 1,942<br />

Diabetes 2,654 2,563 2,610 2,685 2,587 2,637 2,631 2,600 2,537 2,570 2,406<br />

Hypertension 1,895 1,914 1,948 1,979 1,886 1,863 1,856 1,826 1,916 1,821 1,731<br />

Glomerulonephritis 1,600 1,584 1,797 1,731 1,643 1,712 1,641 1,646 1,704 1,630 1,573<br />

Other cause 1,792 1,788 1,870 1,940 1,778 1,863 1,809 1,849 1,773 1,868 1,720<br />

All 2,120 2,088 2,172 2,213 2,109 2,143 2,108 2,095 2,099 2,083 1,961<br />

Overall rates are adjusted for age, gender, race, & primary diagnosis;<br />

rates presented by one of these variables are adjusted for the remaining three.<br />

ESRD cohort from 2003 used as reference.<br />

Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.<br />

Age is determined as of January 1 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995. Because the model-based adjustment method<br />

uses data from the current & previous two years, cells for years prior to 1998 have been left blank.


ON OUR WEBSITE & CD<br />

Total admission rates per 1,000 patient years: transplant patients, by primary diagnosis, adjusted (G.5.1).<br />

Total admission rates per 1,000 patients: transplant patients, adjusted (G.5.2). Transplant patients: counts<br />

of total admissions (G.5.3). Total admission rates per 1,000 patient years: transplant patients, adjusted<br />

(G.5.4). Transplant patients: counts of total admissions, years at risk, & patients used to compute total<br />

admissions per 1,000 patient years in G.5.4 (G.5.5). Bayesian standardized hospitalization ratios (G.a).<br />

MORBIDITY &<br />

2005<br />

HOSPITALIZATIONG<br />

Annual <strong>Data</strong> Report<br />

Table G.5 G.5<br />

Total admission rates per 1,000 patient years: transplant patients<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

including<br />

including<br />

all<br />

all<br />

hospitalizations<br />

hospitalizations<br />

from<br />

from<br />

Part<br />

Part A<br />

institutional<br />

institutional<br />

inpatient<br />

inpatient<br />

claims<br />

claims<br />

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 1,154 1,054 1,348 1,283 1,510 1,467 1,181 1,510 1,482 1,479 1,139<br />

5-9 802 950 869 955 910 1,143 1,264 981 948 1,112 958<br />

10-14 947 854 860 820 878 1,008 743 817 906 995 957<br />

15-19 849 770 1,034 854 851 942 1,049 1,163 1,079 942 1,039<br />

20-29 828 817 883 799 805 867 860 887 848 871 811<br />

30-39 851 948 858 887 843 844 896 877 864 920 843<br />

40-49 860 891 818 817 843 837 819 803 869 866 778<br />

50-59 897 850 895 865 892 837 827 845 881 877 811<br />

60-64 863 894 860 910 968 906 913 1,008 929 915 947<br />

65-69 870 951 1,033 942 884 933 999 917 991 1,007 934<br />

70-79 1,008 1,000 1,003 874 1,045 954 1,053 980 1,082 1,027 1,029<br />

80+ * * * * * 608 837 1,504 1,469 1,965 525<br />

Male 825 845 827 808 807 802 814 824 836 844 797<br />

Female 925 956 954 938 966 964 971 963 994 1,007 928<br />

481<br />

White 825 850 837 822 820 821 843 855 871 886 824<br />

Black 1,047 1,072 1,051 1,032 1,067 1,040 1,007 1,006 1,026 1,040 973<br />

Native American 980 1,038 1,188 1,051 940 1,055 1,072 1,042 1,104 812 920<br />

Asian 554 522 473 404 563 542 584 507 580 542 522<br />

†Hispanic 848 835 878 875 874 832<br />

†Non-Hispanic 869 883 881 905 916 854<br />

Diabetes 1,321 1,386 1,297 1,304 1,262 1,240 1,238 1,232 1,233 1,252 1,188<br />

Hypertension 878 852 798 766 854 826 795 785 827 893 810<br />

Glomerulonephritis 667 711 719 685 691 653 667 712 731 724 695<br />

Other cause 711 689 724 693 699 758 799 777 795 773 692<br />

All 865 890 878 859 870 867 878 881 901 910 851<br />

ADJUSTED<br />

0-19 652 618 1,250 1,004 941 757 698 510 831 611 949<br />

20-44 1,050 1,065 1,006 996 1,014 997 1,014 987 984 1,055 957<br />

45-64 1,018 1,021 961 958 973 945 923 943 970 957 899<br />

65+ 1,022 1,071 1,166 1,045 1,023 1,012 1,116 1,027 1,115 1,124 1,067<br />

Male 1,019 1,055 1,020 975 969 958 952 939 975 982 936<br />

Female 1,044 1,053 1,094 1,021 1,017 1,014 1,088 1,029 1,093 1,101 1,022<br />

White 994 1,001 970 912 902 910 939 926 974 977 911<br />

Black 1,062 1,133 1,215 1,148 1,140 1,093 1,162 1,099 1,149 1,178 1,115<br />

Other race 891 847 833 762 743 855 907 747 830 714 709<br />

†Hispanic 944 865 875 915 903 862<br />

†Non-Hispanic 951 1,005 968 1,020 1,028 961<br />

Diabetes 1,358 1,353 1,311 1,281 1,185 1,179 1,236 1,230 1,276 1,271 1,218<br />

Hypertension 884 914 922 818 929 906 902 815 878 927 870<br />

Glomerulonephritis 781 825 859 832 854 765 819 818 873 809 816<br />

Other cause 732 780 867 820 780 836 904 819 871 867 740<br />

All 1,029 1,049 1,052 990 983 977 1,016 978 1,029 1,034 972<br />

Overall rates are adjusted for age, gender, race, & primary diagnosis;<br />

rates presented by one of these variables are adjusted for the remaining three.<br />

ESRD cohort from 2003 used as reference.<br />

Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.<br />

Age is determined as of January 1 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995. Because the model-based adjustment method<br />

uses data from the current & previous two years, cells for years prior to 1998 have been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.


MORBIDITY & HOSPITALIZATION<br />

GReference section G<br />

Table G.6 G.6<br />

Hospital days per patient year: ESRD patients<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

including<br />

including<br />

all<br />

all<br />

hospitalizations<br />

hospitalizations<br />

from<br />

from<br />

Part<br />

Part A<br />

institutional<br />

institutional<br />

inpatient<br />

inpatient<br />

claims<br />

claims<br />

ON OUR WEBSITE & CD<br />

Hospital days per patient year: ESRD patients, adjusted (G.6.1). Hospital days per patient:<br />

ESRD patients, adjusted (G.6.2). ESRD patients: counts of total hospital days<br />

(G.6.3). Hospital days per patient year: ESRD patients, adjusted (G.6.4). ESRD patients:<br />

counts of hospital days, years at risk, & patients used to compute hospital days per<br />

patient year in G.6.4 (G.6.5).<br />

482<br />

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 19.0 15.7 17.6 16.2 15.8 14.0 15.3 14.6 17.0 15.3 15.0<br />

5-9 11.6 13.9 10.3 11.9 11.6 11.7 10.2 8.9 10.1 8.2 10.4<br />

10-14 11.5 11.2 11.0 8.3 10.0 10.4 8.9 8.1 8.6 10.5 10.2<br />

15-19 11.4 11.8 10.6 9.3 7.9 9.4 9.0 10.1 10.1 10.2 10.6<br />

20-29 12.1 11.0 10.5 9.8 9.2 9.3 9.1 8.8 9.3 9.5 9.4<br />

30-39 13.1 12.8 11.8 11.2 10.8 10.5 10.8 10.6 10.8 10.9 10.4<br />

40-49 13.6 12.9 12.2 11.9 11.3 11.3 11.8 11.6 12.2 12.2 11.6<br />

50-59 15.3 15.0 14.1 13.7 13.3 13.2 13.6 13.5 14.0 13.8 13.4<br />

60-64 16.3 15.9 15.2 15.0 14.4 14.6 15.0 14.9 15.1 15.4 14.7<br />

65-69 17.7 16.9 16.3 15.5 15.4 15.5 15.8 15.5 15.6 15.7 15.4<br />

70-79 18.1 17.1 16.3 15.9 15.8 15.6 16.1 16.2 16.3 16.1 15.5<br />

80+ 18.7 17.7 16.8 16.3 16.4 16.0 16.8 16.2 16.3 15.9 15.4<br />

Male 14.5 14.0 13.2 12.8 12.4 12.4 12.8 12.7 13.0 12.9 12.6<br />

Female 17.1 16.4 15.8 15.3 15.1 15.0 15.6 15.4 15.8 15.8 15.2<br />

White 16.0 15.2 14.6 14.2 13.9 13.9 14.3 14.2 14.3 14.3 13.8<br />

Black 15.9 15.5 14.5 14.1 13.7 13.6 14.3 14.1 14.7 14.7 14.3<br />

Native American 13.8 14.1 13.7 13.4 13.0 12.7 14.0 13.4 13.2 13.8 13.0<br />

Asian 9.8 9.7 9.3 9.8 10.1 10.0 10.4 10.8 10.9 10.6 10.0<br />

†Hispanic 12.8 13.3 13.0 13.5 13.9 13.5<br />

†Non-Hispanic 13.8 14.3 14.1 14.4 14.3 13.9<br />

Diabetes 20.6 19.5 18.2 17.9 17.1 17.1 17.7 17.5 17.7 17.5 16.7<br />

Hypertension 14.9 14.5 13.5 12.8 12.7 12.5 12.9 12.7 13.1 13.1 12.8<br />

Glomerulonephritis 11.8 11.3 11.1 10.4 10.2 10.0 10.3 10.0 10.2 10.1 10.0<br />

Other cause 13.6 12.9 12.5 12.1 11.8 11.9 12.2 12.0 12.2 12.4 11.9<br />

All 15.8 15.2 14.4 14.0 13.7 13.7 14.2 14.0 14.3 14.3 13.8<br />

ADJUSTED<br />

0-19 15.8 19.1 13.4 12.6 10.5 16.3 15.9 13.2 13.4 8.0 8.4<br />

20-44 14.8 14.2 13.3 12.7 12.0 11.9 12.2 11.8 12.3 12.6 11.9<br />

45-64 15.7 15.1 14.1 13.7 13.2 13.1 13.5 13.4 13.8 13.7 13.2<br />

65-74 17.8 16.9 16.1 15.4 15.2 15.2 15.6 15.4 15.4 15.3 15.0<br />

75+ 18.9 18.0 17.2 16.8 16.5 16.1 16.8 16.6 16.6 16.4 15.7<br />

Male 15.8 15.2 14.0 13.6 13.1 13.1 13.4 13.3 13.4 13.3 12.9<br />

Female 17.6 16.7 16.0 15.4 15.1 15.0 15.4 15.2 15.5 15.5 14.9<br />

White 17.0 16.0 15.1 14.5 14.1 14.1 14.3 14.1 14.2 14.1 13.6<br />

Black 17.0 16.4 15.4 15.0 14.5 14.4 15.0 14.8 15.3 15.2 14.8<br />

Native American 13.2 13.3 13.3 13.1 12.9 12.4 13.8 13.0 12.9 13.1 12.2<br />

Asian 10.7 10.7 10.2 10.6 10.7 10.3 10.7 11.1 11.1 10.7 10.1<br />

†Hispanic 12.9 13.3 12.9 13.4 13.7 13.2<br />

†Non-Hispanic 14.1 14.5 14.4 14.6 14.5 13.9<br />

Diabetes 20.7 19.6 18.2 17.9 17.1 17.1 17.7 17.4 17.7 17.4 16.6<br />

Hypertension 14.6 14.2 13.3 12.6 12.4 12.2 12.5 12.4 12.7 12.7 12.4<br />

Glomerulonephritis 13.2 12.5 12.4 11.5 11.4 11.2 11.5 11.3 11.4 11.2 11.1<br />

Other cause 14.3 13.7 13.2 12.9 12.5 12.5 12.9 12.7 12.7 12.9 12.6<br />

All 16.6 15.8 14.9 14.4 14.0 13.9 14.3 14.2 14.4 14.3 13.8<br />

Overall rates are adjusted for age, gender, race, & primary diagnosis;<br />

rates presented by one of these variables are adjusted for the remaining three.<br />

ESRD cohort from 2003 used as reference.<br />

Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.<br />

Age is determined as of January 1 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995. Because the model-based adjustment method<br />

uses data from the current & previous two years, cells for years prior to 1998 have been left blank.


ON OUR WEBSITE & CD<br />

Hospital days per patient year: dialysis patients, adjusted (G.7.1). Hospital days per patient: dialysis<br />

patients, adjusted (G.7.2). Dialysis patients: counts of total hospital days (G.7.3). Hospital<br />

days per patient year: dialysis patients, adjusted (G.7.4). Dialysis patients: counts of hospital<br />

days, years at risk, & patients used to compute hospital days per patient year in G.7.4 (G.7.5).<br />

MORBIDITY &<br />

2005<br />

HOSPITALIZATIONG<br />

Annual <strong>Data</strong> Report<br />

Table G.7 G.7<br />

Hospital days per patient year: dialysis patients<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

including<br />

including<br />

all<br />

all<br />

hospitalizations<br />

hospitalizations<br />

from<br />

from<br />

Part<br />

Part A<br />

institutional<br />

institutional<br />

inpatient<br />

inpatient<br />

claims<br />

claims<br />

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 25.1 19.7 26.6 21.3 20.0 19.4 20.2 20.3 27.2 19.1 23.0<br />

5-9 14.9 18.4 15.5 16.3 17.4 15.8 14.8 16.5 13.4 10.0 12.5<br />

10-14 15.1 13.7 14.4 9.4 12.6 13.0 11.3 9.7 10.5 12.1 11.3<br />

15-19 11.5 12.6 11.4 10.0 8.8 10.2 8.7 10.9 10.5 11.6 11.4<br />

20-29 12.7 11.3 10.4 10.5 9.5 9.6 9.4 9.0 9.6 10.1 10.2<br />

30-39 13.5 13.0 12.4 11.9 11.5 11.2 11.4 11.1 11.3 11.6 11.2<br />

40-49 13.9 13.1 12.7 12.4 11.7 11.8 12.4 12.1 12.7 12.8 12.3<br />

50-59 15.6 15.4 14.4 14.2 13.7 13.6 14.2 14.0 14.5 14.4 14.1<br />

60-64 16.6 16.2 15.5 15.2 14.7 15.0 15.5 15.3 15.5 15.9 15.2<br />

65-69 17.9 17.0 16.4 15.6 15.5 15.7 16.1 15.8 15.9 16.0 15.7<br />

70-79 18.1 17.2 16.4 16.0 15.8 15.7 16.2 16.3 16.4 16.1 15.5<br />

80+ 18.7 17.7 16.8 16.3 16.4 16.0 16.8 16.2 16.3 15.9 15.4<br />

Male 14.9 14.4 13.5 13.3 12.9 12.9 13.3 13.2 13.4 13.4 13.1<br />

Female 17.7 16.9 16.3 15.9 15.6 15.5 16.2 15.9 16.3 16.3 15.8<br />

483<br />

White 16.9 16.0 15.4 15.0 14.7 14.7 15.1 14.9 15.0 15.0 14.6<br />

Black 15.9 15.5 14.6 14.3 13.8 13.8 14.5 14.3 14.9 14.9 14.5<br />

Native American 13.8 13.9 13.8 13.7 13.3 13.1 14.2 13.7 13.5 14.2 13.2<br />

Asian 10.0 9.9 9.7 10.4 10.5 10.4 10.8 11.4 11.4 11.1 10.5<br />

†Hispanic 13.3 13.9 13.5 14.0 14.5 14.2<br />

†Non-Hispanic 14.3 14.8 14.7 14.9 14.9 14.4<br />

Diabetes 20.9 19.7 18.5 18.2 17.4 17.5 18.1 17.8 18.1 17.8 17.0<br />

Hypertension 15.0 14.7 13.7 13.1 12.9 12.7 13.2 13.0 13.3 13.3 13.1<br />

Glomerulonephritis 12.4 11.7 11.6 10.9 10.7 10.6 10.9 10.5 10.7 10.7 10.7<br />

Other cause 14.3 13.7 13.3 13.0 12.6 12.7 12.9 12.8 13.0 13.3 12.9<br />

All 16.3 15.6 14.9 14.6 14.2 14.2 14.7 14.5 14.8 14.8 14.4<br />

ADJUSTED<br />

0-19 18.1 23.7 18.1 15.3 12.5 18.2 13.5 14.8 15.0 8.8 7.6<br />

20-44 15.4 14.7 14.0 13.7 12.8 12.7 13.0 12.5 13.0 13.4 12.8<br />

45-64 15.9 15.3 14.4 14.1 13.5 13.5 14.0 13.8 14.2 14.2 13.8<br />

65-74 17.9 16.9 16.1 15.5 15.3 15.3 15.6 15.6 15.6 15.5 15.2<br />

75+ 19.0 18.0 17.2 16.8 16.5 16.0 16.8 16.6 16.6 16.4 15.7<br />

Male 15.9 15.2 14.2 13.9 13.3 13.3 13.7 13.5 13.6 13.6 13.2<br />

Female 17.8 16.9 16.3 15.8 15.4 15.3 15.8 15.5 15.9 15.9 15.3<br />

White 17.3 16.3 15.5 15.0 14.6 14.5 14.8 14.6 14.6 14.6 14.2<br />

Black 17.0 16.3 15.4 15.1 14.5 14.4 15.1 14.8 15.3 15.3 14.9<br />

Native American 13.1 13.1 13.4 13.4 13.0 12.7 13.9 13.2 13.0 13.5 12.4<br />

Asian 10.7 10.5 10.3 10.8 10.7 10.4 10.8 11.4 11.3 10.8 10.2<br />

†Hispanic 13.1 13.5 13.1 13.5 14.0 13.6<br />

†Non-Hispanic 14.4 14.8 14.7 14.9 14.8 14.3<br />

Diabetes 21.0 19.9 18.6 18.4 17.4 17.5 18.1 17.8 18.0 17.8 16.9<br />

Hypertension 14.6 14.3 13.4 12.8 12.6 12.4 12.7 12.6 12.9 12.9 12.7<br />

Glomerulonephritis 13.4 12.5 12.5 11.7 11.5 11.4 11.8 11.5 11.6 11.6 11.5<br />

Other cause 14.5 14.0 13.4 13.2 12.9 12.9 13.2 13.1 13.2 13.5 13.2<br />

All 16.7 16.0 15.1 14.7 14.3 14.2 14.7 14.4 14.7 14.6 14.2<br />

Overall rates are adjusted for age, gender, race, & primary diagnosis;<br />

rates presented by one of these variables are adjusted for the remaining three.<br />

ESRD cohort from 2003 used as reference.<br />

Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.<br />

Age is determined as of January 1 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995. Because the model-based adjustment method<br />

uses data from the current & previous two years, cells for years prior to 1998 have been left blank.


MORBIDITY & HOSPITALIZATION<br />

GReference section G<br />

Table G.8 G.8<br />

Hospital days per patient year: hemodialysis patients<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

including<br />

including<br />

all<br />

all<br />

hospitalizations<br />

hospitalizations<br />

from<br />

from<br />

Part<br />

Part A<br />

institutional<br />

institutional<br />

inpatient<br />

inpatient<br />

claims<br />

claims<br />

ON OUR WEBSITE & CD<br />

Hospital days per patient year: hemodialysis patients, adjusted (G.8.1). Hospital days per patient:<br />

hemodialysis patients, adjusted (G.8.2). Hemodialysis patients: counts of total hospital<br />

days (G.8.3). Hospital days per patient year: hemodialysis patients, adjusted (G.8.4). Hemodialysis<br />

patients: counts of hospital days, years at risk, & patients used to compute hospital<br />

days per patient year in G.8.4 (G.8.5).<br />

484<br />

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 22.9 19.3 31.4 24.8 15.2 * 24.6 25.1 * 24.5 18.1<br />

5-9 20.1 22.1 24.5 10.1 22.1 17.0 16.0 12.6 16.3 14.9 12.5<br />

10-14 16.9 11.9 11.8 11.2 12.9 16.1 11.1 11.0 11.7 13.3 13.0<br />

15-19 11.6 10.8 11.7 9.9 8.2 8.5 7.7 10.9 9.7 11.4 11.1<br />

20-29 12.5 11.0 9.9 10.0 9.2 9.0 9.1 8.7 9.4 10.0 10.3<br />

30-39 12.9 12.6 11.9 11.5 11.0 10.7 11.2 10.7 11.2 11.4 11.1<br />

40-49 13.1 12.6 12.0 11.8 11.3 11.6 12.3 11.9 12.4 12.7 12.2<br />

50-59 15.0 14.9 13.8 13.5 13.2 13.1 14.0 13.7 14.3 14.2 14.0<br />

60-64 16.2 15.8 15.0 14.7 14.3 14.6 15.3 15.0 15.4 15.7 15.1<br />

65-69 17.4 16.7 15.8 15.2 15.1 15.4 15.9 15.7 15.7 15.9 15.6<br />

70-79 17.8 16.8 16.1 15.6 15.6 15.5 16.0 16.2 16.3 16.2 15.6<br />

80+ 18.4 17.5 16.6 16.2 16.3 15.9 16.8 16.2 16.3 15.9 15.4<br />

Male 14.5 14.1 13.1 12.9 12.6 12.7 13.2 13.0 13.3 13.4 13.1<br />

Female 17.3 16.5 16.0 15.5 15.3 15.4 16.1 15.9 16.3 16.3 15.8<br />

White 16.5 15.7 15.0 14.7 14.4 14.5 15.0 14.8 14.9 15.0 14.6<br />

Black 15.6 15.2 14.3 13.9 13.6 13.6 14.4 14.1 14.8 14.8 14.4<br />

Native American 13.6 13.4 13.1 13.3 12.9 12.8 14.0 13.6 13.3 14.3 13.0<br />

Asian 10.0 9.9 9.9 10.4 10.5 10.4 10.9 11.6 11.4 11.3 10.6<br />

†Hispanic 13.1 13.8 13.5 13.9 14.5 14.2<br />

†Non-Hispanic 14.1 14.7 14.5 14.8 14.8 14.4<br />

Diabetes 20.1 19.1 17.8 17.6 16.9 17.1 17.8 17.5 17.8 17.6 16.9<br />

Hypertension 14.8 14.4 13.4 12.9 12.7 12.6 13.1 12.9 13.2 13.4 13.1<br />

Glomerulonephritis 12.2 11.5 11.2 10.6 10.5 10.4 10.8 10.4 10.6 10.7 10.6<br />

Other cause 14.1 13.4 13.0 12.7 12.5 12.5 12.9 12.8 12.9 13.2 13.0<br />

All 15.9 15.3 14.5 14.2 13.9 14.0 14.6 14.4 14.7 14.8 14.4<br />

ADJUSTED<br />

0-19 20.6 23.2 19.0 16.4 12.7 22.2 15.3 22.3 15.5 8.6 7.1<br />

20-44 15.0 14.5 13.6 13.4 12.5 12.4 12.9 12.3 12.9 13.4 12.8<br />

45-64 15.3 14.8 13.8 13.5 13.1 13.2 13.8 13.6 14.0 14.1 13.7<br />

65-74 17.5 16.5 15.7 15.0 14.9 15.0 15.5 15.4 15.4 15.4 15.1<br />

75+ 18.5 17.7 16.9 16.5 16.3 15.9 16.7 16.5 16.5 16.3 15.6<br />

Male 15.4 14.9 13.7 13.4 13.0 13.0 13.5 13.3 13.5 13.5 13.1<br />

Female 17.3 16.4 15.8 15.3 15.0 14.9 15.6 15.3 15.7 15.8 15.3<br />

White 16.8 15.9 15.0 14.6 14.2 14.2 14.6 14.4 14.5 14.5 14.1<br />

Black 16.5 16.0 15.0 14.6 14.2 14.1 14.9 14.6 15.2 15.2 14.8<br />

Native American 12.8 12.5 12.9 12.9 12.7 12.3 13.8 13.0 12.8 13.6 12.3<br />

Asian 10.4 10.3 10.2 10.5 10.4 10.2 10.7 11.4 11.1 10.8 10.2<br />

†Hispanic 12.8 13.3 12.9 13.3 13.8 13.5<br />

†Non-Hispanic 14.1 14.7 14.5 14.8 14.7 14.3<br />

Diabetes 20.3 19.5 18.1 17.8 17.0 17.2 17.9 17.6 17.8 17.6 16.8<br />

Hypertension 14.3 13.9 13.0 12.4 12.3 12.1 12.6 12.5 12.8 12.9 12.6<br />

Glomerulonephritis 13.1 12.4 12.1 11.3 11.3 11.2 11.6 11.3 11.4 11.5 11.4<br />

Other cause 14.3 13.6 13.1 12.8 12.7 12.6 13.2 13.0 13.1 13.4 13.2<br />

All 16.3 15.6 14.7 14.3 13.9 13.9 14.5 14.2 14.5 14.5 14.1<br />

Overall rates are adjusted for age, gender, race, & primary diagnosis;<br />

rates presented by one of these variables are adjusted for the remaining three.<br />

ESRD cohort from 2003 used as reference.<br />

Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.<br />

Age is determined as of January 1 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995. Because the model-based adjustment method<br />

uses data from the current & previous two years, cells for years prior to 1998 have been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.


ON OUR WEBSITE & CD<br />

Hospital days per patient year: CAPD/CCPD patients, adjusted (G.9.1). Hospital days per patient:<br />

CAPD/CCPD patients, adjusted (G.9.2). CAPD/CCPD patients: counts of total hospital<br />

days (G.9.3). Hospital days per patient year: CAPD/CCPD patients, adjusted (G.9.4). CAPD/<br />

CCPD patients: counts of hospital days, years at risk, & patients used to compute hospital<br />

days per patient year in G.9.4 (G.9.5).<br />

MORBIDITY &<br />

2005<br />

HOSPITALIZATIONG<br />

Annual <strong>Data</strong> Report<br />

Table G.9 G.9<br />

Hospital days per patient year: CAPD/CCPD patients<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

including<br />

including<br />

all<br />

all<br />

hospitalizations<br />

hospitalizations<br />

from<br />

from<br />

Part<br />

Part A<br />

institutional<br />

institutional<br />

inpatient<br />

inpatient<br />

claims<br />

claims<br />

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 23.5 19.2 25.2 20.2 21.1 20.8 18.8 12.5 23.9 18.4 23.8<br />

5-9 9.6 16.2 11.3 18.0 14.9 14.7 13.3 18.4 11.6 7.5 12.6<br />

10-14 14.8 13.8 17.3 8.0 12.3 10.8 11.5 7.3 9.5 10.8 10.1<br />

15-19 10.9 15.0 10.6 10.4 9.9 13.0 11.4 10.7 12.2 11.6 12.7<br />

20-29 13.2 11.8 12.3 12.0 10.4 11.8 10.7 10.8 10.4 10.5 9.8<br />

30-39 15.4 14.1 13.9 13.7 13.6 13.2 12.7 12.9 12.1 12.6 11.6<br />

40-49 16.5 15.3 15.4 15.2 13.6 12.8 13.1 13.3 14.4 13.6 13.8<br />

50-59 18.5 18.0 17.5 17.6 16.2 17.1 16.3 16.0 16.3 15.9 15.5<br />

60-64 18.7 18.8 18.9 18.2 17.4 18.5 17.7 18.2 17.0 17.6 16.0<br />

65-69 20.3 18.8 19.7 18.5 18.1 17.9 17.6 16.6 17.7 17.4 16.2<br />

70-79 19.7 19.2 18.3 19.1 18.5 18.1 18.0 17.8 18.1 15.9 15.3<br />

80+ 22.8 20.1 19.4 17.5 17.4 16.1 18.2 17.6 17.3 16.6 16.2<br />

Male 16.7 15.9 15.8 15.6 14.7 14.9 14.6 14.4 14.6 14.0 13.6<br />

Female 19.2 18.3 18.2 17.8 17.0 16.8 16.5 16.4 16.8 16.2 15.6<br />

485<br />

White 18.0 17.0 17.1 16.5 15.9 15.9 15.9 15.6 15.7 15.1 14.3<br />

Black 18.8 17.9 17.4 18.0 16.5 16.8 15.6 16.0 16.4 16.2 16.1<br />

Native American 14.9 17.1 18.3 16.3 16.1 15.4 16.4 14.1 16.2 13.6 15.7<br />

Asian 9.8 9.8 8.8 10.9 10.3 9.9 9.8 10.0 11.6 9.5 9.5<br />

†Hispanic 14.9 14.7 13.7 15.5 14.6 14.1<br />

†Non-Hispanic 16.0 15.7 15.7 15.7 15.2 14.6<br />

Diabetes 25.0 23.0 22.6 22.6 21.3 21.2 21.4 21.1 21.1 20.4 19.2<br />

Hypertension 16.6 16.5 15.6 15.0 14.8 14.5 14.0 13.8 14.4 12.9 13.1<br />

Glomerulonephritis 12.9 12.1 13.0 12.3 11.6 11.5 11.2 11.1 11.7 11.0 11.2<br />

Other cause 14.7 14.5 14.3 14.3 13.1 13.8 12.9 13.1 12.9 13.4 12.1<br />

All 17.9 17.1 16.9 16.7 15.8 15.9 15.6 15.5 15.7 15.1 14.6<br />

ADJUSTED<br />

0-19 9.4 27.0 14.7 10.9 8.0 9.0 12.3 10.4 15.1 11.4 12.7<br />

20-44 16.8 15.0 15.3 15.1 14.5 14.3 13.9 13.9 13.9 13.9 13.2<br />

45-64 18.5 18.2 17.6 17.5 16.0 16.5 15.9 16.2 16.3 16.0 15.5<br />

65-74 20.6 19.7 19.9 19.8 19.1 18.8 18.3 17.6 18.3 17.1 16.3<br />

75+ 25.5 21.8 20.8 21.2 19.6 19.7 20.1 20.6 19.7 19.8 17.5<br />

Male 18.6 17.4 16.9 16.9 15.7 16.2 15.9 15.6 15.4 15.1 14.4<br />

Female 21.3 20.2 19.8 19.6 18.7 18.4 18.0 18.2 18.7 17.9 16.9<br />

White 19.6 18.4 18.1 17.5 16.8 16.6 16.7 16.3 16.4 15.6 14.7<br />

Black 22.1 20.2 19.7 20.7 18.6 19.5 18.3 18.9 18.7 19.1 17.8<br />

Native American 17.2 20.9 17.6 16.6 16.0 15.4 15.9 15.8 17.0 13.0 13.7<br />

Asian 12.2 12.3 10.4 12.9 12.2 11.5 11.1 11.8 13.4 10.8 10.8<br />

†Hispanic 15.1 15.5 14.4 15.6 15.4 14.6<br />

†Non-Hispanic 17.1 16.9 16.8 16.9 16.1 15.3<br />

Diabetes 26.0 23.5 22.6 22.8 21.3 21.5 21.7 21.3 21.1 20.9 19.6<br />

Hypertension 16.6 16.7 15.7 15.3 15.0 14.6 14.1 14.1 14.7 13.2 13.2<br />

Glomerulonephritis 14.7 13.4 14.8 14.2 13.1 12.8 12.7 12.9 13.6 12.6 12.5<br />

Other cause 16.1 15.7 15.6 16.4 14.3 14.9 13.8 14.4 13.9 14.9 13.0<br />

All 19.9 18.8 18.3 18.3 17.2 17.3 16.9 16.9 17.0 16.4 15.6<br />

Overall rates are adjusted for age, gender, race, & primary diagnosis;<br />

rates presented by one of these variables are adjusted for the remaining three.<br />

ESRD cohort from 2003 used as reference.<br />

Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.<br />

Age is determined as of January 1 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995. Because the model-based adjustment method<br />

uses data from the current & previous two years, cells for years prior to 1998 have been left blank.


MORBIDITY & HOSPITALIZATION<br />

GReference section G<br />

Table G.10 G.10<br />

Hospital days per patient year: transplant patients<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

including<br />

including<br />

all<br />

all<br />

hospitalizations<br />

hospitalizations<br />

from<br />

from<br />

Part<br />

Part A<br />

institutional<br />

institutional<br />

inpatient<br />

inpatient<br />

claims<br />

claims<br />

ON OUR WEBSITE & CD<br />

Hospital days per patient year: transplant patients, adjusted (G.10.1). Hospital days per patient:<br />

transplant patients, adjusted (G.10.2). Transplant patients: counts of total hospital days<br />

(G.10.3). Hospital days per patient year: transplant patients, adjusted (G.10.4). Transplant patients:<br />

counts of hospital days, years at risk, & patients used to compute hospital days per<br />

patient year in G.10.4 (G.10.5).<br />

486<br />

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 7.8 5.5 6.0 7.2 7.2 7.4 5.9 8.4 6.7 6.8 5.6<br />

5-9 4.2 6.3 5.3 5.9 3.7 6.2 5.7 4.3 5.1 5.2 5.0<br />

10-14 5.7 4.6 4.6 4.2 4.7 5.3 4.1 4.2 5.0 6.2 5.7<br />

15-19 5.8 5.3 6.2 5.2 4.7 4.9 5.3 6.5 6.1 5.8 6.0<br />

20-29 5.8 5.4 5.3 4.4 4.6 5.0 4.7 4.5 4.8 4.9 4.1<br />

30-39 6.6 6.9 5.4 5.4 5.1 5.0 5.4 5.4 5.4 5.6 4.7<br />

40-49 7.4 7.2 5.9 5.7 5.6 5.5 5.5 5.6 6.0 5.8 5.1<br />

50-59 7.7 7.4 7.2 6.4 6.7 6.0 5.6 6.3 6.4 6.2 5.7<br />

60-64 7.2 7.6 6.5 7.5 7.4 6.8 6.8 7.1 7.5 7.2 7.2<br />

65-69 7.6 8.8 8.6 7.0 7.0 6.8 7.4 6.7 7.7 7.7 7.1<br />

70-79 9.3 9.0 8.2 6.5 8.5 7.6 9.7 6.8 8.2 7.7 7.9<br />

80+ * * * * * 4.1 4.2 5.8 12.1 14.9 4.1<br />

Male 6.7 6.7 5.8 5.6 5.4 5.3 5.6 5.7 5.8 5.8 5.3<br />

Female 7.3 7.3 6.6 6.1 6.5 6.3 6.1 6.2 6.8 6.8 6.2<br />

White 6.6 6.7 5.8 5.5 5.5 5.4 5.5 5.6 6.0 5.9 5.3<br />

Black 8.7 8.2 7.6 7.2 7.2 6.9 6.7 6.9 7.2 7.5 6.8<br />

Native American 7.7 8.1 7.8 6.8 7.4 6.4 8.1 6.2 7.3 4.4 5.7<br />

Asian 4.1 4.1 3.2 2.6 4.4 3.2 4.0 3.2 4.2 3.8 3.4<br />

†Hispanic 5.2 5.4 5.4 5.9 5.6 5.3<br />

†Non-Hispanic 5.7 5.8 5.9 6.3 6.3 5.7<br />

Diabetes 11.7 11.7 9.9 9.5 9.3 8.7 8.7 8.8 9.5 9.4 8.4<br />

Hypertension 7.1 6.5 5.4 5.1 5.6 5.4 5.0 5.1 5.8 6.0 5.5<br />

Glomerulonephritis 5.0 5.1 4.7 4.3 4.3 4.0 4.0 4.6 4.5 4.4 4.1<br />

Other cause 5.2 5.1 4.8 4.4 4.4 4.7 5.2 4.8 5.0 4.9 4.3<br />

All 7.0 7.0 6.1 5.8 5.9 5.7 5.8 5.9 6.2 6.2 5.6<br />

ADJUSTED<br />

0-19 4.4 3.6 5.2 6.4 5.3 4.4 3.5 2.4 5.3 3.6 7.1<br />

20-44 8.4 7.9 6.7 6.5 6.5 6.1 6.2 6.0 6.5 6.9 5.6<br />

45-64 9.0 8.8 7.6 7.2 7.3 6.8 6.5 6.8 7.3 7.0 6.6<br />

65+ 9.2 9.8 10.0 7.9 8.4 7.7 8.8 7.5 9.1 8.8 8.5<br />

Male 9.3 9.6 8.5 7.4 7.4 6.9 7.3 6.8 7.4 7.4 6.8<br />

Female 8.9 8.6 8.2 7.3 7.8 7.2 7.4 7.1 8.4 8.2 7.6<br />

White 9.0 8.6 7.5 6.6 6.8 6.5 6.6 6.4 7.2 7.0 6.4<br />

Black 9.0 9.8 10.2 8.7 8.6 8.0 8.7 8.0 9.2 9.2 8.8<br />

Other race 6.6 7.4 5.9 5.0 7.4 5.7 7.9 5.3 6.5 5.5 5.2<br />

†Hispanic 6.5 6.0 5.7 7.3 6.3 5.9<br />

†Non-Hispanic 6.8 7.2 6.9 7.7 7.6 7.0<br />

Diabetes 12.9 12.2 11.0 10.0 9.6 8.5 9.1 8.9 10.3 10.2 9.2<br />

Hypertension 7.1 7.4 6.3 5.5 6.7 6.5 6.0 5.5 6.4 6.4 6.3<br />

Glomerulonephritis 6.2 6.6 6.5 5.9 6.2 5.4 5.7 5.7 5.9 5.5 5.6<br />

Other cause 6.1 6.8 7.3 5.8 5.6 6.0 7.3 5.9 6.4 6.1 5.1<br />

All 9.0 9.0 8.3 7.3 7.5 7.0 7.4 6.9 7.8 7.7 7.2<br />

Overall rates are adjusted for age, gender, race, & primary diagnosis;<br />

rates presented by one of these variables are adjusted for the remaining three.<br />

ESRD cohort from 2003 used as reference.<br />

Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.<br />

Age is determined as of January 1 of each calendar year.<br />

†CMS began collecting Hispanic ethnicity data in April 1995. Because the model-based adjustment method<br />

uses data from the current & previous two years, cells for years prior to 1998 have been left blank.<br />

* Values for cells with 10 or fewer patients are suppressed.


Table G.11 G.11<br />

Inpatient utilization by principal diagnosis of hospitalization: ESRD patients, 2001-2003<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity, &<br />

primary<br />

primary<br />

diagnosis;<br />

diagnosis;<br />

hospitalizations<br />

hospitalizations<br />

per<br />

per<br />

100<br />

100<br />

patient<br />

patient<br />

years<br />

years<br />

MORBIDITY &<br />

2005<br />

HOSPITALIZATIONG<br />

Annual <strong>Data</strong> Report<br />

Number of All Vascular Circulatory Digestive Genitourinary Endocrine Respiratory Infectious All<br />

patients causes access diseases diseases diseases metabolic diseases diseases others<br />

0-4 339 212.3 30.2 11.7 27.3 34.1 16.3 19.4 13.9 59.5<br />

5-9 503 175.8 24.1 20.1 12.0 29.7 8.6 9.4 10.4 61.4<br />

10-14 961 155.2 30.8 18.8 13.5 20.4 8.7 6.2 6.3 50.5<br />

15-19 2,082 170.5 29.3 28.4 13.3 18.3 10.1 8.7 7.0 55.3<br />

20-29 12,714 163.3 30.1 30.3 13.6 10.8 19.5 9.1 6.6 43.4<br />

30-39 29,883 175.5 30.5 34.9 15.0 8.7 24.8 10.0 7.9 43.7<br />

40-49 52,675 182.4 31.6 42.4 16.1 6.9 21.8 11.4 8.2 44.0<br />

50-59 74,315 189.0 30.9 49.7 16.2 6.1 20.2 12.7 8.3 44.8<br />

60-64 46,709 198.9 30.5 57.6 16.4 5.7 18.7 15.2 9.0 45.7<br />

65-69 61,348 204.6 30.8 61.3 17.0 5.9 17.0 16.6 9.6 46.4<br />

70-79 109,355 210.9 31.3 64.9 16.9 5.9 13.9 19.4 10.6 47.9<br />

80+ 51,594 220.2 33.0 66.3 17.7 6.4 10.7 22.8 12.3 51.0<br />

Male 208,243 182.8 27.5 51.1 15.1 5.9 17.0 15.0 8.6 42.7<br />

Female 186,908 212.6 35.4 57.0 17.9 7.5 18.8 15.8 10.1 50.2<br />

487<br />

White 239,529 197.8 28.0 54.7 16.1 7.4 17.9 16.7 9.3 47.7<br />

Black 133,585 201.0 36.4 54.5 17.4 5.8 18.0 13.5 9.6 45.9<br />

Native American 5,552 198.4 36.0 37.6 15.5 6.9 26.6 19.1 8.4 48.3<br />

Asian 13,197 132.8 21.7 39.2 10.8 4.7 10.6 11.9 6.6 27.4<br />

Hispanic 47,233 191.6 33.6 51.2 15.8 6.7 20.7 14.0 8.6 41.1<br />

Non-Hispanic 347,918 197.6 30.8 54.2 16.5 6.6 17.4 15.6 9.4 47.0<br />

Diabetes 165,430 228.5 34.7 61.2 16.9 6.2 30.9 15.8 11.1 51.7<br />

Hypertension 111,216 188.5 30.6 59.2 16.9 5.3 10.0 16.4 8.0 42.0<br />

Glomerulonephritis 47,608 153.6 25.2 40.2 14.8 7.4 8.4 12.8 6.3 38.6<br />

Other cause 70,897 174.8 29.2 40.2 15.9 9.3 9.0 14.7 9.8 46.8<br />

All 395,151 196.8 31.2 53.9 16.4 6.7 17.8 15.4 9.3 46.2<br />

Three years of data are included & age is reclassified on January 1 of each calendar year; therefore,<br />

each patient may contribute to a maximum of two consecutive age groups.


MORBIDITY & HOSPITALIZATION<br />

GReference section G<br />

Table G.12 G.12<br />

Inpatient utilization by principal diagnosis of hospitalization: dialysis patients, 2001-2003<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity, &<br />

primary<br />

primary<br />

diagnosis;<br />

diagnosis;<br />

hospitalizations<br />

hospitalizations<br />

per<br />

per<br />

100<br />

100<br />

patient<br />

patient<br />

years<br />

years<br />

488<br />

Number of All Vascular Circulatory Digestive Genitourinary Endocrine Respiratory Infectious All<br />

patients causes access diseases diseases diseases metabolic diseases diseases others<br />

0-4 166 280.7 77.3 16.7 58.6 34.8 16.1 17.4 11.6 48.3<br />

5-9 210 253.6 64.1 38.3 22.6 26.3 6.9 5.1 5.1 85.3<br />

10-14 478 192.7 66.9 27.1 24.5 15.5 8.4 7.3 5.2 37.8<br />

15-19 1,277 195.0 51.0 38.6 18.4 14.1 12.2 11.4 7.7 41.5<br />

20-29 9,911 176.1 40.7 33.0 15.9 8.1 22.1 10.6 6.7 39.1<br />

30-39 23,870 189.6 39.7 38.9 17.0 7.0 26.1 11.5 8.4 41.2<br />

40-49 44,534 193.9 38.1 45.8 17.9 5.9 22.4 12.6 8.6 42.7<br />

50-59 65,842 198.1 35.6 52.9 17.4 5.3 20.2 13.6 8.6 44.5<br />

60-64 42,885 205.8 33.8 60.3 17.5 4.9 18.6 16.0 9.2 45.5<br />

65-69 58,415 208.6 32.9 62.9 17.6 5.3 16.9 17.2 9.7 46.3<br />

70-79 107,755 212.1 32.0 65.3 17.1 5.7 13.9 19.6 10.6 47.8<br />

80+ 51,535 220.3 33.0 66.4 17.7 6.4 10.7 22.8 12.3 51.0<br />

Male 190,078 190.2 31.1 54.2 16.0 5.1 16.8 16.2 9.0 41.9<br />

Female 174,426 220.0 38.8 60.1 18.9 6.5 18.8 16.7 10.4 49.9<br />

White 217,053 208.5 32.0 59.3 17.3 6.4 17.8 18.3 9.7 47.7<br />

Black 127,012 204.6 39.2 55.9 18.0 5.2 17.8 14.0 9.8 44.7<br />

Native American 5,226 203.4 39.2 39.0 16.2 6.2 26.0 20.1 8.5 48.3<br />

Asian 11,976 137.8 24.6 41.2 11.5 3.6 10.7 12.7 6.8 26.7<br />

Hispanic 43,600 199.3 37.8 54.4 16.8 5.7 20.7 15.0 8.8 40.3<br />

Non-Hispanic 320,904 205.1 34.3 57.4 17.5 5.8 17.3 16.6 9.8 46.5<br />

Diabetes 156,993 233.0 37.3 64.1 17.5 5.7 29.6 16.5 11.3 51.1<br />

Hypertension 106,253 192.5 32.9 60.5 17.5 4.9 9.9 17.1 8.2 41.5<br />

Glomerulonephritis 39,794 163.3 30.8 43.2 16.6 5.8 8.8 14.4 6.5 37.1<br />

Other cause 61,464 186.9 34.8 44.0 17.5 7.7 9.4 16.5 10.5 46.6<br />

All 364,504 204.4 34.7 57.0 17.4 5.8 17.7 16.4 9.7 45.7<br />

Three years of data are included & age is reclassified on January 1 of each calendar year; therefore,<br />

each patient may contribute to a maximum of two consecutive age groups.


Table G.13 G.13<br />

Inpatient utilization by principal diagnosis of hospitalization: hemodialysis patients, 2001-2003<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity, &<br />

primary<br />

primary<br />

diagnosis;<br />

diagnosis;<br />

hospitalizations<br />

hospitalizations<br />

per<br />

per<br />

100<br />

100<br />

patient<br />

patient<br />

years<br />

years<br />

MORBIDITY &<br />

2005<br />

HOSPITALIZATIONG<br />

Annual <strong>Data</strong> Report<br />

Number of All Vascular Circulatory Digestive Genitourinary Endocrine Respiratory Infectious All<br />

patients causes access diseases diseases diseases metabolic diseases diseases others<br />

0-4 29 384.2 146.2 25.1 37.6 45.9 12.5 25.1 16.7 75.2<br />

5-9 81 401.4 103.1 46.7 5.5 26.1 13.8 5.5 6.9 193.8<br />

10-14 248 219.2 91.0 28.4 6.9 18.4 6.5 10.8 8.5 48.8<br />

15-19 965 196.2 55.4 39.2 11.3 13.9 11.6 12.5 8.0 44.3<br />

20-29 8,496 177.2 41.8 34.3 12.7 8.2 22.3 11.1 7.1 39.7<br />

30-39 21,028 189.9 40.3 40.0 14.7 7.0 26.0 11.9 8.9 41.2<br />

40-49 40,232 194.3 38.6 46.9 16.2 5.8 22.0 13.1 8.9 42.8<br />

50-59 60,412 198.2 35.9 53.6 16.2 5.2 19.8 14.1 8.8 44.6<br />

60-64 39,805 206.4 34.3 60.9 16.5 4.9 18.2 16.5 9.5 45.7<br />

65-69 54,142 208.7 33.2 63.2 16.7 5.3 16.4 17.6 9.9 46.3<br />

70-79 101,516 213.0 32.4 65.8 16.5 5.7 13.6 20.1 10.8 48.2<br />

80+ 49,523 220.9 33.3 66.6 17.2 6.4 10.5 23.2 12.5 51.2<br />

Male 176,407 190.5 31.3 54.7 15.0 5.1 16.3 16.7 9.3 42.2<br />

Female 161,513 221.5 39.2 61.5 17.7 6.4 18.3 17.3 10.7 50.4<br />

489<br />

White 198,236 210.1 32.4 60.5 16.2 6.3 17.2 19.1 10.1 48.4<br />

Black 120,976 204.2 39.2 56.5 16.9 5.1 17.6 14.3 10.0 44.6<br />

Native American 4,865 203.1 39.5 39.4 15.2 5.9 25.3 20.9 8.7 48.3<br />

Asian 10,877 139.7 24.9 42.6 10.6 3.6 10.6 13.5 7.1 27.0<br />

Hispanic 40,466 200.4 38.1 55.5 15.7 5.6 20.4 15.5 9.0 40.5<br />

Non-Hispanic 297,454 205.9 34.6 58.3 16.4 5.7 16.8 17.2 10.1 46.9<br />

Diabetes 147,007 232.0 37.6 64.4 16.6 5.7 28.4 16.9 11.5 51.0<br />

Hypertension 99,699 193.4 33.0 61.4 16.6 4.8 9.7 17.7 8.4 41.8<br />

Glomerulonephritis 35,184 164.9 31.0 44.5 15.0 5.7 8.7 15.4 6.8 37.9<br />

Other cause 56,030 188.5 35.2 45.1 16.1 7.5 9.1 17.2 11.0 47.3<br />

All 337,920 205.2 35.1 57.9 16.3 5.7 17.3 17.0 9.9 46.1<br />

Three years of data are included & age is reclassified on January 1 of each calendar year; therefore,<br />

each patient may contribute to a maximum of two consecutive age groups.


MORBIDITY & HOSPITALIZATION<br />

GReference section G<br />

Table G.14 G.14<br />

Inpatient utilization by principal diagnosis of hospitalization: CAPD/CCPD patients, 2001-2003<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity, &<br />

primary<br />

primary<br />

diagnosis;<br />

diagnosis;<br />

hospitalizations<br />

hospitalizations<br />

per<br />

per<br />

100<br />

100<br />

patient<br />

patient<br />

years<br />

years<br />

490<br />

Number of All Vascular Circulatory Digestive Genitourinary Endocrine Respiratory Infectious All<br />

patients causes access diseases diseases diseases Metabolic diseases diseases others<br />

0-4 140 263.4 65.3 15.4 63.0 32.3 16.9 16.1 10.8 43.8<br />

5-9 134 178.3 45.1 33.1 31.7 25.4 3.5 4.9 4.2 30.3<br />

10-14 248 168.5 44.3 25.5 41.8 12.6 10.3 4.1 2.2 27.7<br />

15-19 355 184.6 38.1 36.6 36.6 14.3 14.0 7.0 7.3 30.6<br />

20-29 1,813 170.1 34.8 26.3 32.3 7.6 21.2 7.9 4.5 35.5<br />

30-39 3,668 186.8 35.4 31.1 31.7 7.5 26.7 8.8 5.4 40.3<br />

40-49 5,434 189.2 33.5 36.5 32.4 6.7 25.1 8.1 6.2 40.8<br />

50-59 6,791 196.6 32.4 45.7 29.5 6.1 24.6 8.8 6.8 42.7<br />

60-64 3,575 196.8 28.1 53.2 29.5 5.2 23.8 9.2 6.2 41.8<br />

65-69 4,924 207.3 28.6 58.3 28.6 6.2 22.8 11.2 6.4 45.3<br />

70-79 7,249 196.8 25.3 56.9 26.5 6.7 19.5 11.8 7.5 42.6<br />

80+ 2,161 206.2 26.4 60.3 30.7 7.5 17.0 12.4 7.8 44.1<br />

Male 17,216 186.5 28.3 47.6 28.4 6.0 21.8 9.6 5.8 39.0<br />

Female 16,476 202.3 33.6 44.3 31.7 7.6 23.9 9.6 7.1 44.5<br />

White 23,180 192.3 27.9 47.5 28.3 7.1 23.6 10.2 6.3 41.3<br />

Black 8,362 211.0 39.1 45.9 36.2 6.4 22.2 8.6 7.2 45.4<br />

Native American 459 205.7 34.9 33.8 28.5 9.6 34.4 10.0 6.2 48.3<br />

Asian 1,343 119.9 21.6 28.8 19.6 4.0 11.8 6.1 4.0 24.0<br />

Hispanic 3,960 186.4 34.8 40.6 28.7 6.1 23.6 8.8 6.4 37.4<br />

Non-Hispanic 29,732 195.5 30.3 46.7 30.3 6.9 22.8 9.7 6.5 42.4<br />

Diabetes 12,535 246.5 32.4 59.4 31.4 6.4 46.2 10.6 8.4 51.7<br />

Hypertension 8,267 180.2 30.2 48.1 30.2 5.7 13.0 9.7 5.5 37.8<br />

Glomerulonephritis 5,910 151.4 29.5 33.8 28.0 6.7 9.6 7.7 4.5 31.7<br />

Other cause 6,980 171.9 30.6 34.4 29.9 8.8 11.5 9.8 6.4 40.5<br />

All 33,692 194.4 30.9 45.9 30.1 6.8 22.9 9.6 6.5 41.7<br />

Three years of data are included & age is reclassified on January 1 of each calendar year; therefore,<br />

each patient may contribute to a maximum of two consecutive age groups.


Table G.15 G.15<br />

Inpatient utilization by principal diagnosis of hospitalization: transplant patients, 2001-2003<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity, &<br />

primary<br />

primary<br />

diagnosis;<br />

diagnosis;<br />

hospitalizations<br />

hospitalizations<br />

per<br />

per<br />

100<br />

100<br />

patient<br />

patient<br />

years<br />

years<br />

MORBIDITY &<br />

2005<br />

HOSPITALIZATIONG<br />

Annual <strong>Data</strong> Report<br />

Number of All Vascular Circulatory Digestive Genitourinary Endocrine Respiratory Infectious All<br />

patients causes access diseases diseases diseases metabolic diseases diseases others<br />

0-4 213 136.6 4.2 3.4 10.3 17.1 15.6 20.6 13.7 51.7<br />

5-9 339 100.6 1.1 1.9 5.5 17.8 9.6 11.8 12.6 40.5<br />

10-14 570 95.2 4.0 3.4 5.2 11.0 9.3 5.5 6.7 50.0<br />

15-19 989 102.1 4.0 4.7 6.9 11.0 5.9 4.9 4.9 59.8<br />

20-29 3,949 84.3 2.9 4.5 6.5 9.0 8.7 4.7 5.6 42.4<br />

30-39 8,307 87.6 2.4 5.6 8.1 8.3 13.3 5.3 5.7 39.0<br />

40-49 10,752 83.5 2.0 8.9 6.6 6.7 11.8 5.8 5.5 36.2<br />

50-59 11,195 85.3 1.7 12.1 7.7 6.7 10.6 7.0 5.5 34.0<br />

60-64 4,716 92.9 1.1 16.0 6.9 8.2 10.3 8.2 5.9 36.3<br />

65+ 5,551 100.1 1.4 20.1 8.2 8.1 8.0 9.4 7.0 37.9<br />

Male 25,758 82.4 1.6 10.7 6.9 5.5 10.3 6.4 5.2 35.7<br />

Female 17,825 97.4 2.5 10.3 8.0 11.1 11.4 6.9 6.8 40.5<br />

491<br />

White 30,512 85.9 1.7 10.2 7.2 7.7 10.8 6.4 5.8 36.0<br />

Black 10,738 101.1 2.8 12.2 8.3 8.1 11.4 7.5 6.1 44.8<br />

Native American 497 94.4 1.6 9.9 5.4 10.0 17.6 8.1 6.1 35.6<br />

Asian 1,772 54.6 1.5 5.3 4.5 6.2 4.4 5.4 4.4 23.0<br />

Hispanic 5,619 85.8 1.9 8.5 7.1 9.2 10.8 6.6 5.8 35.8<br />

Non-Hispanic 37,964 88.9 2.0 10.8 7.4 7.5 10.8 6.6 5.9 38.0<br />

Diabetes 11,963 122.2 1.9 15.6 8.2 9.5 24.3 7.8 7.8 47.2<br />

Hypertension 7,837 84.2 2.1 12.7 7.9 6.7 7.0 7.3 5.1 35.3<br />

Glomerulonephritis 11,080 71.5 2.2 7.5 6.6 6.4 5.0 5.8 4.8 33.2<br />

Other cause 12,703 75.1 1.8 7.1 6.9 8.1 5.8 5.8 5.4 34.4<br />

All 43,583 88.5 2.0 10.5 7.3 7.8 10.8 6.6 5.9 37.7<br />

Three years of data are included & age is reclassified on January 1 of each calendar year; therefore,<br />

each patient may contribute to a maximum of two consecutive age groups.


MORBIDITY & HOSPITALIZATION<br />

GReference section G<br />

Table G.16 G.16<br />

Total hospital discharges, by general Diagnostic Related Group<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

ON OUR WEBSITE & CD<br />

Total hospital discharges, by detailed Diagnostic Related Group (G.16.1).<br />

492<br />

1998 1999 2000<br />

ALL Medical Procedure All Medical Procedure All Medical Procedure All<br />

Nervous 22,563 2,906 25,469 23,399 2,921 26,320 24,336 3,061 27,397<br />

Eye 291 463 754 294 380 674 391 334 725<br />

Ear, nose, & throat 1,735 345 2,080 2,086 283 2,369 2,057 289 2,346<br />

Respiratory 35,361 1,697 37,058 38,933 1,842 40,775 39,093 2,266 41,359<br />

Circulatory 101,506 80,612 182,118 109,048 82,614 191,662 116,249 83,598 199,847<br />

Gastrointestinal 31,774 7,944 39,718 32,360 7,792 40,152 34,150 7,781 41,931<br />

Hepatic 6,801 2,955 9,756 7,060 3,013 10,073 7,295 3,181 10,476<br />

Muscular/skeletal 9,476 10,619 20,095 10,555 11,261 21,816 11,190 12,015 23,205<br />

Skin/breast 6,435 3,117 9,552 7,227 3,271 10,498 8,073 3,361 11,434<br />

Endocrine 18,473 4,068 22,541 19,778 4,372 24,150 21,325 4,462 25,787<br />

<strong>Renal</strong> 50,884 28,653 79,537 53,390 27,951 81,341 57,564 28,549 86,113<br />

Male reproductive 361 695 1,056 353 714 1,067 425 761 1,186<br />

Female reproductive 392 855 1,247 418 775 1,193 499 890 1,389<br />

Pregnancy 156 81 237 200 82 282 163 91 254<br />

Hematologic 4,031 252 4,283 4,126 228 4,354 4,542 235 4,777<br />

Myeloproliferative 1,396 326 1,722 1,399 335 1,734 1,445 371 1,816<br />

Infection 22,288 5,728 28,016 22,290 5,248 27,538 22,192 5,290 27,482<br />

Psychological 5,336 282 5,618 5,644 276 5,920 5,605 229 5,834<br />

Injury/poisoning 6,746 4,640 11,386 7,145 4,555 11,700 7,469 4,500 11,969<br />

Burns 98 82 180 155 50 205 133 41 174<br />

Other factors 12,161 1,034 13,195 14,560 1,165 15,725 15,745 1,270 17,015<br />

Unclassifed * 3,468 3,468 * 3,589 3,589 * 3,804 3,804<br />

HIV 1,700 176 1,876 1,910 199 2,109 2,113 210 2,323<br />

All 339,964 160,998 500,962 362,330 162,916 525,246 382,054 166,589 548,643<br />

DIALYSIS<br />

Nervous 18,446 2,235 20,681 18,971 2,323 21,294 19,732 2,399 22,131<br />

Eye 216 364 580 217 296 513 282 275 557<br />

Ear, nose, & throat 1,105 237 1,342 1,307 177 1,484 1,415 191 1,606<br />

Respiratory 29,087 1,254 30,341 31,558 1,374 32,932 31,820 1,756 33,576<br />

Circulatory 86,446 70,636 157,082 93,637 72,475 166,112 99,247 72,968 172,215<br />

Gastrointestinal 25,702 6,240 31,942 25,788 6,121 31,909 26,871 5,997 32,868<br />

Hepatic 5,071 2,143 7,214 5,163 2,169 7,332 5,246 2,188 7,434<br />

Muscular/skeletal 7,534 7,782 15,316 8,396 8,439 16,835 9,011 9,009 18,020<br />

Skin/breast 4,687 2,396 7,083 5,382 2,551 7,933 6,057 2,612 8,669<br />

Endocrine 13,471 3,183 16,654 14,466 3,449 17,915 15,575 3,415 18,990<br />

<strong>Renal</strong> 36,867 16,144 53,011 38,971 15,834 54,805 41,695 15,907 57,602<br />

Male reproductive 252 500 752 232 501 733 283 505 788<br />

Female reproductive 274 552 826 294 475 769 359 545 904<br />

Pregnancy 63 24 87 82 33 115 79 38 117<br />

Hematologic 3,067 114 3,181 3,092 123 3,215 3,321 113 3,434<br />

Myeloproliferative 1,036 227 1,263 1,061 215 1,276 1,081 235 1,316<br />

Infection 17,347 4,649 21,996 17,325 4,272 21,597 17,224 4,209 21,433<br />

Psychological 4,336 258 4,594 4,574 240 4,814 4,457 209 4,666<br />

Injury/poisoning 5,536 3,738 9,274 5,817 3,698 9,515 5,987 3,589 9,576<br />

Burns 71 62 133 125 35 160 109 28 137<br />

Other factors 10,153 909 11,062 12,134 1,006 13,140 13,173 1,073 14,246<br />

Unclassifed * 2,764 2,764 * 2,796 2,796 * 2,976 2,976<br />

HIV 1,596 164 1,760 1,774 188 1,962 1,988 190 2,178<br />

All 272,363 126,575 398,938 290,366 128,790 419,156 305,012 130,427 435,439<br />

One DRG per discharge.<br />

*<br />

Values<br />

Values<br />

for<br />

for<br />

cells<br />

cells<br />

with<br />

with<br />

10<br />

10<br />

or<br />

or<br />

fewer<br />

fewer<br />

discharges<br />

patients are<br />

are<br />

suppressed.<br />

suppressed.


MORBIDITY &<br />

2005<br />

HOSPITALIZATIONG<br />

Annual <strong>Data</strong> Report<br />

Table G.16 G.16 (continued)<br />

Total hospital discharges, by general Diagnostic Related Group<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

1998 1999 2000<br />

HEMODIALYSIS Medical Procedure All Medical Procedure All Medical Procedure All<br />

Nervous 15,866 1,935 17,801 16,699 2,095 18,794 17,562 2,145 19,707<br />

Eye 189 330 519 189 265 454 253 255 508<br />

Ear, nose, & throat 995 208 1,203 1,184 160 1,344 1,308 183 1,491<br />

Respiratory 26,530 1,127 27,657 29,073 1,263 30,336 29,410 1,614 31,024<br />

Circulatory 77,966 65,416 143,382 85,842 67,873 153,715 91,394 68,408 159,802<br />

Gastrointestinal 20,114 4,848 24,962 21,208 4,974 26,182 22,286 4,913 27,199<br />

Hepatic 4,317 1,849 6,166 4,612 1,912 6,524 4,671 1,929 6,600<br />

Muscular/skeletal 6,883 7,061 13,944 7,740 7,780 15,520 8,333 8,359 16,692<br />

Skin/breast 4,225 2,169 6,394 4,904 2,312 7,216 5,525 2,353 7,878<br />

Endocrine 11,176 2,853 14,029 12,429 3,087 15,516 13,493 3,108 16,601<br />

<strong>Renal</strong> 31,827 13,366 45,193 34,355 13,359 47,714 36,838 13,574 50,412<br />

Male reproductive 211 444 655 201 446 647 252 455 707<br />

Female reproductive 230 453 683 259 416 675 312 474 786<br />

Pregnancy 55 22 77 76 30 106 73 36 109<br />

Hematologic 2,645 105 2,750 2,699 114 2,813 2,868 98 2,966<br />

Myeloproliferative 902 203 1,105 903 195 1,098 933 207 1,140<br />

Infection 15,391 4,189 19,580 15,738 3,876 19,614 15,695 3,838 19,533<br />

Psychological 3,919 229 4,148 4,251 214 4,465 4,122 197 4,319<br />

Injury/poisoning 2,913 1,770 4,683 3,201 1,801 5,002 3,447 1,859 5,306<br />

Burns 65 58 123 114 32 146 101 28 129<br />

Other factors 8,919 810 9,729 10,840 902 11,742 11,780 956 12,736<br />

Unclassifed * 2,365 2,365 * 2,426 2,426 * 2,632 2,632<br />

HIV 1,429 141 1,570 1,620 161 1,781 1,841 169 2,010<br />

493<br />

All 236,767 111,951 348,718 258,137 115,693 373,830 272,497 117,790 390,287<br />

PERITONEAL DIALYSIS<br />

Nervous 2,070 223 2,293 1,759 181 1,940 1,632 203 1,835<br />

Eye 22 28 50 21 28 49 19 17 36<br />

Ear, nose, & throat 94 23 117 109 15 124 88 * 93<br />

Respiratory 1,805 79 1,884 1,722 73 1,795 1,574 94 1,668<br />

Circulatory 5,859 3,610 9,469 5,048 3,212 8,260 4,859 3,024 7,883<br />

Gastrointestinal 4,918 1,162 6,080 3,942 947 4,889 3,893 894 4,787<br />

Hepatic 620 245 865 453 208 661 444 210 654<br />

Muscular/skeletal 517 600 1,117 505 546 1,051 461 495 956<br />

Skin/breast 372 192 564 349 199 548 378 207 585<br />

Endocrine 1,930 270 2,200 1,674 307 1,981 1,653 241 1,894<br />

<strong>Renal</strong> 2,777 1,125 3,902 2,351 990 3,341 2,281 921 3,202<br />

Male reproductive 33 39 72 25 36 61 22 27 49<br />

Female reproductive 36 83 119 32 53 85 33 60 93<br />

Pregnancy * * * * * * * * *<br />

Hematologic 326 * 335 303 * 309 321 * 329<br />

Myeloproliferative 42 * 52 52 * 57 66 12 78<br />

Infection 1,459 352 1,811 1,115 268 1,383 1,012 265 1,277<br />

Psychological 332 20 352 241 21 262 244 * 250<br />

Injury/poisoning 2,408 1,793 4,201 2,390 1,710 4,100 2,283 1,518 3,801<br />

Burns * * * * * 13 * * *<br />

Other factors 908 66 974 843 67 910 885 68 953<br />

Unclassifed * 298 298 * 266 266 * 245 245<br />

HIV 135 16 151 130 13 143 123 12 135<br />

All 26,673 10,248 36,921 23,080 9,157 32,237 22,283 8,534 30,817<br />

One DRG per discharge.<br />

*<br />

Values<br />

Values<br />

for<br />

for<br />

cells<br />

cells<br />

with<br />

with<br />

10<br />

10<br />

or<br />

or<br />

fewer<br />

fewer<br />

discharges<br />

patients are<br />

are<br />

suppressed.<br />

suppressed.


MORBIDITY & HOSPITALIZATION<br />

GReference section G<br />

Table G.16 G.16 (continued)<br />

Total hospital discharges, by general Diagnostic Related Group<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

494<br />

1998 1999 2000<br />

TRANSPLANT Medical Procedure All Medical Procedure All Medical Procedure All<br />

Nervous 1,684 271 1,955 1,691 239 1,930 1,905 288 2,193<br />

Eye 39 46 85 48 42 90 49 37 86<br />

Ear, nose, & throat 356 67 423 467 70 537 367 64 431<br />

Respiratory 2,742 216 2,958 3,300 234 3,534 3,231 245 3,476<br />

Circulatory 4,525 2,524 7,049 4,705 2,520 7,225 5,076 2,652 7,728<br />

Gastrointestinal 2,413 711 3,124 2,610 673 3,283 2,936 729 3,665<br />

Hepatic 908 428 1,336 958 426 1,384 999 491 1,490<br />

Muscular/skeletal 946 1,544 2,490 1,089 1,451 2,540 1,043 1,588 2,631<br />

Skin/breast 988 361 1,349 1,019 382 1,401 1,145 381 1,526<br />

Endocrine 2,536 415 2,951 2,624 423 3,047 2,745 502 3,247<br />

<strong>Renal</strong> 6,449 2,051 8,500 6,699 2,046 8,745 7,434 2,194 9,628<br />

Male reproductive 51 88 139 57 103 160 59 129 188<br />

Female reproductive 84 187 271 60 188 248 74 219 293<br />

Pregnancy 70 41 111 84 36 120 59 30 89<br />

Hematologic 424 31 455 432 29 461 537 51 588<br />

Myeloproliferative 178 62 240 141 78 219 180 70 250<br />

Infection 2,186 408 2,594 2,181 355 2,536 2,224 371 2,595<br />

Psychological 429 * 432 448 * 452 509 * 513<br />

Injury/poisoning 339 217 556 392 187 579 451 229 680<br />

Burns 17 11 28 13 * 19 * * 18<br />

Other factors 881 38 919 983 51 1,034 1,058 65 1,123<br />

Unclassifed * 292 292 * 329 329 * 372 372<br />

HIV * * * * * * * * *<br />

All 28,253 10,012 38,265 30,005 9,872 39,877 32,091 10,719 42,810<br />

2001 2002 2003<br />

ALL Medical Procedure All Medical Procedure All Medical Procedure All<br />

Nervous 26,101 3,378 29,479 27,847 3,687 31,534 28,168 3,738 31,906<br />

Eye 344 282 626 383 288 671 379 269 648<br />

Ear, nose, & throat 1,997 314 2,311 2,378 321 2,699 2,598 375 2,973<br />

Respiratory 41,952 2,545 44,497 46,211 2,889 49,100 48,545 3,164 51,709<br />

Circulatory 128,520 85,462 213,982 137,779 85,952 223,731 142,716 85,942 228,658<br />

Gastrointestinal 37,251 8,244 45,495 39,987 8,424 48,411 41,012 8,963 49,975<br />

Hepatic 7,991 3,446 11,437 8,960 3,815 12,775 9,210 4,037 13,247<br />

Muscular/skeletal 12,414 13,436 25,850 12,977 14,521 27,498 13,189 15,681 28,870<br />

Skin/breast 8,743 3,634 12,377 9,457 3,766 13,223 9,345 4,202 13,547<br />

Endocrine 23,955 5,343 29,298 27,773 5,711 33,484 27,798 5,758 33,556<br />

<strong>Renal</strong> 62,009 30,006 92,015 65,050 30,384 95,434 66,713 32,103 98,816<br />

Male reproductive 425 722 1,147 468 774 1,242 545 794 1,339<br />

Female reproductive 501 967 1,468 565 1,064 1,629 595 972 1,567<br />

Pregnancy 148 74 222 154 75 229 165 89 254<br />

Hematologic 5,431 270 5,701 6,100 278 6,378 6,198 266 6,464<br />

Myeloproliferative 1,579 378 1,957 1,743 439 2,182 1,542 371 1,913<br />

Infection 23,953 5,630 29,583 27,243 5,994 33,237 28,632 6,388 35,020<br />

Psychological 5,568 257 5,825 5,695 237 5,932 5,443 227 5,670<br />

Injury/poisoning 7,900 4,836 12,736 7,853 4,777 12,630 7,894 4,666 12,560<br />

Burns 128 28 156 117 36 153 156 35 191<br />

Other factors 15,930 1,325 17,255 15,889 1,261 17,150 15,333 1,261 16,594<br />

Unclassifed * 4,300 4,300 * 5,175 5,175 * 5,311 5,311<br />

HIV 2,163 232 2,395 2,168 229 2,397 2,350 252 2,602<br />

All 415,003 175,109 590,112 446,797 180,097 626,894 458,526 184,864 643,390<br />

One DRG per discharge.<br />

*<br />

Values<br />

Values<br />

for<br />

for<br />

cells<br />

cells<br />

with<br />

with<br />

10<br />

10<br />

or<br />

or<br />

fewer<br />

fewer<br />

discharges<br />

patients are<br />

are<br />

suppressed.<br />

suppressed.


MORBIDITY &<br />

2005<br />

HOSPITALIZATIONG<br />

Annual <strong>Data</strong> Report<br />

Table G.16 G.16 (continued)<br />

Total hospital discharges, by general Diagnostic Related Group<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients<br />

patients<br />

2001 2002 2003<br />

DIALYSIS Medical Procedure All Medical Procedure All Medical Procedure All<br />

Nervous 20,792 2,634 23,426 22,390 2,909 25,299 23,052 3,025 26,077<br />

Eye 264 225 489 296 210 506 295 200 495<br />

Ear, nose, & throat 1,330 193 1,523 1,603 202 1,805 1,763 233 1,996<br />

Respiratory 33,827 1,958 35,785 37,460 2,240 39,700 39,804 2,475 42,279<br />

Circulatory 109,185 73,769 182,954 117,985 74,513 192,498 123,159 74,836 197,995<br />

Gastrointestinal 29,146 6,273 35,419 31,323 6,352 37,675 32,450 6,858 39,308<br />

Hepatic 5,837 2,342 8,179 6,589 2,566 9,155 6,946 2,801 9,747<br />

Muscular/skeletal 9,823 9,926 19,749 10,312 10,886 21,198 10,677 11,967 22,644<br />

Skin/breast 6,523 2,756 9,279 7,146 2,913 10,059 7,200 3,349 10,549<br />

Endocrine 17,415 4,138 21,553 20,568 4,470 25,038 21,164 4,575 25,739<br />

<strong>Renal</strong> 44,718 16,095 60,813 47,211 16,365 63,576 47,847 17,754 65,601<br />

Male reproductive 303 498 801 333 515 848 399 551 950<br />

Female reproductive 370 601 971 401 664 1,065 445 607 1,052<br />

Pregnancy 65 34 99 77 32 109 99 51 150<br />

Hematologic 4,030 157 4,187 4,516 160 4,676 4,699 163 4,862<br />

Myeloproliferative 1,165 230 1,395 1,319 287 1,606 1,135 238 1,373<br />

Infection 18,323 4,426 22,749 21,068 4,695 25,763 22,439 5,172 27,611<br />

Psychological 4,397 223 4,620 4,442 216 4,658 4,344 200 4,544<br />

Injury/poisoning 6,278 3,728 10,006 6,298 3,764 10,062 6,304 3,715 10,019<br />

Burns 105 20 125 91 26 117 122 28 150<br />

Other factors 12,950 1,127 14,077 12,999 1,039 14,038 12,467 1,050 13,517<br />

Unclassifed * 3,224 3,224 * 3,717 3,717 * 3,794 3,794<br />

HIV 2,022 208 2,230 1,995 202 2,197 2,194 225 2,419<br />

495<br />

All 328,868 134,785 463,653 356,422 138,943 495,365 369,004 143,867 512,871<br />

HEMODIALYSIS<br />

Nervous 18,573 2,377 20,950 20,188 2,638 22,826 20,998 2,770 23,768<br />

Eye 239 207 446 268 196 464 277 190 467<br />

Ear, nose, & throat 1,211 172 1,383 1,493 186 1,679 1,647 216 1,863<br />

Respiratory 31,617 1,842 33,459 35,204 2,112 37,316 37,401 2,344 39,745<br />

Circulatory 101,407 69,550 170,957 110,400 70,397 180,797 115,971 70,875 186,846<br />

Gastrointestinal 24,660 5,205 29,865 26,785 5,368 32,153 28,028 5,874 33,902<br />

Hepatic 5,217 2,093 7,310 5,877 2,315 8,192 6,261 2,563 8,824<br />

Muscular/skeletal 9,157 9,199 18,356 9,643 10,188 19,831 10,049 11,250 21,299<br />

Skin/breast 5,994 2,564 8,558 6,651 2,724 9,375 6,653 3,107 9,760<br />

Endocrine 15,280 3,785 19,065 18,380 4,134 22,514 19,008 4,252 23,260<br />

<strong>Renal</strong> 39,902 13,979 53,881 42,661 14,294 56,955 43,461 15,686 59,147<br />

Male reproductive 270 459 729 298 469 767 363 492 855<br />

Female reproductive 329 529 858 353 590 943 393 554 947<br />

Pregnancy 58 29 87 75 28 103 90 46 136<br />

Hematologic 3,520 149 3,669 3,996 150 4,146 4,237 154 4,391<br />

Myeloproliferative 1,023 208 1,231 1,176 258 1,434 1,009 219 1,228<br />

Infection 16,730 4,061 20,791 19,052 4,318 23,370 20,324 4,735 25,059<br />

Psychological 4,119 205 4,324 4,147 203 4,350 4,108 187 4,295<br />

Injury/poisoning 3,797 2,065 5,862 4,078 2,124 6,202 4,094 2,076 6,170<br />

Burns 97 19 116 85 20 105 116 27 143<br />

Other factors 11,596 1,013 12,609 11,901 945 12,846 11,413 966 12,379<br />

Unclassifed * 2,863 2,863 * 3,303 3,303 * 3,387 3,387<br />

HIV 1,892 187 2,079 1,829 187 2,016 2,076 197 2,273<br />

All 296,688 122,760 419,448 324,540 127,147 451,687 337,977 132,167 470,144<br />

One DRG per discharge.<br />

*<br />

Values<br />

Values<br />

for<br />

for<br />

cells<br />

cells<br />

with<br />

with<br />

10<br />

10<br />

or<br />

or<br />

fewer<br />

fewer<br />

discharges<br />

patients are<br />

are<br />

suppressed.<br />

suppressed.


GMORBIDITY & HOSPITALIZATION<br />

GReference section G<br />

Table G.16 (continued)<br />

Total hospital discharges, by by general Diagnostic Related Group<br />

period prevalent patients<br />

496<br />

2001 2002 2003<br />

PERITONEAL DIALYSIS Medical Procedure All Medical Procedure All Medical Procedure All<br />

Nervous 1,662 207 1,869 1,694 206 1,900 1,547 207 1,754<br />

Eye 20 14 34 26 12 38 16 * 25<br />

Ear, nose, & throat 99 17 116 95 15 110 94 14 108<br />

Respiratory 1,430 81 1,511 1,544 80 1,624 1,595 86 1,681<br />

Circulatory 4,904 2,886 7,790 4,833 2,796 7,629 4,823 2,801 7,624<br />

Gastrointestinal 3,824 871 4,695 3,912 826 4,738 3,823 811 4,634<br />

Hepatic 477 190 667 560 198 758 513 175 688<br />

Muscular/skeletal 482 565 1,047 503 582 1,085 473 572 1,045<br />

Skin/breast 411 151 562 387 153 540 432 189 621<br />

Endocrine 1,732 292 2,024 1,828 277 2,105 1,823 270 2,093<br />

<strong>Renal</strong> 2,364 844 3,208 2,277 833 3,110 2,184 863 3,047<br />

Male reproductive 23 27 50 30 29 59 30 43 73<br />

Female reproductive 34 56 90 32 65 97 45 47 92<br />

Pregnancy * * 11 * * * * * 14<br />

Hematologic 400 * 406 407 * 415 378 * 386<br />

Myeloproliferative 36 * 44 44 11 55 36 * 42<br />

Infection 1,062 258 1,320 1,461 282 1,743 1,510 347 1,857<br />

Psychological 216 13 229 234 * 242 185 * 193<br />

Injury/poisoning 2,233 1,490 3,723 1,999 1,481 3,480 2,009 1,473 3,482<br />

Burns * * * * * * * * *<br />

Other factors 905 57 962 734 69 803 752 51 803<br />

Unclassifed * 261 261 * 293 293 * 285 285<br />

HIV 88 14 102 122 * 129 87 21 108<br />

All 22,416 8,313 30,729 22,728 8,239 30,967 22,367 8,291 30,658<br />

TRANSPLANT<br />

Nervous 2,039 291 2,330 2,119 264 2,383 2,016 307 2,323<br />

Eye 40 32 72 44 38 82 40 29 69<br />

Ear, nose, & throat 373 80 453 451 79 530 452 73 525<br />

Respiratory 3,498 279 3,777 3,765 323 4,088 3,960 327 4,287<br />

Circulatory 5,575 2,758 8,333 5,857 2,876 8,733 6,117 3,043 9,160<br />

Gastrointestinal 3,303 813 4,116 3,578 875 4,453 3,744 1,018 4,762<br />

Hepatic 1,032 525 1,557 1,117 604 1,721 1,113 637 1,750<br />

Muscular/skeletal 1,238 1,766 3,004 1,219 1,827 3,046 1,206 1,939 3,145<br />

Skin/breast 1,150 429 1,579 1,194 414 1,608 1,230 341 1,571<br />

Endocrine 3,044 548 3,592 3,413 564 3,977 3,033 549 3,582<br />

<strong>Renal</strong> 8,132 2,315 10,447 8,556 2,244 10,800 9,643 2,418 12,061<br />

Male reproductive 53 87 140 57 120 177 77 126 203<br />

Female reproductive 65 211 276 92 237 329 98 224 322<br />

Pregnancy 48 23 71 48 27 75 38 29 67<br />

Hematologic 599 37 636 686 44 730 705 43 748<br />

Myeloproliferative 166 89 255 180 88 268 184 75 259<br />

Infection 2,319 414 2,733 2,589 444 3,033 2,796 444 3,240<br />

Psychological 463 * 473 492 * 497 578 * 586<br />

Injury/poisoning 452 289 741 449 283 732 506 279 785<br />

Burns * * 16 13 * 16 13 * 19<br />

Other factors 1,147 57 1,204 1,124 66 1,190 1,260 70 1,330<br />

Unclassifed * 397 397 * 422 422 * 449 449<br />

HIV * * 11 * * * * * *<br />

All 34,752 11,461 46,213 37,048 11,847 48,895 38,815 12,434 51,249<br />

* Values for cells with One 10 DRG or per fewer discharge. patients are suppressed.<br />

* Values for cells with 10 or fewer discharges are suppressed.


Reference<br />

H<br />

Section<br />

Mortality &<br />

causes of death


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

498<br />

H.1 . 500<br />

Total patient deaths: ESRD patients<br />

by demographic characteristics, primary diagnosis, & patient vintage<br />

H.2 . 504<br />

Annual mortality rates per 1,000 patient years at risk: ESRD patients<br />

period prevalent patients; 2001 ESRD patients used as reference<br />

H.3 . 506<br />

Total patient deaths: dialysis patients<br />

by demographic characteristics, primary diagnosis, & patient vintage<br />

H.4 . 508<br />

Annual mortality rates per 1,000 patient years at risk: dialysis patients<br />

period prevalent patients; 2001 ESRD patients used as reference<br />

H.5 . 510<br />

Total patient deaths: ESRD patients, never on transplant waitlist<br />

by demographic characteristics, primary diagnosis, & patient vintage<br />

H.6 . 512<br />

Annual mortality rates per 1,000 patient years at risk: dialysis patients, never on<br />

transplant waitlist<br />

period prevalent patients; 2001 ESRD patients used as reference<br />

H.7 . 514<br />

Total patient deaths: dialysis patients, on transplant waitlist<br />

by demographic characteristics, primary diagnosis, & patient vintage<br />

H.8 . 516<br />

Annual mortality rates per 1,000 patient years at risk: dialysis patients, on<br />

transplant waitlist<br />

period prevalent patients; 2001 ESRD patients used as reference<br />

H.9 . 518<br />

Total patient deaths: dialysis patients, returned to dialysis from transplant<br />

by demographic characteristics, primary diagnosis, & patient vintage<br />

H.10 . 520<br />

Annual mortality rates per 1,000 patient years at risk: dialysis patients, returned<br />

to dialysis from transplant<br />

period prevalent patients; 2001 ESRD patients used as reference<br />

H.11 . 522<br />

Total patient deaths: hemodialysis patients<br />

by demographic characteristics, primary diagnosis, & patient vintage<br />

H.12 . 524<br />

Annual mortality rates per 1,000 patient years at risk: hemodialysis patients<br />

period prevalent patients; 2001 ESRD patients used as reference<br />

H.13 . 526<br />

Total patient deaths: hemodialysis patients, never on transplant waitlist<br />

by demographic characteristics, primary diagnosis, & patient vintage<br />

H.14 . 528<br />

Annual mortality rates per 1,000 patient years at risk: hemodialysis patients,<br />

never on transplant waitlist<br />

period prevalent patients; 2001 ESRD patients used as reference<br />

H.15 . 530<br />

Total patient deaths: hemodialysis patients, on transplant waitlist<br />

by demographic characteristics, primary diagnosis, & patient vintage<br />

H.16 . 531<br />

Annual mortality rates per 1,000 patient years at risk: hemodialysis patients, on<br />

transplant waitlist<br />

period prevalent patients; 2001 ESRD patients used as reference<br />

H.17 . 532<br />

Total patient deaths: hemodialysis patients, returned to dialysis from transplant<br />

by demographic characteristics, primary diagnosis, & patient vintage<br />

H.18 . 534<br />

Annual mortality rates per 1,000 patient years at risk: hemodialysis patients<br />

period prevalent patients; 2001 ESRD patients used as reference<br />

H.19 . 536<br />

Total patient deaths: CAPD/CCPD patients<br />

by demographic characteristics, primary diagnosis, & patient vintage<br />

H.20 . 538<br />

Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients<br />

period prevalent patients; 2001 ESRD patients used as reference<br />

H.21 . 540<br />

Total patient deaths: CAPD/CCPD patients, never on transplant waitlist<br />

by demographic characteristics, primary diagnosis, & patient vintage<br />

H.22 . 542<br />

Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, never<br />

on transplant waitlist<br />

period prevalent patients; 2001 ESRD patients used as reference<br />

H.23 . 544<br />

Total patient deaths: CAPD/CCPD patients, on transplant waitlist<br />

by demographic characteristics, primary diagnosis, & patient vintage<br />

H.24 . 545<br />

Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, on<br />

transplant waitlist<br />

period prevalent patients; 2001 ESRD patients used as reference<br />

H.25 . 546<br />

Total patient deaths: CAPD/CCPD patients, returned to dialysis from transplant<br />

by demographic characteristics, primary diagnosis, & patient vintage<br />

H.26 . 548<br />

Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients,<br />

returned to dialysis from transplant<br />

period prevalent patients; 2001 ESRD patients used as reference<br />

H.27 . 550<br />

Total patient deaths: transplant patients<br />

by demographic characteristics, primary diagnosis, & patient vintage


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

499<br />

H.28 . 552<br />

Annual mortality rates per 1,000 patient years at risk: transplant patients<br />

period prevalent patients; 2001 ESRD patients used as reference<br />

H.29 . 554<br />

Mortality rates by primary cause of mortality, unadjusted<br />

rates per 1,000 patient years at risk, period prevalent patients, 2001-2003<br />

combined<br />

H.30 . 557<br />

Mortality rates by cause of withdrawal, unadjusted<br />

rates per 1,000 patient years at risk, period prevalent dialysis patients, 2001-<br />

2003 combined<br />

H.31 . 558<br />

Expected remaining lifetimes (years) of the general U.S. population, & of<br />

prevalent dialysis & transplant patients<br />

general U.S. population, 2002<br />

H.32 . 559<br />

First-year mortality rates, ESRD<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics<br />

H.33 . 560<br />

First-year mortality rates, dialysis<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics<br />

H.34 . 561<br />

First-year mortality rates, hemodialysis<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics<br />

H.35 . 562<br />

First-year mortality rates, CAPD/CCPD<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics<br />

H.36 . 563<br />

First-year mortality rates, transplant<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics<br />

H.37 . 564<br />

Second-year mortality rates, ESRD<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics<br />

H.38 . 565<br />

Second-year mortality rates, dialysis<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics<br />

H.39 . 566<br />

Second-year mortality rates, hemodialysis<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics<br />

H.40 . 567<br />

Second-year mortality rates, CAPD/CCPD<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics<br />

H.41 . 568<br />

Second-year mortality rates, transplant<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics<br />

H.42 . 569<br />

Third-year mortality rates, ESRD<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics<br />

H.43 . 570<br />

Third-year mortality rates, dialysis<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics<br />

H.44 . 571<br />

Third-year mortality rates, hemodialysis<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics<br />

H.45 . 572<br />

Third-year mortality rates, CAPD/CCPD<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics<br />

H.46 . 573<br />

Third-year mortality rates, transplant<br />

per 1,000 patient years at risk, incident patients, by modality &<br />

demographic characteristics


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.1 H.1<br />

Total patient deaths: ESRD patients<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

500<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 10 12 12 15 24 23 33 31 43 39 59 45<br />

5-9 14 19 12 * * 15 13 12 14 14 30 17<br />

10-14 28 13 12 10 18 23 24 19 26 27 41 25<br />

15-19 46 63 34 61 48 48 42 50 56 49 83 59<br />

20-29 356 384 359 383 392 411 453 447 525 558 568 521<br />

30-39 797 822 955 941 1,097 1,209 1,393 1,515 1,615 1,632 1,839 1,829<br />

40-49 1,132 1,276 1,258 1,387 1,545 1,702 1,932 2,083 2,295 2,459 2,853 3,040<br />

50-59 2,207 2,359 2,590 2,964 2,938 3,440 3,550 3,781 4,169 4,394 4,673 4,935<br />

60-64 1,494 1,648 1,898 2,076 2,431 2,810 3,053 3,212 3,586 3,741 4,057 4,348<br />

65-69 1,832 1,992 2,134 2,529 2,764 3,216 3,681 4,007 4,557 4,883 5,398 5,830<br />

70-79 2,421 2,860 3,280 3,822 4,535 5,347 5,964 6,978 7,825 8,518 9,635 10,615<br />

80+ 653 776 907 1,093 1,372 1,675 1,969 2,456 2,933 3,345 3,733 4,417<br />

Unknown<br />

0-19 98 107 70 94 99 109 112 112 139 129 213 146<br />

20-44 1,621 1,770 1,872 1,907 2,200 2,343 2,676 2,914 3,147 3,332 3,718 3,782<br />

45-64 4,365 4,719 5,188 5,844 6,203 7,229 7,705 8,124 9,043 9,452 10,272 10,891<br />

65-74 3,268 3,721 4,094 4,769 5,384 6,280 7,011 7,912 8,856 9,493 10,604 11,641<br />

75+ 1,638 1,907 2,227 2,675 3,287 3,958 4,603 5,529 6,459 7,253 8,162 9,221<br />

Unknown<br />

Male 6,231 7,008 7,570 8,549 9,482 11,054 12,330 13,603 15,172 16,105 17,688 18,940<br />

Female 4,759 5,216 5,881 6,740 7,691 8,865 9,777 10,988 12,472 13,554 15,281 16,741<br />

Unknown . . . . . . . . . . . .<br />

White 7,927 8,882 9,839 11,085 12,385 14,242 15,617 17,420 19,497 20,553 22,982 24,850<br />

Black 2,774 3,027 3,229 3,831 4,378 5,183 5,911 6,537 7,339 8,292 9,075 9,902<br />

Native American 25 29 80 91 122 155 195 225 273 293 350 351<br />

Asian 14 11 57 78 127 184 233 261 318 338 479 497<br />

Other/unknown 250 275 246 204 161 155 151 148 217 183 83 81<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 1,226 1,700 2,405 3,249 3,934 5,029 6,035 6,985 8,021 9,045 10,830 12,451<br />

Hypertension 1,208 1,693 2,370 3,008 3,826 4,777 5,331 6,388 7,480 8,506 9,863 10,957<br />

Glomerulonephritis 983 1,208 1,522 1,763 2,045 2,379 2,757 3,071 3,545 3,667 4,114 4,126<br />

Cystic kidney 262 336 363 454 539 619 720 686 810 814 895 861<br />

Other urologic 147 214 321 418 453 593 738 820 892 981 995 975<br />

Other cause 634 791 1,018 1,372 1,658 1,925 2,131 2,386 2,490 2,695 3,072 3,249<br />

Missing disease 5,550 5,234 4,281 3,927 3,581 3,123 2,952 2,769 2,604 2,041 1,380 1,218<br />

Unknown cause 980 1,048 1,171 1,098 1,137 1,474 1,443 1,486 1,802 1,910 1,820 1,844<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.1 H.1 (continued)<br />

Total patient deaths: ESRD patients<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

patient<br />

patient vintage<br />

vintage<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 47 35 41 42 29 40 32 43 38 53 38 33<br />

5-9 16 19 11 16 18 13 13 20 13 20 10 21<br />

10-14 21 22 21 26 22 26 15 34 20 17 29 33<br />

15-19 49 54 56 61 54 55 54 57 58 55 52 78<br />

20-29 610 587 572 600 590 544 526 547 537 589 614 572<br />

30-39 2,039 2,143 2,243 2,358 2,339 2,245 2,186 2,308 2,208 2,258 2,231 2,146<br />

40-49 3,468 3,703 4,058 4,552 4,724 4,870 5,031 5,355 5,489 5,844 5,972 5,940<br />

50-59 5,388 6,073 6,646 7,194 7,629 8,174 8,843 9,937 10,373 11,148 11,613 12,126<br />

60-64 4,769 4,990 5,296 5,665 5,929 6,214 6,657 7,232 7,417 7,778 7,892 8,537<br />

65-69 6,415 6,902 7,226 7,801 8,162 8,609 8,967 9,325 9,649 10,018 10,031 10,391<br />

70-79 12,481 13,917 14,816 16,515 18,077 19,145 20,966 22,687 23,343 24,255 24,845 25,135<br />

80+ 5,201 6,002 6,926 7,745 8,741 10,034 11,364 12,819 13,920 15,192 16,581 17,576<br />

Unknown<br />

0-19 133 130 129 145 123 134 114 154 129 145 129 165<br />

20-44 4,252 4,408 4,629 4,987 4,963 4,826 4,870 5,053 5,012 5,135 5,229 5,048<br />

45-64 12,022 13,088 14,186 15,382 16,248 17,221 18,373 20,326 21,012 22,482 23,093 24,273<br />

65-74 13,361 14,470 15,384 16,728 17,701 18,552 19,712 20,691 21,247 21,932 22,312 22,558<br />

75+ 10,736 12,351 13,584 15,333 17,279 19,236 21,585 24,140 25,665 27,533 29,145 30,544<br />

Unknown<br />

501<br />

Male 21,402 23,318 25,165 27,472 29,560 31,106 33,646 36,542 38,103 40,482 41,997 43,901<br />

Female 19,102 21,123 22,744 25,100 26,754 28,863 31,008 33,821 34,960 36,742 37,911 38,679<br />

Unknown . * * * . . . * * * . *<br />

White 28,218 30,675 32,555 35,450 37,739 40,211 43,326 46,648 48,577 51,248 53,231 54,865<br />

Black 11,122 12,433 13,707 15,099 16,032 16,877 18,159 20,112 20,720 22,087 22,575 23,446<br />

Native American 406 439 501 551 635 671 677 782 872 850 917 941<br />

Asian 614 716 961 1,177 1,404 1,540 1,705 1,922 1,916 2,121 2,225 2,396<br />

Other/unknown 144 184 188 298 504 670 787 900 980 921 960 940<br />

†Hispanic 4,377 5,186 5,877 6,515 6,917 7,543 8,089 8,656<br />

†Non-Hispanic 51,937 54,783 58,777 63,849 66,148 69,684 71,819 73,932<br />

Diabetes 14,418 16,455 18,025 20,480 22,980 25,061 28,047 31,200 32,345 34,815 35,879 37,242<br />

Hypertension 12,293 13,836 15,012 16,085 16,267 17,365 18,289 19,615 20,389 21,413 22,240 23,028<br />

Glomerulonephritis 4,423 4,626 4,923 5,370 5,617 5,760 5,897 6,237 6,322 6,340 6,492 6,522<br />

Cystic kidney 923 1,024 1,018 1,170 1,174 1,236 1,226 1,311 1,311 1,467 1,415 1,417<br />

Other urologic 1,082 1,115 1,035 1,261 1,497 1,595 1,704 1,917 2,069 2,145 2,260 2,287<br />

Other cause 3,509 3,846 4,307 4,800 5,379 5,548 5,852 6,416 6,668 7,099 7,641 7,928<br />

Missing disease 1,708 1,324 1,391 1,060 1,005 925 1,015 1,000 1,052 885 874 971<br />

Unknown cause 2,148 2,221 2,201 2,349 2,395 2,479 2,624 2,668 2,909 3,063 3,107 3,193<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.1 H.1 (continued)<br />

Total patient deaths: ESRD patients, with unknowns dropped<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

502<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 * 11 * 11 22 22 28 30 42 39 53 42<br />

5-9 13 16 10 * * 12 13 12 14 12 30 15<br />

10-14 21 * * * 17 18 22 18 25 24 40 22<br />

15-19 38 53 27 54 39 42 40 49 51 43 79 53<br />

20-29 300 335 325 355 358 374 419 420 478 513 523 483<br />

30-39 725 756 876 857 1,035 1,126 1,321 1,417 1,510 1,514 1,710 1,694<br />

40-49 1,004 1,171 1,153 1,303 1,449 1,559 1,831 1,982 2,153 2,303 2,718 2,891<br />

50-59 2,010 2,147 2,349 2,757 2,761 3,209 3,319 3,564 3,921 4,159 4,436 4,721<br />

60-64 1,335 1,492 1,724 1,925 2,256 2,607 2,864 3,030 3,363 3,522 3,877 4,163<br />

65-69 1,640 1,789 1,892 2,305 2,558 2,946 3,405 3,754 4,262 4,567 5,116 5,595<br />

70-79 2,104 2,463 2,888 3,430 4,145 4,889 5,502 6,471 7,167 7,871 9,057 10,004<br />

80+ 576 679 795 988 1,234 1,497 1,764 2,226 2,656 3,031 3,437 4,079<br />

0-19 81 89 52 81 86 94 103 109 132 118 202 132<br />

20-44 1,442 1,607 1,715 1,757 2,061 2,169 2,520 2,743 2,936 3,094 3,474 3,527<br />

45-64 3,932 4,294 4,712 5,440 5,798 6,706 7,234 7,670 8,489 8,917 9,790 10,425<br />

65-74 2,882 3,280 3,635 4,314 4,963 5,767 6,501 7,394 8,223 8,874 10,022 11,095<br />

75+ 1,438 1,651 1,940 2,409 2,974 3,565 4,170 5,057 5,862 6,595 7,588 8,583<br />

Male 5,554 6,213 6,791 7,812 8,738 10,136 11,420 12,680 14,047 14,916 16,645 17,852<br />

Female 4,221 4,708 5,263 6,189 7,144 8,165 9,108 10,293 11,595 12,682 14,431 15,910<br />

White 7,179 8,076 8,936 10,228 11,530 13,173 14,560 16,365 18,212 19,266 21,731 23,558<br />

Black 2,558 2,808 2,991 3,616 4,115 4,812 5,565 6,148 6,881 7,736 8,564 9,396<br />

Native American 24 27 72 87 118 146 184 217 254 282 334 339<br />

Asian 14 10 55 70 119 170 219 243 295 314 447 469<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 1,190 1,641 2,362 3,216 3,913 5,009 6,017 6,970 7,993 9,022 10,816 12,428<br />

Hypertension 1,201 1,675 2,350 2,988 3,814 4,764 5,323 6,385 7,466 8,485 9,846 10,943<br />

Glomerulonephritis 960 1,181 1,494 1,745 2,032 2,367 2,743 3,061 3,527 3,650 4,107 4,117<br />

Cystic kidney 259 331 361 449 538 615 718 686 806 810 895 861<br />

Other urologic 147 211 318 416 451 590 737 820 888 976 993 974<br />

Other cause 619 783 1,010 1,364 1,650 1,917 2,127 2,378 2,482 2,689 3,069 3,246<br />

Missing disease 5,399 5,099 4,159 3,823 3,484 3,039 2,863 2,673 2,480 1,966 1,350 1,193<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.1 H.1 (continued)<br />

Total patient deaths: ESRD patients, with unknowns dropped<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

patient<br />

patient vintage<br />

vintage<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 41 32 36 36 25 32 27 36 33 42 31 30<br />

5-9 15 17 10 16 17 13 13 17 12 18 10 18<br />

10-14 19 20 20 21 17 24 13 31 17 13 27 27<br />

15-19 46 47 51 57 49 53 44 53 51 48 48 72<br />

20-29 555 540 532 550 544 504 496 501 495 544 580 535<br />

30-39 1,867 1,964 2,049 2,187 2,162 2,111 2,061 2,171 2,068 2,100 2,102 2,026<br />

40-49 3,255 3,486 3,846 4,318 4,443 4,630 4,756 5,078 5,188 5,567 5,684 5,663<br />

50-59 5,140 5,795 6,381 6,916 7,298 7,791 8,415 9,525 9,883 10,644 11,093 11,589<br />

60-64 4,556 4,787 5,086 5,428 5,698 5,953 6,372 6,890 7,056 7,455 7,546 8,177<br />

65-69 6,093 6,600 6,918 7,474 7,826 8,213 8,566 8,932 9,238 9,621 9,616 9,962<br />

70-79 11,811 13,211 14,124 15,710 17,180 18,171 19,932 21,626 22,221 23,088 23,674 23,969<br />

80+ 4,830 5,560 6,482 7,231 8,187 9,350 10,575 11,969 12,949 14,134 15,464 16,421<br />

0-19 121 116 117 130 108 122 97 137 113 121 116 147<br />

20-44 3,912 4,069 4,294 4,645 4,594 4,551 4,589 4,747 4,697 4,823 4,959 4,784<br />

45-64 11,461 12,503 13,600 14,754 15,551 16,438 17,511 19,418 19,993 21,487 22,046 23,206<br />

65-74 12,706 13,819 14,736 16,002 16,906 17,687 18,807 19,816 20,298 21,003 21,353 21,623<br />

75+ 10,028 11,552 12,788 14,413 16,287 18,047 20,266 22,711 24,110 25,840 27,401 28,729<br />

503<br />

Male 20,094 21,918 23,746 25,975 27,958 29,354 31,797 34,590 35,904 38,217 39,693 41,570<br />

Female 18,134 20,136 21,786 23,968 25,488 27,491 29,473 32,238 33,307 35,057 36,182 36,912<br />

White 26,734 29,143 31,047 33,802 36,089 38,415 41,434 44,694 46,470 49,002 50,935 52,483<br />

Black 10,518 11,827 13,084 14,488 15,401 16,303 17,542 19,536 20,036 21,396 21,900 22,773<br />

Native American 396 422 484 530 610 654 663 760 851 835 894 919<br />

Asian 580 667 920 1,124 1,346 1,473 1,631 1,839 1,854 2,041 2,146 2,314<br />

†Hispanic 3,969 4,604 5,194 5,713 6,015 6,670 7,239 7,765<br />

†Non-Hispanic 49,477 52,241 56,076 61,116 63,196 66,604 68,636 70,724<br />

Diabetes 14,392 16,422 17,986 20,385 22,771 24,693 27,612 30,701 31,774 34,264 35,317 36,704<br />

Hypertension 12,284 13,810 14,991 16,030 16,203 17,278 18,179 19,485 20,250 21,265 22,099 22,876<br />

Glomerulonephritis 4,415 4,617 4,913 5,354 5,592 5,730 5,862 6,184 6,265 6,283 6,428 6,452<br />

Cystic kidney 923 1,023 1,017 1,169 1,170 1,229 1,220 1,307 1,301 1,453 1,405 1,411<br />

Other urologic 1,079 1,112 1,034 1,243 1,475 1,575 1,690 1,897 2,046 2,128 2,243 2,265<br />

Other cause 3,502 3,839 4,287 4,769 5,332 5,504 5,798 6,353 6,587 7,038 7,567 7,853<br />

Missing disease 1,633 1,236 1,307 994 903 836 909 902 988 843 816 928<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.2 H.2<br />

Annual mortality rates per 1,000 patient years at at risk: ESRD patients<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

ON OUR WEBSITE & CD<br />

Annual mortality rates per 1,000 patient years at risk: ESRD patients, by primary<br />

diagnosis, adjusted (H.2.1). Annual deaths per 1,000 patients: ESRD patients, by<br />

primary diagnosis (H.2.2). ESRD patients: counts of total deaths, by primary diagnosis<br />

(H.2.3). Annual mortality rates: ESRD patients, unadjusted (H.2.4).<br />

504<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 116.7 105.6 69.4 53.8 71.0 71.0 78.0 73.0 62.7 63.3 66.7 97.2<br />

5-9 61.6 51.6 41.5 21.8 25.5 33.5 26.4 20.7 11.3 21.3 15.5 20.4<br />

10-14 40.6 20.9 20.3 12.7 15.5 34.3 22.7 20.7 22.3 19.1 13.2 14.6<br />

15-19 27.3 35.5 20.3 34.2 26.4 26.1 23.9 24.0 23.9 19.5 16.9 20.5<br />

20-29 49.0 48.9 42.8 42.9 38.5 39.8 40.1 38.2 44.0 42.2 39.8 38.4<br />

30-39 79.5 72.8 75.5 66.0 71.7 68.2 69.2 70.5 67.2 65.1 65.8 60.4<br />

40-49 111.6 109.6 99.0 98.8 95.3 97.1 102.5 96.3 96.0 90.9 92.1 89.0<br />

50-59 153.0 150.6 150.7 160.0 151.6 161.3 155.0 154.1 156.9 152.2 146.8 140.5<br />

60-64 228.3 212.9 215.4 212.8 220.5 227.0 229.9 223.2 225.5 219.9 208.5 206.3<br />

65-69 288.6 280.7 275.1 287.8 274.6 286.6 293.0 276.7 282.0 276.9 274.4 261.9<br />

70-79 351.4 356.1 351.3 351.1 358.1 368.2 361.2 364.4 364.9 364.3 356.1 342.8<br />

80+ 521.1 541.5 526.2 482.9 511.0 514.1 512.5 483.8 518.7 515.1 472.1 476.8<br />

Male 161.8 163.5 159.2 161.2 163.8 172.2 175.6 173.2 177.1 175.0 171.0 167.3<br />

Female 159.0 151.9 154.1 159.8 164.0 169.8 170.7 170.5 176.0 175.2 175.6 175.0<br />

White 164.3 165.2 164.5 168.0 172.6 179.5 180.2 179.5 185.0 181.9 182.3 181.7<br />

Black 152.2 142.6 138.4 145.3 146.4 155.2 160.9 158.8 162.0 165.5 158.9 155.4<br />

Other race 149.8 146.0 158.6 139.7 138.6 142.3 145.7 140.1 144.4 133.8 132.2 113.9<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 258.4 256.6 257.2 266.9 256.8 265.9 268.3 261.6 256.7 245.8 245.0 239.2<br />

Hypertension 137.6 148.5 157.3 165.1 175.6 190.2 187.9 197.2 205.4 205.3 205.2 204.2<br />

Glomerulonephritis 76.8 80.0 86.2 87.0 88.2 91.5 96.0 97.4 103.9 99.3 101.3 95.9<br />

Other cause 187.3 177.6 166.1 164.4 166.4 167.1 166.0 153.4 154.7 154.9 139.9 134.2<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.2 H.2 (continued)<br />

Annual mortality rates per 1,000 patient years at at risk: ESRD patients<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 87.7 70.2 67.1 64.4 48.7 78.1 47.9 68.2 65.4 79.0 60.2 59.9<br />

5-9 17.7 16.4 10.4 16.6 17.6 13.6 12.6 19.5 15.5 18.0 9.7 17.3<br />

10-14 18.2 15.6 12.8 13.2 13.9 14.6 9.0 20.1 8.2 7.3 15.6 18.2<br />

15-19 22.4 19.2 21.3 23.0 18.6 18.6 20.4 16.4 18.6 17.8 16.1 21.6<br />

20-29 40.2 38.3 36.6 37.1 37.2 32.8 31.4 33.8 31.1 34.7 35.9 34.0<br />

30-39 61.7 63.0 61.2 62.3 60.9 57.2 54.9 57.0 53.4 55.1 53.1 50.1<br />

40-49 90.4 86.7 86.1 89.6 85.3 83.7 81.8 82.7 80.3 83.1 82.0 79.4<br />

50-59 137.3 140.6 138.6 138.7 136.3 133.5 131.3 134.0 128.8 129.4 126.2 124.1<br />

60-64 207.2 205.4 196.8 196.9 194.1 190.5 188.2 192.9 185.6 182.7 175.0 179.5<br />

65-69 258.2 256.8 250.0 250.2 247.8 243.3 244.7 242.3 238.4 236.7 229.5 225.3<br />

70-79 347.3 348.3 334.8 335.2 337.3 328.1 332.9 339.4 331.6 329.8 325.7 317.7<br />

80+ 476.9 475.7 469.0 474.4 470.6 478.9 485.0 502.0 488.1 490.6 489.3 480.5<br />

Male 170.2 171.4 168.6 171.3 171.6 167.8 169.5 173.3 169.9 172.1 169.9 170.0<br />

Female 178.3 182.3 179.5 183.5 183.0 184.8 186.8 192.9 188.7 190.4 188.8 185.4<br />

505<br />

White 186.9 189.3 184.9 188.3 188.6 188.2 191.0 194.6 191.1 192.4 191.4 189.6<br />

Black 155.1 159.1 158.7 161.8 159.8 156.6 157.5 164.5 160.2 164.8 161.2 161.1<br />

Other race 118.5 116.8 124.4 132.7 144.3 147.8 146.8 153.2 149.9 144.1 141.4 137.7<br />

†Hispanic 143.5 150.1 154.4 155.0 148.3 148.7 148.0 146.8<br />

†Non-Hispanic 180.4 178.5 180.2 185.7 182.4 184.7 182.7 181.4<br />

Diabetes 239.7 240.3 233.1 235.1 236.6 232.0 236.7 243.2 233.8 236.4 230.0 227.5<br />

Hypertension 204.3 209.3 207.1 208.1 201.4 202.9 203.3 206.5 203.7 205.8 205.1 202.5<br />

Glomerulonephritis 96.4 94.6 93.2 97.1 95.9 93.3 91.1 92.8 91.1 89.1 88.6 87.1<br />

Other cause 138.1 137.4 132.6 134.8 137.3 134.2 133.4 136.9 136.3 137.4 137.4 136.5<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.3 H.3<br />

Total patient deaths: dialysis patients<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

506<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 * * * * * 10 15 14 12 17 18 26<br />

5-9 * * * * * 10 * * * * * *<br />

10-14 * * * * * 10 10 * 14 13 13 11<br />

15-19 21 31 21 37 27 36 23 27 29 21 24 31<br />

20-29 230 251 244 238 247 281 306 296 372 402 391 384<br />

30-39 519 557 640 634 768 871 941 1,112 1,160 1,206 1,341 1,366<br />

40-49 817 895 904 1,036 1,146 1,301 1,473 1,566 1,719 1,844 2,110 2,294<br />

50-59 1,649 1,794 2,012 2,365 2,461 2,802 2,921 3,061 3,386 3,589 3,741 3,987<br />

60-64 1,174 1,267 1,547 1,711 2,088 2,390 2,599 2,748 3,043 3,192 3,371 3,612<br />

65-69 1,357 1,508 1,625 1,996 2,241 2,684 3,119 3,323 3,824 4,214 4,585 4,956<br />

70-79 1,701 2,041 2,401 2,882 3,706 4,376 4,866 5,619 6,395 7,181 8,054 9,001<br />

80+ 359 440 578 706 1,017 1,225 1,511 1,780 2,255 2,679 2,965 3,644<br />

0-19 41 49 38 51 49 66 52 52 62 58 61 77<br />

20-44 1,095 1,200 1,273 1,290 1,534 1,689 1,874 2,116 2,261 2,450 2,687 2,800<br />

45-64 3,294 3,564 4,074 4,694 5,176 5,956 6,366 6,667 7,419 7,783 8,267 8,843<br />

65-74 2,382 2,764 3,075 3,712 4,397 5,210 5,870 6,486 7,376 8,127 8,939 9,887<br />

75+ 1,035 1,225 1,529 1,872 2,567 3,075 3,626 4,236 5,098 5,947 6,665 7,714<br />

Male 4,320 4,956 5,518 6,336 7,427 8,712 9,731 10,582 11,911 12,985 13,972 15,260<br />

Female 3,527 3,846 4,471 5,283 6,296 7,284 8,057 8,975 10,305 11,380 12,647 14,061<br />

Unknown<br />

White 5,582 6,337 7,152 8,225 9,743 11,198 12,303 13,534 15,312 16,500 18,130 20,050<br />

Black 2,077 2,252 2,558 3,113 3,643 4,400 5,013 5,504 6,285 7,198 7,728 8,503<br />

Native American 19 22 69 71 110 132 166 190 229 257 308 306<br />

Asian * * 36 57 102 154 205 234 270 284 408 417<br />

Other/unknown 161 183 174 153 125 112 101 95 120 126 45 45<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 1,065 1,403 1,964 2,712 3,297 4,257 5,106 5,954 6,857 7,748 9,199 10,602<br />

Hypertension 1,038 1,391 1,900 2,497 3,193 4,014 4,483 5,372 6,356 7,181 8,123 9,168<br />

Glomerulonephritis 834 984 1,232 1,432 1,698 1,967 2,256 2,516 2,949 3,016 3,295 3,392<br />

Cystic kidney 225 294 312 383 449 517 614 571 663 701 722 705<br />

Other urologic 114 172 252 342 382 492 629 695 752 833 834 803<br />

Other cause 555 658 835 1,091 1,355 1,561 1,769 1,986 2,062 2,200 2,441 2,687<br />

Unknown cause 832 872 984 901 956 1,224 1,213 1,225 1,458 1,639 1,437 1,476<br />

Missing disease 3,184 3,028 2,510 2,261 2,393 1,964 1,718 1,238 1,119 1,047 568 488<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.3 H.3 (continued)<br />

Total patient deaths: dialysis patients<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 27 18 22 24 18 22 16 21 27 31 21 22<br />

5-9 * 11 * * 10 * * 12 * 15 * 14<br />

10-14 17 14 11 13 14 15 12 21 * * 17 25<br />

15-19 31 30 29 38 31 35 31 37 32 35 31 44<br />

20-29 438 430 429 438 461 420 419 432 430 467 475 479<br />

30-39 1,526 1,625 1,696 1,838 1,873 1,748 1,713 1,845 1,756 1,798 1,791 1,728<br />

40-49 2,692 2,909 3,076 3,507 3,650 3,818 3,956 4,277 4,383 4,693 4,833 4,834<br />

50-59 4,475 4,911 5,356 5,841 6,190 6,644 7,186 8,045 8,424 9,148 9,579 9,961<br />

60-64 3,973 4,175 4,390 4,740 4,963 5,177 5,559 6,034 6,200 6,432 6,582 7,136<br />

65-69 5,396 5,921 6,158 6,609 6,992 7,319 7,618 7,971 8,150 8,499 8,522 8,779<br />

70-79 10,530 11,856 12,591 14,048 15,360 16,387 17,890 19,451 19,952 20,620 21,180 21,430<br />

80+ 4,262 4,993 5,721 6,464 7,275 8,213 9,258 10,477 11,451 12,600 13,735 14,623<br />

0-19 84 73 69 80 73 81 66 91 73 89 73 105<br />

20-44 3,209 3,371 3,507 3,855 3,879 3,734 3,822 4,028 3,983 4,072 4,221 4,079<br />

45-64 9,895 10,679 11,440 12,509 13,258 14,073 15,011 16,605 17,210 18,466 19,039 20,059<br />

65-74 11,303 12,400 13,191 14,279 15,152 15,874 16,806 17,732 18,069 18,625 18,981 19,201<br />

75+ 8,885 10,370 11,279 12,842 14,475 16,045 17,960 20,167 21,484 23,094 24,456 25,631<br />

507<br />

Male 17,406 19,001 20,414 22,401 24,187 25,447 27,486 29,973 31,292 33,239 34,618 36,289<br />

Female 15,970 17,892 19,072 21,164 22,650 24,360 26,179 28,650 29,527 31,107 32,152 32,786<br />

Unknown<br />

White 22,866 24,986 26,298 28,749 30,686 32,597 35,123 37,923 39,436 41,578 43,438 44,737<br />

Black 9,571 10,822 11,857 13,188 14,083 14,820 15,907 17,673 18,159 19,431 19,796 20,622<br />

Native American 355 393 449 472 559 577 603 690 769 744 823 822<br />

Asian 525 609 797 1,015 1,205 1,350 1,464 1,641 1,671 1,836 1,940 2,107<br />

Other/unknown 59 83 85 141 304 463 568 696 784 757 773 787<br />

†Hispanic 3,696 4,454 5,086 5,648 5,914 6,474 7,016 7,534<br />

†Non-Hispanic 43,141 45,353 48,579 52,975 54,905 57,872 59,754 61,541<br />

Diabetes 12,473 14,234 15,531 17,624 19,870 21,663 24,187 27,051 27,985 30,121 31,159 32,448<br />

Hypertension 10,383 11,760 12,710 13,842 14,016 14,804 15,590 16,668 17,314 18,178 18,884 19,560<br />

Glomerulonephritis 3,717 3,852 4,022 4,406 4,560 4,664 4,781 5,085 5,114 5,107 5,283 5,285<br />

Cystic kidney 759 825 806 915 906 968 924 970 963 1,081 1,038 1,047<br />

Other urologic 939 947 866 1,006 1,209 1,276 1,358 1,550 1,669 1,764 1,841 1,870<br />

Other cause 2,875 3,134 3,431 3,769 4,230 4,375 4,629 5,101 5,313 5,574 6,012 6,165<br />

Unknown cause 1,682 1,758 1,749 1,876 1,912 1,963 2,094 2,100 2,337 2,436 2,488 2,563<br />

Missing disease 548 383 371 127 134 94 102 98 124 85 65 137<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.4 H.4<br />

Annual mortality rates per 1,000 patient years at at risk: dialysis patients<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

ON OUR WEBSITE & CD<br />

Annual mortality rates per 1,000 patient years at risk: dialysis patients, by primary<br />

diagnosis, adjusted (H.4.1). Annual deaths per 1,000 patients: dialysis patients, by<br />

primary diagnosis (H.4.2). Dialysis patients: counts of total deaths, by primary diagnosis<br />

(H.4.3). Annual mortality rates: dialysis patients, unadjusted (H.4.4).<br />

508<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 111.7 135.2 90.5 79.3 94.3 91.1 113.9 100.3 98.0 115.6 120.4 169.1<br />

5-9 75.7 61.5 47.6 26.1 36.5 68.8 23.0 21.2 33.9 39.6 33.4 49.1<br />

10-14 40.3 30.4 24.1 19.3 21.4 46.8 34.0 24.3 44.4 40.6 42.0 31.4<br />

15-19 35.2 42.1 28.1 50.9 39.0 47.6 38.3 40.0 36.6 28.2 26.1 35.5<br />

20-29 67.6 68.8 64.2 60.0 57.9 62.5 66.0 64.1 77.7 75.1 69.2 66.5<br />

30-39 94.6 91.3 95.6 85.8 94.9 98.8 102.1 113.8 108.3 106.9 109.2 101.0<br />

40-49 119.9 120.6 109.9 116.9 112.3 121.2 132.9 131.4 134.0 127.6 129.6 126.3<br />

50-59 160.2 157.6 159.6 171.5 165.2 177.9 176.4 179.3 188.3 185.3 179.4 173.7<br />

60-64 230.5 217.2 219.3 217.9 224.5 234.5 239.8 237.6 243.9 243.4 230.8 230.1<br />

65-69 290.1 282.6 277.0 289.3 276.9 289.9 297.0 283.6 290.2 287.8 285.3 275.8<br />

70-79 352.0 357.0 351.8 352.2 359.4 369.6 362.8 366.4 367.8 367.4 359.8 347.6<br />

80+ 521.2 541.1 526.8 481.9 511.3 514.2 513.9 485.1 519.8 516.3 472.9 477.5<br />

Male 184.4 190.4 190.0 195.7 200.7 217.0 226.9 230.6 238.7 237.7 230.1 225.2<br />

Female 179.0 173.6 176.8 186.3 192.2 202.8 206.9 211.1 220.7 220.8 221.4 220.9<br />

White 191.9 197.7 200.3 209.0 218.0 233.2 240.5 247.9 260.1 258.7 258.9 259.2<br />

Black 160.5 151.5 149.2 158.1 157.7 170.3 178.2 177.7 182.4 186.3 177.9 173.7<br />

Other race 169.7 168.6 187.2 167.5 171.1 179.3 185.9 182.4 190.0 177.8 175.1 150.6<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 287.0 288.9 289.0 305.6 292.2 308.7 315.5 315.1 309.8 295.3 293.1 283.7<br />

Hypertension 148.9 161.5 171.4 181.8 193.2 211.5 209.6 223.7 234.5 234.5 232.8 231.5<br />

Glomerulonephritis 93.0 99.6 109.5 112.6 116.8 124.1 133.6 140.0 154.2 148.5 151.8 146.2<br />

Other cause 209.1 202.2 194.1 196.0 201.9 209.7 217.2 207.6 214.5 221.4 201.1 197.3<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.4 H.4 (continued)<br />

Annual mortality rates per 1,000 patient years at at risk: dialysis patients<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 158.1 132.3 116.9 117.3 89.3 128.2 88.4 121.5 139.9 151.7 108.5 119.0<br />

5-9 53.8 54.1 32.5 38.4 51.1 36.0 40.0 55.1 33.7 62.7 17.5 56.4<br />

10-14 46.1 34.8 30.5 30.9 40.2 38.6 27.4 57.0 19.1 21.1 33.6 52.2<br />

15-19 42.3 30.7 34.7 40.2 33.1 34.7 34.5 33.3 37.8 40.1 33.3 44.0<br />

20-29 71.8 64.9 63.8 63.8 63.3 54.8 53.2 55.5 52.2 56.1 58.5 59.3<br />

30-39 104.9 106.0 103.3 105.0 104.8 95.3 92.7 95.9 89.3 91.1 88.8 83.4<br />

40-49 131.9 128.7 124.8 130.7 124.2 123.4 119.8 123.4 120.1 124.6 124.3 122.3<br />

50-59 174.5 175.9 174.7 175.5 172.1 170.2 169.9 174.4 168.6 171.1 169.4 167.3<br />

60-64 233.6 233.6 224.1 224.5 223.4 220.3 221.4 227.7 220.7 218.4 212.3 219.3<br />

65-69 272.5 273.0 268.6 269.0 269.2 266.9 269.0 270.0 266.0 267.2 261.3 259.0<br />

70-79 352.9 355.2 341.4 342.5 345.8 337.9 343.3 351.4 344.8 344.9 342.8 335.8<br />

80+ 478.0 475.9 469.7 475.5 472.0 480.3 486.4 504.2 490.2 493.4 492.8 484.5<br />

Male 230.9 230.4 226.0 228.3 229.5 224.5 226.5 231.9 227.5 230.4 228.6 229.4<br />

Female 225.5 230.7 226.3 231.4 230.8 233.0 236.7 245.5 240.3 243.4 242.9 239.3<br />

509<br />

White 268.4 271.5 264.4 268.2 269.8 269.1 274.1 280.6 275.3 277.2 278.3 276.3<br />

Black 174.2 177.8 177.4 181.3 179.7 176.7 177.8 185.9 181.5 187.5 183.7 184.3<br />

Other race 155.2 152.2 160.5 168.3 181.1 185.1 183.9 192.4 187.8 180.6 177.5 173.8<br />

†Hispanic 179.5 186.6 192.6 194.1 184.4 185.1 185.7 185.5<br />

†Non-Hispanic 235.8 233.7 236.4 244.3 240.4 244.1 242.9 241.8<br />

Diabetes 283.6 283.0 273.5 275.0 276.9 270.2 274.4 282.8 271.2 273.9 267.2 264.6<br />

Hypertension 232.2 237.3 234.2 236.4 230.1 232.7 234.2 238.4 235.3 238.2 237.8 235.8<br />

Glomerulonephritis 150.3 147.4 144.5 149.6 146.9 144.0 142.5 147.1 144.2 142.4 145.7 144.8<br />

Other cause 207.6 207.0 202.3 205.1 210.8 207.9 208.5 214.2 215.9 219.1 222.2 222.0<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.5 H.5<br />

Total patient deaths: dialysis patients, never on on transplant waitlist<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

510<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 * * * * * 10 15 14 11 17 15 23<br />

5-9 * * * * * 10 * * * * * *<br />

10-14 * * * * * 10 10 * 11 12 10 *<br />

15-19 21 31 21 37 27 36 23 27 27 18 19 25<br />

20-29 230 251 244 238 247 281 305 294 356 366 352 329<br />

30-39 519 557 640 633 768 871 941 1,097 1,117 1,118 1,220 1,202<br />

40-49 817 895 904 1,036 1,146 1,300 1,473 1,552 1,644 1,718 1,972 2,111<br />

50-59 1,649 1,794 2,012 2,365 2,461 2,802 2,921 3,053 3,326 3,486 3,599 3,791<br />

60-64 1,174 1,267 1,547 1,711 2,088 2,390 2,599 2,745 3,021 3,161 3,302 3,545<br />

65-69 1,357 1,508 1,625 1,996 2,241 2,684 3,119 3,322 3,808 4,194 4,556 4,925<br />

70-79 1,701 2,041 2,401 2,882 3,706 4,376 4,866 5,619 6,391 7,176 8,045 8,983<br />

80+ 359 440 578 706 1,017 1,225 1,511 1,780 2,255 2,679 2,965 3,643<br />

0-19 41 49 38 51 49 66 52 52 56 51 49 63<br />

20-44 1,095 1,200 1,273 1,289 1,534 1,688 1,873 2,094 2,161 2,259 2,457 2,490<br />

45-64 3,294 3,564 4,074 4,694 5,176 5,956 6,366 6,647 7,303 7,590 7,988 8,488<br />

65-74 2,382 2,764 3,075 3,712 4,397 5,210 5,870 6,485 7,358 8,102 8,901 9,843<br />

75+ 1,035 1,225 1,529 1,872 2,567 3,075 3,626 4,236 5,096 5,947 6,665 7,708<br />

Male 4,320 4,956 5,518 6,336 7,427 8,711 9,730 10,557 11,769 12,743 13,625 14,828<br />

Female 3,527 3,846 4,471 5,282 6,296 7,284 8,057 8,957 10,205 11,206 12,435 13,764<br />

Unknown<br />

White 5,582 6,337 7,152 8,225 9,743 11,198 12,302 13,504 15,149 16,208 17,752 19,536<br />

Black 2,077 2,252 2,558 3,112 3,643 4,399 5,013 5,494 6,218 7,092 7,560 8,307<br />

Native American 19 22 69 71 110 132 166 190 227 250 304 294<br />

Asian * * 36 57 102 154 205 233 263 274 399 410<br />

Other/unknown 161 183 174 153 125 112 101 93 117 125 45 45<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 1,065 1,403 1,964 2,712 3,297 4,257 5,106 5,937 6,761 7,597 9,004 10,340<br />

Hypertension 1,038 1,391 1,900 2,496 3,193 4,014 4,483 5,368 6,319 7,117 8,019 9,032<br />

Glomerulonephritis 834 984 1,232 1,432 1,698 1,967 2,256 2,505 2,909 2,934 3,174 3,246<br />

Cystic kidney 225 294 312 383 449 517 614 570 652 677 698 669<br />

Other urologic 114 172 252 342 382 492 629 694 748 824 827 792<br />

Other cause 555 658 835 1,091 1,355 1,561 1,769 1,982 2,032 2,151 2,371 2,601<br />

Unknown cause 832 872 984 901 956 1,223 1,213 1,224 1,452 1,620 1,417 1,445<br />

Missing disease 3,184 3,028 2,510 2,261 2,393 1,964 1,717 1,234 1,101 1,029 550 467<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.5 H.5 (continued)<br />

Total patient deaths: dialysis patients, never on on transplant waitlist<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 24 17 19 23 15 21 13 19 24 29 20 18<br />

5-9 * * * * * * * 11 * * * 13<br />

10-14 12 12 * 10 10 12 * 14 * * 10 15<br />

15-19 29 20 17 27 25 24 19 28 23 24 18 33<br />

20-29 376 365 348 350 362 318 298 317 317 341 351 341<br />

30-39 1,346 1,430 1,468 1,566 1,541 1,403 1,392 1,462 1,371 1,406 1,406 1,344<br />

40-49 2,437 2,578 2,711 3,024 3,094 3,197 3,328 3,536 3,576 3,862 4,014 3,913<br />

50-59 4,244 4,627 4,914 5,369 5,641 5,962 6,375 7,111 7,341 7,918 8,271 8,481<br />

60-64 3,859 4,057 4,244 4,556 4,717 4,849 5,176 5,601 5,703 5,836 5,965 6,429<br />

65-69 5,343 5,835 6,054 6,455 6,769 7,067 7,356 7,624 7,748 8,051 8,018 8,198<br />

70-79 10,507 11,820 12,540 13,976 15,259 16,257 17,703 19,215 19,633 20,299 20,752 20,928<br />

80+ 4,262 4,993 5,719 6,461 7,272 8,209 9,253 10,469 11,437 12,580 13,701 14,589<br />

0-19 72 57 51 64 58 64 47 72 59 69 50 79<br />

20-44 2,834 2,957 3,015 3,268 3,202 3,009 3,078 3,224 3,134 3,205 3,335 3,194<br />

45-64 9,428 10,100 10,670 11,597 12,153 12,720 13,491 14,803 15,174 16,158 16,672 17,314<br />

65-74 11,231 12,286 13,046 14,061 14,848 15,522 16,406 17,212 17,435 17,936 18,152 18,252<br />

75+ 8,881 10,362 11,267 12,831 14,452 16,011 17,906 20,096 21,383 22,994 24,319 25,463<br />

511<br />

Male 16,838 18,343 19,581 21,423 22,922 24,044 25,911 28,097 29,247 30,918 32,151 33,482<br />

Female 15,608 17,419 18,468 20,398 21,791 23,282 25,017 27,310 27,938 29,444 30,377 30,820<br />

Unknown<br />

White 22,222 24,236 25,384 27,621 29,316 31,097 33,460 35,975 37,317 39,250 41,003 41,972<br />

Black 9,317 10,487 11,389 12,638 13,422 13,971 14,999 16,578 16,875 18,040 18,274 18,954<br />

Native American 340 375 428 445 528 542 569 648 724 698 760 757<br />

Asian 508 583 763 977 1,149 1,272 1,352 1,538 1,528 1,644 1,776 1,897<br />

Other/unknown 59 81 85 140 298 444 548 668 741 730 715 722<br />

†Hispanic 3,522 4,247 4,793 5,307 5,544 6,035 6,489 6,934<br />

†Non-Hispanic 41,191 43,079 46,135 50,100 51,641 54,327 56,039 57,368<br />

Diabetes 12,133 13,805 14,995 17,005 19,061 20,715 23,100 25,720 26,497 28,424 29,379 30,468<br />

Hypertension 10,196 11,540 12,385 13,466 13,569 14,244 15,008 15,966 16,557 17,287 17,972 18,529<br />

Glomerulonephritis 3,550 3,628 3,751 4,064 4,136 4,208 4,285 4,542 4,453 4,468 4,582 4,441<br />

Cystic kidney 711 767 753 809 802 846 786 836 807 916 865 854<br />

Other urologic 921 932 837 974 1,171 1,235 1,304 1,490 1,583 1,664 1,721 1,754<br />

Other cause 2,772 2,999 3,270 3,578 4,007 4,088 4,325 4,743 4,937 5,188 5,552 5,684<br />

Unknown cause 1,631 1,713 1,698 1,802 1,836 1,899 2,021 2,013 2,234 2,332 2,393 2,438<br />

Missing disease 532 378 360 123 131 91 99 97 117 83 64 134<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.6 H.6<br />

Annual mortality rates per 1,000 patient years at at risk: dialysis patients, never on on transplant waitlist<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

512<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 175.7 222.1 155.7 161.5 184.1 151.1 212.4 218.2 209.7 254.4 238.7 350.4<br />

5-9 124.1 106.6 96.1 51.6 76.1 164.5 59.4 64.3 125.8 91.6 75.8 131.9<br />

10-14 63.0 50.1 41.9 36.1 41.9 95.0 81.6 72.2 112.2 139.5 155.2 100.3<br />

15-19 52.1 65.4 44.1 84.9 65.8 88.1 76.7 97.7 91.1 70.7 65.0 85.8<br />

20-29 86.3 90.9 88.1 85.5 85.3 96.5 109.6 120.8 156.7 151.8 142.7 135.4<br />

30-39 109.2 108.1 115.4 106.5 122.6 131.7 144.6 174.8 170.7 166.0 173.5 158.0<br />

40-49 127.5 130.4 120.3 130.4 128.1 143.3 165.6 177.0 181.5 172.7 179.4 175.7<br />

50-59 161.9 160.1 163.5 177.1 172.5 188.7 192.7 204.7 217.5 214.8 209.5 203.1<br />

60-64 230.7 217.7 220.3 219.5 226.9 238.6 246.7 248.9 256.8 257.7 243.9 246.5<br />

65-69 290.1 282.7 277.1 289.6 277.3 290.9 299.6 288.3 295.9 294.6 292.5 283.7<br />

70-79 352.0 357.1 351.9 352.3 359.6 369.8 363.2 367.2 368.7 368.5 361.2 349.2<br />

80+ 521.2 541.1 526.8 481.9 511.3 514.2 514.0 485.5 520.1 516.6 473.2 477.5<br />

Male 196.3 204.1 205.1 213.4 220.9 242.1 259.4 274.3 287.5 287.9 279.7 274.1<br />

Female 189.2 185.2 189.8 201.5 209.3 223.5 232.4 243.1 255.5 255.8 257.9 257.0<br />

White 204.3 211.9 216.3 227.7 239.3 259.1 273.0 291.6 309.0 307.6 308.9 308.0<br />

Black 168.8 160.8 159.3 170.1 171.4 187.5 200.3 205.1 211.9 218.1 208.9 205.5<br />

Other race 184.9 186.8 208.3 189.4 195.4 208.8 225.4 230.8 241.5 226.8 228.6 196.3<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 292.0 295.1 295.1 313.1 301.2 321.2 334.5 343.8 340.4 324.9 323.8 312.8<br />

Hypertension 156.5 170.6 181.3 193.2 206.2 228.3 229.6 250.3 264.3 266.2 265.1 264.7<br />

Glomerulonephritis 106.0 115.3 127.8 132.9 139.7 151.2 167.7 185.4 207.9 201.5 208.3 200.8<br />

Other cause 218.2 212.8 206.6 211.5 220.3 232.8 248.2 246.9 258.9 269.5 248.2 245.7<br />


Table H.6 H.6 (continued)<br />

Annual mortality rates per 1,000 patient years at at risk: dialysis patients, never on on transplant waitlist<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 340.7 275.4 226.1 248.7 157.7 217.9 141.9 238.3 287.3 274.8 192.4 184.3<br />

5-9 172.0 159.5 121.1 100.9 137.4 115.2 99.5 143.2 70.3 113.8 32.0 120.6<br />

10-14 127.6 97.4 78.2 72.7 95.4 102.0 62.6 133.1 56.5 53.9 60.8 81.5<br />

15-19 134.6 77.9 78.3 96.2 81.5 77.1 66.1 78.4 84.4 76.2 57.9 80.6<br />

20-29 147.6 137.1 132.5 133.7 131.4 113.2 102.1 107.3 98.2 101.7 105.4 96.2<br />

30-39 166.8 173.8 170.0 171.9 169.1 151.8 151.2 153.0 142.3 146.1 140.7 127.4<br />

40-49 184.0 180.2 175.4 182.3 173.3 171.5 168.9 172.5 165.7 172.3 172.1 161.7<br />

50-59 207.0 212.3 209.2 215.7 212.7 210.7 211.1 220.4 212.8 216.4 213.1 205.2<br />

60-64 250.0 252.3 245.6 247.1 247.7 245.3 249.9 259.7 254.6 253.4 247.3 254.2<br />

65-69 280.4 281.3 278.2 280.0 281.1 279.9 285.4 289.4 286.9 291.1 287.2 284.5<br />

70-79 355.0 357.5 344.0 345.3 349.0 341.6 347.4 356.3 350.4 352.7 350.7 344.1<br />

80+ 478.1 476.1 469.9 475.6 472.2 480.6 486.8 504.8 490.7 494.2 493.4 485.8<br />

Male 281.4 282.9 278.2 282.1 283.3 277.8 281.5 288.8 284.0 287.2 284.0 280.4<br />

Female 263.1 270.2 265.2 271.7 272.4 274.4 280.1 291.9 285.6 290.7 289.9 282.8<br />

513<br />

White 318.9 324.0 316.2 320.9 322.9 322.6 329.7 338.5 332.8 335.3 336.5 329.8<br />

Black 207.2 213.2 212.7 218.9 217.9 213.7 216.6 227.1 221.3 229.3 222.9 220.7<br />

Other race 200.0 195.3 206.1 216.6 231.6 234.8 232.2 246.8 240.6 232.4 230.4 221.9<br />

†Hispanic 232.0 241.1 248.0 250.7 239.5 240.0 238.0 233.4<br />

†Non-Hispanic 282.7 280.2 284.7 295.3 290.6 295.6 293.9 288.8<br />

Diabetes 313.0 313.5 302.8 306.4 308.5 301.7 308.1 319.0 307.3 311.4 304.3 298.8<br />

Hypertension 266.8 274.9 271.5 275.3 269.0 272.2 275.9 282.1 280.1 283.2 282.5 276.9<br />

Glomerulonephritis 208.6 207.0 205.5 214.2 211.1 208.5 208.4 217.9 210.3 210.3 214.6 205.5<br />

Other cause 260.9 263.6 259.8 263.6 273.2 270.0 271.5 280.2 281.9 287.7 290.8 286.9<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.7 H.7<br />

Total patient deaths: dialysis patients, on on transplant waitlist<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

514<br />

1987 1988 1989 1990 1991 1992 1993 1994<br />

0-4 . . . * * . . *<br />

5-9 . . * . . . * .<br />

10-14 . * * . * * * *<br />

15-19 . * . * * * * *<br />

20-29 . * 16 20 19 23 25 35<br />

30-39 * 19 43 63 72 79 94 99<br />

40-49 * 34 51 57 75 92 142 157<br />

50-59 * 25 56 63 87 87 120 198<br />

60-64 . 10 18 32 31 47 43 55<br />

65-69 . * * 16 17 16 23 44<br />

70-79 . * * * * * 17 22<br />

80+ . . . . * . . *<br />

0-19 . * * * * * * *<br />

20-44 10 43 84 114 129 147 185 216<br />

45-64 * 52 100 121 155 181 239 328<br />

65-74 . * 10 22 20 21 37 62<br />

75+ . * . . * * * *<br />

Male 11 59 114 165 184 220 273 351<br />

Female * 49 82 95 130 133 197 264<br />

Unknown<br />

White 12 66 138 180 223 248 309 390<br />

Black * 37 49 73 83 94 138 201<br />

Native American . * * * * * * 10<br />

Asian . * * * * * 16 14<br />

Other/unknown * * * . . . * .<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes * 40 74 94 112 136 190 240<br />

Hypertension * 18 23 50 58 69 87 137<br />

Glomerulonephritis * 20 40 56 63 61 90 100<br />

Cystic kidney . * 12 10 16 13 21 15<br />

Other urologic . * * * * * * 12<br />

Other cause * 11 26 26 37 48 60 78<br />

Unknown cause . * 12 10 * 15 17 29<br />

Missing disease * 12 * * 10 * * *<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.7 H.7 (continued)<br />

Total patient deaths: dialysis patients, on on transplant waitlist<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 . . * * * * * * .<br />

5-9 . . * . . * . . .<br />

10-14 . * * * * . . * *<br />

15-19 * * * * * * * * *<br />

20-29 39 42 48 52 58 51 58 59 62<br />

30-39 126 158 157 169 209 183 204 191 198<br />

40-49 230 259 286 307 360 399 401 404 440<br />

50-59 218 263 355 414 469 600 676 692 772<br />

60-64 78 109 162 189 210 279 305 329 379<br />

65-69 60 108 125 110 161 182 231 250 288<br />

70-79 21 42 48 67 94 113 125 167 221<br />

80+ * * * . * * * * 11<br />

0-19 * * 10 * * * * 11 10<br />

20-44 273 306 332 369 409 411 425 431 427<br />

45-64 418 525 676 762 897 1,101 1,219 1,244 1,424<br />

65-74 79 146 162 162 231 275 329 382 461<br />

75+ * * 14 15 25 21 35 44 59<br />

515<br />

Male 425 558 676 748 920 1,012 1,162 1,208 1,433<br />

Female 353 431 518 569 648 801 851 904 948<br />

Unknown<br />

White 495 619 691 779 944 1,025 1,151 1,189 1,367<br />

Black 253 325 422 438 535 658 711 760 821<br />

Native American 10 14 25 16 15 18 24 25 40<br />

Asian 20 27 43 67 55 79 105 92 113<br />

Other/unknown . * 13 17 19 33 22 46 40<br />

†Hispanic 84 105 158 174 196 258 315 332<br />

†Non-Hispanic 905 1,089 1,159 1,394 1,617 1,755 1,797 2,049<br />

Diabetes 288 401 494 593 713 805 969 1,000 1,089<br />

Hypertension 162 205 267 245 302 382 423 445 474<br />

Glomerulonephritis 138 192 197 214 254 286 284 286 389<br />

Cystic kidney 46 35 48 51 48 70 57 75 91<br />

Other urologic 15 14 17 27 25 41 38 56 55<br />

Other cause 94 103 144 152 181 167 195 212 225<br />

Unknown cause 32 37 25 35 45 58 46 38 56<br />

Missing disease * * * . . * * . *<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.8 H.8<br />

Annual mortality rates per 1,000 patient years at at risk: dialysis patients, on transplant waitlist<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

516<br />

UNADJUSTED 1987 1988 1989 1990 1991 1992 1993 1994 1995<br />

0-4 . . 75.7 72.1 54.8 . . 47.7 .<br />

5-9 . . . . . . 22.2 . .<br />

10-14 . 49.9 12.7 . 30.9 20.3 18.9 9.6 12.8<br />

15-19 . 6.7 . 11.2 11.0 4.5 20.9 8.1 14.2<br />

20-29 . 9.3 18.5 21.9 21.3 22.3 18.9 25.3 29.5<br />

30-39 11.6 16.5 34.4 41.2 39.4 38.2 40.8 37.0 41.0<br />

40-49 16.0 37.6 42.0 32.9 38.7 43.4 52.7 48.4 61.2<br />

50-59 11.8 35.9 66.7 62.6 66.1 53.4 58.7 79.4 71.1<br />

60-64 . 67.0 84.9 105.4 92.4 109.6 83.5 68.9 82.4<br />

65-69 . 99.8 83.8 103.1 109.4 85.7 65.6 108.6 101.4<br />

70-79 . 378.8 62.9 200.6 118.5 56.1 164.7 151.1 120.1<br />

80+ . . . . 609.8 . . 313.0 383.7<br />

Male 10.3 27.5 43.6 49.0 46.2 49.5 48.5 53.1 54.8<br />

Female 8.1 27.7 37.4 36.4 44.0 36.5 47.6 51.3 60.9<br />

White 9.2 26.4 46.3 49.4 54.2 53.0 55.2 58.5 66.4<br />

Black 7.7 29.4 30.8 36.3 34.2 31.9 37.7 45.9 48.7<br />

Other race 26.0 31.7 35.4 19.3 19.1 23.3 40.7 32.9 31.1<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 40.1 73.0 105.6 100.3 97.2 92.3 96.9 101.5 102.4<br />

Hypertension 7.5 24.6 23.9 40.2 39.3 38.6 39.0 48.1 49.4<br />

Glomerulonephritis 3.6 15.6 25.0 28.0 28.6 26.2 32.6 30.5 35.3<br />

Other cause 7.4 23.2 38.2 33.6 38.8 35.4 36.1 41.1 51.6<br />


Table H.8 H.8 (continued)<br />

Annual mortality rates per 1,000 patient years at at risk: dialysis patient, patients on on transplant waitlist<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

UNADJUSTED 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 . 109.6 118.2 58.3 50.6 53.6 63.3 .<br />

5-9 . . . . 30.7 . . .<br />

10-14 24.7 10.5 21.3 22.8 11.5 11.1 40.9 36.4<br />

15-19 23.6 32.2 22.6 12.4 17.6 29.6 31.0 49.6<br />

20-29 28.6 27.8 30.3 33.9 28.7 38.7 47.7 70.4<br />

30-39 51.0 49.1 47.4 58.5 51.4 57.2 65.0 92.8<br />

40-49 58.6 65.1 62.6 69.9 76.1 80.8 92.1 138.7<br />

50-59 73.2 85.2 87.9 90.1 108.5 115.8 135.1 196.8<br />

60-64 94.9 111.1 111.0 113.2 133.0 131.3 145.2 221.6<br />

65-69 140.6 140.8 103.0 128.1 137.3 146.4 167.9 241.7<br />

70-79 165.3 143.9 163.4 177.1 155.1 147.4 190.5 305.7<br />

80+ 292.8 301.1 . 91.6 69.1 387.6 257.7 238.7<br />

Male 63.1 68.3 68.7 79.2 82.9 93.9 108.6 170.9<br />

Female 64.9 73.5 71.6 77.5 92.6 96.2 115.7 161.2<br />

517<br />

White 73.5 76.3 77.0 88.4 90.5 98.4 112.0 169.7<br />

Black 54.7 63.6 61.0 70.0 84.1 92.2 113.9 168.8<br />

Other race 38.0 63.8 64.5 52.5 75.7 82.3 99.0 142.2<br />

†Hispanic 47.9 50.6 64.3 65.2 65.0 82.8 109.2 154.9<br />

†Non-Hispanic 65.8 73.2 70.8 80.5 90.5 96.9 111.9 168.9<br />

Diabetes 115.0 122.2 124.1 136.4 137.5 154.9 172.5 242.3<br />

Hypertension 55.9 67.9 58.6 65.7 81.7 88.8 106.3 155.4<br />

Glomerulonephritis 43.7 41.8 41.0 47.5 52.9 55.1 64.5 117.1<br />

Other cause 47.5 54.4 56.5 61.5 69.7 66.9 85.5 126.5<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.9 H.9<br />

Total patient deaths: dialysis patients, returned to to dialysis from transplant<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

518<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992<br />

0-4 . . . . . . . * * . * * .<br />

5-9 * * . * . * * * . * * * *<br />

10-14 * * * * . * * * * * * * *<br />

15-19 * * * * * * * * 10 * 10 * *<br />

20-29 20 29 21 25 38 31 37 47 52 65 73 76 81<br />

30-39 31 30 45 49 76 103 115 139 154 178 165 209 203<br />

40-49 25 34 40 54 70 102 104 143 181 204 256 255 284<br />

50-59 25 29 35 55 71 65 117 112 154 144 185 216 225<br />

60-64 * * * * 10 32 27 30 43 54 65 65 87<br />

65-69 . * * * * 11 14 10 32 25 36 39 35<br />

70-79 * . . . . * * * * 12 16 20 25<br />

80+ * . . . . * . . . . . * *<br />

0-19 * * * * * 12 * 11 19 14 16 14 12<br />

20-44 66 76 83 98 153 182 194 260 300 355 374 418 421<br />

45-64 43 50 64 91 112 151 206 211 284 290 370 403 459<br />

65-74 * * * * * 14 20 13 37 35 48 56 53<br />

75+ * . . . . * . * . * * * *<br />

Male 75 91 98 120 177 249 290 320 399 430 507 538 604<br />

Female 41 43 57 76 103 112 137 177 241 266 305 357 350<br />

Unknown<br />

White 91 97 115 132 214 261 288 326 441 486 547 588 655<br />

Black 21 33 34 53 60 92 125 153 186 199 245 289 280<br />

Native American . . . * * * * * * * * * 12<br />

Asian . . . . * * * * * * 12 * *<br />

Other/unknown * * * 10 * * * * * * * * *<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 20 14 27 39 50 66 76 105 136 155 190 201 231<br />

Hypertension * 10 20 30 36 59 62 64 103 121 137 175 187<br />

Glomerulonephritis 26 24 35 48 70 84 123 127 169 182 232 258 231<br />

Cystic kidney * * * * 13 20 25 22 37 32 41 46 57<br />

Other urologic * * * * * * * 13 11 * * 10 20<br />

Other cause * 15 12 13 27 39 60 66 98 93 126 147 147<br />

Unknown cause * 15 15 10 30 29 21 34 34 48 48 34 55<br />

Missing disease 40 48 39 45 52 56 58 66 52 56 33 24 26<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.9 H.9 (continued)<br />

Total patient deaths: dialysis patients, returned to to dialysis from transplant<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 * . . . . . . . . . *<br />

5-9 * . . * * * . * * * *<br />

10-14 * * * * * * * . . * *<br />

15-19 * 12 10 11 * * * * * * *<br />

20-29 56 64 64 78 72 84 81 86 94 86 79<br />

30-39 210 204 217 236 246 239 236 242 255 230 209<br />

40-49 299 301 338 389 464 411 480 508 532 519 540<br />

50-59 250 323 354 342 369 439 491 490 561 605 636<br />

60-64 104 105 113 125 160 176 181 189 225 221 254<br />

65-69 82 63 111 97 105 124 131 172 170 164 198<br />

70-79 30 46 44 62 74 98 104 123 146 177 155<br />

80+ * * * * * * * * * 13 *<br />

0-19 16 14 14 16 12 11 14 * 13 12 12<br />

20-44 418 404 443 497 547 521 511 563 580 575 508<br />

45-64 501 593 643 673 764 828 958 952 1,087 1,086 1,210<br />

65-74 101 96 146 140 157 195 204 258 276 295 311<br />

75+ 16 20 15 20 23 30 35 42 47 59 49<br />

519<br />

Male 623 656 719 809 855 915 1,016 1,051 1,188 1,173 1,174<br />

Female 429 471 542 537 648 670 706 773 815 854 916<br />

Unknown<br />

White 719 725 827 916 975 1,027 1,073 1,155 1,272 1,272 1,289<br />

Black 311 371 403 396 480 510 596 605 663 679 721<br />

Native American * 12 17 13 13 17 16 19 17 26 20<br />

Asian 12 18 14 21 34 31 37 43 50 47 57<br />

Other/unknown * * . . * . . * * * *<br />

†Hispanic 96 104 127 151 143 169 181 165<br />

†Non-Hispanic 1,250 1,399 1,458 1,571 1,681 1,834 1,846 1,925<br />

Diabetes 259 265 277 320 341 393 450 459 505 487 510<br />

Hypertension 224 270 300 284 331 338 398 378 434 454 448<br />

Glomerulonephritis 289 295 349 377 425 421 434 518 537 539 612<br />

Cystic kidney 54 56 75 95 114 96 105 99 120 101 114<br />

Other urologic 25 29 30 29 39 47 48 65 74 86 62<br />

Other cause 152 157 169 185 211 236 244 257 276 308 280<br />

Unknown cause 34 46 59 54 42 51 42 47 56 51 64<br />

Missing disease 15 * * * . * * * * * .<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.10 H.10<br />

Annual mortality rates per 1,000 patient YAR: dialysis patients, returned to to dialysis from transplant<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

520<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 . . . . . . . 126.6 50.1 . 131.6 152.3<br />

5-9 371.3 103.3 . 38.9 . 22.6 47.5 20.6 . 29.9 27.0 24.8<br />

10-14 34.3 71.2 37.1 13.2 . 64.3 34.1 16.1 67.3 39.8 30.7 30.4<br />

15-19 29.8 26.5 15.4 30.1 53.1 42.5 26.1 48.4 48.3 24.5 35.4 28.5<br />

20-29 57.2 73.7 49.8 40.5 48.1 36.1 37.1 41.3 44.8 50.0 47.0 52.2<br />

30-39 80.6 62.4 73.6 66.0 65.7 79.5 78.3 80.5 86.6 80.2 75.0 81.1<br />

40-49 93.0 84.4 92.6 88.1 77.1 98.3 90.7 106.6 118.2 107.6 111.8 97.6<br />

50-59 154.6 105.9 103.0 122.7 123.4 97.8 164.8 132.5 150.8 126.4 148.9 150.2<br />

60-64 262.1 104.8 105.3 107.1 130.2 218.9 163.4 176.4 195.2 180.8 179.8 163.3<br />

65-69 . 372.5 439.5 65.5 265.6 321.9 319.9 105.1 323.4 195.2 265.0 218.3<br />

70-79 . . . . . 364.0 586.3 354.9 171.5 290.0 315.3 321.1<br />

80+ . . . . . . . . . . . .<br />

Male 87.4 80.2 74.8 68.0 70.6 89.9 96.2 91.4 103.5 92.1 98.4 96.6<br />

Female 90.3 69.3 71.4 74.8 75.6 64.6 69.4 78.4 91.1 86.9 89.7 90.9<br />

White 100.1 79.7 82.3 70.2 81.0 86.9 88.2 85.7 104.3 97.0 100.3 99.0<br />

Black 58.9 70.0 53.3 64.9 56.2 67.8 78.8 86.3 89.6 79.5 85.7 88.1<br />

Other race 82.5 61.0 69.4 121.0 41.7 64.0 106.9 102.2 64.1 44.8 81.0 62.5<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 265.5 143.4 215.1 212.8 180.0 214.7 206.2 227.2 231.8 212.5 239.8 225.5<br />

Hypertension 52.5 43.8 62.2 64.6 61.6 80.2 78.8 66.6 88.4 86.8 85.3 94.8<br />

Glomerulonephritis 54.8 34.2 44.3 46.5 46.8 47.5 61.7 56.4 67.6 67.0 73.6 73.8<br />

Other cause 103.3 116.4 84.4 71.5 84.3 90.3 91.5 97.3 105.9 86.1 86.7 82.2<br />


Table H.10 H.10 (continued)<br />

Annual mortality rates per 1,000 patient YAR: dialysis patients, returned to to dialysis from transplant<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 . 193.7 . . . 152.7 . . . 137.9 98.6 132.8<br />

5-9 37.7 13.6 . 33.6 33.9 . 49.4 . 73.1 176.5 . 32.6<br />

10-14 37.7 18.7 12.3 33.8 44.0 21.4 34.6 107.3 8.9 . 63.9 49.9<br />

15-19 40.9 41.8 43.4 36.5 33.1 27.2 36.4 22.9 26.7 38.7 23.0 34.3<br />

20-29 51.3 39.5 44.4 41.7 42.9 43.9 50.2 43.1 47.2 60.2 45.8 54.2<br />

30-39 75.7 74.6 60.2 63.4 73.3 74.8 70.2 70.0 73.4 70.7 64.3 53.0<br />

40-49 99.8 99.4 91.5 102.1 102.7 118.2 100.8 114.3 115.3 119.7 116.1 115.3<br />

50-59 141.0 140.4 150.3 156.6 143.1 150.0 162.8 167.2 159.8 161.1 166.8 161.2<br />

60-64 192.8 202.1 171.0 196.0 178.3 222.5 209.3 224.5 195.5 228.3 224.3 232.3<br />

65-69 154.5 309.8 180.6 299.1 241.1 250.6 297.7 239.3 323.1 285.8 230.6 258.9<br />

70-79 334.3 245.0 320.4 274.7 244.3 331.2 346.7 348.3 351.3 345.1 402.2 312.3<br />

80+ 414.6 404.6 602.9 . 172.1 172.4 376.0 515.0 399.1 505.4 771.8 304.3<br />

Male 101.6 96.6 91.0 96.6 101.2 106.9 108.4 116.2 116.9 126.8 119.0 115.3<br />

Female 82.7 96.0 90.7 105.1 96.8 115.2 112.0 113.1 118.5 119.6 123.6 125.4<br />

521<br />

White 104.9 106.3 95.2 109.1 114.7 122.9 122.6 124.1 130.3 137.0 134.4 130.6<br />

Black 77.2 81.5 84.9 87.6 76.2 92.2 92.2 103.3 100.4 106.5 103.5 106.6<br />

Other race 55.6 65.7 74.2 68.0 71.0 84.8 85.0 87.7 93.3 96.3 94.1 87.0<br />

†Hispanic 75.0 71.4 84.7 94.0 81.3 95.4 98.9 81.6<br />

†Non-Hispanic 101.9 114.5 112.7 117.3 121.8 127.2 123.6 124.2<br />

Diabetes 229.0 229.6 200.1 212.0 223.2 224.6 240.8 266.0 250.8 263.3 243.3 232.4<br />

Hypertension 92.5 100.1 107.6 114.4 97.6 112.0 109.2 123.9 112.9 122.9 122.1 119.1<br />

Glomerulonephritis 64.7 75.9 65.2 76.0 78.3 87.5 79.1 78.9 94.4 93.2 91.9 100.1<br />

Other cause 90.0 78.6 77.5 84.7 86.7 99.2 103.4 100.9 102.3 111.4 111.3 100.9<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.11 H.11<br />

Total patient deaths: hemodialysis patients<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

522<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 * * * * * * * * * * * 10<br />

5-9 * * * * * * . * * * * *<br />

10-14 * * * * * * * * * * * *<br />

15-19 21 26 16 27 20 28 13 18 18 15 15 22<br />

20-29 204 231 218 198 203 234 242 244 295 328 322 303<br />

30-39 446 477 544 532 640 701 722 887 917 954 1,088 1,088<br />

40-49 738 785 790 882 939 1,065 1,140 1,257 1,369 1,488 1,703 1,834<br />

50-59 1,468 1,611 1,780 2,060 2,113 2,323 2,393 2,517 2,770 2,969 3,094 3,241<br />

60-64 1,074 1,159 1,375 1,491 1,801 2,039 2,162 2,290 2,543 2,676 2,805 2,993<br />

65-69 1,248 1,366 1,482 1,765 1,991 2,311 2,645 2,794 3,208 3,617 3,909 4,137<br />

70-79 1,530 1,869 2,171 2,548 3,344 3,862 4,249 4,875 5,535 6,305 7,086 7,834<br />

80+ 315 393 515 603 916 1,086 1,335 1,591 2,019 2,408 2,691 3,293<br />

0-19 35 37 25 33 27 37 28 32 35 34 29 38<br />

20-44 965 1,052 1,100 1,090 1,265 1,364 1,450 1,697 1,778 1,952 2,173 2,211<br />

45-64 2,965 3,211 3,607 4,073 4,431 4,998 5,209 5,498 6,116 6,463 6,839 7,248<br />

65-74 2,178 2,520 2,791 3,285 3,925 4,534 5,031 5,528 6,267 7,026 7,709 8,379<br />

75+ 915 1,108 1,377 1,631 2,326 2,725 3,198 3,732 4,495 5,304 5,977 6,885<br />

Male 3,944 4,503 4,951 5,608 6,493 7,491 8,117 8,937 9,982 11,042 11,854 12,756<br />

Female 3,114 3,425 3,949 4,504 5,481 6,167 6,799 7,550 8,709 9,737 10,873 12,005<br />

Unknown<br />

White 5,003 5,671 6,298 7,054 8,361 9,381 10,037 11,130 12,523 13,666 15,091 16,498<br />

Black 1,887 2,061 2,340 2,798 3,308 3,928 4,462 4,887 5,640 6,518 6,966 7,582<br />

Native American 16 21 66 63 95 108 142 160 181 214 260 261<br />

Asian * * 33 47 96 136 184 223 242 267 370 384<br />

Other/unknown 144 168 163 150 114 105 91 87 105 114 40 36<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 864 1,156 1,634 2,199 2,733 3,493 4,092 4,860 5,654 6,506 7,694 8,801<br />

Hypertension 930 1,245 1,675 2,157 2,837 3,451 3,886 4,661 5,521 6,289 7,140 7,955<br />

Glomerulonephritis 742 890 1,091 1,250 1,480 1,653 1,854 2,095 2,432 2,476 2,734 2,806<br />

Cystic kidney 208 268 283 330 376 440 514 468 543 571 607 584<br />

Other urologic 105 151 225 298 326 431 551 612 656 742 745 700<br />

Other cause 499 598 758 955 1,189 1,353 1,483 1,677 1,732 1,899 2,086 2,271<br />

Unknown cause 739 791 878 789 846 1,052 1,025 1,042 1,223 1,420 1,247 1,241<br />

Missing disease 2,971 2,829 2,356 2,134 2,187 1,785 1,511 1,072 930 876 474 403<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.11 H.11 (continued) (continued)<br />

Total patient deaths: hemodialysis patients<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 11 * * 13 * * * * * 12 * 10<br />

5-9 * * * * * * * * * * * *<br />

10-14 * * * * * * * 13 * * 11 16<br />

15-19 26 23 12 19 22 23 17 23 20 24 19 35<br />

20-29 354 349 321 350 370 354 343 353 376 411 417 405<br />

30-39 1,193 1,244 1,306 1,441 1,500 1,416 1,449 1,593 1,518 1,595 1,566 1,550<br />

40-49 2,108 2,246 2,403 2,768 2,894 3,158 3,327 3,711 3,852 4,168 4,340 4,382<br />

50-59 3,637 3,946 4,327 4,683 5,038 5,507 6,083 6,983 7,430 8,182 8,644 9,048<br />

60-64 3,301 3,363 3,607 3,951 4,107 4,353 4,802 5,322 5,531 5,816 6,011 6,565<br />

65-69 4,518 4,923 5,174 5,497 5,914 6,281 6,670 7,150 7,337 7,708 7,819 8,109<br />

70-79 9,141 10,288 10,791 12,211 13,411 14,538 16,118 17,772 18,334 19,152 19,820 20,112<br />

80+ 3,852 4,525 5,176 5,844 6,648 7,548 8,646 9,920 10,860 11,986 13,168 14,006<br />

0-19 46 41 30 40 36 35 35 45 37 50 39 69<br />

20-44 2,522 2,615 2,701 3,036 3,091 3,064 3,204 3,471 3,461 3,591 3,754 3,653<br />

45-64 8,071 8,533 9,263 10,157 10,818 11,724 12,800 14,491 15,246 16,581 17,224 18,297<br />

65-74 9,600 10,522 11,147 12,060 12,960 13,771 14,873 15,981 16,361 17,033 17,556 17,824<br />

75+ 7,911 9,214 9,994 11,492 13,013 14,596 16,561 18,861 20,170 21,813 23,251 24,403<br />

523<br />

Male 14,473 15,789 17,017 18,741 20,456 21,954 24,239 26,982 28,378 30,458 32,037 33,667<br />

Female 13,677 15,136 16,118 18,044 19,462 21,236 23,234 25,867 26,897 28,610 29,787 30,579<br />

Unknown<br />

White 18,766 20,355 21,406 23,613 25,507 27,553 30,405 33,601 35,252 37,621 39,709 41,141<br />

Black 8,559 9,629 10,554 11,740 12,619 13,538 14,701 16,531 17,092 18,379 18,841 19,676<br />

Native American 304 333 376 407 483 510 542 623 721 693 772 760<br />

Asian 471 538 720 901 1,045 1,189 1,330 1,465 1,505 1,680 1,787 1,940<br />

Other/unknown 50 70 79 124 264 400 495 629 705 695 715 729<br />

†Hispanic 3,286 3,934 4,566 5,186 5,457 5,977 6,557 7,034<br />

†Non-Hispanic 36,632 39,256 42,907 47,663 49,818 53,091 55,267 57,212<br />

Diabetes 10,374 11,697 12,780 14,674 16,699 18,518 21,192 24,270 25,346 27,598 28,794 30,207<br />

Hypertension 8,968 10,133 11,004 11,979 12,272 13,167 14,135 15,327 16,010 16,864 17,755 18,359<br />

Glomerulonephritis 3,044 3,170 3,252 3,639 3,730 3,902 4,049 4,390 4,501 4,562 4,742 4,738<br />

Cystic kidney 626 658 650 720 746 801 766 827 833 956 915 941<br />

Other urologic 824 839 748 886 1,062 1,134 1,236 1,424 1,518 1,634 1,705 1,763<br />

Other cause 2,410 2,595 2,897 3,158 3,625 3,850 4,124 4,618 4,806 5,128 5,560 5,720<br />

Unknown cause 1,430 1,516 1,499 1,621 1,673 1,734 1,881 1,902 2,150 2,255 2,302 2,393<br />

Missing disease 474 317 305 108 111 84 90 91 111 71 51 125<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.12 H.12<br />

Annual mortality rates per 1,000 patient years at at risk: hemodialysis patients<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

ON OUR WEBSITE & CD<br />

Annual mortality rates per 1,000 patient years at risk: hemodialysis patients, by primary diagnosis,<br />

adjusted (H.12.1). Annual deaths per 1,000 patients: hemodialysis patients, by primary<br />

diagnosis (H.12.2). Hemodialysis patients: counts of total deaths, by primary diagnosis<br />

(H.12.3). Annual mortality rates: hemodialysis patients, unadjusted (H.12.4).<br />

524<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 82.7 167.0 101.8 48.6 67.5 114.2 300.1 206.7 216.6 187.5 190.6 272.9<br />

5-9 60.0 42.4 45.7 32.3 17.2 44.5 0.0 43.6 20.3 61.3 41.3 60.5<br />

10-14 42.6 27.4 22.4 18.7 20.7 42.6 39.7 31.5 55.2 65.0 42.4 31.7<br />

15-19 36.2 38.4 24.1 45.0 34.5 49.1 32.3 38.4 32.6 30.0 25.1 34.2<br />

20-29 62.9 68.3 62.3 55.5 56.6 63.1 63.3 66.3 78.8 77.3 71.4 68.5<br />

30-39 87.7 83.9 90.4 83.0 92.2 96.8 96.9 112.7 105.2 105.6 112.6 101.6<br />

40-49 115.1 115.6 106.8 112.5 107.4 118.6 125.3 128.6 130.7 126.2 128.5 126.9<br />

50-59 151.1 153.5 155.3 166.0 162.1 172.1 170.5 173.6 183.0 181.2 176.2 168.6<br />

60-64 221.9 210.7 212.5 209.7 217.3 228.0 233.7 233.6 237.6 238.9 226.0 225.6<br />

65-69 281.4 275.1 273.0 281.9 272.5 283.0 289.9 275.5 281.8 285.3 278.7 265.1<br />

70-79 338.0 351.7 348.1 343.8 355.8 363.0 355.9 358.7 359.4 361.7 356.0 340.9<br />

80+ 504.9 539.1 522.0 454.1 501.6 500.8 505.1 480.2 507.7 507.8 466.7 469.2<br />

Male 178.6 186.3 187.3 194.0 200.8 218.0 224.1 231.3 237.6 240.1 232.3 225.0<br />

Female 168.4 167.6 172.3 177.9 190.0 199.3 205.9 209.8 220.1 222.4 224.5 223.7<br />

White 184.4 193.4 197.5 204.5 219.0 235.0 240.4 250.7 261.6 263.3 265.2 264.4<br />

Black 152.4 146.3 145.7 153.7 155.7 167.6 176.4 176.1 182.6 188.4 179.5 174.0<br />

Other race 159.2 164.9 187.3 169.0 174.1 180.0 189.0 191.7 187.8 182.5 178.6 155.3<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 263.9 271.2 279.9 292.5 287.4 304.8 305.6 308.6 305.4 294.8 290.5 279.8<br />

Hypertension 140.4 154.7 164.8 173.3 190.6 204.5 206.7 221.6 231.7 233.8 233.4 230.5<br />

Glomerulonephritis 88.7 98.2 108.0 111.5 118.8 125.2 133.9 143.0 156.3 150.6 156.1 151.0<br />

Other cause 202.7 199.7 193.5 195.4 202.4 213.0 219.1 210.1 214.7 226.3 207.4 201.6<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.12 H.12 (continued)<br />

Annual mortality rates per 1,000 patient years at at risk: hemodialysis patients<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 350.8 379.8 213.1 281.1 110.9 99.5 164.0 132.9 253.5 329.4 171.8 253.2<br />

5-9 58.2 70.7 66.2 61.1 66.2 29.9 39.8 50.0 36.9 93.8 32.8 90.1<br />

10-14 45.3 35.8 38.0 25.8 42.9 32.9 52.3 77.4 24.8 26.1 42.5 67.3<br />

15-19 53.0 38.6 27.4 37.3 38.9 38.8 32.2 30.3 37.5 39.9 31.4 49.9<br />

20-29 74.9 68.0 62.9 65.7 64.7 57.0 54.3 55.0 54.6 59.4 60.8 59.1<br />

30-39 104.9 105.3 103.6 106.7 106.7 96.1 94.2 98.6 91.0 93.9 89.9 86.4<br />

40-49 130.6 125.2 122.3 128.5 121.5 123.4 119.9 124.5 121.3 125.9 126.0 124.2<br />

50-59 170.8 170.2 170.3 170.7 168.2 165.9 165.9 172.3 167.6 170.7 169.4 167.4<br />

60-64 228.7 223.2 217.5 219.1 216.1 212.9 216.1 223.0 216.2 215.7 211.0 219.2<br />

65-69 265.8 264.7 262.7 260.2 261.4 261.6 263.5 266.6 261.9 263.5 258.8 257.9<br />

70-79 346.7 348.9 330.8 335.8 339.1 333.4 338.4 347.5 341.7 342.6 340.9 334.7<br />

80+ 469.6 467.0 461.7 466.2 466.2 474.6 483.1 502.1 489.3 490.3 491.5 482.4<br />

Male 230.8 229.7 225.7 228.0 229.1 224.5 227.0 233.4 228.7 232.1 231.1 231.5<br />

Female 229.9 232.6 228.1 234.3 233.7 236.4 240.2 249.6 244.8 248.2 247.8 245.1<br />

525<br />

White 274.8 275.9 268.0 272.8 274.5 273.5 278.5 286.1 280.4 282.6 284.1 282.5<br />

Black 175.7 178.4 178.3 181.9 180.1 178.4 179.5 188.1 183.8 189.7 186.3 187.0<br />

Other race 158.8 155.6 168.0 176.4 186.6 190.9 190.7 195.8 192.6 185.9 182.9 177.5<br />

†Hispanic 184.7 189.0 195.1 198.4 188.3 187.4 189.1 188.2<br />

†Non-Hispanic 236.7 235.3 238.2 246.9 243.0 247.4 246.6 245.8<br />

Diabetes 281.9 276.7 265.7 269.2 270.9 264.4 269.6 280.3 269.2 272.5 266.4 264.8<br />

Hypertension 231.3 235.5 233.8 235.6 229.6 233.0 235.4 240.0 237.3 239.4 240.6 238.0<br />

Glomerulonephritis 154.5 152.9 148.0 156.4 151.3 149.4 146.7 151.4 149.3 148.5 151.4 149.7<br />

Other cause 214.2 213.4 210.7 212.3 219.8 217.6 217.2 222.8 223.2 227.9 230.7 231.2<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.13 H.13<br />

Total patient deaths: hemodialysis patients, never on on transplant waitlist<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

526<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 * * * * * * * * * * * *<br />

5-9 * * * * * * . * * * * *<br />

10-14 * * * * * * * * * * * *<br />

15-19 21 26 16 27 20 28 13 18 17 13 11 19<br />

20-29 204 231 218 198 203 234 241 243 283 297 289 261<br />

30-39 446 477 544 532 640 701 722 873 886 887 996 963<br />

40-49 738 785 790 882 939 1,064 1,140 1,244 1,313 1,389 1,589 1,693<br />

50-59 1,468 1,611 1,780 2,060 2,113 2,323 2,393 2,509 2,725 2,885 2,974 3,078<br />

60-64 1,074 1,159 1,375 1,491 1,801 2,039 2,162 2,287 2,525 2,650 2,745 2,945<br />

65-69 1,248 1,366 1,482 1,765 1,991 2,311 2,645 2,793 3,197 3,602 3,885 4,113<br />

70-79 1,530 1,869 2,171 2,548 3,344 3,862 4,249 4,875 5,531 6,300 7,078 7,821<br />

80+ 315 393 515 603 916 1,086 1,335 1,591 2,019 2,408 2,691 3,292<br />

0-19 35 37 25 33 27 37 28 32 31 31 22 32<br />

20-44 965 1,052 1,100 1,090 1,265 1,363 1,449 1,677 1,707 1,801 1,991 1,974<br />

45-64 2,965 3,211 3,607 4,073 4,431 4,998 5,209 5,479 6,025 6,307 6,602 6,966<br />

65-74 2,178 2,520 2,791 3,285 3,925 4,534 5,031 5,527 6,254 7,006 7,677 8,347<br />

75+ 915 1,108 1,377 1,631 2,326 2,725 3,198 3,732 4,493 5,304 5,977 6,879<br />

Male 3,944 4,503 4,951 5,608 6,493 7,490 8,116 8,914 9,875 10,842 11,563 12,419<br />

Female 3,114 3,425 3,949 4,504 5,481 6,167 6,799 7,533 8,635 9,607 10,706 11,779<br />

Unknown<br />

White 5,003 5,671 6,298 7,054 8,361 9,381 10,036 11,103 12,406 13,444 14,790 16,117<br />

Black 1,887 2,061 2,340 2,798 3,308 3,927 4,462 4,877 5,585 6,425 6,819 7,416<br />

Native American 16 21 66 63 95 108 142 160 180 209 257 250<br />

Asian * * 33 47 96 136 184 222 236 258 363 379<br />

Other/unknown 144 168 163 150 114 105 91 85 103 113 40 36<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 864 1,156 1,634 2,199 2,733 3,493 4,092 4,846 5,588 6,392 7,548 8,608<br />

Hypertension 930 1,245 1,675 2,157 2,837 3,451 3,886 4,657 5,491 6,236 7,043 7,845<br />

Glomerulonephritis 742 890 1,091 1,250 1,480 1,653 1,854 2,084 2,400 2,410 2,634 2,687<br />

Cystic kidney 208 268 283 330 376 440 514 467 533 554 587 554<br />

Other urologic 105 151 225 298 326 431 551 611 652 733 738 692<br />

Other cause 499 598 758 955 1,189 1,353 1,483 1,673 1,710 1,858 2,028 2,205<br />

Unknown cause 739 791 878 789 846 1,051 1,025 1,041 1,219 1,405 1,232 1,217<br />

Missing disease 2,971 2,829 2,356 2,134 2,187 1,785 1,510 1,068 917 861 459 390<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.13 H.13 (continued)<br />

Total patient deaths: hemodialysis patients, never on transplant waitlist<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 * * * 12 * * * * * 12 * *<br />

5-9 * * * * * * * * * * * *<br />

10-14 * * * * * * * * * * * 10<br />

15-19 24 16 * 13 17 17 11 17 15 17 10 27<br />

20-29 305 303 261 286 299 278 254 268 280 305 313 289<br />

30-39 1,048 1,104 1,149 1,248 1,251 1,153 1,205 1,286 1,212 1,271 1,260 1,226<br />

40-49 1,927 1,981 2,146 2,414 2,469 2,678 2,850 3,125 3,182 3,494 3,646 3,609<br />

50-59 3,454 3,722 3,965 4,329 4,622 4,972 5,428 6,232 6,515 7,135 7,508 7,763<br />

60-64 3,217 3,272 3,492 3,803 3,928 4,096 4,494 4,964 5,111 5,292 5,474 5,943<br />

65-69 4,471 4,856 5,089 5,364 5,740 6,082 6,458 6,854 6,990 7,327 7,367 7,597<br />

70-79 9,119 10,254 10,750 12,146 13,320 14,428 15,960 17,572 18,055 18,867 19,441 19,673<br />

80+ 3,852 4,525 5,175 5,841 6,645 7,545 8,641 9,914 10,847 11,966 13,136 13,974<br />

0-19 40 33 22 31 27 26 25 33 30 38 24 53<br />

20-44 2,232 2,310 2,376 2,615 2,581 2,516 2,643 2,838 2,774 2,886 3,022 2,914<br />

45-64 7,719 8,072 8,637 9,465 9,988 10,661 11,588 13,037 13,526 14,611 15,179 15,916<br />

65-74 9,535 10,428 11,030 11,870 12,711 13,489 14,543 15,542 15,815 16,440 16,820 16,988<br />

75+ 7,907 9,207 9,984 11,481 12,994 14,566 16,516 18,798 20,077 21,720 23,124 24,256<br />

527<br />

Male 14,037 15,272 16,371 17,999 19,474 20,830 22,973 25,433 26,608 28,466 29,881 31,209<br />

Female 13,396 14,778 15,678 17,463 18,827 20,428 22,342 24,815 25,614 27,229 28,288 28,918<br />

Unknown<br />

White 18,288 19,795 20,749 22,797 24,500 26,424 29,122 32,071 33,505 35,691 37,644 38,797<br />

Black 8,344 9,355 10,165 11,285 12,076 12,841 13,956 15,595 15,979 17,153 17,487 18,190<br />

Native American 292 316 362 387 460 483 514 590 676 656 719 707<br />

Asian 459 516 694 870 1,005 1,127 1,242 1,387 1,389 1,523 1,650 1,762<br />

Other/unknown 50 68 79 123 260 383 481 605 673 672 669 671<br />

†Hispanic 3,150 3,766 4,324 4,896 5,149 5,606 6,118 6,517<br />

†Non-Hispanic 35,151 37,492 40,991 45,352 47,073 50,089 52,051 53,610<br />

Diabetes 10,129 11,365 12,407 14,234 16,115 17,796 20,326 23,209 24,090 26,188 27,263 28,487<br />

Hypertension 8,819 9,960 10,738 11,676 11,894 12,709 13,662 14,723 15,355 16,101 16,945 17,443<br />

Glomerulonephritis 2,915 2,995 3,042 3,367 3,412 3,554 3,686 3,965 3,952 4,010 4,159 4,049<br />

Cystic kidney 586 621 611 645 668 706 660 722 699 814 760 773<br />

Other urologic 810 826 725 860 1,036 1,102 1,191 1,376 1,439 1,545 1,596 1,654<br />

Other cause 2,326 2,494 2,775 3,012 3,452 3,627 3,881 4,328 4,518 4,798 5,176 5,310<br />

Unknown cause 1,388 1,476 1,455 1,564 1,616 1,683 1,821 1,835 2,064 2,170 2,220 2,289<br />

Missing disease 460 313 296 104 108 81 88 90 105 69 50 122<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.14 H.14<br />

Annual mortality rates per 1,000 patient YAR: hemodialysis patients, never on on transplant waitlist<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

528<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 144.9 284.0 173.4 75.5 130.7 156.0 422.9 291.2 329.0 339.5 276.9 428.4<br />

5-9 99.0 77.2 84.7 61.8 31.6 105.1 0.0 124.4 66.2 205.5 85.8 195.0<br />

10-14 68.4 46.4 42.8 36.9 38.6 87.9 88.6 88.7 100.8 182.2 124.8 78.8<br />

15-19 54.4 60.2 38.0 75.9 59.1 90.7 66.2 98.9 79.2 72.9 60.5 86.9<br />

20-29 81.0 90.8 86.5 79.5 83.8 98.2 105.5 124.0 156.7 152.6 145.0 136.5<br />

30-39 102.1 100.1 109.9 103.6 119.7 130.0 137.9 172.5 166.0 162.4 175.9 155.5<br />

40-49 122.6 125.2 117.2 126.1 122.7 140.4 156.5 172.8 175.4 168.9 175.8 174.4<br />

50-59 152.7 156.0 159.2 171.4 169.2 182.5 186.5 198.3 211.3 209.7 204.3 195.4<br />

60-64 222.1 211.2 213.5 211.2 219.8 232.1 240.4 244.8 250.0 252.2 238.2 241.3<br />

65-69 281.4 275.1 273.1 282.1 273.0 283.9 292.4 279.9 287.6 292.3 285.8 272.7<br />

70-79 338.1 351.7 348.2 343.9 355.9 363.2 356.2 359.4 360.2 362.6 357.3 342.7<br />

80+ 504.9 539.1 522.0 454.1 501.6 500.8 505.1 480.3 507.9 507.9 466.9 469.3<br />

Male 190.5 200.2 202.6 211.4 220.7 242.6 255.3 273.5 284.0 287.8 279.0 270.4<br />

Female 178.3 178.9 185.0 192.0 205.8 218.4 229.4 238.9 251.0 253.5 256.6 254.9<br />

White 196.6 207.7 213.5 222.6 239.6 259.9 271.5 292.0 307.0 308.3 311.1 308.4<br />

Black 160.5 155.3 155.7 165.3 168.6 183.8 197.1 201.7 210.2 218.3 208.4 203.2<br />

Other race 174.1 183.3 208.9 190.9 197.7 209.6 229.0 241.2 236.5 229.8 228.1 197.3<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 268.6 276.7 285.6 299.3 295.5 315.8 322.5 333.8 332.7 320.8 317.2 304.8<br />

Hypertension 147.7 163.4 174.5 184.3 203.3 220.4 226.0 247.1 259.8 263.9 263.6 261.5<br />

Glomerulonephritis 101.7 114.5 126.8 131.8 141.9 152.3 167.4 187.6 208.4 200.5 209.6 202.0<br />

Other cause 211.7 210.1 205.9 210.1 219.6 234.8 248.3 247.2 255.0 270.7 251.1 245.6<br />


Table H.14 H.14 (continued)<br />

Annual mortality rates per 1,000 patient YAR: hemodialysis patients, never on on transplant waitlist<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 520.6 706.6 386.8 535.7 173.2 94.6 283.4 208.8 484.5 595.9 269.1 374.0<br />

5-9 148.5 185.5 253.6 175.3 197.5 112.9 153.0 158.2 62.5 115.9 70.2 179.7<br />

10-14 142.5 105.0 91.9 54.0 94.3 96.9 110.5 208.1 94.6 73.1 72.8 97.7<br />

15-19 159.2 93.3 63.0 84.0 91.1 88.9 62.2 72.8 79.5 72.5 49.2 87.1<br />

20-29 151.7 143.6 126.7 135.8 133.1 116.6 104.4 104.8 99.7 105.3 107.7 92.9<br />

30-39 161.2 168.6 166.6 169.8 166.8 149.5 151.3 153.7 141.4 147.4 140.8 129.7<br />

40-49 180.5 170.9 169.0 175.6 165.0 168.1 166.4 171.5 164.7 172.3 171.6 162.1<br />

50-59 201.3 203.5 201.0 207.4 205.5 202.3 203.6 215.8 209.0 213.3 210.3 203.2<br />

60-64 244.8 240.7 237.4 240.0 239.1 236.3 242.7 253.3 247.9 248.3 244.5 252.4<br />

65-69 272.9 272.5 271.5 269.5 272.1 274.0 279.2 284.8 281.5 286.6 283.3 282.2<br />

70-79 348.9 351.1 333.3 338.3 342.0 336.8 342.3 352.3 347.1 350.0 348.5 342.7<br />

80+ 469.6 467.2 462.0 466.3 466.4 474.8 483.5 502.7 489.9 491.0 492.0 483.6<br />

Male 278.0 278.2 273.4 277.1 278.4 273.8 278.4 287.2 281.8 286.1 283.8 279.9<br />

Female 262.2 266.3 260.9 268.5 269.4 272.5 278.6 291.1 285.4 290.7 290.3 284.7<br />

529<br />

White 320.2 322.4 313.3 319.0 321.7 321.4 328.9 339.2 332.9 336.1 337.6 332.0<br />

Black 206.2 211.0 210.3 216.0 214.8 212.9 216.0 226.9 221.5 229.4 223.7 221.8<br />

Other race 200.3 193.5 210.2 220.0 231.5 234.5 234.5 245.7 240.7 233.8 232.2 221.5<br />

†Hispanic 233.2 238.8 246.4 251.2 240.4 239.3 239.5 233.7<br />

†Non-Hispanic 278.3 277.2 282.4 293.9 289.2 295.1 293.8 289.5<br />

Diabetes 307.2 302.1 290.8 296.3 298.6 292.3 299.9 313.8 302.4 307.9 301.3 297.1<br />

Hypertension 263.7 270.7 268.4 271.3 265.2 269.9 274.8 281.2 279.9 282.4 283.4 277.1<br />

Glomerulonephritis 209.2 208.9 203.4 216.1 210.7 210.5 210.2 218.5 211.2 212.2 217.1 208.2<br />

Other cause 262.2 264.8 262.5 265.2 277.1 275.0 276.0 284.9 285.0 291.9 294.4 291.8<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.15 H.15<br />

Total patient deaths: hemodialysis patients, on on transplant waitlist<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

530<br />

1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 . . . * . . . . . . . * * * . . .<br />

5-9 . . . . . . * . . . * . . * . . .<br />

10-14 . * * . * . . * . . . * * . . * *<br />

15-19 . * . * * * * * * * * * * * * * *<br />

20-29 . * 14 19 16 18 16 30 25 27 34 37 43 41 47 49 48<br />

30-39 * 13 32 54 60 63 64 64 85 117 122 131 162 142 164 153 168<br />

40-49 * 25 42 51 59 63 115 110 162 196 210 224 292 339 324 342 360<br />

50-59 * 21 46 52 74 69 94 160 158 190 279 327 360 495 567 584 653<br />

60-64 . * 16 28 25 32 32 41 64 77 119 145 166 233 265 287 326<br />

65-69 . * * 13 12 12 18 38 54 79 101 82 128 149 194 221 252<br />

70-79 . * * * * * 15 17 20 36 38 57 82 90 112 151 193<br />

80+ . . . . * . . . * * * . * . * * *<br />

0-19 . * * * * * * * * * * * * * * * *<br />

20-44 10 29 66 102 105 114 130 142 186 225 252 273 322 331 339 358 346<br />

45-64 * 42 84 102 129 131 191 263 308 382 512 591 701 919 1,028 1,057 1,209<br />

65-74 . * * 18 12 16 31 52 72 113 130 130 188 223 281 337 405<br />

75+ . * . . * * * * * * 11 * 23 16 33 44 49<br />

Male 10 49 94 143 149 163 212 270 322 419 526 583 737 852 986 1,051 1,232<br />

Female * 34 65 82 104 100 145 193 252 308 383 426 503 640 696 752 783<br />

Unknown<br />

White 11 49 107 153 174 180 226 284 346 437 509 594 715 822 935 1,012 1,136<br />

Black * 31 45 67 72 74 110 162 203 256 336 337 455 557 622 659 719<br />

Native American . . * * * * * * * 10 20 13 11 18 18 21 30<br />

Asian . * * * * * 14 10 18 22 32 52 41 69 89 75 96<br />

Other/unknown * * * . . . * . . * 12 13 18 26 18 36 34<br />

†Hispanic 62 85 131 148 159 216 261 277<br />

†Non-Hispanic 665 824 878 1,092 1,333 1,466 1,542 1,738<br />

Diabetes * 27 54 73 89 94 147 165 192 275 370 471 556 670 807 860 928<br />

Hypertension * 14 21 46 47 51 64 109 129 167 208 194 254 325 362 388 418<br />

Glomerulonephritis * 18 32 50 50 45 68 82 114 142 146 146 194 228 229 237 308<br />

Cystic kidney . * 10 * 14 10 15 11 29 27 37 34 33 54 48 64 78<br />

Other urologic . * * * * * * 10 11 * 14 22 21 37 34 51 51<br />

Other cause * * 25 25 31 40 45 59 70 76 112 114 149 125 165 169 183<br />

Unknown cause . * * * * 14 15 24 26 30 20 28 33 49 36 34 47<br />

Missing disease * 10 * * * * * * * * * . . * * . *<br />


Table H.16 H.16<br />

Annual mortality rates per 1,000 patient YAR: hemodialysis patients, on transplant waitlist<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

UNADJUSTED 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 . . . 364.9 . . . . . . 157.1 137.4 126.2 149.3 . . .<br />

5-9 . . . . . . 52.6 . . . . . . 66.4 . . .<br />

10-14 . 105.2 29.7 . 50.1 . . 22.9 22.8 . . 49.8 49.6 0.0 24.4 53.7 52.2<br />

15-19 . 9.3 . 16.1 8.0 7.6 20.5 14.6 22.6 30.3 22.4 24.6 19.6 19.1 15.0 31.7 48.4<br />

20-29 . 9.8 20.5 25.7 21.3 20.0 16.1 27.9 25.0 25.0 26.4 27.0 31.9 29.3 38.1 49.7 68.9<br />

30-39 13.9 14.0 30.1 44.5 42.4 43.2 35.4 33.2 37.7 50.6 51.2 46.3 56.8 51.1 57.4 64.5 96.4<br />

40-49 16.5 34.2 43.5 35.2 38.3 38.4 55.1 43.6 56.4 58.6 60.7 59.6 71.2 78.6 79.9 95.3 137.8<br />

50-59 13.0 34.0 64.2 63.4 69.1 51.1 57.0 83.2 68.3 66.6 87.8 85.7 84.4 108.4 117.5 136.3 196.9<br />

60-64 . 50.7 87.8 111.3 88.9 84.8 74.5 62.9 83.9 83.8 100.6 103.5 104.2 131.6 129.9 147.9 220.9<br />

65-69 . 98.9 80.4 94.3 90.3 79.2 67.5 114.3 111.4 135.0 136.2 94.6 118.6 128.5 139.5 166.2 238.3<br />

70-79 . 378.8 79.1 184.2 84.7 44.6 163.9 133.7 131.5 175.0 136.3 164.4 177.4 138.6 150.2 197.5 311.0<br />

80+ . . . . 721.8 . . . 383.7 343.1 301.1 . 103.4 . 435.8 292.9 193.3<br />

Male 11.0 27.1 43.4 51.9 46.6 46.0 47.8 52.4 53.5 60.6 67.1 66.1 76.6 83.1 93.7 111.3 172.5<br />

Female 9.8 25.1 37.9 39.9 45.9 37.1 46.1 51.6 59.5 63.5 74.0 70.8 77.1 94.2 99.0 120.1 165.6<br />

531<br />

White 10.3 25.1 46.5 54.1 56.5 51.9 54.5 59.4 64.4 71.6 76.5 77.0 85.9 91.4 99.5 118.5 174.8<br />

Black 8.7 29.0 32.4 39.0 34.6 30.4 36.7 45.4 48.2 52.9 61.7 56.3 69.6 82.7 92.6 112.8 168.0<br />

Other race 29.9 21.1 33.6 17.0 19.1 25.0 46.0 31.3 35.9 39.3 68.1 67.5 52.6 85.6 86.3 99.9 145.3<br />

†Hispanic 44.0 51.3 65.3 67.3 63.0 82.8 106.7 152.8<br />

†Non-Hispanic 64.2 72.6 68.4 78.3 91.7 98.1 116.3 172.7<br />

Diabetes 44.8 63.8 103.8 100.7 103.3 86.0 100.0 95.1 90.6 104.7 117.3 122.3 128.3 135.7 150.5 173.5 239.9<br />

Hypertension 8.5 22.1 24.5 43.5 37.0 35.3 35.0 47.2 49.2 56.3 64.4 56.4 64.7 81.1 87.8 106.3 158.1<br />

Glomerulonephritis 4.3 17.3 24.6 31.8 29.6 25.0 32.3 33.8 39.6 43.3 42.9 37.0 47.2 54.5 56.9 68.6 117.0<br />

Other cause 8.8 23.5 42.1 38.4 41.3 38.8 36.0 43.7 51.9 48.4 57.0 54.2 62.0 69.2 70.5 88.4 133.5<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.17 H.17<br />

Total patient deaths: hemodialysis patients, returned to to dialysis from transplant<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

532<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 . . . . . . . * . . * *<br />

5-9 * * . * . . . . . . . .<br />

10-14 * * * * . * * . * * * *<br />

15-19 * * * * * * * * * * * *<br />

20-29 17 28 20 23 34 25 30 38 45 54 57 59<br />

30-39 31 29 43 47 68 84 94 117 120 144 135 160<br />

40-49 24 32 39 49 61 81 82 122 144 154 200 206<br />

50-59 25 26 33 54 62 57 98 100 124 117 166 184<br />

60-64 * * * * * 31 25 23 35 43 57 50<br />

65-69 . * * * * 10 11 10 25 21 26 34<br />

70-79 * . . . . * * * * 11 11 16<br />

80+ * . . . . * . . . . . *<br />

0-19 * * * * * * * * 11 * * *<br />

20-44 62 73 80 94 134 147 157 216 238 280 289 326<br />

45-64 43 46 60 84 99 131 172 184 230 232 326 333<br />

65-74 * * * * * 13 16 11 28 30 35 47<br />

75+ * . . . . * . * . * * *<br />

Male 73 88 93 114 156 212 240 284 316 347 428 442<br />

Female 39 39 55 69 89 86 110 135 191 203 233 276<br />

Unknown<br />

White 87 94 109 121 181 210 225 259 330 364 431 450<br />

Black 21 30 33 52 59 82 112 144 167 176 213 252<br />

Native American . . . * * . * * * * * *<br />

Asian . . . . * * * * * * 10 *<br />

Other/unknown * * * * * * * * * * * *<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 19 14 26 38 42 52 55 81 98 112 139 141<br />

Hypertension * 10 20 28 33 49 54 56 90 100 124 153<br />

Glomerulonephritis 24 23 34 42 60 67 101 112 133 142 189 215<br />

Cystic kidney * * * * 11 16 17 19 29 24 34 38<br />

Other urologic * * * * * * * 11 * * * *<br />

Other cause * 13 12 12 24 33 50 54 77 73 99 120<br />

Unknown cause * 15 14 * 26 23 21 28 30 45 43 23<br />

Missing disease 39 44 36 45 47 50 50 58 42 49 28 21<br />


Table H.17 H.17 (continued)<br />

Total patient deaths: hemodialysis patients, returned to to dialysis from transplant<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

patient<br />

patient vintage<br />

vintage<br />

MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 . . . . . . . . . . . *<br />

5-9 * * . . . * * . * * * *<br />

10-14 * * * * * * * * . . * *<br />

15-19 * * * * * * * * * * * *<br />

20-29 65 43 50 52 54 52 57 57 73 82 74 65<br />

30-39 150 156 159 172 183 185 184 188 190 215 192 178<br />

40-49 213 233 220 261 299 368 334 378 422 446 441 463<br />

50-59 189 202 257 277 269 305 371 420 423 499 534 569<br />

60-64 69 84 93 91 105 131 155 163 170 208 200 235<br />

65-69 30 68 56 91 78 87 112 120 158 156 150 177<br />

70-79 23 28 33 36 55 64 86 86 115 133 157 144<br />

80+ * * * * * * * * * * 12 *<br />

0-19 * * * * 10 * * 11 * * 10 *<br />

20-44 316 318 299 338 379 414 398 401 450 487 486 432<br />

45-64 370 400 480 515 531 627 703 805 828 963 955 1,078<br />

65-74 46 86 77 120 115 130 173 180 237 250 263 282<br />

75+ * 15 19 13 19 22 28 29 41 45 56 46<br />

533<br />

Male 483 491 526 569 648 702 773 859 922 1,050 1,039 1,054<br />

Female 263 337 357 424 406 498 535 567 638 703 731 793<br />

Unknown<br />

White 490 540 533 621 693 753 831 862 963 1,093 1,085 1,126<br />

Black 239 270 329 348 334 412 444 520 543 601 620 651<br />

Native American 11 * * 13 10 10 13 14 19 13 23 19<br />

Asian * * 11 11 17 24 20 30 34 45 41 49<br />

Other/unknown * * * . . * . . * * * *<br />

†Hispanic 78 85 107 122 122 144 157 150<br />

†Non-Hispanic 976 1,115 1,201 1,304 1,438 1,609 1,613 1,697<br />

Diabetes 166 192 189 202 244 261 327 363 388 425 427 458<br />

Hypertension 154 191 233 243 238 286 285 354 338 386 406 407<br />

Glomerulonephritis 183 226 221 276 285 333 330 358 440 472 453 520<br />

Cystic kidney 42 35 44 57 72 90 84 90 91 108 93 101<br />

Other urologic 15 24 23 25 20 30 41 37 59 67 79 58<br />

Other cause 120 121 130 141 147 166 194 188 203 248 266 252<br />

Unknown cause 44 27 36 47 46 34 45 35 40 47 45 51<br />

Missing disease 22 12 * * * . * * * . * .<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.18 H.18<br />

Annual mortality rates per 1,000 patient YAR: hemodialysis patients, returned to to dialysis from transplant<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

534<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 . . . . . . . 365.3 . . 181.5 373.3<br />

5-9 423.9 103.3 . 65.3 . . . . . . . .<br />

10-14 34.8 78.9 40.8 15.5 . 18.4 59.0 . 80.3 32.6 54.0 53.5<br />

15-19 31.1 27.4 15.9 28.4 47.1 37.3 34.4 59.7 28.7 24.9 28.1 28.2<br />

20-29 50.6 75.0 48.8 39.7 51.1 34.7 36.5 43.3 44.5 54.4 47.6 53.4<br />

30-39 82.8 62.9 72.9 70.6 67.6 78.3 76.1 80.6 82.8 80.9 78.4 76.1<br />

40-49 91.1 80.0 96.1 86.3 77.0 89.7 85.3 108.2 120.2 101.2 104.7 100.4<br />

50-59 158.8 99.1 102.2 126.1 118.6 94.6 161.4 134.0 139.8 118.0 158.3 145.7<br />

60-64 262.1 120.6 95.1 74.3 123.6 248.3 176.2 170.3 180.5 174.3 191.2 154.3<br />

65-69 . 372.5 439.5 70.1 269.5 399.7 321.8 121.6 329.1 176.2 227.8 209.0<br />

70-79 . . . . . 364.0 479.5 261.8 145.4 408.4 238.0 291.2<br />

80+ . . . . . . . . . . . .<br />

Male 87.3 80.8 74.1 70.5 71.5 89.0 95.0 98.2 100.9 91.8 102.1 97.7<br />

Female 88.9 65.2 73.1 74.3 78.6 60.8 71.4 75.7 91.5 87.4 90.5 92.2<br />

White 98.7 80.6 83.2 71.3 81.9 86.0 88.7 87.2 100.5 97.2 103.1 99.1<br />

Black 60.0 65.7 51.8 67.1 61.1 66.0 77.9 92.6 93.7 80.1 88.1 91.0<br />

Other race 88.0 48.9 76.7 123.9 39.8 61.3 123.7 110.5 65.8 53.1 97.3 76.0<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 271.0 161.0 238.5 240.2 192.3 208.7 196.1 229.2 232.6 215.3 244.5 217.4<br />

Hypertension 54.1 45.1 65.3 65.3 63.3 74.4 78.3 67.2 86.7 82.7 91.6 96.5<br />

Glomerulonephritis 52.0 34.2 45.8 45.2 47.5 46.0 61.4 60.7 67.2 66.9 75.7 78.4<br />

Other cause 104.4 111.9 80.7 73.2 86.5 92.5 96.7 103.5 107.2 91.5 90.9 84.0<br />


Table H.18 H.18 (continued)<br />

MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Annual mortality rates per 1,000 patient YAR: hemodialysis patients, returned to to dialysis from transplant<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 . . . . . 586.3 . . . 822.6 200.1 386.9<br />

5-9 66.8 43.9 . . . . 55.2 . 97.5 237.3 . 95.2<br />

10-14 30.5 13.6 29.5 45.6 67.0 12.7 67.0 178.2 . . 105.7 65.4<br />

15-19 44.4 54.4 46.9 40.5 39.7 22.4 35.0 18.3 23.4 44.0 32.9 44.4<br />

20-29 52.5 38.0 47.3 43.1 39.0 41.8 44.9 38.8 50.0 67.0 45.9 57.7<br />

30-39 71.0 73.2 61.3 63.8 70.6 71.1 65.6 67.2 72.3 71.8 65.2 53.2<br />

40-49 92.7 94.4 85.8 98.5 98.2 111.8 100.0 107.0 111.9 117.4 115.1 115.3<br />

50-59 139.5 137.0 144.6 148.3 137.6 146.8 160.3 167.1 158.1 164.7 166.1 161.4<br />

60-64 181.5 192.1 182.6 176.9 173.8 204.9 213.3 230.9 202.2 235.8 223.9 238.5<br />

65-69 156.1 315.2 193.6 297.8 228.6 234.5 296.5 242.4 318.7 281.9 230.0 257.9<br />

70-79 344.5 265.6 270.5 267.8 252.4 321.5 332.0 325.4 365.2 353.9 389.0 321.8<br />

80+ 414.6 404.6 602.9 . 172.1 208.2 429.9 475.4 443.4 518.8 829.9 333.2<br />

Male 100.3 94.5 91.7 93.1 99.5 103.5 108.0 114.3 117.9 128.9 119.0 117.0<br />

Female 81.6 100.3 93.8 110.4 95.9 115.0 114.1 114.9 122.4 127.3 130.5 132.4<br />

535<br />

White 104.0 106.7 95.0 109.4 114.5 121.4 124.4 123.7 133.5 143.3 138.6 137.1<br />

Black 77.3 82.9 90.1 87.8 75.0 90.3 92.9 103.3 101.4 108.9 105.0 106.9<br />

Other race 66.9 72.7 74.5 68.8 74.6 82.7 79.2 92.9 103.5 107.1 98.6 92.3<br />

†Hispanic 76.9 70.9 82.8 90.4 83.4 95.1 101.5 87.2<br />

†Non-Hispanic 100.3 112.0 113.5 117.3 123.9 132.2 126.2 127.6<br />

Diabetes 223.1 229.8 192.0 208.6 226.8 222.0 251.1 264.1 259.0 263.7 247.3 238.1<br />

Hypertension 89.4 101.5 110.9 108.3 97.2 111.2 105.8 127.0 112.4 124.2 122.4 122.3<br />

Glomerulonephritis 65.0 75.1 64.2 76.1 74.7 83.0 75.4 80.3 97.0 97.3 92.5 100.8<br />

Other cause 93.5 82.2 84.5 90.0 87.7 99.4 108.9 96.7 104.0 120.1 116.3 106.4<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.19 H.19<br />

Total patient deaths: CAPD/CCPD patients<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

patient<br />

patient<br />

vintage<br />

vintage<br />

536<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 . * * * * * * * * * * 14<br />

5-9 * * * * * * * * * * * *<br />

10-14 . . . * * * * * * * * *<br />

15-19 . * * * * * * * 11 * * *<br />

20-29 * * 15 25 39 38 55 42 69 66 63 75<br />

30-39 10 24 52 60 101 147 186 197 221 225 229 249<br />

40-49 13 26 55 110 169 198 293 273 311 305 373 418<br />

50-59 23 46 124 203 270 403 453 492 553 559 592 680<br />

60-64 10 29 85 152 224 294 378 420 458 468 527 575<br />

65-69 10 38 89 167 194 303 390 475 552 531 597 730<br />

70-79 19 40 128 220 261 406 528 644 741 766 878 1,009<br />

80+ * * 33 59 66 101 130 156 193 220 235 288<br />

0-19 * * * 12 19 25 16 18 23 22 25 32<br />

20-44 17 43 93 130 227 277 365 365 431 442 464 531<br />

45-64 41 86 238 420 576 803 1,000 1,059 1,181 1,181 1,320 1,466<br />

65-74 22 61 166 302 354 550 713 849 977 976 1,104 1,316<br />

75+ 16 24 84 144 167 260 335 426 509 541 606 711<br />

Male 51 114 324 492 748 1,010 1,373 1,464 1,699 1,723 1,921 2,235<br />

Female 46 104 264 516 595 905 1,056 1,253 1,422 1,439 1,598 1,821<br />

Unknown<br />

White 79 185 473 804 1,083 1,523 1,960 2,159 2,500 2,540 2,773 3,178<br />

Black 15 31 106 186 231 345 421 513 539 559 657 802<br />

Native American * . * * 15 24 20 29 47 41 47 44<br />

Asian . * * 10 * 17 19 * 25 16 37 28<br />

Other/unknown * * * * * * * * 10 * * *<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 42 81 202 367 426 628 847 979 1,072 1,118 1,395 1,615<br />

Hypertension 19 39 136 233 269 465 497 613 738 774 885 1,070<br />

Glomerulonephritis 10 24 79 112 163 259 348 373 462 482 506 526<br />

Cystic kidney * * 12 38 61 65 91 95 110 117 104 114<br />

Other urologic * * 19 29 40 48 69 74 81 74 77 89<br />

Other cause 11 20 45 99 140 181 251 281 299 268 316 375<br />

Unknown cause * 26 55 82 82 128 153 155 198 177 156 199<br />

Missing disease * 13 40 48 162 141 173 147 161 152 80 68<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.19 H.19 (continued)<br />

Total patient deaths: CAPD/CCPD patients<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis, &<br />

patient<br />

patient<br />

vintage<br />

vintage<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 12 * 14 11 13 20 10 16 18 19 14 12<br />

5-9 * * * * * * * * * * * *<br />

10-14 10 * * * * * * * * * * *<br />

15-19 * * 13 18 * 12 12 14 11 10 12 *<br />

20-29 67 73 99 80 86 65 71 75 51 56 57 69<br />

30-39 308 337 359 366 349 310 253 239 230 194 219 169<br />

40-49 535 582 604 686 706 636 604 546 510 498 474 433<br />

50-59 770 871 953 1,080 1,099 1,096 1,070 1,018 958 934 899 886<br />

60-64 621 733 706 732 817 793 740 686 645 598 554 550<br />

65-69 790 916 915 1,041 1,028 986 909 790 775 755 682 647<br />

70-79 1,234 1,405 1,640 1,719 1,860 1,706 1,679 1,587 1,480 1,365 1,308 1,259<br />

80+ 338 390 469 562 583 600 548 512 514 535 543 581<br />

0-19 33 24 34 38 36 45 29 46 35 37 33 35<br />

20-44 620 668 737 754 737 640 588 533 500 462 457 406<br />

45-64 1,681 1,928 1,984 2,190 2,320 2,260 2,150 2,031 1,894 1,818 1,746 1,701<br />

65-74 1,527 1,708 1,890 2,084 2,102 1,975 1,839 1,672 1,608 1,502 1,378 1,326<br />

75+ 835 1,003 1,134 1,238 1,369 1,317 1,297 1,217 1,161 1,153 1,155 1,161<br />

537<br />

Male 2,644 2,871 3,099 3,408 3,537 3,299 3,092 2,846 2,723 2,613 2,481 2,518<br />

Female 2,052 2,460 2,680 2,896 3,027 2,938 2,811 2,653 2,475 2,359 2,288 2,111<br />

Unknown<br />

White 3,708 4,171 4,467 4,791 4,920 4,760 4,483 4,121 3,895 3,712 3,600 3,433<br />

Black 891 1,033 1,163 1,326 1,372 1,204 1,160 1,076 1,020 1,000 916 917<br />

Native American 48 57 70 64 76 64 60 67 48 50 49 62<br />

Asian 42 63 74 109 158 154 133 169 158 150 150 161<br />

Other/unknown * * * 14 38 55 67 66 77 60 54 56<br />

†Hispanic 388 497 493 446 437 473 451 480<br />

†Non-Hispanic 6,176 5,740 5,410 5,053 4,761 4,499 4,318 4,149<br />

Diabetes 1,914 2,284 2,516 2,772 3,030 2,988 2,891 2,669 2,503 2,402 2,307 2,163<br />

Hypertension 1,257 1,456 1,544 1,723 1,650 1,530 1,366 1,266 1,211 1,221 1,080 1,147<br />

Glomerulonephritis 616 610 715 720 795 729 699 668 576 518 518 524<br />

Cystic kidney 125 154 147 183 153 164 157 137 126 119 120 100<br />

Other urologic 99 92 108 104 132 127 114 121 137 124 124 103<br />

Other cause 411 479 481 550 565 486 470 449 469 421 436 427<br />

Unknown cause 217 214 229 238 224 207 200 184 168 162 176 159<br />

Missing disease 57 42 39 14 15 * * * * * * *<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.20 H.20<br />

Annual mortality rates per 1,000 patient years at at risk: CAPD/CCPD patients<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

ON OUR WEBSITE & CD<br />

Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, by primary<br />

diagnosis, adjusted (H.20.1). Annual deaths per 1,000 patients: CAPD/CCPD Patients,<br />

by primary diagnosis (H.20.2). CAPD/CCPD Patients: counts of total deaths, by primary<br />

diagnosis (H.20.3). Annual mortality rates: CAPD/CCPD patients, unadjusted (H.20.4).<br />

538<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992<br />

0-4 . 74 85 118 116 104 61 62 47 106 88 149 101<br />

5-9 116 257 44 25 47 93 29 13 26 26 28 49 62<br />

10-14 . . . 15 27 47 16 22 41 27 50 27 49<br />

15-19 . 68 67 56 66 46 42 50 55 29 22 39 30<br />

20-29 60 50 80 89 74 60 82 53 76 71 67 64 57<br />

30-39 174 153 129 97 112 115 123 121 128 115 101 99 108<br />

40-49 210 157 124 166 145 137 174 151 158 134 141 128 140<br />

50-59 263 179 181 204 175 215 208 217 222 214 204 203 197<br />

60-64 187 294 245 298 282 281 276 273 291 278 268 265 273<br />

65-69 364 333 341 372 308 336 332 344 353 307 330 344 312<br />

70-79 548 414 420 434 403 428 428 439 445 429 409 401 403<br />

80+ 1,093 300 572 660 606 706 607 583 709 647 571 579 584<br />

Male 261 206 215 210 202 215 243 237 253 233 228 230 235<br />

Female 237 206 191 249 193 220 209 222 231 214 211 207 203<br />

White 256 218 211 240 209 228 243 245 262 246 241 240 246<br />

Black 207 167 180 193 163 181 179 192 182 165 165 171 160<br />

Other race 342 83 173 186 176 208 178 139 220 155 182 125 130<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 417 353 326 361 297 318 348 351 337 306 318 306 299<br />

Hypertension 308 192 237 249 204 271 225 238 262 241 235 236 237<br />

Glomerulonephritis 97 95 120 116 101 119 134 132 149 144 138 128 135<br />

Other cause 209 198 166 198 202 190 212 207 224 203 175 184 179<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.20 H.20 (continued)<br />

Annual mortality rates per 1,000 patient years at at risk: CAPD/CCPD patients<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

UNADJUSTED 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 62 103 79 92 147 73 123 120 117 93 85<br />

5-9 58 19 24 40 42 43 67 35 39 8 41<br />

10-14 35 25 40 45 43 9 43 15 18 26 40<br />

15-19 15 46 49 24 31 38 44 40 42 44 28<br />

20-29 55 68 58 60 49 49 61 42 43 48 61<br />

30-39 107 105 100 97 91 87 83 83 75 85 65<br />

40-49 140 132 142 136 125 121 119 113 116 112 107<br />

50-59 202 199 199 193 196 197 192 181 178 170 167<br />

60-64 289 258 259 271 275 269 273 270 253 228 220<br />

65-69 329 309 332 336 319 326 315 323 317 294 272<br />

70-79 407 418 402 427 403 419 418 407 393 374 353<br />

80+ 580 567 614 606 640 585 583 575 582 539 543<br />

Male 233 229 235 239 230 228 225 221 216 205 208<br />

Female 219 217 218 219 216 216 216 207 203 197 180<br />

539<br />

White 254 251 254 257 256 255 251 245 239 232 222<br />

Black 167 167 177 177 160 162 159 155 156 145 143<br />

Other race 133 127 130 160 151 142 172 158 140 131 140<br />

†Hispanic 148 173 174 160 151 162 152 155<br />

†Non-Hispanic 238 229 228 228 223 216 208 200<br />

Diabetes 315 315 314 323 318 321 313 301 295 280 260<br />

Hypertension 247 234 243 238 236 224 224 217 224 201 207<br />

Glomerulonephritis 123 133 126 134 124 125 128 117 108 111 114<br />

Other cause 180 168 177 172 160 161 162 167 156 158 147<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.21 H.21<br />

Total patient deaths: CAPD/CCPD patients, never on on transplant waitlist<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

540<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 . * * * * * * * * * * 13<br />

5-9 * * * * * * * * * * * *<br />

10-14 . . . * * * * * * * * *<br />

15-19 . * * * * * * * 10 * * *<br />

20-29 * * 15 25 39 38 55 41 65 64 60 66<br />

30-39 10 24 52 60 101 147 186 196 210 207 204 218<br />

40-49 13 26 55 110 169 198 293 272 294 288 353 384<br />

50-59 23 46 124 203 270 403 453 492 544 540 574 650<br />

60-64 10 29 85 152 224 294 378 420 454 464 519 558<br />

65-69 10 38 89 167 194 303 390 475 548 527 593 723<br />

70-79 19 40 128 220 261 406 528 644 741 766 877 1,006<br />

80+ * * 33 59 66 101 130 156 193 220 235 288<br />

0-19 * * * 12 19 25 16 18 22 19 21 27<br />

20-44 17 43 93 130 227 277 365 363 405 412 425 473<br />

45-64 41 86 238 420 576 803 1,000 1,058 1,162 1,151 1,285 1,403<br />

65-74 22 61 166 302 354 550 713 849 973 972 1,099 1,306<br />

75+ 16 24 84 144 167 260 335 426 509 541 606 711<br />

Male 51 114 324 492 748 1,010 1,373 1,462 1,670 1,689 1,875 2,158<br />

Female 46 104 264 516 595 905 1,056 1,252 1,401 1,406 1,561 1,762<br />

Unknown<br />

White 79 185 473 804 1,083 1,523 1,960 2,156 2,462 2,486 2,709 3,068<br />

Black 15 31 106 186 231 345 421 513 529 549 641 778<br />

Native American * . * * 15 24 20 29 46 39 46 43<br />

Asian . * * 10 * 17 19 * 25 15 35 27<br />

Other/unknown * * * * * * * * * * * *<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 42 81 202 367 426 628 847 976 1,045 1,085 1,353 1,557<br />

Hypertension 19 39 136 233 269 465 497 613 732 769 878 1,050<br />

Glomerulonephritis 10 24 79 112 163 259 348 373 456 469 489 502<br />

Cystic kidney * * 12 38 61 65 91 95 110 111 101 110<br />

Other urologic * * 19 29 40 48 69 74 81 74 77 88<br />

Other cause 11 20 45 99 140 181 251 281 293 262 309 359<br />

Unknown cause * 26 55 82 82 128 153 155 196 175 151 193<br />

Missing disease * 13 40 48 162 141 173 147 158 150 78 61<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.21 H.21 (continued)<br />

Total patient deaths: CAPD/CCPD patients, never on on transplant waitlist<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 12 * 12 11 11 19 * 16 16 17 13 *<br />

5-9 * * * * * * * * * * . *<br />

10-14 * * * * * * * * * * * *<br />

15-19 * * * 14 * * * 11 * * * *<br />

20-29 59 57 80 59 61 39 43 49 35 36 38 49<br />

30-39 274 288 292 296 271 237 180 170 152 130 145 113<br />

40-49 467 526 511 570 584 501 462 400 383 358 355 295<br />

50-59 732 818 884 971 975 956 924 849 803 763 736 700<br />

60-64 595 708 677 701 751 729 666 617 570 526 480 469<br />

65-69 784 898 897 1,024 981 938 864 741 723 692 631 583<br />

70-79 1,234 1,403 1,631 1,713 1,851 1,688 1,650 1,555 1,442 1,334 1,264 1,197<br />

80+ 338 390 468 562 583 599 548 511 513 535 541 579<br />

0-19 28 17 25 32 30 37 22 39 28 30 25 25<br />

20-44 543 573 586 607 581 473 419 378 346 311 312 269<br />

45-64 1,584 1,824 1,858 1,990 2,061 1,989 1,856 1,707 1,597 1,502 1,442 1,357<br />

65-74 1,521 1,689 1,864 2,061 2,049 1,912 1,774 1,595 1,525 1,414 1,289 1,219<br />

75+ 835 1,002 1,132 1,238 1,366 1,313 1,288 1,212 1,153 1,147 1,147 1,140<br />

541<br />

Male 2,530 2,746 2,932 3,200 3,272 3,038 2,807 2,548 2,467 2,310 2,192 2,187<br />

Female 1,981 2,359 2,533 2,728 2,815 2,686 2,552 2,383 2,182 2,094 2,023 1,823<br />

Unknown<br />

White 3,561 4,001 4,237 4,514 4,582 4,413 4,129 3,728 3,548 3,345 3,252 3,038<br />

Black 859 982 1,093 1,240 1,259 1,062 1,006 937 855 847 756 742<br />

Native American 45 56 63 57 68 58 54 58 48 41 40 50<br />

Asian 39 59 67 103 142 138 109 146 132 115 123 131<br />

Other/unknown * * * 14 36 53 61 62 66 56 44 49<br />

†Hispanic 350 461 444 397 376 412 364 400<br />

†Non-Hispanic 5,737 5,263 4,915 4,534 4,273 3,992 3,851 3,610<br />

Diabetes 1,827 2,196 2,372 2,607 2,815 2,776 2,678 2,420 2,287 2,132 2,070 1,919<br />

Hypertension 1,225 1,415 1,492 1,662 1,587 1,437 1,268 1,181 1,113 1,106 985 1,039<br />

Glomerulonephritis 583 568 660 660 695 627 575 554 473 437 408 373<br />

Cystic kidney 117 138 133 154 131 137 126 109 104 98 102 78<br />

Other urologic 97 90 102 99 122 119 106 109 130 113 114 96<br />

Other cause 395 448 447 510 515 427 413 388 383 368 365 360<br />

Unknown cause 211 209 222 222 207 195 187 165 152 145 163 139<br />

Missing disease 56 41 37 14 15 * * * * * * *<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.22 H.22<br />

Annual mortality rates per 1,000 patient years at at risk: CAPD/CCPD patients, never on on transplant waitlist<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

542<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 . 113.1 144.4 260.9 235.4 180.8 134.8 184.5 138.5 219.2 198.3 328.4<br />

5-9 151.5 314.7 78.7 53.1 101.2 193.1 67.8 43.0 102.9 41.7 55.2 93.4<br />

10-14 . . . 24.9 56.2 97.7 41.6 67.0 150.2 110.7 207.3 85.4<br />

15-19 . 100.8 101.6 89.2 103.3 87.0 81.2 105.8 135.5 75.8 52.5 102.7<br />

20-29 72.2 68.0 106.2 126.3 108.2 88.7 134.2 103.9 165.6 161.3 148.3 147.7<br />

30-39 191.4 178.8 154.7 121.7 143.1 151.2 172.0 192.9 204.9 184.5 167.5 170.4<br />

40-49 218.4 173.0 134.5 182.6 166.5 162.3 217.0 208.4 224.2 195.6 205.5 188.6<br />

50-59 277.1 183.0 185.4 212.0 182.8 228.8 226.9 247.8 259.9 248.7 247.0 249.0<br />

60-64 187.3 297.6 248.3 301.6 285.4 287.0 284.1 286.6 309.7 298.7 286.6 285.7<br />

65-69 363.5 333.4 340.5 371.6 309.1 337.9 336.3 351.1 359.6 312.3 338.9 353.0<br />

70-79 548.4 414.0 419.9 433.6 402.8 429.0 429.3 440.6 447.5 431.4 410.3 401.8<br />

80+ . 299.6 572.4 659.7 605.5 706.1 609.6 586.0 711.8 646.6 572.3 579.0<br />

Male 275.3 221.4 233.3 232.1 227.2 244.3 284.3 292.4 317.7 295.5 292.5 297.4<br />

Female 258.0 227.9 208.7 277.3 220.9 254.3 246.9 275.4 294.7 275.0 273.7 272.7<br />

White 278.0 236.2 229.7 265.9 235.3 260.6 283.8 301.8 330.4 312.3 307.8 309.7<br />

Black 211.8 184.9 193.0 212.9 185.4 208.3 212.8 238.0 230.5 211.9 213.4 226.8<br />

Other race 352.0 97.7 197.1 217.4 210.0 244.7 216.7 182.6 303.3 217.2 278.7 195.1<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 429.2 368.4 336.0 371.8 312.6 339.6 377.6 402.5 387.9 357.0 373.9 361.3<br />

Hypertension 317.9 204.9 248.9 265.0 219.1 295.1 250.3 273.1 307.3 284.2 280.5 285.3<br />

Glomerulonephritis 108.4 107.5 138.8 138.0 122.2 147.5 172.9 183.0 213.8 209.5 205.9 194.2<br />

Other cause 228.9 219.0 182.4 227.3 235.2 224.1 257.2 265.0 299.0 271.4 239.6 258.0<br />


Table H.22 H.22 (continued)<br />

Annual mortality rates per 1,000 patient years at at risk: CAPD/CCPD patients, never on on transplant waitlist<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 263.7 133.1 187.6 166.8 161.8 262.0 109.7 254.8 252.6 211.4 171.5 128.6<br />

5-9 197.3 161.1 59.9 49.6 93.5 123.7 82.8 153.4 81.5 97.7 . 92.9<br />

10-14 115.3 87.8 59.7 91.8 106.2 93.7 28.3 85.7 30.9 40.5 50.4 65.9<br />

15-19 112.5 25.9 100.8 131.7 63.5 56.1 79.6 100.4 95.3 92.1 93.9 53.3<br />

20-29 126.7 116.9 158.6 129.2 130.9 98.8 92.7 129.7 89.8 83.1 95.1 121.7<br />

30-39 194.1 190.3 186.5 183.7 177.4 162.9 151.3 149.7 148.3 134.1 144.6 105.7<br />

40-49 202.8 217.5 202.1 217.1 215.2 193.0 188.0 182.5 177.6 172.3 175.6 156.8<br />

50-59 243.2 256.2 256.6 260.9 256.2 267.6 270.3 261.9 254.6 251.8 242.9 228.8<br />

60-64 293.0 314.1 289.1 293.4 307.2 318.0 319.0 328.5 335.8 320.1 286.5 276.9<br />

65-69 324.8 341.7 325.0 356.7 360.1 342.0 354.1 348.8 364.2 355.8 341.5 317.0<br />

70-79 404.6 410.0 421.0 406.5 433.4 411.1 426.3 425.5 415.5 409.7 389.6 367.6<br />

80+ 583.8 580.7 565.8 613.9 606.8 641.3 585.7 584.5 575.2 586.1 542.6 547.0<br />

Male 304.1 307.4 305.7 317.5 323.6 316.8 316.0 312.5 315.5 302.0 288.3 286.8<br />

Female 271.2 293.7 290.8 295.2 302.0 296.5 300.5 305.6 295.7 295.5 285.7 254.5<br />

543<br />

White 318.9 332.2 329.7 336.5 341.4 343.3 345.7 341.3 342.2 332.5 325.7 302.7<br />

Black 215.1 226.2 230.4 245.6 251.2 223.6 228.6 232.0 221.1 227.2 203.4 197.2<br />

Other race 195.4 210.3 191.4 202.6 246.1 238.4 217.3 268.6 255.7 223.8 210.3 232.3<br />

†Hispanic 225.1 265.4 265.7 249.6 232.0 251.2 219.3 227.8<br />

†Non-Hispanic 320.9 311.2 313.0 315.7 314.7 304.8 295.7 277.0<br />

Diabetes 352.7 379.3 376.4 378.3 389.3 386.4 396.7 385.3 381.1 365.3 350.7 324.8<br />

Hypertension 287.0 301.9 290.0 306.6 307.2 303.4 292.0 298.6 288.8 296.1 266.2 271.0<br />

Glomerulonephritis 208.1 193.2 214.6 208.1 218.4 202.4 201.2 216.3 203.6 195.9 192.3 177.3<br />

Other cause 259.5 260.7 248.9 260.4 256.9 243.7 244.8 246.1 257.0 248.4 253.9 230.8<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.23 H.23<br />

Total patient deaths: CAPD/CCPD patients, on on transplant waitlist<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

544<br />

1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 . . . . . . * . . * * . . * * .<br />

5-9 . * . . . . . . . . . . . . . .<br />

10-14 . . . * * * . . * * . . . . * *<br />

15-19 . . . * . * . . * * * . * * * *<br />

20-29 * * * * * * * 14 12 14 13 13 10 11 10 13<br />

30-39 * 10 * 11 16 28 33 39 41 34 37 44 41 39 37 30<br />

40-49 * * * 16 28 25 45 65 58 76 82 68 59 76 61 79<br />

50-59 * 10 * 12 17 25 34 59 72 75 86 107 103 109 105 118<br />

60-64 * * * * 15 11 13 14 32 41 44 44 46 40 41 52<br />

65-69 * * * * * * * * 29 23 27 32 33 35 29 36<br />

70-79 . . * * . * * * * 10 10 11 23 13 16 28<br />

80+ . . . . . . * . . * . . * . . *<br />

0-19 . * . * * * * . * * * . * * * *<br />

20-44 13 16 12 23 32 51 71 82 76 79 92 82 79 85 72 80<br />

45-64 * 16 16 25 48 47 59 109 139 161 170 194 180 190 182 212<br />

65-74 * * * * * * 10 * 33 31 31 41 52 46 45 56<br />

75+ . . . . . * * . * * * * * * . 10<br />

Male * 19 20 32 54 58 76 100 134 148 159 177 158 173 152 201<br />

Female 15 16 12 25 32 50 67 97 119 132 143 142 160 154 151 161<br />

Unknown<br />

White 16 29 25 45 65 80 102 143 175 178 179 223 201 212 172 227<br />

Black * * * 11 19 26 35 49 67 85 101 77 100 89 101 102<br />

Native American * * * . * . * * * * * * . * * 10<br />

Asian . * * * . * * * * 11 15 14 10 16 17 17<br />

Other/unknown * . . . . . . . * * * * * * * *<br />

†Hispanic 22 20 26 26 37 42 54 55<br />

†Non-Hispanic 231 260 276 293 281 285 249 307<br />

Diabetes 12 20 18 23 41 41 73 92 121 124 119 151 134 160 137 159<br />

Hypertension * * * 10 17 22 24 32 37 57 51 48 57 60 56 56<br />

Glomerulonephritis * * * 12 14 21 16 23 49 49 65 59 56 55 48 81<br />

Cystic kidney . * * * * * * 17 * 11 17 15 16 * 11 12<br />

Other urologic . . . * * * * * * * * * * * * *<br />

Other cause * * * * * 14 18 23 27 31 38 31 42 30 42 41<br />

Unknown cause * * * * * * * * * * * 11 * 10 * *<br />

Missing disease * * . * * * * . . . . . . . . .<br />


Table H.24 H.24<br />

Annual mortality rates per 1,000 patient years at at risk: CAPD/CCPD patients, on on transplant waitlist<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

UNADJUSTED 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 . 113.6 . . . . 100.0 . . 108.4 115.7 . . 67.5 101.6 .<br />

5-9 . . . . . . . . . . . . . . . .<br />

10-14 . . . 19.8 37.7 35.8 . . 63.4 20.3 . . 22.7 . 24.7 23.7<br />

15-19 . . . 19.2 0.0 24.5 . . 14.1 55.1 23.2 . 14.7 61.7 33.0 61.6<br />

20-29 7.8 5.9 5.9 23.3 28.6 31.2 18.7 46.1 34.9 34.6 39.0 38.7 29.1 44.5 42.3 74.2<br />

30-39 29.9 54.1 30.8 29.4 25.0 58.3 48.8 50.6 55.3 44.0 53.0 64.1 54.9 58.0 69.9 81.1<br />

40-49 52.4 38.3 17.9 43.6 63.1 45.1 64.1 77.9 53.9 81.8 74.6 67.6 66.8 87.5 78.4 147.1<br />

50-59 40.7 88.8 58.9 53.8 63.8 68.7 64.1 84.7 99.5 77.4 98.2 117.6 111.7 110.6 130.2 201.4<br />

60-64 152.5 74.5 80.6 124.1 276.3 134.4 93.2 79.4 146.4 156.7 152.7 165.9 144.1 147.0 127.6 227.1<br />

65-69 105.4 119.2 167.0 215.3 124.0 58.0 86.3 52.2 164.9 159.5 140.9 179.4 197.2 188.8 180.2 267.2<br />

70-79 . . 448.7 430.7 . 188.4 261.8 51.9 120.2 187.9 161.0 163.4 297.0 125.7 137.1 268.9<br />

80+ . . . . . . . . . . . . 566.3 . . 578.8<br />

Male 26.7 47.7 36.1 44.7 65.2 53.3 56.4 62.3 72.5 76.3 80.7 92.8 84.3 98.0 94.3 168.2<br />

Female 40.6 35.9 24.0 39.9 35.8 54.0 51.5 66.4 69.1 73.6 76.7 80.9 89.9 88.3 100.8 144.3<br />

545<br />

White 31.5 46.8 34.1 47.5 58.1 60.1 58.8 74.4 78.7 78.2 77.9 99.7 90.8 97.5 86.6 152.8<br />

Black 29.4 23.8 18.5 34.5 39.4 43.7 47.0 53.6 64.1 74.9 87.7 71.9 95.4 92.8 126.8 178.2<br />

Other race 107.1 49.2 32.5 21.0 18.5 22.5 34.7 19.7 36.3 54.2 57.6 54.2 43.6 69.0 93.2 131.8<br />

†Hispanic 65.5 50.0 60.1 57.3 77.1 86.3 128.7 173.5<br />

†Non-Hispanic 71.4 77.8 81.0 91.1 88.6 94.3 92.5 154.0<br />

Diabetes 103.7 119.0 91.1 85.8 115.6 92.7 122.6 139.9 142.9 144.0 131.8 172.4 150.5 183.8 167.8 258.9<br />

Hypertension 43.3 22.4 23.9 50.6 54.8 59.5 47.9 51.9 55.5 84.7 70.4 73.3 87.6 96.9 107.9 140.8<br />

Glomerulonephritis 8.4 26.3 15.4 25.7 28.8 34.4 19.7 24.1 46.6 39.4 53.2 50.2 48.7 51.3 51.1 123.7<br />

Other cause 20.0 21.9 14.6 28.5 26.2 39.1 36.5 54.3 46.5 48.6 68.1 62.2 75.5 55.9 76.5 99.6<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.25 H.25<br />

Total patient deaths: CAPD/CCPD patients, returned to to dialysis from transplant<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

546<br />

1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995<br />

0-4 . . . . * . . . . . . . .<br />

5-9 . . . . * . * * * * * . .<br />

10-14 . . * . * * * * * * * . *<br />

15-19 . * * * * * * * * * * * *<br />

20-29 . * * * * * * 12 14 10 * 12 10<br />

30-39 . * 19 18 18 27 29 26 39 49 48 42 37<br />

40-49 . * 20 21 19 32 37 49 37 60 55 64 65<br />

50-59 . * * 18 10 23 25 14 28 26 40 53 67<br />

60-64 . * * . * * * * 11 15 17 * 15<br />

65-69 . * * * . * * * * * 13 * 16<br />

70-79 . . . * * * * * * * * 12 *<br />

80+ . . . . . . . . . . . . .<br />

0-19 . * * * * * * * * * * * *<br />

20-44 . 17 33 33 37 51 60 71 73 91 85 90 89<br />

45-64 . 12 18 30 24 46 47 36 56 69 83 90 105<br />

65-74 . * * * * * * 11 * * 14 18 21<br />

75+ . . . . . . . * . . * * *<br />

Male . 19 32 46 32 73 70 67 73 99 113 111 122<br />

Female . 13 24 22 35 39 48 57 64 75 75 93 101<br />

Unknown . . . . . . . . . . . . .<br />

White . 30 47 58 58 93 101 95 108 139 152 159 172<br />

Black . * * * * 17 16 26 28 34 32 36 45<br />

Native American . . * . * . * * . * * * *<br />

Asian . . * . . * . * * . * * *<br />

Other/unknown . * . * * . . . . . . . .<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes . * 12 19 22 30 37 43 44 57 54 56 64<br />

Hypertension . * * * * 12 13 13 16 27 27 33 44<br />

Glomerulonephritis . 10 16 20 11 34 34 35 36 41 55 66 61<br />

Cystic kidney . * * * * * * * * 15 14 * 16<br />

Other urologic . . . . * * * . * * . * *<br />

Other cause . * * * 10 17 16 18 21 23 28 23 24<br />

Unknown cause . * * . * * * * 10 * * * 11<br />

Missing disease . * * * * * * * * * * * .<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.25 H.25 (continued)<br />

Total patient deaths: CAPD/CCPD patients, returned to to dialysis from transplant<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 . . . . . . . .<br />

5-9 * . * . * * . .<br />

10-14 * * . * . . * *<br />

15-19 * * * * * * * *<br />

20-29 22 20 23 21 11 12 11 11<br />

30-39 47 52 50 43 49 34 33 26<br />

40-49 81 88 65 92 74 69 70 65<br />

50-59 63 57 56 54 51 47 60 56<br />

60-64 19 23 20 12 16 15 14 14<br />

65-69 16 16 * 10 11 * 12 15<br />

70-79 * * 12 15 * 10 18 10<br />

80+ . . . . . * * .<br />

0-19 * * * * * * * *<br />

20-44 107 122 107 97 101 80 80 64<br />

45-64 125 118 107 125 100 97 108 108<br />

65-74 22 24 16 22 17 18 28 22<br />

75+ . * * * * * * *<br />

547<br />

Male 141 135 117 129 108 109 111 98<br />

Female 118 135 118 121 116 91 110 102<br />

Unknown<br />

White 195 200 165 187 161 146 164 130<br />

Black 57 58 56 56 54 46 49 62<br />

Native American * * * * . * * *<br />

Asian * 10 11 * * * * *<br />

Other/unknown . . . . * . . *<br />

†Hispanic 16 15 16 28 18 18 23 11<br />

†Non-Hispanic 243 255 219 222 206 182 198 189<br />

Diabetes 66 68 54 70 54 60 50 33<br />

Hypertension 39 36 42 29 35 35 41 33<br />

Glomerulonephritis 85 87 79 71 67 56 75 86<br />

Cystic kidney 19 24 11 13 * 10 * 10<br />

Other urologic * * * 11 * * * *<br />

Other cause 36 40 38 49 49 25 36 23<br />

Unknown cause * * * * * * * 11<br />

Missing disease . . . . . . . .<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.26 H.26<br />

Annual mortality rates per 1,000 patient YAR: CAPD/CCPD patients, returned to to dialysis from transplant<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

548<br />

UNADJUSTED 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<br />

0-4 . . . . 133.8 . . . . . 117.5<br />

5-9 . . . . 45.1 . 34.4 51.0 53.8 29.0 .<br />

10-14 . . 60.9 . 32.4 74.0 63.3 16.0 14.9 58.8 29.7<br />

15-19 150.2 130.0 79.6 14.2 35.2 120.7 30.0 19.4 24.1 46.3 34.0<br />

20-29 88.7 43.6 30.7 46.6 34.7 50.2 29.4 48.0 51.1 42.9 37.1<br />

30-39 52.5 64.6 115.4 98.5 77.8 109.7 87.4 75.2 99.9 105.5 91.3<br />

40-49 158.0 80.6 191.3 137.7 108.6 126.3 138.3 164.3 89.2 148.4 132.4<br />

50-59 86.6 234.4 113.9 215.4 143.8 259.2 267.2 109.9 229.5 155.4 167.6<br />

60-64 . 266.2 54.8 . 231.0 295.7 250.9 124.5 150.7 292.4 348.5<br />

65-69 . 318.2 129.0 313.9 . 316.3 375.2 546.9 285.8 175.9 299.8<br />

70-79 . . . . 389.4 309.8 . 889.6 415.1 252.2 180.8<br />

80+ . . . . . . . . . . .<br />

Male 51.6 85.5 105.7 117.9 71.6 135.4 112.6 101.5 97.6 121.5 121.3<br />

Female 160.2 76.4 98.7 63.4 86.9 92.1 85.9 89.7 88.4 93.1 84.3<br />

White 104.6 96.9 107.8 99.1 86.2 127.6 106.7 97.4 99.9 119.4 114.1<br />

Black . 13.1 81.4 80.5 44.1 78.1 85.3 95.1 80.5 83.1 76.7<br />

Other race 226.9 107.0 91.9 39.4 85.6 57.7 24.8 65.8 20.1 16.8 65.2<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes . 131.7 257.1 279.5 246.5 237.2 250.6 288.6 256.4 311.0 264.1<br />

Hypertension 83.1 65.1 152.7 101.6 70.1 135.0 109.0 77.7 94.6 126.2 101.0<br />

Glomerulonephritis 94.3 62.9 68.4 73.3 35.9 82.1 75.6 67.8 58.3 69.3 83.2<br />

Other cause 108.1 93.9 87.6 68.6 81.3 110.8 75.5 74.8 83.8 80.7 75.2<br />


Table H.26 H.26 (continued)<br />

MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Annual mortality rates per 1,000 patient YAR: CAPD/CCPD patients, returned to to dialysis from transplant<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

UNADJUSTED 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 . . . . . . . . . .<br />

5-9 . 74.1 33.0 . 65.0 . 89.5 94.5 . .<br />

10-14 . 30.9 37.3 49.4 . 30.0 32.7 . 27.9 46.5<br />

15-19 43.2 32.9 28.2 55.2 35.1 41.8 49.4 31.2 10.2 12.8<br />

20-29 39.4 38.0 65.0 62.9 76.0 71.0 41.9 45.0 53.8 36.1<br />

30-39 67.9 61.3 88.1 93.1 102.6 93.4 102.4 74.7 72.4 57.5<br />

40-49 114.9 128.5 138.5 163.6 109.1 177.7 154.1 147.4 151.3 136.0<br />

50-59 188.0 220.6 176.1 200.0 192.5 193.5 204.2 159.7 204.5 193.1<br />

60-64 104.8 313.3 260.2 370.0 234.6 161.8 189.6 217.5 229.2 219.2<br />

65-69 147.2 302.9 335.9 392.3 196.6 275.7 464.5 372.3 312.5 267.4<br />

70-79 651.3 366.1 165.6 504.8 524.1 520.9 221.3 282.4 619.7 226.0<br />

80+ . . . . . . . 525.5 . .<br />

Male 98.0 121.0 123.8 144.9 118.6 153.1 140.9 135.8 145.4 120.1<br />

Female 85.6 93.0 108.8 126.1 115.1 118.4 115.7 92.4 109.1 100.3<br />

549<br />

White 102.8 114.0 126.9 145.1 125.3 151.6 140.4 124.8 135.9 106.0<br />

Black 61.3 92.7 95.4 114.5 93.9 103.6 106.2 89.4 109.7 127.5<br />

Other race 90.1 71.7 76.0 103.7 120.1 75.0 73.4 67.8 70.6 64.1<br />

†Hispanic 75.7 79.0 88.8 147.7 87.5 86.0 115.1 47.6<br />

†Non-Hispanic 119.8 140.5 119.6 133.0 131.5 114.9 126.3 117.0<br />

Diabetes 241.5 269.5 248.3 266.6 238.4 339.6 292.6 353.2 335.2 207.8<br />

Hypertension 104.7 151.0 108.0 122.7 130.8 92.8 135.6 115.5 148.1 108.1<br />

Glomerulonephritis 75.6 77.9 101.1 121.2 104.2 87.9 93.7 80.8 99.7 113.8<br />

Other cause 61.1 72.0 93.2 114.6 89.2 145.2 118.3 83.3 100.2 78.2<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.27 H.27<br />

Total patient deaths: transplant patients<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

550<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 * * * * * * * * * * * *<br />

5-9 * * * * * * * * * * * *<br />

10-14 12 * * * * 12 10 * * * . *<br />

15-19 * 21 11 13 14 * 15 17 17 16 * 13<br />

20-29 36 51 49 83 73 75 77 89 91 78 80 76<br />

30-39 89 90 140 151 204 188 247 233 273 257 263 255<br />

40-49 101 124 149 141 186 187 249 265 317 362 422 431<br />

50-59 64 95 116 146 150 210 219 293 327 367 414 436<br />

60-64 20 13 22 27 54 62 75 85 111 120 179 215<br />

65-69 * * * 14 17 16 29 25 56 62 109 105<br />

70-79 * * * * * * * 11 17 29 39 39<br />

80+ . * . * . * * * * * * *<br />

0-19 27 31 21 21 25 28 37 38 31 30 15 26<br />

20-44 161 198 261 304 381 365 448 445 515 515 554 553<br />

45-64 149 175 215 244 286 357 419 520 604 669 804 860<br />

65-74 * * 10 16 17 22 35 36 67 85 143 140<br />

75+ * * * * * * * * * * * 10<br />

Male 230 278 317 385 464 506 619 691 837 871 1,030 1,061<br />

Female 111 134 191 203 246 268 323 350 388 435 494 528<br />

Unknown<br />

White 249 307 407 472 531 601 717 780 932 978 1,165 1,212<br />

Black 72 85 81 95 161 151 200 232 255 290 316 335<br />

Native American * * . * * * 12 12 10 10 19 10<br />

Asian . . * * * * * 10 16 16 17 30<br />

Other/unknown 19 19 18 13 13 13 * * 12 12 * *<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 47 65 102 115 177 185 259 283 347 387 431 505<br />

Hypertension 27 36 48 47 83 89 140 141 164 187 238 274<br />

Glomerulonephritis 59 78 103 124 127 159 202 230 252 294 349 336<br />

Cystic kidney 16 20 21 31 38 42 52 63 81 67 111 100<br />

Other urologic * * 13 * 10 14 22 24 27 30 34 53<br />

Other cause 20 23 29 52 66 99 95 121 130 136 172 144<br />

Unknown cause 35 31 55 53 57 58 51 42 80 66 90 73<br />

Missing disease 134 155 137 157 152 128 121 137 144 139 99 104<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.27 H.27 (continued)<br />

Total patient deaths: transplant patients<br />

by<br />

by<br />

demographic<br />

demographic<br />

characteristics,<br />

characteristics,<br />

primary<br />

primary<br />

diagnosis,<br />

diagnosis,<br />

& patient<br />

patient<br />

vintage<br />

vintage<br />

1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 * * * * * * * * * * * *<br />

5-9 * * * * * * * * * * * *<br />

10-14 * * * * * * * * * * 10 *<br />

15-19 * 15 13 19 15 16 18 11 16 11 15 19<br />

20-29 68 78 63 60 61 63 56 67 50 72 75 42<br />

30-39 251 279 261 276 251 299 269 292 275 299 266 248<br />

40-49 432 428 558 616 649 606 659 632 650 738 710 654<br />

50-59 389 540 593 647 760 814 853 954 1,017 1,056 1,062 1,161<br />

60-64 225 258 295 333 363 408 392 485 496 556 565 651<br />

65-69 159 190 215 291 294 329 398 386 480 499 539 609<br />

70-79 76 87 129 181 226 223 327 396 442 526 568 702<br />

80+ * 10 * * * 17 18 16 38 42 49 63<br />

0-19 19 25 23 32 23 32 26 29 29 20 35 34<br />

20-44 522 550 556 584 609 646 615 608 612 685 625 558<br />

45-64 843 1,033 1,214 1,348 1,475 1,544 1,614 1,822 1,876 2,036 2,053 2,198<br />

65-74 222 257 322 433 472 500 656 674 794 866 938 1,074<br />

75+ 16 30 28 46 55 69 87 124 166 201 218 300<br />

551<br />

Male 1,038 1,264 1,367 1,592 1,696 1,724 1,892 2,050 2,145 2,382 2,401 2,565<br />

Female 584 631 776 851 938 1,067 1,106 1,207 1,332 1,426 1,468 1,599<br />

Unknown<br />

White 1,259 1,454 1,665 1,881 2,024 2,162 2,305 2,470 2,648 2,918 2,895 3,173<br />

Black 315 390 418 474 510 531 590 673 695 740 814 839<br />

Native American 17 18 18 22 34 29 26 36 44 46 50 53<br />

Asian 24 30 39 53 55 64 69 73 84 95 104 91<br />

Other/unknown * * * 13 11 * * * * * * *<br />

†Hispanic 176 185 195 215 272 295 297 314<br />

†Non-Hispanic 2,458 2,606 2,803 3,042 3,205 3,513 3,572 3,850<br />

Diabetes 544 594 711 793 835 939 1,096 1,130 1,220 1,360 1,386 1,512<br />

Hypertension 260 319 386 405 451 492 505 553 586 637 690 698<br />

Glomerulonephritis 336 390 439 527 601 616 615 659 751 800 760 821<br />

Cystic kidney 101 141 134 186 196 193 245 269 285 324 299 328<br />

Other urologic 36 51 54 62 61 76 76 90 96 95 110 113<br />

Other cause 153 184 211 251 282 272 262 346 317 386 387 462<br />

Unknown cause 91 128 118 138 126 140 129 123 137 118 151 152<br />

Missing disease 101 88 90 81 82 63 70 87 85 88 86 78<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.28 H.28<br />

Annual mortality rates per 1,000 patient years at at risk: transplant patients<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

ON OUR WEBSITE & CD<br />

Annual mortality rates per 1,000 patient years at risk: CAPD/CCPD patients, by primary<br />

diagnosis, adjusted (H.28.1). Annual deaths per 1,000 patients: CAPD/CCPD patients,<br />

by primary diagnosis (H.28.2). CAPD/CCPD patients: counts of total deaths, by primary<br />

diagnosis (H.28.3). Annual mortality rates: CAPD/CCPD patients, unadjusted (H.28.4).<br />

552<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 124.2 63.7 40.8 25.3 43.9 47.8 38.8 43.4 34.1 17.0 17.4 25.1<br />

5-9 48.9 43.3 36.7 18.6 17.0 13.2 28.0 20.5 2.6 14.5 8.6 10.0<br />

10-14 40.9 12.8 17.2 7.6 11.2 26.2 16.6 18.9 11.1 8.9 . 6.4<br />

15-19 17.4 28.1 12.3 17.6 15.8 9.8 13.4 13.7 15.8 13.5 10.4 9.6<br />

20-29 16.2 20.1 15.7 23.3 17.1 16.4 15.9 15.8 15.4 13.1 12.3 12.0<br />

30-39 41.4 32.7 38.4 33.4 37.3 28.0 31.0 25.1 25.7 22.8 21.7 19.4<br />

40-49 72.3 65.4 61.5 45.8 48.8 39.9 42.0 36.9 37.7 36.5 37.3 34.3<br />

50-59 66.3 79.3 73.5 73.8 62.8 70.7 57.2 60.1 55.3 52.9 54.1 50.2<br />

60-64 131.2 59.7 92.8 78.0 126.0 91.9 89.8 70.7 69.5 57.8 70.7 70.2<br />

65-69 62.1 91.0 103.3 165.1 112.7 99.0 119.9 59.2 92.2 77.9 101.9 71.7<br />

70-79 158.6 62.2 186.4 35.2 26.0 58.3 79.5 91.7 81.2 108.1 96.2 75.7<br />

80+ . 824.5 . 1168.8 . 483.1 180.0 156.2 163.3 76.0 148.0 251.1<br />

Male 49.1 46.5 41.7 41.4 41.5 37.8 38.5 36.0 37.9 35.5 38.1 35.6<br />

Female 34.9 33.2 38.5 34.0 34.5 31.3 31.8 28.8 27.6 27.4 27.9 26.8<br />

White 38.9 37.6 39.7 38.0 35.8 33.9 34.0 31.0 32.2 30.3 32.5 30.6<br />

Black 61.1 55.9 42.2 39.8 55.6 43.3 46.8 45.2 43.1 44.0 44.1 42.3<br />

Other race 71.3 60.3 50.7 43.3 30.5 30.0 28.7 27.2 29.4 25.0 24.7 20.9<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 79.3 75.2 82.5 66.9 78.9 63.5 68.0 57.2 58.5 56.5 54.4 55.8<br />

Hypertension 35.1 36.0 36.9 28.1 38.9 34.3 43.5 35.8 35.4 35.5 40.6 41.3<br />

Glomerulonephritis 22.2 23.0 24.4 24.0 20.6 21.6 23.2 22.5 21.6 22.6 24.5 21.4<br />

Other cause 54.0 48.9 44.0 44.9 41.5 37.7 32.5 31.6 33.2 28.6 30.4 26.1<br />


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.28 H.28 (continued)<br />

Annual mortality rates per 1,000 patient years at at risk: transplant patients<br />

period<br />

from day<br />

prevalent<br />

91 to one<br />

patients;<br />

year +<br />

2001<br />

90 days,<br />

ESRD<br />

by<br />

patients<br />

age, gender,<br />

used<br />

race,<br />

as reference<br />

ethnicity, primary diagnosis, & vintage<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 17.5 15.3 15.2 10.0 5.1 32.6 13.9 23.3 4.3 16.3 22.9 15.1<br />

5-9 7.1 5.3 3.4 8.7 6.7 6.5 4.5 8.9 10.0 3.0 7.1 5.6<br />

10-14 4.9 6.8 5.4 5.9 3.7 6.0 2.6 7.4 4.7 2.3 8.5 5.2<br />

15-19 7.9 10.7 11.6 12.2 9.6 8.3 11.7 6.2 7.8 6.5 6.9 9.5<br />

20-29 10.3 12.0 8.9 8.8 9.1 8.9 7.3 9.4 7.2 10.0 9.9 5.5<br />

30-39 17.6 18.3 16.9 16.9 14.9 17.0 15.1 15.8 14.7 16.4 14.4 13.5<br />

40-49 30.6 27.0 31.7 32.0 30.9 28.0 28.2 25.5 24.8 26.3 24.7 22.0<br />

50-59 38.3 49.1 47.7 47.2 49.7 47.1 44.4 44.8 42.8 41.3 37.6 38.2<br />

60-64 68.8 65.6 66.4 70.3 66.8 68.5 59.0 64.3 62.2 62.3 56.4 59.5<br />

65-69 87.0 86.5 79.2 92.2 84.8 77.4 87.0 74.7 83.1 77.7 75.9 74.5<br />

70-79 94.5 85.9 109.4 118.1 115.5 99.3 117.1 121.6 115.3 115.7 109.6 117.2<br />

80+ 113.6 397.0 208.4 122.7 81.6 177.8 181.1 129.8 199.5 168.8 150.9 141.6<br />

Male 31.5 35.4 35.1 37.9 37.3 35.5 36.4 36.9 36.2 38.0 36.1 36.4<br />

Female 26.5 26.2 29.5 29.9 30.5 32.3 31.2 31.7 32.8 33.1 32.1 33.0<br />

553<br />

White 28.7 30.5 32.2 33.9 33.9 34.0 34.0 34.1 34.4 35.9 33.7 34.9<br />

Black 35.8 40.7 39.8 40.5 39.3 37.5 38.5 40.9 39.4 39.4 40.6 39.3<br />

Other race 21.1 19.6 20.8 27.0 27.7 24.9 23.8 23.9 25.6 26.2 25.7 22.7<br />

†Hispanic 27.5 26.2 25.0 24.6 28.2 27.9 25.6 24.5<br />

†Non-Hispanic 35.2 34.9 35.2 35.9 35.5 36.9 35.5 36.3<br />

Diabetes 52.7 52.0 55.2 55.7 53.0 54.5 58.8 55.8 56.1 58.5 55.7 56.8<br />

Hypertension 35.3 39.2 43.0 40.8 41.4 41.8 40.0 41.1 41.0 42.3 43.0 40.8<br />

Glomerulonephritis 19.4 20.9 21.9 24.7 26.4 25.5 24.0 24.1 26.0 26.3 23.8 24.4<br />

Other cause 24.1 27.4 26.0 28.8 27.9 26.1 25.7 28.1 26.4 27.3 26.3 27.3<br />


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.29 H.29<br />

Mortality rates by primary cause of mortality, unadjusted<br />

rates<br />

rates<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

2001-2003<br />

2001-2003<br />

combined<br />

combined<br />

ON OUR WEBSITE & CD<br />

Mortality rates by primary cause of mortality, diabetic patients, unadjusted<br />

(H.29.1). Mortality rates by primary cause of mortality, non-diabetic patients, unadjusted<br />

(H.29.2). Mortality rates by specific cause of mortality: ESRD patients,<br />

unadjusted (H.a.1).<br />

554<br />

ESRD<br />

Male Female White Black N. Am. Asian All<br />

Acute M.I. 14.2 13.7 15.3 11.8 13.1 11.4 14.0<br />

Hyperkalemia 2.2 2.7 3.1 1.3 2.3 1.7 2.4<br />

Pericarditis 0.2 0.2 0.2 0.3 0.3 0.1 0.2<br />

Atherosclerotic H.D. 4.9 5.2 6.0 3.4 3.6 4.1 5.0<br />

Cardiomyopathy 6.7 5.5 7.5 3.9 4.2 4.0 6.2<br />

Cardiac arrhythmia 7.4 7.3 8.1 6.3 5.6 5.9 7.4<br />

Cardiac arrest 37.5 41.0 39.8 38.9 35.8 32.6 39.1<br />

Valvular heart disease 0.9 1.0 1.1 0.8 0.6 0.6 1.0<br />

Pulmonary edema 1.4 1.7 1.8 1.2 1.9 0.7 1.5<br />

AIDS 0.8 0.5 0.1 1.9 0.1 . 0.7<br />

Cachexia 1.4 2.0 2.0 1.2 0.9 1.1 1.7<br />

Cerebrovascular disease 7.0 10.5 8.5 8.4 9.4 8.7 8.6<br />

G.I. hemorrhage 1.2 1.3 1.2 1.3 0.5 1.3 1.3<br />

Other hemorrhage 1.5 1.8 1.5 1.7 1.5 1.9 1.6<br />

Septicemia 16.7 22.9 18.7 21.3 20.2 13.7 19.5<br />

Pulmonary infection 4.1 3.5 4.4 2.7 3.6 4.0 3.8<br />

Viral infection 0.3 0.3 0.3 0.3 0.1 0.4 0.3<br />

Other infection 0.8 1.2 1.0 0.9 1.4 0.8 1.0<br />

Malignant disease 7.1 5.9 7.5 5.5 4.5 3.6 6.6<br />

Other cause 45.7 50.1 53.6 39.9 40.1 25.7 47.6<br />

Unknown cause 6.8 8.0 7.1 8.2 7.9 3.6 7.4<br />

All 168.9 186.3 188.9 161.1 157.5 125.8 176.7<br />

Years at risk 664,419 541,674 738,258 388,295 16,194 49,379 1,206,092<br />

Patients 793,476 654,611 894,997 459,156 19,038 57,409 1,448,087<br />

DIALYSIS<br />

Male Female White Black N. Am. Asian All<br />

Acute M.I. 19.5 18.0 22.6 13.7 15.8 15.3 18.8<br />

Hyperkalemia 3.1 3.5 4.7 1.6 2.9 2.2 3.3<br />

Pericarditis 0.3 0.3 0.2 0.3 0.4 0.2 0.3<br />

Atherosclerotic H.D. 6.9 6.9 9.1 4.0 4.5 5.6 6.9<br />

Cardiomyopathy 9.4 7.2 11.4 4.6 5.3 5.5 8.4<br />

Cardiac arrhythmia 10.4 9.6 12.3 7.3 6.9 8.1 10.1<br />

Cardiac arrest 52.6 54.2 60.0 45.4 44.8 44.3 53.3<br />

Valvular heart disease 1.2 1.4 1.6 0.9 0.6 0.9 1.3<br />

Pulmonary edema 1.9 2.3 2.6 1.4 2.3 1.0 2.1<br />

AIDS 1.2 0.6 0.2 2.2 0.2 . 0.9<br />

Cachexia 2.0 2.7 3.1 1.4 1.1 1.5 2.3<br />

Cerebrovascular disease 9.7 13.6 12.7 9.8 11.3 11.8 11.5<br />

G.I. hemorrhage 1.6 1.8 1.8 1.5 0.6 1.7 1.7<br />

Other hemorrhage 2.0 2.3 2.2 2.0 1.8 2.5 2.1<br />

Septicemia 23.1 30.0 27.9 24.8 24.3 18.4 26.3<br />

Pulmonary infection 5.5 4.5 6.5 3.0 4.2 5.3 5.0<br />

Viral infection 0.4 0.3 0.4 0.3 0.1 0.5 0.4<br />

Other infection 1.1 1.5 1.5 1.1 1.7 1.1 1.3<br />

Malignant disease 9.4 7.4 10.5 6.2 4.9 4.6 8.5<br />

Other cause 54.7 59.6 69.8 42.4 44.2 30.2 57.0<br />

Unknown cause 9.4 10.5 10.6 9.6 9.8 4.9 9.9<br />

All 225.5 238.4 271.6 183.4 187.6 165.5 231.5<br />

Years at risk 464,855 404,402 480,284 328,078 12,802 35,774 869,257<br />

Patients 587,994 513,489 629,205 397,398 15,555 43,539 1,101,483<br />

"All" category includes patients of other & unknown races.<br />

U.S. only; patients of unknown age or gender are excluded.<br />

"." Zero values in this cell.


ON OUR WEBSITE & CD<br />

Mortality rates by specific cause of mortality: dialysis patients, unadjusted (H.a.2).<br />

Mortality rates by specific cause of mortality: hemodialysis patients, unadjusted<br />

(H.a.3). Mortality rates by specific cause of mortality: CAPD/CCPD patients, unadjusted<br />

(H.a.4). Bayesian standardized mortality ratios: by state & territory (H.b).<br />

MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.29 H.29 (continued)<br />

Mortality rates by primary cause of mortality, unadjusted<br />

rates<br />

rates<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

2001-2003<br />

2001-2003<br />

combined<br />

combined<br />

TRANSPLANT<br />

Male Female White Black N. Am. Asian All<br />

Acute M.I. 1.8 1.2 1.5 1.8 2.9 1.0 1.6<br />

Hyperkalemia 0.1 0.1 0.1 0.1 . 0.2 0.1<br />

Pericarditis


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.29 H.29 (continued)<br />

Mortality rates by primary cause of mortality, unadjusted<br />

rates<br />

rates<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

patients,<br />

patients,<br />

2001-2003<br />

2001-2003<br />

combined<br />

combined<br />

556<br />

CAPD/CCPD<br />

Male Female White Black N. Am. Asian All<br />

Acute M.I. 19.9 15.6 20.6 12.3 17.8 12.9 17.8<br />

Hyperkalemia 1.6 2.6 2.8 0.6 5.9 0.8 2.1<br />

Pericarditis 0.3 0.2 0.2 0.3 . 0.3 0.2<br />

Atherosclerotic H.D. 7.0 4.6 7.4 2.4 4.9 4.6 5.8<br />

Cardiomyopathy 12.4 6.9 12.6 4.2 4.0 4.1 9.7<br />

Cardiac arrhythmia 10.7 6.9 10.5 5.8 9.9 5.1 8.8<br />

Cardiac arrest 43.7 36.8 45.0 33.0 21.7 26.1 40.3<br />

Valvular heart disease 1.4 1.1 1.5 0.8 1.0 0.5 1.2<br />

Pulmonary edema 1.2 1.3 1.6 0.6 1.0 0.5 1.3<br />

AIDS 0.8 0.3 0.2 1.5 . . 0.5<br />

Cachexia 2.1 2.8 3.2 1.1 1.0 1.8 2.5<br />

Cerebrovascular disease 8.7 11.0 11.0 8.0 3.0 6.6 9.8<br />

G.I. hemorrhage 1.5 0.9 1.4 0.9 . 0.3 1.2<br />

Other hemorrhage 1.1 1.2 1.2 0.7 4.0 1.3 1.1<br />

Septicemia 25.4 33.4 30.9 26.4 32.6 19.0 29.3<br />

Pulmonary infection 4.2 3.2 4.5 2.1 2.0 2.3 3.7<br />

Viral infection 0.2 0.2 0.2 0.2 . 0.3 0.2<br />

Other infection 1.6 2.5 2.3 1.3 4.9 1.8 2.0<br />

Malignant disease 6.2 4.2 6.4 2.8 4.9 2.8 5.2<br />

Other cause 44.9 44.0 51.3 33.4 33.6 22.3 44.5<br />

Unknown cause 6.8 7.5 7.4 6.8 7.9 4.8 7.1<br />

All 201.8 187.2 222.3 145.1 160.1 117.8 194.7<br />

Years at risk 38,200 36,527 48,970 19,744 1,012 3,948 74,727<br />

Patients 48,014 45,158 62,456 23,471 1,233 4,685 93,172<br />

"All" category includes patients of other & unknown races.<br />

U.S. only; patients of unknown age or gender are excluded so that rates can be calculated appropriately.<br />

"." Zero values in this cell.


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.30 H.30<br />

Mortality rates by cause of withdrawal, unadjusted<br />

rates<br />

rates<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

dialysis<br />

dialysis<br />

patients,<br />

patients,<br />

2001-2003<br />

2001-2003<br />

combined<br />

combined<br />

0-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59<br />

Withdraw, access failure . 2.5 1.1 . 0.4 0.3 0.4 0.6<br />

Withdraw, transplant failure . . . . 0.2 0.1 0.1 0.1<br />

Withdraw, failure to thrive 5.3 1.3 1.1 0.3 1.1 2.6 4.8 8.7<br />

Withdraw, med. complication 8.0 2.5 2.3 1.8 2.6 4.3 6.2 9.7<br />

Withdraw, other 1.3 1.3 2.8 0.5 1.0 2.3 3.1 5.0<br />

Did not withdraw 82.4 25.2 21.5 31.5 46.4 69.8 97.9 131.6<br />

Missing data 10.6 8.8 3.4 2.3 4.1 5.8 8.3 10.9<br />

Other cause . . . . . . . .<br />

All 107.6 41.6 32.3 36.4 55.9 85.2 120.8 166.7<br />

Years at risk 753 793 1,765 3,904 28,207 67,691 125,167 178,713<br />

Patients 947 984 2,189 4,709 32,597 78,460 148,370 218,847<br />

557<br />

60-64 65-69 70-79 80+ Male Female White Black<br />

Withdraw, access failure 0.7 0.9 1.4 2.5 0.7 1.2 1.1 0.7<br />

Withdraw, transplant failure 0.1


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.31 H.31<br />

Expected remaining lifetimes* of of the general U.S. population, & of of prevalent dialysis & transplant patients<br />

general U.S. population, 2002<br />

general U.S. population, 2002<br />

558<br />

All races White Black<br />

All M F All M F All M F<br />

0-14 70.9 68.2 73.4 71.3 68.7 73.7 66.4 62.9 69.7<br />

15-19 61.1 58.4 63.6 61.4 58.9 63.9 56.7 53.3 59.9<br />

20-24 56.3 53.8 58.7 56.7 54.2 59.0 52.0 48.7 55.0<br />

25-29 51.6 49.1 53.9 51.9 49.5 54.2 47.4 44.3 50.2<br />

30-34 46.8 44.4 49.0 47.1 44.8 49.3 42.8 39.8 45.5<br />

35-39 42.1 39.8 44.2 42.4 40.1 44.5 38.3 35.4 40.8<br />

40-44 37.5 35.2 39.5 37.7 35.6 39.7 33.9 31.1 36.3<br />

45-49 33.0 30.8 34.9 33.2 31.1 35.1 29.7 26.9 32.0<br />

50-54 28.6 26.6 30.4 28.8 26.8 30.5 25.7 23.1 27.8<br />

55-59 24.4 22.5 26.0 24.5 22.7 26.1 22.0 19.6 23.9<br />

60-64 20.4 18.7 21.9 20.5 18.8 21.9 18.5 16.4 20.1<br />

65-69 16.8 15.2 18.0 16.8 15.2 18.0 15.3 13.5 16.7<br />

70-74 13.4 12.0 14.4 13.4 12.0 14.4 12.4 10.8 13.5<br />

75-79 10.4 9.3 11.1 10.3 9.2 11.1 9.9 8.6 10.7<br />

80-84 7.8 6.9 8.3 7.7 6.9 8.2 7.8 6.8 8.3<br />

85+ 4.3 3.8 4.5 4.2 3.7 4.3 4.6 4.2 4.8<br />

Overall 25.2 23.4 26.6 25.3 23.5 26.7 23.0 20.8 24.7<br />

Dialysis All races White Black N Am Asian<br />

2003 All Male Female All Male Female All Male Female All Male Female All Male Female<br />

0-14 18.3 19.2 17.3 19.2 20.0 18.4 15.6 16.7 14.4 18.1 17.3 18.4 31.6 32.5 30.3<br />

15-19 16.0 16.9 15.1 16.3 17.0 15.5 15.0 16.1 13.9 15.6 16.0 15.3 25.1 26.0 24.2<br />

20-24 13.9 14.8 12.9 13.9 14.6 13.1 13.3 14.4 12.2 13.4 13.9 13.0 22.0 22.8 21.2<br />

25-29 12.0 12.7 11.3 11.8 12.3 11.1 11.9 12.7 11.0 11.5 11.6 11.4 19.2 19.8 18.6<br />

30-34 10.5 10.8 10.0 10.0 10.2 9.7 10.6 11.1 10.0 10.0 10.0 10.1 16.6 17.1 16.2<br />

35-39 9.0 9.2 8.7 8.4 8.5 8.3 9.3 9.7 8.8 8.6 8.4 8.7 14.0 14.3 13.7<br />

40-44 7.8 8.0 7.6 7.2 7.3 7.1 8.3 8.6 7.8 7.4 7.3 7.5 11.8 12.0 11.6<br />

45-49 6.8 7.0 6.7 6.3 6.4 6.2 7.3 7.5 7.0 6.7 6.6 6.8 9.9 10.1 9.8<br />

50-54 5.9 6.0 5.9 5.4 5.5 5.4 6.4 6.5 6.3 6.2 6.0 6.4 8.4 8.5 8.2<br />

55-59 5.0 5.0 5.0 4.6 4.6 4.6 5.6 5.6 5.5 5.3 5.2 5.4 6.9 7.0 6.7<br />

60-64 4.3 4.3 4.4 3.9 3.9 3.9 4.9 4.9 4.9 4.6 4.5 4.8 5.9 5.9 5.8<br />

65-69 3.7 3.6 3.7 3.4 3.3 3.4 4.1 4.1 4.2 4.1 4.0 4.2 5.0 4.9 5.0<br />

70-74 3.1 3.1 3.1 2.9 2.9 2.9 3.5 3.5 3.5 3.5 3.3 3.6 4.1 4.2 4.1<br />

75-79 2.6 2.6 2.7 2.5 2.5 2.5 3.0 2.9 3.0 3.0 2.8 3.1 3.4 3.5 3.3<br />

80-84 2.2 2.2 2.2 2.1 2.1 2.1 2.5 2.5 2.5 2.5 2.4 2.6 2.8 2.9 2.8<br />

85+ 1.8 1.7 1.8 1.7 1.7 1.7 2.0 1.9 2.0 2.1 1.9 2.2 2.2 2.2 2.2<br />

Overall 5.5 5.6 5.4 5.2 5.2 5.1 5.9 6.0 5.7 5.7 5.5 5.8 8.0 8.2 7.9<br />

Transplant All races White Black N Am Asian<br />

2003 All Male Female All Male Female All Male Female All Male Female All Male Female<br />

0-14 50.0 50.2 49.9 50.7 50.9 50.5 46.6 46.8 46.2 36.9 39.8 33.3 59.5 57.9 62.1<br />

15-19 39.7 39.6 39.8 40.1 40.1 40.2 37.1 37.1 37.2 32.1 34.6 29.7 48.3 46.6 50.9<br />

20-24 36.2 36.1 36.4 36.5 36.4 36.7 33.9 33.9 34.0 30.3 32.5 28.4 44.5 42.9 47.2<br />

25-29 32.3 32.1 32.6 32.5 32.4 32.9 30.2 30.1 30.5 27.5 29.6 25.6 40.4 38.7 43.1<br />

30-34 28.5 28.3 28.9 28.7 28.5 29.1 26.7 26.4 27.0 24.6 26.5 22.9 36.2 34.6 39.0<br />

35-39 25.2 24.8 25.8 25.4 25.0 25.9 23.5 23.2 24.1 22.5 23.9 21.1 32.4 30.8 35.2<br />

40-44 21.9 21.5 22.7 22.1 21.7 22.8 20.4 20.0 21.0 20.0 20.9 18.9 28.6 26.9 31.4<br />

45-49 19.0 18.5 19.8 19.1 18.7 20.0 17.4 17.0 18.1 17.6 18.4 16.6 24.9 23.2 27.7<br />

50-54 16.3 15.7 17.2 16.5 15.9 17.4 14.7 14.3 15.4 15.4 16.1 14.5 21.4 19.9 24.2<br />

55-59 13.8 13.2 14.7 14.0 13.4 15.0 12.3 11.9 13.0 13.4 14.1 12.6 18.3 16.8 21.0<br />

60-64 11.5 11.0 12.5 11.7 11.1 12.7 10.2 9.8 10.9 11.7 12.3 11.3 15.5 14.1 18.1<br />

65-69 9.6 9.1 10.6 9.7 9.2 10.7 8.6 8.1 9.3 10.4 10.7 10.1 13.0 11.8 15.5<br />

70-74 7.9 7.4 8.9 7.9 7.4 9.0 7.0 6.5 7.8 8.9 9.1 8.8 10.8 9.7 13.3<br />

75-79 6.7 6.2 7.7 6.7 6.2 7.7 6.0 5.4 6.9 8.0 7.8 8.3 9.3 8.4 11.6<br />

Overall 15.1 14.6 15.9 15.2 14.7 16.1 13.7 13.3 14.4 14.4 15.1 13.8 19.7 18.4 22.4<br />

*Years<br />

*Years


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.32 H.32<br />

First-year mortality rates, ESRD<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients,<br />

by<br />

by<br />

modality<br />

modality<br />

& demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

UNADJUSTED 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 164.9 200.0 116.9 144.0 123.2 124.8 88.0 106.0 121.6 134.4 169.9 117.8 104.7<br />

5-9 29.4 16.4 24.5 46.9 . 28.2 43.8 38.9 . 39.7 33.2 20.2 64.4<br />

10-14 37.4 25.3 54.5 42.6 7.9 26.0 30.3 21.8 22.6 20.4 26.4 19.7 30.2<br />

15-19 24.9 38.3 36.8 29.2 41.4 25.0 31.8 17.2 36.2 22.1 21.3 21.2 23.6<br />

20-29 75.6 72.4 63.4 69.6 74.9 76.3 58.4 46.8 50.5 46.6 63.2 51.4 62.4<br />

30-39 101.6 108.9 105.0 112.4 106.1 119.5 101.5 92.8 91.3 94.4 92.9 88.7 86.0<br />

40-49 116.6 127.3 124.5 117.8 121.9 114.5 110.2 103.5 115.4 109.3 109.1 114.4 116.5<br />

50-59 169.5 170.5 159.0 160.9 152.1 152.8 157.0 151.6 155.5 149.8 155.4 151.1 152.3<br />

60-64 242.1 230.7 230.5 210.6 213.3 221.2 201.2 199.7 221.1 208.5 212.1 201.8 209.5<br />

65-69 280.1 284.4 279.6 258.9 269.4 260.6 249.4 262.7 268.8 266.4 258.5 263.0 262.4<br />

70-79 378.8 382.1 378.5 357.0 355.7 352.9 343.6 358.9 356.7 362.2 363.5 360.2 361.8<br />

80+ 517.6 522.4 536.9 493.6 494.8 505.2 507.6 519.3 553.2 536.9 546.2 546.5 528.8<br />

Male 228.6 234.9 236.5 221.2 225.5 227.8 221.8 226.3 233.0 230.8 235.6 232.2 238.3<br />

Female 229.1 236.1 231.4 227.8 228.0 228.1 228.4 236.6 246.9 247.9 250.9 250.6 254.4<br />

559<br />

White 259.5 269.1 269.3 255.0 256.7 256.0 254.1 264.9 269.7 267.1 270.4 272.4 276.2<br />

Black 176.4 180.1 174.8 176.1 179.6 184.6 175.0 175.2 190.0 191.2 198.9 191.7 198.7<br />

Other race 140.9 132.6 146.3 135.8 149.0 168.9 181.4 168.8 184.8 182.0 171.9 159.3 168.4<br />

†Hispanic 176.9 184.7 181.1 184.3 169.9 175.3 185.8<br />

†Non-Hispanic 231.3 237.2 247.3 246.2 253.3 250.3 254.7<br />

Diabetes 259.5 253.2 251.7 232.3 235.4 238.4 235.2 243.2 252.8 245.0 246.4 243.9 247.4<br />

Hypertension 248.4 259.3 256.8 251.8 250.1 241.1 241.5 254.5 261.5 264.0 265.9 265.9 266.2<br />

Glomerulonephritis 133.0 149.6 133.3 120.5 139.3 132.4 124.2 122.7 122.5 132.1 126.5 124.5 127.5<br />

Other cause 217.0 227.0 232.9 235.7 230.6 250.2 243.9 237.3 247.5 249.2 264.2 258.3 272.5<br />

All 228.8 235.5 234.0 224.3 226.7 228.0 224.8 231.1 239.5 238.7 242.7 240.6 245.6<br />

ADJUSTED<br />

0-19 95.9 124.5 105.3 109.4 79.3 84.2 86.7 70.2 84.2 80.0 96.7 75.0 87.8<br />

20-44 106.6 112.8 110.7 114.0 109.7 114.8 98.3 91.3 95.6 94.2 95.7 93.3 94.7<br />

45-64 184.5 181.0 172.6 164.5 161.7 162.1 157.1 151.0 161.5 153.5 157.0 153.4 156.6<br />

65-74 309.0 313.1 305.8 280.7 292.1 282.0 271.3 283.1 284.7 282.5 280.7 281.6 286.3<br />

75+ 455.8 455.5 463.5 443.5 431.1 438.9 432.7 447.3 459.2 457.2 459.9 457.3 448.6<br />

Male 274.0 275.1 272.0 251.0 252.2 253.2 238.0 237.6 242.9 235.8 239.5 235.7 237.5<br />

Female 252.0 253.2 244.7 239.1 234.9 232.4 228.2 232.0 241.5 240.2 239.6 238.2 238.6<br />

White 291.1 293.3 286.5 266.5 262.6 258.7 249.2 254.6 257.5 251.1 251.7 252.2 251.3<br />

Black 218.4 218.6 212.2 212.9 215.1 218.5 204.7 200.7 216.3 218.0 223.8 215.2 220.6<br />

Other race 170.6 158.4 169.8 155.1 167.1 180.3 187.9 173.7 193.0 184.1 175.9 164.2 170.9<br />

Diabetes 297.1 285.1 278.6 254.5 254.4 255.3 246.6 251.1 259.9 248.8 248.1 244.5 245.6<br />

Hypertension 232.2 238.8 237.1 228.0 225.7 215.8 211.5 219.7 224.5 224.8 225.0 226.3 221.3<br />

Glomerulonephritis 190.8 207.4 186.0 168.4 186.5 179.8 162.7 162.4 162.7 169.6 165.7 168.3 166.1<br />

Other cause 271.6 281.9 284.7 291.5 282.2 297.8 287.3 273.8 287.6 287.2 302.2 295.3 307.9<br />

All 262.9 264.0 258.1 244.7 243.3 242.5 232.9 234.5 241.8 237.6 239.2 236.5 237.6<br />

Reference cohort is 1996 incident ESRD patients.<br />

Reference Overall mortality cohort rates is 1996 are incident adjusted ESRD for age, patients. gender, race, & primary diagnosis.<br />

Overall Mortality mortality rates for rates one are of the adjusted four variables for age, are gender, adjusted race, for & primary the remaining diagnosis. three.<br />

Mortality Hispanic & rates non-Hispanic for one of mortality the four variables rates are are unadjusted.<br />

for the remaining three.<br />

Hispanic The age of & non-Hispanic the incident patient mortality is determined rates are unadjusted. as of the date of ESRD initiation.<br />

The age 90-day of the rule incident has been patient applied. is determined as of the date of ESRD initiation.<br />

The U.S. 90-day patients rule only; has patients been applied. of unknown age or gender, or age >110, are excluded.<br />

U.S. †CMS patients began only; collecting patients Hispanic of unknown ethnicity age data or gender, in April or 1995; of age cells >110, for years are excluded. prior to 1996 have therefore been left blank.<br />

†CMS "." Zero began values collecting this cell. Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.33 H.33<br />

First-year mortality rates, dialysis<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients,<br />

by<br />

by<br />

modality<br />

modality<br />

& demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

560<br />

UNADJUSTED 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 233.1 250.0 148.2 186.8 164.1 163.5 134.5 151.3 158.0 200.1 221.6 160.0 129.4<br />

5-9 62.9 43.4 62.2 80.8 . 22.2 84.1 26.5 . 31.8 44.1 31.5 90.8<br />

10-14 46.1 29.0 82.1 58.4 12.7 26.3 41.9 37.5 28.1 33.7 37.3 24.2 47.9<br />

15-19 29.7 44.8 35.0 35.1 47.9 28.5 38.2 22.3 46.1 27.2 27.2 31.0 33.3<br />

20-29 90.6 83.2 75.7 85.4 86.9 89.2 68.7 52.7 60.4 55.1 73.6 59.6 71.8<br />

30-39 116.9 127.0 119.9 127.8 119.8 136.0 114.4 104.1 103.8 105.4 103.8 100.3 96.6<br />

40-49 123.7 140.4 136.0 127.3 131.1 122.1 118.2 111.6 125.2 118.1 119.1 124.2 126.1<br />

50-59 174.3 176.9 164.4 165.6 155.5 158.5 161.9 158.3 162.3 155.9 162.8 158.3 159.8<br />

60-64 244.7 234.4 233.9 213.2 215.4 225.8 204.4 203.9 225.2 211.7 216.8 206.5 215.5<br />

65-69 280.9 285.5 280.5 260.1 271.2 262.6 251.1 265.6 271.2 269.4 262.1 267.1 267.3<br />

70-79 379.4 382.3 378.9 357.6 356.1 353.6 343.9 359.4 357.3 363.1 364.5 361.7 363.3<br />

80+ 517.2 521.8 536.9 493.6 494.8 505.2 507.6 519.3 553.5 537.0 546.4 546.7 529.0<br />

Male 243.7 250.6 250.5 234.2 236.7 240.8 233.2 237.9 244.7 241.7 247.1 243.8 250.0<br />

Female 240.7 248.4 242.9 237.7 237.7 237.8 236.9 246.0 257.2 257.7 261.5 261.1 264.9<br />

White 280.4 291.0 289.6 273.4 272.8 273.1 269.3 282.0 287.4 283.4 287.2 290.1 293.5<br />

Black 179.9 184.0 178.3 178.9 182.9 189.0 178.7 177.8 192.7 193.8 201.9 194.2 201.7<br />

Other race 147.6 140.7 151.5 141.4 155.1 174.7 187.0 173.6 190.5 187.2 178.1 164.6 173.7<br />

†Hispanic 181.0 190.1 186.1 189.1 174.9 180.5 191.2<br />

†Non-Hispanic 242.4 248.6 259.3 257.6 265.6 262.5 267.0<br />

Diabetes 269.2 263.6 261.0 239.7 242.8 245.3 242.0 249.4 259.2 250.5 252.2 249.5 253.2<br />

Hypertension 253.8 264.3 262.2 256.4 254.0 245.3 245.1 258.5 265.5 267.8 270.4 270.2 270.9<br />

Glomerulonephritis 147.5 166.5 148.2 133.8 152.1 147.5 136.7 136.0 135.4 144.7 139.7 138.7 141.7<br />

Other cause 241.7 255.2 257.8 261.6 253.9 276.5 266.1 261.9 274.3 275.8 293.9 288.4 302.2<br />

All 242.3 249.6 246.9 235.8 237.2 239.4 234.9 241.7 250.6 249.2 253.8 251.8 256.8<br />

ADJUSTED<br />

0-19 123.3 148.8 122.9 132.4 98.4 96.5 110.3 87.5 107.3 98.5 121.0 96.9 109.5<br />

20-44 119.7 129.9 126.4 131.4 125.1 130.8 112.1 103.7 109.1 106.1 108.5 106.5 108.0<br />

45-64 191.0 189.8 181.0 171.5 168.2 170.7 164.9 159.5 170.9 161.9 166.1 162.4 166.0<br />

65-74 309.7 313.8 306.8 282.1 293.6 283.9 272.8 285.4 286.9 285.1 283.8 285.3 290.5<br />

75+ 455.9 455.2 463.5 443.6 431.1 439.1 432.8 447.5 459.5 457.4 460.2 457.9 449.0<br />

Male 273.0 275.4 272.8 252.2 252.6 255.2 240.1 240.8 246.5 239.2 243.3 240.2 242.5<br />

Female 254.7 258.1 249.8 243.7 240.5 238.0 233.9 238.9 248.9 247.2 247.6 246.4 247.1<br />

White 293.4 298.0 292.1 272.1 267.9 265.1 255.9 263.2 266.6 259.8 261.4 262.6 262.0<br />

Black 217.7 219.0 212.3 212.5 215.3 219.4 205.7 201.4 217.1 218.5 224.8 216.1 222.1<br />

Other race 168.6 159.4 168.9 155.8 169.0 181.8 189.9 175.7 195.0 186.7 178.8 166.7 173.0<br />

Diabetes 299.1 289.4 283.5 258.7 259.4 261.2 253.3 257.8 267.3 255.5 255.0 251.9 253.4<br />

Hypertension 237.1 243.8 242.5 233.4 230.8 220.9 216.7 225.6 230.6 230.6 231.4 232.5 228.1<br />

Glomerulonephritis 183.7 202.5 181.7 164.5 181.5 178.2 160.7 161.2 161.1 167.3 165.0 167.8 166.0<br />

Other cause 270.8 283.6 284.4 292.0 281.7 300.6 287.2 277.8 292.0 291.6 308.6 302.7 315.0<br />

All 263.8 266.8 261.3 247.8 246.4 246.5 236.9 239.7 247.4 242.8 245.1 242.9 244.4<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.<br />

Mortality rates for one of the four variables are adjusted for the remaining three.<br />

Hispanic & non-Hispanic mortality rates are unadjusted.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The 90-day rule has been applied.<br />

U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.34 H.34<br />

First-year mortality rates, hemodialysis<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients,<br />

by<br />

by<br />

modality<br />

modality<br />

& demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

UNADJUSTED 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 395.1 197.2 186.8 333.9 581.2 316.6 . 157.2 189.5 306.3 500.5 320.4 289.0<br />

5-9 93.9 . . 166.0 . 30.8 184.3 . . 63.1 91.6 52.0 203.3<br />

10-14 33.9 19.8 113.1 58.3 28.2 26.3 33.6 70.1 50.5 70.6 29.5 34.3 75.5<br />

15-19 34.3 51.0 37.8 33.8 34.3 29.0 47.8 23.3 46.8 28.1 31.9 36.7 38.7<br />

20-29 92.8 85.6 83.3 86.8 88.9 94.5 72.5 61.2 63.9 60.9 77.6 61.7 74.8<br />

30-39 123.8 138.4 124.6 136.4 122.1 145.6 120.8 109.5 110.8 114.8 114.1 108.0 103.2<br />

40-49 129.9 150.2 138.0 129.2 135.0 131.5 124.4 115.9 131.8 123.5 125.0 132.9 130.1<br />

50-59 178.9 179.9 165.6 162.9 156.0 160.9 164.5 162.6 164.5 161.1 166.9 164.7 164.9<br />

60-64 249.6 239.7 233.8 204.8 210.3 225.6 203.4 204.8 224.8 209.3 219.5 208.1 219.8<br />

65-69 280.9 284.8 282.9 259.0 265.9 260.1 251.8 265.6 275.8 270.7 266.4 267.9 270.4<br />

70-79 374.8 380.6 373.8 348.3 351.8 353.9 346.4 358.7 358.4 366.8 368.7 365.8 366.0<br />

80+ 509.7 520.7 521.1 471.8 486.8 505.3 510.5 511.8 552.1 537.8 552.1 544.5 528.1<br />

Male 251.5 259.5 255.3 236.1 239.9 247.3 238.9 243.7 249.3 247.8 253.5 250.9 255.2<br />

Female 248.4 256.4 248.2 237.5 240.0 245.7 244.5 250.9 265.8 264.9 270.7 268.8 273.1<br />

561<br />

White 295.4 307.4 301.6 278.8 280.8 284.9 280.7 291.4 296.6 293.6 298.3 300.6 302.0<br />

Black 183.2 187.3 179.5 177.6 182.2 192.1 182.5 181.9 197.7 198.6 206.7 199.1 207.0<br />

Other race 145.7 147.7 159.0 150.5 160.1 188.4 195.1 178.6 199.2 189.5 184.5 171.3 180.4<br />

†Hispanic 185.4 193.6 191.5 197.4 181.4 184.5 194.1<br />

†Non-Hispanic 249.5 254.4 266.0 264.1 273.7 270.7 274.2<br />

Diabetes 272.4 267.7 260.6 234.9 237.9 247.2 243.1 247.8 262.2 253.7 255.0 253.4 255.1<br />

Hypertension 258.3 270.0 263.1 255.3 254.7 247.1 248.8 262.6 267.5 271.8 277.6 274.2 277.1<br />

Glomerulonephritis 160.8 180.7 157.7 141.6 164.4 159.4 147.0 145.9 147.2 157.3 152.3 148.9 152.5<br />

Other cause 255.9 269.2 274.0 269.8 267.6 298.0 284.0 281.0 288.8 289.1 309.2 306.1 317.1<br />

All 250.1 258.0 251.9 236.8 240.0 246.5 241.6 247.1 257.0 255.8 261.5 259.2 263.4<br />

ADJUSTED<br />

0-19 119.9 110.5 120.4 130.8 108.6 105.0 112.7 85.9 108.7 104.4 129.9 119.6 147.8<br />

20-44 126.2 140.5 132.0 138.0 129.7 140.4 119.8 111.2 116.5 113.9 117.3 114.4 114.1<br />

45-64 198.4 197.5 185.3 170.0 169.5 176.0 169.1 164.4 174.9 166.7 171.3 169.0 171.8<br />

65-74 309.7 313.6 307.2 280.0 292.0 283.6 276.3 287.3 291.2 289.0 289.4 290.2 293.8<br />

75+ 449.9 457.0 455.8 428.1 424.1 441.8 436.0 443.7 460.3 460.1 466.0 457.9 451.7<br />

Male 276.0 280.8 274.5 250.4 252.5 259.2 244.2 244.6 249.2 244.1 248.6 245.7 245.9<br />

Female 257.1 260.9 250.0 238.7 238.7 241.4 237.9 240.5 254.2 251.5 253.9 250.7 252.7<br />

White 298.6 304.4 294.8 269.1 268.5 269.1 260.7 266.2 270.2 264.8 267.8 267.9 266.1<br />

Black 216.6 218.6 209.6 206.3 210.4 219.6 207.0 203.6 220.5 222.1 228.1 219.5 226.4<br />

Other race 161.3 162.8 172.5 161.0 169.0 192.2 194.3 178.0 200.1 187.2 182.6 171.6 177.8<br />

Diabetes 301.0 292.5 281.7 252.5 253.2 262.0 254.1 255.8 270.1 258.7 257.8 255.4 255.1<br />

Hypertension 240.2 248.8 243.8 231.3 232.0 222.2 221.1 229.5 232.6 234.3 238.2 235.9 233.2<br />

Glomerulonephritis 191.0 211.9 186.0 167.7 188.0 185.8 168.2 168.0 169.4 177.0 175.1 175.9 175.2<br />

Other cause 275.7 288.5 291.6 290.2 286.9 314.0 297.6 289.5 299.5 299.3 318.4 313.5 323.3<br />

All 266.4 270.6 262.0 244.3 245.4 250.0 240.8 242.3 251.3 247.3 250.8 247.7 248.7<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.<br />

Mortality rates for one of the four variables are adjusted for the remaining three.<br />

Hispanic & non-Hispanic mortality rates are unadjusted.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The 90-day rule has been applied.<br />

U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.35 H.35<br />

First-year mortality rates, CAPD/CCPD<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients,<br />

by<br />

by<br />

modality<br />

modality<br />

& demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

562<br />

UNADJUSTED 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 209.9 269.0 140.1 160.8 108.7 124.4 153.1 159.6 154.9 182.0 170.9 119.4 102.5<br />

5-9 31.7 . 103.2 75.3 . 19.8 52.0 40.2 . 16.5 20.2 18.7 23.0<br />

10-14 36.1 37.1 44.5 33.6 . 36.6 59.9 14.2 12.1 . 39.0 13.2 13.1<br />

15-19 . 49.8 35.0 32.1 68.6 26.7 19.2 10.0 39.5 11.3 14.6 12.7 13.8<br />

20-29 105.3 72.9 61.8 65.7 59.3 59.9 63.1 11.2 37.6 17.5 45.4 43.7 49.2<br />

30-39 101.8 77.8 98.5 89.0 85.8 100.6 75.9 66.7 62.7 42.8 41.6 35.4 48.6<br />

40-49 108.6 108.1 109.4 98.3 100.1 80.9 79.6 80.6 73.4 73.5 68.2 47.6 85.2<br />

50-59 155.8 163.7 138.9 143.9 121.1 132.1 135.0 110.8 135.8 101.3 113.8 93.4 92.9<br />

60-64 239.9 194.1 211.2 188.7 199.1 206.4 195.3 185.8 175.9 207.0 168.3 173.0 127.9<br />

65-69 279.3 254.4 208.6 223.8 245.8 221.5 215.6 247.3 213.6 219.3 224.5 225.4 212.9<br />

70-79 437.4 366.7 375.4 354.4 351.6 291.6 307.3 311.9 292.6 313.3 325.0 249.3 277.1<br />

80+ 513.5 489.1 510.8 545.4 522.2 422.0 499.6 570.5 510.8 515.7 472.9 460.8 539.6<br />

Male 195.0 175.5 174.0 172.1 167.3 158.8 160.9 147.8 154.2 145.7 150.1 127.9 147.4<br />

Female 196.5 172.8 167.2 163.2 165.6 152.7 152.3 158.3 148.1 148.0 149.4 139.8 132.9<br />

White 210.2 190.0 180.2 180.8 179.6 166.9 175.5 172.2 171.7 163.4 169.8 152.3 162.3<br />

Black 164.2 144.9 154.1 147.0 147.0 145.0 116.0 109.5 106.9 99.9 100.2 95.7 92.3<br />

Other race 124.0 81.5 118.6 95.4 96.8 88.2 109.3 93.8 95.1 124.2 106.3 74.8 99.0<br />

†Hispanic 111.4 123.5 95.4 88.3 81.3 81.7 120.7<br />

†Non-Hispanic 162.7 156.2 158.2 154.5 159.1 140.3 143.6<br />

Diabetes 244.0 217.9 211.1 196.5 204.9 195.1 197.1 203.5 192.0 183.4 188.6 160.6 184.4<br />

Hypertension 210.6 179.9 179.2 191.5 194.2 149.4 153.7 157.4 173.9 167.5 164.3 153.1 145.0<br />

Glomerulonephritis 84.1 105.4 86.0 71.3 71.5 72.2 74.6 67.6 52.9 47.5 48.0 65.4 40.2<br />

Other cause 186.4 143.9 153.9 165.5 140.6 150.0 143.3 112.5 124.0 126.5 137.9 112.2 117.2<br />

All 195.6 174.3 170.8 167.9 166.5 156.0 156.8 152.8 151.2 146.8 149.8 133.6 140.6<br />

ADJUSTED<br />

0-19 135.3 241.5 149.3 172.1 107.8 121.0 147.3 117.5 134.6 120.4 153.0 97.7 87.8<br />

20-44 110.6 91.4 102.0 95.7 91.3 90.9 75.2 61.0 60.0 50.5 52.1 40.3 56.3<br />

45-64 168.3 153.6 145.0 140.1 131.4 132.9 131.2 117.1 126.7 112.9 112.0 99.4 97.4<br />

65-74 310.2 282.2 256.2 236.3 267.8 242.0 226.8 238.5 207.0 233.0 234.6 198.2 231.1<br />

75+ 541.2 437.2 479.2 509.1 463.2 342.9 421.7 444.1 436.1 404.1 409.7 385.7 371.7<br />

Male 264.5 235.8 230.1 223.9 214.4 201.9 200.5 177.6 186.8 173.3 176.0 148.4 174.3<br />

Female 260.9 235.4 227.8 217.4 220.8 199.5 199.2 208.0 190.6 188.6 193.3 177.2 163.7<br />

White 279.6 254.4 237.8 232.0 226.6 210.5 218.4 209.5 208.6 197.3 202.0 179.5 188.8<br />

Black 264.8 226.5 242.4 232.5 229.8 214.0 176.5 165.4 156.8 147.1 148.8 138.1 130.7<br />

Other race 185.7 126.6 175.6 133.4 149.5 118.8 140.3 127.0 136.5 163.2 153.3 95.1 126.0<br />

Diabetes 308.3 278.4 271.0 245.1 254.6 242.9 241.4 240.4 228.0 216.6 220.9 186.7 213.8<br />

Hypertension 226.2 201.1 191.1 207.1 206.8 160.8 159.6 162.5 176.9 168.4 166.6 150.2 143.3<br />

Glomerulonephritis 144.0 171.4 147.0 116.6 116.2 114.6 119.9 112.4 89.4 79.5 76.3 104.2 62.7<br />

Other cause 282.5 221.3 236.5 255.8 214.2 227.0 222.6 174.6 196.0 192.0 210.9 167.9 179.4<br />

All 263.0 235.5 228.8 220.8 217.0 200.5 199.5 190.7 188.2 179.9 182.8 161.0 169.0<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.<br />

Mortality rates for one of the four variables are adjusted for the remaining three.<br />

Hispanic & non-Hispanic mortality rates are unadjusted.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The 90-day rule has been applied.<br />

U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.36 H.36<br />

First-year mortality rates, transplant<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients,<br />

by<br />

by<br />

modality<br />

modality<br />

& demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

UNADJUSTED 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 163.9 75.7 76.5 42.9 85.8 44.5 27.9 33.3 10.9 42.2 32.1 23.2 42.9<br />

5-9 92.4 16.9 10.0 35.7 22.2 42.9 16.3 9.2 25.8 17.9 10.8 8.4 7.4<br />

10-14 80.6 25.2 24.4 18.1 17.0 26.0 21.3 5.7 10.4 13.4 10.6 14.5 4.9<br />

15-19 64.1 25.0 30.9 22.7 36.7 11.3 3.1 9.8 10.6 8.3 6.0 8.7 3.0<br />

20-29 27.1 22.8 31.5 26.3 15.8 20.7 13.0 14.6 10.5 16.0 12.6 13.5 16.5<br />

30-39 47.7 34.6 37.8 32.3 37.4 25.9 32.4 27.0 26.9 24.0 24.7 20.8 23.2<br />

40-49 71.8 51.1 51.9 45.9 50.2 47.0 41.4 42.9 33.9 35.0 34.9 32.8 32.4<br />

50-59 95.2 72.3 85.0 84.4 77.4 73.7 66.7 79.3 57.5 64.5 69.2 53.7 55.5<br />

60-64 136.6 107.2 113.3 98.0 84.6 98.4 92.1 78.7 95.1 91.4 89.3 87.7 70.5<br />

65-69 150.4 143.4 141.4 147.1 102.6 150.7 127.1 123.2 98.0 102.1 109.4 99.4 79.5<br />

70-79 171.0 188.1 129.5 218.7 173.3 113.8 97.6 158.7 169.7 128.7 118.8 128.5 115.9<br />

80+ . 287.7 693.1 405.5 693.1 . . . 133.5 133.5 95.3 . 117.8<br />

Male 74.6 54.9 59.2 55.3 57.6 54.9 48.8 48.7 46.0 48.3 52.8 46.8 46.5<br />

Female 63.6 47.2 56.4 52.9 44.9 45.1 46.4 54.4 43.3 45.2 44.8 42.2 40.8<br />

563<br />

White 74.8 52.7 59.0 55.1 54.4 56.4 48.1 50.4 44.0 45.7 47.1 42.1 42.3<br />

Black 55.4 50.1 59.5 55.7 50.0 39.7 48.9 57.0 50.3 51.3 59.8 54.5 50.8<br />

Other race 61.8 44.7 38.1 35.5 40.4 31.6 38.7 32.6 34.8 47.4 40.1 41.8 40.4<br />

†Hispanic 34.0 33.6 32.4 39.1 42.4 35.3 29.8<br />

†Non-Hispanic 49.4 53.1 46.6 48.1 50.5 46.3 46.4<br />

Diabetes 88.9 80.3 82.5 78.0 72.4 72.4 67.9 72.1 66.4 66.4 70.3 64.1 64.9<br />

Hypertension 75.7 44.7 65.4 58.3 51.4 53.7 45.5 62.4 45.9 57.5 70.8 58.7 48.3<br />

Glomerulonephritis 48.1 36.1 35.8 31.2 32.9 33.3 32.2 31.4 28.4 30.8 29.2 21.8 28.0<br />

Other cause 73.2 47.2 54.1 51.2 52.3 46.1 44.0 42.6 37.8 37.9 36.2 37.7 34.5<br />

All 70.1 51.8 58.0 54.3 52.5 51.1 47.8 51.0 44.9 47.1 49.5 44.9 44.2<br />

ADJUSTED<br />

0-19 93.8 34.3 35.9 29.5 37.4 25.8 14.9 13.8 14.1 17.3 12.1 13.7 11.0<br />

20-44 57.1 43.8 49.5 39.1 40.0 33.9 33.7 32.8 28.7 30.8 30.3 27.8 27.1<br />

45-64 111.6 81.0 89.4 86.4 79.5 79.6 71.2 76.7 64.2 68.0 70.4 59.9 59.0<br />

65-74 174.8 172.6 146.6 170.7 127.8 146.6 129.0 139.7 117.5 110.0 116.9 106.6 90.6<br />

75+ 174.8 172.6 146.6 170.7 127.8 146.6 129.0 139.7 117.5 110.0 116.9 106.6 90.6<br />

Male 195.5 142.0 147.9 134.7 136.1 126.3 108.9 106.3 96.6 100.4 105.4 92.2 88.4<br />

Female 186.4 132.9 153.8 141.7 117.0 116.5 113.1 132.7 102.9 107.7 101.6 93.0 86.1<br />

White 206.7 142.5 153.6 141.8 134.9 135.8 112.2 116.7 97.5 101.0 98.5 87.0 83.1<br />

Black 126.6 111.6 129.7 115.9 104.8 82.0 96.7 108.5 94.1 95.1 108.8 96.0 88.4<br />

Other race 161.9 117.4 99.3 89.6 93.0 80.1 84.3 71.8 75.3 98.1 81.7 80.8 78.8<br />

Diabetes 180.5 157.6 157.8 147.5 132.7 129.3 117.2 121.3 109.3 106.1 108.4 97.8 96.5<br />

Hypertension 136.2 81.5 115.2 101.0 89.2 90.9 74.5 99.5 71.9 89.6 108.3 86.9 70.2<br />

Glomerulonephritis 141.6 104.7 100.5 89.7 91.1 88.5 84.5 82.1 73.6 77.9 71.5 52.4 64.2<br />

Other cause 178.1 115.1 127.4 120.6 121.2 105.8 97.8 93.1 81.1 81.9 73.9 77.6 69.3<br />

All 189.7 136.9 148.5 135.8 127.4 121.2 109.1 114.8 97.7 101.7 102.6 91.2 86.3<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.<br />

Mortality rates for one of the four variables are adjusted for the remaining three.<br />

Hispanic & non-Hispanic mortality rates are unadjusted.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The 90-day rule has been applied.<br />

U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.37 H.37<br />

Second-year mortality rates, ESRD<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients,<br />

by<br />

by<br />

modality<br />

modality<br />

& demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

564<br />

UNADJUSTED 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />

0-4 50.4 58.3 29.0 31.5 66.7 67.8 50.2 43.9 40.3 41.7 27.8 63.7 41.2<br />

5-9 8.4 30.3 8.3 . 40.8 25.8 7.2 7.5 8.0 22.1 20.5 6.8 13.7<br />

10-14 21.4 24.1 12.9 21.8 26.4 8.0 19.0 11.6 18.6 15.3 6.9 10.1 20.5<br />

15-19 20.0 21.2 28.6 13.9 30.1 14.2 18.2 36.6 31.3 21.5 26.1 32.8 21.9<br />

20-29 47.6 55.6 59.3 55.6 46.4 45.4 51.0 45.2 48.2 39.8 43.4 49.1 47.1<br />

30-39 86.1 91.7 97.0 90.0 82.9 94.1 77.6 83.1 76.2 78.9 71.9 70.6 68.6<br />

40-49 121.9 107.1 124.1 108.7 117.3 109.4 104.5 109.2 100.7 98.3 103.9 102.7 96.9<br />

50-59 166.6 174.8 168.2 164.3 157.9 151.0 157.9 149.0 148.8 156.0 147.3 143.4 141.6<br />

60-64 230.9 230.5 229.0 225.6 211.9 205.4 210.4 200.0 201.1 202.1 190.3 184.7 183.6<br />

65-69 276.0 287.1 279.1 260.7 249.5 259.2 253.3 244.0 256.5 249.7 245.3 230.8 206.2<br />

70-79 343.2 354.6 344.9 333.2 335.7 329.9 324.0 314.6 334.5 314.5 308.8 314.7 296.0<br />

80+ 430.3 476.1 497.0 459.5 484.5 459.1 450.6 450.9 471.9 439.0 447.3 441.1 426.6<br />

Male 196.4 205.3 208.0 200.0 196.1 195.8 190.3 194.3 198.7 193.2 192.5 187.6 183.7<br />

Female 195.5 204.6 209.9 200.8 205.3 203.6 206.5 200.6 210.6 206.1 202.8 206.5 191.9<br />

White 219.6 231.0 234.4 226.6 229.3 228.4 226.8 227.4 234.4 225.1 221.7 221.3 212.7<br />

Black 157.9 163.4 171.7 160.9 157.4 154.5 153.5 149.2 157.5 159.5 161.2 157.1 151.0<br />

Other race 137.9 139.4 127.9 133.1 132.5 148.6 156.8 158.5 157.1 155.9 142.4 148.0 129.5<br />

†Hispanic 170.8 171.6 166.6 154.4 141.1 149.7<br />

†Non-Hispanic 200.9 208.7 203.7 203.5 205.0 193.3<br />

Diabetes 251.3 264.5 259.4 248.9 244.5 244.5 241.4 237.2 242.9 237.8 230.7 226.7 217.2<br />

Hypertension 207.7 225.0 224.1 211.5 217.8 207.8 205.2 204.5 217.2 211.2 212.3 211.3 203.4<br />

Glomerulonephritis 121.7 114.8 127.9 117.8 115.3 115.2 112.8 112.3 111.8 102.8 107.2 103.9 93.5<br />

Other cause 154.3 150.8 158.8 154.3 151.6 155.5 157.8 159.0 161.3 158.6 156.4 160.2 149.9<br />

All 196.0 204.9 208.9 200.4 200.4 199.5 197.9 197.2 204.2 199.1 197.2 196.3 187.4<br />

ADJUSTED<br />

0-19 46.7 57.4 47.1 33.6 74.4 43.4 44.5 58.6 54.1 46.7 42.6 58.2 48.4<br />

20-44 90.9 93.1 102.4 94.3 92.0 91.7 85.2 86.8 77.9 80.5 79.1 78.0 78.1<br />

45-64 184.1 183.8 181.3 173.1 165.7 158.2 160.4 153.6 152.7 153.9 147.7 143.6 140.4<br />

65-74 296.5 308.0 296.7 279.8 281.5 279.8 266.9 263.4 275.8 262.0 256.6 252.4 227.2<br />

75+ 397.5 421.3 422.4 403.2 401.3 396.3 400.8 379.8 405.2 378.6 376.8 376.4 365.2<br />

Male 260.2 266.8 264.4 249.6 239.6 235.4 227.8 224.2 225.7 217.2 211.6 205.4 200.5<br />

Female 235.3 241.6 240.5 227.1 230.0 223.8 224.0 213.2 220.8 214.9 210.4 210.4 194.4<br />

White 273.9 282.8 278.2 262.3 259.7 252.3 247.3 239.8 243.6 231.6 224.6 221.8 211.8<br />

Black 208.1 211.3 217.1 203.6 197.3 192.5 189.3 181.7 188.7 190.1 192.5 185.0 176.8<br />

Other race 183.7 180.2 161.5 162.3 159.9 176.5 177.8 174.6 170.8 173.8 152.5 159.9 140.7<br />

Diabetes 306.8 315.9 304.4 288.1 278.6 275.7 268.9 258.8 262.1 254.8 244.4 238.3 226.8<br />

Hypertension 214.8 227.9 223.4 211.8 214.0 201.9 198.8 193.1 203.2 195.6 195.8 193.6 187.0<br />

Glomerulonephritis 192.6 181.0 195.4 179.6 175.9 169.1 167.7 160.3 162.6 149.8 151.0 148.1 137.7<br />

Other cause 204.9 204.4 214.3 203.6 201.4 204.7 203.1 202.8 202.4 200.5 196.7 199.8 187.5<br />

All 247.7 254.2 252.2 238.0 234.5 229.3 225.5 218.5 223.0 215.7 210.7 207.5 197.2<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.<br />

Mortality rates for one of the four variables are adjusted for the remaining three.<br />

Hispanic & non-Hispanic mortality rates are unadjusted.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The 90-day rule has been applied.<br />

U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.38 H.38<br />

Second-year mortality rates, dialysis<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients,<br />

by<br />

by<br />

modality<br />

modality<br />

& demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

UNADJUSTED 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />

0-4 80.0 108.9 34.5 38.1 91.9 100.3 66.6 59.0 67.6 77.4 14.6 124.9 94.0<br />

5-9 31.7 79.0 . . 72.5 39.7 . 21.1 . 60.8 41.9 . 35.2<br />

10-14 12.7 48.9 12.0 47.8 40.2 21.6 32.2 30.0 44.2 40.5 . 17.5 48.4<br />

15-19 26.1 30.9 38.5 19.9 49.0 24.5 33.8 64.3 53.4 38.3 48.7 61.4 36.4<br />

20-29 74.6 85.9 87.7 76.8 65.4 63.4 70.2 65.3 66.9 52.4 57.4 63.8 61.7<br />

30-39 118.6 123.3 130.8 119.8 109.2 121.6 101.5 106.5 95.4 102.5 91.1 89.3 85.3<br />

40-49 147.4 123.9 153.5 130.6 142.4 128.5 122.6 127.6 119.0 116.4 120.3 119.0 113.2<br />

50-59 182.6 190.8 185.9 180.4 173.0 165.3 173.2 162.0 164.0 172.2 161.0 157.0 156.1<br />

60-64 242.4 241.5 237.5 235.0 219.0 213.5 219.9 209.3 210.6 213.6 199.7 196.1 193.8<br />

65-69 279.3 291.1 283.9 263.5 253.2 262.4 259.1 249.3 263.6 255.3 252.5 238.2 214.4<br />

70-79 344.2 356.2 345.4 333.5 336.9 330.9 325.9 316.0 335.9 316.0 310.8 317.7 298.4<br />

80+ 429.6 476.4 497.0 458.9 484.5 459.1 450.7 451.2 471.7 439.1 447.6 441.2 426.7<br />

Male 234.4 241.8 242.7 230.8 225.3 222.4 217.3 219.4 224.0 217.0 213.6 208.5 204.9<br />

Female 222.9 229.5 236.2 223.4 227.5 224.1 226.8 218.6 230.4 225.7 221.9 226.2 208.7<br />

565<br />

White 270.3 280.2 282.1 269.1 270.5 265.5 264.6 262.2 272.0 260.1 253.3 252.5 243.5<br />

Black 168.6 171.8 181.2 169.6 165.9 163.2 162.2 156.3 163.9 166.5 167.8 164.2 156.7<br />

Other race 163.6 158.7 148.2 147.6 145.9 161.8 170.0 171.3 168.2 168.0 152.4 159.2 138.8<br />

†Hispanic 185.5 186.5 181.4 166.1 152.1 161.3<br />

†Non-Hispanic 224.0 232.7 226.8 225.2 227.2 214.0<br />

Diabetes 284.5 292.5 286.0 272.6 265.0 264.8 260.4 254.2 259.6 254.1 244.2 239.4 229.8<br />

Hypertension 222.4 240.2 238.4 224.1 230.7 219.1 216.7 214.5 228.1 220.5 221.5 221.7 212.4<br />

Glomerulonephritis 161.6 147.8 165.6 149.6 147.2 142.8 139.1 139.3 139.8 128.4 133.0 129.6 116.3<br />

Other cause 193.7 189.3 199.9 191.3 188.1 190.5 194.6 192.3 196.4 194.1 190.5 196.8 183.9<br />

All 228.9 235.9 239.6 227.2 226.4 223.2 221.9 219.1 227.0 221.1 217.4 216.7 206.7<br />

ADJUSTED<br />

0-19 56.5 92.8 56.0 49.0 105.3 68.8 69.6 101.0 93.5 87.4 62.9 102.1 88.3<br />

20-44 125.9 124.4 139.8 125.1 123.7 120.7 111.7 113.2 99.8 104.4 98.8 97.6 98.2<br />

45-64 203.4 200.9 200.7 192.0 182.6 174.4 177.9 170.0 170.0 172.0 163.6 159.2 156.2<br />

65-74 298.4 311.0 299.7 281.9 284.8 282.6 271.5 267.6 280.9 266.5 262.3 258.9 233.7<br />

75+ 397.7 421.9 422.3 402.8 401.7 396.6 401.3 380.2 405.7 378.9 377.1 377.0 366.0<br />

Male 271.4 278.2 274.6 259.7 249.1 244.3 238.0 233.7 236.0 227.4 219.8 213.7 210.2<br />

Female 245.3 250.0 252.2 236.5 240.4 233.6 234.1 222.6 231.7 225.9 221.1 221.9 204.5<br />

White 288.3 297.1 293.1 275.9 273.8 265.3 261.7 253.8 259.5 246.6 238.1 235.7 226.3<br />

Black 210.8 212.5 219.9 206.4 200.1 196.0 192.8 184.3 191.1 193.4 195.4 188.6 179.5<br />

Other race 192.3 183.8 168.5 165.6 162.9 179.9 182.4 179.8 174.6 178.0 156.4 164.5 144.8<br />

Diabetes 324.5 331.0 320.4 303.0 292.0 289.6 283.7 272.8 276.3 269.4 256.4 249.5 239.0<br />

Hypertension 222.1 236.4 231.6 218.9 221.9 209.4 206.6 200.2 211.7 202.8 203.0 201.6 194.4<br />

Glomerulonephritis 199.8 183.9 202.4 184.0 182.0 172.2 171.1 166.2 168.8 156.1 157.3 155.7 143.9<br />

Other cause 214.4 213.9 224.9 213.3 211.8 214.1 215.4 212.2 213.7 212.2 207.6 212.8 200.2<br />

All 258.4 264.2 263.4 248.0 244.7 238.9 235.9 228.2 233.8 226.5 220.2 217.4 207.3<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.<br />

Mortality rates for one of the four variables are adjusted for the remaining three.<br />

Hispanic & non-Hispanic mortality rates are unadjusted.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The 90-day rule has been applied.<br />

U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.39 H.39<br />

Second-year mortality rates, hemodialysis<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients,<br />

by<br />

by<br />

modality<br />

modality<br />

& demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

566<br />

UNADJUSTED 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />

0-4 287.7 182.3 117.8 287.7 268.3 . . 223.1 . 287.7 . 149.0 235.6<br />

5-9 117.8 80.0 . . 223.1 . . 64.5 . 51.3 74.1 . .<br />

10-14 . . . 24.7 66.7 21.1 22.5 19.8 19.4 72.1 . 14.8 46.3<br />

15-19 30.8 33.3 36.1 18.3 44.4 22.3 36.3 67.1 57.1 29.9 55.5 61.2 38.1<br />

20-29 74.7 85.1 85.5 75.8 66.9 64.6 72.1 65.7 64.2 51.2 58.6 68.5 61.0<br />

30-39 116.4 121.8 130.4 120.2 111.5 118.4 103.2 109.0 95.4 102.9 91.0 91.7 84.0<br />

40-49 143.9 127.7 149.4 127.3 135.8 120.7 120.2 128.4 116.4 114.9 119.9 120.1 114.9<br />

50-59 182.1 189.7 177.5 172.3 166.0 154.5 166.0 156.1 159.3 169.3 161.0 155.3 153.6<br />

60-64 234.2 235.8 226.6 219.1 213.9 202.7 209.4 201.1 204.0 207.5 196.4 196.2 191.4<br />

65-69 272.0 293.6 273.2 249.0 241.7 262.9 251.0 242.5 253.7 248.3 246.9 233.7 213.7<br />

70-79 332.6 349.8 334.7 324.5 329.6 318.8 313.7 310.0 333.9 310.6 304.4 312.0 297.4<br />

80+ 421.8 482.8 485.2 435.7 470.0 449.1 438.0 449.4 468.7 439.2 442.8 436.1 426.7<br />

Male 232.8 244.3 238.1 224.7 223.8 218.2 212.3 217.3 221.7 215.1 211.5 207.2 204.3<br />

Female 222.4 234.7 233.6 220.0 225.0 220.2 224.6 218.0 230.6 225.3 222.9 227.2 211.9<br />

White 274.2 287.4 281.8 266.9 270.8 264.8 261.6 263.8 272.5 259.1 253.2 252.6 245.9<br />

Black 166.8 176.3 180.0 167.3 166.0 158.3 162.7 156.2 165.1 167.9 169.5 165.3 158.2<br />

Other race 155.2 170.4 145.1 146.8 150.4 170.4 167.4 170.1 168.9 169.6 153.0 164.4 140.1<br />

†Hispanic 183.6 184.3 182.4 164.5 154.8 160.9<br />

†Non-Hispanic 222.7 231.8 225.3 224.8 226.6 215.5<br />

Diabetes 273.9 287.6 273.1 257.2 254.8 252.5 247.9 245.6 252.3 247.4 239.0 236.8 227.4<br />

Hypertension 220.6 242.4 235.6 218.9 227.1 215.0 215.6 213.0 227.2 219.5 221.0 218.3 213.8<br />

Glomerulonephritis 165.6 161.3 166.5 152.2 153.8 144.2 140.0 148.7 144.0 129.9 139.1 136.1 118.1<br />

Other cause 203.4 200.1 206.7 200.9 197.1 197.5 201.5 198.4 203.4 202.0 194.5 200.8 190.3<br />

All 227.8 239.7 235.9 222.4 224.4 219.2 218.2 217.6 225.9 219.9 216.8 216.4 207.8<br />

ADJUSTED<br />

0-19 76.1 72.3 68.8 48.2 137.4 40.0 68.2 136.1 96.9 97.0 94.5 116.5 99.3<br />

20-44 124.7 126.0 139.8 126.3 124.2 118.0 113.2 114.6 98.9 104.3 100.4 99.9 98.1<br />

45-64 201.4 200.5 193.7 184.3 178.1 165.7 172.4 167.2 167.0 170.1 163.7 160.0 155.8<br />

65-74 290.5 309.5 292.1 272.4 276.0 279.1 263.7 261.0 277.8 261.8 258.0 255.2 232.9<br />

75+ 386.4 423.7 409.6 387.5 395.8 385.3 388.4 380.0 401.6 376.1 371.1 372.2 367.0<br />

Male 265.2 276.0 266.1 250.3 244.3 237.2 230.5 230.6 232.2 224.4 217.0 211.8 208.9<br />

Female 239.4 250.4 244.7 228.0 233.0 225.5 227.9 219.1 229.1 222.9 219.7 221.1 205.2<br />

White 283.0 294.8 283.7 265.3 266.3 257.7 252.5 250.6 255.1 241.7 234.2 233.0 225.5<br />

Black 204.0 213.1 214.4 199.7 196.0 186.9 190.5 181.7 190.2 193.4 196.0 188.4 179.7<br />

Other race 178.3 190.8 160.4 160.6 163.1 183.8 176.0 175.3 173.0 176.9 155.4 167.4 144.4<br />

Diabetes 310.5 323.9 305.1 284.5 280.0 275.4 269.3 263.3 268.3 262.1 250.9 246.9 236.3<br />

Hypertension 219.5 237.3 228.9 214.2 217.1 206.2 205.4 200.4 211.4 202.4 202.9 199.0 195.6<br />

Glomerulonephritis 199.2 192.8 197.5 180.8 184.6 167.0 167.1 174.5 170.0 154.2 161.2 160.0 143.6<br />

Other cause 218.1 218.8 224.9 216.6 214.3 214.9 216.9 213.2 216.1 216.0 208.2 213.8 202.8<br />

All 252.1 263.1 255.2 238.8 238.5 231.2 229.0 224.7 230.5 223.4 218.0 216.0 206.9<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.<br />

Mortality rates for one of the four variables are adjusted for the remaining three.<br />

Hispanic & non-Hispanic mortality rates are unadjusted.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The 90-day rule has been applied.<br />

U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.40 H.40<br />

Second-year mortality rates, CAPD/CCPD<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients,<br />

by<br />

by<br />

modality<br />

modality<br />

& demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

UNADJUSTED 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />

0-4 . 137.0 . 29.9 43.7 74.3 123.5 53.8 101.0 51.5 18.0 126.0 61.9<br />

5-9 . 107.1 . . . 89.1 . . . 46.5 29.9 . 75.3<br />

10-14 32.8 102.8 . 110.3 39.2 . 30.8 48.6 69.9 18.0 . 23.0 40.6<br />

15-19 20.6 21.1 . 17.7 107.6 23.0 42.4 73.0 35.6 86.4 20.6 53.9 37.5<br />

20-29 86.2 100.7 93.9 69.2 62.1 73.0 48.5 71.7 74.3 44.6 51.0 28.6 67.5<br />

30-39 123.1 128.1 116.8 117.7 106.4 122.0 71.3 92.6 100.6 91.5 75.2 57.3 83.7<br />

40-49 165.9 113.3 180.1 123.9 145.1 144.4 132.9 112.2 115.6 118.0 119.4 103.2 86.6<br />

50-59 206.6 211.5 232.3 199.2 177.6 190.0 190.0 175.7 180.3 175.5 162.1 152.4 167.4<br />

60-64 273.9 312.3 294.6 285.8 225.1 236.4 256.2 256.0 214.3 257.3 208.8 189.1 190.1<br />

65-69 345.7 301.3 345.8 314.6 271.6 239.8 271.0 273.8 331.6 254.6 291.4 276.3 179.2<br />

70-79 452.3 455.6 356.0 366.6 367.4 376.8 380.0 368.0 343.5 350.4 358.0 394.6 280.8<br />

80+ 432.1 524.1 536.8 594.7 559.6 576.4 644.4 467.0 557.5 405.5 508.1 453.1 433.2<br />

Male 235.3 241.3 246.3 222.7 192.1 206.7 201.6 202.2 201.1 199.2 187.7 174.3 177.1<br />

Female 211.4 205.0 205.4 189.8 200.1 197.0 200.8 181.3 188.9 181.4 178.3 182.0 151.8<br />

567<br />

White 249.0 269.8 254.7 235.1 225.8 226.5 236.5 215.0 230.0 219.1 211.6 202.2 193.9<br />

Black 174.7 137.6 171.5 150.0 142.9 168.9 131.0 145.0 120.2 138.2 125.3 132.4 111.8<br />

Other race 156.7 51.6 162.0 141.3 108.7 94.2 153.8 153.4 137.6 118.6 107.4 112.5 92.3<br />

†Hispanic 140.4 165.4 115.3 143.5 104.0 124.2<br />

†Non-Hispanic 199.2 199.0 200.7 188.7 188.9 170.3<br />

Diabetes 310.4 335.8 336.4 301.4 285.0 276.8 285.7 266.2 273.6 269.2 257.6 229.6 219.2<br />

Hypertension 232.4 223.0 200.0 194.5 204.7 198.4 185.2 188.1 178.0 171.7 174.6 196.3 165.7<br />

Glomerulonephritis 150.8 98.1 133.3 104.9 77.7 113.2 98.4 85.2 87.8 95.9 76.3 73.6 80.6<br />

Other cause 145.8 149.7 143.0 131.5 116.7 138.3 130.2 131.6 144.3 117.4 118.5 138.1 114.7<br />

All 224.1 223.9 227.5 207.0 195.9 202.1 201.2 192.1 195.3 190.5 183.2 177.9 164.7<br />

ADJUSTED<br />

0-19 31.2 163.1 . 71.8 118.3 86.1 104.1 96.7 107.8 99.3 31.5 108.7 96.7<br />

20-44 133.3 126.9 141.2 114.1 117.1 124.9 91.3 107.7 100.7 104.8 77.8 68.3 89.5<br />

45-64 223.0 222.3 237.3 205.6 183.6 191.7 189.2 170.3 170.9 173.7 161.4 145.4 148.8<br />

65-74 380.2 355.4 324.3 314.9 300.8 279.8 281.2 295.6 291.3 279.9 296.0 295.1 215.2<br />

75+ 497.6 513.9 483.6 506.3 438.6 503.6 568.4 428.5 490.2 376.0 432.6 455.6 342.3<br />

Male 321.9 336.4 336.2 299.6 251.4 268.3 259.6 256.2 247.4 242.2 226.4 209.0 205.4<br />

Female 310.8 284.7 286.4 268.1 278.7 273.4 269.8 241.9 258.2 240.2 239.2 242.8 197.6<br />

White 344.5 367.4 343.8 315.0 293.9 290.9 301.1 269.1 283.4 267.0 259.5 243.6 228.5<br />

Black 281.5 224.7 268.0 237.7 223.7 264.0 192.6 220.8 185.2 202.2 186.1 196.3 160.0<br />

Other race 228.3 78.0 259.7 212.5 154.3 147.0 210.7 199.7 185.2 169.5 144.7 172.9 120.0<br />

Diabetes 408.2 434.9 437.2 393.5 362.0 349.1 360.6 331.5 331.5 326.1 313.2 275.5 258.9<br />

Hypertension 268.9 256.8 232.8 219.9 236.1 224.5 209.3 202.7 192.8 179.8 184.0 211.4 169.9<br />

Glomerulonephritis 240.4 162.7 208.1 176.6 122.5 181.2 153.3 130.9 143.2 156.0 124.9 114.4 125.6<br />

Other cause 212.2 218.9 214.8 198.4 176.4 208.5 192.6 202.6 217.7 182.1 174.4 207.0 168.9<br />

All 316.1 311.8 313.6 284.5 263.6 269.9 263.8 249.1 251.3 240.7 231.2 222.9 201.2<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.<br />

Mortality rates for one of the four variables are adjusted for the remaining three.<br />

Hispanic & non-Hispanic mortality rates are unadjusted.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The 90-day rule has been applied.<br />

U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.41 H.41<br />

Second-year mortality rates, transplant<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients,<br />

by<br />

by<br />

modality<br />

modality<br />

& demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

568<br />

UNADJUSTED 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />

0-4 12.6 . . 11.4 17.7 15.0 . 58.3 34.5 22.2 17.4 10.9 15.7<br />

5-9 . . 8.6 . 18.3 . 8.8 16.5 9.3 . 18.2 10.9 .<br />

10-14 . 15.4 . . 6.1 5.7 5.3 . . . . 5.3 9.8<br />

15-19 14.1 10.0 7.2 23.8 9.9 16.2 5.7 12.6 6.6 10.7 8.3 12.1 8.7<br />

20-29 18.8 14.2 15.0 15.3 12.7 4.8 11.3 10.7 13.2 9.8 8.1 7.7 11.1<br />

30-39 27.4 21.9 24.4 22.6 18.1 20.4 17.4 16.4 15.7 13.7 15.7 19.5 15.9<br />

40-49 38.0 36.6 28.3 28.2 27.2 31.8 19.5 26.8 20.1 24.3 17.6 19.4 26.2<br />

50-59 46.6 37.0 33.2 41.7 46.9 44.5 36.6 40.8 28.8 32.2 26.6 33.1 37.5<br />

60-64 82.6 48.3 55.0 52.1 47.6 53.3 45.3 46.0 36.8 46.2 39.7 43.8 53.6<br />

65-69 66.9 53.8 73.1 65.0 54.3 70.3 81.9 55.2 64.2 56.5 59.8 71.6 46.6<br />

70-79 66.7 126.3 90.2 88.9 105.4 84.6 58.4 80.0 65.8 72.6 75.8 65.1 69.6<br />

80+ . . . 405.5 693.1 . . . . 336.5 154.2 223.1 .<br />

Male 34.7 28.1 27.5 29.2 29.1 31.6 26.6 26.5 24.9 27.5 25.1 28.8 29.5<br />

Female 31.7 29.4 27.0 29.7 27.1 26.5 21.9 30.5 21.3 22.7 19.6 25.5 29.5<br />

White 31.7 26.4 27.4 28.0 28.2 29.7 24.3 28.1 23.6 22.9 21.2 24.3 29.3<br />

Black 43.4 37.2 30.1 36.0 32.5 32.7 26.9 31.8 22.4 35.5 29.8 38.0 34.7<br />

Other race 17.0 25.2 13.5 23.1 11.4 13.8 20.3 11.3 26.5 20.2 16.3 25.4 13.0<br />

†Hispanic 21.4 19.0 12.5 15.6 19.1 25.1<br />

†Non-Hispanic 28.9 24.0 27.3 23.9 28.6 30.2<br />

Diabetes 52.6 48.7 49.9 52.8 42.7 37.4 40.1 42.2 40.3 39.8 34.6 43.2 45.3<br />

Hypertension 39.4 33.8 29.7 35.1 37.8 30.7 29.4 35.5 23.8 28.1 26.2 36.9 32.9<br />

Glomerulonephritis 22.5 16.7 15.3 15.7 17.0 20.5 16.5 18.8 13.5 14.0 15.2 15.2 20.3<br />

Other cause 26.7 22.2 19.5 20.7 20.5 29.9 16.0 18.9 17.3 20.6 17.4 18.9 21.2<br />

All 33.5 28.6 27.3 29.4 28.3 29.6 24.8 28.1 23.5 25.5 22.9 27.4 29.5<br />

ADJUSTED<br />

0-19 8.6 9.0 5.1 12.6 12.4 12.0 5.7 17.8 10.7 7.8 9.3 10.6 9.5<br />

20-44 31.2 27.5 26.2 28.2 21.7 21.2 19.0 20.8 18.6 18.9 18.8 21.1 21.3<br />

45-64 61.7 47.0 43.1 43.6 47.5 48.5 37.1 41.4 31.8 35.9 28.5 34.4 41.7<br />

65-74 78.7 78.5 82.7 79.9 74.6 82.7 80.6 64.2 66.9 65.7 66.4 66.6 51.1<br />

75+ 78.7 78.5 82.7 79.9 74.6 82.7 80.6 64.2 66.9 65.7 66.4 66.6 51.1<br />

Male 98.1 76.1 73.4 75.3 73.4 77.0 63.1 60.8 56.1 59.4 53.9 59.4 59.9<br />

Female 95.6 87.5 77.2 82.5 73.9 69.5 57.1 75.2 52.6 54.9 47.1 58.7 65.7<br />

White 94.1 75.1 76.1 74.9 74.8 75.6 60.2 67.1 56.0 51.9 48.0 52.2 62.0<br />

Black 101.6 87.1 68.1 79.9 68.8 69.6 56.5 64.0 43.4 67.9 56.4 70.9 62.1<br />

Other race 47.1 67.3 36.2 60.8 28.7 32.0 51.9 25.0 59.1 44.8 34.3 52.5 25.6<br />

Diabetes 114.9 103.3 102.3 105.6 84.6 71.6 74.7 76.2 71.0 68.5 57.9 69.9 71.9<br />

Hypertension 74.4 62.0 55.0 62.8 67.0 54.1 50.7 59.2 38.6 44.9 41.5 57.5 49.4<br />

Glomerulonephritis 70.3 50.5 45.6 45.1 49.9 57.9 44.9 50.3 36.0 37.1 39.2 38.1 49.7<br />

Other cause 66.7 54.4 47.7 49.0 48.6 69.6 36.7 42.0 37.7 44.5 37.7 38.6 43.8<br />

All 96.2 79.6 74.1 77.4 72.8 73.4 60.3 65.7 54.2 57.0 50.7 58.5 61.4<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.<br />

Mortality rates for one of the four variables are adjusted for the remaining three.<br />

Hispanic & non-Hispanic mortality rates are unadjusted.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The 90-day rule has been applied.<br />

U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.42 H.42<br />

Third-year mortality rates, ESRD<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients, by<br />

by<br />

modality<br />

modality &<br />

demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

UNADJUSTED 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />

0-4 29.3 26.2 10.1 22.3 32.5 42.3 8.8 14.8 39.2 42.0 7.1 21.4 47.7<br />

5-9 10.5 . 23.3 . 8.3 16.8 13.2 14.5 46.2 . 7.5 6.9 20.6<br />

10-14 14.7 10.9 9.8 21.9 22.3 22.6 28.5 7.7 15.7 11.3 . 6.9 10.2<br />

15-19 19.2 30.8 19.5 13.5 16.1 20.6 14.4 26.1 20.7 28.2 22.0 28.6 17.3<br />

20-29 37.2 43.4 45.7 40.2 41.4 42.7 40.7 44.2 35.6 35.3 35.9 44.5 40.6<br />

30-39 71.8 72.4 72.1 74.8 82.4 71.9 68.3 70.8 64.5 67.6 63.0 66.6 60.7<br />

40-49 102.7 111.0 111.1 108.6 108.3 107.3 103.1 103.4 101.5 99.4 103.2 96.5 100.6<br />

50-59 167.5 171.3 166.2 168.4 177.6 164.2 165.8 158.0 159.7 149.1 144.9 145.8 138.7<br />

60-64 219.2 229.5 231.4 224.7 231.0 227.4 214.2 214.1 218.6 194.5 195.6 204.6 188.6<br />

65-69 270.1 289.3 293.3 283.0 284.9 274.0 264.3 255.4 269.8 252.9 249.5 246.1 234.8<br />

70-79 346.4 344.6 366.6 346.2 365.5 337.9 353.3 344.9 334.5 333.5 333.6 326.3 307.8<br />

80+ 506.2 496.4 505.7 497.1 480.7 489.1 502.3 502.9 451.4 475.4 503.6 481.7 445.3<br />

Male 175.1 177.7 186.0 182.9 197.6 187.0 187.6 181.9 185.0 184.7 182.7 184.5 177.8<br />

Female 171.8 192.6 195.6 197.6 198.9 196.1 199.0 201.0 202.0 192.3 197.5 196.7 186.9<br />

569<br />

White 193.4 202.6 212.6 211.2 222.8 214.2 219.6 215.3 218.7 211.6 210.6 213.7 205.4<br />

Black 142.2 157.8 159.1 159.0 162.9 158.4 156.8 154.5 154.4 152.2 160.1 155.8 147.2<br />

Other race 137.1 136.7 125.7 134.5 144.7 146.6 135.0 163.4 161.7 163.9 152.0 146.9 140.4<br />

†Hispanic 169.8 160.4 153.6 158.5 139.9<br />

†Non-Hispanic 196.1 192.1 194.7 194.8 189.0<br />

Diabetes 241.0 252.8 252.6 254.1 254.7 250.4 242.3 246.4 244.0 235.8 237.2 235.9 225.1<br />

Hypertension 188.8 195.8 203.9 205.7 213.9 205.8 214.8 202.3 200.1 202.2 203.0 202.6 193.7<br />

Glomerulonephritis 101.6 113.0 113.4 107.0 115.3 105.3 104.7 106.4 110.7 95.7 101.3 106.1 92.2<br />

Other cause 136.2 135.1 144.9 130.4 144.4 132.7 135.9 133.2 140.3 136.7 134.4 132.6 130.3<br />

All 173.6 184.6 190.5 189.7 198.2 191.2 193.0 190.8 192.8 188.2 189.5 190.0 181.9<br />

ADJUSTED<br />

0-19 35.2 41.7 32.0 29.2 35.2 45.1 32.7 35.8 48.0 41.6 23.4 36.3 38.1<br />

20-44 79.4 79.0 81.0 79.9 83.8 80.3 77.7 80.2 71.4 73.3 71.8 75.6 74.3<br />

45-64 181.8 186.8 183.8 179.8 184.9 174.3 167.2 162.5 164.5 150.7 150.1 149.8 141.6<br />

65-74 299.2 313.0 317.8 308.1 308.0 293.1 297.2 283.2 280.5 277.4 273.2 263.7 249.8<br />

75+ 436.7 412.7 449.6 412.4 441.1 415.5 424.6 429.6 407.9 403.0 414.1 406.3 379.1<br />

Male 264.9 255.5 264.1 251.7 268.3 247.1 244.0 235.9 230.4 226.9 222.0 218.5 209.2<br />

Female 232.7 249.3 249.2 243.5 240.8 235.1 234.2 232.5 228.8 215.3 219.6 217.4 202.5<br />

White 281.1 276.8 286.8 274.6 282.0 264.0 263.6 255.3 249.3 238.6 234.4 233.7 221.6<br />

Black 199.1 217.5 215.6 209.8 215.0 207.1 204.0 198.6 196.1 190.4 199.5 194.2 180.4<br />

Other race 208.1 195.5 175.4 179.6 187.9 188.3 170.6 197.5 190.8 189.2 180.5 166.9 159.7<br />

Diabetes 317.1 323.4 317.1 312.3 308.3 297.2 284.8 285.5 277.2 265.5 264.7 259.9 245.7<br />

Hypertension 219.0 218.5 224.1 221.3 231.4 218.8 226.2 212.2 204.3 204.8 202.8 201.9 191.5<br />

Glomerulonephritis 180.9 197.0 197.1 177.8 193.0 175.4 167.6 171.4 172.5 151.4 161.1 163.7 142.0<br />

Other cause 198.2 192.4 211.4 189.4 205.2 188.8 191.8 185.6 191.9 184.1 183.3 179.2 174.1<br />

All 248.5 252.1 256.5 247.3 254.2 240.8 238.8 233.8 229.2 220.9 220.5 217.7 205.7<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.<br />

Mortality rates for one of the four variables are adjusted for the remaining three.<br />

Hispanic & non-Hispanic mortality rates are unadjusted.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The 90-day rule has been applied.<br />

U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.43 H.43<br />

Third-year mortality rates, dialysis<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients,<br />

by<br />

by<br />

modality<br />

modality<br />

& demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

570<br />

UNADJUSTED 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />

0-4 75.9 85.3 37.7 102.2 51.5 94.2 24.1 25.3 103.6 102.7 . 33.9 55.3<br />

5-9 74.1 . 91.3 . 40.8 102.9 55.6 51.3 33.9 . 27.4 33.9 24.7<br />

10-14 26.7 20.2 16.8 72.3 55.3 64.1 91.2 35.2 41.3 32.9 . 15.0 13.6<br />

15-19 34.1 68.4 37.8 24.0 19.7 37.2 23.0 43.8 30.4 27.2 44.7 51.6 33.3<br />

20-29 68.2 76.1 81.0 67.2 73.9 66.9 68.5 58.7 56.3 54.9 58.7 62.6 56.4<br />

30-39 109.5 115.0 113.2 116.9 124.9 106.4 101.0 104.7 90.0 96.4 87.9 89.8 82.7<br />

40-49 139.4 155.5 150.5 149.8 151.0 141.2 134.6 132.7 128.9 125.0 131.1 123.4 127.3<br />

50-59 197.6 200.9 194.7 196.0 207.7 190.2 194.0 183.1 184.9 174.6 168.4 168.1 161.7<br />

60-64 236.5 246.3 246.6 244.8 249.1 245.3 228.7 234.6 238.1 212.4 211.4 221.6 207.9<br />

65-69 275.2 297.4 303.2 292.6 292.7 282.7 273.4 264.9 279.0 262.4 261.4 260.4 248.0<br />

70-79 347.4 345.4 368.6 347.8 366.7 339.5 355.6 348.3 337.1 335.8 337.0 330.0 312.7<br />

80+ 506.2 496.4 507.6 497.1 480.7 489.5 502.3 503.2 451.2 475.6 504.8 482.0 445.8<br />

Male 235.0 236.3 243.1 236.4 251.6 234.5 231.6 224.8 225.0 222.5 219.5 219.0 211.2<br />

Female 213.9 236.6 237.0 238.7 238.7 230.7 234.7 234.0 232.4 222.9 228.8 226.9 215.5<br />

White 272.6 281.2 290.6 285.8 296.6 279.4 282.6 276.0 275.6 268.9 265.7 265.9 254.4<br />

Black 161.0 178.2 176.6 176.0 181.2 174.5 173.1 170.2 168.3 163.3 172.0 167.3 158.5<br />

Other race 174.9 180.2 160.6 171.4 172.8 172.9 156.9 187.1 182.2 182.5 172.4 163.6 158.6<br />

†Hispanic 194.5 185.7 176.9 177.9 158.9<br />

†Non-Hispanic 233.7 228.1 231.0 229.9 222.7<br />

Diabetes 297.3 309.6 300.5 299.3 300.1 288.1 278.6 279.7 275.5 264.9 264.8 261.2 248.7<br />

Hypertension 215.5 221.4 229.8 231.0 240.0 230.4 237.9 222.2 217.8 218.9 219.6 218.3 210.7<br />

Glomerulonephritis 155.8 175.3 169.1 156.9 169.3 148.6 147.3 148.9 152.5 133.6 142.6 148.5 127.3<br />

Other cause 190.1 189.1 204.7 188.0 198.5 179.3 184.4 181.2 185.2 181.9 180.1 176.7 174.1<br />

All 224.5 236.5 240.1 237.5 245.2 232.6 233.1 229.3 228.6 222.7 223.9 222.7 213.2<br />

ADJUSTED<br />

0-19 74.2 98.1 71.6 74.5 56.1 98.9 76.2 77.3 72.6 63.6 57.3 73.8 57.1<br />

20-44 123.1 127.5 128.2 127.1 131.8 122.3 118.6 116.4 103.6 105.2 102.1 104.1 102.5<br />

45-64 214.9 220.9 213.9 211.6 220.0 203.6 196.4 192.0 193.7 177.7 176.4 175.2 166.4<br />

65-74 302.1 318.1 324.8 314.7 313.5 299.6 304.4 291.1 287.5 284.9 282.7 274.0 260.4<br />

75+ 437.2 412.3 450.5 412.3 441.4 415.7 425.1 430.4 408.2 403.5 415.0 407.3 380.6<br />

Male 290.7 281.8 290.0 275.6 293.4 267.9 264.6 256.4 248.9 244.7 240.0 234.9 225.3<br />

Female 250.4 268.4 267.5 263.4 260.5 252.2 252.9 249.4 244.7 232.1 236.9 233.8 218.7<br />

White 309.7 305.6 315.8 303.2 311.3 288.8 289.7 280.1 272.7 263.1 258.5 256.4 243.7<br />

Black 206.5 226.8 223.4 217.5 224.1 214.8 212.7 206.7 203.0 195.4 205.4 200.1 186.5<br />

Other race 218.8 214.3 189.2 195.1 197.3 197.7 178.5 207.3 198.0 195.1 188.8 173.5 168.3<br />

Diabetes 354.0 360.4 349.2 343.4 341.3 324.4 312.0 311.7 303.0 289.6 288.5 281.3 265.7<br />

Hypertension 231.1 231.4 237.9 234.8 245.4 233.3 240.5 224.2 214.9 215.5 213.5 212.0 203.2<br />

Glomerulonephritis 197.7 220.0 215.0 194.4 212.6 187.8 181.4 186.9 186.9 165.6 178.8 181.7 156.8<br />

Other cause 218.1 212.2 234.8 214.0 225.4 205.3 211.3 206.6 208.5 202.3 202.4 197.4 192.9<br />

All 270.2 275.1 278.8 269.5 276.7 260.0 258.7 252.9 246.7 238.4 238.3 234.2 222.0<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.<br />

Mortality rates for one of the four variables are adjusted for the remaining three.<br />

Hispanic & non-Hispanic mortality rates are unadjusted.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The 90-day rule has been applied.<br />

U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.44 H.44<br />

Third-year mortality rates, hemodialysis<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients,<br />

by<br />

by<br />

modality<br />

modality<br />

& demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

UNADJUSTED 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />

0-4 287.7 223.1 . 182.3 . 95.3 . 87.0 . 87.0 . 182.3 287.7<br />

5-9 . . . . . . 64.5 . 95.3 . . 95.3 .<br />

10-14 57.2 33.9 33.9 125.8 97.7 . 83.1 . 42.6 30.8 . 30.8 .<br />

15-19 38.3 72.1 36.0 24.8 22.0 42.8 24.8 41.6 36.5 22.3 33.1 40.8 23.0<br />

20-29 73.5 79.2 71.7 62.5 70.5 66.6 68.2 56.2 54.7 57.4 60.3 63.6 51.7<br />

30-39 98.6 112.4 114.9 114.1 119.1 102.8 91.1 104.4 90.4 98.9 87.9 89.5 82.6<br />

40-49 132.3 150.6 135.9 142.8 138.4 129.3 132.1 130.5 126.5 123.6 128.7 123.1 124.9<br />

50-59 195.8 197.9 190.0 182.7 205.9 178.4 186.7 175.2 179.9 166.6 165.7 165.3 161.2<br />

60-64 221.9 249.6 242.1 242.7 236.6 234.4 217.9 222.2 230.4 208.2 207.4 216.4 200.5<br />

65-69 261.3 291.0 291.2 276.9 283.3 269.1 259.2 255.3 273.2 257.9 251.7 252.4 245.1<br />

70-79 338.7 346.6 359.5 333.0 352.1 332.0 345.5 342.8 336.9 331.0 335.1 325.8 310.0<br />

80+ 510.2 499.0 505.3 483.3 476.6 483.4 480.1 492.6 444.4 464.2 505.9 475.5 442.4<br />

Male 227.4 241.0 237.9 230.3 245.7 225.6 223.0 218.9 221.7 217.4 215.5 215.6 206.7<br />

Female 212.3 237.5 236.8 233.1 236.1 229.1 232.5 234.3 234.1 224.6 231.7 227.6 218.3<br />

571<br />

White 267.3 288.2 291.3 283.9 294.5 272.5 277.5 274.3 275.6 268.2 267.3 265.3 254.2<br />

Black 162.5 181.6 174.4 171.1 179.5 175.1 171.5 169.6 171.3 164.1 171.5 167.6 158.1<br />

Other race 178.0 180.4 168.1 174.9 182.3 177.1 161.7 189.2 182.0 181.5 169.6 162.8 162.0<br />

†Hispanic 191.3 186.0 173.7 175.7 159.0<br />

†Non-Hispanic 233.2 226.0 230.6 228.5 221.5<br />

Diabetes 289.6 307.9 288.8 284.3 290.2 272.2 264.7 271.0 268.2 259.3 259.0 257.1 246.0<br />

Hypertension 210.2 222.2 229.1 225.7 230.7 225.7 232.2 215.9 216.2 216.9 222.5 214.5 210.7<br />

Glomerulonephritis 157.7 177.9 170.5 154.9 178.5 146.4 149.2 154.9 155.0 131.4 141.4 152.2 127.0<br />

Other cause 183.3 198.3 206.8 190.6 200.3 186.4 185.7 186.4 193.7 184.5 182.7 178.6 171.2<br />

All 219.9 239.3 237.4 231.7 240.9 227.3 227.6 226.4 227.6 220.8 223.1 221.2 212.1<br />

ADJUSTED<br />

0-19 98.5 132.4 68.7 90.0 71.1 83.9 84.6 83.8 86.1 55.4 59.0 92.9 46.1<br />

20-44 114.4 127.0 122.0 125.6 124.8 116.5 115.0 117.4 104.4 108.7 101.3 104.4 100.4<br />

45-64 209.4 220.6 208.1 203.2 214.6 193.3 189.2 184.2 189.8 172.9 174.8 173.4 164.6<br />

65-74 289.1 313.0 314.2 303.1 304.3 288.4 292.4 285.7 284.7 281.0 278.0 268.7 260.2<br />

75+ 434.2 420.0 445.7 393.3 427.8 413.3 413.8 422.2 407.8 397.0 414.4 402.5 375.6<br />

Male 278.5 283.2 279.1 264.9 284.4 254.9 252.3 247.5 244.8 237.8 234.9 230.6 220.1<br />

Female 243.8 263.5 261.7 251.9 251.6 245.1 246.0 245.4 243.0 231.0 237.3 232.1 219.7<br />

White 295.1 303.1 306.5 291.4 299.5 273.7 277.0 271.6 267.9 257.5 256.0 252.0 240.7<br />

Black 204.8 226.2 215.7 207.2 217.8 211.3 207.2 203.1 203.8 194.1 203.2 199.1 184.6<br />

Other race 220.7 209.8 191.4 194.0 202.8 197.3 178.7 204.3 193.9 191.9 183.3 170.7 169.4<br />

Diabetes 344.2 356.7 334.0 325.5 328.9 305.8 295.9 301.1 295.1 283.4 282.2 277.2 263.1<br />

Hypertension 225.4 231.7 236.5 228.7 236.0 227.2 235.6 217.7 215.1 214.2 217.2 208.6 203.5<br />

Glomerulonephritis 194.9 217.7 208.6 186.2 216.7 180.9 177.5 188.8 188.3 159.3 173.5 182.9 153.7<br />

Other cause 206.4 216.2 230.6 210.2 220.6 206.5 206.4 207.3 212.8 201.2 201.3 196.4 187.1<br />

All 260.7 273.2 270.3 258.3 267.4 249.8 249.0 246.3 243.7 234.3 235.8 231.1 219.7<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.<br />

Mortality rates for one of the four variables are adjusted for the remaining three.<br />

Hispanic & non-Hispanic mortality rates are unadjusted.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The 90-day rule has been applied.<br />

U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

Table H.45 H.45<br />

Third-year mortality rates, CAPD/CCPD<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients,<br />

by<br />

by<br />

modality<br />

modality<br />

& demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

572<br />

UNADJUSTED 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />

0-4 . 69.0 60.6 117.8 . 82.7 30.8 . 128.1 127.8 . . 42.6<br />

5-9 182.3 . 87.0 . . 87.0 64.5 80.0 . . 57.2 . 46.5<br />

10-14 . . . . . 154.2 51.3 81.8 46.5 40.8 . . 36.4<br />

15-19 44.5 88.8 69.0 42.6 22.5 40.8 . 24.7 19.8 51.3 57.7 124.4 76.2<br />

20-29 57.8 74.7 111.7 83.4 85.7 62.6 40.8 61.1 59.3 55.6 52.2 81.3 72.3<br />

30-39 140.1 127.8 103.3 114.3 157.5 148.1 125.6 101.0 87.3 70.0 84.6 80.5 83.6<br />

40-49 193.2 195.5 211.4 168.8 203.6 172.6 151.0 140.3 147.3 131.0 141.6 105.2 153.8<br />

50-59 236.7 235.4 209.7 264.0 206.3 241.9 229.3 203.1 208.9 231.1 172.1 189.3 150.8<br />

60-64 356.3 256.2 292.3 248.8 273.7 287.0 244.8 282.2 258.7 226.5 231.4 290.6 252.3<br />

65-69 315.0 379.0 349.6 350.2 314.1 342.1 367.5 271.5 280.1 331.3 368.4 360.3 288.2<br />

70-79 359.8 457.2 516.1 412.8 501.7 355.0 428.5 348.0 355.1 415.7 365.1 407.6 350.1<br />

80+ 539.0 777.7 439.4 418.7 503.9 583.9 781.7 775.8 630.2 621.2 693.1 590.5 470.4<br />

Male 258.6 244.5 262.4 240.1 258.5 247.6 246.3 218.0 222.0 246.0 235.1 217.6 232.4<br />

Female 208.6 232.7 220.3 219.0 212.4 221.2 211.4 195.9 187.6 180.6 176.5 201.6 149.4<br />

White 277.0 278.7 280.6 267.2 281.9 278.2 274.5 240.6 241.0 247.6 229.6 238.3 223.0<br />

Black 149.1 160.7 179.7 166.6 160.8 159.3 158.6 154.6 138.7 145.0 155.6 156.6 139.3<br />

Other race 154.0 217.4 111.3 128.5 108.8 174.1 127.0 150.7 160.9 193.8 184.1 158.8 124.2<br />

†Hispanic 188.2 142.8 178.6 177.9 138.5<br />

†Non-Hispanic 207.2 223.4 209.3 214.7 201.0<br />

Diabetes 363.5 350.8 355.2 337.2 317.6 340.6 338.9 305.8 301.6 293.1 295.0 291.9 248.6<br />

Hypertension 231.7 243.2 229.1 215.0 259.2 226.1 231.5 200.3 191.3 218.8 166.6 214.8 179.7<br />

Glomerulonephritis 137.6 144.0 146.8 129.8 105.6 148.4 120.8 107.6 113.7 119.4 132.3 93.7 96.3<br />

Other cause 169.4 164.7 174.4 164.6 181.3 137.3 132.8 114.9 110.8 140.8 128.8 135.9 173.2<br />

All 234.2 238.8 241.5 230.2 235.6 234.8 229.4 207.3 204.8 214.0 205.4 209.9 192.2<br />

ADJUSTED<br />

0-19 65.5 85.8 97.5 82.6 17.5 139.7 50.7 74.1 77.8 95.4 44.0 64.8 85.0<br />

20-44 163.3 144.9 144.9 121.2 163.9 158.3 123.2 105.2 105.1 82.0 105.1 97.3 123.4<br />

45-64 276.5 248.1 253.0 255.4 231.7 242.6 225.4 215.7 206.6 211.6 178.9 189.3 169.2<br />

65-74 348.4 434.9 422.9 361.0 371.1 351.3 383.3 287.7 302.5 364.0 350.7 365.8 298.0<br />

75+ 466.4 548.5 535.1 519.0 633.8 431.6 606.4 553.7 474.3 497.2 492.6 487.2 419.1<br />

Male 380.1 347.0 385.4 339.0 360.3 331.4 334.5 291.1 291.2 317.0 296.6 270.0 285.8<br />

Female 331.8 364.6 321.7 322.4 316.1 324.2 308.3 276.7 262.3 256.8 241.4 283.1 208.0<br />

White 412.9 403.0 399.5 373.3 390.8 373.0 369.3 317.5 309.2 315.4 287.7 299.0 274.5<br />

Black 259.7 266.3 300.4 267.6 262.5 253.5 253.6 233.1 217.8 228.7 233.1 237.7 213.9<br />

Other race 257.4 326.2 168.1 206.4 169.2 241.0 194.3 218.0 219.7 269.4 267.6 220.6 195.8<br />

Diabetes 502.7 479.0 482.9 452.0 425.6 446.6 441.0 396.1 385.1 368.4 367.0 365.2 306.9<br />

Hypertension 287.1 297.4 276.2 262.8 314.0 270.2 277.1 241.1 220.6 249.8 180.1 237.3 206.1<br />

Glomerulonephritis 231.6 235.2 245.3 200.0 180.6 231.5 197.0 169.8 172.4 197.3 219.5 155.1 148.0<br />

Other cause 248.1 242.0 252.3 247.7 272.5 204.2 202.5 169.8 170.7 208.3 201.2 198.4 263.2<br />

All 356.9 353.6 353.9 330.9 338.5 327.2 321.3 283.5 276.7 288.1 269.2 274.6 249.1<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.<br />

Mortality rates for one of the four variables are adjusted for the remaining three.<br />

Hispanic & non-Hispanic mortality rates are unadjusted.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The 90-day rule has been applied.<br />

U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


MORTALITY & CAUSES OF DEATH<br />

2005 Annual <strong>Data</strong> ReportH<br />

Table H.46 H.46<br />

Third-year mortality rates, transplant<br />

per<br />

per<br />

1,000<br />

1,000<br />

patient<br />

patient<br />

years<br />

years<br />

at<br />

at<br />

risk,<br />

risk,<br />

incident<br />

incident<br />

patients,<br />

patients,<br />

by<br />

by<br />

modality<br />

modality<br />

& demographic<br />

demographic<br />

characteristics<br />

characteristics<br />

UNADJUSTED 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />

0-4 26.7 12.7 13.8 . 11.6 18.0 . 11.4 . 8.8 11.3 . 22.2<br />

5-9 . . . 8.7 10.1 . . 8.9 25.3 9.4 . 9.2 11.0<br />

10-14 . 6.3 7.8 6.4 12.4 . . . . . 5.2 . 5.4<br />

15-19 16.5 7.1 3.4 18.3 20.3 10.0 5.4 5.7 12.8 13.3 . 11.2 6.1<br />

20-29 14.4 19.1 16.7 19.8 15.6 20.5 13.7 13.9 14.9 11.7 7.4 9.0 6.0<br />

30-39 34.8 21.9 27.1 24.0 19.6 25.5 20.8 17.2 19.0 19.3 17.4 17.9 16.3<br />

40-49 40.7 34.6 39.1 28.6 35.4 31.6 27.1 25.7 29.5 25.5 25.6 25.2 18.8<br />

50-59 56.3 52.5 41.4 48.5 46.3 49.8 45.9 42.4 36.3 39.5 37.7 34.4 34.6<br />

60-64 45.8 50.5 64.5 72.1 43.8 76.0 69.9 63.8 49.6 55.2 56.3 73.2 43.8<br />

65-69 93.7 88.4 80.5 73.7 86.7 77.3 79.2 73.2 79.6 73.7 77.3 85.0 49.7<br />

70-79 129.2 189.2 144.6 58.3 110.5 104.0 114.1 102.9 49.8 130.6 66.7 67.0 90.5<br />

80+ . . . . . . . . . . 223.1 . .<br />

Male 40.0 31.0 37.2 35.7 32.0 36.7 30.6 30.0 28.9 29.6 31.9 30.4 24.5<br />

Female 29.8 31.6 26.4 25.9 31.2 31.5 30.5 27.5 29.4 31.0 24.1 30.4 27.7<br />

573<br />

White 31.6 29.4 34.8 29.1 29.4 34.9 29.0 28.7 27.0 28.3 29.4 29.4 25.0<br />

Black 52.4 41.0 30.9 40.8 42.1 35.2 35.2 34.2 35.4 36.3 27.5 36.3 32.5<br />

Other race 31.2 17.3 8.6 33.2 21.3 27.8 30.3 8.2 28.9 29.0 23.9 19.6 10.9<br />

†Hispanic 17.8 21.1 22.5 26.6 9.7<br />

†Non-Hispanic 30.4 31.3 29.6 30.9 28.1<br />

Diabetes 57.9 45.8 56.0 43.9 54.6 56.4 41.0 41.8 44.1 50.1 45.9 49.6 40.2<br />

Hypertension 48.2 48.7 38.3 34.4 34.9 35.3 38.1 36.9 39.8 32.0 32.9 29.2 34.0<br />

Glomerulonephritis 20.4 18.1 19.7 25.2 20.0 22.5 24.8 18.4 19.2 18.2 20.6 20.4 14.8<br />

Other cause 30.3 24.8 25.7 27.2 23.5 26.8 21.6 22.9 18.2 22.7 17.7 23.1 18.4<br />

All 36.0 31.3 32.8 31.7 31.7 34.6 30.6 29.0 29.1 30.2 28.7 30.4 25.8<br />

ADJUSTED<br />

0-19 12.8 7.3 5.7 12.6 17.3 8.2 3.2 6.0 11.0 9.7 3.3 7.0 9.6<br />

20-44 37.9 29.3 30.7 27.8 26.9 29.7 25.9 23.0 22.1 21.7 19.8 19.9 17.2<br />

45-64 59.1 55.6 56.3 55.7 50.5 57.1 46.8 44.7 43.4 43.9 42.5 44.9 36.1<br />

65-74 117.3 109.4 95.7 80.3 101.7 84.1 92.8 85.0 79.3 91.0 78.1 86.5 66.5<br />

75+ 117.3 109.4 95.7 80.3 101.7 84.1 92.8 85.0 79.3 91.0 78.1 86.5 66.5<br />

Male 113.6 87.5 100.4 94.5 82.2 92.1 74.1 70.7 66.1 66.4 68.7 64.7 50.3<br />

Female 93.1 97.4 79.9 75.3 88.5 87.5 81.3 72.7 73.5 77.8 59.1 74.4 64.5<br />

White 96.3 87.6 98.9 80.9 79.1 92.7 73.6 70.9 64.2 67.3 66.7 66.4 53.6<br />

Black 121.8 97.6 73.5 93.4 94.7 75.5 75.7 72.6 72.4 71.1 53.4 70.0 61.5<br />

Other race 94.5 47.1 22.5 87.2 55.2 68.9 68.8 20.8 62.5 63.8 52.0 40.3 22.0<br />

Diabetes 131.9 104.6 123.9 93.8 114.8 117.1 82.1 81.3 83.2 92.3 82.4 86.7 67.9<br />

Hypertension 91.1 91.4 69.2 62.6 61.6 61.5 66.2 62.9 65.4 51.3 51.7 45.6 52.3<br />

Glomerulonephritis 62.6 56.1 59.0 74.0 56.6 64.8 69.3 49.2 50.5 47.9 54.4 52.1 36.5<br />

Other cause 74.5 61.1 62.3 65.9 55.2 62.9 49.9 52.0 40.0 49.2 38.0 49.4 37.2<br />

All 104.7 90.2 91.4 86.1 83.6 89.2 75.9 70.5 68.0 69.7 64.2 67.4 55.0<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall mortality rates are adjusted for age, gender, race, & primary diagnosis.<br />

Mortality rates for one of the four variables are adjusted for the remaining three.<br />

Hispanic & non-Hispanic mortality rates are unadjusted.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The 90-day rule has been applied.<br />

U.S. patients only; patients of unknown age or gender, or of age >110, are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


HMORTALITY & CAUSES OF DEATH<br />

Reference section H<br />

574


Reference<br />

I<br />

Section<br />

Patient<br />

survival


IPATIENT SURVIVAL<br />

Reference section I<br />

576<br />

I.1 . 5 78<br />

Incident patient counts: ESRD patients<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

I.2 . 582<br />

90-day survival probabilities: incident ESRD patients<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

I.3 . 584<br />

One-year survival probabilities: incident ESRD patients<br />

from day 91 to one year + 90 days, by age, gender, race, ethnicity, & primary<br />

diagnosis<br />

I.4 . 586<br />

Two-year survival probabilities: incident ESRD patients<br />

from day 91 to two years + 90 days, by age, gender, race, ethnicity, &<br />

primary diagnosis<br />

I.5 . 588<br />

Three-year survival probabilities: incident ESRD patients<br />

from day 91 to three years + 90 days, by age, gender, race, ethnicity, &<br />

primary diagnosis<br />

I.6 . 590<br />

Five-year survival probabilities: incident ESRD patients<br />

from day 91 to five years + 90 days, by age, gender, race, ethnicity, &<br />

primary diagnosis<br />

I.7 . 592<br />

Ten-year survival probabilities: incident ESRD patients<br />

from day 91 to ten years + 90 days, by age, gender, race, ethnicity, &<br />

primary diagnosis<br />

I.8 . 593<br />

Incident patient counts: dialysis patients, unknowns dropped<br />

dialysis patients alive on day 91, by age, gender, race, ethnicity, & primary<br />

diagnosis<br />

I.9 . 595<br />

90-day survival probabilities: incident dialysis patients<br />

censored at transplant, by age, gender, race, ethnicity, & primary diagnosis<br />

I.10 . 597<br />

One-year survival probabilities: incident dialysis patients<br />

censored at transplant, from day 91 to one year + 90 days, by age, gender,<br />

race, ethnicity, & primary diagnosis<br />

I.11 . 599<br />

Two-year survival probabilities: incident dialysis patients<br />

censored at transplant, from day 91 to two years + 90 days, by age, gender,<br />

race, ethnicity, & primary diagnosis<br />

I.12 . 601<br />

Three-year survival probabilities: incident dialysis patients<br />

censored at transplant, from day 91 to three years + 90 days, by age, gender,<br />

race, ethnicity, & primary diagnosis<br />

I.13 . 603<br />

Five-year survival probabilities: incident dialysis patients<br />

censored at transplant, from day 91 to five years + 90 days, by age, gender,<br />

race, ethnicity, & primary diagnosis<br />

I.14 . 605<br />

Ten-year survival probabilities: incident dialysis patients<br />

censored at transplant, from day 91 to ten years + 90 days, by age, gender,<br />

race, & primary diagnosis<br />

I.15 . 606<br />

Incident patient counts: hemodialysis patients, unknowns dropped<br />

dialysis patients alive on day 91, by age, gender, race, ethnicity, & primary<br />

diagnosis<br />

I.16 . 608<br />

90-day survival probabilities: incident hemodialysis patients<br />

censored at transplant, by age, gender, race, ethnicity, & primary diagnosis<br />

I.17 . 610<br />

One-year survival probabilities: incident hemodialysis patients<br />

censored at transplant, from day 91 to one year + 90 days, by age, gender,<br />

race, ethnicity, & primary diagnosis<br />

I.18 . 612<br />

Two-year survival probabilities: incident hemodialysis patients<br />

censored at transplant, from day 91 to two years + 90 days, by age, gender,<br />

race, ethnicity, & primary diagnosis<br />

I.19 . 614<br />

Three-year survival probabilities: incident hemodialysis patients<br />

censored at transplant, from day 91 to three years + 90 days, by age, gender,<br />

race, ethnicity, & primary diagnosis<br />

I.20 . 616<br />

Five-year survival probabilities: incident hemodialysis patients<br />

censored at transplant, from day 91 to five years + 90 days, by age, gender,<br />

race, ethnicity, & primary diagnosis<br />

I.21 . 617<br />

Ten-year survival probabilities: incident hemodialysis patients<br />

censored at transplant, from day 91 to ten years + 90 days, by age, gender,<br />

race, & primary diagnosis<br />

I.22 . 618<br />

Incident patient counts: CAPD/CCPD patients, unknowns dropped<br />

dialysis patients alive on day 91, by age, gender, race, ethnicity, & primary<br />

diagnosis


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

577<br />

I.23 . 620<br />

90-day survival probabilities: incident CAPD/CCPD patients<br />

censored at transplant, by age, gender, race, ethnicity, & primary diagnosis<br />

I.24 . 622<br />

One-year survival probabilities: incident CAPD/CCPD patients<br />

censored at transplant, from day 91 to one year + 90 days, by age, gender,<br />

race, ethnicity, & primary diagnosis<br />

I.25 . 624<br />

Two-year survival probabilities: incident CAPD/CCPD patients<br />

censored at transplant, from day 91 to two years + 90 days, by age, gender,<br />

race, ethnicity, & primary diagnosis<br />

I.26 . 626<br />

Three-year survival probabilities: incident CAPD/CCPD patients<br />

censored at transplant, from day 91 to three years + 90 days, by age, gender,<br />

race, ethnicity, & primary diagnosis<br />

I.27 . 628<br />

Five-year survival probabilities: incident CAPD/CCPD patients<br />

censored at transplant, from day 91 to five years + 90 days, by age, gender,<br />

race, ethnicity, & primary diagnosis<br />

I.28 . 630<br />

Ten-year survival probabilities: incident CAPD/CCPD patients<br />

censored at transplant, from day 91 to ten years + 90 days, by age, gender,<br />

race, & primary diagnosis<br />

I.29 . 631<br />

90-day patient survival probabilities: first transplants, deceased donors<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

I.30 . 633<br />

One-year patient survival probabilities: first transplants, deceased donors<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

I.31 . 635<br />

Two-year patient survival probabilities: first transplants, deceased donors<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

I.32 . 637<br />

Three-year patient survival probabilities: first transplants, deceased donors<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

I.33 . 639<br />

Five-year patient survival probabilities: first transplants, deceased donors<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

I.34 . 641<br />

Ten-year patient survival probabilities: first transplants, deceased donors<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

I.35 . 642<br />

90-day patient survival probabilities: first transplants, living donors<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

I.36 . 643<br />

One-year patient survival probabilities: first transplants, living donors<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

I.37 . 645<br />

Two-year patient survival probabilities: first transplants, living donors<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

I.38 . 647<br />

Three-year patient survival probabilities: first transplants, living donors<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

I.39 . 649<br />

Five-year patient survival probabilities: first transplants, living donors<br />

by age, gender, race/ethnicity, & primary diagnosis<br />

I.40 . 651<br />

Ten-year patient survival probabilities: first transplants, living donors<br />

by age, gender, race/ethnicity, & primary diagnosis


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.1 I.1<br />

Incident patient counts: ESRD patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

578<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 46 66 98 106 107 134 132 137 135 144 125<br />

5-9 94 94 105 87 108 101 122 112 99 124 138<br />

10-14 178 185 222 210 221 213 207 217 220 197 218<br />

15-19 425 467 455 438 424 433 452 468 497 512 488<br />

20-29 1,502 1,662 1,869 1,804 1,956 2,049 2,109 2,129 2,324 2,501 2,555<br />

30-39 2,166 2,430 2,697 2,788 2,996 3,220 3,561 3,703 4,141 4,493 4,692<br />

40-49 2,379 2,663 2,810 3,138 3,300 3,595 3,870 4,374 4,850 5,500 6,032<br />

50-59 3,610 4,218 4,505 4,631 4,932 5,250 5,559 6,032 6,863 7,416 7,972<br />

60-64 1,999 2,317 2,616 3,025 3,338 3,695 3,855 4,382 4,762 5,203 5,735<br />

65-69 1,968 2,055 2,325 3,041 3,155 3,535 4,069 4,654 5,215 6,010 6,669<br />

70-79 2,182 2,403 2,955 4,128 4,307 5,030 5,791 6,651 7,318 8,670 9,675<br />

80+ 359 404 541 842 914 1,137 1,401 1,622 1,960 2,432 2,813<br />

Unknown . * * * * 17 11 * * * *<br />

Male 9,423 10,476 11,658 13,294 14,225 15,396 16,981 18,633 20,536 23,232 25,226<br />

Female 7,485 8,488 9,548 10,951 11,541 13,009 14,157 15,853 17,852 19,979 21,893<br />

Unknown . * . * * * * * * . .<br />

White 11,766 13,146 14,672 16,369 17,451 19,179 21,138 23,126 25,330 28,389 31,037<br />

Black 4,657 5,275 5,956 7,164 7,524 8,315 8,952 10,166 11,600 13,292 14,230<br />

Other race 426 485 559 692 768 892 1,005 1,164 1,413 1,497 1,801<br />

Unknown 59 59 19 22 24 23 44 31 46 33 51<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 2,577 3,845 5,002 5,831 7,080 8,166 9,471 10,802 12,304 14,862 17,015<br />

Hypertension 2,988 4,266 5,414 5,893 6,610 7,581 8,227 9,519 11,004 12,764 13,956<br />

Glomerulonephritis 2,716 3,524 4,112 4,322 4,614 4,874 5,103 5,586 5,982 6,286 6,674<br />

Cystic kidney 753 927 1,065 1,081 1,122 1,196 1,285 1,340 1,363 1,390 1,537<br />

Other urologic 451 638 819 907 920 1,092 1,129 1,250 1,270 1,293 1,200<br />

Other cause 1,709 2,128 2,674 2,953 3,123 3,365 3,471 3,484 3,626 4,107 4,238<br />

Missing cause 4,209 2,110 835 1,949 943 735 783 668 843 563 459<br />

Unknown cause 1,505 1,527 1,285 1,311 1,355 1,400 1,670 1,838 1,997 1,946 2,040<br />

All 16,908 18,965 21,206 24,247 25,767 28,409 31,139 34,487 38,389 43,211 47,119<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.1 I.1 (continued)<br />

Incident patient counts: ESRD patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 171 145 179 138 162 178 170 166 167 192 198 177<br />

5-9 123 124 131 157 144 140 131 137 154 153 150 178<br />

10-14 240 245 240 253 273 268 278 269 298 307 307 342<br />

15-19 479 526 521 518 567 575 528 535 597 571 573 575<br />

20-29 2,576 2,719 2,768 2,745 2,629 2,663 2,603 2,699 2,615 2,645 2,677 2,553<br />

30-39 4,994 5,347 5,422 5,721 5,648 5,718 5,657 5,691 5,831 5,675 5,626 5,685<br />

40-49 6,799 7,325 7,761 8,184 8,734 9,404 9,393 10,184 10,386 10,655 10,672 10,978<br />

50-59 8,653 9,617 10,122 11,331 11,552 12,225 13,283 14,424 15,516 16,066 16,860 17,505<br />

60-64 6,300 6,622 6,965 7,329 7,620 8,008 8,420 8,877 9,131 9,421 9,738 10,013<br />

65-69 7,386 7,990 8,333 8,912 8,923 9,713 10,014 10,288 10,407 10,510 10,769 11,048<br />

70-79 11,349 12,713 13,368 14,882 15,281 17,217 18,399 19,415 20,613 21,069 21,182 22,297<br />

80+ 3,284 3,874 4,199 4,731 5,125 6,088 6,946 7,613 8,583 9,269 9,656 11,218<br />

Unknown * * * * * . . * . . . .<br />

Male 27,885 30,172 31,930 34,285 35,140 38,491 40,387 42,710 45,078 46,366 47,543 50,351<br />

Female 24,470 27,076 28,076 30,620 31,518 33,705 35,435 37,589 39,218 40,166 40,865 42,217<br />

Unknown * * * . * * . . * * . *<br />

579<br />

White 34,337 37,303 38,661 41,573 41,937 45,771 48,400 50,965 54,184 55,886 56,877 59,424<br />

Black 15,927 17,521 18,613 20,152 20,788 22,048 22,871 24,404 24,878 25,055 25,849 27,117<br />

Other race 2,032 2,335 2,630 3,000 3,763 4,270 4,460 4,830 5,140 5,473 5,610 5,956<br />

Unknown 61 90 106 180 173 108 91 100 96 119 72 72<br />

†Hispanic 8,362 8,565 9,134 9,923 10,666 10,976 11,882<br />

†Non-Hispanic 63,835 67,257 71,165 74,375 75,867 77,432 80,687<br />

Diabetes 19,534 21,711 23,136 25,747 28,048 31,369 33,627 35,757 37,587 39,113 40,184 41,649<br />

Hypertension 15,571 17,426 18,076 19,542 17,560 18,684 19,860 20,925 22,150 22,557 23,311 24,775<br />

Glomerulonephritis 6,949 7,157 7,376 7,919 8,040 8,406 8,317 8,466 8,503 8,276 8,147 8,369<br />

Cystic kidney 1,599 1,691 1,766 1,804 1,902 1,851 1,935 2,127 2,144 2,152 2,198 2,202<br />

Other urologic 1,381 1,441 1,250 1,294 1,912 2,151 2,193 2,203 2,585 2,424 2,469 2,669<br />

Other cause 4,613 4,979 5,216 5,623 6,438 6,729 6,882 7,507 7,734 8,091 8,208 8,878<br />

Missing cause 419 381 469 300 255 247 211 310 412 482 359 393<br />

Unknown cause 2,291 2,463 2,721 2,676 2,506 2,760 2,797 3,004 3,183 3,438 3,532 3,634<br />

All 52,357 57,249 60,010 64,905 66,661 72,197 75,822 80,299 84,298 86,533 88,408 92,569<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age, gender, race, or primary cause of ESRD are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.1 I.1 (continued)<br />

Incident patient counts: ESRD patients, unknowns dropped<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

580<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 41 57 88 104 101 131 120 128 126 135 117<br />

5-9 83 82 99 82 104 92 112 103 96 119 129<br />

10-14 161 164 207 197 208 199 194 204 207 178 200<br />

15-19 384 431 422 430 404 413 422 445 468 479 460<br />

20-29 1,384 1,554 1,768 1,713 1,885 1,943 2,023 2,013 2,168 2,379 2,412<br />

30-39 2,020 2,291 2,570 2,668 2,881 3,083 3,379 3,548 3,923 4,266 4,475<br />

40-49 2,205 2,504 2,688 3,014 3,172 3,464 3,717 4,203 4,693 5,305 5,791<br />

50-59 3,291 3,935 4,294 4,422 4,716 5,061 5,314 5,777 6,603 7,161 7,701<br />

60-64 1,819 2,131 2,463 2,871 3,161 3,519 3,666 4,172 4,553 5,005 5,524<br />

65-69 1,751 1,849 2,135 2,820 2,961 3,356 3,850 4,377 4,929 5,754 6,393<br />

70-79 1,925 2,087 2,679 3,809 3,976 4,663 5,362 6,185 6,788 8,197 9,197<br />

80+ 315 339 489 769 815 1,035 1,267 1,450 1,791 2,246 2,627<br />

Male 8,541 9,599 10,876 12,538 13,453 14,555 16,012 17,570 19,367 22,103 23,986<br />

Female 6,838 7,825 9,026 10,361 10,931 12,404 13,414 15,035 16,978 19,121 21,040<br />

White 10,662 11,971 13,712 15,415 16,446 18,141 19,926 21,799 23,950 27,059 29,621<br />

Black 4,279 4,949 5,651 6,821 7,202 7,959 8,523 9,693 11,029 12,724 13,639<br />

Other race 438 504 539 663 736 859 977 1,113 1,366 1,441 1,766<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 2,573 3,845 4,998 5,823 7,072 8,147 9,455 10,789 12,290 14,849 17,000<br />

Hypertension 2,985 4,262 5,409 5,878 6,601 7,566 8,215 9,502 10,990 12,751 13,937<br />

Glomerulonephritis 2,713 3,522 4,109 4,319 4,613 4,867 5,097 5,581 5,977 6,282 6,666<br />

Cystic kidney 753 927 1,063 1,080 1,121 1,195 1,285 1,340 1,363 1,389 1,537<br />

Other urologic 450 638 819 905 918 1,092 1,128 1,249 1,264 1,290 1,200<br />

Other cause 1,708 2,125 2,672 2,948 3,120 3,359 3,468 3,477 3,620 4,102 4,228<br />

Missing cause 4,197 2,105 832 1,946 939 733 778 667 841 561 458<br />

All 15,379 17,424 19,902 22,899 24,384 26,959 29,426 32,605 36,345 41,224 45,026<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age, gender, race, or primary cause of ESRD are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.1 I.1 (continued)<br />

Incident patient counts: ESRD patients, unknowns dropped<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 157 132 155 124 156 173 162 163 160 185 193 167<br />

5-9 117 111 111 137 137 136 129 128 144 138 141 165<br />

10-14 221 222 209 235 257 256 249 244 269 281 264 310<br />

15-19 443 491 486 467 528 530 501 491 550 520 516 507<br />

20-29 2,429 2,553 2,570 2,571 2,487 2,500 2,445 2,530 2,450 2,476 2,476 2,361<br />

30-39 4,730 5,080 5,093 5,421 5,379 5,460 5,419 5,421 5,579 5,393 5,373 5,416<br />

40-49 6,543 7,038 7,431 7,855 8,464 9,057 9,067 9,815 10,018 10,288 10,268 10,569<br />

50-59 8,369 9,309 9,793 10,993 11,246 11,890 12,963 14,030 15,106 15,623 16,373 17,004<br />

60-64 6,084 6,390 6,715 7,126 7,403 7,754 8,202 8,661 8,886 9,145 9,480 9,732<br />

65-69 7,092 7,706 8,008 8,608 8,630 9,432 9,704 9,986 10,117 10,168 10,429 10,708<br />

70-79 10,789 12,117 12,744 14,211 14,613 16,485 17,646 18,671 19,757 20,171 20,281 21,380<br />

80+ 3,034 3,584 3,930 4,438 4,791 5,699 6,461 7,084 8,009 8,617 8,987 10,503<br />

Male 26,500 28,667 30,318 32,665 33,646 36,903 38,710 40,942 43,204 44,286 45,468 48,198<br />

Female 23,508 26,066 26,927 29,521 30,445 32,469 34,238 36,282 37,841 38,719 39,313 40,624<br />

581<br />

White 32,708 35,555 36,827 39,699 40,228 43,883 46,365 48,859 51,845 53,392 54,300 56,761<br />

Black 15,320 16,876 17,828 19,447 20,097 21,294 22,192 23,628 24,150 24,255 25,053 26,278<br />

Other race 1,980 2,302 2,590 3,040 3,766 4,195 4,391 4,737 5,050 5,358 5,428 5,783<br />

†Hispanic 8,045 8,272 8,800 9,565 10,266 10,578 11,439<br />

†Non-Hispanic 61,327 64,676 68,424 71,480 72,739 74,203 77,383<br />

Diabetes 19,515 21,685 23,123 25,729 28,025 31,343 33,601 35,727 37,558 39,075 40,145 41,596<br />

Hypertension 15,547 17,409 18,062 19,530 17,535 18,662 19,833 20,905 22,130 22,527 23,284 24,742<br />

Glomerulonephritis 6,945 7,155 7,374 7,915 8,037 8,402 8,312 8,455 8,496 8,271 8,142 8,362<br />

Cystic kidney 1,598 1,691 1,766 1,803 1,901 1,850 1,935 2,127 2,144 2,152 2,197 2,201<br />

Other urologic 1,377 1,439 1,248 1,292 1,908 2,147 2,191 2,199 2,582 2,422 2,466 2,664<br />

Other cause 4,607 4,973 5,206 5,618 6,431 6,721 6,865 7,501 7,724 8,077 8,188 8,866<br />

Missing cause 419 381 466 299 254 247 211 310 411 481 359 391<br />

All 50,008 54,733 57,245 62,186 64,091 69,372 72,948 77,224 81,045 83,005 84,781 88,822<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age, gender, race, or primary cause of ESRD are excluded.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.2 I.2<br />

90-day survival probabilities: incident ESRD patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

582<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 97.9 98.5 98.0 100.0 98.2 100.0 97.1 96.5 97.1 96.6 85.6<br />

5-9 100.0 98.9 100.0 98.9 99.1 99.0 100.0 100.0 96.1 97.6 92.0<br />

10-14 99.4 100.0 100.0 100.0 98.7 100.0 98.6 100.0 100.0 99.0 88.6<br />

15-19 99.5 99.4 100.0 99.5 99.8 99.8 99.6 100.0 99.2 98.8 91.4<br />

20-29 99.1 99.2 99.3 98.8 98.7 99.2 99.2 98.9 98.9 98.7 98.0<br />

30-39 98.2 98.7 98.5 98.8 98.6 98.5 98.1 98.2 98.5 98.3 97.4<br />

40-49 98.3 98.0 98.3 97.8 98.2 98.1 98.2 97.9 98.2 97.9 97.3<br />

50-59 97.2 97.1 96.9 96.3 97.2 96.4 96.8 97.0 96.8 97.0 96.4<br />

60-64 95.1 95.2 94.7 95.0 95.2 94.3 94.0 95.2 94.7 95.0 94.2<br />

65-69 90.9 91.1 90.0 91.6 90.0 90.3 91.6 91.2 92.3 92.1 92.2<br />

70-79 87.2 88.4 87.7 88.5 87.8 87.2 88.0 89.3 88.2 88.7 89.1<br />

80+ 83.7 84.7 84.5 83.4 83.5 82.6 84.5 83.7 85.8 83.8 83.9<br />

Male 94.9 95.1 94.5 94.2 94.2 93.5 93.7 93.9 93.7 93.7 93.0<br />

Female 95.1 95.6 95.1 94.5 94.3 93.9 94.2 94.4 94.4 94.0 93.6<br />

White 94.5 94.7 93.9 93.3 93.3 92.6 92.9 93.1 93.0 92.6 92.2<br />

Black 96.4 96.6 96.9 96.7 96.2 96.0 96.0 96.2 96.2 96.3 95.4<br />

Other race 94.5 97.1 96.2 95.3 96.6 95.4 96.5 97.3 96.1 96.5 96.3<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 96.6 95.6 95.1 94.5 95.0 94.5 94.8 94.7 94.9 94.9 94.5<br />

Hypertension 95.9 95.0 93.5 93.5 93.0 92.7 92.8 92.5 92.7 92.4 91.6<br />

Glomerulonephritis 98.3 97.7 97.2 97.3 96.7 96.7 96.2 96.1 96.6 95.9 95.3<br />

Other cause 93.2 94.2 94.2 93.4 93.2 92.0 92.7 94.0 92.9 92.8 92.3<br />

All 95.0 95.3 94.8 94.4 94.2 93.7 93.9 94.1 94.0 93.8 93.3<br />

ADJUSTED<br />

0-19 99.0 98.8 99.6 99.3 98.4 99.6 98.1 99.0 97.6 96.9 81.9<br />

20-44 98.8 98.8 98.8 98.8 98.8 98.7 98.5 98.4 98.6 98.4 97.7<br />

45-64 97.2 97.0 96.6 96.2 96.7 96.0 96.1 96.5 96.3 96.5 95.8<br />

65-74 91.1 91.2 89.9 91.4 89.9 89.8 91.0 91.3 91.3 91.6 91.5<br />

75+ 87.5 88.0 87.7 87.2 87.2 86.3 87.0 87.4 87.4 86.5 87.1<br />

Male 94.2 94.1 93.4 93.6 93.5 92.8 93.1 93.4 93.3 93.3 92.7<br />

Female 94.4 94.5 94.0 94.0 93.6 93.3 93.8 94.0 94.0 93.8 93.4<br />

White 93.5 93.5 92.6 92.6 92.6 92.0 92.5 92.8 92.9 92.6 92.3<br />

Black 96.1 95.6 95.9 96.3 95.3 95.1 95.1 95.4 95.3 95.4 94.4<br />

Other race 93.9 96.5 94.9 94.5 95.7 94.2 95.7 96.7 95.2 95.7 95.5<br />

Diabetes 94.9 93.5 93.1 92.5 93.3 92.8 93.3 93.5 93.8 93.9 93.7<br />

Hypertension 94.9 94.3 93.0 93.3 92.9 92.9 93.3 93.2 93.3 93.2 92.7<br />

Glomerulonephritis 97.0 96.1 95.4 95.8 95.1 95.4 94.8 94.7 95.4 94.8 93.9<br />

Other cause 91.9 92.6 92.6 92.7 92.3 91.0 91.8 93.2 92.1 92.0 91.3<br />

All 94.3 94.3 93.7 93.8 93.5 93.0 93.4 93.7 93.6 93.5 93.0<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.2 I.2 (continued)<br />

90-day survival probabilities: incident ESRD patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 96.6 96.7 97.3 95.8 97.0 97.3 97.1 96.0 93.3 97.5 96.6 97.8<br />

5-9 98.4 100.0 99.2 98.7 98.6 97.9 99.2 100.0 98.7 99.4 98.7 98.9<br />

10-14 97.6 100.0 99.6 98.4 99.6 99.6 99.3 100.0 99.7 99.4 99.4 99.7<br />

15-19 98.8 99.6 99.4 98.9 99.8 99.3 99.4 99.3 98.8 99.3 98.5 99.1<br />

20-29 98.5 97.9 98.4 97.9 97.4 98.4 98.2 98.7 98.6 98.4 98.8 98.3<br />

30-39 97.7 97.6 97.3 97.1 97.6 97.3 97.7 97.7 97.9 97.6 97.9 97.8<br />

40-49 98.0 97.6 97.3 97.0 96.8 96.8 96.7 96.9 96.7 97.0 97.0 96.7<br />

50-59 96.7 96.9 96.0 95.7 95.8 95.8 96.0 95.7 95.3 95.7 95.3 95.8<br />

60-64 94.7 94.5 94.5 93.8 93.9 93.8 93.7 93.4 93.9 93.8 93.4 93.9<br />

65-69 92.2 92.5 92.8 92.6 92.7 92.8 92.1 92.3 92.5 91.9 92.3 92.6<br />

70-79 89.5 89.6 89.1 89.6 89.2 89.0 88.5 88.7 88.7 88.9 88.2 88.7<br />

80+ 84.9 85.3 84.7 84.0 83.8 84.3 82.9 82.4 82.4 82.8 82.3 83.0<br />

Male 93.5 93.3 93.2 92.9 92.9 92.7 92.3 92.2 92.2 92.3 91.8 92.2<br />

Female 94.0 94.1 93.5 93.3 93.0 92.9 92.3 92.4 92.1 92.0 91.9 91.8<br />

583<br />

White 92.7 92.7 92.2 92.0 91.8 91.7 91.1 91.1 91.0 91.1 90.8 90.8<br />

Black 95.8 95.6 95.3 95.0 95.0 94.9 94.6 94.4 94.3 94.1 93.8 94.2<br />

Other race 96.5 95.9 95.6 95.3 94.2 94.2 94.2 94.1 93.7 94.6 94.3 95.1<br />

†Hispanic 94.8 94.3 94.1 94.5 94.1 93.8 94.5<br />

†Non-Hispanic 92.5 92.1 92.0 91.8 91.9 91.6 91.7<br />

Diabetes 94.8 94.8 94.3 94.2 93.8 93.8 93.5 93.3 93.1 93.0 92.9 93.2<br />

Hypertension 92.0 92.1 92.0 91.7 91.6 91.9 90.9 90.9 90.7 90.8 90.5 90.7<br />

Glomerulonephritis 96.2 96.3 96.0 95.5 96.1 95.7 95.5 95.1 95.3 95.9 95.7 96.0<br />

Other cause 92.9 92.4 91.9 91.2 91.1 90.2 89.8 90.4 90.2 90.4 89.8 89.7<br />

All 93.7 93.7 93.3 93.1 92.9 92.8 92.3 92.3 92.1 92.2 91.9 92.1<br />

ADJUSTED<br />

0-19 96.3 98.7 98.2 96.7 98.5 97.8 98.1 98.1 96.6 98.1 97.0 98.2<br />

20-44 98.1 97.9 97.8 97.5 97.5 97.6 97.8 97.9 97.9 97.9 98.0 97.9<br />

45-64 96.2 96.2 95.7 95.3 95.3 95.3 95.3 95.1 95.1 95.3 95.0 95.3<br />

65-74 91.5 91.8 91.9 92.0 91.6 91.6 91.1 91.3 91.4 91.2 91.0 91.4<br />

75+ 87.9 87.8 87.0 86.8 86.7 86.8 85.8 85.6 85.7 85.9 85.4 85.9<br />

Male 93.3 93.2 93.1 92.8 92.9 92.9 92.7 92.6 92.7 92.9 92.4 92.9<br />

Female 93.9 94.1 93.5 93.3 93.1 93.2 92.8 92.8 92.7 92.7 92.7 92.7<br />

White 92.9 93.1 92.7 92.6 92.5 92.6 92.2 92.2 92.3 92.4 92.2 92.4<br />

Black 94.9 94.7 94.4 94.0 94.1 94.0 93.8 93.6 93.5 93.4 93.1 93.5<br />

Other race 95.9 95.2 94.9 94.6 93.7 93.7 93.7 93.6 93.4 94.2 93.9 94.9<br />

Diabetes 94.1 94.2 93.8 93.8 93.4 93.6 93.4 93.2 93.2 93.2 93.1 93.5<br />

Hypertension 93.1 93.2 93.3 93.0 93.0 93.4 92.7 92.7 92.7 92.8 92.5 92.8<br />

Glomerulonephritis 95.2 95.3 94.9 94.6 95.3 94.9 94.6 94.2 94.6 95.2 94.7 95.2<br />

Other cause 92.1 91.7 90.9 90.3 90.3 89.7 89.5 90.0 90.0 90.2 89.6 89.6<br />

All 93.6 93.6 93.3 93.1 93.0 93.0 92.7 92.7 92.7 92.8 92.5 92.8<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.3 I.3<br />

One-year survival probabilities: incident ESRD patients<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

one<br />

one<br />

year<br />

year<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

584<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 93.5 92.4 89.8 89.6 86.9 89.6 90.8 90.5 81.5 84.7 84.8<br />

5-9 93.6 94.7 95.2 97.7 95.4 95.0 98.4 99.1 99.0 96.8 97.1<br />

10-14 97.7 97.8 98.6 98.1 97.3 97.6 99.5 98.6 95.5 95.9 96.3<br />

15-19 96.5 95.9 96.3 95.0 96.7 95.8 95.8 96.6 98.0 98.6 97.5<br />

20-29 91.9 93.4 93.7 93.6 93.7 92.4 94.4 92.4 93.1 92.9 92.7<br />

30-39 89.7 89.0 89.2 90.3 88.8 89.4 89.7 89.3 89.9 89.6 90.3<br />

40-49 88.1 87.5 87.0 87.7 88.3 88.0 87.7 88.1 88.8 88.6 89.0<br />

50-59 83.9 83.4 84.1 81.8 82.0 82.3 82.8 83.6 83.9 83.6 84.4<br />

60-64 78.6 77.9 78.3 77.8 76.2 76.6 77.4 76.6 77.2 78.0 78.5<br />

65-69 72.8 73.6 74.0 72.1 73.0 71.4 73.1 73.1 73.5 74.1 75.6<br />

70-79 67.1 68.2 68.6 65.3 66.6 67.0 66.2 65.4 66.2 67.5 68.5<br />

80+ 57.9 53.6 62.0 54.9 56.2 58.0 58.6 55.3 55.7 58.0 59.6<br />

Male 81.5 82.0 81.8 79.3 79.3 78.9 78.7 78.5 78.4 78.8 79.6<br />

Female 82.3 81.6 82.1 79.7 80.0 79.5 79.9 78.5 79.6 79.2 79.5<br />

White 80.4 80.3 80.4 77.6 77.5 77.2 77.2 76.1 76.4 76.7 77.1<br />

Black 85.3 85.6 85.3 83.3 84.1 83.2 83.3 83.5 83.8 83.2 83.8<br />

Other race 82.3 81.8 86.0 83.6 83.0 83.9 86.0 82.1 84.6 85.9 86.9<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 76.2 74.8 74.3 74.8 74.9 74.3 75.6 75.3 76.8 77.2 77.1<br />

Hypertension 84.4 82.4 81.1 79.0 78.2 79.1 77.9 76.7 77.0 77.1 78.0<br />

Glomerulonephritis 91.4 89.7 89.4 88.4 87.9 88.1 86.9 86.7 87.2 86.8 87.5<br />

Other cause 79.6 81.4 83.7 78.4 80.2 78.7 80.2 79.3 78.8 79.1 80.5<br />

All 81.8 81.8 81.9 79.5 79.6 79.2 79.3 78.5 79.0 79.0 79.5<br />

ADJUSTED<br />

0-19 92.9 92.4 92.5 91.3 91.6 91.3 93.2 93.5 91.3 92.6 92.1<br />

20-44 88.2 88.5 88.9 89.5 89.1 89.0 89.5 89.0 89.7 89.3 89.9<br />

45-64 80.4 80.2 81.1 80.1 80.0 80.3 81.2 81.4 82.0 82.7 83.3<br />

65-74 70.0 70.8 72.4 69.1 70.3 69.4 70.3 70.4 71.2 72.0 73.5<br />

75+ 61.1 62.2 62.1 58.8 61.0 62.3 62.0 59.4 60.2 62.5 63.5<br />

Male 73.9 74.5 74.9 73.3 73.5 73.7 74.2 74.2 74.5 75.6 76.9<br />

Female 75.4 75.2 76.7 75.3 76.0 75.9 77.1 76.2 77.4 77.8 78.5<br />

White 71.8 72.0 73.2 71.6 72.0 72.3 73.1 72.7 73.6 74.8 75.7<br />

Black 80.8 80.5 80.5 79.2 79.9 79.2 79.8 80.0 80.2 79.8 80.9<br />

Other race 74.1 75.3 78.4 77.6 77.0 79.4 82.4 77.9 81.3 83.1 84.8<br />

Diabetes 69.7 68.4 68.6 69.6 70.1 69.9 71.8 71.9 73.9 74.8 75.2<br />

Hypertension 81.4 80.2 79.6 78.3 77.7 79.3 78.9 78.0 78.3 79.0 80.1<br />

Glomerulonephritis 84.6 82.7 82.7 82.1 82.0 83.0 81.5 81.3 82.1 82.4 83.3<br />

Other cause 75.3 75.9 78.8 75.6 76.6 74.9 76.7 76.1 75.3 75.9 77.1<br />

All 74.6 74.8 75.7 74.2 74.7 74.8 75.6 75.2 75.9 76.7 77.7<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

TTable Table I.3 (continued)<br />

One-year survival probabilities: incident ESRD patients<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

one<br />

one<br />

year<br />

year<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 81.9 89.0 86.6 88.4 88.3 91.6 89.9 88.6 87.4 84.4 88.9 90.1<br />

5-9 98.4 97.6 95.4 100.0 97.2 95.7 96.2 100.0 96.1 96.7 98.0 93.8<br />

10-14 97.5 94.7 95.8 99.2 97.4 97.0 97.8 97.8 98.0 97.4 98.0 97.0<br />

15-19 96.2 96.4 97.1 95.9 97.5 96.9 98.3 96.4 97.8 97.9 97.9 97.7<br />

20-29 93.0 93.9 93.3 92.8 92.7 94.3 95.4 95.1 95.4 93.9 95.0 94.0<br />

30-39 89.7 90.0 89.4 89.9 88.7 90.3 91.1 91.3 91.0 91.1 91.5 91.8<br />

40-49 88.0 88.3 88.9 88.5 89.2 89.6 90.2 89.1 89.6 89.7 89.2 89.0<br />

50-59 84.3 85.3 85.1 85.9 85.8 85.5 85.9 85.6 86.1 85.6 86.0 85.9<br />

60-64 79.4 79.4 81.0 80.8 80.2 81.8 81.9 80.2 81.2 80.9 81.7 81.1<br />

65-69 75.2 75.6 77.2 76.4 77.1 77.9 76.9 76.4 76.6 77.2 76.9 76.9<br />

70-79 68.2 68.5 70.0 70.1 70.3 70.9 69.8 70.0 69.6 69.5 69.8 69.6<br />

80+ 59.3 58.5 61.0 61.0 60.3 60.2 59.5 57.5 58.5 57.9 57.9 58.9<br />

Male 79.1 78.9 80.2 79.8 79.6 80.1 79.8 79.2 79.4 79.0 79.3 78.8<br />

Female 79.0 79.3 79.6 79.6 79.6 79.6 78.9 78.1 78.0 77.8 77.8 77.5<br />

585<br />

White 76.4 76.4 77.5 77.4 77.4 77.6 76.7 76.4 76.6 76.3 76.2 75.9<br />

Black 83.5 84.0 83.9 83.6 83.1 83.9 83.9 82.7 82.6 82.0 82.6 82.0<br />

Other race 87.6 86.4 87.3 86.2 84.5 83.4 84.5 83.1 83.4 84.2 85.3 84.5<br />

†Hispanic 83.8 83.1 83.4 83.2 84.4 83.9 83.0<br />

†Non-Hispanic 79.4 78.9 78.1 78.2 77.6 77.9 77.5<br />

Diabetes 77.6 77.7 79.3 79.0 78.8 79.0 78.4 77.7 78.3 78.2 78.4 78.1<br />

Hypertension 77.2 77.4 77.7 77.9 78.6 78.5 77.5 77.0 76.8 76.7 76.6 76.6<br />

Glomerulonephritis 86.1 87.5 88.6 87.0 87.6 88.3 88.5 88.5 87.6 88.1 88.3 88.0<br />

Other cause 79.7 79.2 79.0 79.4 77.9 78.4 78.9 78.1 77.9 76.8 77.2 76.1<br />

All 79.0 79.1 79.9 79.7 79.6 79.9 79.4 78.7 78.8 78.5 78.6 78.2<br />

ADJUSTED<br />

0-19 89.9 91.4 91.0 93.4 93.1 92.8 94.1 93.0 93.3 92.0 93.7 92.7<br />

20-44 89.4 89.6 89.3 89.6 89.2 90.6 91.2 90.9 91.0 90.8 91.1 90.9<br />

45-64 83.6 84.3 84.9 85.2 85.2 85.6 86.1 85.2 85.9 85.6 85.9 85.6<br />

65-74 73.2 73.7 75.6 74.7 75.5 76.3 75.4 75.3 75.5 75.6 75.6 75.2<br />

75+ 63.5 63.0 64.3 65.1 64.5 65.0 64.0 63.3 63.4 63.2 63.4 63.9<br />

Male 76.8 77.0 78.6 78.5 78.4 79.5 79.6 79.2 79.7 79.4 79.7 79.6<br />

Female 78.4 79.1 79.5 79.8 80.0 80.3 80.0 79.3 79.4 79.5 79.6 79.5<br />

White 75.6 76.1 77.5 77.8 78.1 78.8 78.4 78.2 78.6 78.6 78.6 78.6<br />

Black 80.9 81.4 81.3 81.1 80.9 82.0 82.3 81.1 81.0 80.5 81.2 80.8<br />

Other race 85.8 84.9 86.0 85.1 84.0 83.5 84.6 83.1 83.8 84.4 85.3 84.8<br />

Diabetes 76.0 76.5 78.2 78.2 78.2 78.8 78.4 77.8 78.6 78.7 78.9 78.8<br />

Hypertension 79.6 79.7 80.4 80.5 81.3 81.6 81.0 80.6 80.6 80.6 80.5 80.8<br />

Glomerulonephritis 82.0 83.7 85.0 83.6 84.1 85.5 85.5 85.5 84.9 85.3 85.1 85.2<br />

Other cause 76.4 76.2 75.7 76.4 75.3 76.0 77.0 76.0 76.1 75.0 75.5 74.7<br />

All 77.6 78.0 79.0 79.1 79.2 79.9 79.8 79.3 79.6 79.5 79.7 79.6<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.4 I.4<br />

Two-year survival probabilities: incident ESRD patients<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

two<br />

two<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

586<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 87.0 90.9 85.7 83.0 85.0 82.8 84.7 86.1 77.0 80.6 80.0<br />

5-9 92.6 91.5 93.3 94.3 93.5 94.1 94.3 97.3 97.0 96.0 94.2<br />

10-14 95.5 95.1 96.8 97.1 95.5 95.3 96.1 98.2 93.6 93.9 94.0<br />

15-19 95.1 92.9 93.4 92.7 93.9 93.8 93.1 95.1 95.2 96.7 95.5<br />

20-29 86.4 87.7 88.8 87.5 88.2 86.8 89.0 86.2 88.4 88.6 87.7<br />

30-39 80.8 81.3 80.7 82.6 80.3 80.7 81.1 81.3 82.7 82.2 82.4<br />

40-49 77.4 77.1 76.8 76.5 77.8 78.1 77.4 78.1 79.1 78.4 80.0<br />

50-59 70.9 70.7 71.0 68.6 67.9 68.1 68.7 69.3 69.7 70.7 70.9<br />

60-64 63.9 62.1 62.0 62.1 59.5 59.3 61.1 60.0 61.2 61.9 62.3<br />

65-69 55.0 56.0 55.9 52.4 55.4 53.1 53.9 55.4 56.2 56.2 56.7<br />

70-79 47.0 49.1 49.5 44.4 46.7 47.0 46.4 45.7 46.7 47.9 48.0<br />

80+ 30.9 33.4 37.8 30.4 36.6 35.8 35.1 32.9 33.3 37.7 37.0<br />

Male 68.0 69.2 68.8 65.0 65.4 64.0 64.5 63.8 64.5 64.7 64.8<br />

Female 70.0 69.3 69.0 65.4 66.1 65.9 65.1 64.5 65.3 65.2 64.8<br />

White 67.0 67.3 66.9 62.8 63.0 62.4 62.1 61.2 61.2 61.5 61.2<br />

Black 73.4 74.0 73.3 70.1 71.3 70.0 70.3 70.0 71.9 71.0 71.2<br />

Other race 71.5 68.2 74.9 72.1 71.2 69.8 71.7 69.9 72.3 74.8 75.6<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 59.0 57.7 56.1 57.7 56.0 56.3 57.1 57.4 59.1 60.1 59.2<br />

Hypertension 72.4 69.5 68.0 64.1 65.0 64.1 62.7 61.6 62.7 62.7 62.3<br />

Glomerulonephritis 83.3 81.3 80.8 79.2 79.0 77.7 76.8 76.8 78.0 76.9 78.1<br />

Other cause 66.1 69.3 71.8 64.0 67.4 66.6 68.1 67.2 66.7 67.8 69.2<br />

All 68.9 69.2 68.9 65.2 65.7 64.9 64.8 64.1 64.9 64.9 64.8<br />

ADJUSTED<br />

0-19 89.6 87.5 88.0 86.8 87.6 86.6 87.3 90.6 86.8 89.1 87.8<br />

20-44 78.1 79.7 80.2 80.6 80.3 80.2 81.0 80.3 82.0 81.8 82.1<br />

45-64 66.1 65.6 66.4 65.4 64.9 65.2 66.4 66.6 67.7 69.1 69.6<br />

65-74 50.5 52.4 53.6 48.6 51.8 50.4 51.0 52.0 53.3 53.7 54.2<br />

75+ 38.9 41.8 40.4 36.1 40.3 41.0 40.2 38.2 38.9 42.2 41.8<br />

Male 56.8 58.3 58.5 56.3 57.2 56.6 58.0 57.6 58.9 60.3 60.9<br />

Female 60.0 60.0 61.1 59.0 60.4 60.8 60.9 61.3 62.2 63.2 63.4<br />

White 54.7 55.8 56.6 54.3 55.5 55.7 56.2 56.5 57.3 59.1 59.3<br />

Black 66.1 65.9 65.6 63.7 64.7 63.8 64.9 64.6 66.4 65.9 66.6<br />

Other race 59.9 58.5 62.6 62.4 62.2 62.6 65.3 63.5 66.9 70.5 72.0<br />

Diabetes 50.5 49.6 48.9 51.0 50.0 50.6 52.1 53.1 55.3 56.9 56.7<br />

Hypertension 67.6 66.2 65.8 63.2 64.4 64.6 64.3 63.6 64.6 65.4 65.5<br />

Glomerulonephritis 71.0 69.8 70.0 68.9 69.6 69.0 68.2 68.3 70.0 69.7 71.1<br />

Other cause 60.1 61.6 64.4 59.8 62.2 61.2 63.1 62.5 61.8 63.3 64.4<br />

All 58.3 59.1 59.8 57.6 58.7 58.6 59.4 59.4 60.5 61.7 62.1<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.4 I.4 (continued)<br />

Two-year survival probabilities: incident ESRD patients<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

two<br />

two<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />

0-4 79.5 86.2 81.0 82.6 84.0 87.6 86.4 84.9 85.0 79.2 85.3<br />

5-9 97.6 97.6 91.6 97.5 96.5 95.0 95.4 97.8 94.2 96.1 96.7<br />

10-14 96.3 92.7 93.3 98.4 95.6 95.9 96.0 96.3 97.3 96.4 96.1<br />

15-19 93.5 95.1 94.2 94.6 95.8 93.4 95.3 94.4 95.3 94.7 95.8<br />

20-29 87.7 88.8 89.1 88.7 88.1 90.2 90.9 91.4 91.4 89.4 90.6<br />

30-39 81.4 82.3 82.3 81.9 82.1 83.1 84.4 84.4 84.7 84.9 85.4<br />

40-49 77.8 79.2 79.1 79.3 80.3 80.3 81.5 80.8 80.8 80.9 81.0<br />

50-59 71.3 72.4 72.7 73.9 73.3 73.6 74.0 73.2 74.3 74.2 74.6<br />

60-64 63.1 63.4 65.5 65.8 64.9 67.0 67.0 65.5 67.1 67.2 68.0<br />

65-69 56.9 58.3 60.1 58.9 59.8 61.1 59.5 59.5 59.9 61.3 62.6<br />

70-79 48.3 49.1 50.0 50.4 50.8 51.8 50.0 51.1 51.1 50.8 51.9<br />

80+ 36.1 36.9 37.6 38.5 38.5 38.3 37.1 37.1 37.4 37.3 37.8<br />

Male 64.2 64.6 65.9 65.6 65.8 66.0 65.4 65.3 65.5 65.5 66.0<br />

Female 64.0 64.9 64.8 65.0 64.8 65.1 63.9 63.6 63.7 63.3 64.2<br />

587<br />

White 60.4 60.9 61.6 61.6 61.7 61.8 60.7 61.0 61.3 61.2 61.6<br />

Black 70.3 71.5 71.6 71.6 71.3 72.3 71.7 70.5 70.3 70.0 71.0<br />

Other race 77.1 75.6 76.5 74.3 72.2 71.2 72.2 71.1 72.3 72.6 74.9<br />

†Hispanic 70.6 70.0 70.6 71.3 73.3 72.3<br />

†Non-Hispanic 64.9 64.0 63.7 63.8 63.2 64.2<br />

Diabetes 59.9 60.6 62.1 61.9 61.9 62.3 61.5 61.2 62.1 62.3 63.1<br />

Hypertension 61.7 62.6 62.5 63.3 64.0 64.0 62.4 62.3 62.1 62.0 62.5<br />

Glomerulonephritis 75.8 77.8 79.0 77.5 78.3 78.9 79.1 79.8 78.7 79.4 80.4<br />

Other cause 68.0 67.9 67.9 68.0 66.5 66.8 67.1 66.6 66.7 65.4 66.5<br />

All 64.1 64.8 65.4 65.3 65.3 65.6 64.7 64.5 64.7 64.5 65.2<br />

ADJUSTED<br />

0-19 86.5 88.9 85.6 90.1 89.7 88.4 89.9 89.5 90.1 87.7 90.0<br />

20-44 80.9 81.7 81.6 82.0 82.1 83.2 84.5 83.9 84.2 84.1 84.3<br />

45-64 70.0 71.1 72.2 73.0 72.8 73.6 74.1 73.3 74.3 74.4 74.9<br />

65-74 54.6 56.0 57.3 56.7 58.0 58.9 57.5 58.2 58.6 59.0 60.4<br />

75+ 41.8 42.2 43.2 43.9 43.4 44.6 42.9 43.5 43.7 43.6 44.2<br />

Male 61.0 61.9 63.6 63.8 64.1 65.2 65.1 65.3 66.0 66.2 66.7<br />

Female 63.4 64.6 64.8 65.4 65.5 66.4 65.8 65.6 65.9 65.9 66.9<br />

White 59.5 60.6 61.8 62.4 62.9 63.8 63.3 63.8 64.5 64.7 65.2<br />

Black 66.3 67.5 67.8 68.0 68.0 69.3 69.1 68.1 67.8 67.9 69.0<br />

Other race 74.0 73.2 74.3 72.5 71.6 71.3 72.5 71.1 73.0 73.0 75.0<br />

Diabetes 57.9 59.0 60.8 60.9 61.2 62.3 61.8 61.7 62.9 63.3 64.1<br />

Hypertension 65.4 66.1 66.5 67.4 68.1 68.7 67.6 67.8 67.7 67.9 68.2<br />

Glomerulonephritis 69.3 71.4 72.7 72.0 72.5 74.1 74.0 74.8 74.2 74.7 75.2<br />

Other cause 63.3 63.7 63.4 63.8 63.0 63.6 64.3 63.7 64.0 63.0 64.0<br />

All 62.2 63.3 64.2 64.6 64.8 65.8 65.5 65.5 66.0 66.1 66.8<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.5 I.5<br />

Three-year survival probabilities: incident ESRD patients<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

three<br />

three<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

588<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 84.8 89.4 84.7 80.2 82.2 82.1 80.9 82.5 74.8 78.5 79.2<br />

5-9 92.6 90.4 92.4 92.0 91.7 92.1 93.4 95.5 96.0 96.0 92.0<br />

10-14 94.4 90.3 93.7 94.8 93.7 93.4 94.7 96.3 92.3 92.9 93.1<br />

15-19 92.7 91.0 92.1 91.8 92.2 91.2 91.2 92.9 93.4 93.8 93.6<br />

20-29 82.2 83.4 84.6 83.9 84.0 82.9 84.5 82.5 85.2 84.8 83.8<br />

30-39 76.0 75.4 73.3 76.1 74.2 74.6 75.4 74.8 77.0 76.5 76.7<br />

40-49 69.1 69.2 68.9 67.9 69.6 70.0 69.1 70.3 71.4 70.2 71.5<br />

50-59 60.5 60.0 59.2 57.3 57.1 56.2 57.3 58.7 58.9 59.6 60.0<br />

60-64 51.9 50.0 48.7 49.3 46.8 46.8 47.2 47.4 49.1 49.2 49.5<br />

65-69 40.5 43.1 42.3 38.3 41.6 39.9 40.2 41.5 42.9 42.1 42.3<br />

70-79 33.6 34.3 35.0 30.0 32.5 32.6 31.9 32.0 33.1 33.9 33.3<br />

80+ 18.7 20.7 18.9 18.2 21.3 21.8 20.9 21.5 20.1 23.0 22.3<br />

Male 58.6 59.4 58.4 54.5 55.2 53.2 53.4 53.4 54.1 54.2 53.8<br />

Female 60.2 59.7 58.3 54.8 55.3 55.4 54.3 53.9 55.0 53.8 53.3<br />

White 57.4 57.4 56.5 52.1 52.7 51.7 51.1 50.5 50.5 50.3 49.5<br />

Black 63.8 64.9 62.3 59.5 60.6 59.4 59.4 60.0 62.3 60.7 60.7<br />

Other race 62.9 57.4 65.2 63.2 60.5 60.0 61.2 60.3 63.0 65.2 66.6<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 46.6 45.9 43.3 44.3 43.6 43.6 44.4 44.9 46.5 46.6 46.0<br />

Hypertension 62.9 59.2 56.3 53.3 53.1 53.0 51.1 50.3 51.9 51.5 50.8<br />

Glomerulonephritis 77.1 74.2 73.3 72.3 71.4 68.6 68.3 68.8 70.4 68.7 69.7<br />

Other cause 56.3 59.7 62.1 53.5 58.2 57.5 58.3 58.5 58.2 59.2 59.9<br />

All 59.3 59.5 58.3 54.6 55.3 54.2 53.8 53.6 54.5 54.0 53.6<br />

ADJUSTED<br />

0-19 86.7 83.4 85.1 84.1 84.5 83.3 84.1 86.9 84.2 85.8 85.4<br />

20-44 72.0 73.1 72.9 73.9 74.1 73.8 74.8 74.0 76.0 75.8 76.0<br />

45-64 54.5 54.2 54.2 53.4 53.2 53.4 54.2 55.5 56.8 57.7 58.3<br />

65-74 36.4 38.6 38.9 34.1 38.1 36.8 36.6 38.0 39.8 39.6 39.8<br />

75+ 25.3 27.5 25.9 22.8 24.9 26.2 26.3 25.6 25.3 28.1 26.9<br />

Male 45.9 46.8 46.6 44.5 45.9 45.0 46.0 46.6 47.8 49.2 49.3<br />

Female 48.7 49.0 49.0 47.6 48.9 49.7 49.6 50.2 51.4 51.6 51.7<br />

White 43.7 44.4 44.8 42.7 44.4 44.3 44.6 45.3 46.1 47.6 47.5<br />

Black 54.8 55.1 52.8 51.8 52.6 52.0 53.0 53.6 55.8 54.6 55.2<br />

Other race 49.5 46.5 49.9 51.4 49.3 51.3 53.2 52.6 56.4 59.8 62.0<br />

Diabetes 38.1 37.7 36.1 37.5 37.7 38.2 39.4 40.8 42.6 43.5 43.6<br />

Hypertension 57.0 55.4 53.9 52.4 52.6 53.7 53.1 52.8 54.2 54.8 54.7<br />

Glomerulonephritis 61.5 59.6 59.5 59.7 59.7 57.5 57.6 58.3 60.5 59.6 60.6<br />

Other cause 49.5 50.9 53.1 48.6 52.1 51.2 52.5 52.9 52.5 54.0 54.0<br />

All 47.2 47.9 47.7 46.0 47.3 47.2 47.7 48.3 49.5 50.3 50.5<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.5 I.5 (continued)<br />

Three-year survival probabilities: incident ESRD patients<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

three<br />

three<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />

0-4 77.8 83.4 77.7 81.9 82.7 84.3 82.8 84.3 83.2 75.5<br />

5-9 97.6 96.8 90.1 96.2 95.1 90.7 95.4 97.1 93.5 94.1<br />

10-14 94.2 90.6 91.3 95.7 94.9 94.4 95.0 96.3 96.6 95.4<br />

15-19 92.3 93.5 92.3 93.2 93.3 91.5 92.6 92.3 92.6 93.1<br />

20-29 84.2 85.2 85.3 85.1 84.2 87.0 87.8 88.1 87.4 85.8<br />

30-39 75.5 75.8 76.6 76.5 76.5 77.9 78.9 79.2 79.2 79.9<br />

40-49 69.8 71.1 71.0 71.6 72.4 72.5 73.8 72.8 73.4 73.2<br />

50-59 60.2 60.6 61.7 62.6 62.6 62.8 63.8 63.4 64.2 64.6<br />

60-64 50.4 50.3 52.2 53.1 52.4 53.8 55.1 53.9 54.7 55.7<br />

65-69 42.9 43.8 45.7 45.3 46.3 46.6 46.2 46.4 46.9 48.5<br />

70-79 34.2 34.1 35.7 35.4 36.0 37.1 35.8 36.6 36.9 37.3<br />

80+ 21.9 22.8 23.1 23.3 23.3 24.4 23.1 22.4 23.1 23.9<br />

Male 53.5 53.0 54.6 54.4 54.9 54.8 54.4 54.4 54.5 54.8<br />

Female 52.5 53.2 53.3 53.2 53.0 53.2 52.8 52.2 52.3 52.5<br />

589<br />

White 48.9 48.7 49.7 49.4 49.8 49.6 49.1 49.4 49.5 49.8<br />

Black 60.0 60.7 61.1 61.2 61.1 62.0 61.6 60.1 60.2 60.5<br />

Other race 67.4 65.4 66.0 64.9 61.3 60.6 61.3 61.1 62.4 63.1<br />

†Hispanic 59.6 59.7 60.6 60.8 63.7<br />

†Non-Hispanic 53.3 52.8 52.4 52.5 52.3<br />

Diabetes 46.5 47.0 48.3 48.6 48.4 48.8 48.6 48.3 49.1 49.7<br />

Hypertension 50.2 50.5 50.9 51.0 52.3 52.4 51.0 50.9 50.7 51.1<br />

Glomerulonephritis 68.1 69.3 71.1 69.8 70.3 70.7 71.9 72.1 70.8 72.4<br />

Other cause 59.7 58.8 59.4 59.3 58.2 58.1 58.6 58.2 58.4 57.4<br />

All 53.0 53.1 54.0 53.8 54.0 54.1 53.6 53.4 53.5 53.7<br />

ADJUSTED<br />

0-19 84.3 86.1 82.3 87.5 86.9 84.7 86.6 87.6 87.2 84.7<br />

20-44 75.0 75.5 75.6 76.1 76.0 77.7 78.8 78.3 78.3 78.3<br />

45-64 58.9 59.5 61.0 62.1 62.2 62.8 64.1 63.4 64.3 64.9<br />

65-74 40.5 41.5 43.0 42.5 44.1 44.8 43.9 44.6 45.4 46.2<br />

75+ 27.8 27.4 28.7 28.9 28.4 29.8 28.8 28.9 29.3 30.0<br />

Male 49.9 49.9 52.0 52.3 52.9 53.9 54.1 54.4 55.1 55.7<br />

Female 52.0 53.0 53.4 53.9 54.1 54.9 55.0 54.7 55.0 55.7<br />

White 48.0 48.6 50.1 50.6 51.3 52.2 52.3 52.8 53.4 54.0<br />

Black 55.2 55.9 56.6 56.9 57.1 58.3 58.5 57.2 57.3 58.0<br />

Other race 63.4 62.4 63.2 62.7 60.6 60.7 61.7 61.0 63.3 63.7<br />

Diabetes 44.6 45.6 47.3 47.9 48.1 49.1 49.3 49.2 50.3 51.2<br />

Hypertension 54.7 54.8 55.7 56.0 57.2 58.0 57.1 57.3 57.4 57.9<br />

Glomerulonephritis 60.1 61.1 63.0 62.8 63.0 64.2 65.2 65.4 64.8 66.3<br />

Other cause 54.1 53.7 54.2 54.4 54.0 54.2 55.2 54.7 55.1 54.5<br />

All 50.9 51.4 52.7 53.1 53.5 54.4 54.6 54.6 55.1 55.7<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.6 I.6<br />

Five-year survival probabilities: incident ESRD patients<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

five<br />

five<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

590<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 80.4 80.3 80.6 77.4 76.6 79.1 76.3 78.1 74.1 77.1 76.0<br />

5-9 88.3 88.3 86.7 89.7 89.8 90.1 90.2 95.5 93.9 91.9 89.1<br />

10-14 88.1 85.4 91.4 91.4 91.0 90.6 91.8 95.4 89.5 88.3 88.5<br />

15-19 89.9 87.4 87.9 89.0 86.8 85.2 87.6 88.5 88.3 89.3 89.8<br />

20-29 77.5 76.3 78.6 76.3 76.5 75.9 78.8 76.9 78.7 77.8 77.7<br />

30-39 65.3 65.9 64.5 65.7 65.2 64.9 66.4 64.1 67.8 68.1 67.6<br />

40-49 56.0 55.5 55.7 53.8 57.0 56.7 57.3 58.2 58.7 57.4 58.1<br />

50-59 42.4 43.2 41.9 40.6 40.3 40.0 41.7 43.2 42.1 42.2 42.2<br />

60-64 32.0 32.2 30.4 30.3 28.0 28.6 30.2 29.2 31.1 30.7 31.4<br />

65-69 23.6 25.2 24.4 20.9 22.7 22.8 22.3 23.4 23.7 23.9 23.7<br />

70-79 16.1 16.4 17.5 14.1 15.5 15.8 15.1 15.8 15.9 16.5 15.9<br />

80+ 7.5 6.5 6.5 6.4 7.5 8.0 7.6 7.7 7.1 9.1 9.0<br />

Male 44.7 44.6 44.2 40.1 40.5 39.4 40.1 39.5 39.9 39.8 39.2<br />

Female 45.0 45.8 44.0 40.1 40.7 40.2 39.7 39.0 39.4 38.0 37.3<br />

White 43.5 43.0 42.5 38.1 38.6 38.0 37.8 36.6 36.1 35.7 34.8<br />

Black 48.1 50.3 47.0 43.5 44.6 43.0 43.7 44.0 46.1 44.4 44.5<br />

Other race 46.8 46.5 54.6 51.4 47.5 47.8 49.5 50.2 50.2 52.2 50.4<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 32.2 29.8 27.4 28.0 27.5 27.5 29.3 28.4 29.8 29.4 28.5<br />

Hypertension 48.5 43.6 41.0 37.6 37.7 37.2 35.7 35.0 36.4 35.4 35.3<br />

Glomerulonephritis 66.3 63.4 61.8 59.3 58.1 55.9 56.7 57.0 58.0 57.3 57.4<br />

Other cause 40.6 45.3 48.2 40.3 44.8 45.0 45.8 46.3 45.0 46.8 47.1<br />

All 44.9 45.1 44.1 40.1 40.6 39.8 39.9 39.3 39.7 39.0 38.3<br />

ADJUSTED<br />

0-19 80.9 77.4 79.4 80.1 78.3 77.1 79.2 82.4 79.3 80.2 80.0<br />

20-44 61.5 62.4 62.9 62.4 64.0 63.6 65.6 64.0 65.9 66.6 66.6<br />

45-64 36.1 36.8 36.9 36.1 36.1 36.4 38.5 39.2 40.2 40.5 40.7<br />

65-74 19.2 20.8 21.0 17.4 19.4 19.8 19.1 20.6 21.2 21.6 21.6<br />

75+ 10.8 11.0 11.0 8.9 10.5 11.1 10.9 10.7 10.4 12.2 11.2<br />

Male 31.3 31.3 31.8 29.8 30.9 31.1 32.4 32.5 33.3 34.6 34.4<br />

Female 32.8 34.5 34.2 32.7 34.0 34.2 34.7 35.2 35.6 35.7 35.7<br />

White 29.5 29.6 30.5 28.6 30.0 30.5 31.1 31.3 31.8 33.1 32.6<br />

Black 37.6 38.9 36.4 34.9 35.9 35.1 36.7 37.2 38.6 37.6 38.3<br />

Other race 32.4 35.3 37.5 38.0 35.1 38.1 40.1 41.4 42.1 45.5 44.2<br />

Diabetes 24.8 23.0 21.9 22.7 22.8 23.4 25.2 25.3 26.7 27.0 26.8<br />

Hypertension 42.1 39.4 38.8 37.1 37.4 38.1 37.7 38.0 38.9 39.0 39.4<br />

Glomerulonephritis 46.6 45.8 44.9 43.8 43.9 42.5 44.0 44.4 45.7 46.2 45.9<br />

Other cause 33.6 35.9 38.2 34.5 37.8 37.8 39.0 39.7 38.4 40.7 40.1<br />

All 32.0 32.8 32.9 31.2 32.3 32.6 33.5 33.8 34.4 35.1 35.0<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.6 I.6 (continued)<br />

Five-year survival probabilities: incident ESRD patients<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

five<br />

five<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998<br />

0-4 76.6 81.4 75.4 79.7 79.0 82.0 79.9 80.7<br />

5-9 95.1 93.5 87.8 94.9 93.8 90.0 95.4 94.9<br />

10-14 91.7 87.8 88.3 92.9 93.4 92.9 92.4 92.6<br />

15-19 87.7 90.9 88.7 90.3 90.3 88.0 89.6 88.3<br />

20-29 78.4 78.8 79.7 79.8 78.8 81.4 82.0 81.8<br />

30-39 66.3 66.5 67.8 67.4 67.8 68.6 70.1 70.2<br />

40-49 56.9 58.6 58.6 58.6 59.9 59.2 60.7 60.0<br />

50-59 43.7 43.4 44.9 45.5 45.5 45.5 46.9 46.7<br />

60-64 31.1 32.1 33.3 33.9 33.3 34.7 36.1 35.6<br />

65-69 22.9 24.7 25.2 26.1 25.9 26.6 26.0 27.3<br />

70-79 16.3 16.1 16.9 16.8 17.5 18.2 17.5 18.4<br />

80+ 7.9 7.7 8.1 8.4 8.9 8.8 8.4 8.4<br />

Male 38.5 38.2 39.4 39.0 39.7 39.2 38.7 39.0<br />

Female 36.4 36.9 36.8 36.9 36.4 36.2 36.2 36.1<br />

591<br />

White 33.9 33.8 34.3 33.9 34.0 33.6 33.2 33.8<br />

Black 43.5 44.1 44.5 44.6 45.2 45.3 45.0 43.9<br />

Other race 51.5 49.2 50.2 49.1 44.8 44.2 46.4 46.1<br />

†Hispanic 43.3 43.4 44.6<br />

†Non-Hispanic 37.1 36.8 36.8<br />

Diabetes 28.7 29.2 30.0 30.3 29.9 29.9 30.0 30.2<br />

Hypertension 33.9 34.5 34.5 34.5 36.0 35.7 34.9 34.7<br />

Glomerulonephritis 55.9 57.0 58.8 57.4 58.3 58.2 59.3 60.2<br />

Other cause 47.3 46.5 47.5 47.6 46.4 46.1 46.6 46.7<br />

All 37.5 37.6 38.2 38.0 38.1 37.8 37.6 37.7<br />

ADJUSTED<br />

0-19 79.8 82.4 78.2 83.9 83.4 81.4 83.2 82.5<br />

20-44 65.5 65.9 66.6 67.0 66.9 67.8 69.0 68.6<br />

45-64 41.9 42.7 44.2 45.0 45.3 45.9 47.5 47.2<br />

65-74 21.3 22.6 23.2 23.7 24.1 25.0 24.4 25.6<br />

75+ 11.7 10.7 11.6 11.5 12.3 12.8 12.3 12.9<br />

Male 34.7 34.9 36.5 36.7 37.5 38.1 38.3 38.9<br />

Female 36.0 36.8 37.1 37.7 37.8 38.4 38.8 39.0<br />

White 33.0 33.7 34.7 35.2 35.6 36.4 36.6 37.5<br />

Black 38.3 38.7 39.4 39.7 40.7 41.1 41.4 40.7<br />

Other race 46.6 45.5 46.6 46.3 44.2 44.5 47.0 46.3<br />

Diabetes 27.7 28.6 29.7 30.3 30.3 31.0 31.4 31.9<br />

Hypertension 38.7 39.0 39.6 39.8 41.2 41.6 41.4 41.6<br />

Glomerulonephritis 46.2 46.6 48.4 48.2 48.9 49.7 50.2 51.2<br />

Other cause 40.7 40.6 41.4 41.7 41.2 41.4 42.4 42.4<br />

All 35.3 35.9 36.8 37.2 37.7 38.3 38.6 39.0<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


592<br />

IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.7 I.7<br />

I.7<br />

Ten-year survival probabilities: incident ESRD patients<br />

from from<br />

day day<br />

91 91<br />

to to<br />

to<br />

ten ten<br />

years years<br />

+ 90 90<br />

90<br />

days, by days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<br />

0-4 76.1 69.7 76.5 72.6 72.9 72.4 74.8 76.6 65.9 74.3 71.2 72.5 75.9 73.7<br />

0-4 76.1 69.7 76.5 72.6 72.9 72.4 74.8 76.6 65.9 74.3 71.2 72.5 75.9 73.7<br />

5-9 80.9 79.8 79.0 82.8 87.0 83.2 86.1 83.9 89.9 85.5 84.8 90.2 89.5 80.2<br />

5-9 80.9 79.8 79.0 82.8 87.0 83.2 86.1 83.9 89.9 85.5 84.8 90.2 89.5 80.2<br />

10-14 79.1 77.8 77.5 82.4 82.8 82.5 85.5 89.4 80.9 80.2 79.8 86.3 81.6 82.0<br />

10-14 79.1 77.8 77.5 82.4 82.8 82.5 85.5 89.4 80.9 80.2 79.8 86.3 81.6 82.0<br />

15-19 80.0 79.0 79.3 81.1 78.5 76.7 78.5 78.8 80.3 83.2 82.6 79.1 80.4 79.8<br />

15-19 80.0 79.0 79.3 81.1 78.5 76.7 78.5 78.8 80.3 83.2 82.6 79.1 80.4 79.8<br />

20-29 64.4 62.1 65.1 63.7 64.2 64.1 65.8 65.0 67.2 64.6 65.9 64.7 66.1 68.9<br />

20-29 64.4 62.1 65.1 63.7 64.2 64.1 65.8 65.0 67.2 64.6 65.9 64.7 66.1 68.9<br />

30-39 47.2 47.7 48.1 49.4 49.1 47.7 49.6 47.9 49.7 50.1 50.8 49.6 50.6 51.0<br />

30-39 47.2 47.7 48.1 49.4 49.1 47.7 49.6 47.9 49.7 50.1 50.8 49.6 50.6 51.0<br />

40-49 33.7 32.7 33.7 34.1 36.1 35.9 36.5 36.2 36.6 34.8 36.1 35.0 37.3 37.5<br />

40-49 33.7 32.7 33.7 34.1 36.1 35.9 36.5 36.2 36.6 34.8 36.1 35.0 37.3 37.5<br />

50-59 16.7 18.1 18.4 16.7 17.6 18.3 19.1 19.9 18.3 18.5 18.6 19.7 19.6 19.9<br />

50-59 16.7 18.1 18.4 16.7 17.6 18.3 19.1 19.9 18.3 18.5 18.6 19.7 19.6 19.9<br />

60-64 8.7 8.8 7.4 8.9 8.8 9.6 9.2 9.0 9.6 9.1 9.2 9.6 10.1 10.4<br />

60-64 8.7 8.8 7.4 8.9 8.8 9.6 9.2 9.0 9.6 9.1 9.2 9.6 10.1 10.4<br />

65-69 4.9 5.9 4.5 4.9 5.6 6.4 5.2 5.0 5.3 5.0 5.5 4.9 5.1 5.8<br />

65-69 4.9 5.9 4.5 4.9 5.6 6.4 5.2 5.0 5.3 5.0 5.5 4.9 5.1 5.8<br />

70-79 2.8 2.5 3.0 2.4 3.0 2.9 2.4 2.8 2.7 2.4 2.1 2.1 2.2 2.5<br />

70-79 2.8 2.5 3.0 2.4 3.0 2.9 2.4 2.8 2.7 2.4 2.1 2.1 2.2 2.5<br />

80+ 1.9 1.0 1.9 0.2 1.4 0.9 0.9 0.9 0.6 0.8 0.5 0.8 0.6 0.7<br />

80+ 1.9 1.0 1.9 0.2 1.4 0.9 0.9 0.9 0.6 0.8 0.5 0.8 0.6 0.7<br />

Male 25.5 25.6 26.0 23.6 24.2 23.5 23.8 22.9 22.5 21.9 22.0 20.8 21.2 21.7<br />

Male 25.5 25.6 26.0 23.6 24.2 23.5 23.8 22.9 22.5 21.9 22.0 20.8 21.2 21.7<br />

Female 25.7 25.6 24.7 22.2 23.0 22.5 21.5 20.6 21.0 19.4 18.6 18.3 18.3 18.2<br />

Female 25.7 25.6 24.7 22.2 23.0 22.5 21.5 20.6 21.0 19.4 18.6 18.3 18.3 18.2<br />

White 26.0 25.5 25.5 23.0 23.6 22.9 22.5 21.6 20.7 19.6 19.4 18.5 18.6 18.8<br />

White 26.0 25.5 25.5 23.0 23.6 22.9 22.5 21.6 20.7 19.6 19.4 18.5 18.6 18.8<br />

Black 24.2 25.5 23.9 21.8 22.7 22.3 22.1 21.4 22.8 22.0 21.2 20.7 21.4 21.3<br />

Black 24.2 25.5 23.9 21.8 22.7 22.3 22.1 21.4 22.8 22.0 21.2 20.7 21.4 21.3<br />

Other race 28.0 29.0 37.6 34.0 33.8 32.1 33.1 30.4 31.8 30.9 31.7 30.3 28.1 29.3<br />

Other race 28.0 29.0 37.6 34.0 33.8 32.1 33.1 30.4 31.8 30.9 31.7 30.3 28.1 29.3<br />

Diabetes 14.0 12.7 12.1 11.7 12.2 12.5 12.8 12.0 11.9 11.6 10.7 10.6 10.9 11.2<br />

Diabetes 14.0 12.7 12.1 11.7 12.2 12.5 12.8 12.0 11.9 11.6 10.7 10.6 10.9 11.2<br />

Hypertension 26.0 21.8 19.9 18.3 18.5 17.5 17.1 15.5 16.9 15.9 16.0 15.4 16.2 16.0<br />

Hypertension 26.0 21.8 19.9 18.3 18.5 17.5 17.1 15.5 16.9 15.9 16.0 15.4 16.2 16.0<br />

Glomerulonephritis 47.8 43.5 42.3 40.8 40.5 39.7 40.0 39.1 39.8 38.8 39.2 37.1 39.7 40.3<br />

Glomerulonephritis 47.8 43.5 42.3 40.8 40.5 39.7 40.0 39.1 39.8 38.8 39.2 37.1 39.7 40.3<br />

Other cause 21.9 25.9 29.4 24.9 28.6 28.9 29.2 30.0 29.2 29.7 31.2 31.4 30.3 31.3<br />

Other cause 21.9 25.9 29.4 24.9 28.6 28.9 29.2 30.0 29.2 29.7 31.2 31.4 30.3 31.3<br />

All 25.6 25.6 25.4 23.0 23.6 23.0 22.8 21.9 21.8 20.7 20.4 19.6 19.8 20.0<br />

All 25.6 25.6 25.4 23.0 23.6 23.0 22.8 21.9 21.8 20.7 20.4 19.6 19.8 20.0<br />

ADJUSTED<br />

ADJUSTED<br />

0-19 68.2 66.0 66.4 69.2 68.8 66.4 70.0 71.4 68.8 72.0 70.8 70.7 71.4 69.0<br />

0-19 68.2 66.0 66.4 69.2 68.8 66.4 70.0 71.4 68.8 72.0 70.8 70.7 71.4 69.0<br />

20-44 43.4 43.3 45.1 45.7 47.0 46.7 48.1 46.8 48.2 48.4 49.0 48.0 49.1 49.9<br />

20-44 43.4 43.3 45.1 45.7 47.0 46.7 48.1 46.8 48.2 48.4 49.0 48.0 49.1 49.9<br />

45-64 13.3 14.1 14.7 14.4 15.5 16.1 17.1 17.5 17.4 17.5 17.7 18.6 19.7 20.3<br />

45-64 13.3 14.1 14.7 14.4 15.5 16.1 17.1 17.5 17.4 17.5 17.7 18.6 19.7 20.3<br />

65-74 3.7 4.1 3.8 3.6 4.5 5.0 4.1 4.2 4.3 4.2 4.5 4.1 4.5 5.0<br />

65-74 3.7 4.1 3.8 3.6 4.5 5.0 4.1 4.2 4.3 4.2 4.5 4.1 4.5 5.0<br />

75+ 2.0 1.7 2.0 1.1 1.9 1.5 1.4 1.7 1.6 1.4 1.0 1.3 1.2 1.4<br />

75+ 2.0 1.7 2.0 1.1 1.9 1.5 1.4 1.7 1.6 1.4 1.0 1.3 1.2 1.4<br />

Male 14.9 14.9 15.7 15.2 16.1 16.6 17.1 17.0 16.9 17.2 17.6 17.4 18.1 18.8<br />

Male 14.9 14.9 15.7 15.2 16.1 16.6 17.1 17.0 16.9 17.2 17.6 17.4 18.1 18.8<br />

Female 16.1 16.8 16.7 16.3 17.6 17.6 17.3 17.6 17.9 17.5 17.4 17.9 18.2 18.6<br />

Female 16.1 16.8 16.7 16.3 17.6 17.6 17.3 17.6 17.9 17.5 17.4 17.9 18.2 18.6<br />

White 14.9 14.9 15.6 15.2 16.4 16.6 16.7 17.0 16.8 17.1 17.2 17.3 18.0 18.7<br />

White 14.9 14.9 15.6 15.2 16.4 16.6 16.7 17.0 16.8 17.1 17.2 17.3 18.0 18.7<br />

Black 15.4 16.2 15.4 15.0 15.8 16.0 16.3 16.0 16.7 16.2 16.2 16.4 16.8 17.1<br />

Black 15.4 16.2 15.4 15.0 15.8 16.0 16.3 16.0 16.7 16.2 16.2 16.4 16.8 17.1<br />

Other race 16.2 18.8 21.0 20.9 21.8 21.9 23.1 21.6 23.3 23.5 24.7 24.9 24.4 25.1<br />

Other race 16.2 18.8 21.0 20.9 21.8 21.9 23.1 21.6 23.3 23.5 24.7 24.9 24.4 25.1<br />

Diabetes 10.1 9.5 9.5 9.4 10.1 10.6 10.8 10.9 10.8 10.7 10.6 10.8 11.3 12.0<br />

Diabetes 10.1 9.5 9.5 9.4 10.1 10.6 10.8 10.9 10.8 10.7 10.6 10.8 11.3 12.0<br />

Hypertension 21.1 19.2 18.7 18.5 18.7 18.8 18.7 18.3 18.9 18.7 19.0 18.8 19.5 19.7<br />

Hypertension 21.1 19.2 18.7 18.5 18.7 18.8 18.7 18.3 18.9 18.7 19.0 18.8 19.5 19.7<br />

Glomerulonephritis 26.2 24.8 24.4 24.4 25.5 25.6 26.2 25.5 26.4 26.3 26.0 26.2 27.7 28.1<br />

Glomerulonephritis 26.2 24.8 24.4 24.4 25.5 25.6 26.2 25.5 26.4 26.3 26.0 26.2 27.7 28.1<br />

Other cause 16.4 18.0 20.0 18.9 21.4 21.6 21.8 22.7 22.1 22.9 23.4 23.9 23.6 24.4<br />

Other cause 16.4 18.0 20.0 18.9 21.4 21.6 21.8 22.7 22.1 22.9 23.4 23.9 23.6 24.4<br />

All 15.5 15.8 16.2 15.7 16.8 17.1 17.2 17.3 17.3 17.3 17.5 17.6 18.1 18.7<br />

All 15.5 15.8 16.2 15.7 16.8 17.1 17.2 17.3 17.3 17.3 17.5 17.6 18.1 18.7<br />

Reference cohort is 1996 incident ESRD patients.<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded. Includes U.S. & territories; no unknown or foreign states.<br />

Patients of unknown age, gender, or of age >110 are excluded. Includes U.S. & territories; no unknown or foreign states.


Table I.8 (continued)<br />

Table Incident Table I.8 I.8 patient counts: dialysis patients, unknowns dropped<br />

Incident dialysis patients patient alive on counts: day 91, dialysis by age, gender, patients, race, ethnicity, unknowns & primary dropped<br />

diagnosis<br />

dialysis dialysis patients patients alive alive on on day day 91, 91, by by age, age, gender, gender, race, race, ethnicity, ethnicity, & primary primary diagnosis diagnosis<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4<br />

1980<br />

128<br />

1981<br />

109<br />

1982<br />

120<br />

1983<br />

105<br />

1984<br />

126<br />

1985<br />

128<br />

1986<br />

128<br />

1987<br />

138<br />

1988<br />

122<br />

1989<br />

152<br />

1990<br />

154 143<br />

5-9<br />

0-4 27<br />

66<br />

44<br />

65<br />

59<br />

67 104<br />

82 80<br />

90<br />

104<br />

92<br />

99<br />

87<br />

96<br />

89 103<br />

96 108<br />

99<br />

91<br />

98 107<br />

10-14<br />

5-9<br />

158<br />

62<br />

169<br />

56<br />

160<br />

69<br />

179<br />

64<br />

179<br />

76<br />

191<br />

55<br />

186<br />

78<br />

175<br />

75<br />

198<br />

67<br />

205<br />

77<br />

197<br />

91<br />

241<br />

15-19<br />

10-14 129<br />

366<br />

134<br />

431<br />

173<br />

406<br />

159<br />

362<br />

149<br />

420<br />

148<br />

430<br />

130<br />

412<br />

133<br />

420<br />

140<br />

446<br />

117<br />

433<br />

146<br />

419 410<br />

20-29<br />

15-19<br />

2,181<br />

331<br />

2,330<br />

370<br />

2,326<br />

351<br />

2,357<br />

369<br />

2,269<br />

336<br />

2,310<br />

343<br />

2,253<br />

324<br />

2,311<br />

341<br />

2,218<br />

387<br />

2,273<br />

402<br />

2,248<br />

371<br />

2,191<br />

30-39<br />

20-29 1,218<br />

4,314<br />

1,384<br />

4,655<br />

1,577<br />

4,688<br />

1,534<br />

5,018<br />

1,690<br />

4,937<br />

1,726<br />

5,055<br />

1,789<br />

5,036<br />

1,767<br />

4,971<br />

1,904<br />

5,206<br />

2,078<br />

4,997<br />

2,148<br />

4,989 4,986<br />

40-49<br />

30-39 1,869<br />

6,153<br />

2,095<br />

6,650<br />

2,368<br />

7,114<br />

2,450<br />

7,489<br />

2,655<br />

8,046<br />

2,832<br />

8,594<br />

3,011<br />

8,631<br />

3,180<br />

9,317<br />

3,548<br />

9,493<br />

3,904<br />

9,716<br />

4,096<br />

9,685 9,990<br />

50-59<br />

40-49 2,101<br />

8,179<br />

2,407<br />

9,080<br />

2,573<br />

9,587 10,776<br />

2,889<br />

10,976<br />

3,022<br />

11,585<br />

3,301<br />

12,621<br />

3,490<br />

13,646<br />

3,931<br />

14,715<br />

4,405<br />

15,129<br />

5,023<br />

15,820<br />

5,443<br />

16,438<br />

60-64<br />

50-59 3,242<br />

6,039<br />

3,892<br />

6,336<br />

4,222<br />

6,654<br />

4,360<br />

7,068<br />

4,639<br />

7,332<br />

4,986<br />

7,674<br />

5,188<br />

8,107<br />

5,610<br />

8,569<br />

6,440<br />

8,778<br />

7,019<br />

9,003<br />

7,510<br />

9,320 9,533<br />

65-69<br />

60-64 1,816<br />

7,072<br />

2,122<br />

7,683<br />

2,459<br />

7,976<br />

2,859<br />

8,585<br />

3,154<br />

8,595<br />

3,504<br />

9,394<br />

3,644<br />

9,646<br />

4,135<br />

9,925 10,050<br />

4,524<br />

10,084<br />

4,965<br />

10,332<br />

5,488<br />

10,588<br />

70-79<br />

65-69<br />

10,784<br />

1,749<br />

12,107<br />

1,848<br />

12,733<br />

2,135<br />

14,199<br />

2,819<br />

14,597<br />

2,956<br />

16,475<br />

3,347<br />

17,633<br />

3,843<br />

18,661<br />

4,364<br />

19,726<br />

4,921<br />

20,131<br />

5,740<br />

20,225<br />

6,378<br />

21,320<br />

80+<br />

70-79 1,925<br />

3,032<br />

2,086<br />

3,584<br />

2,679<br />

3,930<br />

3,807<br />

4,438<br />

3,969<br />

4,791<br />

4,658<br />

5,699<br />

5,356<br />

6,461<br />

6,179<br />

7,082<br />

6,779<br />

8,008<br />

8,190<br />

8,616<br />

9,188<br />

8,985 10,503<br />

80+<br />

Male<br />

314<br />

25,599<br />

339<br />

27,813<br />

489<br />

29,440<br />

769<br />

31,822<br />

814<br />

32,636<br />

1,033<br />

35,832<br />

1,265<br />

37,667<br />

1,449<br />

39,845<br />

1,791<br />

42,044<br />

2,246<br />

43,052<br />

2,625<br />

44,122 46,819<br />

Female<br />

Male<br />

22,873<br />

8,163<br />

25,386<br />

9,179 10,407<br />

26,321<br />

12,065<br />

28,858<br />

12,944<br />

29,722<br />

14,011<br />

31,795<br />

15,257<br />

33,534<br />

16,753<br />

35,459<br />

18,555<br />

37,019<br />

21,291<br />

37,786<br />

23,144<br />

38,350 39,631<br />

Female<br />

White<br />

6,620<br />

31,376<br />

7,598<br />

34,235<br />

8,747<br />

35,523<br />

10,096<br />

38,450<br />

10,596<br />

38,859<br />

12,026<br />

42,469<br />

12,960<br />

44,850<br />

14,507<br />

47,164<br />

16,447<br />

50,100<br />

18,578<br />

51,528<br />

20,431<br />

52,278 54,731<br />

Black<br />

White 10,157<br />

15,174<br />

11,424<br />

16,709<br />

13,094<br />

17,696<br />

14,802<br />

19,240<br />

15,736<br />

19,799<br />

17,355<br />

21,040<br />

18,881<br />

22,021<br />

20,673<br />

23,479<br />

22,817<br />

23,977<br />

25,892<br />

24,065<br />

28,370<br />

24,869 26,046<br />

Other<br />

Black<br />

race<br />

4,210<br />

1,922<br />

4,868<br />

2,255<br />

5,554<br />

2,542<br />

6,736<br />

2,990<br />

7,104<br />

3,700<br />

7,863<br />

4,118<br />

8,401<br />

4,330<br />

9,540<br />

4,661<br />

10,870<br />

4,986<br />

12,580<br />

5,245<br />

13,499<br />

5,325 5,673<br />

Other race<br />

†Hispanic<br />

416 485 506 623 700 819<br />

7,950<br />

935<br />

8,182<br />

1,047<br />

8,674<br />

1,315<br />

9,454<br />

1,397<br />

10,118<br />

1,706<br />

10,438 11,259<br />

†Non-Hispanic<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 19,069 21,298 22,715 25,310 27,582<br />

59,677<br />

30,849<br />

63,019<br />

33,142<br />

66,630<br />

35,274<br />

69,609<br />

37,110<br />

70,720<br />

38,617<br />

72,034<br />

39,626<br />

75,191<br />

41,048<br />

Hypertension<br />

Diabetes<br />

15,419<br />

2,468<br />

17,247<br />

3,684<br />

17,942<br />

4,803<br />

19,404<br />

5,633<br />

17,409<br />

6,843<br />

18,548<br />

7,903<br />

19,706<br />

9,102 10,416<br />

20,766<br />

11,923<br />

22,000<br />

14,459<br />

22,375<br />

16,595<br />

23,084 24,507<br />

Glomerulonephritis<br />

Hypertension 2,943<br />

6,607<br />

4,206<br />

6,784<br />

5,334<br />

7,006<br />

5,824<br />

7,568<br />

6,542<br />

7,614<br />

7,497<br />

8,009<br />

8,110<br />

7,909<br />

9,389<br />

8,003<br />

10,851<br />

8,018<br />

12,656<br />

7,798<br />

13,822<br />

7,646 7,840<br />

Cystic<br />

Glomerulonephritis<br />

kidney<br />

2,565<br />

1,438<br />

3,372<br />

1,525<br />

3,902<br />

1,607<br />

4,108<br />

1,672<br />

4,389<br />

1,701<br />

4,598<br />

1,653<br />

4,819<br />

1,749<br />

5,238<br />

1,852<br />

5,663<br />

1,907<br />

5,939<br />

1,862<br />

6,310<br />

1,863 1,852<br />

Other<br />

Cystic<br />

urologic<br />

kidney<br />

1,293<br />

740<br />

1,379<br />

895 1,036<br />

1,168<br />

1,045<br />

1,207<br />

1,074<br />

1,772<br />

1,142<br />

2,039<br />

1,181<br />

2,058<br />

1,231<br />

2,089<br />

1,251<br />

2,484<br />

1,276<br />

2,290<br />

1,374<br />

2,328 2,496<br />

Other<br />

Other<br />

cause<br />

urologic<br />

4,371<br />

417<br />

4,745<br />

598<br />

4,975<br />

785<br />

5,387<br />

876<br />

6,160<br />

872 1,048<br />

6,428<br />

1,059<br />

6,560<br />

1,182<br />

7,228<br />

1,202<br />

7,425<br />

1,217<br />

7,755<br />

1,137<br />

7,805 8,482<br />

Missing<br />

Other cause<br />

cause<br />

1,605<br />

275<br />

2,023<br />

221<br />

2,553<br />

348<br />

2,825<br />

132<br />

2,972<br />

120<br />

3,201<br />

101<br />

3,284<br />

77<br />

3,269<br />

92<br />

3,439<br />

119<br />

3,891<br />

141<br />

4,029<br />

120 225<br />

Missing cause<br />

All<br />

4,045<br />

48,472<br />

1,999<br />

53,199<br />

741<br />

55,761<br />

1,850<br />

60,680<br />

848<br />

62,358<br />

648<br />

67,627<br />

662<br />

71,201<br />

535<br />

75,304<br />

673<br />

79,063<br />

431<br />

80,838<br />

308<br />

82,472 86,450<br />

All 14,783 16,777 19,154 22,161 23,540 26,037 28,217 31,260 35,002 39,869 43,575<br />

I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

593<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90 day rule.<br />

The<br />

The<br />

age<br />

incident<br />

of the<br />

cohorts<br />

incident<br />

are<br />

patient<br />

determined<br />

is determined<br />

at the time<br />

as of<br />

of<br />

the<br />

ESRD<br />

date<br />

initiation<br />

of ESRD<br />

with<br />

initiation.<br />

the 60-day stable modality rule & the 90 day rule.<br />

Patients<br />

The age<br />

of<br />

of<br />

unknown<br />

the incident<br />

age,<br />

patient<br />

gender,<br />

is determined<br />

race, or primary<br />

as of<br />

cause<br />

the date<br />

of ESRD<br />

of ESRD<br />

are<br />

initiation.<br />

excluded.<br />

Includes Patients of residents unknown of the age, 50 gender, states, race, the District or primary of Columbia, cause of ESRD Puerto are Rico, excluded. & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


594<br />

IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.8 (continued)<br />

Table Incident Table I.8 I.8(continued)<br />

patient counts: dialysis patients, unknowns dropped<br />

Incident patient counts: dialysis patients, unknowns dropped<br />

dialysis patients alive on day 91, by age, gender, race, ethnicity, & primary diagnosis<br />

dialysis dialysis patients patients alive alive on on day day 91, 91, by by age, age, gender, gender, race, race, ethnicity, ethnicity, & primary primary diagnosis diagnosis<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 1980 128 1981 109 1982 120 1983 105 1984 126 1985 128 1986 128 1987 138 1988 122 1989 152 1990 154 143<br />

5-9 0-4 27 66 44 65 59 67 104 82 80 90 104 92 99 87 96 89 103 96 108 99 91 98 107<br />

10-14 5-9 158 62 169 56 160 69 179 64 179 76 191 55 186 78 175 198 67 205 77 197 91 241<br />

15-19 10-14 129 366 134 431 173 406 159 362 149 420 148 430 130 412 133 420 140 446 117 433 146 419 410<br />

20-29 15-19 2,181 331 2,330 370 2,326 351 2,357 369 2,269 336 2,310 343 2,253 324 2,311 341 2,218 387 2,273 402 2,248 371 2,191<br />

30-39 20-29 1,218 4,314 1,384 4,655 1,577 4,688 1,534 5,018 1,690 4,937 1,726 5,055 1,789 5,036 1,767 4,971 1,904 5,206 2,078 4,997 2,148 4,989 4,986<br />

40-49 30-39 1,869 6,153 2,095 6,650 2,368 7,114 2,450 7,489 2,655 8,046 2,832 8,594 3,011 8,631 3,180 9,317 3,548 9,493 3,904 9,716 4,096 9,685 9,990<br />

50-59 40-49 2,101 8,179 2,407 9,080 2,573 9,587 10,776 2,889 10,976 3,022 11,585 3,301 12,621 3,490 13,646 3,931 14,715 4,405 15,129 5,023 15,820 5,443 16,438<br />

60-64 50-59 3,242 6,039 3,892 6,336 4,222 6,654 4,360 7,068 4,639 7,332 4,986 7,674 5,188 8,107 5,610 8,569 6,440 8,778 7,019 9,003 7,510 9,320 9,533<br />

65-69 60-64 1,816 7,072 2,122 7,683 2,459 7,976 2,859 8,585 3,154 8,595 3,504 9,394 3,644 9,646 4,135 9,925 10,050 4,524 10,084 4,965 10,332 5,488 10,588<br />

70-79 65-69 10,784 1,749 12,107 1,848 12,733 2,135 14,199 2,819 14,597 2,956 16,475 3,347 17,633 3,843 18,661 4,364 19,726 4,921 20,131 5,740 20,225 6,378 21,320<br />

80+ 70-79 1,925 3,032 2,086 3,584 2,679 3,930 3,807 4,438 3,969 4,791 4,658 5,699 5,356 6,461 6,179 7,082 6,779 8,008 8,190 8,616 9,188 8,985 10,503<br />

80+<br />

Male<br />

314<br />

25,599<br />

339<br />

27,813<br />

489<br />

29,440<br />

769<br />

31,822<br />

814<br />

32,636<br />

1,033<br />

35,832<br />

1,265<br />

37,667<br />

1,449<br />

39,845<br />

1,791<br />

42,044<br />

2,246<br />

43,052<br />

2,625<br />

44,122 46,819<br />

Female Male 22,873 8,163 25,386 9,179 10,407 26,321 12,065 28,858 12,944 29,722 14,011 31,795 15,257 33,534 16,753 35,459 18,555 37,019 21,291 37,786 23,144 38,350 39,631<br />

Female<br />

White<br />

6,620<br />

31,376<br />

7,598<br />

34,235<br />

8,747<br />

35,523<br />

10,096<br />

38,450<br />

10,596<br />

38,859<br />

12,026<br />

42,469<br />

12,960<br />

44,850<br />

14,507<br />

47,164<br />

16,447<br />

50,100<br />

18,578<br />

51,528<br />

20,431<br />

52,278 54,731<br />

Black White 10,157 15,174 11,424 16,709 13,094 17,696 14,802 19,240 15,736 19,799 17,355 21,040 18,881 22,021 20,673 23,479 22,817 23,977 25,892 24,065 28,370 24,869 26,046<br />

Other Black race 4,210 1,922 4,868 2,255 5,554 2,542 6,736 2,990 7,104 3,700 7,863 4,118 8,401 4,330 9,540 4,661 10,870 4,986 12,580 5,245 13,499 5,325 5,673<br />

Other race<br />

†Hispanic<br />

416 485 506 623 700 819<br />

7,950<br />

935<br />

8,182<br />

1,047<br />

8,674<br />

1,315<br />

9,454<br />

1,397<br />

10,118<br />

1,706<br />

10,438 11,259<br />

†Non-Hispanic †Hispanic<br />

†Non-Hispanic<br />

Diabetes 19,069 21,298 22,715 25,310 27,582<br />

59,677<br />

30,849<br />

63,019<br />

33,142<br />

66,630<br />

35,274<br />

69,609<br />

37,110<br />

70,720<br />

38,617<br />

72,034<br />

39,626<br />

75,191<br />

41,048<br />

Hypertension Diabetes 15,419 2,468 17,247 3,684 17,942 4,803 19,404 5,633 17,409 6,843 18,548 7,903 19,706 9,102 10,416 20,766 11,923 22,000 14,459 22,375 16,595 23,084 24,507<br />

Glomerulonephritis Hypertension 2,943 6,607 4,206 6,784 5,334 7,006 5,824 7,568 6,542 7,614 7,497 8,009 8,110 7,909 9,389 8,003 10,851 8,018 12,656 7,798 13,822 7,646 7,840<br />

Cystic Glomerulonephritis kidney 2,565 1,438 3,372 1,525 3,902 1,607 4,108 1,672 4,389 1,701 4,598 1,653 4,819 1,749 5,238 1,852 5,663 1,907 5,939 1,862 6,310 1,863 1,852<br />

Other Cystic urologic kidney 1,293 740 1,379 895 1,036 1,168 1,045 1,207 1,074 1,772 1,142 2,039 1,181 2,058 1,231 2,089 1,251 2,484 1,276 2,290 1,374 2,328 2,496<br />

Other Other cause urologic 4,371 417 4,745 598 4,975 785 5,387 876 6,160 872 1,048 6,428 1,059 6,560 1,182 7,228 1,202 7,425 1,217 7,755 1,137 7,805 8,482<br />

Missing Other cause cause 1,605 275 2,023 221 2,553 348 2,825 132 2,972 120 3,201 101 3,284 77 3,269 92 3,439 119 3,891 141 4,029 120 225<br />

Missing cause<br />

All<br />

4,045<br />

48,472<br />

1,999<br />

53,199<br />

741<br />

55,761<br />

1,850<br />

60,680<br />

848<br />

62,358<br />

648<br />

67,627<br />

662<br />

71,201<br />

535<br />

75,304<br />

673<br />

79,063<br />

431<br />

80,838<br />

308<br />

82,472 86,450<br />

All 14,783 16,777 19,154 22,161 23,540 26,037 28,217 31,260 35,002 39,869 43,575<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90 day rule.<br />

The The age incident of the cohorts incident are patient determined is determined at the time as of of the ESRD date initiation of ESRD with initiation. the 60-day stable modality rule & the 90 day rule.<br />

Patients<br />

The age<br />

of<br />

of<br />

unknown<br />

the incident<br />

age,<br />

patient<br />

gender,<br />

is determined<br />

race, or primary<br />

as of<br />

cause<br />

the date<br />

of ESRD<br />

of ESRD<br />

are<br />

initiation.<br />

excluded.<br />

Includes Patients of residents unknown of the age, 50 gender, states, race, the District or primary of Columbia, cause of ESRD Puerto are Rico, excluded. & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.9 I.9<br />

90-day survival probabilities: incident dialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 97.4 100.0 97.4 100.0 97.8 100.0 96.6 95.6 96.4 95.9 84.3<br />

5-9 100.0 98.6 100.0 98.6 98.9 98.7 100.0 100.0 96.2 97.8 93.9<br />

10-14 99.4 100.0 100.0 100.0 98.9 100.0 100.0 100.0 100.0 99.3 89.0<br />

15-19 99.5 99.5 100.0 99.5 99.7 99.7 99.7 100.0 99.1 99.1 92.2<br />

20-29 99.1 99.2 99.4 98.9 98.7 99.3 99.2 99.0 98.9 98.8 98.1<br />

30-39 98.3 98.8 98.6 98.9 98.6 98.5 98.0 98.1 98.4 98.2 97.5<br />

40-49 98.4 98.0 98.4 97.8 98.3 98.1 98.1 97.8 98.2 97.9 97.4<br />

50-59 97.3 97.2 96.8 96.3 97.1 96.4 96.8 97.0 96.8 97.0 96.4<br />

60-64 95.0 95.2 94.7 95.0 95.2 94.3 94.0 95.1 94.7 95.0 94.2<br />

65-69 90.9 91.1 90.0 91.6 90.0 90.3 91.6 91.2 92.3 92.1 92.2<br />

70-79 87.2 88.4 87.7 88.4 87.8 87.2 88.0 89.3 88.2 88.7 89.1<br />

80+ 83.8 84.9 84.6 83.4 83.5 82.5 84.5 83.7 85.8 83.8 83.9<br />

Male 94.8 95.0 94.4 94.1 94.1 93.4 93.5 93.7 93.6 93.5 93.0<br />

Female 95.1 95.5 95.0 94.5 94.2 93.8 94.1 94.2 94.3 93.9 93.6<br />

595<br />

White 94.4 94.7 93.8 93.2 93.2 92.4 92.7 92.8 92.8 92.4 92.1<br />

Black 96.5 96.5 96.8 96.7 96.1 96.0 96.0 96.2 96.2 96.2 95.4<br />

Other race 94.3 97.0 96.0 95.2 96.4 95.4 96.5 97.2 96.1 96.6 96.2<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 96.6 95.5 95.0 94.4 94.9 94.4 94.6 94.6 94.8 94.8 94.5<br />

Hypertension 95.9 94.9 93.5 93.5 93.0 92.6 92.8 92.4 92.6 92.3 91.6<br />

Glomerulonephritis 98.3 97.7 97.1 97.2 96.6 96.6 96.1 95.9 96.5 95.8 95.3<br />

Other cause 93.1 94.2 94.1 93.3 93.0 91.7 92.4 93.7 92.7 92.6 92.2<br />

All 94.9 95.3 94.7 94.3 94.1 93.6 93.8 94.0 93.9 93.7 93.2<br />

ADJUSTED<br />

0-19 98.8 99.2 99.5 99.2 98.4 99.5 98.6 98.6 97.2 97.1 82.5<br />

20-44 98.8 98.9 98.8 98.9 98.8 98.7 98.4 98.3 98.6 98.3 97.8<br />

45-64 97.3 97.0 96.6 96.2 96.7 96.0 96.1 96.5 96.3 96.4 95.7<br />

65-74 91.1 91.2 89.9 91.4 89.9 89.8 91.0 91.3 91.3 91.6 91.4<br />

75+ 87.6 88.1 87.7 87.2 87.2 86.3 87.0 87.4 87.4 86.5 87.1<br />

Male 94.2 94.1 93.4 93.6 93.4 92.8 93.1 93.4 93.3 93.3 92.8<br />

Female 94.4 94.6 94.0 94.0 93.6 93.3 93.7 94.0 94.0 93.8 93.4<br />

White 93.6 93.6 92.7 92.7 92.6 92.0 92.5 92.8 92.8 92.6 92.4<br />

Black 96.1 95.6 95.9 96.2 95.2 95.1 95.1 95.4 95.3 95.4 94.4<br />

Other race 93.8 96.5 94.8 94.4 95.6 94.3 95.8 96.6 95.3 95.8 95.5<br />

Diabetes 94.9 93.5 93.2 92.5 93.2 92.8 93.3 93.4 93.8 93.9 93.7<br />

Hypertension 94.9 94.3 93.0 93.3 92.9 92.9 93.3 93.2 93.3 93.2 92.7<br />

Glomerulonephritis 97.0 96.1 95.4 95.8 95.2 95.4 94.8 94.6 95.4 94.7 94.1<br />

Other cause 92.0 92.8 92.7 92.7 92.2 90.9 91.8 93.1 92.1 92.0 91.5<br />

All 94.3 94.3 93.7 93.8 93.5 93.0 93.4 93.7 93.6 93.5 93.1<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.9 I.9 (continued)<br />

90-day survival probabilities: incident dialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

596<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 97.3 96.7 97.3 96.0 96.5 97.8 97.1 96.0 92.8 97.0 96.4 97.5<br />

5-9 98.8 100.0 100.0 98.4 99.1 98.0 100.0 100.0 98.2 99.2 98.2 98.4<br />

10-14 97.9 100.0 99.5 98.1 99.5 100.0 99.1 100.0 99.6 99.1 99.6 99.6<br />

15-19 98.8 99.8 99.3 98.6 99.8 99.2 99.3 99.4 98.6 99.2 98.3 99.2<br />

20-29 98.5 97.8 98.3 97.7 97.2 98.3 98.1 98.6 98.5 98.3 98.7 98.2<br />

30-39 97.7 97.5 97.2 97.0 97.4 97.2 97.5 97.6 97.8 97.5 97.8 97.7<br />

40-49 98.0 97.6 97.2 97.0 96.7 96.7 96.6 96.8 96.6 96.9 96.9 96.6<br />

50-59 96.7 96.9 96.0 95.7 95.8 95.7 96.0 95.6 95.2 95.7 95.2 95.7<br />

60-64 94.7 94.5 94.5 93.7 93.9 93.8 93.6 93.4 93.8 93.7 93.4 93.8<br />

65-69 92.2 92.4 92.8 92.6 92.7 92.8 92.1 92.3 92.5 91.9 92.3 92.5<br />

70-79 89.5 89.6 89.1 89.6 89.2 89.0 88.5 88.7 88.7 88.9 88.2 88.7<br />

80+ 84.9 85.3 84.7 84.0 83.8 84.3 82.9 82.4 82.4 82.8 82.3 83.0<br />

Male 93.4 93.2 93.1 92.7 92.8 92.6 92.2 92.0 92.0 92.2 91.7 92.1<br />

Female 93.9 94.0 93.4 93.1 92.9 92.8 92.2 92.2 92.0 91.8 91.8 91.7<br />

White 92.5 92.5 92.0 91.8 91.7 91.5 90.9 90.9 90.8 90.9 90.5 90.6<br />

Black 95.8 95.6 95.3 94.9 94.9 94.8 94.5 94.4 94.3 94.0 93.8 94.1<br />

Other race 96.6 95.8 95.6 95.3 94.2 94.1 94.2 94.0 93.7 94.5 94.2 95.0<br />

†Hispanic 94.8 94.3 94.0 94.4 94.0 93.8 94.5<br />

†Non-Hispanic 92.4 91.9 91.9 91.7 91.7 91.4 91.5<br />

Diabetes 94.7 94.7 94.2 94.2 93.7 93.7 93.4 93.2 93.1 92.9 92.8 93.1<br />

Hypertension 92.0 92.1 92.0 91.6 91.6 91.8 90.8 90.8 90.7 90.8 90.4 90.6<br />

Glomerulonephritis 96.1 96.2 95.8 95.4 96.0 95.5 95.3 94.9 95.1 95.7 95.5 95.8<br />

Other cause 92.7 92.1 91.5 90.9 90.7 89.9 89.4 89.9 89.7 89.8 89.2 89.1<br />

All 93.6 93.6 93.2 92.9 92.8 92.7 92.2 92.1 92.0 92.0 91.7 91.9<br />

ADJUSTED<br />

0-19 96.7 98.8 98.2 96.2 98.2 98.1 98.0 98.0 96.0 97.7 96.7 98.0<br />

20-44 98.1 97.8 97.7 97.4 97.4 97.5 97.7 97.8 97.8 97.8 97.9 97.8<br />

45-64 96.2 96.1 95.6 95.2 95.3 95.2 95.2 95.0 95.0 95.2 94.9 95.2<br />

65-74 91.5 91.8 91.8 91.9 91.6 91.6 91.1 91.3 91.3 91.1 91.0 91.3<br />

75+ 87.9 87.8 87.0 86.8 86.7 86.8 85.8 85.6 85.7 85.9 85.4 85.9<br />

Male 93.3 93.2 93.1 92.8 92.9 92.9 92.6 92.5 92.7 92.8 92.3 92.8<br />

Female 93.9 94.0 93.5 93.3 93.1 93.1 92.7 92.8 92.6 92.6 92.6 92.6<br />

White 92.9 93.0 92.7 92.5 92.5 92.5 92.1 92.1 92.2 92.3 92.1 92.3<br />

Black 94.9 94.7 94.3 93.9 94.0 94.0 93.8 93.6 93.5 93.3 93.0 93.5<br />

Other race 96.0 95.2 94.9 94.6 93.7 93.6 93.7 93.5 93.4 94.2 93.8 94.8<br />

Diabetes 94.1 94.2 93.7 93.8 93.4 93.6 93.4 93.2 93.2 93.1 93.1 93.5<br />

Hypertension 93.1 93.2 93.3 93.0 93.0 93.3 92.7 92.7 92.7 92.8 92.5 92.8<br />

Glomerulonephritis 95.2 95.3 94.9 94.6 95.2 94.8 94.6 94.1 94.5 95.1 94.6 95.1<br />

Other cause 92.1 91.6 90.8 90.2 90.2 89.6 89.4 89.8 89.8 89.9 89.3 89.4<br />

All 93.6 93.6 93.2 93.0 93.0 93.0 92.7 92.6 92.6 92.7 92.5 92.8<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.10 I.10<br />

One-year survival probabilities: incident dialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

one<br />

one<br />

year<br />

year<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 96.2 92.7 89.4 89.8 85.3 85.2 90.3 92.5 79.4 83.6 79.2<br />

5-9 93.1 92.3 95.9 98.1 90.2 90.1 100.0 100.0 98.4 98.6 93.9<br />

10-14 96.4 98.5 97.8 98.4 96.8 97.7 99.0 99.0 95.5 97.1 95.5<br />

15-19 96.0 94.6 95.4 94.6 96.8 93.5 94.2 95.7 98.0 98.4 97.1<br />

20-29 90.9 92.6 92.4 92.5 92.6 90.9 93.3 90.7 92.0 91.5 91.3<br />

30-39 89.2 89.1 88.5 89.6 87.2 88.1 88.2 87.7 88.4 88.1 89.0<br />

40-49 87.8 87.5 86.6 87.4 87.5 87.0 86.6 87.0 87.8 87.9 88.4<br />

50-59 83.9 83.6 84.0 81.6 81.8 82.1 82.3 83.1 83.5 83.2 84.0<br />

60-64 78.5 77.8 78.3 77.7 76.1 76.4 77.2 76.3 77.0 77.7 78.3<br />

65-69 72.9 73.6 74.0 72.1 72.9 71.3 73.0 73.0 73.4 74.0 75.5<br />

70-79 67.1 68.1 68.6 65.3 66.6 66.9 66.2 65.3 66.2 67.4 68.4<br />

80+ 58.1 53.6 62.0 54.9 56.3 57.9 58.6 55.3 55.7 58.0 59.6<br />

Male 80.4 80.9 80.5 77.7 77.7 77.2 76.9 76.8 76.8 77.5 78.4<br />

Female 81.4 81.0 81.1 78.7 78.9 78.3 78.8 77.2 78.7 78.3 78.6<br />

597<br />

White 79.0 79.0 78.9 75.8 75.6 75.1 75.0 74.0 74.5 75.0 75.6<br />

Black 85.0 85.4 85.0 82.9 83.7 82.8 82.8 83.0 83.4 82.8 83.5<br />

Other race 81.8 81.1 84.5 81.7 82.0 82.5 84.9 80.3 84.0 84.9 86.3<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 74.8 73.9 73.1 73.4 73.4 72.9 74.1 74.0 75.7 76.2 76.4<br />

Hypertension 83.8 82.0 80.5 78.5 77.7 78.5 77.3 76.0 76.5 76.8 77.6<br />

Glomerulonephritis 90.5 88.7 88.0 87.1 86.7 86.7 85.2 84.9 85.8 85.4 86.3<br />

Other cause 78.7 80.4 82.6 77.0 78.4 76.6 78.1 77.2 76.8 77.2 78.5<br />

All 80.8 80.9 80.8 78.2 78.2 77.7 77.7 77.0 77.7 77.8 78.5<br />

ADJUSTED<br />

0-19 92.4 90.9 91.6 91.0 89.7 87.2 91.3 93.3 90.4 92.8 89.2<br />

20-44 87.7 88.6 88.3 88.7 87.8 87.7 88.2 87.6 88.4 87.8 88.7<br />

45-64 81.2 80.7 81.3 80.1 79.9 80.1 80.7 80.8 81.4 82.1 82.7<br />

65-74 70.2 70.9 72.5 69.3 70.4 69.4 70.4 70.4 71.2 72.0 73.4<br />

75+ 61.2 62.2 62.1 58.8 61.1 62.3 62.0 59.4 60.2 62.5 63.5<br />

Male 75.2 75.8 75.8 73.7 73.9 73.9 74.1 74.2 74.4 75.5 76.8<br />

Female 76.4 76.2 77.2 75.6 76.1 75.9 76.9 75.8 77.2 77.5 78.1<br />

White 73.0 73.3 74.0 71.9 72.1 72.3 72.9 72.3 73.1 74.4 75.2<br />

Black 81.3 81.0 80.9 79.5 80.1 79.3 79.8 80.0 80.3 79.8 80.9<br />

Other race 75.9 76.3 78.9 77.5 77.6 79.4 82.5 77.5 81.7 83.0 84.9<br />

Diabetes 70.5 69.5 69.2 69.6 70.0 69.8 71.4 71.6 73.5 74.4 74.8<br />

Hypertension 81.2 80.2 79.4 78.0 77.4 78.9 78.4 77.4 77.8 78.5 79.6<br />

Glomerulonephritis 86.0 84.2 83.8 83.1 83.0 83.6 82.0 81.8 82.7 82.8 83.7<br />

Other cause 76.0 77.0 79.6 75.7 76.6 74.7 76.6 75.8 75.2 75.7 76.9<br />

All 75.8 76.0 76.5 74.6 74.9 74.9 75.5 75.0 75.7 76.5 77.4<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.10 I.10 (continued)<br />

One-year survival probabilities: incident dialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

one<br />

one<br />

year<br />

year<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

598<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 77.9 86.2 83.0 84.9 84.9 87.4 86.0 85.4 81.9 80.1 85.2 87.9<br />

5-9 95.8 94.0 92.2 100.0 97.8 91.9 97.4 100.0 96.9 95.7 96.9 91.3<br />

10-14 97.1 92.1 94.3 98.7 97.4 95.9 96.3 97.2 96.7 96.3 97.6 95.3<br />

15-19 95.6 96.6 96.6 95.3 97.2 96.3 97.8 95.5 97.3 97.3 96.9 96.7<br />

20-29 92.0 92.7 91.8 91.7 91.5 93.4 94.9 94.1 94.6 92.9 94.2 93.1<br />

30-39 88.1 88.7 88.0 88.7 87.3 89.2 90.1 90.1 90.0 90.1 90.5 90.8<br />

40-49 86.9 87.3 88.0 87.7 88.5 88.9 89.4 88.2 88.9 88.8 88.3 88.2<br />

50-59 83.8 84.8 84.7 85.6 85.3 85.0 85.4 85.0 85.6 85.0 85.4 85.2<br />

60-64 79.1 79.1 80.8 80.6 79.8 81.5 81.6 79.8 80.9 80.5 81.3 80.6<br />

65-69 75.2 75.5 77.1 76.2 76.9 77.8 76.7 76.2 76.4 76.9 76.6 76.5<br />

70-79 68.2 68.5 69.9 70.0 70.2 70.9 69.8 70.0 69.6 69.5 69.7 69.5<br />

80+ 59.3 58.5 61.0 61.0 60.3 60.2 59.5 57.5 58.4 57.9 57.9 58.9<br />

Male 77.8 77.8 79.1 78.9 78.6 79.2 78.8 78.3 78.5 78.1 78.4 77.9<br />

Female 78.0 78.4 78.8 78.8 78.8 78.9 78.2 77.3 77.3 77.0 77.0 76.7<br />

White 74.8 74.9 76.1 76.1 76.1 76.4 75.4 75.0 75.3 75.0 74.8 74.6<br />

Black 83.2 83.7 83.6 83.3 82.8 83.6 83.7 82.5 82.4 81.7 82.4 81.7<br />

Other race 86.9 85.9 86.8 85.6 84.0 82.9 84.1 82.7 82.9 83.7 84.8 84.1<br />

†Hispanic 83.4 82.7 83.0 82.8 84.0 83.5 82.6<br />

†Non-Hispanic 78.5 78.0 77.2 77.3 76.7 76.9 76.6<br />

Diabetes 76.8 77.0 78.7 78.4 78.2 78.5 77.9 77.2 77.8 77.7 77.9 77.6<br />

Hypertension 76.8 76.9 77.4 77.6 78.3 78.3 77.2 76.7 76.5 76.3 76.3 76.3<br />

Glomerulonephritis 84.7 86.2 87.5 85.9 86.3 87.2 87.3 87.3 86.5 87.0 87.0 86.8<br />

Other cause 77.5 77.3 77.0 77.6 75.8 76.6 77.0 76.0 75.9 74.5 74.9 73.9<br />

All 77.9 78.1 79.0 78.9 78.7 79.1 78.5 77.8 77.9 77.6 77.7 77.4<br />

ADJUSTED<br />

0-19 87.2 89.2 88.5 91.3 91.4 90.3 92.2 90.5 91.2 89.4 91.4 90.3<br />

20-44 87.8 88.1 87.7 88.2 87.7 89.4 90.1 89.6 89.9 89.7 89.8 89.7<br />

45-64 82.8 83.6 84.4 84.6 84.5 84.9 85.4 84.5 85.2 84.8 85.2 84.9<br />

65-74 73.1 73.7 75.5 74.6 75.4 76.2 75.3 75.2 75.3 75.4 75.3 74.9<br />

75+ 63.5 63.0 64.3 65.1 64.5 64.9 64.0 63.3 63.4 63.2 63.4 63.9<br />

Male 76.6 76.8 78.3 78.3 78.1 79.2 79.2 78.8 79.3 79.0 79.2 79.1<br />

Female 77.9 78.5 79.0 79.2 79.4 79.7 79.4 78.6 78.7 78.7 78.8 78.7<br />

White 74.9 75.3 76.8 77.1 77.3 78.0 77.5 77.2 77.7 77.6 77.5 77.6<br />

Black 80.8 81.3 81.3 81.1 80.8 81.8 82.2 81.0 80.9 80.4 81.0 80.6<br />

Other race 85.6 84.8 85.9 84.8 83.8 83.2 84.3 82.8 83.4 84.1 85.0 84.5<br />

Diabetes 75.5 75.9 77.7 77.7 77.5 78.1 77.8 77.1 77.9 78.0 78.2 78.1<br />

Hypertension 79.1 79.2 79.8 80.0 80.8 81.1 80.4 80.0 80.0 80.0 79.9 80.2<br />

Glomerulonephritis 82.3 83.9 85.3 83.9 84.2 85.6 85.5 85.5 85.0 85.2 85.0 85.1<br />

Other cause 76.0 75.9 75.4 76.1 74.7 75.7 76.4 75.4 75.4 74.2 74.6 73.8<br />

All 77.2 77.6 78.6 78.7 78.7 79.5 79.3 78.7 79.0 78.9 79.0 78.9<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.11 I.11<br />

Two-year survival probabilities: incident dialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

two<br />

two<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 84.5 90.0 86.2 82.6 83.2 77.7 79.0 82.4 71.5 77.1 71.0<br />

5-9 89.5 92.3 91.1 89.2 85.7 90.1 86.7 100.0 98.4 95.5 86.8<br />

10-14 95.0 94.8 94.3 96.9 90.8 94.9 95.8 99.0 90.2 95.9 90.9<br />

15-19 94.2 90.2 91.8 90.1 93.6 90.7 89.6 93.8 94.3 95.9 94.1<br />

20-29 82.8 84.6 84.8 83.4 84.3 80.8 85.0 81.7 85.3 84.9 83.8<br />

30-39 78.8 79.8 77.7 80.2 75.9 75.9 75.9 76.8 78.9 78.2 78.6<br />

40-49 76.6 75.8 75.5 75.0 75.2 75.2 74.2 74.2 76.2 75.8 78.1<br />

50-59 70.8 70.4 70.5 67.8 66.8 66.8 66.9 67.4 68.1 69.3 69.4<br />

60-64 64.1 61.9 61.9 61.9 59.1 58.8 60.6 59.3 60.5 61.0 61.5<br />

65-69 55.0 55.9 55.9 52.3 55.3 53.0 53.8 55.2 56.0 55.9 56.4<br />

70-79 47.0 49.0 49.5 44.4 46.6 47.0 46.4 45.6 46.7 47.8 47.9<br />

80+ 31.0 33.6 37.8 30.4 36.6 35.8 35.1 32.9 33.3 37.7 37.0<br />

Male 65.2 66.0 65.1 61.2 61.4 59.4 59.9 59.5 60.6 61.3 61.5<br />

Female 67.9 67.2 66.6 63.0 63.2 62.9 62.0 61.4 62.7 62.6 62.5<br />

599<br />

White 63.6 63.7 62.9 58.4 58.4 57.2 56.7 56.1 56.6 57.2 57.1<br />

Black 72.6 73.1 72.1 69.0 69.9 68.7 68.9 68.5 70.7 70.0 70.3<br />

Other race 69.1 66.1 70.9 67.4 67.7 65.5 68.3 66.2 69.8 72.1 73.6<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 56.4 54.6 52.8 54.6 52.1 52.3 53.1 54.0 56.2 57.4 57.0<br />

Hypertension 70.9 68.3 66.5 62.7 63.6 62.4 61.0 59.8 61.1 61.4 61.0<br />

Glomerulonephritis 80.2 78.0 76.9 75.2 75.3 72.9 72.1 72.2 74.0 72.6 74.4<br />

Other cause 63.8 66.8 68.9 60.4 63.2 62.3 63.6 62.6 62.4 63.6 65.0<br />

All 66.4 66.6 65.8 62.0 62.2 61.1 60.9 60.4 61.6 61.9 62.0<br />

ADJUSTED<br />

0-19 88.3 84.6 85.7 83.4 83.5 82.0 81.2 89.2 83.5 88.2 82.2<br />

20-44 75.7 78.1 77.3 77.8 75.8 75.1 76.3 75.9 78.2 77.7 78.6<br />

45-64 67.0 65.7 66.3 65.0 63.9 63.9 64.8 64.7 65.9 67.3 68.0<br />

65-74 50.9 52.6 53.8 48.7 51.9 50.5 51.0 52.0 53.2 53.6 54.0<br />

75+ 38.9 41.9 40.5 36.2 40.3 40.9 40.2 38.1 38.9 42.2 41.8<br />

Male 57.9 59.0 58.8 56.0 56.6 55.6 56.8 56.4 57.7 59.2 59.7<br />

Female 60.9 60.7 61.2 58.8 59.7 60.0 59.9 60.0 61.1 62.0 62.2<br />

White 55.5 56.2 56.6 53.7 54.4 54.2 54.6 54.7 55.5 57.3 57.5<br />

Black 66.8 66.3 65.8 63.9 64.5 63.6 64.5 64.1 66.1 65.6 66.4<br />

Other race 60.9 59.6 62.4 61.2 61.6 61.3 64.8 62.6 66.7 69.6 71.6<br />

Diabetes 51.0 49.3 48.2 50.2 48.4 48.8 50.1 51.2 53.6 55.3 55.2<br />

Hypertension 67.2 65.9 65.2 62.4 63.6 63.5 63.2 62.3 63.5 64.3 64.4<br />

Glomerulonephritis 72.6 71.0 70.7 69.4 70.1 68.7 68.0 68.0 69.7 69.1 70.8<br />

Other cause 60.4 62.3 64.8 59.1 61.2 60.3 62.0 61.2 60.6 62.2 63.1<br />

All 59.3 59.8 59.9 57.3 58.1 57.7 58.2 58.1 59.4 60.5 60.9<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.11 I.11 (continued) (continued)<br />

Two-year survival probabilities: incident dialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

two<br />

two<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

600<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />

0-4 75.2 83.0 75.7 76.8 79.4 82.4 80.3 79.0 80.7 70.7 77.6<br />

5-9 95.8 94.0 85.8 96.1 97.8 90.0 97.4 94.1 92.9 95.7 93.6<br />

10-14 96.0 87.8 90.6 96.6 94.3 93.1 92.2 93.4 96.7 94.7 93.0<br />

15-19 92.0 94.7 91.9 93.0 94.0 90.3 92.7 91.9 92.7 91.5 93.5<br />

20-29 84.3 85.9 86.0 86.0 85.3 87.5 88.7 89.3 89.4 87.2 88.6<br />

30-39 77.3 78.7 78.9 78.6 78.9 80.2 81.9 81.4 82.2 82.4 83.1<br />

40-49 74.5 76.6 76.4 77.1 78.3 78.2 79.4 78.5 78.8 78.8 78.9<br />

50-59 69.6 70.8 71.3 72.6 71.8 72.3 72.4 71.6 72.8 72.6 73.0<br />

60-64 62.4 62.6 64.9 65.1 64.0 66.1 66.1 64.5 66.3 66.2 67.0<br />

65-69 56.6 58.0 59.8 58.6 59.4 60.6 58.9 59.1 59.3 60.6 61.8<br />

70-79 48.3 49.0 49.9 50.3 50.7 51.7 49.9 51.0 51.0 50.6 51.7<br />

80+ 36.1 36.9 37.6 38.5 38.4 38.3 37.1 37.1 37.4 37.2 37.8<br />

Male 61.1 61.8 63.2 63.2 63.2 63.6 63.0 63.0 63.4 63.4 63.8<br />

Female 61.6 62.7 62.8 63.0 62.8 63.4 62.1 61.7 61.9 61.4 62.5<br />

White 56.4 57.2 58.0 58.4 58.4 58.8 57.5 57.8 58.5 58.3 58.6<br />

Black 69.4 70.6 70.8 70.7 70.4 71.5 71.1 69.8 69.7 69.3 70.4<br />

Other race 74.9 74.1 75.0 72.8 70.8 69.9 71.0 69.9 71.2 71.4 73.8<br />

†Hispanic 69.3 68.6 69.2 70.1 72.1 71.0<br />

†Non-Hispanic 62.7 61.8 61.5 61.7 61.1 62.1<br />

Diabetes 57.7 58.7 60.4 60.2 60.3 60.9 60.1 59.9 61.0 61.2 61.9<br />

Hypertension 60.5 61.5 61.4 62.3 63.0 63.2 61.5 61.5 61.3 61.1 61.7<br />

Glomerulonephritis 71.7 74.2 75.5 74.5 75.1 75.9 75.9 76.8 75.7 76.4 77.5<br />

Other cause 63.4 63.8 63.8 64.1 62.4 63.2 63.2 62.6 62.7 61.2 62.4<br />

All 61.3 62.2 63.0 63.1 63.0 63.5 62.6 62.4 62.7 62.5 63.2<br />

ADJUSTED<br />

0-19 83.0 85.5 80.6 85.8 85.9 82.5 84.7 83.8 86.3 81.6 84.4<br />

20-44 76.7 78.0 77.7 78.4 78.6 79.9 81.7 80.8 81.5 81.5 81.6<br />

45-64 68.1 69.3 70.6 71.4 71.0 71.9 72.3 71.4 72.6 72.6 73.1<br />

65-74 54.4 55.8 57.0 56.5 57.7 58.6 57.1 57.8 58.2 58.4 59.8<br />

75+ 41.8 42.3 43.2 43.9 43.4 44.6 42.8 43.5 43.7 43.5 44.1<br />

Male 59.8 60.7 62.4 62.7 62.9 64.0 63.8 64.0 64.9 65.0 65.4<br />

Female 62.0 63.3 63.4 64.0 64.1 65.1 64.2 64.0 64.4 64.3 65.4<br />

White 57.5 58.6 59.8 60.5 60.9 61.8 61.1 61.6 62.5 62.6 63.0<br />

Black 65.9 67.1 67.5 67.6 67.5 68.9 68.8 67.6 67.4 67.5 68.6<br />

Other race 73.2 72.8 73.8 71.8 70.9 70.5 71.7 70.3 72.2 72.2 74.3<br />

Diabetes 56.2 57.4 59.3 59.4 59.6 60.6 60.1 60.0 61.4 61.8 62.5<br />

Hypertension 64.2 65.0 65.4 66.2 67.0 67.6 66.4 66.6 66.6 66.6 67.0<br />

Glomerulonephritis 68.5 70.9 72.1 71.7 72.0 73.4 73.2 74.1 73.6 73.8 74.4<br />

Other cause 61.8 62.4 62.0 62.5 61.3 62.3 62.7 62.0 62.3 61.1 62.1<br />

All 60.8 62.0 62.9 63.3 63.5 64.5 64.0 64.0 64.6 64.7 65.4<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.12 I.12<br />

Three-year survival probabilities: incident dialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

three<br />

three<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 84.5 85.9 86.2 75.1 73.9 77.7 76.5 72.5 66.3 70.8 68.4<br />

5-9 89.5 92.3 91.1 80.3 85.7 84.1 82.1 89.5 91.4 95.5 79.2<br />

10-14 95.0 85.9 94.3 92.8 90.8 90.3 89.9 90.2 87.8 94.0 89.4<br />

15-19 90.0 87.4 91.0 88.7 91.9 86.7 83.4 90.3 91.1 89.6 90.6<br />

20-29 77.3 79.2 78.7 77.7 76.8 73.5 77.0 75.8 79.7 78.7 77.3<br />

30-39 73.1 72.0 67.2 71.7 67.4 66.7 66.6 67.3 70.7 69.7 70.2<br />

40-49 67.3 66.6 66.0 64.0 64.4 64.8 63.5 64.0 66.3 64.9 67.2<br />

50-59 59.8 59.1 58.0 55.6 54.9 53.5 53.8 55.4 55.9 56.7 57.1<br />

60-64 51.9 49.7 48.4 48.7 46.0 45.7 46.1 46.1 47.8 47.7 48.1<br />

65-69 40.5 42.9 42.3 38.3 41.4 39.6 39.9 41.2 42.5 41.6 41.7<br />

70-79 33.6 34.3 35.0 30.0 32.3 32.5 31.9 31.9 33.0 33.8 33.1<br />

80+ 18.6 20.8 18.9 18.2 21.4 21.8 20.8 21.5 20.1 23.0 22.3<br />

Male 53.9 54.0 52.3 48.2 48.5 45.7 45.9 46.8 47.9 48.4 48.3<br />

Female 56.8 56.2 54.0 50.6 50.6 50.6 49.2 48.9 50.7 49.4 49.3<br />

601<br />

White 52.0 51.4 49.8 45.3 45.2 43.5 42.5 42.7 43.1 43.2 42.7<br />

Black 62.1 63.3 60.0 57.1 57.8 56.9 56.9 57.4 60.2 58.5 59.0<br />

Other race 58.9 53.1 58.8 56.8 54.5 52.7 54.5 54.4 58.6 60.2 62.7<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 42.3 41.4 38.2 39.3 37.7 37.5 38.4 39.7 41.8 42.1 42.2<br />

Hypertension 60.3 57.0 53.5 50.9 50.1 50.0 48.1 47.5 49.3 49.2 48.5<br />

Glomerulonephritis 72.0 68.2 66.7 65.8 64.9 59.8 60.0 61.0 63.3 61.0 62.9<br />

Other cause 52.5 55.3 56.9 47.8 51.7 50.8 50.8 51.3 51.6 52.6 53.0<br />

All 55.2 55.0 53.1 49.3 49.5 48.0 47.5 47.8 49.2 48.9 48.8<br />

ADJUSTED<br />

0-19 83.9 78.4 85.0 78.8 80.5 76.4 73.5 80.2 78.2 80.7 77.3<br />

20-44 68.4 69.6 67.3 68.8 66.6 65.1 66.5 66.5 69.5 68.8 69.5<br />

45-64 55.1 53.8 53.3 52.0 51.1 50.7 51.1 52.1 53.6 54.4 55.3<br />

65-74 36.8 38.8 39.1 34.3 38.0 36.8 36.5 37.9 39.6 39.3 39.4<br />

75+ 25.3 27.6 25.9 22.9 24.9 26.1 26.3 25.6 25.3 28.1 26.8<br />

Male 46.0 46.5 45.7 43.0 43.9 42.3 43.2 44.0 45.3 46.7 46.8<br />

Female 49.1 49.0 48.3 46.5 47.2 47.9 47.4 47.9 49.4 49.3 49.5<br />

White 43.4 43.6 43.5 40.8 41.8 41.2 41.2 42.0 42.8 44.2 44.0<br />

Black 55.3 55.4 52.6 51.2 51.7 51.2 52.0 52.5 55.0 53.6 54.4<br />

Other race 49.9 46.7 49.1 50.0 47.8 48.8 51.1 50.7 55.3 57.8 60.6<br />

Diabetes 37.3 36.5 34.1 35.3 34.6 34.7 35.8 37.5 39.5 40.4 40.7<br />

Hypertension 56.2 54.6 52.7 51.0 50.9 51.9 51.1 50.9 52.3 53.0 52.8<br />

Glomerulonephritis 62.7 60.1 59.6 59.4 59.3 55.5 55.8 56.6 58.9 57.3 58.9<br />

Other cause 49.1 50.7 52.6 46.7 50.1 49.0 49.7 50.2 50.1 51.6 51.3<br />

All 51.3 50.8 50.6 48.6 49.2 48.4 48.7 49.6 51.0 51.8 52.0<br />

47.4 47.7 46.9 44.6 45.5 45.0 45.2 45.9 47.2 47.9 48.1<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.12 I.12 (continued)<br />

Three-year survival probabilities: incident dialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

three<br />

three<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

602<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />

0-4 67.9 78.8 68.9 74.9 77.5 74.3 72.5 79.0 78.0 66.9<br />

5-9 95.8 90.2 77.4 90.9 92.9 87.0 97.4 91.6 89.8 93.4<br />

10-14 89.3 83.1 85.0 88.2 91.1 89.3 89.2 93.4 95.2 93.4<br />

15-19 89.8 92.8 88.6 90.9 89.9 87.6 90.2 87.9 88.0 88.5<br />

20-29 78.8 79.7 80.4 80.3 80.4 82.7 84.0 84.2 83.9 82.4<br />

30-39 68.7 69.5 70.9 71.0 71.0 73.3 74.4 74.5 75.1 75.9<br />

40-49 64.2 65.9 66.3 67.4 68.6 68.8 70.1 68.9 69.6 69.4<br />

50-59 57.2 57.5 58.9 59.8 59.8 60.1 60.8 60.5 61.6 61.8<br />

60-64 48.8 48.8 50.8 51.8 50.6 52.1 53.4 52.2 53.1 53.8<br />

65-69 42.2 43.3 45.1 44.6 45.5 45.9 45.3 45.5 45.7 47.3<br />

70-79 34.1 34.0 35.6 35.3 35.8 36.9 35.7 36.4 36.6 37.0<br />

80+ 22.0 22.8 23.0 23.3 23.2 24.4 23.1 22.4 23.1 23.9<br />

Male 48.2 48.0 50.0 50.1 50.5 50.8 50.4 50.6 50.9 51.3<br />

Female 48.5 49.4 49.9 49.8 49.7 50.3 49.7 49.1 49.3 49.5<br />

White 42.4 42.5 43.9 44.0 44.3 44.6 43.9 44.3 44.8 45.2<br />

Black 58.2 58.9 59.5 59.5 59.4 60.5 60.3 58.8 58.9 59.2<br />

Other race 63.1 62.4 63.1 62.3 58.8 58.2 59.2 58.8 60.5 60.9<br />

†Hispanic 57.1 57.0 58.0 58.7 61.5<br />

†Non-Hispanic 49.7 49.2 48.8 49.0 48.9<br />

Diabetes 42.8 43.4 45.3 45.6 45.6 46.2 46.1 45.9 47.0 47.7<br />

Hypertension 48.0 48.4 48.8 49.1 50.5 50.8 49.4 49.4 49.3 49.5<br />

Glomerulonephritis 61.3 62.7 65.1 64.3 64.7 65.1 66.4 66.6 65.3 67.3<br />

Other cause 52.6 52.3 53.3 53.3 52.1 52.5 52.7 52.3 52.6 51.4<br />

All 48.4 48.7 49.9 50.0 50.1 50.5 50.1 49.9 50.2 50.5<br />

ADJUSTED<br />

0-19 77.7 81.3 73.9 80.2 80.2 77.4 80.0 79.7 80.7 77.6<br />

20-44 67.9 68.8 69.1 70.0 70.3 72.3 73.7 73.2 73.7 73.8<br />

45-64 55.6 56.0 58.0 59.0 59.0 59.7 60.9 60.3 61.3 61.9<br />

65-74 40.1 41.1 42.6 42.0 43.4 44.2 43.3 43.9 44.5 45.4<br />

75+ 27.8 27.4 28.7 28.9 28.4 29.8 28.8 28.9 29.3 29.9<br />

Male 47.4 47.4 49.7 50.0 50.5 51.7 51.7 52.1 53.0 53.5<br />

Female 49.5 50.6 51.1 51.5 51.8 52.7 52.6 52.2 52.6 53.2<br />

White 44.5 45.0 46.8 47.2 47.9 48.9 48.8 49.3 50.1 50.7<br />

Black 54.3 55.0 55.7 55.9 56.1 57.5 57.7 56.3 56.4 57.1<br />

Other race 61.6 61.2 61.9 61.4 59.1 59.3 60.5 59.6 62.0 62.2<br />

Diabetes 41.6 42.5 44.5 45.0 45.2 46.3 46.5 46.4 47.7 48.7<br />

Hypertension 52.8 52.9 53.7 54.1 55.4 56.3 55.3 55.6 55.6 56.1<br />

Glomerulonephritis 58.1 59.1 61.3 61.3 61.2 62.4 63.4 63.3 62.8 64.3<br />

Other cause 51.2 51.1 51.8 51.9 51.1 51.8 52.4 51.9 52.3 51.6<br />

All 52.1 52.8 53.5 54.2 54.3 55.0 55.4 55.2 55.9 56.1<br />

48.4 48.9 50.4 50.7 51.1 52.1 52.2 52.1 52.8 53.4<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.13 I.13<br />

Five-year survival probabilities: incident dialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

five<br />

five<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 84.5 79.3 86.2 75.1 60.9 67.7 72.0 72.5 66.3 70.8 57.9<br />

5-9 89.5 92.3 69.4 80.3 85.7 75.7 77.0 89.5 91.4 76.4 79.2<br />

10-14 82.3 76.4 88.1 92.8 84.7 90.3 80.9 86.6 73.3 85.3 84.9<br />

15-19 87.7 81.0 79.9 85.4 84.6 72.9 76.0 84.0 79.6 79.6 84.2<br />

20-29 73.4 68.1 68.9 66.1 63.2 60.9 66.7 64.7 68.4 65.3 66.3<br />

30-39 60.0 59.5 53.9 56.5 54.4 52.8 52.2 50.7 56.5 56.8 55.4<br />

40-49 53.2 50.6 50.3 46.8 48.9 47.9 47.6 48.3 49.7 47.4 48.8<br />

50-59 40.7 40.9 39.6 37.2 35.9 35.1 36.2 37.4 36.5 36.3 36.2<br />

60-64 32.0 31.5 29.7 29.5 26.6 27.0 28.4 26.8 28.7 28.1 28.8<br />

65-69 23.6 25.1 24.3 20.7 22.4 22.4 21.9 22.8 23.0 22.9 22.8<br />

70-79 16.1 16.4 17.4 14.0 15.3 15.7 14.9 15.7 15.8 16.3 15.7<br />

80+ 7.6 6.5 6.5 6.4 7.4 7.9 7.5 7.8 7.1 9.2 9.0<br />

Male 37.3 35.6 34.2 30.2 29.8 28.5 28.9 29.1 30.0 30.2 29.9<br />

Female 39.3 39.7 36.8 33.2 32.8 32.3 31.5 31.1 31.9 30.6 30.5<br />

603<br />

White 35.3 33.2 31.8 27.5 27.0 25.9 25.3 24.8 24.7 24.6 24.0<br />

Black 44.7 46.8 42.7 39.0 39.3 38.4 39.1 39.2 41.7 40.0 40.5<br />

Other race 38.2 39.0 46.1 42.2 37.7 36.2 39.0 41.4 41.5 43.2 41.8<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 26.4 23.5 20.1 21.1 19.5 19.1 21.0 21.0 22.9 22.2 22.2<br />

Hypertension 44.3 39.4 36.2 33.4 32.4 32.4 30.5 30.2 31.7 31.1 31.0<br />

Glomerulonephritis 57.0 52.8 49.9 46.3 45.1 41.2 42.3 43.3 44.5 43.7 44.6<br />

Other cause 34.6 37.6 39.3 31.4 34.3 34.5 34.5 34.9 34.1 36.0 35.9<br />

All 38.2 37.5 35.5 31.6 31.2 30.3 30.1 30.1 31.0 30.4 30.2<br />

ADJUSTED<br />

0-19 77.8 69.5 70.9 . 71.0 63.0 65.1 74.3 66.2 68.9 70.1<br />

20-44 56.5 55.5 53.1 52.3 52.2 50.0 52.3 51.2 54.0 54.1 54.3<br />

45-64 35.6 35.1 34.6 33.1 31.9 31.8 33.4 33.5 34.5 34.4 34.9<br />

65-74 19.5 20.9 21.1 17.4 19.2 19.6 18.9 20.3 20.7 20.9 21.0<br />

75+ 10.9 11.1 11.0 8.9 10.6 11.0 10.8 10.7 10.4 12.2 11.1<br />

Male 30.0 29.0 28.9 26.2 26.6 26.6 27.5 27.7 28.5 29.7 29.4<br />

Female 31.9 32.9 31.9 30.0 30.6 30.6 30.7 31.2 31.6 31.5 31.7<br />

White 27.5 26.7 26.9 24.6 25.2 25.3 25.4 25.6 26.0 27.1 26.7<br />

Black 37.1 38.3 35.2 33.2 33.6 33.1 34.5 34.9 36.5 35.3 36.2<br />

Other race 30.1 33.6 36.4 36.0 31.9 33.5 36.4 38.3 38.7 41.6 40.4<br />

Diabetes 22.7 20.2 17.8 18.7 18.1 18.1 19.8 20.0 21.7 21.6 21.7<br />

Hypertension 40.5 37.4 36.5 34.5 34.2 35.2 34.5 34.8 35.6 35.8 36.1<br />

Glomerulonephritis 46.4 44.3 43.0 40.4 40.4 38.1 39.1 39.7 40.9 41.0 41.1<br />

Other cause 31.8 33.8 35.8 30.9 33.6 33.7 34.4 34.7 33.4 35.9 35.0<br />

All 30.9 30.8 30.3 28.0 28.5 28.5 29.0 29.3 30.0 30.5 30.5<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.13 I.13 (continued)<br />

Five-year survival probabilities: incident dialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

five<br />

five<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

604<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998<br />

0-4 62.0 68.7 62.8 66.4 70.8 66.7 67.3 70.8<br />

5-9 95.8 78.9 71.9 88.2 78.4 87.0 97.4 87.9<br />

10-14 83.3 78.8 78.6 81.1 86.0 86.7 86.8 81.2<br />

15-19 82.6 87.0 79.7 83.3 85.2 81.5 84.2 79.2<br />

20-29 67.3 69.3 70.9 71.2 72.1 73.9 74.4 74.2<br />

30-39 54.8 56.1 58.4 57.8 58.3 59.7 61.7 61.4<br />

40-49 47.4 48.8 49.4 50.5 52.1 51.5 53.0 52.0<br />

50-59 37.8 37.7 39.5 39.9 40.0 39.9 40.9 41.0<br />

60-64 28.6 29.2 30.6 31.3 29.9 31.4 32.7 32.3<br />

65-69 21.8 23.7 24.0 24.9 24.4 25.1 24.3 25.7<br />

70-79 16.2 15.9 16.7 16.6 17.3 17.9 17.2 18.1<br />

80+ 7.9 7.7 8.1 8.4 8.9 8.8 8.4 8.4<br />

Male 29.7 29.8 31.3 31.6 32.1 32.0 31.8 32.3<br />

Female 29.7 30.4 30.8 30.9 30.7 30.8 30.7 30.7<br />

White 23.6 24.0 24.8 25.1 25.0 25.1 24.5 25.4<br />

Black 39.7 40.1 40.9 41.0 41.7 42.0 42.1 41.1<br />

Other race 42.8 43.0 44.2 43.5 39.8 39.4 41.9 42.0<br />

†Hispanic 38.1 37.7 39.2<br />

†Non-Hispanic 30.5 30.4 30.5<br />

Diabetes 22.7 23.5 24.6 25.1 25.0 25.4 25.5 26.0<br />

Hypertension 29.8 30.4 30.5 31.0 32.5 32.4 31.7 31.7<br />

Glomerulonephritis 44.0 44.6 47.2 46.3 47.8 47.8 48.3 49.7<br />

Other cause 35.8 36.1 37.6 37.9 36.5 36.7 37.3 37.1<br />

All 29.7 30.1 31.0 31.2 31.4 31.4 31.3 31.5<br />

ADJUSTED<br />

0-19 69.5 72.9 64.1 70.9 72.9 70.8 73.9 68.0<br />

20-44 53.2 54.6 55.5 56.4 56.8 57.8 59.3 58.9<br />

45-64 36.1 36.5 38.5 39.2 39.3 39.9 41.4 41.2<br />

65-74 20.5 22.0 22.4 22.9 23.1 24.0 23.2 24.5<br />

75+ 11.7 10.7 11.5 11.4 12.2 12.8 12.2 12.8<br />

Male 30.0 30.1 31.8 32.2 32.8 33.7 33.7 34.4<br />

Female 31.7 32.6 32.9 33.5 33.7 34.3 34.6 34.8<br />

White 27.0 27.7 28.9 29.4 29.7 30.6 30.5 31.6<br />

Black 36.1 36.4 37.2 37.5 38.5 39.0 39.5 38.7<br />

Other race 42.6 42.8 43.7 43.4 41.1 41.5 44.1 43.7<br />

Diabetes 22.6 23.4 24.7 25.4 25.4 26.1 26.5 27.1<br />

Hypertension 35.5 35.7 36.2 36.6 38.0 38.6 38.2 38.5<br />

Glomerulonephritis 41.7 41.6 43.7 43.6 44.3 45.1 45.2 46.4<br />

Other cause 35.2 35.6 36.6 37.0 35.9 36.5 37.4 37.2<br />

All 30.7 31.3 32.4 32.8 33.2 33.9 34.1 34.6<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.14 I.14<br />

Ten-year survival probabilities: incident dialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

ten<br />

ten<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<br />

0-4 72.4 68.0 69.0 62.6 53.3 37.0 72.0 65.9 45.0 63.0 42.2 57.6 60.2 56.3<br />

5-9 89.5 71.2 52.1 80.3 85.7 63.0 77.0 78.3 91.4 66.9 67.9 42.6 71.8 35.9<br />

10-14 61.4 60.8 63.0 83.0 67.2 82.1 65.9 86.6 54.4 64.5 61.5 72.2 65.1 73.0<br />

15-19 79.1 63.1 64.6 73.8 65.8 58.5 58.2 60.1 68.2 69.1 65.5 68.4 64.2 65.9<br />

20-29 54.5 47.5 48.3 46.7 44.9 44.0 46.3 45.1 46.9 44.3 46.3 45.2 48.3 52.9<br />

30-39 38.7 36.5 32.5 34.5 33.5 31.3 30.0 29.6 31.3 33.7 32.8 32.6 33.6 34.8<br />

40-49 26.7 23.8 23.7 22.7 25.0 22.6 21.5 22.5 24.1 20.5 21.8 20.5 22.4 22.5<br />

50-59 13.8 14.3 14.4 12.0 12.0 12.9 12.0 12.1 11.4 11.2 11.0 12.0 11.6 11.7<br />

60-64 8.3 8.1 6.7 7.7 7.3 7.9 7.4 6.7 7.3 6.4 6.5 6.8 6.9 7.5<br />

65-69 4.9 5.7 4.4 4.8 5.3 5.9 4.7 4.3 4.6 4.3 4.7 4.0 4.4 4.8<br />

70-79 2.8 2.5 3.0 2.4 3.0 2.8 2.3 2.7 2.6 2.3 2.0 1.9 2.1 2.3<br />

80+ 2.0 1.0 1.9 0.2 1.3 0.9 0.8 0.9 0.6 0.8 0.5 0.8 0.6 0.7<br />

Male 14.4 13.0 12.2 10.9 11.3 10.7 10.5 10.3 10.2 9.8 10.2 9.7 10.2 10.6<br />

Female 16.5 15.8 13.8 12.5 12.2 11.9 10.4 10.1 10.9 9.8 9.2 9.2 9.2 9.6<br />

605<br />

White 14.2 12.0 11.1 9.5 9.7 8.9 7.9 7.9 7.5 6.7 6.8 6.5 6.7 7.0<br />

Black 18.0 19.1 16.4 15.3 15.2 15.5 14.7 13.9 15.7 15.1 14.3 14.3 14.6 14.8<br />

Other race 16.6 17.7 21.2 18.4 19.2 15.7 18.1 16.6 16.7 16.2 17.2 16.3 16.2 18.3<br />

Diabetes 8.1 6.1 5.1 5.0 5.0 5.0 4.7 4.9 5.2 4.4 4.5 4.6 4.6 5.0<br />

Hypertension 18.6 15.2 12.3 12.1 11.7 11.2 10.2 9.3 10.5 10.2 9.6 9.6 10.1 10.1<br />

Glomerulonephritis 31.7 25.3 21.6 20.1 20.6 19.6 19.1 18.7 18.6 18.6 19.4 18.1 20.5 21.6<br />

Other cause 12.5 14.1 15.8 12.7 14.0 14.4 13.7 14.5 14.7 14.6 15.3 15.4 15.5 16.6<br />

All 15.4 14.4 13.0 11.7 11.7 11.3 10.4 10.2 10.6 9.8 9.7 9.4 9.7 10.1<br />

ADJUSTED<br />

0-19 62.4 48.2 47.0 62.4 51.6 46.0 49.1 54.0 51.5 54.6 49.1 52.5 50.9 49.5<br />

20-44 34.5 31.3 29.3 30.3 30.6 28.8 29.0 28.5 29.6 30.1 30.3 29.7 30.8 31.8<br />

45-64 11.2 10.9 11.1 10.0 10.4 10.8 10.7 10.6 10.8 10.3 10.6 11.4 11.6 12.1<br />

65-74 3.7 4.1 3.7 3.6 4.3 4.8 3.8 3.8 3.9 3.8 3.9 3.5 4.0 4.3<br />

75+ 2.0 1.7 2.0 1.1 1.9 1.5 1.4 1.6 1.6 1.4 0.9 1.3 1.1 1.3<br />

Male 11.3 10.4 10.6 9.8 10.6 11.2 11.0 10.7 10.5 10.6 10.9 10.9 11.3 11.9<br />

Female 12.9 12.9 12.3 11.8 12.5 12.4 11.4 11.7 12.3 11.8 11.4 11.8 12.0 12.5<br />

White 10.7 9.8 10.0 9.2 10.1 10.3 9.6 9.9 9.7 9.6 9.8 9.8 10.3 10.8<br />

Black 13.2 13.9 12.5 12.3 12.5 12.9 12.4 12.2 13.2 12.6 12.3 12.7 12.7 13.1<br />

Other race 12.6 15.0 16.5 15.8 16.2 15.0 17.6 16.3 16.2 17.3 17.3 18.2 18.3 19.4<br />

Diabetes 7.1 5.6 5.0 5.0 5.3 5.6 5.0 5.3 5.5 4.8 5.1 5.3 5.4 5.9<br />

Hypertension 17.4 15.6 14.4 14.3 14.4 14.7 14.1 13.8 14.0 14.1 13.8 13.9 14.3 14.5<br />

Glomerulonephritis 22.9 19.6 18.2 17.1 18.7 18.6 17.9 17.3 17.8 17.7 17.6 17.6 18.9 19.4<br />

Other cause 12.4 13.3 14.9 13.3 14.9 15.1 14.7 15.3 15.0 15.4 15.5 15.8 15.8 16.6<br />

All 12.0 11.6 11.4 10.7 11.5 11.7 11.1 11.2 11.3 11.1 11.1 11.3 11.6 12.1<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table Table I.15 I.15<br />

Incident patient counts: hemodialysis patients, unknowns dropped<br />

dialysis dialysis patients patients alive alive on on day day 91, 91, by by age, age, gender, gender, race, race, ethnicity, ethnicity, & primary primary diagnosis diagnosis<br />

606<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 14 13 11 14 * 18 25 15 15 25 22<br />

5-9 36 34 33 20 20 11 16 26 16 20 31<br />

10-14 103 95 91 83 61 77 60 61 61 58 61<br />

15-19 303 325 270 276 245 243 224 230 283 284 246<br />

20-29 1,093 1,182 1,308 1,239 1,311 1,372 1,367 1,333 1,412 1,587 1,596<br />

30-39 1,600 1,751 1,881 1,880 2,067 2,139 2,263 2,390 2,696 2,901 2,999<br />

40-49 1,844 2,084 2,055 2,302 2,379 2,542 2,657 3,016 3,433 3,820 4,155<br />

50-59 2,823 3,319 3,484 3,540 3,714 3,954 4,126 4,459 5,225 5,608 5,900<br />

60-64 1,630 1,791 2,047 2,351 2,604 2,820 2,953 3,314 3,696 4,083 4,429<br />

65-69 1,552 1,580 1,827 2,417 2,421 2,618 3,032 3,463 3,996 4,721 5,208<br />

70-79 1,683 1,827 2,286 3,255 3,362 3,777 4,385 5,010 5,623 6,929 7,706<br />

80+ 273 287 415 655 677 826 1,042 1,232 1,526 1,949 2,297<br />

Male 7,220 7,910 8,627 9,878 10,364 11,007 11,991 13,134 14,843 17,014 18,375<br />

Female 5,734 6,378 7,081 8,154 8,506 9,390 10,159 11,415 13,139 14,971 16,275<br />

White 8,791 9,548 10,554 11,769 12,294 13,107 14,401 15,722 17,640 20,087 21,784<br />

Black 3,796 4,296 4,710 5,723 5,998 6,583 6,970 7,937 9,210 10,719 11,409<br />

Other race 367 444 444 540 578 707 779 890 1,132 1,179 1,457<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 2,016 2,979 3,734 4,341 5,308 6,064 7,013 8,046 9,450 11,522 13,140<br />

Hypertension 2,576 3,645 4,485 4,869 5,474 6,099 6,612 7,723 9,017 10,536 11,414<br />

Glomerulonephritis 2,212 2,879 3,198 3,315 3,474 3,558 3,711 4,000 4,333 4,529 4,776<br />

Cystic kidney 661 750 866 874 842 897 916 939 971 970 1,009<br />

Other urologic 367 518 655 731 711 839 879 985 1,006 1,045 942<br />

Other cause 1,396 1,743 2,119 2,264 2,368 2,465 2,547 2,484 2,714 3,055 3,133<br />

Missing cause 3,726 1,774 651 1,638 693 475 472 372 491 328 236<br />

All 12,954 14,288 15,708 18,032 18,870 20,397 22,150 24,549 27,982 31,985 34,650<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90 day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age, gender, race, or primary cause of ESRD are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table Table I.15 I.15 (continued)<br />

(continued)<br />

Incident patient counts: hemodialysis patients, unknowns dropped<br />

dialysis dialysis patients patients alive alive on on day day 91, 91, by by age, age, gender, gender, race, race, ethnicity, ethnicity, & primary primary diagnosis diagnosis<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 17 17 23 19 29 12 32 21 26 31 35 28<br />

5-9 19 17 18 31 33 28 28 35 40 34 38 47<br />

10-14 50 80 72 82 78 77 88 87 102 107 109 136<br />

15-19 258 281 270 238 287 302 292 313 348 323 324 330<br />

20-29 1,615 1,719 1,726 1,759 1,768 1,819 1,841 1,932 1,899 1,942 1,951 1,924<br />

30-39 3,085 3,381 3,404 3,686 3,754 4,028 4,116 4,149 4,380 4,291 4,320 4,332<br />

40-49 4,529 5,013 5,370 5,752 6,287 6,940 7,204 7,996 8,192 8,480 8,546 8,945<br />

50-59 6,416 7,058 7,591 8,554 8,883 9,574 10,684 11,799 12,904 13,413 14,039 14,743<br />

60-64 4,840 5,054 5,407 5,743 6,046 6,541 7,090 7,605 7,800 8,050 8,435 8,663<br />

65-69 5,633 6,185 6,390 7,017 7,072 7,933 8,358 8,741 8,872 8,944 9,312 9,556<br />

70-79 8,804 9,885 10,588 11,703 12,475 14,136 15,585 16,742 17,701 18,160 18,561 19,646<br />

80+ 2,605 3,072 3,403 3,841 4,241 5,070 5,850 6,549 7,402 7,976 8,416 9,900<br />

Male 19,825 21,733 23,285 25,306 26,540 29,859 32,370 34,938 37,102 38,277 39,702 42,389<br />

Female 18,046 20,029 20,977 23,119 24,413 26,601 28,798 31,031 32,564 33,474 34,384 35,861<br />

607<br />

White 23,521 25,772 27,173 29,587 30,686 34,240 37,406 40,361 43,160 44,860 46,181 48,830<br />

Black 12,755 14,129 14,983 16,381 17,203 18,739 20,015 21,537 22,055 22,254 23,147 24,337<br />

Other race 1,595 1,861 2,106 2,457 3,064 3,481 3,747 4,071 4,451 4,637 4,758 5,083<br />

†Hispanic 6,749 7,147 7,703 8,473 9,123 9,546 10,254<br />

†Non-Hispanic 49,711 54,021 58,266 61,193 62,628 64,540 67,996<br />

Diabetes 14,826 16,572 18,012 20,169 22,479 25,699 28,500 30,938 32,765 34,389 35,812 37,254<br />

Hypertension 12,577 14,234 14,831 16,135 14,799 16,124 17,469 18,693 19,859 20,296 21,189 22,627<br />

Glomerulonephritis 4,874 4,996 5,241 5,635 5,827 6,228 6,384 6,584 6,720 6,537 6,467 6,746<br />

Cystic kidney 1,022 1,076 1,143 1,197 1,252 1,229 1,334 1,491 1,512 1,501 1,486 1,519<br />

Other urologic 1,063 1,102 937 976 1,455 1,741 1,774 1,868 2,215 2,022 2,087 2,256<br />

Other cause 3,311 3,632 3,846 4,231 5,050 5,363 5,651 6,325 6,507 6,899 6,949 7,670<br />

Missing cause 198 150 252 82 91 76 56 70 88 107 96 178<br />

All 37,871 41,762 44,262 48,425 50,953 56,460 61,168 65,969 69,666 71,751 74,086 78,250<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90 day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age, gender, race, or primary cause of ESRD are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.16 I.16<br />

90-day survival probabilities: incident hemodialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

608<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 94.4 93.0 92.4<br />

5-9 100.0 100.0 100.0 95.8 100.0 100.0 100.0 100.0 100.0 100.0 97.2<br />

10-14 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0<br />

15-19 100.0 99.7 100.0 99.7 100.0 100.0 99.6 100.0 100.0 99.3 99.6<br />

20-29 99.8 99.7 99.9 99.9 99.7 99.8 99.7 99.7 99.5 99.5 99.5<br />

30-39 99.5 99.6 99.1 99.3 99.3 99.2 98.9 99.1 99.3 99.3 98.8<br />

40-49 99.3 99.0 99.4 98.9 99.2 99.2 99.1 98.9 99.0 99.0 98.9<br />

50-59 98.9 98.6 98.6 98.5 98.8 98.3 98.5 98.7 98.8 98.7 98.2<br />

60-64 98.1 97.8 97.7 97.4 98.1 97.8 97.3 97.5 97.6 98.0 97.3<br />

65-69 96.7 96.7 96.6 96.4 95.8 96.0 96.4 96.1 96.8 96.6 96.5<br />

70-79 95.5 95.9 95.6 95.5 94.5 94.4 94.8 95.0 94.2 94.6 95.2<br />

80+ 94.8 94.9 94.0 93.5 92.6 91.8 93.0 91.6 93.6 92.4 93.0<br />

Male 98.1 98.1 97.8 97.5 97.4 97.3 97.1 97.1 97.0 97.0 97.0<br />

Female 98.3 98.2 98.1 97.6 97.4 97.1 97.3 97.1 97.5 97.2 97.0<br />

White 98.1 97.9 97.6 97.1 97.0 96.7 96.7 96.5 96.7 96.5 96.4<br />

Black 98.6 98.6 98.8 98.5 98.3 98.2 98.1 98.2 98.1 98.2 97.9<br />

Other race 97.6 98.1 98.4 98.0 98.4 98.7 98.1 98.1 98.2 98.5 98.6<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 98.5 97.5 98.1 97.5 97.8 97.6 97.4 97.5 97.5 97.6 97.4<br />

Hypertension 98.4 98.0 97.6 97.0 96.8 96.7 96.8 96.5 96.6 96.3 96.3<br />

Glomerulonephritis 99.2 99.1 98.7 98.9 98.4 98.5 98.2 97.8 98.5 98.0 97.9<br />

Other cause 97.7 98.0 97.7 97.3 97.1 96.6 96.7 97.0 96.8 96.8 96.6<br />

All 98.2 98.1 98.0 97.6 97.4 97.2 97.2 97.1 97.2 97.1 97.0<br />

ADJUSTED<br />

0-19 . 99.5 . 98.8 . . 99.3 . 99.3 97.8 97.6<br />

20-44 99.6 99.6 99.5 99.5 99.5 99.4 99.2 99.3 99.3 99.2 99.1<br />

45-64 98.9 98.5 98.5 98.2 98.6 98.3 98.2 98.3 98.4 98.5 97.9<br />

65-74 96.8 96.8 96.5 96.3 95.6 95.6 96.0 96.1 96.0 96.0 96.2<br />

75+ 95.6 95.7 95.5 95.3 94.2 93.7 94.3 93.5 94.1 93.9 94.3<br />

Male 97.8 97.7 97.4 97.3 97.2 97.0 96.9 97.0 96.9 96.9 96.9<br />

Female 98.1 97.8 97.8 97.4 97.2 96.9 97.2 97.0 97.4 97.2 97.0<br />

White 97.8 97.5 97.2 96.9 96.8 96.5 96.6 96.6 96.8 96.6 96.6<br />

Black 98.4 98.2 98.4 98.3 97.9 97.7 97.7 97.8 97.7 97.8 97.4<br />

Other race 97.2 97.7 97.8 97.6 98.0 98.3 97.7 97.6 97.8 98.2 98.4<br />

Diabetes 97.8 96.5 97.4 96.7 97.1 96.9 96.8 97.0 97.0 97.3 97.1<br />

Hypertension 97.9 97.7 97.4 96.9 96.7 96.7 97.0 96.8 96.9 96.7 96.8<br />

Glomerulonephritis 98.6 98.5 98.0 98.3 97.8 97.9 97.7 97.1 98.0 97.6 97.5<br />

Other cause 97.3 97.6 97.2 97.1 96.9 96.2 96.5 96.8 96.6 96.7 96.4<br />

All 98.0 97.7 97.6 97.4 97.2 96.9 97.0 97.0 97.1 97.0 96.9<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.16 I.16 (continued)<br />

90-day survival probabilities: incident hemodialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 95.0 94.4 100.0 95.5 100.0 100.0 100.0 95.8 96.4 97.1 97.4 94.0<br />

5-9 100.0 100.0 100.0 97.5 100.0 100.0 100.0 100.0 97.7 100.0 100.0 100.0<br />

10-14 100.0 100.0 100.0 100.0 100.0 100.0 99.0 100.0 100.0 99.2 99.2 99.4<br />

15-19 100.0 100.0 99.7 99.3 99.7 99.7 100.0 99.7 99.5 99.7 98.9 99.7<br />

20-29 99.6 98.8 99.3 99.1 99.0 99.3 99.2 99.3 99.2 99.4 99.3 99.0<br />

30-39 98.7 98.7 98.6 98.6 99.0 98.9 98.9 98.9 99.0 98.8 98.8 99.0<br />

40-49 99.0 99.1 98.9 98.4 98.5 98.7 98.7 98.5 98.6 98.8 98.7 98.7<br />

50-59 98.7 98.5 98.3 98.3 98.2 98.1 98.2 98.1 98.1 98.4 98.1 98.1<br />

60-64 97.8 97.6 97.9 97.3 97.4 97.4 97.3 97.1 97.4 97.4 97.2 97.4<br />

65-69 96.6 96.7 96.8 96.9 96.6 96.8 96.6 96.6 96.7 96.4 96.6 96.9<br />

70-79 94.9 95.0 95.4 95.1 95.3 95.1 94.8 95.0 95.0 94.9 94.7 95.0<br />

80+ 92.9 93.8 93.2 93.6 92.7 93.3 92.3 92.5 92.7 92.6 92.6 92.9<br />

Male 97.1 96.8 97.1 96.8 96.9 96.8 96.6 96.6 96.8 96.7 96.4 96.7<br />

Female 97.0 97.2 97.0 97.0 96.7 96.8 96.5 96.4 96.4 96.4 96.5 96.4<br />

609<br />

White 96.4 96.4 96.4 96.3 96.2 96.2 95.8 95.9 96.0 96.0 95.9 96.0<br />

Black 98.0 98.0 98.1 97.8 97.8 97.8 97.8 97.6 97.6 97.5 97.3 97.4<br />

Other race 98.4 97.9 97.9 98.1 97.4 98.1 97.7 97.6 97.3 97.7 97.7 97.7<br />

†Hispanic 98.0 97.8 97.4 97.5 97.3 97.3 97.6<br />

†Non-Hispanic 96.6 96.4 96.4 96.4 96.4 96.3 96.4<br />

Diabetes 97.6 97.5 97.5 97.5 97.2 97.3 97.2 96.9 97.0 96.9 96.9 97.1<br />

Hypertension 96.3 96.5 96.7 96.3 96.4 96.6 96.0 96.2 96.2 96.2 96.0 96.0<br />

Glomerulonephritis 98.2 98.1 97.9 97.8 98.4 97.8 97.8 97.6 98.0 97.9 97.9 98.2<br />

Other cause 96.3 96.2 96.2 95.7 95.6 95.4 95.2 95.6 95.4 95.5 95.3 95.2<br />

All 97.0 97.0 97.1 96.9 96.8 96.8 96.6 96.5 96.6 96.5 96.4 96.5<br />

ADJUSTED<br />

0-19 99.3 99.4 99.4 97.7 99.4 99.5 99.4 99.0 98.4 98.7 97.4 98.4<br />

20-44 99.0 99.0 99.0 98.8 98.9 99.0 99.1 99.0 99.0 99.1 99.0 99.0<br />

45-64 98.4 98.2 98.2 97.9 98.0 97.9 97.9 97.8 97.9 98.1 97.9 98.0<br />

65-74 96.0 96.2 96.4 96.4 96.1 96.1 96.1 96.2 96.1 96.0 96.0 96.2<br />

75+ 94.2 94.4 94.4 94.1 94.2 94.4 93.6 93.6 93.9 93.8 93.7 94.0<br />

Male 97.0 96.8 97.1 96.8 97.0 96.9 96.8 96.8 97.0 96.9 96.7 97.0<br />

Female 97.0 97.2 97.1 97.1 96.8 97.0 96.7 96.7 96.7 96.7 96.8 96.8<br />

White 96.7 96.8 96.8 96.7 96.6 96.7 96.4 96.5 96.6 96.6 96.5 96.7<br />

Black 97.6 97.5 97.7 97.3 97.4 97.4 97.4 97.2 97.3 97.2 97.0 97.1<br />

Other race 98.1 97.6 97.7 97.9 97.3 98.0 97.5 97.5 97.3 97.6 97.5 97.7<br />

Diabetes 97.4 97.3 97.3 97.4 97.1 97.2 97.1 96.9 97.0 97.0 97.0 97.2<br />

Hypertension 96.8 97.0 97.2 96.9 97.0 97.2 96.8 96.9 97.0 97.0 96.8 96.9<br />

Glomerulonephritis 97.9 97.7 97.5 97.5 98.1 97.5 97.4 97.3 97.7 97.6 97.5 98.0<br />

Other cause 96.1 96.1 96.0 95.5 95.4 95.3 95.3 95.6 95.5 95.6 95.4 95.3<br />

All 97.0 97.0 97.1 96.9 96.9 96.9 96.8 96.7 96.8 96.8 96.7 96.9<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.17 I.17<br />

One-year survival probabilities: incident hemodialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

one<br />

one<br />

year<br />

year<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

610<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 100.0 90.0 88.9 91.7 90.9 93.8 86.2 85.9 55.5 72.0 67.4<br />

5-9 90.9 90.3 100.0 94.1 100.0 100.0 100.0 100.0 92.9 100.0 91.0<br />

10-14 96.9 98.0 98.7 96.9 96.5 96.8 100.0 98.0 94.2 98.4 96.7<br />

15-19 96.0 94.5 96.2 95.0 97.7 92.9 95.2 96.1 97.3 99.1 96.6<br />

20-29 91.1 92.9 92.7 93.0 92.8 90.8 93.3 90.9 91.4 91.0 91.1<br />

30-39 90.4 90.1 88.9 90.3 87.4 89.0 88.4 87.5 88.5 87.8 88.4<br />

40-49 88.4 88.1 87.2 88.4 88.0 87.8 87.3 87.1 87.7 87.5 87.8<br />

50-59 84.5 84.4 84.8 82.1 82.2 83.1 82.8 83.3 83.7 83.3 83.6<br />

60-64 80.0 78.7 79.0 78.8 76.7 76.6 77.7 76.8 77.1 77.8 77.9<br />

65-69 73.7 74.3 74.9 72.6 73.8 71.9 73.5 73.6 73.2 74.4 75.5<br />

70-79 68.6 68.9 69.5 66.1 67.4 67.0 66.7 65.6 66.3 67.3 68.7<br />

80+ 58.0 54.1 64.4 56.7 57.6 59.1 59.5 56.3 55.2 59.0 60.1<br />

Male 81.1 81.4 80.5 77.9 77.8 77.3 76.8 76.7 76.3 76.9 77.8<br />

Female 82.4 81.8 82.2 79.3 79.4 78.9 79.2 77.3 78.4 78.1 78.0<br />

White 79.9 79.6 79.2 75.8 75.5 75.0 74.9 73.6 73.6 74.1 74.4<br />

Black 85.8 85.9 85.5 83.7 84.3 83.5 83.2 83.1 83.4 82.7 83.3<br />

Other race 82.0 81.0 85.1 81.0 81.8 82.1 84.5 80.2 83.3 83.9 86.4<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 77.2 75.2 74.1 74.4 74.2 74.0 74.7 74.5 75.5 76.1 76.2<br />

Hypertension 85.1 82.9 81.4 79.4 78.5 78.8 77.7 76.2 76.5 76.8 77.2<br />

Glomerulonephritis 91.3 88.6 88.2 87.0 86.7 86.6 84.7 84.2 85.1 84.4 85.1<br />

Other cause 79.0 80.7 82.4 76.6 77.6 76.4 77.9 76.7 76.1 76.2 77.4<br />

All 81.7 81.6 81.3 78.5 78.5 78.1 77.9 77.0 77.3 77.4 77.9<br />

ADJUSTED<br />

0-19 92.5 90.2 93.8 90.6 . 88.9 92.2 93.0 90.5 95.2 90.2<br />

20-44 88.5 89.4 88.8 89.3 87.9 88.2 88.2 87.2 88.2 87.3 88.1<br />

45-64 82.3 81.6 82.0 80.9 80.3 80.6 81.2 81.0 81.4 81.9 82.1<br />

65-74 71.8 71.6 73.6 70.2 71.3 69.8 70.8 70.9 71.1 72.0 73.4<br />

75+ 62.1 63.8 63.4 59.7 62.2 62.9 62.8 59.9 60.1 62.9 63.8<br />

Male 76.3 76.5 76.2 74.4 74.4 74.3 74.4 74.4 74.2 75.3 76.5<br />

Female 78.0 77.6 78.9 76.6 77.0 76.8 77.7 76.2 77.3 77.7 77.9<br />

White 74.5 74.6 75.1 72.6 72.8 72.7 73.3 72.5 72.9 74.2 74.8<br />

Black 82.4 81.8 81.8 80.8 81.0 80.2 80.4 80.4 80.6 80.1 80.9<br />

Other race 76.4 76.2 79.9 76.9 77.7 79.3 82.3 77.6 81.2 82.3 85.4<br />

Diabetes 73.0 71.0 70.5 70.9 71.0 70.9 72.2 72.1 73.4 74.4 74.7<br />

Hypertension 82.5 81.0 80.3 78.9 78.2 79.0 78.7 77.6 77.8 78.6 79.3<br />

Glomerulonephritis 87.1 84.3 84.4 83.3 83.5 83.7 82.0 81.3 82.3 82.1 83.1<br />

Other cause 76.5 77.5 79.7 75.8 76.4 74.9 76.7 75.7 74.9 75.4 76.5<br />

All 77.1 77.0 77.5 75.5 75.7 75.5 76.0 75.3 75.7 76.5 77.2<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.17 I.17 (continued)<br />

One-year survival probabilities: incident hemodialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

one<br />

one<br />

year<br />

year<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 82.1 83.0 71.6 55.9 72.9 100.0 85.5 82.7 73.6 60.6 72.6 74.9<br />

5-9 100.0 100.0 84.7 100.0 97.0 83.2 100.0 100.0 93.9 91.2 94.9 81.6<br />

10-14 98.0 89.3 94.3 97.2 97.4 96.7 93.2 95.1 93.2 97.1 96.6 92.7<br />

15-19 95.0 96.3 96.7 96.6 97.1 95.3 97.7 95.4 97.2 96.9 96.4 96.2<br />

20-29 91.8 92.0 91.7 91.5 91.0 93.0 94.1 93.8 94.1 92.5 94.0 92.8<br />

30-39 87.1 88.3 87.2 88.5 86.5 88.6 89.6 89.5 89.2 89.2 89.8 90.2<br />

40-49 86.1 87.1 87.9 87.4 87.7 88.3 89.1 87.6 88.4 88.3 87.6 87.8<br />

50-59 83.5 84.7 85.0 85.6 85.1 84.8 85.0 84.8 85.1 84.6 84.8 84.8<br />

60-64 78.7 79.1 81.5 81.0 79.8 81.6 81.5 79.9 81.1 80.3 81.2 80.3<br />

65-69 75.2 75.4 77.2 76.6 77.1 77.7 76.7 75.9 76.3 76.6 76.5 76.3<br />

70-79 68.3 68.8 70.6 70.3 70.2 70.7 69.9 69.9 69.3 69.2 69.4 69.3<br />

80+ 59.4 59.4 62.4 61.5 60.3 60.0 59.9 57.6 58.4 57.6 58.0 59.0<br />

Male 77.1 77.5 79.0 78.7 78.1 78.7 78.4 77.9 78.0 77.6 77.8 77.5<br />

Female 77.4 78.0 78.9 78.7 78.2 78.3 77.8 76.7 76.7 76.3 76.4 76.1<br />

611<br />

White 73.5 74.0 75.7 75.5 75.2 75.5 74.7 74.3 74.6 74.2 74.0 73.9<br />

Black 82.9 83.6 83.7 83.3 82.5 83.3 83.4 82.1 82.0 81.3 81.9 81.3<br />

Other race 86.3 85.3 86.0 85.2 82.8 82.3 83.6 81.9 82.7 83.2 84.3 83.5<br />

†Hispanic 83.1 82.4 82.6 82.1 83.4 83.2 82.4<br />

†Non-Hispanic 77.9 77.5 76.6 76.8 76.1 76.3 76.0<br />

Diabetes 76.5 77.1 79.1 78.8 78.1 78.4 78.1 76.9 77.6 77.5 77.6 77.5<br />

Hypertension 76.3 76.9 77.5 77.5 78.1 78.0 76.9 76.5 76.2 75.8 76.0 75.8<br />

Glomerulonephritis 83.5 85.4 86.8 84.8 85.3 86.3 86.4 86.3 85.4 85.9 86.2 85.9<br />

Other cause 76.4 76.0 76.4 76.5 74.2 75.3 75.5 74.9 74.9 73.4 73.6 72.8<br />

All 77.3 77.7 78.9 78.7 78.2 78.5 78.1 77.3 77.4 77.0 77.2 76.8<br />

ADJUSTED<br />

0-19 91.0 90.2 89.4 91.1 91.5 90.9 92.9 91.2 91.5 89.5 90.4 88.2<br />

20-44 86.9 87.6 87.1 87.8 86.8 88.6 89.4 88.9 89.2 88.9 89.1 89.1<br />

45-64 82.2 83.2 84.5 84.5 84.0 84.6 85.0 84.1 84.8 84.4 84.6 84.4<br />

65-74 73.1 73.6 75.6 74.8 75.4 75.9 75.1 74.8 75.0 75.0 74.9 74.7<br />

75+ 63.4 63.4 65.2 65.5 64.3 64.7 64.2 63.2 63.2 62.8 63.3 63.7<br />

Male 76.2 76.7 78.4 78.3 77.8 78.9 78.9 78.5 78.9 78.6 78.8 78.8<br />

Female 77.7 78.5 79.3 79.3 79.2 79.4 79.2 78.2 78.4 78.2 78.5 78.3<br />

White 74.4 75.1 77.0 77.0 77.0 77.6 77.2 76.9 77.3 77.1 77.1 77.2<br />

Black 80.8 81.5 81.8 81.4 80.7 81.7 82.0 80.7 80.6 80.1 80.8 80.2<br />

Other race 85.3 84.5 85.4 84.8 83.0 82.8 84.1 82.4 83.4 83.7 84.6 84.1<br />

Diabetes 75.3 76.0 78.2 78.1 77.5 78.0 77.9 76.9 77.7 77.8 77.9 78.0<br />

Hypertension 78.7 79.0 80.0 79.9 80.6 80.7 80.1 79.9 79.7 79.5 79.6 79.8<br />

Glomerulonephritis 81.5 83.5 85.0 83.4 83.5 84.9 85.0 84.8 84.2 84.4 84.3 84.4<br />

Other cause 75.6 75.3 75.4 75.7 73.8 74.9 75.5 74.8 74.8 73.5 73.9 73.2<br />

All 76.9 77.6 78.9 78.8 78.5 79.2 79.1 78.4 78.7 78.4 78.7 78.6<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.18 I.18<br />

Two-year survival probabilities: incident hemodialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

two<br />

two<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

612<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 100.0 90.0 88.9 91.7 90.9 78.1 62.2 64.5 55.5 54.0 56.1<br />

5-9 90.9 90.3 90.0 94.1 100.0 100.0 88.9 100.0 92.9 88.9 84.0<br />

10-14 96.9 98.0 94.0 94.0 89.1 94.0 97.1 98.0 86.0 98.4 96.7<br />

15-19 93.9 89.9 92.8 89.8 95.9 91.2 90.2 94.2 93.0 96.1 93.5<br />

20-29 83.7 85.4 85.9 83.2 85.4 81.2 84.3 82.5 84.9 84.4 83.7<br />

30-39 81.2 81.3 77.7 80.8 76.2 76.8 76.3 76.4 79.3 78.2 78.2<br />

40-49 77.9 77.1 76.9 76.4 76.7 76.5 75.1 74.4 76.0 75.8 77.3<br />

50-59 71.9 71.3 71.8 68.8 67.3 67.9 67.8 68.4 68.4 69.4 69.2<br />

60-64 65.0 63.2 63.2 63.6 60.6 59.3 61.9 60.3 61.1 61.5 61.5<br />

65-69 56.2 56.3 57.0 53.1 56.5 54.4 55.1 56.2 56.1 56.7 56.3<br />

70-79 48.3 50.1 50.3 45.3 48.2 47.2 47.3 46.1 47.0 48.3 48.5<br />

80+ 31.9 34.3 40.2 30.7 37.7 36.2 36.4 33.8 33.7 38.7 37.1<br />

Male 66.1 66.5 65.1 61.2 61.9 59.7 60.3 59.3 60.4 60.9 60.9<br />

Female 69.3 68.5 68.2 63.7 64.0 63.6 62.7 61.9 62.5 62.5 61.7<br />

White 64.8 64.5 63.4 58.3 58.6 57.2 57.0 55.9 55.7 56.4 55.8<br />

Black 73.5 73.8 72.8 69.9 70.9 69.4 69.2 68.6 70.8 70.0 69.8<br />

Other race 69.0 66.5 71.6 67.1 66.5 65.2 67.8 67.3 69.7 71.9 72.9<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 59.5 56.4 54.3 55.7 53.9 54.1 54.2 54.8 56.4 57.9 57.1<br />

Hypertension 72.9 69.3 67.2 64.0 64.6 62.5 61.6 60.2 61.2 61.6 60.6<br />

Glomerulonephritis 81.2 78.2 77.0 74.8 75.4 72.9 71.7 71.3 73.7 71.5 72.5<br />

Other cause 64.2 67.0 68.8 59.7 62.4 62.0 63.8 62.2 61.5 62.2 63.4<br />

All 67.6 67.4 66.5 62.4 62.9 61.6 61.4 60.5 61.4 61.7 61.3<br />

ADJUSTED<br />

0-19 90.1 84.6 87.1 83.0 . . 81.4 88.4 83.2 89.3 85.2<br />

20-44 77.7 79.4 77.8 77.9 76.2 75.6 75.8 75.5 78.1 77.3 77.9<br />

45-64 68.4 67.0 67.6 66.2 65.0 64.7 65.8 65.3 66.0 67.2 67.5<br />

65-74 52.6 53.4 55.1 49.7 53.4 51.2 52.1 52.6 53.3 54.0 54.1<br />

75+ 40.0 43.6 41.7 36.8 41.6 41.5 41.4 38.9 39.4 42.9 41.9<br />

Male 59.2 59.8 59.2 56.6 57.8 56.1 57.6 56.7 57.9 59.3 59.6<br />

Female 63.0 62.5 63.5 60.2 61.1 61.0 61.0 60.8 61.3 62.4 62.0<br />

White 57.4 57.7 58.0 54.5 55.7 55.0 55.7 55.3 55.5 57.4 57.2<br />

Black 68.0 67.4 67.0 65.3 66.0 64.6 65.2 64.6 66.6 66.2 66.4<br />

Other race 61.2 60.1 63.7 61.1 60.8 61.5 64.5 64.0 66.8 69.8 71.6<br />

Diabetes 54.0 51.2 49.9 51.5 50.2 50.5 51.2 52.1 53.8 55.9 55.4<br />

Hypertension 68.9 66.8 66.0 63.5 64.6 63.4 63.7 62.7 63.5 64.5 64.1<br />

Glomerulonephritis 73.9 71.5 71.5 69.5 71.1 69.1 68.2 67.5 70.0 68.5 69.7<br />

Other cause 61.0 62.8 65.2 59.1 61.3 60.5 62.8 61.3 60.3 61.7 62.5<br />

All 61.0 61.1 61.2 58.3 59.4 58.5 59.2 58.7 59.5 60.8 60.8<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.18 I.18 (continued)<br />

Two-year survival probabilities: incident hemodialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

two<br />

two<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />

0-4 73.0 62.2 54.8 55.9 72.9 80.0 85.5 62.1 73.6 52.2 57.4<br />

5-9 100.0 100.0 67.8 100.0 97.0 78.0 100.0 95.0 87.2 91.2 94.9<br />

10-14 98.0 87.1 88.2 95.2 95.2 94.8 91.4 88.5 93.2 95.7 92.3<br />

15-19 91.7 94.5 92.5 94.5 93.7 89.1 92.3 92.6 92.0 91.1 92.8<br />

20-29 84.3 85.3 85.7 85.8 84.7 87.1 88.2 89.1 88.7 86.4 88.5<br />

30-39 76.4 78.3 78.0 78.6 78.0 79.5 81.5 80.8 81.4 81.4 82.5<br />

40-49 74.1 76.7 76.7 77.4 77.7 77.7 79.3 78.1 78.4 78.3 78.1<br />

50-59 69.9 71.3 72.0 73.3 72.1 72.6 72.5 71.6 72.5 72.5 72.7<br />

60-64 62.7 63.6 65.8 66.2 64.7 66.7 66.4 64.9 66.6 66.0 67.1<br />

65-69 57.2 58.7 60.6 58.9 60.0 61.0 59.5 59.2 59.6 60.6 61.8<br />

70-79 48.9 49.7 50.8 51.1 51.3 51.9 50.0 51.2 51.1 50.6 51.5<br />

80+ 36.6 38.4 39.0 39.2 38.9 38.3 37.5 37.1 37.5 37.2 37.9<br />

Male 60.8 61.9 63.1 63.2 63.2 63.4 62.8 62.9 63.2 63.1 63.4<br />

Female 61.3 62.6 63.0 63.1 62.5 63.0 61.8 61.2 61.4 60.8 61.8<br />

613<br />

White 55.5 56.6 57.7 57.9 57.9 58.0 56.9 57.4 57.9 57.6 57.9<br />

Black 69.3 70.7 70.9 71.1 70.1 71.3 70.7 69.4 69.2 68.9 70.0<br />

Other race 74.6 73.7 74.0 71.9 70.1 69.4 70.6 69.2 71.0 70.5 73.2<br />

†Hispanic 69.1 68.5 68.8 69.6 71.5 70.8<br />

†Non-Hispanic 62.4 61.5 61.2 61.3 60.6 61.5<br />

Diabetes 58.2 59.6 61.3 61.2 61.0 61.3 60.6 60.1 61.1 61.2 61.8<br />

Hypertension 60.3 61.8 61.7 62.5 63.0 63.0 61.3 61.4 61.1 60.9 61.4<br />

Glomerulonephritis 70.7 73.3 74.4 73.4 74.1 74.4 74.8 75.8 74.3 75.0 76.6<br />

Other cause 62.1 62.2 62.7 62.8 60.7 61.7 61.6 61.2 61.7 60.1 60.9<br />

All 61.0 62.2 63.1 63.2 62.8 63.2 62.3 62.1 62.3 62.0 62.7<br />

ADJUSTED<br />

0-19 86.1 86.9 80.0 88.3 86.7 81.5 85.9 84.5 84.8 81.6 83.5<br />

20-44 75.8 77.4 77.1 78.2 77.7 79.2 81.1 80.2 80.7 80.5 80.9<br />

45-64 68.0 69.5 71.0 71.9 71.0 71.8 72.2 71.2 72.3 72.2 72.7<br />

65-74 54.8 56.3 57.6 56.7 58.1 58.7 57.1 57.8 58.2 58.3 59.6<br />

75+ 42.2 43.2 44.1 44.7 43.8 44.4 43.2 43.5 43.8 43.5 44.1<br />

Male 59.9 61.1 62.8 63.1 63.1 63.9 63.8 64.0 64.7 64.8 65.1<br />

Female 62.2 63.7 64.1 64.5 64.3 65.0 64.3 63.8 64.2 63.9 65.0<br />

White 57.5 59.0 60.3 60.8 61.1 61.7 61.1 61.7 62.4 62.3 62.7<br />

Black 66.2 67.7 68.1 68.4 67.6 69.0 68.7 67.4 67.2 67.2 68.3<br />

Other race 73.5 72.8 73.4 71.5 70.6 70.5 71.7 70.0 72.2 71.7 74.0<br />

Diabetes 56.8 58.4 60.2 60.4 60.3 61.0 60.7 60.2 61.5 61.7 62.5<br />

Hypertension 64.1 65.2 65.7 66.3 66.9 67.3 66.2 66.5 66.4 66.4 66.7<br />

Glomerulonephritis 68.2 70.8 71.7 71.5 71.7 72.4 72.6 73.6 72.6 72.8 73.9<br />

Other cause 61.4 61.7 61.9 62.1 60.4 61.6 61.8 61.3 61.8 60.4 61.3<br />

All 61.0 62.4 63.4 63.8 63.7 64.4 64.0 63.9 64.5 64.4 65.1<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.19 I.19<br />

Three-year survival probabilities: incident hemodialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

three<br />

three<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

614<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 100.0 90.0 88.9 55.0 60.6 78.1 54.4 43.0 41.6 43.2 56.1<br />

5-9 90.9 90.3 90.0 94.1 100.0 100.0 74.1 81.8 92.9 88.9 84.0<br />

10-14 96.9 90.9 94.0 90.2 89.1 85.3 86.5 91.5 81.2 95.1 93.4<br />

15-19 89.3 87.9 92.8 88.9 95.9 89.9 82.2 89.8 89.5 89.4 90.2<br />

20-29 78.9 80.1 80.1 77.6 77.0 73.3 76.5 76.7 78.9 78.0 77.9<br />

30-39 75.7 73.9 67.1 72.8 67.2 67.9 66.7 67.1 71.8 69.8 69.7<br />

40-49 68.9 68.0 68.0 66.1 65.9 65.4 63.9 64.7 66.6 65.2 67.5<br />

50-59 61.0 59.9 59.0 56.4 55.6 54.4 55.2 56.2 56.2 56.9 57.2<br />

60-64 53.3 50.7 49.9 50.2 47.1 46.2 46.9 47.1 49.0 48.0 48.3<br />

65-69 41.5 42.6 42.9 39.3 42.1 41.0 41.5 42.2 43.2 42.4 42.1<br />

70-79 34.7 35.1 35.6 30.4 33.5 32.6 33.0 32.7 33.5 34.1 33.8<br />

80+ 19.1 22.5 20.3 18.4 21.3 22.3 20.9 22.1 20.2 23.5 22.4<br />

Male 54.9 54.4 52.1 48.1 48.8 45.8 46.4 46.9 48.2 47.9 48.0<br />

Female 58.4 57.2 55.3 51.3 50.6 51.1 49.6 49.3 50.5 49.3 48.7<br />

White 53.3 52.0 50.0 45.1 45.1 43.2 42.7 42.7 42.7 42.3 41.7<br />

Black 63.2 63.7 60.7 57.5 58.4 57.4 57.3 57.4 60.2 58.4 58.6<br />

Other race 57.6 52.7 58.8 56.6 51.8 53.0 53.4 54.9 58.4 60.0 61.6<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 45.2 42.9 39.7 40.4 39.0 38.9 39.0 40.8 42.3 42.5 42.8<br />

Hypertension 62.3 58.2 54.2 52.0 50.8 49.9 48.7 47.8 49.6 49.3 48.2<br />

Glomerulonephritis 73.4 67.9 66.2 65.3 64.4 59.5 59.8 60.0 63.0 59.8 61.1<br />

Other cause 53.0 55.4 56.3 46.7 50.5 50.6 51.1 51.2 51.2 51.0 51.5<br />

All 56.5 55.7 53.6 49.6 49.7 48.3 47.9 48.0 49.3 48.5 48.3<br />

ADJUSTED<br />

0-19 84.7 80.1 . . . 80.7 69.5 77.3 77.2 80.3 .<br />

20-44 70.7 71.2 68.1 69.0 66.5 65.2 65.9 66.4 69.9 68.4 69.3<br />

45-64 56.8 54.9 54.5 53.2 52.0 51.3 52.0 52.8 53.9 54.3 55.2<br />

65-74 38.1 39.2 40.0 35.2 39.1 37.5 37.7 38.9 40.1 39.8 39.8<br />

75+ 26.5 28.9 26.6 23.1 25.5 26.4 27.2 26.2 25.7 28.3 27.0<br />

Male 47.3 47.2 46.1 43.5 44.9 42.7 44.1 44.6 45.8 46.7 47.1<br />

Female 51.2 50.6 50.2 47.7 48.0 48.7 48.3 48.8 49.7 49.7 49.5<br />

White 45.3 45.0 44.7 41.6 42.8 41.8 42.2 42.8 43.2 44.3 44.1<br />

Black 56.6 56.1 53.7 52.2 52.8 52.0 52.8 53.1 55.5 54.1 54.8<br />

Other race 49.1 46.4 49.7 50.0 45.7 49.6 50.3 51.6 55.3 58.1 60.5<br />

Diabetes 39.8 37.9 35.7 36.5 35.9 35.9 36.6 38.6 39.9 40.9 41.4<br />

Hypertension 57.7 55.6 53.5 52.0 51.5 51.5 51.6 51.2 52.6 53.1 52.6<br />

Glomerulonephritis 64.5 60.1 60.0 59.4 59.9 55.6 56.3 56.3 59.2 56.9 58.3<br />

Other cause 49.8 51.0 52.5 46.4 49.8 49.4 50.5 50.6 50.3 51.0 50.9<br />

All 49.1 48.8 48.0 45.5 46.4 45.6 46.1 46.6 47.7 48.1 48.3<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.19 I.19 (continued)<br />

Three-year survival probabilities: incident hemodialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

three<br />

three<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />

0-4 60.8 62.2 49.8 55.9 66.8 80.0 78.3 62.1 61.3 39.2<br />

5-9 100.0 100.0 67.8 93.8 97.0 70.9 100.0 95.0 79.3 91.2<br />

10-14 86.5 79.0 88.2 87.6 95.2 90.8 88.7 88.5 90.4 95.7<br />

15-19 89.4 92.5 88.6 92.2 89.9 86.0 90.2 89.6 88.3 89.0<br />

20-29 79.2 79.5 80.2 80.1 80.0 82.5 83.3 83.9 83.3 82.1<br />

30-39 68.2 69.5 70.4 71.8 70.2 72.6 73.8 74.0 74.4 74.9<br />

40-49 64.2 66.8 67.4 67.9 68.2 68.4 70.0 68.7 69.3 69.1<br />

50-59 58.3 58.1 60.2 60.8 60.5 60.6 61.4 60.7 61.4 61.7<br />

60-64 49.2 50.2 52.0 53.2 51.8 53.0 54.0 52.7 53.7 54.0<br />

65-69 43.4 44.3 46.3 45.5 46.5 46.4 46.0 46.0 46.3 47.5<br />

70-79 35.1 35.0 36.4 36.2 36.4 37.0 35.9 36.6 36.9 37.1<br />

80+ 22.6 23.8 24.0 24.3 23.8 24.6 23.6 22.4 23.3 23.9<br />

Male 48.3 48.4 50.4 50.6 50.7 50.8 50.5 50.7 50.9 51.3<br />

Female 48.5 49.4 50.1 50.0 49.4 49.8 49.4 48.5 48.9 48.9<br />

615<br />

White 41.8 42.2 44.0 43.9 44.0 44.0 43.5 43.9 44.4 44.7<br />

Black 58.4 59.1 59.5 59.9 59.2 60.0 60.0 58.4 58.5 58.9<br />

Other race 62.6 61.4 62.0 61.1 58.0 57.9 58.9 58.4 60.3 60.0<br />

†Hispanic 57.1 56.9 57.8 58.4 60.9<br />

†Non-Hispanic 49.4 49.1 48.6 48.8 48.6<br />

Diabetes 43.8 44.6 46.7 47.0 46.5 46.9 46.8 46.4 47.2 47.8<br />

Hypertension 48.1 49.0 49.3 49.6 50.7 50.8 49.3 49.2 49.3 49.3<br />

Glomerulonephritis 60.5 61.4 64.3 63.3 63.5 63.7 65.6 65.8 63.9 66.0<br />

Other cause 51.3 50.9 52.0 52.2 50.4 50.9 51.2 51.0 51.6 50.6<br />

All 48.4 48.9 50.2 50.3 50.1 50.3 50.0 49.7 50.0 50.2<br />

ADJUSTED<br />

0-19 80.1 82.1 75.1 82.5 . 76.4 82.3 80.8 78.9 78.8<br />

20-44 67.2 68.7 68.9 70.0 69.4 71.5 73.0 72.7 72.9 73.1<br />

45-64 55.9 56.4 58.8 59.8 59.4 59.8 61.1 60.2 61.1 61.6<br />

65-74 40.8 41.8 43.4 42.7 44.0 44.5 43.4 44.1 44.8 45.2<br />

75+ 28.6 28.3 29.3 29.7 28.9 29.7 29.2 29.0 29.5 30.0<br />

Male 47.9 48.0 50.4 50.8 51.0 51.8 52.0 52.3 53.0 53.5<br />

Female 50.1 51.2 51.8 52.1 51.9 52.6 52.6 52.0 52.5 52.9<br />

White 44.9 45.6 47.6 47.9 48.3 48.9 48.9 49.4 50.1 50.5<br />

Black 55.0 55.7 56.4 56.8 56.4 57.4 57.7 56.2 56.2 57.0<br />

Other race 61.8 60.8 61.6 61.1 59.0 59.5 60.5 59.6 62.1 61.8<br />

Diabetes 42.6 43.7 45.9 46.4 46.1 46.9 47.1 46.8 48.0 48.8<br />

Hypertension 52.9 53.5 54.3 54.3 55.6 56.0 55.2 55.3 55.6 55.8<br />

Glomerulonephritis 58.1 58.7 61.3 61.3 60.8 61.4 63.2 63.2 61.9 63.7<br />

Other cause 51.0 50.8 51.5 51.7 50.3 51.0 51.7 51.3 51.9 51.2<br />

All 48.9 49.6 51.1 51.4 51.5 52.2 52.3 52.1 52.8 53.2<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.20 I.20<br />

Five-year survival probabilities: incident hemodialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

five<br />

five<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

616<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998<br />

0-4 100.0 72.0 88.9 55.0 . 78.1 45.3 43.0 41.6 43.2 28.1 22.8 62.2 49.8 28.0 66.8 40.0 78.3 62.1<br />

5-9 90.9 90.3 60.0 94.1 100.0 100.0 74.1 81.8 92.9 88.9 84.0 100.0 80.0 45.2 93.8 97.0 70.9 100.0 95.0<br />

10-14 84.2 81.1 87.8 90.2 89.1 85.3 72.1 91.5 58.2 87.2 93.4 86.5 72.6 83.6 81.1 90.9 85.8 85.1 88.5<br />

15-19 86.7 81.2 79.8 84.6 92.0 79.3 75.4 83.7 77.8 78.9 86.7 81.3 85.9 76.9 85.4 87.1 80.3 83.1 80.1<br />

20-29 75.3 69.6 71.2 66.7 64.0 60.4 66.2 65.3 67.2 66.1 67.7 67.2 69.3 70.3 71.3 72.3 73.9 73.3 73.9<br />

30-39 63.0 61.5 54.0 58.9 55.2 53.7 53.0 50.7 57.3 57.0 55.4 54.9 57.0 58.4 58.6 58.4 59.3 61.4 61.4<br />

40-49 55.2 52.3 52.3 48.7 50.3 48.7 47.6 49.7 50.0 48.0 49.5 48.3 50.5 50.5 50.9 52.0 51.6 53.4 52.0<br />

50-59 41.7 41.1 40.4 37.2 36.5 36.2 36.7 37.5 37.2 36.8 37.2 39.1 38.6 40.5 41.1 41.1 40.6 41.6 41.2<br />

60-64 32.8 32.7 30.4 30.5 27.8 27.9 28.9 27.2 29.8 28.7 29.3 29.4 30.7 31.7 32.2 30.8 32.2 33.3 33.1<br />

65-69 24.1 25.1 24.8 21.3 22.9 23.3 23.0 23.5 23.6 23.6 23.2 22.8 24.7 25.1 25.9 25.2 25.6 24.9 26.2<br />

70-79 16.7 16.6 17.9 14.3 16.2 16.1 15.7 15.9 16.3 16.6 16.4 16.8 16.6 17.4 17.3 17.8 18.1 17.5 18.3<br />

80+ 7.9 7.0 7.0 6.3 7.5 8.4 7.6 8.0 7.1 9.3 9.1 8.4 8.0 8.5 8.7 9.0 8.8 8.6 8.4<br />

Male 38.2 36.0 34.1 30.0 30.2 28.6 29.0 28.9 30.3 30.0 30.0 30.0 30.4 31.6 32.1 32.5 32.3 32.0 32.5<br />

Female 40.4 40.3 37.4 33.3 32.7 33.1 31.4 31.1 31.8 30.5 30.2 29.7 30.4 30.9 31.0 30.5 30.3 30.5 30.3<br />

White 36.3 33.7 31.6 27.2 26.7 25.9 25.0 24.3 24.4 24.0 23.7 23.3 23.8 24.7 25.0 24.8 24.7 24.2 25.1<br />

Black 45.4 46.9 43.3 38.9 40.0 39.1 39.1 39.0 41.6 39.7 40.2 39.8 40.3 40.8 41.3 41.4 41.5 41.9 40.8<br />

Other race 38.7 37.8 45.9 42.1 35.7 36.0 37.2 41.7 41.8 42.9 40.8 42.1 42.5 42.7 42.0 39.6 39.2 41.6 41.6<br />

†Hispanic 38.2 37.7 39.3<br />

†Non-Hispanic 30.4 30.4 30.4<br />

Diabetes 28.5 24.3 20.7 21.5 20.2 20.0 21.5 21.8 23.3 22.6 23.3 23.8 24.8 25.7 26.2 25.9 26.0 26.1 26.5<br />

Hypertension 46.2 40.4 36.4 33.7 33.0 32.7 30.5 30.1 32.0 31.3 30.8 30.2 30.8 30.8 31.5 32.7 32.5 31.9 31.8<br />

Glomerulonephritis 59.0 53.0 49.6 46.1 44.9 40.9 41.6 42.0 44.6 42.8 43.4 43.4 43.3 46.9 45.5 46.7 46.9 47.5 48.8<br />

Other cause 34.7 37.4 38.9 30.5 33.4 35.0 34.5 34.4 33.6 35.0 34.8 34.8 35.1 36.5 36.9 35.3 35.2 36.1 36.0<br />

All 39.1 38.0 35.6 31.6 31.4 30.7 30.2 29.9 31.0 30.2 30.1 29.9 30.4 31.2 31.5 31.5 31.3 31.2 31.4<br />

ADJUSTED<br />

0-19 78.1 69.9 69.6 . 81.8 70.0 60.9 71.9 62.6 . 75.4 69.8 73.1 62.3 73.7 77.9 69.2 74.3 70.3<br />

20-44 59.2 57.0 53.8 53.0 52.5 49.7 51.9 50.9 54.1 54.0 54.6 53.0 55.2 55.3 56.5 56.5 57.3 58.8 58.6<br />

45-64 36.9 36.0 35.5 33.5 32.7 32.7 33.7 33.6 34.8 34.5 35.4 36.8 37.1 39.2 39.8 39.7 40.0 41.6 41.1<br />

65-74 20.3 21.2 21.7 17.9 20.0 20.2 19.9 20.8 21.3 21.4 21.3 21.2 22.6 23.1 23.6 23.5 24.2 23.5 24.7<br />

75+ 11.3 11.5 11.4 9.1 11.0 11.5 11.2 10.9 10.6 12.2 11.6 12.1 11.2 11.9 11.8 12.5 12.6 12.4 12.9<br />

Male 31.1 29.5 29.3 26.6 27.6 26.9 28.1 27.9 28.9 29.9 30.0 30.6 30.9 32.4 32.9 33.3 33.9 34.0 34.6<br />

Female 33.3 34.0 33.0 30.7 31.2 31.6 31.2 31.5 32.0 31.9 32.0 32.2 33.2 33.5 34.0 33.9 34.1 34.6 34.7<br />

White 28.9 27.7 27.6 25.1 25.9 25.9 26.1 25.9 26.4 27.4 27.2 27.6 28.4 29.5 30.1 30.1 30.7 30.7 31.7<br />

Black 38.0 38.6 36.2 33.7 34.8 34.0 35.0 35.2 37.0 35.7 36.6 36.9 37.1 37.8 38.3 38.7 39.0 39.6 38.7<br />

Other race 30.9 32.5 36.8 35.9 30.4 33.8 35.1 39.0 39.1 41.9 40.5 42.8 43.1 43.1 43.0 41.6 41.9 44.1 43.7<br />

Diabetes 24.2 20.9 18.5 19.2 18.8 18.7 20.3 20.7 22.0 22.0 22.7 23.5 24.7 25.6 26.3 26.2 26.6 26.9 27.4<br />

Hypertension 41.9 38.1 36.7 34.7 34.7 35.2 34.6 34.7 35.8 36.0 36.0 35.8 36.0 36.6 36.9 38.2 38.4 38.3 38.4<br />

Glomerulonephritis 48.6 44.7 43.6 40.7 41.2 38.1 39.2 39.0 41.8 40.8 41.1 42.0 41.4 44.2 43.9 44.1 44.7 45.1 46.2<br />

Other cause 32.1 33.9 35.9 30.8 33.7 34.7 34.8 34.7 33.5 40.8 34.9 35.3 35.6 36.5 37.0 35.6 35.8 36.9 36.7<br />

All 32.1 31.6 31.0 28.5 29.3 29.1 29.5 29.7 30.4 30.8 30.9 31.4 32.0 32.9 33.4 33.6 34.0 34.3 34.7<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.21 I.21<br />

Ten-year survival probabilities: incident hemodialysis patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

ten<br />

ten<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<br />

0-4 50.0 72.0 . 36.7 . . 45.3 21.5 20.8 43.2 28.1 22.8 62.2 49.8<br />

5-9 90.9 67.8 60.0 94.1 100.0 100.0 74.1 65.5 92.9 88.9 84.0 33.3 80.0 .<br />

10-14 64.1 63.4 62.7 80.7 59.4 85.3 72.1 91.5 29.1 81.3 76.7 76.8 59.2 73.2<br />

15-19 77.2 64.9 62.8 71.9 77.2 66.2 59.7 51.1 65.6 68.5 70.5 70.6 65.2 64.7<br />

20-29 55.0 48.7 50.2 48.3 45.9 43.4 46.2 45.2 46.3 45.3 46.8 45.3 47.8 52.9<br />

30-39 41.4 38.3 32.0 36.4 33.8 32.4 29.9 29.6 32.1 34.2 32.7 33.0 34.9 33.7<br />

40-49 27.7 24.8 25.7 23.0 25.3 23.4 21.9 22.7 23.9 20.5 21.9 20.8 22.8 22.5<br />

50-59 14.0 14.4 15.0 11.9 12.5 12.9 12.1 12.0 11.5 11.5 11.1 12.4 11.7 11.7<br />

60-64 8.5 7.9 6.8 8.2 7.4 8.4 7.6 7.0 7.5 6.5 6.5 7.0 7.2 7.5<br />

65-69 5.2 5.6 4.6 5.0 5.1 6.0 5.1 4.7 4.7 4.4 4.9 4.2 4.4 4.9<br />

70-79 2.7 2.4 3.0 2.4 3.4 3.0 2.3 2.6 2.5 2.1 2.0 1.9 2.1 2.3<br />

80+ 1.6 0.9 2.0 0.3 1.2 0.9 0.8 1.0 0.5 0.7 0.4 0.7 0.6 0.6<br />

Male 14.6 12.9 12.0 10.5 11.2 10.7 10.3 10.0 10.1 9.6 10.1 9.7 10.2 10.3<br />

Female 16.9 16.0 14.0 12.4 11.8 12.0 10.2 9.8 10.5 9.5 8.8 8.9 8.9 9.1<br />

617<br />

White 14.4 12.0 10.8 9.1 9.3 8.8 7.6 7.5 7.2 6.2 6.4 6.1 6.3 6.6<br />

Black 18.2 19.1 16.7 15.2 15.1 15.6 14.4 13.7 15.1 14.6 14.0 14.1 14.3 14.2<br />

Other race 16.7 16.5 21.0 17.0 18.4 15.2 17.2 15.1 15.8 14.9 15.7 15.0 14.7 16.0<br />

Diabetes 8.5 6.4 5.5 4.9 5.0 5.2 4.8 4.9 5.0 4.4 4.7 4.8 4.8 5.1<br />

Hypertension 19.7 15.3 12.1 12.0 11.8 11.5 10.1 9.1 10.3 10.1 9.6 9.5 10.2 9.7<br />

Glomerulonephritis 32.7 26.0 20.9 20.0 19.6 19.3 18.3 17.5 18.4 18.0 18.6 17.9 19.7 20.6<br />

Other cause 12.3 13.5 15.6 12.0 13.5 14.2 13.3 14.1 14.3 13.6 14.1 14.5 14.3 15.4<br />

All 15.6 14.4 12.9 11.4 11.5 11.3 10.2 9.9 10.3 9.5 9.4 9.3 9.5 9.7<br />

ADJUSTED<br />

0-19 62.2 50.3 45.4 60.2 59.5 56.8 . 42.4 48.8 58.3 58.9 55.4 52.3 50.7<br />

20-44 35.9 31.9 29.8 30.6 30.2 28.6 28.3 27.6 29.3 30.0 30.0 29.6 31.0 30.7<br />

45-64 11.5 10.9 11.4 9.9 10.5 11.0 10.7 10.5 10.7 10.1 10.6 11.4 11.4 11.9<br />

65-74 3.9 4.1 3.9 3.7 4.3 4.8 4.0 3.9 3.9 3.6 3.9 3.4 3.9 4.2<br />

75+ 1.8 1.6 2.1 1.1 2.1 1.5 1.3 1.6 1.5 1.3 0.9 1.2 1.0 1.3<br />

Male 11.5 10.4 10.9 9.8 10.9 11.2 11.1 10.8 10.5 10.5 11.0 11.1 11.3 11.7<br />

Female 13.3 13.2 12.7 12.0 12.5 12.6 11.4 11.6 12.1 11.6 11.3 11.7 11.9 12.2<br />

White 11.0 10.0 10.2 9.3 10.4 10.5 9.8 9.9 9.8 9.5 9.8 9.8 10.3 10.7<br />

Black 13.5 14.0 13.0 12.5 12.8 13.2 12.6 12.4 13.0 12.6 12.5 12.9 12.8 13.1<br />

Other race 12.6 13.7 17.2 14.3 15.8 15.1 17.2 15.3 15.6 16.4 16.9 17.6 17.5 17.6<br />

Diabetes 7.1 5.8 5.3 4.8 5.2 5.6 5.1 5.2 5.3 4.7 5.2 5.4 5.4 5.9<br />

Hypertension 17.9 15.5 14.2 14.1 14.5 14.8 14.1 13.6 13.8 14.0 13.7 13.7 14.2 14.1<br />

Glomerulonephritis 23.9 20.0 18.4 17.3 18.5 18.6 17.7 16.9 18.1 17.5 17.5 17.9 18.7 19.1<br />

Other cause 12.3 13.0 15.2 13.1 15.1 15.3 14.6 15.3 15.0 14.9 15.0 15.6 15.3 16.0<br />

All 12.3 11.7 11.7 10.8 11.6 11.8 11.2 11.1 11.2 11.0 11.1 11.3 11.6 11.9<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.22<br />

Table I.22<br />

Incident patient patient counts: counts: CAPD/CCPD patients, unknowns dropped dropped<br />

dialysis patients alive on day 91, by age, gender, race, ethnicity, & primary diagnosis<br />

dialysis patients alive on day 91, by age, gender, race, ethnicity, & primary diagnosis<br />

618<br />

1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 * 23 36 52 53 75 62 59 64 57 50<br />

5-9 * 14 27 33 48 32 42 35 33 41 40<br />

10-14 * 20 51 60 73 51 53 56 52 45 63<br />

15-19 * 21 53 65 64 71 62 76 65 86 82<br />

20-29 54 107 174 198 235 221 267 264 304 300 361<br />

30-39 107 191 326 398 389 442 455 499 569 649 706<br />

40-49 114 182 362 411 434 489 540 564 621 772 889<br />

50-59 158 332 503 558 625 646 651 704 750 918 1,000<br />

60-64 60 196 282 349 341 420 397 447 482 523 641<br />

65-69 47 145 236 217 228 276 296 345 347 422 540<br />

70-79 45 129 310 271 265 336 290 389 397 490 594<br />

80+ * 25 59 54 52 60 64 69 92 115 118<br />

Male 326 694 1,263 1,429 1,535 1,652 1,738 1,868 2,035 2,380 2,714<br />

Female 297 691 1,156 1,237 1,272 1,467 1,441 1,639 1,741 2,038 2,370<br />

White 497 1,051 1,762 1,953 2,073 2,387 2,393 2,630 2,799 3,212 3,715<br />

Black 107 313 617 655 660 661 701 789 858 1,074 1,210<br />

Other race 19 21 40 58 74 71 85 88 119 132 159<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 173 425 788 851 928 1,039 1,143 1,291 1,327 1,696 1,992<br />

Hypertension 131 314 627 587 579 685 688 727 898 1,023 1,265<br />

Glomerulonephritis 161 290 466 507 579 625 629 700 774 859 926<br />

Cystic kidney 42 86 114 114 156 145 161 174 173 203 243<br />

Other urologic 13 57 90 95 88 107 80 93 95 90 100<br />

Other cause 87 167 304 377 392 434 397 440 404 478 523<br />

Missing cause 16 46 30 135 85 84 81 82 105 69 35<br />

All 623 1,385 2,419 2,666 2,807 3,119 3,179 3,507 3,776 4,418 5,084<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90 day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age, gender, race, or primary cause of ESRD are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

*Values for cells with 10 or fewer patients are suppressed.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table Table I.22 I.22 (continued)<br />

Incident patient counts: CAPD/CCPD patients, unknowns dropped<br />

dialysis dialysis patients patients alive alive on on day day 91, 91, by by age, age, gender, gender, race, race, ethnicity, ethnicity, & primary primary diagnosis diagnosis<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 75 67 76 64 77 104 89 108 93 113 108 101<br />

5-9 29 31 34 57 49 56 55 49 59 56 55 52<br />

10-14 66 52 58 71 75 94 84 78 83 86 75 94<br />

15-19 68 101 90 87 95 106 101 86 85 93 84 67<br />

20-29 318 330 365 341 333 322 285 269 242 232 220 179<br />

30-39 775 807 789 834 816 754 655 621 627 551 491 507<br />

40-49 1,029 1,014 1,130 1,094 1,288 1,230 1,077 997 993 949 921 830<br />

50-59 1,048 1,205 1,205 1,353 1,445 1,399 1,446 1,379 1,343 1,264 1,386 1,287<br />

60-64 658 706 711 757 828 749 721 672 648 644 646 623<br />

65-69 499 464 616 574 630 552 519 533 510 515 518 490<br />

70-79 615 650 694 791 750 805 769 747 736 729 758 714<br />

80+ 96 131 146 170 163 193 202 172 194 196 237 223<br />

Male 2,910 2,931 3,159 3,284 3,477 3,348 3,159 2,976 2,919 2,881 2,880 2,765<br />

Female 2,366 2,627 2,755 2,909 3,072 3,016 2,844 2,735 2,694 2,547 2,619 2,402<br />

619<br />

White 3,850 4,008 4,164 4,361 4,559 4,533 4,345 4,073 4,087 3,909 3,892 3,608<br />

Black 1,249 1,324 1,485 1,495 1,574 1,421 1,277 1,247 1,195 1,135 1,196 1,154<br />

Other race 177 226 265 337 416 410 381 391 331 384 411 405<br />

†Hispanic 695 594 591 615 622 597 639<br />

†Non-Hispanic 5,669 5,409 5,120 4,998 4,806 4,902 4,528<br />

Diabetes 2,145 2,333 2,436 2,598 2,914 2,931 2,711 2,596 2,565 2,447 2,440 2,314<br />

Hypertension 1,212 1,246 1,401 1,423 1,288 1,115 1,143 1,088 1,067 1,052 1,073 1,060<br />

Glomerulonephritis 974 1,010 1,032 1,121 1,177 1,172 1,069 998 920 940 895 789<br />

Cystic kidney 279 280 316 325 329 321 319 285 318 279 317 274<br />

Other urologic 98 122 123 107 170 150 167 136 149 156 155 160<br />

Other cause 539 544 579 600 658 662 585 601 587 551 614 554<br />

Missing cause 29 23 27 19 13 13 9 * * * * 16<br />

All 5,276 5,558 5,914 6,193 6,549 6,364 6,003 5,711 5,613 5,428 5,499 5,167<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90 day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age, gender, race, or primary cause of ESRD are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

*Values for cells with 10 or fewer patients are suppressed.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.23 I.23<br />

90-day survival probabilities: incident CAPD/CCPD patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

620<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 100.0 100.0 97.6 100.0 98.2 100.0 100.0 98.5 100.0 100.0 94.8 98.8<br />

5-9 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 97.7 100.0<br />

10-14 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 98.6 100.0<br />

15-19 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 98.9 100.0<br />

20-29 100.0 99.1 99.5 99.5 99.6 99.1 99.6 98.9 100.0 99.4 99.0 99.4<br />

30-39 99.1 98.6 98.6 99.3 99.0 98.9 98.4 98.9 98.8 98.8 99.1 99.0<br />

40-49 100.0 99.0 99.2 98.9 98.7 99.0 98.8 98.8 99.5 99.8 99.4 99.5<br />

50-59 98.8 98.4 98.3 98.5 98.8 97.9 98.8 98.8 98.3 98.8 99.1 98.5<br />

60-64 98.6 99.5 98.7 98.6 98.1 95.7 97.0 97.3 97.7 99.3 98.4 98.3<br />

65-69 96.4 97.6 94.3 94.8 94.5 97.0 97.8 95.7 96.8 96.5 97.6 98.1<br />

70-79 96.2 95.9 92.6 93.4 95.2 95.5 94.4 95.9 94.9 96.3 95.6 97.1<br />

80+ 100.0 100.0 94.1 89.9 93.4 87.8 88.6 89.8 93.6 96.1 94.8 90.7<br />

Male 99.4 98.6 97.1 97.7 98.1 97.4 97.8 98.0 98.2 98.6 98.3 98.6<br />

Female 98.2 98.3 97.6 97.9 97.9 97.8 98.1 97.7 98.0 98.5 98.2 98.3<br />

White 98.7 98.3 96.8 97.7 97.9 97.3 97.7 97.7 97.9 98.4 98.2 98.5<br />

Black 99.1 99.1 98.7 98.3 98.3 98.7 98.7 98.1 98.5 99.0 98.6 98.4<br />

Other race 100.0 100.0 100.0 95.4 98.7 96.3 97.8 100.0 100.0 98.6 98.2 99.5<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 97.8 99.1 96.9 97.6 98.3 97.8 97.6 98.0 97.7 98.6 98.4 98.1<br />

Hypertension 100.0 97.8 96.3 96.7 96.3 97.4 97.5 96.6 98.0 97.3 97.2 98.7<br />

Glomerulonephritis 99.4 99.3 98.1 98.8 99.1 98.3 98.4 99.0 99.1 99.5 99.1 99.5<br />

Other cause 98.6 97.9 98.2 98.0 98.1 97.0 98.3 97.6 97.9 98.8 98.5 98.2<br />

All 98.8 98.5 97.3 97.8 98.0 97.6 97.9 97.8 98.1 98.5 98.3 98.5<br />

ADJUSTED<br />

0-19 . . 99.5 . 99.6 . . 99.6 . . 97.8 99.6<br />

20-44 99.5 98.5 98.8 99.3 99.1 99.0 98.7 98.7 99.4 99.2 99.0 99.3<br />

45-64 99.0 99.0 98.6 98.6 98.6 97.4 98.3 98.4 98.3 99.2 99.0 98.7<br />

65-74 95.9 96.3 94.4 95.4 94.8 96.2 96.7 96.5 95.7 96.8 96.9 98.0<br />

75+ . . 91.9 90.1 95.6 94.2 92.3 92.8 95.8 96.0 95.6 94.7<br />

Male 99.1 98.1 96.2 96.8 97.3 96.3 96.8 97.1 97.5 98.0 97.6 98.0<br />

Female 96.9 97.5 96.6 96.8 96.7 96.7 97.0 96.6 96.9 97.8 97.6 97.6<br />

White 97.7 97.4 95.6 96.4 96.8 96.0 96.5 96.7 97.0 97.7 97.5 97.8<br />

Black 98.4 98.7 98.0 97.6 97.4 98.0 97.8 96.9 97.4 98.3 97.6 97.4<br />

Other race . . . 94.0 98.0 94.2 96.6 . . 98.2 97.2 99.2<br />

Diabetes 96.3 98.5 95.4 96.2 97.3 96.4 96.3 97.1 96.6 98.0 97.8 97.3<br />

Hypertension . 97.5 96.0 96.1 95.5 97.2 97.1 96.3 97.8 97.2 97.1 98.5<br />

Glomerulonephritis 98.7 98.7 96.9 97.9 98.3 96.9 97.1 98.2 98.4 99.2 98.5 99.1<br />

Other cause 97.2 96.9 97.4 97.1 97.1 95.4 97.2 96.4 96.6 98.1 97.5 97.1<br />

All 98.1 97.8 96.4 96.8 97.0 96.5 96.9 96.9 97.2 97.9 97.6 97.8<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.23 I.23 (continued)<br />

90-day survival probabilities: incident CAPD/CCPD patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 98.6 100.0 98.7 97.6 99.1 96.9 97.3 96.0 98.3 100.0 99.1<br />

5-9 100.0 100.0 100.0 100.0 98.4 100.0 100.0 98.5 100.0 98.3 100.0<br />

10-14 100.0 98.4 98.8 98.8 100.0 99.0 100.0 100.0 100.0 100.0 100.0<br />

15-19 100.0 100.0 100.0 100.0 99.1 100.0 100.0 100.0 98.0 98.9 100.0<br />

20-29 98.9 99.7 99.7 100.0 99.4 100.0 99.7 99.2 100.0 99.6 100.0<br />

30-39 98.9 99.2 99.0 99.4 99.6 99.3 99.8 99.2 99.6 99.8 99.3<br />

40-49 99.1 98.8 99.4 99.2 99.1 99.0 99.5 99.3 99.4 99.6 99.6<br />

50-59 99.0 98.9 98.9 99.1 99.0 99.5 98.8 99.4 99.0 99.2 99.2<br />

60-64 98.6 98.8 98.4 98.4 98.9 98.8 98.7 99.1 98.8 98.9 99.1<br />

65-69 97.8 99.1 98.5 98.2 97.3 98.9 98.0 98.1 98.9 99.4 99.4<br />

70-79 97.0 96.2 98.1 97.4 96.8 97.7 97.4 97.1 97.1 97.4 97.6<br />

80+ 93.5 92.9 92.2 94.8 92.8 96.3 93.9 96.7 95.4 97.4 95.2<br />

Male 98.4 98.4 98.8 98.8 98.5 98.9 98.6 98.8 98.7 99.0 98.7<br />

Female 98.6 98.6 98.5 98.7 98.5 98.9 98.8 98.7 98.8 99.1 99.2<br />

621<br />

White 98.5 98.4 98.7 98.6 98.5 98.8 98.5 98.8 98.6 98.9 98.8<br />

Black 98.3 98.7 98.5 98.8 98.5 99.2 99.0 98.9 99.2 99.3 99.2<br />

Other race 99.6 98.9 99.2 99.1 98.4 99.2 99.0 98.3 98.8 99.0 99.5<br />

†Hispanic 99.3 98.4 98.3 99.8 99.4 99.5 99.1<br />

†Non-Hispanic 98.4 99.0 98.7 98.6 98.7 99.0 98.9<br />

Diabetes 98.5 98.5 98.8 98.9 98.4 99.0 98.7 98.9 98.8 98.9 99.0<br />

Hypertension 98.0 97.9 98.3 98.2 97.8 98.5 98.3 98.9 98.1 98.7 98.5<br />

Glomerulonephritis 99.5 99.2 99.3 99.2 99.6 99.6 99.4 99.3 99.9 99.7 99.5<br />

Other cause 98.2 98.6 98.2 98.4 98.2 98.4 98.4 98.0 98.2 99.0 98.7<br />

All 98.5 98.5 98.7 98.7 98.5 98.9 98.7 98.8 98.7 99.0 98.9<br />

ADJUSTED<br />

0-19 99.6 99.7 99.4 99.2 99.3 99.0 99.2 98.7 99.1 99.6 99.8<br />

20-44 98.9 99.1 99.2 99.6 99.4 99.5 99.8 99.3 99.6 99.6 99.5<br />

45-64 99.0 98.9 98.9 98.9 99.0 99.2 98.9 99.3 99.1 99.3 99.3<br />

65-74 98.0 98.3 98.3 98.1 97.4 98.3 98.1 97.5 98.3 98.5 98.7<br />

75+ 94.8 94.2 96.3 96.0 94.7 97.5 95.5 97.5 96.2 97.5 96.7<br />

Male 97.7 97.8 98.4 98.3 97.9 98.5 98.1 98.4 98.3 98.7 98.4<br />

Female 98.0 98.1 97.8 98.1 97.8 98.5 98.3 98.2 98.3 98.7 98.9<br />

White 97.9 97.9 98.2 98.1 98.0 98.4 98.1 98.4 98.2 98.7 98.5<br />

Black 97.2 97.7 97.5 98.0 97.4 98.6 98.3 98.1 98.6 98.8 98.8<br />

Other race 99.3 98.3 98.7 98.6 97.8 98.9 98.4 97.6 98.3 98.8 99.4<br />

Diabetes 97.9 98.0 98.4 98.5 97.9 98.7 98.3 98.6 98.5 98.7 98.8<br />

Hypertension 97.8 97.8 98.3 98.0 97.7 98.5 98.3 98.9 98.2 98.8 98.6<br />

Glomerulonephritis 99.1 98.6 98.7 98.7 99.3 99.3 98.9 98.6 99.8 99.4 99.1<br />

Other cause 97.0 97.7 97.0 97.4 96.9 97.3 97.2 96.8 97.1 98.3 98.0<br />

All 97.8 97.9 98.1 98.2 97.9 98.5 98.2 98.3 98.3 98.7 98.6<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.24 I.24<br />

One-year survival probabilities: incident CAPD/CCPD patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

one<br />

one<br />

year<br />

year<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

622<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 85.7 100.0 85.5 85.9 81.6 82.7 93.2 96.4 80.5 90.4 81.1<br />

5-9 80.0 100.0 89.9 100.0 84.7 83.3 100.0 100.0 100.0 100.0 96.9<br />

10-14 75.0 100.0 98.0 100.0 96.2 98.1 97.6 100.0 94.2 94.9 96.5<br />

15-19 100.0 100.0 91.0 93.3 93.8 92.7 94.7 95.0 100.0 97.0 100.0<br />

20-29 95.8 90.8 90.5 88.5 91.0 91.8 94.8 89.1 92.7 91.5 90.0<br />

30-39 81.3 87.6 85.5 88.4 86.7 86.3 84.6 87.6 88.3 88.9 90.3<br />

40-49 85.4 83.5 84.0 85.1 84.9 85.0 83.5 87.7 87.8 87.6 89.7<br />

50-59 81.0 81.5 80.3 79.9 81.5 78.3 79.8 82.4 83.0 82.6 85.6<br />

60-64 77.9 73.6 75.7 74.1 71.8 76.6 76.8 74.7 78.1 77.6 78.7<br />

65-69 69.2 68.9 67.7 71.6 67.1 68.5 68.6 67.8 74.4 73.9 75.6<br />

70-79 52.0 65.0 63.6 60.3 63.1 71.0 65.2 65.3 65.1 67.0 64.6<br />

80+ 62.5 61.5 51.6 40.3 44.1 48.5 50.0 44.2 50.0 46.3 59.8<br />

Male 79.2 78.8 79.7 78.1 78.7 79.5 79.9 80.9 80.4 80.7 82.3<br />

Female 79.9 79.5 75.6 78.9 78.5 78.6 78.6 77.9 82.0 81.4 82.2<br />

White 78.7 77.8 76.8 77.8 77.4 78.1 78.0 78.3 79.9 79.6 81.0<br />

Black 81.7 82.7 80.3 79.7 82.0 81.9 82.4 82.5 83.7 83.9 84.9<br />

Other race 89.7 94.4 76.1 86.4 81.5 83.1 87.7 86.3 90.3 89.0 88.3<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 63.2 68.3 70.3 72.8 71.1 72.9 71.8 74.3 77.7 76.6 78.3<br />

Hypertension 81.5 80.1 75.9 75.3 75.7 78.5 79.5 77.2 79.3 78.2 81.0<br />

Glomerulonephritis 88.9 88.5 85.9 89.6 87.2 90.3 88.8 89.7 90.3 90.8 91.9<br />

Other cause 84.9 82.5 82.8 80.1 83.2 79.1 82.3 81.6 80.5 83.6 83.0<br />

All 79.6 79.1 77.7 78.5 78.6 79.1 79.3 79.5 81.1 81.0 82.2<br />

ADJUSTED<br />

0-19 75.7 . 84.4 89.1 81.0 80.1 91.9 94.5 85.6 90.9 88.6<br />

20-44 84.8 87.2 86.4 87.2 86.3 87.0 86.9 88.0 88.2 88.3 89.7<br />

45-64 79.2 77.7 78.7 78.4 78.8 78.8 79.3 80.8 82.6 82.9 84.7<br />

65-74 59.8 66.9 66.0 65.6 64.9 68.2 67.5 67.5 71.2 73.1 73.4<br />

75+ 54.9 56.1 53.7 49.6 53.1 63.2 56.9 55.4 56.0 54.8 58.6<br />

Male 70.5 72.1 73.6 71.0 71.4 73.8 73.9 75.3 74.9 75.9 77.8<br />

Female 69.5 72.3 69.4 71.8 71.0 71.7 71.7 72.3 76.1 76.2 78.1<br />

White 67.2 69.1 69.5 69.7 68.9 71.2 70.8 72.1 73.9 74.8 76.7<br />

Black 72.0 75.9 73.8 71.8 74.3 73.9 74.9 74.3 75.7 76.5 77.8<br />

Other race 82.8 92.1 66.5 81.1 70.7 74.8 83.2 80.9 86.5 84.5 83.7<br />

Diabetes 54.9 61.0 64.1 66.6 64.6 67.3 66.1 69.1 73.1 72.2 74.7<br />

Hypertension 79.1 78.3 74.6 72.8 72.8 77.7 78.2 76.3 78.1 77.5 80.5<br />

Glomerulonephritis 81.7 82.9 79.3 83.5 79.5 85.8 82.2 84.0 84.7 86.2 87.1<br />

Other cause 77.1 78.3 78.6 74.8 78.1 72.9 76.3 75.9 74.0 77.8 76.6<br />

All 70.1 72.1 71.5 71.3 71.2 72.8 72.9 73.8 75.5 76.1 77.9<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.24 I.24 (continued)<br />

One-year survival probabilities: incident CAPD/CCPD patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

one<br />

one<br />

year<br />

year<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 76.4 86.9 85.1 89.7 88.3 85.8 85.2 85.6 83.4 84.3 88.7 90.3<br />

5-9 100.0 90.2 92.7 100.0 98.0 94.9 96.1 100.0 98.4 98.0 98.1 97.7<br />

10-14 96.4 95.6 96.7 100.0 96.4 94.2 98.6 98.8 100.0 96.2 98.7 98.7<br />

15-19 95.1 96.6 96.8 93.4 97.4 98.1 99.0 96.1 98.9 98.6 98.7 98.6<br />

20-29 93.0 94.0 93.6 94.2 94.2 93.9 98.9 96.3 98.3 95.6 95.7 95.2<br />

30-39 92.5 90.6 91.5 91.8 90.4 92.7 93.5 93.9 95.8 95.9 96.5 95.3<br />

40-49 89.8 89.6 90.6 90.5 92.2 92.3 92.3 92.9 92.9 93.4 95.4 91.8<br />

50-59 84.9 87.0 86.6 88.6 87.6 87.4 89.5 87.3 90.4 89.2 91.1 91.1<br />

60-64 82.4 81.0 82.8 81.9 81.3 82.3 83.0 83.9 81.3 84.5 84.1 88.0<br />

65-69 77.5 81.2 79.9 78.2 80.1 80.6 78.1 80.8 80.3 79.9 79.8 80.8<br />

70-79 69.3 68.7 70.2 70.4 74.7 73.5 73.2 74.6 73.1 72.3 77.9 75.8<br />

80+ 61.3 60.0 58.0 59.3 65.6 60.7 56.5 60.0 59.7 62.3 63.1 58.3<br />

Male 83.9 84.0 84.2 84.6 85.3 85.1 86.3 85.7 86.4 86.1 88.0 86.3<br />

Female 84.1 84.6 84.9 84.7 85.8 85.9 85.4 86.2 86.2 86.1 87.0 87.6<br />

623<br />

White 82.7 83.5 83.5 83.6 84.6 83.9 84.2 84.2 84.9 84.4 85.9 85.0<br />

Black 86.5 85.7 86.3 86.3 86.5 89.0 89.6 89.9 90.5 90.5 90.9 91.2<br />

Other race 92.2 88.8 90.9 90.8 91.6 89.6 91.0 90.9 88.3 89.9 92.8 90.6<br />

†Hispanic 89.5 88.4 90.9 91.5 92.2 92.2 88.6<br />

†Non-Hispanic 85.0 85.5 85.4 85.7 85.3 86.9 86.6<br />

Diabetes 80.4 81.0 82.2 81.5 82.3 82.1 81.6 82.5 83.2 82.8 85.2 83.2<br />

Hypertension 83.5 83.6 82.6 82.3 86.1 85.8 85.4 84.0 84.6 84.9 85.8 86.5<br />

Glomerulonephritis 90.0 91.8 93.1 93.1 93.0 92.8 93.5 94.8 95.4 95.3 93.7 96.1<br />

Other cause 86.6 85.7 84.7 86.9 86.1 86.6 89.4 88.3 88.1 87.1 89.4 88.9<br />

All 84.0 84.3 84.5 84.7 85.6 85.5 85.8 86.0 86.3 86.1 87.5 86.9<br />

ADJUSTED<br />

0-19 80.8 87.4 85.7 90.7 89.6 87.4 89.9 88.5 89.6 87.1 91.4 92.2<br />

20-44 91.4 90.4 91.0 91.4 91.4 92.8 94.1 94.2 95.1 95.0 96.1 94.6<br />

45-64 85.9 86.6 87.0 87.8 87.7 87.8 89.0 88.2 89.4 89.5 90.6 90.8<br />

65-74 75.5 77.4 78.9 76.6 78.6 79.7 78.8 81.3 79.3 79.1 82.0 79.4<br />

75+ 64.9 62.3 60.4 63.2 71.2 65.8 64.3 64.8 66.9 66.5 68.1 69.1<br />

Male 79.8 80.3 80.7 81.4 82.4 82.5 84.2 83.5 84.5 84.3 86.6 84.5<br />

Female 79.9 80.5 81.3 81.0 82.7 82.7 82.0 83.3 83.4 83.1 84.3 85.4<br />

White 78.5 79.7 80.1 80.5 81.7 81.2 81.8 81.9 82.7 82.4 84.1 83.4<br />

Black 80.5 79.4 80.1 80.3 81.5 84.4 85.3 86.0 86.8 86.7 87.5 88.1<br />

Other race 88.5 84.6 87.9 86.7 89.2 87.3 88.4 87.7 85.5 86.3 91.1 88.4<br />

Diabetes 76.8 77.3 79.1 78.4 79.3 79.4 79.4 80.4 81.2 80.9 83.5 81.4<br />

Hypertension 82.4 83.2 81.9 81.9 85.6 85.6 85.4 84.3 84.9 85.1 86.4 87.0<br />

Glomerulonephritis 84.9 86.8 89.3 89.4 89.5 89.1 89.7 91.7 92.6 92.8 90.4 94.0<br />

Other cause 81.0 79.8 78.5 81.5 80.6 80.9 84.6 82.9 83.2 81.7 85.1 84.2<br />

All 79.9 80.4 81.0 81.2 82.5 82.6 83.2 83.4 84.1 83.8 85.6 84.9<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories; no unknown or foreign states.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.25 I.25<br />

Two-year survival probabilities: incident CAPD/CCPD patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

two<br />

two<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

624<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 42.9 95.5 80.5 76.0 78.2 75.8 90.1 92.2 72.0 90.4 70.7<br />

5-9 80.0 100.0 89.9 91.7 77.0 83.3 83.1 100.0 100.0 100.0 87.0<br />

10-14 75.0 78.8 98.0 100.0 89.5 98.1 93.3 100.0 94.2 91.9 87.0<br />

15-19 100.0 100.0 88.0 89.8 87.0 87.9 88.7 92.4 97.0 95.0 97.9<br />

20-29 80.8 78.1 82.7 81.7 76.4 80.8 87.1 78.2 86.5 83.9 81.4<br />

30-39 66.0 76.7 75.2 80.5 75.1 73.3 71.9 76.3 79.2 78.6 79.5<br />

40-49 72.7 70.1 68.9 70.1 69.5 73.3 70.0 75.2 75.9 74.2 80.1<br />

50-59 65.8 67.3 64.2 64.5 66.0 61.3 61.8 62.7 66.4 67.2 69.3<br />

60-64 66.2 52.5 52.8 54.6 52.6 55.7 55.8 57.7 60.4 59.0 57.6<br />

65-69 40.4 54.9 47.5 51.3 51.2 48.1 42.9 46.4 52.9 52.3 56.0<br />

70-79 46.0 42.9 43.2 38.1 37.5 47.4 38.2 43.0 42.4 42.6 40.9<br />

80+ 12.5 35.9 21.9 22.6 25.2 32.9 25.7 16.9 23.5 30.1 35.4<br />

Male 65.1 64.0 63.8 61.8 61.8 60.2 61.1 63.5 64.0 63.8 64.6<br />

Female 63.3 62.9 57.5 63.2 62.2 63.8 60.0 60.9 66.3 65.9 66.9<br />

White 62.0 62.0 58.8 61.1 59.8 60.2 57.9 59.9 62.8 62.1 61.9<br />

Black 71.8 67.8 65.8 65.6 67.4 67.4 67.9 69.4 71.5 70.4 74.0<br />

Other race 79.2 66.2 62.5 69.9 68.3 64.8 67.9 59.3 67.0 76.1 83.9<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 39.2 47.6 48.4 53.5 48.0 49.8 48.3 52.0 56.1 56.2 56.0<br />

Hypertension 64.6 64.3 60.8 57.8 62.0 63.3 62.1 60.4 65.9 62.0 64.8<br />

Glomerulonephritis 82.2 76.1 74.0 78.8 76.8 76.8 76.8 79.0 78.3 78.1 83.3<br />

Other cause 72.0 69.1 66.8 66.2 67.5 65.2 64.9 67.3 67.0 72.3 71.5<br />

All 64.2 63.4 60.7 62.5 61.9 62.0 60.6 62.3 65.1 64.7 65.7<br />

ADJUSTED<br />

0-19 54.4 . . . 71.6 73.7 80.5 90.6 78.5 . 76.0<br />

20-44 67.8 75.7 75.0 77.2 73.9 74.5 75.9 76.4 78.3 77.7 79.4<br />

45-64 64.8 60.2 60.4 61.5 60.9 61.1 60.4 63.4 66.7 67.0 68.4<br />

65-74 40.8 48.7 45.1 44.6 44.6 47.3 41.3 46.5 50.3 50.6 52.0<br />

75+ 29.1 33.8 30.9 28.0 30.0 39.7 31.2 29.6 29.5 33.9 35.6<br />

Male 53.7 55.5 55.4 52.9 52.3 53.0 53.3 55.9 56.9 57.5 58.0<br />

Female 48.8 52.8 50.1 54.1 52.4 55.1 50.8 53.8 57.9 58.7 61.2<br />

White 47.0 51.0 49.6 51.1 49.2 51.8 48.9 52.2 55.1 55.9 56.1<br />

Black 59.0 57.5 56.8 55.0 56.4 56.0 57.3 58.1 60.0 59.6 63.6<br />

Other race 67.1 . 50.7 . 54.4 52.0 60.5 49.1 56.8 69.0 78.0<br />

Diabetes 31.7 40.1 41.5 46.6 40.8 44.1 42.1 45.9 50.1 50.7 51.1<br />

Hypertension 61.2 62.2 59.3 54.6 58.5 62.7 60.6 59.5 64.5 61.3 64.2<br />

Glomerulonephritis 72.2 67.2 64.8 69.2 65.7 68.8 66.7 70.0 68.8 69.5 75.1<br />

Other cause 60.5 63.1 60.8 59.4 60.1 57.1 56.3 59.5 58.4 64.3 63.1<br />

All 51.6 54.0 52.7 53.4 52.3 54.1 52.2 54.8 57.4 58.1 59.5<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110 are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.25 I.25 (continued)<br />

Two-year survival probabilities: incident CAPD/CCPD patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

two<br />

two<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />

0-4 76.4 84.4 81.5 83.3 78.0 81.3 77.1 81.4 81.9 74.3 83.4<br />

5-9 100.0 90.2 92.7 91.5 98.0 94.9 96.1 95.5 95.5 98.0 91.0<br />

10-14 96.4 85.7 93.0 100.0 93.5 89.7 91.9 97.0 100.0 94.0 94.8<br />

15-19 95.1 94.9 87.0 91.2 93.3 91.2 95.5 88.2 96.9 93.4 95.1<br />

20-29 84.6 87.7 88.0 87.6 89.7 87.4 91.8 92.1 93.4 92.9 89.5<br />

30-39 82.3 80.6 82.3 81.2 84.2 84.5 84.6 85.7 88.9 90.6 88.8<br />

40-49 75.0 79.2 78.4 78.3 80.8 82.5 82.2 82.6 82.5 84.2 87.4<br />

50-59 67.3 71.3 72.5 73.3 72.5 73.3 74.7 73.2 76.8 76.6 77.0<br />

60-64 61.3 60.8 66.1 64.7 63.0 63.7 67.0 64.8 66.0 69.9 69.6<br />

65-69 54.9 59.3 60.9 61.5 61.1 61.3 56.1 62.6 60.0 60.6 66.7<br />

70-79 48.5 47.6 48.6 48.3 51.1 50.9 51.9 52.6 51.1 48.7 58.9<br />

80+ 35.8 33.1 33.1 33.3 34.4 38.0 32.4 40.0 35.9 39.6 40.9<br />

Male 65.6 67.3 69.5 68.8 69.7 69.6 70.5 70.2 71.6 72.3 73.7<br />

Female 68.5 70.0 69.5 69.6 70.2 71.6 70.7 71.9 72.2 71.8 74.7<br />

625<br />

White 64.1 66.0 66.6 66.6 66.8 67.7 66.9 67.7 68.7 68.9 70.7<br />

Black 72.9 73.8 74.8 72.9 75.9 77.0 79.5 78.3 79.8 79.2 81.3<br />

Other race 78.4 77.1 81.5 82.6 78.5 76.9 79.3 80.8 79.3 80.3 84.6<br />

†Hispanic 77.7 74.9 81.0 79.3 83.1 81.4<br />

†Non-Hispanic 69.6 70.1 69.8 70.9 70.6 73.3<br />

Diabetes 57.4 59.9 61.8 61.8 61.8 62.9 62.1 63.1 64.3 65.8 68.4<br />

Hypertension 68.4 68.8 67.3 67.5 71.6 71.1 71.5 70.8 71.0 69.7 72.7<br />

Glomerulonephritis 78.8 82.6 86.2 83.1 84.3 85.2 85.6 86.2 88.4 88.5 86.4<br />

Other cause 75.1 75.2 75.4 75.7 75.6 76.0 77.4 78.6 78.3 75.9 79.7<br />

All 66.9 68.5 69.5 69.2 70.0 70.5 70.6 71.1 71.9 72.1 74.2<br />

ADJUSTED<br />

0-19 . 81.6 76.7 83.5 81.1 79.7 81.1 80.5 . 78.5 83.2<br />

20-44 79.8 81.0 81.3 81.0 83.7 83.6 85.3 85.1 88.2 88.8 88.0<br />

45-64 68.3 71.0 72.9 72.9 73.0 74.5 75.4 74.5 76.4 77.7 78.4<br />

65-74 55.0 56.9 58.8 58.3 59.7 59.7 59.3 61.8 59.3 59.3 66.4<br />

75+ 40.6 38.1 39.4 38.7 40.9 43.3 39.8 44.9 43.7 42.5 48.6<br />

Male 59.5 61.6 64.5 64.1 65.3 65.5 67.3 67.1 68.8 69.7 71.6<br />

Female 62.4 63.8 63.8 63.9 65.3 66.8 65.4 67.4 67.5 67.1 70.7<br />

White 58.4 60.6 62.0 62.4 62.7 64.0 63.7 64.6 65.7 66.3 68.4<br />

Black 63.3 64.1 65.5 63.4 68.4 68.9 71.8 71.4 73.0 72.3 75.4<br />

Other race 70.4 70.2 76.5 76.0 73.8 73.0 74.8 75.3 75.1 73.9 81.5<br />

Diabetes 52.3 54.6 57.3 57.5 57.5 59.0 59.0 59.9 61.2 63.0 65.9<br />

Hypertension 66.9 68.3 66.4 67.1 70.7 71.2 71.6 71.6 71.8 70.2 73.9<br />

Glomerulonephritis 70.4 74.0 79.7 75.6 77.7 78.9 78.6 79.3 82.3 83.3 80.4<br />

Other cause 66.6 66.7 67.0 67.5 67.7 67.2 69.3 70.2 70.8 67.6 72.8<br />

All 60.8 62.6 64.2 64.0 65.3 66.2 66.5 67.3 68.3 68.6 71.2<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110 are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.26 I.26<br />

Three-year survival probabilities: incident CAPD/CCPD patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

three<br />

three<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

626<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 42.9 95.5 80.5 76.0 78.2 75.8 90.1 86.5 72.0 84.4 66.5 67.9<br />

5-9 80.0 100.0 89.9 91.7 77.0 69.4 83.1 100.0 83.3 100.0 79.8 100.0<br />

10-14 75.0 52.5 98.0 93.8 89.5 98.1 93.3 94.1 94.2 91.9 87.0 96.4<br />

15-19 100.0 100.0 88.0 85.7 82.6 77.9 85.1 89.7 92.8 87.0 91.4 91.2<br />

20-29 74.9 70.1 73.0 76.5 72.0 76.2 78.8 71.9 81.6 77.9 72.8 77.9<br />

30-39 57.6 65.5 64.3 69.9 68.6 63.5 63.1 65.7 68.9 69.2 71.7 73.4<br />

40-49 57.0 61.0 56.9 57.3 57.9 63.6 60.5 62.4 62.5 61.0 64.8 63.3<br />

50-59 55.1 56.8 52.4 51.2 53.3 48.3 47.8 48.1 52.4 53.1 56.2 51.7<br />

60-64 49.9 39.7 38.7 42.8 39.1 42.1 44.1 43.8 42.3 45.7 43.0 47.8<br />

65-69 30.8 43.9 36.4 35.2 36.5 35.6 30.5 32.4 38.6 35.8 39.4 38.7<br />

70-79 38.0 28.8 29.3 26.5 23.2 31.8 21.1 26.2 29.6 27.0 24.4 32.1<br />

80+ . 15.4 10.9 12.9 19.4 12.5 16.8 10.4 13.7 13.8 22.8 23.6<br />

Male 51.8 51.9 51.9 49.5 48.6 47.3 47.4 47.8 49.4 49.9 49.7 51.6<br />

Female 54.1 51.8 45.0 50.6 51.5 51.1 49.3 49.3 53.8 52.2 53.7 55.0<br />

White 49.5 49.2 46.4 47.1 47.8 46.7 44.4 45.0 47.6 47.0 46.7 49.1<br />

Black 65.3 60.1 54.1 57.4 55.2 56.8 57.9 58.6 61.6 60.0 61.8 61.7<br />

Other race 73.1 53.5 50.5 56.2 61.2 49.2 61.6 53.3 57.5 61.2 75.1 68.9<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 26.3 33.9 33.1 36.3 34.0 35.4 35.6 36.2 39.0 39.5 39.3 41.0<br />

Hypertension 56.7 51.5 48.7 48.3 49.1 51.9 50.3 46.8 52.2 48.6 51.5 55.2<br />

Glomerulonephritis 72.0 69.1 65.0 70.2 67.3 63.8 65.1 68.0 68.2 67.6 72.0 69.2<br />

Other cause 59.4 57.9 56.6 54.8 57.4 53.3 52.5 55.4 56.6 61.3 60.0 63.7<br />

All 52.9 51.9 48.5 50.1 50.0 49.2 48.3 48.6 51.5 51.0 51.6 53.2<br />

ADJUSTED<br />

0-19 . 82.3 . 75.1 . 65.2 . . . . 68.7 .<br />

20-44 58.5 65.1 64.3 68.1 66.2 65.8 66.9 65.8 67.3 67.9 69.4 71.2<br />

45-64 50.3 48.8 47.4 47.9 47.5 48.1 47.9 49.5 51.6 53.2 54.0 53.9<br />

65-74 . 35.5 32.0 31.0 30.4 33.6 27.5 30.7 36.3 33.7 35.0 39.1<br />

75+ . 20.0 19.9 17.0 18.5 23.0 16.1 17.9 18.9 20.2 21.4 24.8<br />

Male 40.1 43.3 43.3 40.7 39.1 40.7 39.8 40.2 42.3 43.7 42.8 45.4<br />

Female 39.1 41.3 38.2 41.4 41.7 42.5 40.1 42.5 45.1 44.6 47.8 48.6<br />

White 34.5 38.2 37.6 37.4 37.4 39.1 36.0 37.8 40.4 41.2 41.4 43.8<br />

Black 51.1 48.8 44.3 45.9 43.2 44.3 46.1 46.0 48.4 47.8 49.6 50.6<br />

Other race . 37.3 . . . 36.4 54.3 . 47.2 53.3 67.7 59.6<br />

Diabetes 20.8 27.5 27.4 30.6 28.1 31.1 30.1 31.1 33.7 34.7 34.9 36.5<br />

Hypertension 53.4 49.4 47.7 45.1 45.8 51.8 48.9 46.6 51.2 48.5 51.3 53.9<br />

Glomerulonephritis 59.3 59.4 55.0 59.0 55.0 54.9 53.7 57.2 56.9 57.2 61.0 59.6<br />

Other cause 46.7 51.6 50.5 47.7 49.4 44.9 43.6 47.1 47.5 52.3 51.0 53.8<br />

All 39.8 42.2 40.6 41.0 40.3 41.6 39.9 41.2 43.6 44.2 45.1 46.8<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.26 I.26 (continued)<br />

Three-year survival probabilities: incident CAPD/CCPD patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

three<br />

three<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />

0-4 84.4 75.0 80.8 78.0 71.5 67.8 81.4 81.9 71.2<br />

5-9 90.2 85.0 85.8 90.5 94.9 96.1 90.2 95.5 93.5<br />

10-14 85.7 79.7 95.0 86.1 85.6 88.3 97.0 100.0 90.6<br />

15-19 92.8 83.5 91.2 91.0 89.4 90.8 83.2 85.5 86.5<br />

20-29 80.5 82.7 84.1 84.4 82.4 86.8 87.4 86.1 86.4<br />

30-39 68.8 70.9 71.7 76.1 77.4 78.9 78.8 82.0 83.3<br />

40-49 64.6 66.0 67.3 70.2 71.2 72.1 71.7 74.2 72.2<br />

50-59 58.0 56.9 58.3 59.1 59.5 59.3 61.7 63.6 65.9<br />

60-64 46.3 49.6 50.6 47.5 49.2 53.4 51.4 49.3 54.3<br />

65-69 43.3 43.3 42.6 46.6 46.3 40.2 43.3 41.9 45.4<br />

70-79 28.8 34.1 31.4 36.1 35.7 34.3 36.5 34.0 34.3<br />

80+ 20.0 18.5 15.3 15.8 20.3 17.4 20.0 19.9 24.7<br />

Male 51.9 54.2 53.8 56.1 55.7 55.2 55.5 57.6 57.3<br />

Female 56.6 55.7 56.3 57.7 59.4 59.0 60.3 59.0 61.8<br />

627<br />

White 49.8 50.4 50.6 52.5 53.2 52.2 53.8 54.2 55.2<br />

Black 62.8 63.8 62.2 65.0 67.1 68.8 67.0 68.3 68.9<br />

Other race 69.2 68.5 72.8 67.5 65.5 65.4 67.2 67.7 71.0<br />

†Hispanic 64.4 64.9 67.8 66.4 72.3<br />

†Non-Hispanic 56.6 56.1 56.7 57.2 57.8<br />

Diabetes 43.6 44.0 44.0 45.5 46.5 46.3 46.9 48.1 51.3<br />

Hypertension 53.1 53.7 53.6 58.6 58.7 57.5 59.9 57.3 58.3<br />

Glomerulonephritis 74.3 74.3 73.7 75.7 76.1 76.0 75.5 80.5 80.4<br />

Other cause 62.7 65.7 66.3 67.4 68.0 67.2 69.1 68.3 63.8<br />

All 54.2 55.0 55.0 56.9 57.5 57.0 57.9 58.3 59.5<br />

ADJUSTED<br />

0-19 . 66.4 78.9 . 73.2 73.2 76.6 . 71.7<br />

20-44 69.5 70.0 72.2 75.7 75.7 78.9 77.0 80.3 78.9<br />

45-64 57.2 58.0 59.0 59.6 61.3 61.7 62.9 63.8 66.1<br />

65-74 40.1 42.1 40.5 45.4 44.7 41.9 44.2 41.9 44.7<br />

75+ 20.8 26.0 21.7 24.1 27.4 24.7 27.9 27.4 28.4<br />

Male 46.1 49.1 48.7 51.3 51.5 51.7 52.4 54.7 54.7<br />

Female 49.8 49.5 50.1 52.4 54.1 53.3 55.4 53.8 56.6<br />

White 44.7 46.1 46.6 48.7 49.9 49.4 51.1 51.4 52.9<br />

Black 51.4 52.9 51.2 56.0 57.1 58.8 58.3 59.3 60.0<br />

Other race 61.3 62.6 64.7 61.7 60.9 59.9 60.4 62.5 62.9<br />

Diabetes 38.7 39.8 40.1 41.5 42.9 43.4 44.1 45.0 48.5<br />

Hypertension 52.7 53.2 53.4 57.7 59.0 58.0 61.3 58.7 59.0<br />

Glomerulonephritis 63.4 65.1 63.9 67.0 67.8 66.1 65.5 71.6 72.9<br />

Other cause 52.8 56.2 56.7 58.4 57.9 57.7 58.8 59.5 53.9<br />

All 47.8 49.3 49.4 51.8 52.7 52.5 53.8 54.4 55.7<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.27 I.27<br />

Five-year survival probabilities: incident CAPD/CCPD patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

five<br />

five<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

628<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 42.9 95.5 80.5 76.0 78.2 62.0 90.1 86.5 72.0 84.4 66.5<br />

5-9 80.0 100.0 89.9 91.7 77.0 52.1 69.2 100.0 83.3 81.8 79.8<br />

10-14 75.0 26.3 87.1 93.8 79.5 98.1 93.3 87.4 84.8 73.5 80.3<br />

15-19 100.0 100.0 78.2 85.7 67.6 64.3 75.6 85.5 83.9 78.1 77.2<br />

20-29 70.8 54.4 57.5 65.9 52.3 62.5 64.0 59.8 70.9 60.7 56.1<br />

30-39 47.0 49.7 47.0 49.7 51.4 47.8 46.4 47.5 54.1 54.8 53.8<br />

40-49 41.4 43.1 42.8 39.8 40.3 47.3 44.6 41.1 46.7 43.5 45.3<br />

50-59 35.5 39.3 34.7 34.4 33.9 30.3 32.4 31.3 30.5 33.1 32.1<br />

60-64 36.3 21.6 22.1 22.7 19.2 22.0 27.0 25.0 24.6 24.5 22.1<br />

65-69 19.2 21.3 17.6 16.5 19.3 21.9 17.1 17.1 19.3 16.8 21.8<br />

70-79 18.0 12.9 11.6 10.3 8.2 15.9 7.1 14.2 11.4 12.7 9.9<br />

80+ . 2.6 3.1 . 7.8 1.6 9.2 1.3 4.9 6.5 7.1<br />

Male 36.2 31.4 31.9 30.3 29.2 31.2 31.5 30.7 30.4 31.8 29.7<br />

Female 39.5 35.9 30.1 33.2 33.7 31.9 33.4 32.2 36.0 33.4 33.6<br />

White 33.1 30.1 28.8 28.4 29.3 28.5 28.1 27.5 28.1 27.9 25.9<br />

Black 57.1 43.8 36.7 40.0 36.0 40.5 42.0 41.5 45.7 42.8 44.0<br />

Other race 53.1 53.5 34.7 34.1 40.4 34.2 53.0 41.9 39.5 40.9 51.2<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 16.3 18.5 17.1 18.4 17.3 18.3 18.4 17.1 20.6 19.2 17.4<br />

Hypertension 41.9 31.6 32.4 33.9 31.7 35.6 35.4 32.2 34.3 31.8 33.8<br />

Glomerulonephritis 52.4 48.0 46.7 46.5 46.3 47.0 49.2 52.8 48.9 52.5 53.7<br />

Other cause 43.2 40.3 37.0 35.9 37.5 34.0 38.5 38.8 38.9 42.8 40.6<br />

All 37.8 33.7 31.1 31.7 31.4 31.6 32.4 31.4 33.1 32.5 31.6<br />

ADJUSTED<br />

0-19 . . . . 59.7 51.1 . 78.3 . 66.8 60.2<br />

20-44 46.6 49.6 49.4 49.4 48.2 51.0 51.2 50.2 52.3 52.0 51.0<br />

45-64 32.8 30.3 30.1 30.1 28.0 28.9 31.6 30.4 32.3 33.0 31.2<br />

65-74 16.8 16.1 13.9 14.1 14.3 20.3 13.3 16.6 17.2 15.7 18.6<br />

75+ . 6.6 7.5 4.0 7.1 7.8 6.1 8.0 6.1 9.7 6.8<br />

Male 25.9 24.9 25.6 23.8 22.2 26.7 25.4 24.7 25.0 27.1 24.4<br />

Female 26.1 26.8 24.9 25.8 26.1 25.6 25.9 27.3 28.8 27.4 29.4<br />

White 20.8 21.9 22.6 21.7 21.8 23.8 22.1 23.0 23.5 24.4 23.1<br />

Black 42.1 32.5 27.7 29.2 25.4 28.9 30.6 29.6 32.3 31.1 32.0<br />

Other race 40.0 . 25.3 31.7 28.9 24.0 44.8 30.1 30.7 33.9 42.7<br />

Diabetes 12.9 15.0 14.0 15.6 14.4 16.9 15.2 14.8 17.6 16.8 15.8<br />

Hypertension 39.6 29.7 32.8 31.4 29.3 36.3 33.8 33.1 34.5 32.4 34.4<br />

Glomerulonephritis 38.0 39.0 37.5 36.0 35.5 39.3 38.3 41.7 37.2 42.1 41.4<br />

Other cause 30.1 34.7 31.7 29.7 30.0 26.8 30.5 31.2 30.5 34.4 32.3<br />

All 26.1 25.7 25.1 24.7 24.0 26.2 25.6 25.9 26.8 27.2 26.7<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.27 I.27 (continued)<br />

Five-year survival probabilities: incident CAPD/CCPD patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

five<br />

five<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998<br />

0-4 67.9 68.3 61.7 72.2 64.4 65.3 64.2 70.7<br />

5-9 100.0 90.2 85.0 80.0 67.0 94.9 96.1 82.0<br />

10-14 72.3 85.7 63.8 84.4 86.1 85.6 88.3 67.9<br />

15-19 81.3 89.2 83.5 81.2 87.9 82.2 87.7 76.8<br />

20-29 67.2 70.1 73.3 75.5 71.6 74.3 82.1 75.7<br />

30-39 53.5 52.3 55.3 59.0 58.8 62.2 64.3 62.9<br />

40-49 45.9 42.6 49.9 49.1 52.2 50.8 50.5 51.9<br />

50-59 30.4 36.8 38.2 36.0 36.9 38.1 37.5 41.6<br />

60-64 25.9 26.0 28.6 29.5 26.7 27.2 31.1 27.0<br />

65-69 16.8 23.2 23.5 21.8 23.6 23.2 20.9 22.7<br />

70-79 13.8 13.5 13.3 12.3 16.8 15.7 14.7 16.0<br />

80+ 6.6 6.9 4.5 6.8 4.9 5.4 5.8 5.4<br />

Male 30.8 32.2 35.0 34.0 35.6 34.3 34.1 34.1<br />

Female 34.6 37.1 36.9 36.7 37.4 39.8 39.5 40.1<br />

629<br />

White 27.8 29.7 30.5 29.7 31.1 31.1 30.6 31.6<br />

Black 42.8 44.8 46.5 44.8 47.2 50.1 49.9 47.9<br />

Other race 45.8 45.6 49.7 55.2 44.6 43.6 50.8 51.5<br />

†Hispanic 44.1 43.5 43.1<br />

†Non-Hispanic 36.1 35.9 36.3<br />

Diabetes 19.4 21.4 23.7 24.4 23.1 24.6 24.8 24.8<br />

Hypertension 35.3 36.2 36.8 34.4 40.2 39.5 37.5 37.4<br />

Glomerulonephritis 51.1 58.7 54.8 53.2 59.0 56.8 58.7 59.7<br />

Other cause 43.5 44.2 48.2 48.1 48.8 50.8 49.6 53.1<br />

All 32.5 34.6 35.9 35.3 36.5 37.0 36.7 37.0<br />

ADJUSTED<br />

0-19 62.5 71.0 58.9 65.9 . 67.0 . 59.8<br />

20-44 52.9 52.5 56.2 58.3 58.5 59.6 62.2 60.1<br />

45-64 33.0 36.0 38.7 37.7 38.6 40.0 40.5 42.1<br />

65-74 18.0 21.7 21.6 19.9 23.5 22.2 21.3 22.5<br />

75+ 8.8 7.2 8.0 8.0 9.2 11.3 9.7 11.4<br />

Male 26.4 27.9 31.2 30.4 31.8 31.1 31.6 32.1<br />

Female 29.5 31.6 31.9 31.4 33.2 35.4 34.9 36.3<br />

White 25.0 26.8 28.3 27.7 29.2 29.9 30.0 31.1<br />

Black 31.8 33.3 35.4 33.9 37.9 39.3 39.1 38.5<br />

Other race 36.3 37.8 44.2 47.3 38.9 39.7 45.5 44.9<br />

Diabetes 17.5 19.1 21.6 22.2 21.4 22.8 23.6 23.8<br />

Hypertension 35.0 36.5 37.0 34.9 39.6 40.3 38.8 40.2<br />

Glomerulonephritis 41.8 45.9 43.8 41.5 48.2 46.8 46.8 47.6<br />

Other cause 33.6 34.7 38.7 37.9 39.5 39.6 39.6 41.7<br />

All 27.8 29.6 31.5 30.9 32.5 33.2 33.2 34.1<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.28 I.28<br />

Ten-year survival probabilities: incident CAPD/CCPD patients<br />

censored<br />

censored<br />

at<br />

at<br />

transplant,<br />

transplant,<br />

from<br />

from<br />

day<br />

day<br />

91<br />

91<br />

to<br />

to<br />

ten<br />

ten<br />

years<br />

years<br />

+ 90<br />

90<br />

days,<br />

days,<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

630<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<br />

0-4 42.9 95.5 80.5 76.0 67.0 49.6 90.1 86.5 48.0 70.3 35.5 60.4 54.6 52.9<br />

5-9 80.0 80.0 67.4 91.7 77.0 34.7 69.2 100.0 83.3 65.5 59.8 100.0 75.2 34.0<br />

10-14 . 26.3 56.5 82.0 79.5 65.4 35.0 87.4 70.7 36.7 40.2 72.3 85.7 63.8<br />

15-19 100.0 57.1 68.4 71.4 25.4 38.7 52.0 79.8 77.9 67.4 46.5 44.7 58.4 46.4<br />

20-29 56.6 34.5 33.0 48.0 39.6 38.9 41.4 36.3 44.9 39.2 38.4 38.4 46.4 50.7<br />

30-39 25.4 26.0 24.2 27.5 29.4 24.8 28.3 24.2 28.3 29.3 31.4 29.0 23.5 31.4<br />

40-49 19.9 19.7 15.0 21.4 20.0 19.5 17.4 19.3 21.8 19.8 18.5 19.7 16.8 22.2<br />

50-59 14.6 13.6 9.7 11.1 9.6 11.1 8.3 9.5 9.0 9.4 10.0 8.2 10.0 9.6<br />

60-64 7.6 7.4 4.6 4.8 5.1 5.1 6.9 4.5 6.2 4.7 3.3 4.3 5.4 5.6<br />

65-69 5.8 4.3 2.7 3.8 4.6 7.9 4.0 1.7 2.6 3.4 3.9 2.6 4.1 3.8<br />

70-79 6.0 1.2 1.7 1.9 0.7 3.3 1.9 1.9 0.9 1.4 1.3 1.9 1.8 1.1<br />

80+ . 2.6 . . 3.9 . . . 1.0 0.8 0.8 0.9 1.4 .<br />

Male 15.6 12.7 10.7 12.7 10.8 11.0 11.4 10.8 10.3 10.7 10.0 9.9 10.5 11.5<br />

Female 18.5 13.5 9.8 13.7 14.6 13.1 12.6 11.8 14.9 13.1 12.1 12.4 12.2 12.9<br />

White 15.0 11.8 9.7 11.3 10.9 10.2 9.8 8.8 8.1 8.3 8.0 7.8 8.5 8.9<br />

Black 24.9 16.6 11.6 17.4 16.8 17.1 17.2 17.2 22.6 19.5 17.6 17.9 17.5 18.4<br />

Other race 23.9 26.7 12.6 18.6 17.7 14.0 17.6 22.8 21.1 19.7 21.2 18.8 15.7 20.6<br />

Diabetes 5.7 4.4 2.0 5.2 5.8 4.9 3.5 4.0 5.8 3.9 3.1 3.7 3.7 4.3<br />

Hypertension 13.5 12.8 10.2 14.4 12.7 11.8 13.0 10.0 13.4 11.4 11.0 13.4 11.2 14.2<br />

Glomerulonephritis 28.5 17.8 21.4 20.4 24.2 21.8 25.0 23.3 21.5 25.5 24.9 19.7 27.5 26.1<br />

Other cause 21.5 18.2 14.1 16.9 13.5 15.5 15.7 16.7 15.4 17.8 18.2 18.5 19.1 18.8<br />

All 16.9 13.1 10.2 13.1 12.6 12.0 12.0 11.3 12.5 11.9 11.0 11.0 11.4 12.2<br />

ADJUSTED<br />

0-19 . 42.0 42.0 . 38.9 28.9 43.1 . . 44.5 27.5 39.1 43.9 33.2<br />

20-44 27.7 27.7 23.3 28.7 29.2 27.0 28.4 27.5 28.7 28.1 27.3 26.9 25.7 30.2<br />

45-64 11.8 10.4 8.4 10.2 8.6 9.3 9.0 9.1 10.6 10.0 9.0 9.5 10.4 11.7<br />

65-74 4.6 2.5 2.6 3.1 3.1 6.2 3.5 2.3 2.4 3.2 3.4 3.4 3.6 3.5<br />

75+ . 1.5 0.6 . 1.9 3.1 0.9 1.3 1.1 0.3 0.6 0.6 1.6 0.3<br />

Male 11.3 10.4 8.8 10.1 7.8 10.6 9.5 8.7 8.3 9.0 8.2 8.7 9.4 10.7<br />

Female 11.3 10.3 8.7 10.6 12.0 11.4 9.9 10.9 12.4 11.1 11.2 11.2 11.2 11.6<br />

White 9.4 9.2 8.2 9.0 8.5 10.3 8.6 8.5 8.0 8.3 8.3 8.3 9.2 9.8<br />

Black 14.8 10.3 8.0 11.5 10.8 11.0 10.4 10.5 13.7 12.1 11.0 11.4 11.2 11.8<br />

Other race 17.8 17.2 10.9 20.5 12.6 8.7 16.6 12.5 13.8 16.6 16.0 14.1 12.3 20.1<br />

Diabetes 4.7 4.0 2.2 5.0 5.5 5.9 3.6 4.2 5.4 3.9 3.5 3.9 4.2 4.7<br />

Hypertension 17.1 13.0 12.9 14.4 11.8 15.1 13.2 12.3 14.4 13.0 12.2 14.0 12.7 15.1<br />

Glomerulonephritis 17.4 14.6 15.8 14.3 17.6 17.9 17.6 15.8 14.1 18.8 17.0 15.2 19.1 18.0<br />

Other cause 14.0 15.5 11.3 13.2 10.0 11.7 12.0 12.3 10.7 12.9 13.9 12.7 13.8 13.9<br />

All 11.4 10.2 8.7 10.2 9.8 11.0 9.7 9.6 10.2 10.0 9.6 9.8 10.2 11.1<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.29 I.29<br />

90-day patient survival probabilities: first transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 92.9 92.0 94.4 94.1 95.7 95.0 97.8 94.6 100.0 97.9 92.5 97.5<br />

5-9 97.0 98.2 98.1 100.0 97.8 100.0 100.0 100.0 98.5 98.5 91.5 100.0<br />

10-14 96.7 98.7 100.0 98.3 99.2 97.6 97.6 96.7 97.6 97.8 98.1 98.0<br />

15-19 98.0 96.9 97.1 96.7 97.3 97.5 97.7 97.5 98.7 96.6 96.7 99.1<br />

20-29 95.1 97.2 97.1 97.4 97.2 98.0 97.0 97.7 97.5 97.1 98.4 98.6<br />

30-39 93.1 94.1 94.8 95.5 97.0 96.7 96.3 97.0 97.0 97.0 96.8 97.9<br />

40-49 92.2 92.5 95.2 94.1 95.7 95.2 95.5 94.8 96.2 95.9 95.9 97.0<br />

50-59 90.2 90.3 89.9 93.0 93.2 90.8 92.3 92.8 93.4 94.1 95.0 95.6<br />

60-64 100.0 95.5 90.9 91.5 90.8 94.6 92.1 94.8 91.0 94.6 93.9 96.3<br />

65+ 88.9 87.5 80.0 100.0 95.5 93.1 84.8 82.8 89.6 91.9 93.1 92.0<br />

Male 94.2 94.6 95.3 95.7 96.0 95.8 95.2 95.3 95.5 95.7 96.1 97.1<br />

Female 92.8 94.4 94.9 95.2 96.6 96.1 96.4 96.4 96.6 96.7 96.3 97.3<br />

White 93.8 94.7 95.1 95.4 96.3 96.0 95.4 95.6 95.9 95.9 95.9 97.2<br />

Black 92.6 94.0 95.7 95.7 95.9 95.9 96.2 96.0 96.1 96.7 97.3 97.3<br />

Other race 97.4 93.9 94.2 96.4 96.6 92.1 98.1 97.3 95.9 96.0 95.7 96.7<br />

631<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 91.2 92.9 94.1 93.7 96.0 95.4 93.4 94.4 94.5 95.6 95.2 96.3<br />

Hypertension 97.1 94.6 95.6 97.2 96.5 94.6 95.8 95.7 96.8 96.1 96.8 97.5<br />

Glomerulonephritis 96.6 96.4 96.8 96.9 96.9 97.5 97.2 96.8 96.1 96.4 97.1 98.2<br />

Other cause 91.5 93.8 94.2 94.4 95.7 95.4 95.8 95.7 96.3 96.0 95.8 96.7<br />

All 93.7 94.5 95.2 95.5 96.2 95.9 95.7 95.7 95.9 96.1 96.2 97.2<br />

ADJUSTED<br />

0-19 95.9 95.9 97.4 97.1 97.7 98.7 98.3 96.0 97.6 96.6 93.1 98.0<br />

20-44 92.6 93.8 94.8 95.0 96.4 96.7 96.3 96.1 96.7 96.5 96.9 97.8<br />

45-64 88.1 89.8 90.9 92.2 92.6 91.2 92.1 93.3 93.6 94.3 94.3 95.8<br />

65+ 93.0 . 85.9 90.5 92.9 93.4 86.4 87.3 87.4 89.1 94.1 92.6<br />

Male 84.5 85.5 87.6 88.6 89.8 89.7 88.8 89.4 90.3 90.6 91.9 94.0<br />

Female 80.5 84.4 86.8 87.9 91.4 90.5 91.4 91.8 92.6 92.7 92.2 94.5<br />

White 82.6 85.1 86.7 87.6 90.4 89.9 88.9 89.7 90.8 90.9 91.3 94.2<br />

Black 83.8 86.4 90.1 90.6 90.9 91.5 92.2 92.2 92.7 93.6 94.7 94.8<br />

Other race . 83.6 83.8 88.6 91.6 81.0 94.9 92.8 90.4 91.2 91.1 93.0<br />

Diabetes 83.2 86.3 88.8 88.4 92.4 91.7 88.1 90.4 90.7 92.4 92.1 93.9<br />

Hypertension 94.6 89.8 91.9 94.9 94.0 90.8 93.0 92.7 94.9 94.0 95.1 96.2<br />

Glomerulonephritis 91.0 90.4 91.8 92.0 92.4 93.9 93.4 92.9 91.8 92.5 94.0 96.4<br />

Other cause 82.2 86.1 86.9 87.7 90.4 90.0 91.1 91.1 92.8 92.2 91.8 93.8<br />

All 83.1 85.3 87.4 88.4 90.5 90.0 89.8 90.4 91.2 91.5 92.0 94.2<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of ESRD initiation.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.29 I.29 (continued)<br />

90-day patient survival probabilities: first transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 96.0 93.3 97.5 97.6 96.4 96.4 97.7 96.6 97.4 100.0 98.2<br />

5-9 100.0 98.2 96.2 96.3 98.5 98.3 96.4 98.1 96.0 100.0 100.0<br />

10-14 98.9 100.0 99.4 98.3 97.1 99.1 100.0 99.3 99.1 97.6 100.0<br />

15-19 99.1 97.8 99.2 99.1 98.9 98.3 99.5 98.8 99.5 99.4 99.4<br />

20-29 97.8 98.9 99.0 98.9 99.2 99.1 98.9 99.2 98.7 98.9 98.1<br />

30-39 97.8 98.4 98.0 98.0 98.1 97.8 98.2 98.0 98.4 98.7 98.7<br />

40-49 97.1 97.1 97.4 97.5 96.7 97.1 97.7 97.4 97.6 97.7 97.3<br />

50-59 95.5 95.5 96.0 95.9 96.3 95.8 96.9 95.9 96.0 96.4 96.5<br />

60-64 93.2 95.3 96.2 93.4 94.7 96.4 97.0 95.0 94.6 95.4 96.1<br />

65+ 93.3 92.5 95.5 94.2 95.2 93.9 95.7 94.1 94.7 94.5 94.9<br />

632<br />

Male 96.8 97.0 97.3 97.0 96.9 97.2 97.8 97.2 96.9 97.2 97.3<br />

Female 96.8 97.4 97.7 97.3 97.4 96.8 97.4 97.0 97.4 97.7 97.2<br />

White 96.6 97.2 97.2 96.7 97.2 96.9 97.5 97.1 97.1 97.4 97.3<br />

Black 97.4 96.9 97.8 98.0 96.7 97.2 97.8 97.3 96.9 97.2 97.2<br />

Other race 97.5 98.6 98.5 97.7 98.5 98.1 98.5 96.8 98.4 97.5 97.5<br />

†Hispanic 99.0 97.3 98.4 97.6 97.3 98.0 98.2<br />

†Non-Hispanic 96.9 97.0 97.6 97.0 97.1 97.3 97.1<br />

Diabetes 95.4 96.7 96.4 96.1 96.6 96.5 96.9 96.0 96.8 96.7 96.7<br />

Hypertension 96.7 97.2 97.9 96.8 97.1 96.9 98.2 97.5 96.0 96.8 96.7<br />

Glomerulonephritis 97.7 98.1 98.5 97.9 97.9 97.9 98.2 98.3 98.3 98.8 98.4<br />

Other cause 97.3 96.8 97.3 97.7 97.1 97.1 97.8 97.0 97.3 97.5 97.6<br />

All 96.8 97.2 97.4 97.1 97.1 97.1 97.7 97.1 97.1 97.4 97.3<br />

ADJUSTED<br />

0-19 97.9 97.2 98.1 98.3 97.7 98.0 98.5 98.1 . 98.2 .<br />

20-44 97.3 98.4 98.2 98.1 98.2 98.2 98.4 98.1 98.3 98.6 98.5<br />

45-64 95.6 95.6 96.3 96.1 96.0 96.1 97.0 96.3 96.5 96.8 96.6<br />

65+ 92.5 93.3 94.7 92.5 93.9 93.6 95.4 94.1 93.8 94.2 94.9<br />

Male 93.6 94.2 94.8 94.5 94.5 95.1 96.3 95.2 95.0 95.5 95.8<br />

Female 93.6 94.9 95.6 94.9 95.3 94.4 95.6 94.8 95.7 96.2 95.7<br />

White 93.2 94.5 94.7 94.0 95.0 94.6 95.8 95.0 95.4 95.9 95.8<br />

Black 95.0 94.5 96.1 96.5 94.4 95.4 96.4 95.6 95.0 95.7 95.8<br />

Other race 94.7 97.2 97.2 95.3 97.4 96.5 97.4 94.8 97.4 95.9 96.1<br />

Diabetes 92.6 94.8 94.4 94.1 94.9 94.9 95.6 94.5 95.7 95.6 95.8<br />

Hypertension 95.1 95.9 96.9 95.5 95.9 95.8 97.6 96.7 94.7 96.0 95.8<br />

Glomerulonephritis 95.5 96.2 97.1 96.1 96.1 96.2 96.8 97.0 97.0 97.9 97.3<br />

Other cause 95.0 94.1 94.9 95.8 94.9 94.9 96.1 94.8 95.5 95.8 96.0<br />

All 93.6 94.5 95.1 94.7 94.9 94.8 96.0 95.1 95.3 95.8 95.8<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.30 I.30<br />

One-year patient survival probabilities: first transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 71.4 88.0 94.4 91.2 91.5 91.7 97.8 91.1 86.0 95.7 84.9 90.0<br />

5-9 97.0 98.2 98.1 100.0 97.8 98.4 96.3 98.5 98.5 95.6 91.5 98.1<br />

10-14 91.3 96.1 100.0 94.9 98.3 95.3 97.6 95.9 96.0 94.4 93.5 97.1<br />

15-19 95.9 93.8 95.2 96.3 94.9 96.3 95.1 94.6 98.3 94.0 96.0 97.9<br />

20-29 90.6 93.5 93.9 94.4 94.2 96.1 93.8 95.2 94.4 95.4 96.6 96.8<br />

30-39 86.2 89.0 90.6 89.9 92.9 93.5 92.5 93.4 94.0 94.3 93.9 95.3<br />

40-49 83.5 83.9 88.6 87.3 88.7 90.1 89.7 89.2 91.9 91.4 91.5 94.3<br />

50-59 81.9 79.9 78.0 83.5 85.9 83.0 84.8 85.8 87.9 89.5 90.1 91.4<br />

60-64 75.0 72.7 81.8 78.7 84.6 88.2 86.5 87.0 84.4 88.3 87.8 90.6<br />

65+ 77.8 62.5 40.0 90.0 63.6 72.4 69.7 81.0 83.0 87.4 83.1 84.7<br />

Male 87.3 88.6 90.0 91.1 90.9 91.3 90.6 90.8 91.3 92.1 91.9 93.9<br />

Female 86.6 88.6 90.3 88.5 92.1 92.9 91.8 92.2 93.0 93.3 93.2 94.6<br />

White 87.2 89.1 89.9 89.9 91.4 92.2 90.8 91.2 91.9 92.2 91.8 93.9<br />

Black 86.3 87.1 91.8 90.7 91.4 91.1 91.4 91.6 92.9 93.6 94.4 94.8<br />

Other race 89.7 87.8 82.6 93.6 92.4 89.5 92.9 92.5 89.8 92.5 92.4 94.7<br />

633<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 82.1 83.5 85.9 84.7 88.6 91.0 86.6 88.5 89.3 91.3 90.4 91.3<br />

Hypertension 91.3 91.3 91.6 90.9 91.7 89.1 92.5 92.0 93.3 92.7 92.5 95.2<br />

Glomerulonephritis 92.6 92.9 93.9 93.7 93.0 95.0 93.6 93.7 93.3 94.0 94.7 95.6<br />

Other cause 83.7 86.6 88.3 89.3 91.3 91.1 91.1 90.8 92.0 92.2 92.0 94.5<br />

All 87.1 88.6 90.2 90.2 91.4 91.9 91.0 91.3 92.0 92.6 92.4 94.1<br />

ADJUSTED<br />

0-19 90.2 93.1 96.9 94.3 95.5 96.2 96.7 92.8 93.6 93.6 90.2 94.9<br />

20-44 85.4 87.6 89.6 89.7 91.4 93.6 92.1 92.1 93.0 93.4 93.7 95.0<br />

45-64 76.3 77.9 81.2 82.2 84.7 83.4 84.0 86.1 88.1 88.9 89.0 91.9<br />

65+ . 65.9 46.1 72.0 61.6 71.6 77.9 81.0 77.2 82.9 83.7 84.5<br />

Male 68.8 71.6 75.1 77.9 78.2 79.6 79.0 80.0 82.0 83.4 83.7 87.7<br />

Female 66.7 70.6 76.1 73.0 80.9 83.2 81.2 83.0 85.1 85.9 85.9 89.0<br />

White 66.9 71.3 74.4 74.6 78.7 81.0 78.9 80.3 82.5 83.5 83.3 87.8<br />

Black 71.7 72.6 81.8 80.4 81.4 82.1 82.9 84.0 86.6 87.7 89.3 90.1<br />

Other race 76.4 69.7 58.5 80.8 81.8 75.3 82.1 81.0 77.8 83.9 84.6 88.8<br />

Diabetes 67.6 70.1 74.6 73.1 79.2 83.9 76.8 80.9 82.4 85.2 84.4 86.1<br />

Hypertension 84.2 83.9 85.0 84.2 86.3 82.0 87.6 86.7 89.6 88.8 88.7 92.7<br />

Glomerulonephritis 81.0 81.5 84.9 84.3 83.3 88.1 85.6 86.3 86.2 87.6 89.4 91.2<br />

Other cause 67.9 72.0 75.0 77.5 81.4 81.1 81.8 81.7 84.7 85.0 84.8 89.7<br />

All 68.2 71.5 75.6 76.2 79.3 81.0 79.9 81.2 83.2 84.4 84.6 88.2<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.30 I.30 (continued)<br />

One-year patient survival probabilities: first transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 92.0 91.1 92.5 95.2 96.4 94.5 97.7 93.1 97.4 97.8 94.5<br />

5-9 100.0 94.6 94.3 92.6 98.5 98.3 96.4 96.3 94.0 100.0 98.4<br />

10-14 98.9 99.0 95.5 98.3 96.2 98.3 99.0 97.9 98.1 97.6 100.0<br />

15-19 97.7 96.0 96.7 97.8 98.4 96.6 97.3 97.9 99.1 98.9 98.9<br />

20-29 95.8 97.1 97.3 97.5 97.5 97.4 97.8 97.6 97.4 96.9 96.5<br />

30-39 95.1 95.8 94.9 96.2 96.0 96.0 96.5 96.6 96.4 97.6 96.9<br />

40-49 93.8 94.2 93.8 94.2 93.9 94.5 95.3 94.3 94.6 95.2 94.7<br />

50-59 90.2 91.4 91.6 91.7 92.3 91.0 92.6 92.5 90.6 92.3 93.0<br />

60-64 88.2 87.4 89.9 87.7 89.7 90.8 89.2 88.9 89.0 90.6 90.9<br />

65+ 88.8 82.5 87.6 87.4 90.6 85.8 88.9 87.6 88.5 86.6 89.2<br />

634<br />

Male 93.3 93.7 93.4 93.8 94.1 93.9 94.5 94.1 93.3 94.1 94.1<br />

Female 93.8 93.9 94.3 94.5 94.5 93.8 94.6 94.1 94.2 94.6 94.8<br />

White 93.1 93.5 93.4 93.4 94.1 93.8 94.4 94.1 93.6 94.6 94.3<br />

Black 94.2 94.2 94.4 95.6 94.5 93.7 94.6 94.1 93.3 93.8 94.3<br />

Other race 95.8 96.1 95.5 95.7 95.0 95.7 96.2 94.1 95.2 94.1 94.7<br />

†Hispanic 96.3 95.6 95.9 94.8 94.6 96.0 96.4<br />

†Non-Hispanic 94.0 93.7 94.4 94.0 93.5 94.1 94.0<br />

Diabetes 91.1 91.8 91.9 92.2 92.4 92.5 92.8 92.4 91.9 93.0 92.6<br />

Hypertension 93.1 93.7 94.4 94.0 94.9 92.9 94.6 93.3 91.9 92.9 94.0<br />

Glomerulonephritis 95.8 96.2 96.0 95.8 95.6 95.6 96.0 96.4 96.3 97.0 96.4<br />

Other cause 93.9 93.8 93.3 94.5 94.7 94.5 95.2 94.6 94.6 94.8 95.2<br />

All 93.5 93.8 93.8 94.1 94.2 93.9 94.6 94.1 93.6 94.3 94.3<br />

ADJUSTED<br />

0-19 96.4 94.4 93.7 . . 96.6 97.4 96.1 . . 97.7<br />

20-44 94.4 95.8 95.3 96.1 95.9 96.3 96.6 96.5 96.3 96.9 96.9<br />

45-64 90.8 91.1 91.7 91.7 92.4 91.9 93.0 92.3 91.8 93.1 93.2<br />

65+ 87.4 83.4 86.4 85.5 87.5 85.6 88.1 87.4 87.4 87.4 88.8<br />

Male 87.0 88.0 87.8 88.8 89.5 89.5 90.8 90.2 89.3 90.8 90.8<br />

Female 87.8 88.4 89.3 89.8 90.3 89.2 90.9 89.9 90.6 91.3 91.8<br />

White 86.7 87.6 87.7 88.0 89.6 89.3 90.6 90.0 90.0 91.4 91.4<br />

Black 89.2 89.8 90.1 92.2 90.7 89.7 91.4 90.7 89.4 90.6 91.3<br />

Other race 91.2 92.2 91.6 91.3 91.3 92.3 93.4 90.7 92.3 90.6 91.7<br />

Diabetes 86.0 87.1 87.7 88.4 88.9 89.3 90.0 89.6 89.3 90.8 90.4<br />

Hypertension 89.9 90.9 91.8 91.5 92.9 90.4 92.9 91.1 89.5 91.1 92.4<br />

Glomerulonephritis 91.7 92.4 92.3 92.4 92.0 92.0 92.9 93.5 93.5 94.8 94.1<br />

Other cause 88.6 88.6 87.9 90.1 90.7 90.5 91.9 90.8 91.2 91.5 92.1<br />

All 87.3 88.2 88.4 89.2 89.9 89.4 90.8 90.1 89.8 91.0 91.3<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.31 I.31<br />

Two-year patient survival probabilities: first transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991<br />

0-4 64.3 80.0 94.4 91.2 91.5 90.0 91.1 91.1 84.0 93.6 84.9 87.5<br />

5-9 97.0 92.9 94.3 100.0 97.8 96.7 94.4 98.5 97.1 95.6 89.8 98.1<br />

10-14 89.1 93.5 97.9 90.6 98.3 93.7 95.2 95.1 95.2 93.3 91.7 97.1<br />

15-19 93.9 93.3 93.2 93.8 93.4 92.9 91.7 93.3 97.0 92.1 94.5 96.6<br />

20-29 86.1 90.4 89.3 91.4 90.7 93.8 91.3 92.4 92.2 93.6 94.5 94.8<br />

30-39 81.0 83.1 85.5 85.2 88.4 88.5 88.6 88.8 90.2 91.4 91.7 92.9<br />

40-49 77.3 78.3 82.7 80.1 83.0 86.6 84.3 84.2 87.9 87.3 87.9 91.2<br />

50-59 73.9 73.8 72.4 74.1 79.0 77.7 79.6 79.9 83.5 84.2 86.1 88.1<br />

60-64 65.0 72.7 78.8 68.1 80.0 81.7 78.6 77.6 77.2 82.9 84.8 84.8<br />

65+ 66.7 62.5 20.0 80.0 54.5 55.2 63.6 75.9 79.2 81.1 76.9 80.1<br />

Male 81.7 83.6 85.8 85.2 86.0 87.0 86.1 85.7 87.3 88.5 89.0 91.0<br />

Female 82.2 84.7 84.5 84.4 88.4 89.4 88.2 89.0 89.9 89.9 90.2 91.8<br />

White 82.0 84.8 85.1 85.0 87.1 88.5 86.7 87.0 88.4 88.9 89.0 91.1<br />

Black 81.8 81.0 86.6 84.5 86.1 86.4 87.0 86.4 88.4 89.3 90.8 91.6<br />

Other race 79.5 85.4 81.4 87.3 88.1 86.8 89.0 89.2 87.2 90.5 89.8 93.1<br />

635<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 72.1 75.5 76.8 76.9 80.0 84.3 80.8 81.2 83.5 86.2 85.5 86.7<br />

Hypertension 87.0 86.3 87.7 85.1 86.6 84.6 88.2 87.5 89.7 88.6 89.3 92.2<br />

Glomerulonephritis 90.0 89.7 91.2 89.7 90.7 92.6 90.9 91.0 90.8 91.7 92.9 94.1<br />

Other cause 77.6 82.1 83.3 84.5 87.4 87.6 86.9 87.0 88.7 89.2 89.7 92.2<br />

All 81.9 84.0 85.3 84.9 86.9 87.9 86.8 86.9 88.3 89.0 89.5 91.3<br />

ADJUSTED<br />

0-19 88.5 89.2 94.9 91.5 . 93.3 92.2 92.4 92.4 91.6 88.5 93.4<br />

20-44 79.0 82.0 83.6 84.4 86.0 89.1 88.0 87.7 89.5 90.5 90.8 92.5<br />

45-64 68.2 71.1 74.5 72.6 78.3 78.2 77.9 79.4 82.6 83.3 84.9 87.9<br />

65+ 59.2 . . 62.9 51.6 . 67.9 72.1 70.9 76.7 78.4 78.2<br />

Male 57.9 61.5 66.2 65.6 68.2 70.8 70.2 70.3 74.5 76.6 78.3 82.2<br />

Female 57.8 62.3 64.0 64.7 72.8 75.9 73.9 76.5 78.9 79.2 80.2 83.7<br />

White 56.6 62.3 64.2 64.3 69.7 72.8 70.6 72.0 75.7 77.1 78.2 82.4<br />

Black 63.7 61.6 71.3 69.0 71.4 73.5 74.9 75.1 78.9 80.0 82.7 84.5<br />

Other race 57.4 64.7 . 65.1 72.7 69.7 73.5 73.7 . 79.9 79.5 85.4<br />

Diabetes 52.8 57.9 60.3 61.2 65.4 73.1 67.7 69.9 73.5 77.2 76.9 79.2<br />

Hypertension 77.0 75.4 78.4 74.9 78.4 75.0 80.8 79.6 84.2 82.8 84.1 88.1<br />

Glomerulonephritis 75.2 74.1 78.6 75.2 78.1 82.7 79.8 80.7 81.3 83.0 85.9 88.2<br />

Other cause 58.0 64.0 65.6 68.4 73.8 74.4 74.0 74.9 79.0 79.6 80.6 85.4<br />

All 58.0 62.0 65.5 65.4 70.0 72.8 71.6 72.7 76.2 77.7 79.1 82.8<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.31 I.31 (continued)<br />

Two-year patient survival probabilities: first transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />

0-4 90.0 86.7 90.0 95.2 92.7 92.7 97.7 93.1 94.7 95.6<br />

5-9 100.0 94.6 94.3 90.7 95.4 98.3 96.4 96.3 94.0 98.4<br />

10-14 95.6 98.0 92.9 97.5 94.2 97.4 98.0 97.9 97.2 95.2<br />

15-19 96.7 93.8 95.9 97.8 96.8 94.9 96.3 96.7 98.1 98.3<br />

20-29 93.9 95.6 96.7 96.0 96.1 95.8 96.6 96.5 95.9 95.2<br />

30-39 92.2 93.7 92.0 94.2 93.9 93.6 94.7 94.6 93.7 94.8<br />

40-49 90.5 90.2 90.3 92.1 90.8 92.1 92.4 92.2 92.3 91.7<br />

50-59 86.0 87.2 87.2 87.7 88.3 87.6 88.9 88.9 87.0 87.5<br />

60-64 82.2 83.3 84.8 83.6 84.8 86.4 84.6 83.9 83.4 85.3<br />

65+ 83.9 75.4 81.6 80.9 84.9 80.1 82.0 83.4 82.7 81.8<br />

636<br />

Male 90.1 90.3 89.9 91.0 91.2 91.0 91.4 91.4 90.2 90.5<br />

Female 90.4 91.0 91.6 92.3 91.2 91.3 92.1 91.8 91.1 91.1<br />

White 89.8 90.2 90.1 90.8 90.9 90.9 91.8 91.7 91.0 90.9<br />

Black 90.8 90.8 91.1 92.7 91.4 91.3 90.9 91.0 89.2 90.1<br />

Other race 93.3 94.7 94.2 94.0 93.8 92.7 93.9 92.1 92.3 92.2<br />

†Hispanic 93.5 93.0 94.6 92.9 92.6 92.8<br />

†Non-Hispanic 90.9 90.9 91.3 91.4 90.3 90.4<br />

Diabetes 85.8 87.4 88.1 88.7 88.2 88.3 88.9 89.0 88.0 87.9<br />

Hypertension 89.5 89.8 91.2 90.8 91.2 90.3 91.5 90.2 87.7 89.4<br />

Glomerulonephritis 94.0 94.0 93.6 94.0 93.3 93.6 94.3 94.6 94.2 94.4<br />

Other cause 91.4 91.4 90.0 92.7 92.6 92.7 92.8 92.7 92.5 92.1<br />

All 90.2 90.6 90.6 91.5 91.2 91.1 91.7 91.5 90.6 90.7<br />

ADJUSTED<br />

0-19 94.3 92.1 91.2 96.2 94.5 95.6 96.9 . 95.7 95.5<br />

20-44 91.4 93.4 93.0 94.3 93.9 94.1 94.7 94.5 94.0 94.4<br />

45-64 86.5 86.5 87.2 88.3 88.3 88.6 89.3 89.4 88.6 88.6<br />

65+ 80.8 77.2 80.2 79.2 81.5 79.2 81.8 81.3 80.8 82.3<br />

Male 81.1 82.0 81.7 83.9 84.6 84.7 85.7 85.8 84.6 85.2<br />

Female 81.6 83.0 84.5 85.9 84.7 85.0 86.6 86.1 85.8 85.9<br />

White 80.8 81.7 82.0 83.7 84.2 84.5 86.4 86.2 86.0 85.9<br />

Black 83.0 84.2 84.5 87.4 85.6 85.9 85.5 85.7 83.1 85.0<br />

Other race 86.2 89.5 . 87.8 89.1 86.8 89.3 87.4 87.8 87.7<br />

Diabetes 78.2 80.7 82.1 83.2 83.0 83.5 84.7 85.0 84.3 84.2<br />

Hypertension 84.7 85.3 87.4 87.0 87.9 87.0 88.8 87.2 84.2 86.8<br />

Glomerulonephritis 88.2 88.2 88.0 89.1 87.9 88.4 89.7 90.4 90.0 90.6<br />

Other cause 84.2 84.4 82.2 87.0 87.2 87.5 87.7 87.5 87.9 87.1<br />

All 81.4 82.5 82.8 84.7 84.7 84.9 86.2 86.0 85.1 85.6<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.32 I.32<br />

Three-year patient survival probabilities: first transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 64.3 76.0 91.7 91.2 89.4 88.3 86.7 89.3 80.0 93.6 83.0<br />

5-9 97.0 91.1 94.3 97.6 93.5 93.4 94.4 98.5 97.1 94.1 89.8<br />

10-14 88.0 92.2 92.6 89.7 97.5 89.8 92.1 95.1 95.2 91.0 90.7<br />

15-19 93.4 89.2 90.8 92.5 91.4 91.7 89.4 93.3 94.8 90.2 92.6<br />

20-29 83.2 88.3 85.8 88.4 88.1 90.4 88.8 90.6 90.0 91.4 92.3<br />

30-39 76.3 79.3 80.2 80.7 83.9 84.8 84.4 85.2 86.5 89.1 89.0<br />

40-49 71.4 74.1 77.3 73.6 78.4 80.5 78.5 80.0 84.0 83.6 84.1<br />

50-59 67.8 68.5 65.6 66.8 71.6 72.1 74.6 73.5 78.5 79.8 82.2<br />

60-64 55.0 68.2 72.7 63.8 72.3 68.8 71.4 71.4 72.7 77.8 79.0<br />

65+ 44.4 50.0 20.0 70.0 54.5 48.3 54.5 67.2 70.8 73.0 70.0<br />

Male 78.1 80.0 80.1 80.1 81.4 82.2 81.2 81.6 83.3 85.3 85.4<br />

Female 76.8 81.2 81.3 81.0 84.8 85.4 85.1 85.9 86.8 86.7 87.5<br />

White 77.5 81.1 80.6 80.7 82.6 84.4 82.7 83.5 85.0 85.9 85.5<br />

Black 78.5 77.8 80.5 79.3 82.7 80.6 81.4 81.7 83.6 85.4 88.0<br />

Other race 74.4 82.9 80.2 82.7 84.7 81.6 88.3 87.6 84.2 88.5 88.8<br />

637<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 67.9 71.5 68.8 69.7 73.0 77.4 75.1 76.1 78.3 81.9 80.4<br />

Hypertension 81.6 82.7 83.0 80.2 83.2 80.1 83.3 82.4 85.1 84.2 85.9<br />

Glomerulonephritis 86.7 87.1 87.8 86.2 87.4 89.9 87.4 87.8 88.5 89.6 90.6<br />

Other cause 73.1 78.1 78.8 80.5 83.4 83.0 83.1 84.5 85.4 86.6 87.1<br />

All 77.6 80.4 80.6 80.4 82.7 83.4 82.6 83.2 84.7 85.9 86.2<br />

ADJUSTED<br />

0-19 . 86.1 92.1 90.3 93.0 89.8 88.8 92.2 . 90.5 87.5<br />

20-44 74.1 78.1 78.1 79.5 81.2 84.5 83.4 84.3 85.8 87.6 88.0<br />

45-64 61.8 65.6 67.4 65.3 72.3 71.5 72.3 73.3 77.7 78.8 80.2<br />

65+ 28.2 . . . 47.9 45.4 59.4 65.6 63.3 68.1 70.9<br />

Male 51.8 55.1 55.8 56.3 59.7 62.0 61.5 63.2 67.5 70.9 72.0<br />

Female 48.3 55.4 57.9 58.3 65.5 67.7 67.8 70.4 73.0 73.3 75.0<br />

White 48.8 55.3 55.9 56.4 61.1 64.8 63.3 65.6 69.6 71.6 71.9<br />

Black 58.1 56.3 60.4 60.1 65.1 63.6 65.4 67.2 70.8 73.2 77.7<br />

Other race . . . 54.7 65.6 59.0 . . 66.4 . .<br />

Diabetes 47.1 52.2 49.2 51.2 55.1 62.5 59.3 62.4 65.8 70.6 69.4<br />

Hypertension 68.4 69.6 71.0 67.3 73.3 68.3 73.5 71.9 77.4 76.5 79.1<br />

Glomerulonephritis 68.1 68.5 71.4 68.1 71.5 76.9 73.2 74.7 77.2 79.1 81.7<br />

Other cause 51.4 57.5 58.0 61.5 66.7 66.2 67.5 70.5 73.3 75.1 76.1<br />

All 50.7 55.5 56.7 57.2 62.0 64.2 63.9 66.0 69.6 71.9 73.2<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.32 I.32 (continued)<br />

Three-year patient survival probabilities: first transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />

0-4 87.5 90.0 86.7 90.0 92.9 92.7 89.1 95.5 91.4 92.1<br />

5-9 94.4 100.0 94.6 94.3 90.7 92.3 98.3 96.4 96.3 94.0<br />

10-14 94.1 92.2 97.0 92.9 96.7 94.2 97.4 98.0 96.4 95.3<br />

15-19 94.4 94.4 92.1 95.5 97.0 94.6 93.2 96.3 96.3 97.6<br />

20-29 92.3 92.7 93.4 94.5 94.5 94.1 93.9 95.6 95.2 94.5<br />

30-39 90.5 89.6 90.7 89.8 91.6 92.0 91.7 92.9 92.1 91.4<br />

40-49 88.1 87.0 86.5 87.4 89.4 87.4 89.2 89.1 89.5 90.0<br />

50-59 83.0 81.6 83.4 83.0 83.1 84.1 83.1 84.3 84.7 83.6<br />

60-64 79.8 78.6 76.3 80.1 78.4 79.3 80.7 79.2 77.6 78.6<br />

65+ 75.0 75.0 69.4 74.2 73.5 78.9 72.0 76.1 77.4 77.4<br />

638<br />

Male 87.3 86.9 86.8 86.9 87.7 88.0 87.8 87.9 88.2 87.7<br />

Female 89.1 87.3 87.7 88.6 89.2 87.9 87.9 89.4 88.6 87.9<br />

White 88.0 86.7 86.7 87.2 87.6 87.9 87.8 88.4 88.5 88.4<br />

Black 87.8 87.0 87.3 87.6 89.2 87.7 87.5 88.1 87.5 85.7<br />

Other race 89.5 91.3 92.0 91.7 92.8 90.3 90.0 91.2 89.9 90.9<br />

†Hispanic 91.6 90.7 92.1 89.7 91.6<br />

†Non-Hispanic 87.6 87.5 88.1 88.2 87.3<br />

Diabetes 83.1 80.7 82.3 84.6 84.7 84.0 83.7 84.5 84.4 84.1<br />

Hypertension 88.7 86.1 86.7 87.6 87.0 87.3 87.3 88.2 87.4 84.3<br />

Glomerulonephritis 91.1 92.0 91.5 90.9 91.9 90.9 91.2 91.5 92.1 92.6<br />

Other cause 88.9 88.9 88.6 87.7 89.9 90.4 89.9 90.9 90.2 90.3<br />

All 88.0 87.0 87.1 87.6 88.3 88.0 87.8 88.5 88.3 87.8<br />

ADJUSTED<br />

0-19 91.2 . . . 95.1 92.9 94.2 96.5 94.7 94.4<br />

20-44 89.8 88.9 90.6 90.4 91.8 91.7 92.0 92.9 92.4 91.9<br />

45-64 83.0 81.9 81.7 83.4 84.2 84.1 84.4 85.1 85.4 85.2<br />

65+ 71.9 72.9 70.7 72.9 72.3 74.8 71.4 75.2 74.1 75.7<br />

Male 75.6 75.5 75.9 76.7 78.5 79.4 79.5 80.3 80.8 80.8<br />

Female 78.5 75.8 77.2 79.3 80.5 79.3 79.4 82.2 80.9 80.7<br />

White 76.8 75.4 75.7 77.2 78.4 79.4 79.5 81.2 81.2 82.0<br />

Black 77.6 76.4 78.3 78.7 81.4 79.7 80.0 81.2 80.4 77.9<br />

Other race 78.0 82.0 83.9 84.6 85.3 83.0 82.1 84.4 83.8 85.5<br />

Diabetes 73.8 70.8 73.2 77.1 77.6 77.1 77.2 78.7 78.9 79.3<br />

Hypertension 83.1 79.9 81.0 82.4 81.6 82.6 82.9 84.5 83.5 79.9<br />

Glomerulonephritis 82.6 84.6 83.6 83.0 85.4 84.0 84.4 85.0 86.1 87.3<br />

Other cause 79.7 79.9 79.6 78.4 82.3 83.4 82.9 84.6 83.5 84.5<br />

All 76.8 75.7 76.5 77.7 79.4 79.4 79.6 81.1 80.9 80.8<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.33 I.33<br />

Five-year patient survival probabilities: first transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 64.3 72.0 88.9 88.2 85.1 86.7 84.4 87.5 80.0 91.5 83.0<br />

5-9 97.0 87.5 81.1 97.6 89.1 90.2 92.6 95.5 91.2 89.7 89.8<br />

10-14 84.8 87.0 87.4 86.3 93.3 85.8 84.9 91.8 92.8 88.8 89.8<br />

15-19 90.8 82.6 86.5 90.0 89.1 83.8 86.4 90.8 88.8 88.3 90.8<br />

20-29 77.6 82.0 80.7 81.3 82.4 84.8 82.2 85.4 85.3 85.8 87.6<br />

30-39 68.1 69.9 73.8 72.6 72.9 77.0 75.9 76.5 80.1 83.0 83.6<br />

40-49 61.4 65.7 65.7 63.2 69.3 68.7 67.0 69.0 74.6 76.0 76.3<br />

50-59 52.2 58.1 53.1 54.7 59.7 61.8 61.9 61.8 66.6 69.0 71.7<br />

60-64 20.0 45.5 57.6 53.2 52.3 54.8 50.0 58.9 57.8 66.5 68.0<br />

65+ 33.3 25.0 . 50.0 40.9 27.6 39.4 51.7 60.4 63.1 53.8<br />

Male 69.7 71.2 71.6 71.9 72.0 73.3 70.9 72.4 74.8 77.4 78.0<br />

Female 68.8 74.2 74.4 72.7 77.0 77.4 77.3 78.0 79.0 80.5 81.0<br />

White 69.6 73.2 73.2 72.9 74.2 76.0 73.5 75.0 76.8 78.5 78.5<br />

Black 69.3 67.9 70.7 68.9 72.7 71.1 71.0 71.8 74.8 77.9 80.3<br />

Other race 64.1 79.3 73.3 80.0 76.3 76.3 83.8 82.3 80.1 84.5 83.6<br />

639<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 53.1 62.4 58.5 57.6 59.4 63.0 61.6 62.8 66.3 71.3 70.1<br />

Hypertension 75.8 73.7 73.3 71.7 72.8 72.2 73.5 71.6 76.1 76.4 78.3<br />

Glomerulonephritis 82.2 80.8 81.3 80.7 81.3 83.5 79.7 81.4 81.4 84.4 85.0<br />

Other cause 63.4 69.2 71.3 71.8 75.5 75.7 75.3 78.0 79.3 80.4 81.7<br />

All 69.4 72.2 72.6 72.2 73.9 74.9 73.2 74.5 76.5 78.6 79.2<br />

ADJUSTED<br />

0-19 85.7 80.0 84.2 86.9 89.3 83.7 84.8 89.6 85.6 86.7 85.7<br />

20-44 65.6 68.8 71.0 70.8 71.6 75.7 74.5 75.8 78.2 81.1 82.2<br />

45-64 46.8 54.2 52.9 52.5 59.1 59.1 58.1 60.5 65.9 68.0 69.6<br />

65+ . 25.0 10.7 37.5 35.6 29.4 39.2 47.7 50.0 57.4 55.8<br />

Male 39.5 41.7 42.6 43.6 45.1 47.8 46.1 49.0 54.3 58.1 60.0<br />

Female 36.9 43.9 46.6 45.2 52.1 53.9 54.6 57.1 59.9 62.6 63.8<br />

White 37.4 42.7 44.1 44.1 47.4 50.5 48.8 51.9 56.3 59.4 60.7<br />

Black 44.9 42.6 45.8 45.2 49.9 50.0 50.3 52.8 57.9 61.8 65.2<br />

Other race 35.1 51.8 41.5 48.4 50.4 49.4 61.6 58.5 58.4 67.5 67.0<br />

Diabetes 30.5 41.2 37.1 37.2 38.7 43.9 42.6 45.9 50.7 56.2 55.9<br />

Hypertension 60.1 56.7 57.1 55.6 59.2 57.7 60.0 56.9 65.0 65.8 68.8<br />

Glomerulonephritis 59.5 56.6 59.3 58.0 60.2 64.7 59.5 63.2 64.9 69.9 71.8<br />

Other cause 38.7 44.4 46.7 48.0 53.7 54.1 55.0 59.8 63.4 65.0 67.0<br />

All 38.7 42.7 44.2 44.4 47.7 50.2 49.2 52.1 56.5 59.9 61.6<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.33 I.33 (continued)<br />

Five-year patient survival probabilities: first transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998<br />

0-4 87.5 88.0 82.2 90.0 90.5 92.7 87.3 90.9<br />

5-9 92.6 98.1 91.1 92.5 88.9 87.7 98.3 94.6<br />

10-14 90.2 91.1 94.1 90.9 95.0 93.3 95.7 93.9<br />

15-19 91.5 92.1 89.4 92.2 93.5 91.4 88.1 94.7<br />

20-29 88.8 88.0 88.6 91.1 90.3 88.7 90.2 92.4<br />

30-39 83.4 83.3 84.4 83.7 85.7 87.2 86.8 89.1<br />

40-49 80.2 77.3 80.2 79.3 81.5 79.5 82.3 82.7<br />

50-59 71.7 70.5 72.1 73.6 73.5 74.5 72.7 75.3<br />

60-64 64.8 67.6 61.6 64.4 65.3 69.4 69.9 66.7<br />

65+ 58.0 58.5 54.4 60.3 56.3 62.8 58.7 64.7<br />

640<br />

Male 78.5 78.6 78.7 79.1 79.9 80.4 80.8 81.2<br />

Female 82.5 79.4 80.6 81.4 81.8 80.7 80.3 82.9<br />

White 80.2 78.7 79.3 80.1 80.1 80.6 80.7 82.0<br />

Black 79.3 78.0 78.1 78.9 80.5 79.3 79.3 80.4<br />

Other race 81.6 84.6 88.4 83.8 87.9 84.7 85.5 87.4<br />

†Hispanic 86.6 84.5 86.3<br />

†Non-Hispanic 79.9 80.2 81.3<br />

Diabetes 72.7 69.0 71.7 73.2 75.0 73.4 73.4 75.5<br />

Hypertension 79.6 77.3 77.6 79.6 77.6 78.8 80.6 80.4<br />

Glomerulonephritis 84.5 85.6 85.9 85.2 85.6 85.4 85.8 86.8<br />

Other cause 82.7 82.8 83.0 83.0 84.5 85.4 84.2 86.3<br />

All 80.1 78.9 79.5 80.0 80.6 80.5 80.6 81.9<br />

ADJUSTED<br />

0-19 87.5 90.1 88.0 89.0 92.3 89.9 92.4 91.7<br />

20-44 83.4 82.3 84.6 84.4 86.2 86.2 86.7 88.8<br />

45-64 71.3 70.2 71.1 73.3 73.6 74.2 75.0 76.1<br />

65+ 56.1 57.0 54.7 58.2 57.7 61.2 58.5 63.7<br />

Male 61.2 62.1 63.1 64.5 66.3 67.7 68.9 70.3<br />

Female 67.2 62.9 65.7 67.7 68.4 68.2 68.0 72.2<br />

White 64.0 62.7 63.9 66.1 66.9 68.4 68.8 71.6<br />

Black 64.2 62.6 64.5 65.7 68.2 67.4 68.3 70.0<br />

Other race 63.3 68.8 76.7 71.0 75.6 73.3 74.1 77.6<br />

Diabetes 59.9 55.6 59.3 62.1 64.8 63.6 64.3 67.4<br />

Hypertension 70.3 68.3 69.0 71.8 69.3 71.7 74.5 74.7<br />

Glomerulonephritis 70.9 73.3 73.9 73.5 75.0 75.1 75.5 77.3<br />

Other cause 69.3 69.8 70.3 70.5 73.2 75.3 73.7 77.1<br />

All 63.6 62.5 64.3 65.9 67.3 68.0 68.6 71.2<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.34 I.34<br />

Ten-year patient survival probabilities: first transplants, deceased donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<br />

0-4 57.1 68.0 80.6 85.3 78.7 81.7 84.4 83.9 72.0 89.4 79.2 85.0 82.0 71.1<br />

5-9 87.9 80.4 69.8 85.7 73.9 85.2 87.0 85.1 82.4 83.8 78.0 87.0 96.2 83.9<br />

10-14 80.4 76.6 75.8 76.9 81.7 76.4 73.8 82.8 80.8 80.9 83.3 77.5 86.7 84.2<br />

15-19 78.6 71.8 77.8 82.2 81.6 71.7 77.7 82.1 82.0 80.5 82.0 82.5 82.8 79.7<br />

20-29 63.9 68.6 67.2 69.5 68.2 72.3 68.4 72.3 72.3 73.1 74.2 75.7 72.4 76.1<br />

30-39 49.6 49.9 55.3 55.3 55.4 58.5 56.6 58.2 63.1 63.8 64.5 64.2 65.4 67.1<br />

40-49 40.2 42.2 43.7 42.7 44.9 45.9 45.4 47.8 51.8 53.5 55.1 55.2 55.0 58.6<br />

50-59 29.7 30.5 29.1 30.8 32.8 29.9 32.8 36.5 39.5 42.4 43.9 43.8 41.7 46.1<br />

60-64 10.0 9.1 30.3 21.3 16.9 29.0 23.0 29.2 24.9 34.6 32.3 33.3 31.7 30.5<br />

65+ 11.1 . . 10.0 18.2 6.9 9.1 31.0 27.4 30.6 20.0 22.7 24.1 20.6<br />

Male 50.8 52.1 52.5 53.8 52.4 54.2 51.4 53.6 54.4 56.7 56.9 56.4 56.0 58.0<br />

Female 54.6 56.3 59.2 58.3 59.5 58.2 58.3 59.7 59.8 61.6 60.8 61.3 59.0 60.8<br />

White 54.5 56.2 55.7 57.3 55.7 57.5 54.7 56.9 57.5 59.1 58.3 58.3 57.1 59.3<br />

Black 45.2 44.3 51.2 47.6 51.6 49.6 49.0 51.1 52.1 55.2 57.1 56.8 55.0 55.1<br />

Other race 47.4 54.9 67.4 70.9 65.3 63.2 71.4 65.6 64.3 69.0 67.8 65.5 68.6 75.3<br />

641<br />

Diabetes 32.1 37.9 37.3 33.4 35.4 37.8 35.4 38.7 40.0 44.3 43.4 43.2 40.9 45.7<br />

Hypertension 55.6 50.7 54.0 52.3 50.6 49.7 47.8 49.6 51.1 53.1 54.5 55.5 52.9 55.3<br />

Glomerulonephritis 67.7 65.5 65.0 66.2 64.2 67.7 66.1 65.4 65.7 68.4 69.2 67.7 66.9 69.2<br />

Other cause 46.2 51.3 54.8 57.8 59.1 58.9 58.8 62.4 62.6 64.1 63.3 64.5 66.0 66.8<br />

All 52.2 53.6 55.0 55.5 55.0 55.7 53.9 55.9 56.5 58.6 58.4 58.3 57.2 59.1<br />

ADJUSTED<br />

0-19 75.4 66.3 70.9 75.7 77.5 71.8 74.5 77.0 75.3 76.6 76.3 77.6 81.8 75.3<br />

20-44 46.3 49.2 52.9 53.2 53.2 57.1 55.8 57.3 60.5 62.6 63.5 63.6 63.6 67.3<br />

45-64 26.2 28.7 28.1 29.8 31.4 31.0 31.3 36.0 38.1 40.8 41.6 42.8 41.1 44.9<br />

65+ . . . 3.3 12.7 7.8 14.4 19.6 17.5 24.1 20.6 20.3 20.8 19.8<br />

Male 20.4 21.8 22.2 23.6 23.7 25.6 24.7 27.5 30.0 32.2 33.5 33.4 33.8 36.8<br />

Female 21.8 23.3 27.7 27.5 29.4 29.4 30.3 33.0 34.3 36.8 36.3 38.0 35.9 39.0<br />

White 21.7 23.8 24.1 25.9 25.8 27.7 27.0 29.9 32.1 34.4 34.8 35.6 35.4 38.1<br />

Black 20.3 19.6 24.9 22.8 26.1 25.8 25.9 29.2 31.0 33.4 35.2 35.6 33.6 35.8<br />

Other race 20.7 23.2 34.1 34.2 35.9 30.6 41.4 34.6 36.3 43.5 43.2 39.7 43.6 55.7<br />

Diabetes 13.5 17.9 17.3 15.5 16.7 18.8 17.4 21.4 22.8 25.7 26.1 26.6 24.8 29.3<br />

Hypertension 36.8 31.8 35.8 34.4 35.1 33.3 32.4 33.4 37.1 39.6 41.6 42.4 40.8 43.6<br />

Glomerulonephritis 37.5 34.7 35.9 36.7 35.9 40.6 40.0 40.4 42.5 45.8 47.8 46.2 45.6 48.8<br />

Other cause 21.9 25.0 27.5 30.9 32.9 32.9 34.0 38.8 41.0 43.0 41.9 43.9 46.3 47.3<br />

All 21.1 22.5 24.3 25.1 25.8 27.1 26.8 29.6 31.7 34.0 34.7 35.3 34.7 37.8<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.35 I.35<br />

90-day patient survival probabilities: first transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 100.0 100.0 95.2 100.0 95.1 100.0 100.0 100.0 94.3 100.0 92.2<br />

5-9 100.0 100.0 100.0 96.7 100.0 100.0 97.6 100.0 97.2 98.2 92.7<br />

10-14 100.0 100.0 98.5 98.8 99.0 100.0 98.0 100.0 100.0 99.0 92.0<br />

15-19 97.6 97.6 100.0 98.8 99.3 98.2 99.4 100.0 100.0 100.0 94.5<br />

20-29 99.3 98.7 98.9 98.3 98.1 98.7 98.8 99.4 99.1 98.3 99.2<br />

30-39 97.3 97.4 98.4 97.0 98.9 98.3 99.0 98.7 98.4 99.6 97.8<br />

40-49 98.5 96.3 94.9 97.7 97.6 97.0 98.6 98.6 98.8 99.7 97.7<br />

50-59 94.4 91.8 98.4 95.8 95.7 96.6 98.1 98.5 96.2 97.6 96.2<br />

60-64 100.0 100.0 80.0 90.9 100.0 100.0 95.0 98.4 95.2 94.6 96.8<br />

65+ 100.0 100.0 . 100.0 100.0 100.0 90.0 100.0 100.0 75.0 95.0<br />

642<br />

Male 98.2 97.9 98.1 97.5 98.9 98.5 98.3 99.0 98.6 98.7 97.3<br />

Female 98.6 97.0 97.9 98.0 97.0 97.5 99.0 99.1 98.5 99.1 96.9<br />

White 98.1 97.8 97.9 97.5 98.5 98.2 98.6 99.1 98.3 98.9 97.1<br />

Black 100.0 95.9 98.6 98.3 95.9 98.3 98.9 98.9 100.0 98.6 96.7<br />

Other race 100.0 94.9 98.1 100.0 100.0 94.9 97.2 98.2 100.0 100.0 98.7<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 98.1 96.6 95.2 95.3 97.2 95.2 98.0 97.6 98.6 99.5 97.6<br />

Hypertension 98.7 98.0 98.2 97.2 98.5 98.5 98.7 100.0 97.2 98.9 94.6<br />

Glomerulonephritis 99.0 98.4 98.8 99.5 98.3 99.1 98.8 99.1 98.7 99.0 97.8<br />

Other cause 97.9 96.9 98.5 97.3 98.4 98.8 98.6 99.4 98.8 98.4 96.8<br />

All 98.4 97.5 98.0 97.7 98.2 98.1 98.6 99.0 98.6 98.9 97.1<br />

ADJUSTED<br />

0-19 97.6 99.1 98.5 98.7 97.7 . 98.3 . 97.8 . 87.7<br />

20-44 97.7 96.2 97.4 96.8 98.0 97.9 98.7 98.7 98.4 98.6 98.1<br />

45-64 . 94.0 96.2 95.4 95.9 95.9 97.1 98.4 96.9 98.0 95.9<br />

65+ . . . . . . 91.4 96.9 . . 90.0<br />

Male 93.1 91.7 93.2 91.3 96.1 95.5 94.8 96.9 95.2 95.7 91.1<br />

Female 94.7 90.2 93.3 93.6 91.0 93.0 97.2 97.5 95.3 97.2 91.3<br />

White 92.6 91.8 92.9 91.3 94.9 94.7 95.8 97.3 94.3 96.3 91.1<br />

Black . 89.0 95.6 95.4 88.7 95.8 97.1 97.3 . 95.8 90.5<br />

Other race . 86.9 . . . 88.4 92.7 95.8 . . .<br />

Diabetes 95.7 92.7 89.8 89.8 93.9 90.6 95.8 95.3 97.0 . 95.1<br />

Hypertension 97.0 95.7 95.8 94.9 97.0 97.0 97.6 . 94.2 97.6 89.6<br />

Glomerulonephritis 96.6 95.1 96.4 98.3 95.3 97.5 97.1 97.6 96.2 97.0 93.5<br />

Other cause 93.6 90.8 95.8 92.3 95.5 96.9 96.5 98.6 96.2 95.3 91.1<br />

All 93.7 91.0 93.2 92.2 94.0 94.4 95.8 97.1 95.2 96.3 91.1<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.35 I.35 (continued)<br />

90-day patient survival probabilities: first transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999<br />

0-4 95.7 93.5 98.9 95.7 95.8 100.0 100.0 100.0 100.0<br />

5-9 98.7 100.0 100.0 100.0 96.1 98.6 100.0 98.5 100.0<br />

10-14 98.0 98.1 100.0 100.0 100.0 99.2 100.0 99.2 98.6<br />

15-19 98.8 98.1 100.0 100.0 99.5 99.5 100.0 98.9 100.0<br />

20-29 99.8 99.4 99.0 99.8 99.3 99.7 99.5 100.0 99.7<br />

30-39 98.8 99.2 98.8 99.1 99.2 99.2 99.4 98.9 99.4<br />

40-49 99.3 99.4 99.8 99.5 99.1 98.7 98.9 99.2 99.2<br />

50-59 98.2 98.3 97.9 98.6 97.2 97.0 97.5 98.8 98.0<br />

60-64 91.5 93.8 100.0 96.6 96.1 98.7 98.0 97.4 98.1<br />

65+ 94.1 100.0 97.6 100.0 95.9 96.8 97.4 96.1 98.2<br />

Male 98.7 98.8 99.2 99.2 98.4 98.7 99.0 98.9 98.9<br />

Female 98.8 98.6 99.0 99.4 98.8 98.9 98.7 99.1 99.1<br />

White 98.7 98.8 99.2 99.3 98.4 98.6 98.9 98.9 99.0<br />

Black 98.6 98.1 98.7 99.0 99.2 99.1 98.9 99.3 99.0<br />

Other race 100.0 98.9 99.0 100.0 99.3 100.0 99.4 98.9 99.5<br />

643<br />

†Hispanic 98.2 99.3 99.0 99.2<br />

†Non-Hispanic 98.8 98.8 98.9 99.0<br />

Diabetes 97.6 98.3 98.7 98.2 97.4 98.0 97.5 97.9 98.9<br />

Hypertension 99.6 98.7 99.4 99.5 98.6 99.1 98.9 99.2 98.6<br />

Glomerulonephritis 99.5 99.2 99.4 99.4 99.4 99.3 99.6 99.7 98.9<br />

Other cause 98.5 98.6 99.0 99.7 98.5 98.6 99.0 99.0 99.3<br />

All 98.7 98.7 99.1 99.3 98.6 98.7 98.9 99.0 99.0<br />

ADJUSTED<br />

0-19 96.4 96.0 . . 97.2 98.8 . 98.4 99.3<br />

20-44 99.0 99.1 98.7 99.3 98.9 99.1 99.2 98.9 99.3<br />

45-64 98.1 98.1 98.7 98.5 97.6 97.7 97.7 98.7 98.2<br />

65+ 89.2 92.4 . . 95.8 95.4 95.9 95.7 98.1<br />

Male 95.7 96.3 97.5 97.6 95.6 96.6 97.6 97.3 97.5<br />

Female 96.8 96.4 97.4 98.5 97.2 97.3 96.9 97.9 98.1<br />

White 96.0 96.5 97.6 98.0 95.8 96.5 97.1 97.3 97.7<br />

Black . 95.5 97.0 97.5 98.2 98.1 97.7 98.6 98.0<br />

Other race . . . . . . 98.8 98.0 .<br />

Diabetes 95.3 96.8 97.6 96.9 95.7 96.7 96.0 96.6 98.3<br />

Hypertension . 97.6 99.0 99.1 97.6 98.5 98.2 98.8 97.7<br />

Glomerulonephritis 98.7 97.7 98.2 98.3 98.4 98.3 99.1 99.2 97.6<br />

Other cause 95.4 96.3 97.2 99.1 96.3 96.6 97.6 97.6 98.5<br />

All 96.2 96.3 97.4 98.0 96.3 96.9 97.2 97.5 97.7<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.36 I.36<br />

One-year patient survival probabilities: first transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 100.0 100.0 90.5 93.3 92.7 100.0 91.8 98.5 88.7 96.4 88.2<br />

5-9 96.2 100.0 97.1 93.3 97.9 98.1 97.6 100.0 97.2 98.2 92.7<br />

10-14 100.0 100.0 98.5 97.6 98.1 98.8 98.0 100.0 97.1 98.0 89.7<br />

15-19 96.4 96.0 97.5 96.3 98.6 98.2 98.9 97.7 98.7 98.5 93.3<br />

20-29 97.0 96.5 96.2 97.3 96.2 97.4 97.6 97.9 98.3 96.4 98.4<br />

30-39 94.2 94.6 94.8 94.8 97.4 95.6 97.0 96.2 96.6 99.1 97.4<br />

40-49 93.3 91.4 91.1 93.4 95.2 95.4 96.6 95.9 96.4 97.6 96.6<br />

50-59 88.9 87.7 93.4 92.3 93.3 95.3 95.9 96.9 93.1 93.5 93.0<br />

60-64 100.0 100.0 70.0 90.9 100.0 100.0 93.3 93.4 90.5 94.6 90.3<br />

65+ . 100.0 . 100.0 100.0 88.9 86.7 100.0 85.7 75.0 90.0<br />

644<br />

Male 94.5 95.0 94.8 94.9 97.0 96.9 96.3 96.7 96.8 96.8 95.9<br />

Female 96.6 94.7 94.8 95.9 95.4 95.7 97.5 97.3 96.5 97.8 95.7<br />

White 95.4 95.0 95.1 95.4 96.7 96.4 96.8 96.8 96.4 97.1 95.5<br />

Black 95.0 94.3 94.7 94.8 94.2 97.3 98.0 97.5 98.1 97.1 96.7<br />

Other race 95.0 92.3 88.5 96.3 98.4 93.7 93.5 98.2 98.2 100.0 98.7<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 91.3 91.8 88.9 89.8 93.0 90.6 93.9 94.1 95.6 98.4 95.5<br />

Hypertension 96.2 95.0 95.8 96.1 98.0 98.1 97.2 98.6 96.1 97.2 94.1<br />

Glomerulonephritis 98.0 97.6 97.5 98.4 97.5 97.9 98.1 97.3 98.2 96.6 96.7<br />

Other cause 94.2 93.5 94.7 94.8 96.5 98.0 97.3 97.7 96.0 97.2 95.6<br />

All 95.4 94.8 94.8 95.3 96.4 96.5 96.8 97.0 96.6 97.2 95.8<br />

ADJUSTED<br />

0-19 95.3 97.2 95.6 93.4 96.0 98.2 95.6 97.9 93.4 96.8 84.9<br />

20-44 93.2 92.6 92.7 94.1 95.5 95.3 96.6 95.7 97.0 96.7 97.0<br />

45-64 90.4 87.5 91.1 91.2 93.1 94.2 94.7 95.8 92.6 95.0 93.4<br />

65+ 60.2 . . . . . 85.8 . 76.2 . 85.1<br />

Male 80.2 81.7 82.9 83.1 90.0 91.0 89.3 90.5 89.1 89.5 87.0<br />

Female 87.9 83.4 83.7 87.6 86.3 88.2 93.2 92.9 89.6 93.7 88.1<br />

White 83.1 82.2 84.0 84.5 89.2 89.6 90.8 90.9 88.4 90.9 86.8<br />

Black 84.5 84.9 84.7 86.6 . . 94.9 93.9 94.5 91.9 .<br />

Other race 88.9 . 70.4 90.1 95.5 . 83.7 . . . .<br />

Diabetes 81.8 83.1 77.4 79.0 85.5 82.3 87.9 88.4 90.6 96.6 90.8<br />

Hypertension 91.1 89.4 90.5 92.9 . . 94.5 97.5 91.9 94.2 88.6<br />

Glomerulonephritis 93.4 92.7 92.4 95.0 93.0 94.3 95.2 93.2 . 90.3 90.4<br />

Other cause 83.4 81.1 85.9 85.6 90.3 94.9 93.3 94.6 87.9 91.7 88.0<br />

All 83.2 82.2 83.2 84.9 88.5 89.8 90.9 91.4 89.2 91.3 87.3<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.36 I.36 (continued)<br />

One-year patient survival probabilities: first transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002<br />

0-4 95.7 93.5 97.8 91.3 94.4 98.7 98.9 100.0 100.0 97.0 98.2 97.9<br />

5-9 98.7 100.0 98.3 98.3 96.1 98.6 100.0 98.5 100.0 100.0 98.7 98.9<br />

10-14 97.0 96.3 97.3 99.0 98.3 98.3 100.0 99.2 98.6 100.0 98.6 100.0<br />

15-19 97.6 96.2 99.5 98.4 98.9 99.5 99.1 98.9 99.5 99.1 100.0 99.6<br />

20-29 99.2 98.6 98.1 99.5 99.0 99.5 98.8 99.4 99.1 99.1 99.2 99.1<br />

30-39 98.4 98.0 97.5 98.3 98.2 98.3 98.0 98.6 98.6 98.1 97.9 98.6<br />

40-49 97.4 97.9 97.8 97.2 97.7 98.1 97.2 97.4 97.8 97.9 98.3 98.0<br />

50-59 94.1 95.5 94.3 96.1 94.4 95.6 95.2 97.1 96.3 95.9 96.2 96.5<br />

60-64 87.2 83.8 96.4 93.3 92.2 93.6 96.0 95.2 95.8 97.1 94.6 96.1<br />

65+ 94.1 96.4 87.8 100.0 91.9 95.7 93.9 89.5 94.6 93.9 94.8 95.5<br />

Male 97.3 97.2 97.3 97.1 96.7 97.9 97.9 97.6 97.5 97.4 97.4 97.6<br />

Female 97.7 96.8 97.2 98.8 97.8 97.7 96.7 97.8 98.3 97.8 97.7 97.9<br />

White 97.5 97.2 97.4 97.9 96.8 97.7 97.3 97.9 97.9 97.6 97.5 97.7<br />

Black 96.9 95.5 96.2 97.5 98.1 97.9 97.2 96.6 97.5 97.0 97.3 97.4<br />

Other race 100.0 97.9 97.9 97.6 99.3 100.0 99.4 97.9 98.1 97.6 98.5 98.3<br />

645<br />

†Hispanic 97.5 98.5 98.4 98.5 97.5 97.5 98.2<br />

†Non-Hispanic 97.9 97.2 97.6 97.8 97.5 97.5 97.6<br />

Diabetes 95.2 95.7 95.3 96.7 95.7 96.5 94.6 95.5 96.7 96.2 95.5 96.1<br />

Hypertension 97.6 97.1 96.6 97.0 96.9 97.7 97.2 97.9 97.3 95.9 97.3 97.9<br />

Glomerulonephritis 98.8 98.0 98.6 98.5 98.3 98.9 98.7 99.1 98.0 98.2 98.8 98.2<br />

Other cause 97.8 96.9 97.6 98.3 97.2 97.8 97.9 97.8 98.5 98.5 97.9 98.2<br />

All 97.5 97.0 97.3 97.8 97.2 97.8 97.4 97.7 97.8 97.5 97.5 97.7<br />

ADJUSTED<br />

0-19 95.5 94.0 97.1 96.3 95.6 98.0 99.2 . . 98.8 98.6 99.0<br />

20-44 97.9 97.7 97.4 98.1 97.9 98.5 97.7 98.3 97.9 98.1 97.7 98.1<br />

45-64 94.8 95.0 95.0 95.5 94.9 96.0 95.1 96.4 96.4 96.1 96.3 96.6<br />

65+ . 77.6 87.1 . 90.7 92.6 92.7 89.7 95.2 93.2 94.3 94.8<br />

Male 91.7 91.6 92.1 91.9 91.3 94.8 94.7 94.4 94.3 94.3 94.5 95.1<br />

Female 93.9 91.7 92.9 96.9 94.8 94.8 92.3 95.0 96.3 95.2 95.3 95.8<br />

White 92.4 91.9 92.7 94.2 91.9 94.3 93.3 95.0 95.2 94.9 94.7 95.4<br />

Black 92.2 89.8 91.1 94.1 95.6 95.4 94.2 93.1 94.9 94.3 95.0 95.2<br />

Other race . . . 95.2 . . . 96.1 96.1 95.3 97.6 97.1<br />

Diabetes 90.8 92.1 91.4 94.1 92.8 94.3 91.5 93.0 95.2 94.5 93.7 94.7<br />

Hypertension 95.2 94.6 93.8 94.5 94.8 96.3 95.5 96.6 95.8 93.8 96.1 97.1<br />

Glomerulonephritis 96.6 94.8 96.1 96.0 95.7 97.3 96.8 97.9 95.4 96.0 97.5 96.3<br />

Other cause 93.6 91.7 93.7 95.5 92.9 94.8 95.1 95.1 96.7 96.8 95.6 96.4<br />

All 92.6 91.6 92.4 94.1 92.8 94.7 93.6 94.6 95.1 94.7 94.8 95.4<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.37 I.37<br />

Two-year patient survival probabilities: first transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 100.0 100.0 85.7 90.0 92.7 100.0 91.8 97.0 84.9 96.4 88.2<br />

5-9 96.2 100.0 97.1 90.0 97.9 98.1 92.9 97.5 97.2 98.2 92.7<br />

10-14 91.8 98.0 98.5 96.4 97.1 98.8 95.0 97.8 95.1 98.0 88.5<br />

15-19 94.0 94.4 96.8 95.7 97.1 97.6 97.7 97.1 97.4 98.5 93.3<br />

20-29 95.7 94.3 94.9 95.8 95.1 96.6 96.1 95.8 97.0 94.3 97.7<br />

30-39 93.3 90.1 92.6 91.3 95.7 93.0 95.4 94.6 95.0 97.4 96.2<br />

40-49 88.1 89.0 88.6 89.9 92.7 94.0 94.8 92.1 95.6 95.5 93.7<br />

50-59 88.9 86.3 89.3 89.4 90.9 92.7 94.0 93.8 88.5 91.2 90.3<br />

60-64 100.0 100.0 70.0 90.9 95.2 100.0 91.7 91.8 85.7 94.6 90.3<br />

65+ . 100.0 . 100.0 100.0 55.6 86.7 100.0 85.7 75.0 85.0<br />

646<br />

Male 92.9 92.0 92.7 92.5 95.6 95.2 94.6 94.5 94.9 95.1 94.7<br />

Female 93.5 92.4 93.5 93.6 93.6 94.3 96.0 94.8 95.1 96.5 94.1<br />

White 93.4 92.3 93.3 93.2 95.1 95.1 95.1 94.4 94.9 95.6 94.3<br />

Black 93.1 91.9 92.8 91.3 92.9 94.6 96.6 95.3 95.3 95.2 94.8<br />

Other race 85.0 89.7 86.5 94.4 95.2 89.9 91.7 96.5 94.7 100.0 97.5<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 86.4 83.6 84.5 83.6 89.9 88.1 91.0 89.1 92.2 94.8 93.6<br />

Hypertension 94.9 94.1 94.6 94.4 95.5 96.5 95.6 95.9 94.4 96.7 92.4<br />

Glomerulonephritis 96.0 97.1 96.5 97.4 96.3 96.9 96.5 96.4 97.1 95.2 95.6<br />

Other cause 92.4 90.4 93.0 92.7 95.6 96.4 96.2 95.8 94.8 96.3 94.4<br />

All 93.2 92.2 93.0 92.9 94.8 94.9 95.1 94.6 95.0 95.7 94.4<br />

ADJUSTED<br />

0-19 89.5 . . 90.8 95.4 97.6 93.0 95.3 90.7 . .<br />

20-44 91.2 87.3 90.0 90.5 93.5 93.5 94.4 93.5 95.3 94.2 95.8<br />

45-64 83.3 86.0 87.9 88.3 89.3 91.4 92.5 90.8 88.7 92.3 89.3<br />

65+ . . . . . 77.5 . . . . .<br />

Male 75.1 72.6 76.6 76.1 85.4 86.2 84.5 84.5 83.3 84.2 83.4<br />

Female 78.0 76.9 80.0 81.1 81.4 84.5 89.1 86.5 85.7 89.9 84.1<br />

White 76.5 73.9 78.7 78.0 84.4 85.9 86.2 84.5 84.1 86.2 83.2<br />

Black 78.6 78.8 79.3 78.2 80.9 86.7 91.2 88.6 86.5 . 85.2<br />

Other race 69.9 74.8 66.3 . . 77.8 . . 85.4 . .<br />

Diabetes 72.7 68.3 69.7 67.9 79.4 77.9 82.4 79.5 84.0 89.5 87.1<br />

Hypertension 88.3 87.3 . 89.9 91.2 93.3 . 92.5 88.5 . 85.6<br />

Glomerulonephritis 87.3 91.3 89.7 92.3 90.0 91.6 91.6 91.0 91.5 86.9 87.6<br />

Other cause 78.4 73.1 81.5 79.9 87.6 90.9 90.6 90.0 84.2 . 84.8<br />

All 76.1 74.2 77.9 78.0 83.7 85.4 86.3 85.2 84.2 86.5 83.5<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.37 I.37 (continued)<br />

Two-year patient survival probabilities: first transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />

0-4 95.7 93.5 97.8 91.3 94.4 94.9 95.7 97.4 96.7 97.0 97.3<br />

5-9 98.7 100.0 94.8 98.3 96.1 98.6 98.1 98.5 98.6 98.5 98.7<br />

10-14 97.0 95.3 97.3 99.0 98.3 97.5 100.0 99.2 98.6 100.0 97.9<br />

15-19 97.0 95.0 98.9 97.9 97.9 99.5 98.2 97.8 98.6 97.8 99.6<br />

20-29 98.0 97.8 97.6 98.6 97.6 98.5 98.3 98.2 98.6 97.9 97.9<br />

30-39 96.3 97.0 96.1 97.7 97.0 96.8 97.5 97.2 97.7 97.3 97.3<br />

40-49 94.8 96.6 97.0 94.5 96.2 96.1 96.1 95.8 96.3 96.0 96.9<br />

50-59 92.2 93.7 91.9 93.4 91.3 92.8 93.6 95.2 95.1 93.3 93.8<br />

60-64 85.1 82.5 92.9 88.8 87.6 91.7 94.4 93.9 93.2 94.1 92.2<br />

65+ 88.2 92.9 85.4 90.7 86.5 92.6 90.4 86.8 89.9 89.3 90.0<br />

Male 95.7 96.2 96.3 95.8 95.0 96.3 96.8 96.1 95.9 95.3 95.9<br />

Female 96.0 95.6 95.8 96.7 96.1 95.8 95.7 96.3 97.4 96.2 95.9<br />

White 95.8 96.2 96.3 96.4 95.1 96.1 96.2 96.4 96.5 95.7 95.8<br />

Black 95.2 93.9 94.5 95.3 96.7 95.3 96.1 94.8 95.9 95.2 95.5<br />

Other race 100.0 96.8 97.9 96.1 96.7 100.0 98.8 96.8 98.1 95.9 98.2<br />

647<br />

†Hispanic 96.5 97.8 97.2 97.7 96.0 96.2<br />

†Non-Hispanic 96.1 96.1 96.1 96.3 95.6 95.9<br />

Diabetes 91.2 92.9 93.1 94.7 92.0 93.6 92.6 92.5 94.4 92.1 93.3<br />

Hypertension 96.8 96.2 94.9 95.2 95.5 95.2 96.1 96.5 96.6 94.1 95.4<br />

Glomerulonephritis 97.6 97.5 98.1 97.4 97.0 97.9 98.4 98.5 96.9 97.4 97.6<br />

Other cause 97.0 96.2 96.7 96.5 96.1 96.6 96.6 96.6 97.3 97.0 96.6<br />

All 95.8 95.9 96.1 96.2 95.5 96.1 96.3 96.2 96.5 95.7 95.9<br />

ADJUSTED<br />

0-19 . 92.6 . . . . 97.2 . . 97.6 97.9<br />

20-44 95.6 96.4 96.3 97.0 96.2 96.5 96.8 96.6 96.6 96.6 96.6<br />

45-64 92.0 93.2 92.7 91.8 91.9 93.5 93.4 94.2 94.7 93.3 93.9<br />

65+ . . 82.7 . 83.4 88.9 89.4 86.7 90.8 87.6 90.0<br />

Male 87.0 88.6 89.4 88.4 87.0 90.8 91.8 90.9 90.7 89.9 91.4<br />

Female 89.4 88.8 89.3 91.8 90.7 90.6 90.1 91.8 94.1 92.0 91.8<br />

White 87.6 89.1 89.7 90.3 87.6 90.5 90.6 91.7 92.1 90.9 91.3<br />

Black 87.9 86.1 86.9 88.6 92.5 89.7 91.8 89.3 91.8 90.9 91.6<br />

Other race . . . . 92.9 . . . . 92.0 .<br />

Diabetes 83.6 87.1 87.5 90.8 87.0 89.8 88.5 88.4 91.8 88.7 90.6<br />

Hypertension 93.5 92.8 . 91.3 92.5 92.2 93.7 94.4 94.7 91.3 93.2<br />

Glomerulonephritis 93.3 93.4 94.8 93.2 92.7 94.9 . 96.3 93.2 94.5 94.9<br />

Other cause 91.2 89.8 91.2 90.8 90.2 91.6 92.0 92.3 93.9 93.7 92.7<br />

All 87.9 88.5 89.2 89.8 88.5 90.6 91.0 91.2 92.0 90.7 91.5<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.38 I.38<br />

Three-year patient survival probabilities: first transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 100.0 100.0 85.7 76.7 90.2 100.0 89.8 95.5 84.9 94.6 88.2<br />

5-9 96.2 92.0 94.1 90.0 97.9 98.1 90.5 97.5 97.2 98.2 92.7<br />

10-14 89.8 94.1 97.0 96.4 96.2 98.8 95.0 97.8 94.1 98.0 88.5<br />

15-19 94.0 93.6 96.8 94.5 95.7 96.4 97.2 95.4 96.1 97.8 92.7<br />

20-29 94.7 91.5 92.5 93.1 94.1 95.7 94.8 93.7 96.0 94.0 97.1<br />

30-39 90.6 86.3 89.3 88.4 93.2 91.2 94.3 93.3 92.8 96.3 93.9<br />

40-49 83.0 82.2 85.2 87.5 87.9 90.5 93.8 91.1 94.8 92.4 90.8<br />

50-59 80.6 80.8 82.8 85.2 87.8 90.6 91.7 91.3 85.5 86.5 88.6<br />

60-64 50.0 100.0 70.0 90.9 90.5 100.0 90.0 86.9 85.7 91.9 90.3<br />

65+ . 100.0 . 100.0 100.0 55.6 83.3 88.0 85.7 75.0 80.0<br />

648<br />

Male 90.2 88.1 89.8 89.7 93.5 93.1 93.1 92.6 93.2 93.9 92.9<br />

Female 91.6 88.9 90.9 91.1 90.7 93.1 94.9 93.3 94.0 94.6 93.0<br />

White 90.9 88.5 90.7 90.4 92.9 93.5 93.8 92.7 93.7 94.1 92.7<br />

Black 92.1 87.0 88.0 88.7 89.6 92.3 94.9 93.9 92.4 93.2 92.9<br />

Other race 80.0 89.7 86.5 94.4 93.7 88.6 90.7 93.9 93.0 100.0 97.5<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 82.5 76.0 78.2 77.7 85.4 83.8 88.6 86.1 89.2 92.3 90.5<br />

Hypertension 92.3 93.1 90.4 91.7 93.6 95.0 94.9 93.9 92.1 93.9 90.8<br />

Glomerulonephritis 93.4 95.0 95.6 95.8 94.2 95.9 95.5 94.9 96.4 94.5 94.8<br />

Other cause 90.6 85.8 90.6 90.5 94.0 95.4 95.1 94.7 94.0 95.0 93.2<br />

All 90.8 88.4 90.2 90.3 92.5 93.1 93.8 92.9 93.5 94.2 92.9<br />

ADJUSTED<br />

0-19 . 91.7 93.5 87.7 93.2 96.4 91.4 93.8 . . .<br />

20-44 88.4 82.8 86.2 86.6 91.3 91.6 93.0 91.5 93.2 92.9 93.6<br />

45-64 74.0 76.7 82.4 84.9 82.9 87.7 90.4 88.4 86.6 87.7 86.8<br />

65+ 26.9 . . . . . . 84.5 . . .<br />

Male 67.0 61.9 68.8 68.6 79.3 80.5 80.8 79.5 78.4 80.7 78.3<br />

Female 71.9 67.9 72.7 74.3 73.8 81.2 86.1 82.8 82.6 84.6 81.2<br />

White 68.7 63.5 71.5 70.2 78.0 81.4 82.8 80.0 80.5 81.9 79.1<br />

Black . . 67.5 72.2 72.6 81.1 86.9 85.3 79.0 . .<br />

Other race . . . . 83.6 . 78.2 86.3 . . .<br />

Diabetes . 55.8 58.7 57.7 70.7 70.1 77.6 73.9 77.7 . 80.9<br />

Hypertension . . . 85.3 87.6 90.5 . 89.0 84.4 87.7 .<br />

Glomerulonephritis 79.5 85.2 86.9 87.6 84.4 88.9 89.2 87.4 89.5 85.0 85.4<br />

Other cause 73.6 62.5 75.5 74.6 83.4 88.5 88.0 87.4 . 85.3 81.7<br />

All 68.8 64.1 70.2 70.8 77.0 80.7 82.8 80.8 80.0 82.2 79.3<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.38 I.38 (continued)<br />

Three-year patient survival probabilities: first transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000<br />

0-4 95.7 91.9 95.7 91.3 94.4 94.9 95.7 97.4 96.7 95.5<br />

5-9 98.7 98.6 94.8 98.3 94.8 97.2 98.1 98.5 98.6 96.9<br />

10-14 97.0 93.5 97.3 99.0 98.3 97.5 100.0 98.5 97.8 100.0<br />

15-19 95.8 92.5 98.4 96.9 97.9 98.5 96.4 97.8 97.7 97.4<br />

20-29 96.9 96.6 95.9 97.3 96.2 96.6 97.5 97.1 97.0 97.6<br />

30-39 94.1 95.7 94.2 96.3 96.3 95.9 96.2 95.5 96.7 96.7<br />

40-49 92.4 94.5 95.1 93.1 94.5 94.4 94.0 94.3 94.9 94.3<br />

50-59 89.5 91.3 86.8 88.4 88.5 91.1 91.5 93.2 91.8 90.8<br />

60-64 83.0 80.0 86.9 79.8 83.7 87.3 91.4 90.0 85.3 90.9<br />

65+ 88.2 85.7 78.0 81.4 82.4 88.3 85.1 82.2 86.9 84.7<br />

Male 93.9 94.4 93.7 93.9 93.5 94.7 95.1 94.3 93.9 93.5<br />

Female 94.5 93.7 94.0 94.3 94.5 94.3 93.9 94.9 95.2 94.7<br />

White 94.2 94.7 93.9 94.4 93.6 94.5 94.5 94.7 94.5 93.9<br />

Black 92.5 90.1 93.0 93.3 95.0 93.7 94.7 93.2 93.1 94.1<br />

Other race 98.8 94.7 95.8 92.1 96.7 99.3 95.7 95.8 97.2 95.6<br />

649<br />

†Hispanic 95.2 96.3 95.9 96.3 95.2<br />

†Non-Hispanic 94.5 94.4 94.4 94.1 93.9<br />

Diabetes 87.0 89.7 89.3 90.9 89.1 90.8 88.9 89.5 90.5 89.4<br />

Hypertension 94.8 94.3 91.4 92.4 93.9 92.7 93.7 94.2 94.4 92.1<br />

Glomerulonephritis 96.7 95.8 96.8 95.9 95.9 96.7 97.7 97.7 95.7 96.3<br />

Other cause 96.4 95.0 94.9 95.2 95.1 95.8 95.5 95.3 95.6 95.8<br />

All 94.2 94.1 93.8 94.1 94.0 94.5 94.6 94.6 94.4 94.0<br />

ADJUSTED<br />

0-19 . 90.2 94.7 94.9 . . 96.0 . 96.3 .<br />

20-44 93.6 94.2 93.9 95.3 94.9 94.9 95.1 94.7 95.1 95.8<br />

45-64 88.5 90.5 88.1 87.3 88.9 91.0 90.7 91.9 90.8 90.6<br />

65+ . 67.8 . 79.1 . 84.2 83.6 81.3 86.0 82.7<br />

Male 81.8 83.6 82.3 83.4 83.4 86.8 87.8 86.7 86.3 86.3<br />

Female 85.4 84.1 84.9 86.0 87.0 87.2 86.1 88.6 89.2 88.9<br />

White 83.3 84.9 83.2 85.0 83.8 86.6 86.6 87.7 87.6 87.1<br />

Black 81.4 78.0 83.5 83.9 88.6 86.3 88.7 86.2 86.2 88.7<br />

Other race . 87.9 . 84.8 . . 92.3 . . .<br />

Diabetes 75.9 81.2 80.6 84.0 82.1 85.1 82.5 83.8 86.0 84.7<br />

Hypertension . 89.4 85.1 86.6 89.9 88.4 90.2 91.0 91.5 88.5<br />

Glomerulonephritis 90.9 89.2 91.4 89.4 90.1 92.1 94.5 94.5 90.5 92.2<br />

Other cause 89.3 86.8 86.7 87.5 87.7 89.7 89.3 89.3 90.0 91.1<br />

All 83.2 83.6 83.2 84.4 84.8 86.9 86.9 87.4 87.4 87.3<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.39 I.39<br />

Five-year patient survival probabilities: first transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990<br />

0-4 90.0 93.3 71.4 70.0 90.2 100.0 85.7 88.1 83.0 94.6 88.2<br />

5-9 96.2 92.0 85.3 90.0 97.9 96.2 90.5 97.5 91.7 98.2 89.1<br />

10-14 85.7 90.2 97.0 92.9 94.3 97.6 93.1 97.8 93.1 96.0 85.1<br />

15-19 91.6 89.6 95.6 92.7 93.5 92.8 93.7 94.9 92.8 96.3 91.5<br />

20-29 92.3 88.6 89.0 87.6 90.9 90.9 89.9 90.1 93.4 91.9 95.1<br />

30-39 83.9 78.0 83.6 84.2 88.3 86.2 90.4 88.9 86.5 92.1 90.3<br />

40-49 75.6 75.5 77.6 81.3 82.4 84.2 88.7 87.2 87.3 86.2 85.9<br />

50-59 66.7 72.6 73.0 78.9 79.3 82.8 86.7 84.5 81.7 78.2 80.0<br />

60-64 50.0 75.0 60.0 72.7 90.5 83.9 86.7 78.7 61.9 73.0 74.2<br />

65+ . 100.0 . 100.0 66.7 44.4 70.0 80.0 85.7 75.0 70.0<br />

650<br />

Male 84.9 81.3 84.7 84.2 89.4 87.3 88.7 88.3 89.1 90.3 89.7<br />

Female 87.4 85.0 85.4 87.1 86.4 88.6 90.4 89.4 88.4 90.0 88.2<br />

White 86.0 82.9 85.5 85.4 88.7 88.2 89.3 88.7 89.8 90.2 88.6<br />

Black 87.1 81.3 82.8 83.9 84.2 86.9 90.3 88.3 83.9 87.0 91.0<br />

Other race 75.0 84.6 82.7 90.7 92.1 82.3 88.9 90.4 84.2 98.4 93.7<br />

†Hispanic<br />

†Non-Hispanic<br />

Diabetes 71.8 67.1 69.4 67.9 76.3 74.4 80.9 78.2 81.4 85.0 84.2<br />

Hypertension 85.9 86.1 86.1 86.7 89.6 91.2 91.8 91.2 82.6 87.3 84.9<br />

Glomerulonephritis 90.4 90.0 91.7 92.1 90.5 90.8 91.9 92.2 94.4 92.3 92.5<br />

Other cause 86.1 81.0 85.5 86.9 91.6 91.8 91.4 91.0 90.2 91.9 89.9<br />

All 85.9 82.8 85.0 85.4 88.2 87.8 89.4 88.7 88.9 90.1 89.0<br />

ADJUSTED<br />

0-19 84.1 87.3 89.2 83.4 90.5 92.8 87.3 . 86.0 94.2 81.1<br />

20-44 81.3 74.9 79.6 80.0 86.2 85.1 87.4 86.2 87.3 88.3 89.7<br />

45-64 65.0 66.3 72.0 76.7 73.8 79.0 84.0 82.3 77.6 77.9 77.5<br />

65+ . . . . . . 70.6 72.1 . . .<br />

Male 53.8 47.1 56.9 55.8 67.9 66.7 70.1 69.2 67.2 70.6 69.8<br />

Female 60.4 58.6 59.4 64.4 63.1 69.9 74.8 73.4 68.4 72.5 69.5<br />

White 56.1 50.6 58.9 58.3 67.1 68.5 71.6 70.6 69.9 71.6 68.7<br />

Black 63.1 56.6 56.0 62.1 60.3 69.2 76.2 73.0 59.5 66.0 74.8<br />

Other race . . 58.6 76.4 79.1 63.4 . 78.3 61.2 96.3 .<br />

Diabetes 48.2 43.1 45.6 43.3 55.0 55.2 63.9 60.8 63.4 70.5 69.3<br />

Hypertension 69.9 72.1 70.5 76.5 79.7 83.0 84.6 83.8 66.5 74.8 72.0<br />

Glomerulonephritis 71.2 72.0 76.5 77.8 75.3 76.5 80.9 81.1 83.9 79.2 79.1<br />

Other cause 63.8 53.4 64.9 66.9 77.8 80.4 80.0 79.4 72.1 77.3 74.0<br />

All 56.2 51.4 57.8 59.1 65.9 67.9 71.9 70.8 67.6 71.3 69.4<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


I<br />

PATIENT SURVIVAL<br />

2005 Annual <strong>Data</strong> Report<br />

Table I.39 I.39 (continued)<br />

Five-year patient survival probabilities: first transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1991 1992 1993 1994 1995 1996 1997 1998<br />

0-4 95.7 90.3 94.6 91.3 91.7 93.6 92.4 97.4<br />

5-9 96.2 98.6 93.1 98.3 94.8 97.2 98.1 96.9<br />

10-14 93.9 92.5 94.7 97.9 96.6 95.8 97.3 97.7<br />

15-19 95.2 91.2 95.2 95.8 96.3 96.6 91.4 96.1<br />

20-29 95.5 94.5 94.0 94.8 92.5 94.3 94.8 94.5<br />

30-39 90.6 92.7 90.8 91.7 93.1 92.4 91.5 92.3<br />

40-49 86.3 87.6 89.2 88.4 90.0 89.3 90.3 90.1<br />

50-59 81.7 86.7 77.8 81.5 82.5 84.3 84.5 85.0<br />

60-64 76.6 68.8 75.0 65.2 75.2 82.8 79.8 79.5<br />

65+ 82.4 78.6 65.9 69.8 73.0 79.8 74.6 66.4<br />

Male 90.5 91.0 89.4 89.2 89.6 90.6 90.0 89.1<br />

Female 90.5 89.5 89.3 90.4 90.2 90.2 89.1 90.3<br />

White 90.9 90.9 89.7 90.2 89.3 90.4 89.6 89.9<br />

Black 87.1 86.2 87.4 87.9 91.5 89.6 89.1 87.7<br />

Other race 93.8 91.6 89.6 88.2 92.8 93.4 92.7 91.5<br />

651<br />

†Hispanic 91.4 92.8 92.5<br />

†Non-Hispanic 90.3 89.2 89.2<br />

Diabetes 80.0 82.3 80.5 82.1 82.1 83.7 80.7 80.5<br />

Hypertension 88.4 90.5 87.4 86.4 87.7 87.1 87.9 88.4<br />

Glomerulonephritis 94.0 93.2 93.8 93.9 94.1 93.0 94.0 94.4<br />

Other cause 95.0 92.2 91.4 92.2 91.5 93.8 91.5 91.9<br />

All 90.5 90.3 89.3 89.7 89.8 90.4 89.6 89.6<br />

ADJUSTED<br />

0-19 92.8 88.3 91.1 . 92.9 92.7 90.6 .<br />

20-44 89.8 90.2 90.0 90.3 89.8 90.4 89.7 90.4<br />

45-64 79.9 82.9 78.6 79.5 82.7 84.3 83.4 83.7<br />

65+ . 55.8 59.1 66.9 67.6 75.7 72.1 65.9<br />

Male 72.7 74.5 71.6 72.0 74.2 77.4 76.3 75.8<br />

Female 75.5 74.1 73.6 77.0 77.2 78.3 75.5 78.6<br />

White 74.5 75.1 72.7 74.9 74.0 77.5 75.4 77.3<br />

Black 69.2 70.1 71.6 72.3 80.9 77.8 77.4 75.3<br />

Other race 85.7 79.9 76.4 77.0 84.3 87.4 86.5 84.7<br />

Diabetes 64.0 68.4 66.0 69.6 71.0 74.0 70.3 70.5<br />

Hypertension 77.6 82.2 77.9 75.9 79.9 79.3 80.9 81.9<br />

Glomerulonephritis 83.7 82.9 83.8 84.3 85.7 83.6 86.1 86.8<br />

Other cause 85.6 80.3 78.5 80.5 79.5 85.4 80.9 82.3<br />

All 73.7 74.1 72.2 74.0 75.3 77.6 75.8 76.8<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.<br />

"." Zero values in this cell.


IPATIENT SURVIVAL<br />

Reference section I<br />

Table I.40 I.40<br />

Ten-year patient survival probabilities: first transplants, living donors<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race/ethnicity,<br />

race/ethnicity,<br />

& primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

UNADJUSTED 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993<br />

0-4 80.0 80.0 66.7 66.7 85.4 91.4 85.7 85.1 77.4 92.9 86.3 91.3 83.9 90.3<br />

5-9 84.6 92.0 70.6 80.0 93.7 94.2 83.3 85.0 88.9 96.4 85.5 92.4 92.9 91.4<br />

10-14 77.6 80.4 89.4 83.3 85.7 95.2 84.2 90.1 88.2 87.0 79.3 86.9 86.9 85.0<br />

15-19 81.9 86.4 87.3 89.0 84.2 86.7 84.1 84.6 90.2 90.3 84.2 88.5 80.5 87.6<br />

20-29 86.3 80.1 79.5 77.7 81.1 80.8 80.8 79.2 88.3 84.0 87.3 86.9 83.6 85.1<br />

30-39 69.5 65.8 68.3 71.8 73.3 71.4 76.7 75.3 72.5 79.9 79.2 77.3 80.5 78.5<br />

40-49 56.3 54.6 60.3 64.2 64.0 65.9 68.6 66.0 65.1 71.0 67.8 69.5 71.1 71.3<br />

50-59 38.9 52.1 43.4 62.0 64.0 57.5 57.8 64.1 58.8 53.5 51.9 53.9 59.1 54.5<br />

60-64 . 75.0 50.0 45.5 61.9 58.1 65.0 44.3 47.6 40.5 35.5 53.2 38.8 45.2<br />

65+ . 100.0 . 25.0 33.3 11.1 30.0 52.0 28.6 25.0 50.0 64.7 50.0 24.4<br />

652<br />

Male 73.7 69.3 70.5 72.3 75.1 72.4 71.9 72.3 77.3 77.6 76.9 78.1 76.4 75.3<br />

Female 74.4 74.4 72.8 75.5 75.5 75.7 77.2 74.8 77.5 79.0 75.7 76.3 74.6 75.1<br />

White 74.7 72.4 71.0 74.3 76.2 74.8 73.8 73.8 78.2 78.2 76.7 78.2 76.2 76.5<br />

Black 70.3 63.4 72.2 68.7 67.2 67.8 72.7 69.6 72.0 74.4 71.4 70.4 70.8 68.3<br />

Other race 65.0 69.2 75.0 77.8 84.1 72.2 81.5 76.3 77.2 90.2 82.3 82.5 78.9 77.1<br />

Diabetes 53.4 45.2 47.6 46.7 51.3 50.8 55.0 54.9 60.3 64.5 62.3 56.0 56.8 55.7<br />

Hypertension 69.2 76.2 68.7 72.8 77.2 71.5 72.5 71.3 69.7 74.0 70.3 72.7 72.1 72.0<br />

Glomerulonephritis 81.5 80.3 82.1 81.7 80.4 81.5 81.8 79.7 84.9 83.6 82.0 83.2 81.0 82.8<br />

Other cause 74.6 71.0 72.8 78.7 81.7 80.7 79.1 79.1 83.1 82.2 81.3 87.5 82.6 81.5<br />

All 74.0 71.3 71.3 73.6 75.3 73.7 74.0 73.3 77.4 78.2 76.4 77.3 75.6 75.3<br />

ADJUSTED<br />

0-19 67.7 78.1 75.1 72.5 80.2 86.5 77.5 78.0 79.1 86.1 72.9 83.1 77.8 81.2<br />

20-44 67.3 60.2 63.8 65.8 68.4 69.0 70.7 70.1 73.5 75.1 77.2 74.4 74.1 74.9<br />

45-64 38.3 44.4 45.7 54.8 55.1 53.5 57.0 55.7 54.0 52.6 46.8 55.9 55.2 53.9<br />

65+ . . . 41.1 50.6 22.5 32.8 34.3 26.1 36.5 40.0 52.6 38.1 23.5<br />

Male 35.6 30.6 34.9 37.6 42.0 42.2 42.1 42.8 44.8 46.3 45.8 48.7 47.4 46.4<br />

Female 35.4 39.2 37.0 41.8 42.0 45.0 48.7 46.2 46.3 49.3 45.3 47.7 46.1 46.8<br />

White 35.6 33.8 35.0 38.8 43.0 44.0 44.0 44.2 46.3 47.5 46.2 48.8 46.5 47.4<br />

Black 38.2 36.0 42.6 42.8 37.9 42.5 49.4 46.2 43.8 47.0 42.9 46.0 49.7 44.7<br />

Other race 46.7 45.2 52.3 55.7 67.4 52.6 63.9 59.2 54.7 81.5 67.6 67.3 59.9 59.6<br />

Diabetes 27.8 22.2 23.2 22.4 26.0 29.0 32.0 32.9 35.4 41.8 39.0 34.6 36.8 35.4<br />

Hypertension 44.8 56.9 43.3 56.7 60.0 52.7 55.4 53.8 47.7 54.2 50.8 53.8 53.8 55.2<br />

Glomerulonephritis 52.9 53.3 57.2 56.8 56.3 58.8 62.2 58.1 63.5 61.4 56.9 61.3 59.0 61.7<br />

Other cause 43.4 37.8 44.0 52.0 57.5 58.8 56.9 57.6 57.0 56.3 57.1 67.7 60.4 58.3<br />

All 35.4 33.8 35.7 39.3 42.1 43.3 44.7 44.1 45.4 47.5 45.5 48.1 46.7 46.5<br />

Reference cohort is 1996 incident ESRD patients.<br />

Overall adjusted survival probabilities are adjusted for age, gender, race, & primary diagnosis.<br />

Adjusted survival probabilities for one of the four variables are adjusted for the remaining three.<br />

The incident cohorts are determined at the time of ESRD initiation with the 60-day stable modality rule & the 90-day rule.<br />

The age of the incident patient is determined as of the date of transplant.<br />

Patients of unknown age or gender, or of age >110, are excluded.<br />

Includes residents of the 50 states, the District of Columbia, Puerto Rico, & the Territories.<br />

"." Zero values in this cell.


Reference<br />

J<br />

Section<br />

Provider<br />

characteristics


JPROVIDER CHARACTERISTICS<br />

Reference section J<br />

654<br />

J.1 . 655<br />

Certified dialysis & transplant facilities: by Medicare certification<br />

J.2 . 655<br />

Transplant facilities, patients transplanted, & donor types<br />

J.3 . 655<br />

Dialysis facilities, stations, & patient flow<br />

J.4 . 656<br />

Dialysis & transplant facilities: by state & territory<br />

J.5 . 657<br />

Dialysis & transplant facilities: by ESRD network<br />

J.6 . 657<br />

Dialysis & transplant facilities: by certification type<br />

J.7 . 657<br />

Dialysis & transplant facilities: by service type<br />

J.8 . 658<br />

Dialysis & transplant facilities: by ownership type<br />

J.9 . 658<br />

Dialysis treatments: by modality<br />

J.10 . 659<br />

Median number of patients: by certification type<br />

J.11 . 659<br />

Dialysis & transplant patients: by Medicare entitlement<br />

J.12 . 660<br />

Dialysis patients: by state & territory<br />

J.13 . 661<br />

Dialysis patients: by ESRD network<br />

J.14 . 661<br />

Dialysis patients: by certification type<br />

J.15 . 661<br />

Dialysis patients: by treatment modality<br />

J.16 . 662<br />

Patient & treatment counts: by detailed facility survey field


Table J.1 J.1<br />

Certified dialysis & transplant facilities: by Medicare certification<br />

Table J.1<br />

by ownership type<br />

Certified dialysis<br />

#<br />

& transplant facilities: by Medicare certification<br />

Table J.1<br />

by Certified ownership dialysis type # & transplant facilities: by Medicare certification<br />

by ownership type #<br />

Certified units VA Total Total<br />

Dialysis Patients Dialysis Patients Total Dialysis Patients<br />

Certified Facilities units Patients Transplanted VA Facilities Patients Transplanted Facilities Patients Total Transplanted Total<br />

1991 2,148 Dialysis 141,942 Patients 9,997 12 Dialysis 546 Patients 14 Total 2,160 Dialysis 142,488 Patients 10,011<br />

1992 Certified Facilities 2,292 units Patients 156,834 Transplanted 10,090 VA Facilities 12 Patients 520 Transplanted 11 Facilities 2,304 Patients 157,354 Total Transplanted 10,101 Total<br />

1993 1991 2,148 2,456 Dialysis 141,942 170,958 Patients 10,903 9,997 13 12 Dialysis 521 546 Patients 147 Total 2,469 2,160 Dialysis 142,488 171,479 Patients 10,011 10,910<br />

1992 1994 Facilities 2,292 2,624 Patients 156,834 186,316 Transplanted 10,090 11,295 Facilities 12 13 Patients 520 506 Transplanted 111 Facilities 2,637 2,304 Patients 157,354 186,822 Transplanted 10,101 11,296<br />

1993 1991 1995 2,148 2,456 2,876 141,942 170,958 199,711 10,903 11,885 9,997 13 12 521 451 546 147 . 2,469 2,160 2,888 142,488 171,479 200,162 10,011 10,910 11,885<br />

1996 1992 1994 3,083 2,292 2,624 213,731 156,834 186,316 12,179 10,090 11,295 12 13 372 520 506 111 . 2,637 2,304 3,095 157,354 186,822 214,103 10,101 11,296 12,179<br />

1997 1993 1995 3,344 2,456 2,876 229,834 170,958 199,711 12,367 10,903 11,885 11 13 12 356 521 451 7 . 2,469 3,355 2,888 171,479 230,190 200,162 10,910 12,367 11,885<br />

1998 1996 1994 3,576 3,083 2,624 245,365 213,731 186,316 13,316 12,179 11,295 11 12 13 345 372 506 1 . 2,637 3,587 3,095 186,822 245,710 214,103 11,296 13,316 12,179<br />

1999 1997 1995 3,833 3,344 2,876 259,159 229,834 199,711 13,479 12,367 11,885 10 11 12 334 356 451 . 3,843 3,355 2,888 259,493 230,190 200,162 13,479 12,367 11,885<br />

1998 1996 2000 4,013 3,576 3,083 273,009 245,365 213,731 14,300 13,316 12,179 10 11 12 324 345 372 . 4,023 3,587 3,095 273,333 245,710 214,103 14,300 13,316 12,179<br />

1999 1997 2001 3,833 4,175 3,344 259,159 285,645 229,834 13,479 14,608 12,367 10 11 334 337 356 . 4,185 3,843 3,355 285,982 259,493 230,190 14,608 13,479 12,367<br />

1998 2002 2000 4,379 4,013 3,576 296,322 273,009 245,365 15,055 14,300 13,316 54 10 11 2,030 324 345 22 . 4,023 3,587 4,433 273,333 245,710 298,352 14,300 13,316 15,077<br />

2003 1999 2001 4,530 3,833 4,175 307,909 259,159 285,645 15,661 13,479 14,608 61 10 2,186 334 337 51 . 4,185 3,843 4,591 285,982 259,493 310,095 14,608 13,479 15,712<br />

2002 2000 4,379 4,013 296,322 273,009 15,055 14,300 54 10 2,030 324 22. 4,023 4,433 273,333 298,352 14,300 15,077<br />

2003 2001 4,530 4,175 307,909 285,645 15,661 14,608 61 10 2,186 337 51. 4,185 4,591 285,982 310,095 14,608 15,712<br />

2002 4,379 296,322 15,055 54 2,030 22 4,433 298,352 15,077<br />

2003 4,530 307,909 15,661 61 2,186 51 4,591 310,095 15,712<br />

Table J.2<br />

Table Transplant J.2 facilities, patients transplanted, & donor types<br />

by Table type J.2& year<br />

Transplant facilities, patients transplanted, & donor types<br />

by<br />

Table<br />

type<br />

J.2<br />

& Facilities year<br />

Transplant facilities, patients transplanted, & donor types<br />

by type & Facilities year<br />

Patients<br />

Performing Patients Living Cadaveric Total Awaiting<br />

Transplants Transplanted Donors Transplants Transplants Transplant Patients<br />

1991 Performing 222 Patients 10,011 Living 2,382 Cadaveric 7,644 10,026 Total Awaiting 18,201<br />

1992 Transplants Facilities 223 Transplanted 10,101 Donors 2,536 Transplants 7,579 Transplants 10,115 Transplant Patients 21,609<br />

1993 1991 Performing 228 222 Patients 10,910 10,011 Living 2,828 2,382 Cadaveric 8,106 7,644 10,934 10,026 Total Awaiting 22,910 18,201<br />

1994 1992 Transplants 233 223 Transplanted 11,296 10,101 Donors 3,000 2,536 Transplants 8,312 7,579 Transplants 11,312 10,115 Transplant 26,592 21,609<br />

1995 1993 1991 233 228 222 11,885 10,910 10,011 3,416 2,828 2,382 8,486 8,106 7,644 11,902 10,934 10,026 28,883 22,910 18,201<br />

1996 1994 1992 236 233 223 12,179 11,296 10,101 3,703 3,000 2,536 8,495 8,312 7,579 12,198 11,312 10,115 32,739 26,592 21,609<br />

1997 1995 1993 234 233 228 12,367 11,885 10,910 3,905 3,416 2,828 8,468 8,486 8,106 12,373 11,902 10,934 35,893 28,883 22,910<br />

1998 1996 1994 236 233 13,316 12,179 11,296 4,520 3,703 3,000 8,752 8,495 8,312 13,272 12,198 11,312 38,300 32,739 26,592<br />

1999 1997 1995 238 234 233 13,479 12,367 11,885 4,644 3,905 3,416 8,839 8,468 8,486 13,483 12,373 11,902 40,739 35,893 28,883<br />

2000 1998 1996 235 233 236 14,300 13,316 12,179 5,427 4,520 3,703 8,884 8,752 8,495 14,311 13,272 12,198 41,122 38,300 32,739<br />

2001 1999 1997 233 238 234 14,608 13,479 12,367 5,804 4,644 3,905 8,824 8,839 8,468 14,628 13,483 12,373 47,256 40,739 35,893<br />

2002 2000 1998 236 235 233 15,077 14,300 13,316 5,893 5,427 4,520 9,213 8,884 8,752 15,106 14,311 13,272 47,525 41,122 38,300<br />

2003 2001 1999 237 233 238 15,712 14,608 13,479 6,244 5,804 4,644 9,494 8,824 8,839 15,738 14,628 13,483 51,002 47,256 40,739<br />

2002 2000 236 235 15,077 14,300 5,893 5,427 9,213 8,884 15,106 14,311 47,525 41,122<br />

2003 2001 237 233 15,712 14,608 6,244 5,804 9,494 8,824 15,738 14,628 51,002 47,256<br />

2002 236 15,077 5,893 9,213 15,106 47,525<br />

2003 237 15,712 6,244 9,494 15,738 51,002<br />

Table J.3<br />

Dialysis facilities, stations, & patient flow<br />

Table J.3<br />

Table Dialysis J.3 facilities, stations, & patient flow<br />

Facilities with<br />

Dialysis facilities, stations, & patient flow<br />

Patients<br />

Patients Patients Beginning Added Lost Lost-to- Ending<br />

Facilities During Year with at End of Year Stations Patients of Year During Year During Year Followup Year<br />

1991 Patients 2,154 Patients 2,046 28,985 Beginning 129,706 Added 82,345 69,209 Lost Lost-to- 354 142,488 Ending<br />

1992 Facilities During 2,289 Year with at End of 2,181 Year Stations 30,641 Patients 142,780 of Year During 91,011 Year During 76,138 Year Followup 299 157,354 Year<br />

1991 1993 Patients 2,154 2,469 Patients 2,046 2,353 28,985 35,240 Beginning 129,706 157,525 Added 82,345 99,821 69,209 85,637 Lost Lost-to- 354 230 142,488 171,479 Ending<br />

1992 1994 During 2,289 2,637 Year at End of 2,181 2,523 Year Stations 30,641 38,169 142,780 171,536 of Year During 108,534 91,011 Year During 92,921 76,138 Year Followup 327 299 186,822 157,354 Year<br />

1991 1993 1995 2,154 2,469 2,888 2,046 2,353 2,751 28,985 35,240 41,809 129,706 157,525 186,649 115,940 82,345 99,821 102,035 69,209 85,637 392 354 230 200,162 142,488 171,479<br />

1992 1994 1996 2,289 2,637 3,095 2,181 2,523 2,957 30,641 38,169 45,728 142,780 171,536 199,974 108,534 122,943 91,011 108,483 92,921 76,138 331 327 299 214,103 186,822 157,354<br />

1993 1995 1997 2,469 2,888 3,355 2,353 2,751 3,196 35,240 41,809 50,569 157,525 186,649 214,179 115,940 133,695 99,821 102,035 117,305 85,637 392 379 230 200,162 230,190 171,479<br />

1994 1996 1998 2,637 3,095 3,587 2,523 2,957 3,407 38,169 45,728 54,575 171,536 199,974 230,181 108,534 122,943 142,609 108,483 126,698 92,921 331 382 327 214,103 245,710 186,822<br />

1995 1997 1999 2,888 3,824 3,355 3,630 2,751 3,196 58,895 41,809 50,569 245,575 186,649 214,179 149,445 115,940 133,695 135,065 102,035 117,305 462 392 379 259,493 200,162 230,190<br />

1996 1998 2000 4,023 3,095 3,587 3,832 2,957 3,407 61,537 45,728 54,575 259,824 199,974 230,181 154,764 122,943 142,609 140,766 108,483 126,698 489 331 382 273,333 214,103 245,710<br />

1997 2001 1999 4,181 3,824 3,355 3,991 3,630 3,196 68,133 58,895 50,569 273,169 245,575 214,179 159,114 149,445 133,695 145,580 135,065 117,305 721 462 379 285,982 259,493 230,190<br />

1998 2002 2000 4,432 4,023 3,587 4,204 3,832 3,407 72,115 61,537 54,575 287,263 259,824 230,181 167,568 154,764 142,609 155,886 140,766 126,698 593 489 382 298,352 273,333 245,710<br />

2003 2001 1999 4,586 4,181 3,824 4,373 3,991 3,630 76,294 68,133 58,895 299,644 273,169 245,575 170,306 159,114 149,445 159,111 145,580 135,065 744 721 462 310,095 285,982 259,493<br />

2002 2000 4,432 4,023 4,204 3,832 72,115 61,537 287,263 259,824 167,568 154,764 155,886 140,766 593 489 298,352 273,333<br />

2003 2001 4,586 4,181 4,373 3,991 76,294 68,133 299,644 273,169 170,306 159,114 159,111 145,580 744 721 310,095 285,982<br />

2002 4,432 4,204 72,115 287,263 167,568 155,886 593 298,352<br />

2003 4,586 4,373 76,294 299,644 170,306 159,111 744 310,095<br />

PROVIDER CHARACTERISTICS<br />

2005 Annual <strong>Data</strong> Report<br />

J<br />

655<br />

"." Zero values in this cell.<br />

"." Zero values in this cell.<br />

"." Zero values in this cell.<br />

"." Zero values in this cell.


JPROVIDER CHARACTERISTICS<br />

Reference section J<br />

656<br />

Table J.4 J.4<br />

Dialysis & transplant facilities: by state & territory<br />

by ownership type #<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Alabama 42 46 49 52 66 76 80 93 96 95 99 101 106<br />

Alaska 3 3 2 2 2 2 2 2 2 2 2 2 2<br />

Arizona 43 47 55 57 64 68 76 77 80 81 87 91 94<br />

Arkansas 35 35 38 38 41 42 46 52 58 58 64 64 65<br />

California 249 250 261 276 296 313 328 346 354 355 366 383 408<br />

Colorado 21 21 20 20 22 25 28 32 34 37 39 42 42<br />

Connecticut 20 20 21 23 24 23 23 23 33 34 33 32 32<br />

Delaware 6 6 7 7 8 8 8 10 11 12 13 15 15<br />

District of Columbia 21 21 21 21 23 23 23 23 23 22 23 23 24<br />

Florida 146 157 167 177 185 201 216 228 248 253 262 264 269<br />

Georgia 84 88 97 100 115 126 140 151 165 182 199 216 219<br />

Hawaii 12 12 12 12 14 13 13 14 14 16 18 19 18<br />

Idaho 7 7 7 7 6 6 7 8 10 8 7 7 7<br />

Illinois 87 96 99 102 105 109 110 109 113 133 148 158 172<br />

Indiana 38 41 40 46 47 51 62 64 72 77 82 93 93<br />

Iowa 15 18 19 23 25 29 41 42 43 47 49 51 55<br />

Kansas 18 20 22 24 25 30 36 38 41 42 40 42 43<br />

Kentucky 28 32 32 35 36 40 45 48 49 50 51 57 65<br />

Louisiana 72 75 76 86 86 95 96 101 118 126 132 135 134<br />

Maine 6 6 6 6 7 8 9 9 13 13 13 15 18<br />

Maryland 53 57 61 63 72 73 89 92 103 106 106 115 116<br />

Massachusetts 39 46 49 51 55 61 64 66 68 66 70 73 75<br />

Michigan 54 60 65 73 81 84 92 105 107 111 118 125 139<br />

Minnesota 34 37 44 46 55 57 68 68 67 75 69 74 72<br />

Mississippi 33 39 44 47 48 50 52 56 59 64 65 66 67<br />

Missouri 52 54 59 60 64 72 77 89 98 104 102 108 111<br />

Montana 7 7 7 9 12 13 13 14 16 14 15 15 15<br />

Nebraska 12 12 14 14 14 17 18 20 21 24 25 31 36<br />

Nevada 6 7 7 6 7 8 10 12 14 17 19 22 22<br />

New Hampshire 6 6 6 6 6 6 9 9 10 10 10 11 10<br />

New Jersey 37 41 41 47 63 70 76 77 85 91 93 101 108<br />

New Mexico 19 19 20 20 25 27 27 29 28 28 30 30 31<br />

New York 116 125 124 133 142 151 164 186 204 220 223 239 239<br />

North Carolina 62 66 70 81 88 91 95 98 107 110 118 130 138<br />

North Dakota 10 11 11 11 12 13 14 14 14 13 13 14 14<br />

Ohio 53 57 65 71 86 104 123 135 141 152 160 173 186<br />

Oklahoma 34 41 46 49 52 54 57 58 67 61 58 62 62<br />

Oregon 16 18 23 25 31 32 33 42 43 44 43 46 45<br />

Pennsylvania 102 106 119 126 139 150 166 180 193 209 223 231 232<br />

Rhode Island 6 8 10 10 10 10 10 11 13 13 13 14 14<br />

South Carolina 45 47 50 53 56 62 66 66 72 77 82 86 92<br />

South Dakota 8 7 8 10 14 16 17 18 19 21 21 22 22<br />

Tennessee 64 67 73 74 78 82 92 108 113 111 116 127 130<br />

Texas 152 161 176 201 228 235 250 260 281 297 309 324 341<br />

Utah 16 16 16 16 16 16 15 19 21 21 23 27 25<br />

Vermont 2 2 2 2 2 3 4 4 4 6 6 6 6<br />

Virginia 72 78 84 91 95 100 107 109 116 122 125 126 131<br />

Washington 24 25 29 31 33 34 38 41 41 43 49 53 50<br />

West Virginia 15 15 17 18 18 21 20 23 22 23 22 23 22<br />

Wisconsin 34 39 44 45 50 53 56 63 71 79 82 90 98<br />

Wyoming 2 2 3 3 5 6 6 7 10 9 9 9 9<br />

American Samoa 1 1 1 1 1 1 1 1 1 1 1 1 1<br />

Guam 1 1 2 2 2 3 3 3 3 3 3 3 3<br />

Northern Marianas 1 1 1 1 1 1 1 1 1 1 . . .<br />

Puerto Rico 18 23 26 26 28 29 31 31 31 32 34 42 42<br />

Virgin Islands 1 1 1 1 2 2 2 2 2 2 2 2 3<br />

All 2,160 2,304 2,469 2,637 2,888 3,095 3,355 3,587 3,843 4,023 4,184 4,431 4,588<br />

"." Zero values in this cell.


Table J.5 J.5<br />

Dialysis & transplant facilities: by ESRD network<br />

by ownership type #<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2,003<br />

1 CT, MA, ME, NH, RI, VT 79 88 94 98 104 111 119 122 141 142 145 151 155<br />

2 NY 116 125 124 133 142 151 164 186 204 220 223 239 239<br />

3 NJ, PR , VI 56 65 68 74 93 101 109 110 118 125 129 145 153<br />

4 DE, PA 108 112 126 133 147 158 174 190 204 221 236 246 247<br />

5 MD, DC, VA, WV 161 171 183 193 208 217 239 247 264 273 276 287 293<br />

6 NC, SC, GA 191 201 217 234 259 279 301 315 344 369 399 432 449<br />

7 FL 146 157 167 177 185 201 216 228 248 253 262 264 269<br />

8 AL, MS, TN 139 152 166 173 192 208 224 257 268 270 280 295 304<br />

9 IN, KY, OH 119 130 137 152 169 195 230 247 262 279 293 323 345<br />

10 IL 87 96 99 102 105 109 110 109 113 133 148 157 171<br />

11 MI, MN, ND, SD, WI 140 154 172 185 212 223 247 268 278 299 303 325 345<br />

12 IA, KS, MO, NE 97 103 114 121 128 148 172 189 203 217 216 233 246<br />

13 AR, LA, OK 142 153 160 173 179 191 199 211 243 245 254 261 261<br />

14 TX 152 161 176 201 228 235 250 260 281 297 309 324 341<br />

15 AZ, CO, NV, NM, UT, WY 107 112 121 122 139 150 162 176 187 193 207 221 223<br />

16 AK, ID, MT, OR, WA 56 59 68 74 84 87 93 107 112 111 116 123 119<br />

17 N. CA, HI , Guam, AS 106 107 112 119 131 136 139 145 148 149 154 162 168<br />

18 S. CA 158 158 165 173 183 195 207 220 225 227 235 245 263<br />

PROVIDER CHARACTERISTICS<br />

2005 Annual <strong>Data</strong> Report<br />

J<br />

657<br />

All 2,160 2,304 2,469 2,637 2,888 3,095 3,355 3,587 3,843 4,023 4,185 4,433 4,591<br />

Table<br />

Table<br />

J.6<br />

J.6<br />

Dialysis & transplant facilities: by certification type<br />

by unit type<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2,003<br />

Freestanding for-profit 1,173 1,281 1,431 1,561 1,775 1,979 2,226 2,523 2,790 2,949 3,124 3,148 3,272<br />

Freestanding non-profit 214 230 244 264 283 282 277 243 244 258 265 370 392<br />

Unknown profit status . . . . . . . . . . . 32 37<br />

Hospital center 333 348 341 340 337 330 328 312 304 290 267 329 346<br />

Hospital facility 209 213 216 235 255 265 281 271 259 280 287 313 306<br />

Transplant center only 65 66 67 73 76 82 86 88 98 96 104 110 108<br />

Transplant & dialysis center 165 164 169 164 162 157 156 150 148 148 134 129 129<br />

Other 1 2 1 . . . 1 . . 2 4 2 1<br />

All 2,160 2,304 2,469 2,637 2,888 3,095 3,355 3,587 3,843 4,023 4,185 4,433 4,591<br />

Table J.7 J.7<br />

Dialysis & transplant facilities: by service type<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Short stay hospitals 626 644 640 644 646 632 623 604 604 585 570 601 588<br />

Long stay hospitals 3 1 1 2 3 3 3 3 3 3 3 3 3<br />

Hospital-based chronic<br />

renal care facilities . . . . 2 . 1 1 1 2 1 1 .<br />

<strong>Renal</strong> disease treatment<br />

Center (hospital satellites) 120 123 126 142 156 176 205 221 217 226 226 236 229<br />

Children's hospitals 24 25 28 28 30 30 30 30 30 31 30 31 33<br />

Non-hospital renal<br />

disease treatment centers 1,386 1,511 1,674 1,821 2,050 2,253 2,492 2,727 2,987 3,175 3,351 3,555 3,731<br />

Hospital-based special<br />

purpose renal dialysis facilities . . . . . . . . . 1 3 1 .<br />

Independent special purpose renal<br />

dialysis facilities . . . . . . . . . . . . .<br />

Unknown 1 . . . 1 1 1 1 1 . 1 5 7<br />

All 2,160 2,304 2,469 2,637 2,888 3,095 3,355 3,587 3,843 4,023 4,185 4,433 4,591<br />

"." Zero values in this cell.


JPROVIDER CHARACTERISTICS<br />

Reference section J<br />

658<br />

Table Table J.8 J.8<br />

Dialysis & transplant facilities: by ownership type<br />

by ownership type #<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001<br />

City govt. non-federal 15 15 18 19 21 21 20 19 19 19 16<br />

City/county govt. non-federal 6 6 7 6 6 6 5 5 5 5 5<br />

Corporation for profit 920 1,003 1,174 1,279 1,426 1,517 1,647 1,836 1,999 2,077 2,200<br />

Corporation not for profit 692 722 763 796 827 816 809 761 747 725 686<br />

County govt. non-federal 27 28 26 28 28 28 27 22 22 23 22<br />

Hospital district/auth govt. non-federal 30 32 33 34 37 30 30 27 27 27 27<br />

Individual for profit 46 56 61 64 67 66 67 62 67 155 248<br />

Individual not for profit 7 7 5 5 4 4 4 4 5 29 65<br />

Other for profit 137 146 108 125 177 312 464 596 706 716 677<br />

Other govt. federal 2 2 1 1 1 1 1 1 1 1 1<br />

Other govt. non-federal 7 7 4 3 3 3 3 2 2 2 2<br />

Other not for profit 110 110 77 76 77 77 71 65 66 65 59<br />

Partnership for profit 97 105 121 128 142 144 139 123 118 117 115<br />

Partnership/not for profit . . 2 2 3 3 4 2 3 4 4<br />

Public health service govt. federal 3 3 3 3 3 2 2 2 2 4 4<br />

State govt. non-federal 48 49 53 55 54 53 51 48 43 43 43<br />

Veterans Administration govt. federal<br />

13 13 13 13 12 12 11 11 10 10 11<br />

Unknown . . . . . . . 1 1 1 .<br />

All 2,160 2,304 2,469 2,637 2,888 3,095 3,355 3,587 3,843 4,023 4,185<br />

Table<br />

Table<br />

J.9<br />

J.9<br />

Dialysis treatments: by modality<br />

by ownership type #<br />

1991 1992 1993 1994 1995 1996 1997<br />

Outpatient<br />

HD 16,104,132 17,578,766 19,407,490 21,251,535 23,513,163 25,655,177 27,908,131<br />

IPD 54,919 51,126 64,080 43,382 103,165 24,443 84,763<br />

Training<br />

HD 27,760 28,262 29,702 38,218 40,432 15,159 13,104<br />

IPD 848 705 653 902 745 704 817<br />

CAPD 126,476 133,450 112,347 112,936 155,201 76,423 98,262<br />

CCPD 30,987 34,402 27,433 27,514 71,230 41,103 70,092<br />

1998 1999 2000 2001 2002 2003<br />

Outpatient<br />

HD 30,611,792 32,993,464 35,320,743 36,838,702 39,034,690 41,022,561<br />

IPD 67,290 116,040 18,447 9,180 3,661 3,372<br />

Training<br />

HD 11,303 8,940 11,183 31,409 21,802 8,139<br />

IPD 422 422 160 79 240 67<br />

CAPD 76,275 74,950 84,922 114,965 82,376 55,793<br />

CCPD 62,283 51,413 75,618 122,171 76,558 63,146<br />

"." Zero values in this cell.


PROVIDER CHARACTERISTICS<br />

2005 Annual <strong>Data</strong> Report<br />

J<br />

Table J.10 J.10<br />

Median number of of patients: by certification type<br />

by ownership type<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Dialysis Facility<br />

Freestanding for-profit 54 58 59 60 57 58 58 59 59 60 61 63 63<br />

Freestanding non-profit 67 69 67 68 64 68 73 73 72 70 70 56 57<br />

Unknown profit status . . . . . . . . . . . 26 12<br />

Hospital center 62 61 64 67 67 62 64 64 59 60 61 49 47<br />

Hospital facility 31 34 32 32 32 33 32 31 35 35 38 36 39<br />

Transplant center only . . . . . . . . . . . . .<br />

Transplant & dialysis center 56 56 50 53 49 41 41 32 27 27 30 21 22<br />

Other . . . . . . 121 . . 8 1 36 80<br />

Median for all facilities 52 55 55 56 55 55 56 57 56 57 57 57 57<br />

Table Table J.11 J.11<br />

Dialysis & transplant patients: by Medicare entitlement<br />

by ownership type<br />

659<br />

Dialysis patients<br />

Transplant patients<br />

Medicare Medicare Medicare Medicare<br />

approved pending Non-Medicare approved pending Non-Medicare<br />

1991 123,751 8,500 10,237 8,465 732 814<br />

1992 135,883 9,516 11,955 8,385 708 1,008<br />

1993 148,899 9,759 12,821 9,107 729 1,074<br />

1994 161,235 11,263 14,324 9,358 888 1,050<br />

1995 172,261 11,324 16,577 9,588 984 1,313<br />

1996 183,588 12,599 17,916 9,659 1,107 1,413<br />

1997 196,368 13,042 20,780 9,884 852 1,631<br />

1998 207,218 14,512 23,980 10,241 1,115 1,960<br />

1999 216,232 16,279 26,982 9,900 1,183 2,396<br />

2000 227,238 18,763 27,332 10,260 1,540 2,500<br />

2001 238,838 23,064 24,080 10,669 1,777 2,162<br />

2002 266,632 18,643 13,077 12,969 1,188 920<br />

2003 275,830 20,363 13,902 13,427 1,272 1,013<br />

"." Zero values in this cell.


PROVIDER CHARACTERISTICS<br />

JReference section J<br />

Table J.12 J.12<br />

Dialysis patients: by state & territory<br />

660<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Alabama 3,012 3,275 3,553 3,787 4,110 4,541 4,946 5,157 5,378 5,695 5,959 6,072 6,297<br />

Alaska 89 105 96 124 134 151 184 185 191 205 230 229 264<br />

Arizona 2,186 2,559 2,881 3,114 3,350 3,570 3,902 4,219 4,564 4,859 5,105 5,315 5,619<br />

Arkansas 1,170 1,222 1,364 1,603 1,771 1,887 2,069 2,191 2,297 2,374 2,504 2,554 2,584<br />

California 16,416 17,904 19,325 21,346 22,729 24,279 25,848 27,698 29,653 31,688 34,034 36,332 38,047<br />

Colorado 1,237 1,387 1,531 1,690 1,721 1,852 1,973 2,187 2,317 2,456 2,532 2,663 2,781<br />

Connecticut 1,748 1,924 2,064 2,171 2,288 2,402 2,570 2,653 2,847 2,992 3,030 3,133 3,184<br />

Delaware 451 538 582 601 647 678 686 707 745 782 814 895 922<br />

District of Columbia 1,276 1,372 1,446 1,461 1,474 1,548 1,664 1,680 1,632 1,677 1,645 1,716 1,741<br />

Florida 7,858 8,737 9,757 10,662 11,274 12,075 12,988 13,775 14,858 15,726 16,512 17,119 17,961<br />

Georgia 4,690 5,314 5,813 6,582 7,157 7,756 8,353 8,983 9,510 10,156 10,756 11,339 11,870<br />

Hawaii 834 894 1,024 1,184 1,247 1,320 1,444 1,513 1,561 1,701 1,794 1,870 1,970<br />

Idaho 247 264 302 353 361 393 450 470 520 542 605 629 632<br />

Illinois 6,588 7,099 7,842 8,328 8,912 9,391 10,105 10,684 11,064 11,782 11,944 12,719 13,091<br />

Indiana 2,908 3,275 3,593 3,817 4,071 4,304 4,697 5,061 5,318 5,586 5,810 6,035 6,162<br />

Iowa 1,001 1,181 1,214 1,302 1,350 1,472 1,580 1,679 1,839 1,916 2,044 2,065 2,185<br />

Kansas 1,012 1,157 1,178 1,275 1,356 1,419 1,623 1,704 1,821 1,922 1,968 2,047 2,082<br />

Kentucky 1,599 1,797 1,924 2,042 2,179 2,282 2,460 2,747 2,848 3,140 3,254 3,328 3,599<br />

Louisiana 3,383 3,772 4,065 4,418 4,746 5,050 5,529 5,982 6,417 6,599 6,827 7,098 7,369<br />

Maine 317 346 410 461 517 553 630 666 711 740 754 806 870<br />

Maryland 3,172 3,445 3,724 4,174 4,544 4,920 5,376 5,652 5,801 5,877 6,186 6,505 6,870<br />

Massachusetts 2,705 3,060 3,384 3,645 3,877 4,024 4,253 4,452 4,442 4,508 4,565 4,698 4,783<br />

Michigan 4,907 5,405 5,963 6,485 6,982 7,663 8,015 8,613 8,893 9,223 9,740 10,080 10,552<br />

Minnesota 1,715 1,852 2,030 2,160 2,198 2,264 2,395 2,552 2,626 2,662 2,816 2,977 3,011<br />

Mississippi 2,072 2,286 2,533 2,824 3,019 3,298 3,553 3,786 3,993 4,154 4,373 4,570 4,712<br />

Missouri 2,829 3,104 3,428 3,621 3,872 4,227 4,504 4,901 5,230 5,447 5,725 5,904 6,032<br />

Montana 306 329 352 366 396 396 429 447 517 523 564 587 602<br />

Nebraska 619 677 776 810 832 887 973 1,071 1,134 1,159 1,269 1,357 1,170<br />

Nevada 508 560 610 693 777 893 960 1,062 1,200 1,272 1,399 1,528 1,688<br />

New Hampshire 357 377 402 421 457 451 493 531 604 648 682 732 751<br />

New Jersey 5,043 5,511 5,947 6,364 6,837 7,148 7,571 8,088 8,468 8,810 8,969 9,338 9,597<br />

New Mexico 902 1,012 1,109 1,186 1,319 1,429 1,589 1,660 1,770 1,947 2,047 2,093 2,189<br />

New York 11,541 12,655 13,653 14,579 15,359 16,148 17,131 18,228 19,391 20,407 20,749 21,438 22,040<br />

North Carolina 4,466 5,173 5,748 6,330 6,790 7,393 7,993 8,657 9,061 9,611 10,154 10,679 11,012<br />

North Dakota 260 318 326 344 370 376 406 408 420 422 462 506 514<br />

Ohio 5,340 5,850 6,296 7,032 7,586 8,231 8,994 9,614 9,994 10,989 11,668 11,797 12,445<br />

Oklahoma 1,335 1,439 1,635 1,783 1,925 2,072 2,313 2,488 2,609 2,782 2,860 2,992 3,177<br />

Oregon 1,187 1,253 1,355 1,464 1,583 1,656 1,740 1,857 1,905 2,000 2,130 2,232 2,349<br />

Pennsylvania 7,449 7,901 8,353 9,002 9,633 10,161 10,911 11,543 11,979 12,383 12,754 12,838 12,994<br />

Rhode Island 600 608 678 739 750 783 788 881 886 898 889 894 903<br />

South Carolina 2,600 2,880 3,231 3,584 3,901 4,180 4,515 4,802 5,121 5,289 5,520 5,743 6,101<br />

South Dakota 211 222 248 326 449 536 582 588 627 647 651 661 688<br />

Tennessee 3,119 3,427 3,612 4,057 4,443 4,696 5,020 5,355 5,728 5,989 6,196 6,406 6,561<br />

Texas 10,334 11,608 12,695 13,880 15,082 16,477 17,869 19,155 20,612 22,053 23,359 24,689 26,099<br />

Utah 432 465 535 581 620 634 647 731 787 863 937 960 1,010<br />

Vermont 127 127 121 134 153 165 182 221 213 241 266 272 288<br />

Virginia 3,690 4,367 4,805 5,182 5,593 5,996 6,571 7,025 7,372 7,524 7,873 8,319 8,474<br />

Washington 1,909 2,052 2,215 2,447 2,685 2,788 2,977 3,155 3,377 3,556 3,792 4,006 4,171<br />

West Virginia 797 838 929 994 1,080 1,180 1,249 1,330 1,362 1,476 1,562 1,549 1,613<br />

Wisconsin 1,793 2,016 2,200 2,412 2,590 2,762 2,940 3,171 3,370 3,469 3,627 3,806 4,087<br />

Wyoming 53 47 48 63 97 114 136 146 181 205 210 216 229<br />

American Samoa 28 31 35 39 44 51 47 41 54 63 69 73 76<br />

Guam 83 99 121 131 153 170 205 228 259 262 287 314 319<br />

Northern Marianas 20 26 30 32 40 47 53 68 77 89 . . .<br />

Puerto Rico 1,926 2,174 2,349 2,575 2,657 2,875 3,005 3,146 3,207 3,236 3,300 3,366 3,484<br />

Virgin Islands 31 38 39 42 75 89 104 116 132 111 122 136 135<br />

All 142,488 157,354 171,479 186,822 200,162 214,103 230,190 245,710 259,493 273,333 285,893 298,225 309,956<br />

"." Zero values in this cell.


Table J.13 J.13<br />

Dialysis patients: by ESRD network<br />

by network<br />

PROVIDER CHARACTERISTICS<br />

2005 Annual <strong>Data</strong> Report<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2,003<br />

1 CT, MA, ME, NH, RI, VT 5,854 6,442 7,059 7,571 8,042 8,378 8,916 9,404 9,703 10,027 10,186 10,535 10,779<br />

2 NY 11,541 12,655 13,653 14,579 15,359 16,148 17,131 18,228 19,391 20,407 20,749 21,438 22,040<br />

3 NJ, PR , VI 7,000 7,723 8,335 8,981 9,569 10,112 10,680 11,350 11,807 12,157 12,391 12,840 13,216<br />

4 DE, PA 7,900 8,439 8,935 9,603 10,280 10,839 11,597 12,250 12,724 13,165 13,568 13,733 13,916<br />

5 MD, DC, VA, WV 8,935 10,022 10,904 11,811 12,691 13,644 14,860 15,687 16,167 16,554 17,266 18,089 18,698<br />

6 NC, SC, GA 11,756 13,367 14,792 16,496 17,848 19,329 20,861 22,442 23,692 25,056 26,430 27,761 28,983<br />

7 FL 7,858 8,737 9,757 10,662 11,274 12,075 12,988 13,775 14,858 15,726 16,512 17,119 17,961<br />

8 AL, MS, TN 8,203 8,988 9,698 10,668 11,572 12,535 13,519 14,298 15,099 15,838 16,528 17,086 17,606<br />

9 IN, KY, OH 9,847 10,922 11,813 12,891 13,836 14,817 16,151 17,422 18,160 19,715 20,732 21,160 22,206<br />

10 IL 6,588 7,099 7,842 8,328 8,912 9,391 10,105 10,684 11,064 11,782 11,944 12,699 13,071<br />

11 MI, MN, ND, SD, WI 8,886 9,813 10,767 11,727 12,589 13,601 14,338 15,332 15,936 16,423 17,296 18,030 18,852<br />

12 IA, KS, MO, NE 5,461 6,068 6,596 7,008 7,410 8,005 8,680 9,355 10,024 10,444 11,006 11,393 11,489<br />

13 AR, LA, OK 5,901 6,499 7,064 7,804 8,442 9,009 9,911 10,661 11,323 11,755 12,191 12,644 13,130<br />

14 TX 10,334 11,608 12,695 13,880 15,082 16,477 17,869 19,155 20,612 22,053 23,359 24,689 26,099<br />

15 AZ, CO, NV, NM, UT, WY 5,318 6,030 6,714 7,327 7,884 8,492 9,207 10,005 10,819 11,602 12,230 12,775 13,516<br />

16 AK, ID, MT, OR, WA 3,725 3,988 4,320 4,754 5,159 5,384 5,780 6,114 6,510 6,826 7,321 7,683 8,018<br />

17 N. CA, HI , Guam, AS 6,901 7,489 8,213 9,093 9,608 10,251 11,062 11,829 12,695 13,752 14,686 15,382 16,056<br />

18 S. CA 10,480 11,465 12,322 13,639 14,605 15,616 16,535 17,719 18,909 20,051 21,587 23,296 24,459<br />

J<br />

661<br />

All 142,488 157,354 171,479 186,822 200,162 214,103 230,190 245,710 259,493 273,333 285,982 298,352 310,095<br />

Table<br />

Table<br />

J.14<br />

J.14<br />

Dialysis patients: by certification type<br />

by unit type<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Freestanding for-profit 79,324 90,558 101,901 113,512 125,452 139,047 155,185 177,044 194,605 208,044 221,789 227,386 237,457<br />

Freestanding non-profit 16,915 18,748 20,442 22,149 23,627 24,881 25,516 22,799 21,368 22,313 22,680 26,867 27,689<br />

Unknown profit status . . . . . . . . . . . 1,194 812<br />

Hospital center 24,428 25,331 26,142 26,716 26,429 25,286 24,988 23,141 21,259 20,735 19,094 20,274 21,379<br />

Hospital facility 9,478 9,812 10,414 11,666 12,082 12,919 12,803 12,599 12,678 13,469 14,494 15,719 16,325<br />

Transplant center only 4 179 . . . . 12 . . . . 424 .<br />

Transplant & dialysis center 12,339 12,726 12,580 12,779 12,572 11,970 11,565 10,127 9,583 8,756 7,836 6,416 6,353<br />

Other . . . . . . 121 . . 16 89 72 80<br />

All 142,488 157,354 171,479 186,822 200,162 214,103 230,190 245,710 259,493 273,333 285,982 298,352 310,095<br />

Table Table J.15 J.15<br />

Dialysis patients: by treatment modality<br />

by ownership type #<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

Outpatient<br />

Hemodialysis 116,699 128,458 139,835 153,100 166,109 181,000 198,416 215,899 230,649 244,950 257,872 269,968 281,340<br />

IPD 230 193 141 145 88 77 102 35 48 43 29 22 13<br />

Training<br />

Hemodialysis 120 226 224 90 64 125 56 61 35 37 28 12 14<br />

IPD 4 2 5 . 2 1 6 3 . . 1 . .<br />

CAPD 266 266 401 275 194 231 257 181 203 90 143 106 72<br />

CCPD 52 57 74 64 114 99 131 131 97 87 122 31 21<br />

Home<br />

Hemodialysis 2,266 2,161 2,256 2,328 2,086 1,897 1,884 1,607 1,521 1,480 1,277 1,273 1,396<br />

IPD 173 205 164 181 137 111 100 75 44 19 28 34 17<br />

CAPD 18,881 20,872 22,573 23,708 21,369 19,187 16,703 14,817 13,276 12,529 11,614 11,199 10,630<br />

CCPD 3,797 4,914 5,806 6,931 9,999 11,375 12,535 12,901 13,620 14,098 14,868 15,707 16,592<br />

All 142,488 157,354 171,479 186,822 200,162 214,103 230,190 245,710 259,493 273,333 285,982 298,352 310,095<br />

"." Zero values in this cell.<br />

"." Zero values in this cell.


JPROVIDER CHARACTERISTICS<br />

JReference section J<br />

Table J.16 J.16<br />

Patient & treatment counts: by detailed facility survey field<br />

by ownership type<br />

662<br />

1991 1992 1993 1994 1995 1996 1997<br />

01 Beginning in-unit 106,959 117,491 129,033 140,626 153,558 166,518 181,495<br />

02 Beginning home 22,747 25,289 28,492 30,910 33,091 33,456 32,684<br />

03 Beginning total 129,706 142,780 157,525 171,536 186,649 199,974 214,179<br />

04A In-unit - started for first time 44,515 49,604 52,699 57,407 59,077 64,366 70,884<br />

04B Home - started for first time 8,919 9,202 9,883 10,127 10,071 9,683 9,100<br />

05A In-unit - restarted 727 789 880 968 1,054 1,060 1,134<br />

05B Home - restarted 125 106 104 135 163 144 165<br />

06A In-Unit - transferred in 22,186 24,511 27,925 30,886 35,407 38,013 42,450<br />

06B Home - transferred in 3,242 4,187 5,404 6,059 7,139 6,639 6,772<br />

07A In-unit - returned after transplant 2,194 2,148 2,437 2,450 2,557 2,615 2,762<br />

07B Home - returned after transplant 437 464 489 502 472 423 428<br />

08A In-unit - deaths 26,371 29,859 32,685 34,699 37,467 41,039 44,687<br />

08B Home - deaths 4,793 5,541 6,365 6,958 7,441 7,276 7,042<br />

09A In-unit - recovered kidney function 1,696 1,774 1,962 2,260 2,409 2,464 2,721<br />

09B Home - recovered kidney function 242 261 279 302 341 284 280<br />

10A In-unit - received transplant 6,197 6,286 6,628 6,776 7,401 7,604 8,030<br />

10B Home - received transplant 2,412 2,442 2,785 2,958 2,950 2,957 2,803<br />

11A In-unit - transfer to other dialysis unit 22,517 24,732 28,351 31,469 34,607 37,836 42,209<br />

11B Home - transfer to other dialysis unit 3,263 3,802 5,034 5,783 7,013 6,739 7,079<br />

12A In-unit - discontinued dialysis 1,500 1,293 1,362 1,525 2,115 1,982 2,177<br />

12B Home - discontinued dialysis 218 148 186 191 291 302 277<br />

13A In-unit - other (lost-to-followup) 309 259 205 285 336 274 313<br />

13B Home - other (lost-to-followup) 45 40 25 42 56 57 66<br />

14 Outpatient dialysis - HD 116,699 128,458 139,835 153,100 166,109 181,000 198,416<br />

15 Outpatient dialysis - IPD 230 193 141 145 88 77 102<br />

16 Self-dialysis training - HD 120 226 224 90 64 125 56<br />

17 Self-dialysis training - IPD 4 2 5 . 2 1 6<br />

18 Self-dialysis training - CAPD 266 266 401 275 194 231 257<br />

19 Self-dialysis training - CCPD 52 57 74 64 114 99 131<br />

20 Total in-unit patients, sum (14-19) 117,371 129,202 140,680 153,674 166,571 181,533 198,968<br />

21 Home dialysis - hemodialysis 2,266 2,161 2,256 2,328 2,086 1,897 1,884<br />

22 Home dialysis - IPD 173 205 164 181 137 111 100<br />

23 Home dialysis - CAPD 18,881 20,872 22,573 23,708 21,369 19,187 16,703<br />

24 Home dialysis - CCPD 3,797 4,914 5,806 6,931 9,999 11,375 12,535<br />

25 Total home patients, sum (21-24) 25,117 28,152 30,799 33,148 33,591 32,570 31,222<br />

26 Total patients, sum 20 & 25 142,488 157,354 171,479 186,822 200,162 214,103 230,190<br />

27 Currently enrolled in Medicare 123,751 135,883 148,899 161,235 172,261 183,588 196,368<br />

28 Medicare application pending 8,500 9,516 9,759 11,263 11,324 12,599 13,042<br />

29 Non-Medicare 10,237 11,955 12,821 14,324 16,577 17,916 20,780<br />

30 HD completed training 681 854 651 587 524 530 422<br />

31 IPD completed training 138 99 77 137 114 104 90<br />

32 CAPD completed training 11,753 12,271 13,428 14,179 12,550 12,406 10,493<br />

33 CCPD completed training 2,680 3,394 3,842 4,408 7,221 7,338 7,439<br />

34 Transient patients treated 34,905 37,978 40,136 43,013 47,411 55,734 61,881<br />

35 Transient patient treatments 146,016 166,669 181,041 218,517 228,668 269,015 295,798<br />

36 HD outpatient treatments 16,104,132 17,578,766 19,407,490 21,251,535 23,513,163 25,655,177 27,908,131<br />

37 IPD outpatient treatments 54,919 51,126 64,080 43,382 103,165 24,443 84,763<br />

38 HD training treatments 27,760 28,262 29,702 38,218 40,432 15,159 13,104<br />

39 IPD training treatments 848 705 653 902 745 704 817<br />

40 CAPD training treatments 126,476 133,450 112,347 112,936 155,201 76,423 98,262<br />

41 CCPD training treatments 30,987 34,402 27,433 27,514 71,230 41,103 70,092<br />

42 Patients transplanted at this facility 10,011 10,101 10,910 11,296 11,885 12,179 12,367<br />

43 Patients transplanted & enrolled in Medicare 8,465 8,385 9,107 9,358 9,588 9,659 9,884<br />

44 Patients transplanted & Medicare app. pending 732 708 729 888 984 1,107 852<br />

45 Patients transplanted & non-Medicare -US residents 663 860 931 957 1,201 1,227 1,497<br />

46 Patients transplanted & non-Medicare-other 151 148 143 93 112 186 134<br />

47 Living-related donor transplant performed 2,296 2,391 2,631 2,738 2,992 3,084 3,210<br />

48 Living-unrelated donor transplant performed 86 145 197 262 424 619 705<br />

49 Cadaveric donor transplant performed 7,644 7,579 8,106 8,312 8,486 8,495 8,512<br />

50 Total transplant performed 10,026 10,115 10,934 11,312 11,902 12,198 12,427<br />

51 Dialysis patients awaiting transplant 17,018 19,970 21,165 24,130 26,539 29,725 32,608<br />

52 Non-dialysis patients awaiting transplant 1,218 1,648 1,809 2,465 2,344 3,014 3,371<br />

53 Cadaver harvest & transplant at this facility 1,108 1,055 1,072 1,036 967 864 3<br />

54 Cadaver harvest sent to other US facility 1,338 1,398 1,593 1,702 1,777 1,724 .<br />

55 Cadaver harvest sent outside US * 9 4 7 1 . .<br />

56 Cadaver harvest & nonviable 188 169 213 230 270 347 .<br />

57 Total cadaver harvest at this facility 2,636 2,631 2,882 2,975 3,015 2,935 3<br />

"." Zero values in this cell.


PROVIDER CHARACTERISTICS<br />

JReference section J<br />

Table J.16 J.16 (continued)<br />

Patient & treatment counts: by detailed facility survey field<br />

by ownership type #<br />

PROVIDER CHARACTERISTICS<br />

2005 Annual <strong>Data</strong> Report<br />

J<br />

1998 1999 2000 2001 2002 2003<br />

01 Beginning in-unit 198,993 216,324 231,248 245,072 259,125 271,322<br />

02 Beginning home 31,188 29,251 28,576 28,097 28,138 28,322<br />

03 Beginning total 230,181 245,575 259,824 273,169 287,263 299,644<br />

04A In-unit - started for first time 76,272 80,953 83,827 87,313 90,278 92,645<br />

04B Home - started for first time 8,194 7,876 7,852 7,392 6,420 6,792<br />

05A In-unit - restarted 1,191 1,323 1,353 1,545 1,687 1,856<br />

05B Home - restarted 156 123 128 120 121 129<br />

06A In-Unit - transferred in 46,746 49,524 50,853 51,978 57,637 57,333<br />

06B Home - transferred in 6,604 5,961 6,585 6,268 6,613 6,655<br />

07A In-unit - returned after transplant 3,060 3,274 3,744 4,021 4,361 4,449<br />

07B Home - returned after transplant 386 411 422 477 451 447<br />

08A In-unit - deaths 49,886 55,545 58,090 61,636 65,565 68,531<br />

08B Home - deaths 6,423 5,868 5,899 5,660 5,441 5,511<br />

09A In-unit - recovered kidney function 2,841 3,137 3,533 3,841 4,195 4,463<br />

09B Home - recovered kidney function 196 202 221 279 255 257<br />

10A In-unit - received transplant 8,950 9,393 9,763 10,140 10,617 10,875<br />

10B Home - received transplant 2,757 2,532 2,610 2,605 2,675 2,675<br />

11A In-unit - transfer to other dialysis unit 46,599 49,649 51,733 52,471 58,646 58,836<br />

11B Home - transfer to other dialysis unit 6,983 6,283 6,760 6,528 6,927 6,745<br />

12A In-unit - discontinued dialysis 1,866 2,280 2,030 2,290 1,475 1,160<br />

12B Home - discontinued dialysis 197 176 127 130 90 58<br />

13A In-unit - other (lost-to-followup) 337 416 441 544 547 691<br />

13B Home - other (lost-to-followup) 45 46 48 177 46 53<br />

14 Outpatient dialysis - HD 215,899 230,649 244,950 257,872 269,968 281,340<br />

15 Outpatient dialysis - IPD 35 48 43 29 22 13<br />

16 Self-dialysis training - HD 61 35 37 28 12 14<br />

17 Self-dialysis training - IPD 3 . . 1 . .<br />

18 Self-dialysis training - CAPD 181 203 90 143 106 72<br />

19 Self-dialysis training - CCPD 131 97 87 122 31 21<br />

20 Total in-unit patients, sum (14-19) 216,310 231,032 245,207 258,195 270,139 281,460<br />

21 Home dialysis - hemodialysis 1,607 1,521 1,480 1,277 1,273 1,396<br />

22 Home dialysis - IPD 75 44 19 28 34 17<br />

23 Home dialysis - CAPD 14,817 13,276 12,529 11,614 11,199 10,630<br />

24 Home dialysis - CCPD 12,901 13,620 14,098 14,868 15,707 16,592<br />

25 Total home patients, sum (21-24) 29,400 28,461 28,126 27,787 28,213 28,635<br />

26 Total patients, sum 20 & 25 245,710 259,493 273,333 285,982 298,352 310,095<br />

27 Currently enrolled in Medicare 207,218 216,232 227,238 238,838 266,632 275,830<br />

28 Medicare application pending 14,512 16,279 18,763 23,064 18,643 20,363<br />

29 Non-Medicare 23,980 26,982 27,332 24,080 13,077 13,902<br />

30 HD completed training 418 358 309 372 241 448<br />

31 IPD completed training 29 54 17 16 35 7<br />

32 CAPD completed training 9,350 8,519 8,619 8,728 9,140 7,704<br />

33 CCPD completed training 7,116 6,991 7,174 7,633 7,456 8,194<br />

34 Transient patients treated 65,422 71,436 78,117 76,461 78,770 81,270<br />

35 Transient patient treatments 298,627 324,152 290,130 355,086 286,142 281,008<br />

36 HD outpatient treatments 30,611,792 32,993,464 35,320,743 36,838,702 39,034,690 41,022,561<br />

37 IPD outpatient treatments 67,290 116,040 18,447 9,180 3,661 3,372<br />

38 HD training treatments 11,303 8,940 11,183 31,409 21,802 8,139<br />

39 IPD training treatments 422 422 160 79 240 67<br />

40 CAPD training treatments 76,275 74,950 84,922 114,965 82,376 55,793<br />

41 CCPD training treatments 62,283 51,413 75,618 122,171 76,558 63,146<br />

42 Patients transplanted at this facility 13,316 13,479 14,300 14,608 15,077 15,712<br />

43 Patients transplanted & enrolled in Medicare 10,241 9,900 10,260 10,669 12,969 13,427<br />

44 Patients transplanted & Medicare app. pending 1,115 1,183 1,540 1,777 1,188 1,272<br />

45 Patients transplanted & non-Medicare -US residents 1,796 2,262 2,381 2,042 888 994<br />

46 Patients transplanted & non-Medicare-other 164 134 119 120 32 19<br />

47 Living-related donor transplant performed 3,453 3,583 4,052 4,236 4,182 4,262<br />

48 Living-unrelated donor transplant performed 1,067 1,061 1,375 1,568 1,711 1,982<br />

49 Cadaveric donor transplant performed 8,752 8,839 8,884 8,824 9,213 9,494<br />

50 Total transplant performed 13,272 13,483 14,311 14,628 15,106 15,738<br />

51 Dialysis patients awaiting transplant 34,845 36,803 35,620 40,474 41,921 45,974<br />

52 Non-dialysis patients awaiting transplant 3,459 3,947 5,549 6,782 5,775 6,580<br />

53 Cadaver harvest & transplant at this facility 5,128 226 . . * *<br />

54 Cadaver harvest sent to other US facility . . . . * *<br />

55 Cadaver harvest sent outside US . . . . * *<br />

56 Cadaver harvest & nonviable . . . . * *<br />

57 Total cadaver harvest at this facility 5,128 206 . . * *<br />

663<br />

*<strong>Data</strong> was not collected in 2002 & 2003.<br />

"." Zero values in this cell.


JPROVIDER CHARACTERISTICS<br />

Reference section J<br />

664


Reference<br />

K<br />

Section<br />

Medicare costs<br />

for ESRD


K<br />

MEDICARE COSTS FOR ESRD<br />

Reference section K<br />

666<br />

K.1 . 667<br />

Total Medicare costs ($) of reported ESRD per calendar year: by patient<br />

characteristics<br />

all ESRD patients with at least one Medicare claim<br />

K.2 . 669<br />

Total Medicare costs ($) of reported ESRD patients: by claim type<br />

period prevalent ESRD patients<br />

K.3 . 671<br />

Medicare costs ($) for ESRD patients: by payor status & claim type<br />

period prevalent ESRD patients, as-treated model<br />

K.4 . 673<br />

Per person per year costs: all ESRD patients, with unknowns dropped (model 1)<br />

period prevalent ESRD patients, as-treated model, primary payor only<br />

K.5 . 674<br />

Per person per year costs; all dialysis patients, with unknowns dropped (model 1)<br />

period prevalent ESRD patients, as-treated model, primary payor only<br />

K.6 . 675<br />

Per person per year costs; hemodialysis patients, with unknowns dropped (model<br />

1)<br />

period prevalent ESRD patients, as-treated model, primary payor only<br />

K.7 . 676<br />

Per person per year costs; CAPD/CCPD patients, with unknowns dropped (model<br />

1)<br />

period prevalent ESRD patients, as-treated model, primary payor only<br />

K.8 . 677<br />

Per person per year costs; all transplant patients, with unknowns dropped (model<br />

1)<br />

period prevalent ESRD patients, as-treated model, primary payor only<br />

K.9 . 678<br />

Per person per year costs: dialysis patients (model 2)<br />

period prevalent ESRD patients, primary payor only<br />

K.10 . 679<br />

Per person per year costs: transplant event within the year (model 2)<br />

period prevalent ESRD patients, primary payor only<br />

K.11 . 680<br />

Per person per year costs: functioning graft patients (model 2)<br />

period prevalent ESRD patients, primary payor only<br />

K.12 . 681<br />

Per person per year costs: graft failure within the year (model 2)<br />

period prevalent ESRD patients, primary payor only<br />

K.13 . 682<br />

Part B Medicare costs ($) per patient YAR: by physician/supplier specialty<br />

period prevalent patients, as-treated model; Medicare primary payor only


Table K.1 K.1<br />

Total Medicare costs ($) of of reported ESRD per calendar year: by patient characteristics<br />

all<br />

all<br />

ESRD<br />

ESRD<br />

patients<br />

patients<br />

with<br />

with<br />

at<br />

at<br />

least<br />

least<br />

one<br />

one<br />

Medicare<br />

Medicare<br />

claim<br />

claim<br />

MEDICARE COSTS FOR ESRD<br />

2005 Annual <strong>Data</strong> ReportK<br />

1991 1992 1993 1994 1995 1996 1997<br />

0-4 8,033,630 9,644,783 9,685,284 10,131,550 11,032,215 11,107,298 10,778,155<br />

5-9 10,404,252 8,173,896 9,188,963 11,214,556 9,360,857 10,741,388 10,982,348<br />

10-14 16,963,733 17,420,685 17,719,445 19,190,922 19,685,594 19,172,404 20,313,554<br />

15-19 40,945,037 40,428,177 41,392,282 46,430,784 46,987,449 48,198,046 46,664,000<br />

20-29 268,761,726 282,591,539 305,259,190 323,987,862 335,598,056 353,112,445 353,819,056<br />

30-39 554,134,631 620,037,610 680,186,521 759,056,053 815,068,863 864,087,855 885,722,142<br />

40-49 708,860,827 816,456,524 912,955,630 1,039,442,056 1,180,151,636 1,343,464,087 1,429,269,380<br />

50-59 877,062,110 1,005,491,602 1,146,588,142 1,319,942,112 1,475,822,862 1,682,292,599 1,825,324,867<br />

60-64 615,535,870 691,658,546 756,540,557 843,627,440 936,407,203 1,056,694,349 1,128,211,156<br />

65-69 832,514,800 960,634,146 1,072,692,842 1,228,317,263 1,357,641,191 1,509,465,057 1,593,205,695<br />

70-79 1,192,853,058 1,440,435,115 1,620,565,866 1,911,282,127 2,203,819,484 2,531,283,984 2,763,877,259<br />

80+ 331,399,251 399,671,139 483,090,702 588,853,500 692,440,134 825,659,262 934,801,568<br />

Unknown 1,048,409 1,113,422 367,498 530,495 814,615 311,214 264,581<br />

0-19 76,346,652 75,667,541 77,985,974 86,967,813 87,066,115 89,219,136 88,738,056<br />

20-44 1,173,533,684 1,301,761,215 1,426,205,490 1,575,920,408 1,700,691,853 1,832,048,861 1,887,213,335<br />

45-64 1,850,821,479 2,114,474,606 2,375,324,550 2,710,135,115 3,042,356,767 3,467,602,474 3,735,133,266<br />

65-74 1,535,008,355 1,807,356,860 2,032,385,820 2,358,855,170 2,652,342,982 2,973,971,273 3,164,272,017<br />

75+ 821,758,753 993,383,541 1,143,963,591 1,369,597,721 1,601,557,826 1,892,437,030 2,127,612,505<br />

Unknown 1,048,409 1,113,422 367,498 530,495 814,615 311,214 264,581<br />

667<br />

Male 2,755,832,631 3,182,985,750 3,564,409,605 4,097,194,317 4,567,708,047 5,159,079,109 5,550,426,039<br />

Female 2,702,608,212 3,110,547,512 3,491,534,131 4,004,577,772 4,517,112,246 5,096,460,803 5,452,775,519<br />

Unknown 76,489 223,922 289,187 234,633 9,865 50,076 32,202<br />

White 3,398,019,285 3,873,027,806 4,287,301,051 4,854,258,525 5,407,975,715 6,043,852,283 6,457,586,463<br />

Black 1,896,514,419 2,224,123,602 2,526,575,941 2,954,179,212 3,323,269,676 3,771,098,948 4,047,020,289<br />

Native American 57,995,562 68,171,998 83,409,850 98,842,547 111,856,183 131,093,262 139,806,972<br />

Asian 103,098,473 126,525,980 156,972,536 189,900,217 222,666,058 265,387,743 294,255,960<br />

Other/unknown 2,889,593 1,907,799 1,973,545 4,826,221 19,062,525 44,157,753 64,564,077<br />

†Hispanic 959,381,774 1,099,270,166<br />

†Non-Hispanic 6,480,670,356 7,782,072,728<br />

Unknown 2,815,537,858 2,121,890,866<br />

Diabetes 1,748,688,256 2,112,575,429 2,475,503,729 2,926,327,959 3,414,922,930 4,038,340,419 4,473,963,006<br />

Hypertension 1,613,142,034 1,893,544,099 2,138,377,348 2,458,040,559 2,696,895,141 2,929,726,474 3,077,002,916<br />

Glomerulonephritis 881,984,964 965,584,442 1,042,926,209 1,164,136,394 1,276,989,746 1,388,213,869 1,447,263,311<br />

Other cause 917,455,003 1,013,933,049 1,080,950,752 1,200,209,535 1,334,361,876 1,505,962,421 1,594,494,084<br />

Unknown 297,247,075 308,120,167 318,474,885 353,292,276 361,660,464 393,346,805 410,510,444<br />

All 5,458,517,332 6,293,757,185 7,056,232,923 8,102,006,722 9,084,830,158 10,255,589,988 11,003,233,760<br />

Includes all Medicare costs, beginning with the date of first ESRD service.<br />

Medicare hospital pass-through costs for indirect medical education, organ acquisition, etc. are included.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.


K<br />

MEDICARE COSTS FOR ESRD<br />

Reference section K<br />

Table K.1 K.1 (continued)<br />

Total Medicare costs ($) of reported ESRD per calendar year: by patient characteristics<br />

all<br />

all<br />

ESRD<br />

ESRD<br />

patients<br />

patients<br />

with<br />

with<br />

at<br />

at<br />

least<br />

least<br />

one<br />

one<br />

Medicare<br />

Medicare<br />

claim<br />

claim<br />

668<br />

1998 1999 2000 2001 2002 2003<br />

0-4 8,742,724 7,829,121 7,687,179 7,941,125 9,950,262 10,920,349<br />

5-9 11,329,635 9,373,601 9,533,863 9,803,473 10,328,767 10,252,858<br />

10-14 18,833,801 17,052,693 16,674,110 18,364,175 21,124,657 24,471,609<br />

15-19 47,662,848 45,102,720 46,920,949 49,240,940 53,101,644 53,468,892<br />

20-29 345,740,666 351,207,482 354,421,227 377,195,417 394,136,676 399,829,255<br />

30-39 851,480,122 865,112,729 897,654,737 973,748,303 1,039,513,099 1,057,944,873<br />

40-49 1,423,674,163 1,483,094,334 1,602,389,506 1,781,543,856 1,942,712,565 2,034,785,280<br />

50-59 1,861,480,110 1,982,482,544 2,197,620,282 2,502,595,516 2,825,719,923 3,029,788,122<br />

60-64 1,140,307,512 1,187,906,430 1,287,522,303 1,457,561,988 1,627,375,685 1,764,947,689<br />

65-69 1,601,441,688 1,618,106,071 1,718,341,046 1,925,924,735 2,170,317,942 2,282,766,884<br />

70-79 2,884,527,759 3,013,032,527 3,245,882,676 3,648,961,673 3,996,158,152 4,146,760,318<br />

80+ 1,004,497,355 1,089,715,680 1,219,151,465 1,447,402,286 1,691,801,875 1,846,892,284<br />

Unknown 325,344 336,895 602,710 228,415 703,908 571,602<br />

0-19 86,569,009 79,358,136 80,816,101 85,349,713 94,505,331 99,113,708<br />

20-44 1,846,536,782 1,885,277,757 1,964,165,383 2,137,309,335 2,289,898,978 2,333,728,898<br />

45-64 3,776,145,790 3,984,525,762 4,375,442,672 4,955,335,745 5,539,558,969 5,953,566,320<br />

65-74 3,214,472,842 3,273,135,737 3,483,930,351 3,897,660,457 4,308,977,518 4,489,817,349<br />

75+ 2,275,993,960 2,447,718,541 2,699,444,837 3,124,628,237 3,549,300,451 3,786,602,137<br />

Unknown 325,344 336,895 602,710 228,415 703,908 571,602<br />

Male 5,674,675,040 5,925,213,433 6,426,805,665 7,265,452,989 8,126,906,143 8,637,932,791<br />

Female 5,525,311,388 5,745,108,978 6,177,544,382 6,935,012,942 7,655,974,714 8,025,310,684<br />

Unknown 57,299 30,417 52,006 45,973 64,297 156,538<br />

White 6,517,813,617 6,701,958,936 7,249,534,643 8,194,942,928 9,096,250,589 9,581,099,199<br />

Black 4,150,114,599 4,387,803,790 4,714,223,419 5,287,354,437 5,850,585,340 6,201,087,326<br />

Native American 144,822,920 162,930,494 171,208,109 187,582,497 213,333,444 221,632,412<br />

Asian 310,224,309 333,567,701 373,271,653 425,272,230 497,579,865 521,418,411<br />

Other/unknown 77,068,282 84,091,907 96,164,229 105,359,810 125,195,916 138,162,666<br />

†Hispanic 1,168,817,965 1,254,665,968 1,387,748,776 1,624,094,339 1,878,033,203 2,049,862,554<br />

†Non-Hispanic 8,521,177,874 9,330,564,223 10,440,635,317 12,008,844,534 13,457,536,379 14,291,399,669<br />

Unknown 1,510,047,889 1,085,122,637 776,017,960 567,573,031 447,375,573 322,137,790<br />

Diabetes 4,651,129,356 4,888,304,763 5,376,738,971 6,168,769,252 6,918,523,463 7,412,248,690<br />

Hypertension 3,098,082,566 3,224,380,613 3,433,645,471 3,857,186,473 4,278,563,128 4,528,550,006<br />

Glomerulonephritis 1,434,929,291 1,464,650,664 1,531,621,520 1,660,116,516 1,792,624,295 1,842,840,958<br />

Other cause 1,604,555,621 1,667,033,732 1,799,950,224 2,011,859,720 2,226,808,824 2,315,372,607<br />

Unknown 411,346,895 425,983,057 462,445,867 502,579,942 566,425,445 564,387,753<br />

All 11,200,043,727 11,670,352,828 12,604,402,053 14,200,511,904 15,782,945,154 16,663,400,013<br />

Includes all Medicare costs, beginning with the date of first ESRD service.<br />

Medicare hospital pass-through costs for indirect medical education, organ acquisition, etc. are included.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.


MEDICARE COSTS FOR ESRD<br />

2005 Annual <strong>Data</strong> ReportK<br />

Table K.2 K.2<br />

Total Medicare costs ($) of reported ESRD patients: by by claim type<br />

period prevalent ESRD patients, all ESRD patients with at least one Medicare claim<br />

period prevalent ESRD patients, all ESRD patients with at least one Medicare claim<br />

1991 1992 1993 1994 1995 1996 1997<br />

Patients 196,898 214,869 230,411 254,215 267,967 284,788 302,340<br />

Patient years at risk 163,270 178,032 192,692 211,753 224,521 238,525 252,753<br />

Total Medicare 5,458,517,332 6,293,757,185 7,056,232,923 8,102,006,722 9,084,830,158 10,255,589,988 11,003,233,760<br />

Total inpatient ($) 2,246,679,753 2,664,135,417 2,897,820,522 3,269,734,886 3,601,353,482 4,049,958,824 4,357,588,782<br />

Medical DRG 698,326,298 888,013,412 1,006,204,517 1,162,503,836 1,339,327,353 1,570,322,312 1,766,177,301<br />

Surgical DRG 1,209,139,229 1,441,105,395 1,548,822,518 1,747,047,373 1,909,169,681 2,118,779,037 2,214,653,219<br />

Other DRG 23,626,320 22,115,802 21,806,409 24,273,802 23,761,206 27,148,084 33,631,915<br />

Transplant DRG 124,795,152 139,323,266 158,566,113 172,457,632 188,959,376 196,438,742 190,517,937<br />

Non-transplant pass-throughs 179,664,867 163,588,790 152,134,314 153,504,400 131,228,125 129,659,908 144,660,891<br />

Transplant pass-throughs 11,127,886 9,988,752 10,286,650 9,947,843 8,907,741 7,610,741 7,947,521<br />

Total outpatient ($) 1,895,329,216 2,159,429,740 2,529,442,321 2,846,733,992 3,196,926,976 3,648,820,314 3,878,013,585<br />

Outpatient hemodialysis 1,226,120,801 1,317,594,597 1,485,091,770 1,640,698,402 1,769,250,995 1,961,792,900 2,098,108,393<br />

Outpatient peritoneal dialysis 156,825,285 172,225,708 199,506,160 225,273,473 243,211,060 241,824,537 222,684,970<br />

Outpatient other dialysis 454,170 247,691 272,979 288,834 250,625 371,467 399,800<br />

Outpatient EPO 245,809,935 338,964,231 422,262,824 469,808,327 567,512,877 701,813,547 735,478,803<br />

Outpatient vitamin D hormones 138 5,295,447 34,202,577 72,233,365 92,309,164 117,958,373 133,423,862<br />

Outpatient iron 0 81,420 13,424,494 34,664,019 49,471,181 85,256,370 121,713,654<br />

Outpatient other injectables 22,098 289,781 5,209,060 13,210,852 18,640,602 25,292,383 32,290,420<br />

Radiology 30,242,997 37,072,870 41,175,066 47,532,625 56,063,503 69,152,263 74,072,130<br />

Pharmacy 56,591,816 71,674,582 75,838,707 51,155,236 62,743,167 61,626,643 64,456,353<br />

Ambulance 2,373,465 2,891,041 3,314,941 4,239,650 4,914,290 5,557,262 6,539,183<br />

Laboratory/pathology 67,950,872 80,635,406 87,900,752 94,245,618 101,405,063 107,754,466 109,788,945<br />

Outpatient other 108,937,639 132,456,967 161,242,993 193,383,591 231,154,449 270,420,103 279,057,073<br />

669<br />

Skilled nursing facility 32,527,037 51,280,520 72,991,474 115,180,914 162,688,961 228,093,578 285,416,129<br />

Home health agency 63,483,830 101,290,542 149,570,940 217,007,766 288,875,148 348,884,078 382,277,803<br />

Hospice 2,075,663 3,879,094 5,474,301 7,777,479 8,544,483 10,110,897 12,184,741<br />

Total physician/supplier ($) 1,218,421,833 1,313,741,872 1,400,933,365 1,645,571,685 1,826,441,107 1,969,722,298 2,087,752,720<br />

Transplant surgery 18,446,022 15,128,168 15,913,965 18,373,072 20,079,545 19,146,930 18,995,220<br />

Inpatient surgery 106,547,334 99,903,754 101,303,906 120,892,807 135,295,005 133,402,693 136,665,508<br />

Outpatient surgery 42,643,405 44,065,513 50,583,978 64,183,789 79,880,743 84,811,555 89,641,065<br />

~E&M nephrology inpatient 53,751 45,884,100 53,288,058 62,845,107 69,384,283 71,406,697 76,914,233<br />

~E&M nephrology outpatient 6,114,572 6,537,493 7,646,925 9,321,028 11,039,781 11,038,095 11,632,879<br />

~E&M non-nephrology inpatient 463,797 92,152,579 103,381,474 130,689,498 155,034,057 169,224,804 193,000,138<br />

~E&M non-nephrology outpatient 16,080,478 31,892,629 38,507,667 51,006,338 63,988,664 69,916,483 80,989,906<br />

Dialysis capitation 135,284,272 158,168,175 179,080,914 215,123,268 251,095,346 328,353,757 288,780,153<br />

Inpatient dialysis 107,695,022 105,477,884 104,437,182 112,718,383 118,253,413 110,314,288 104,370,941<br />

Home dialysis 111,899,584 126,873,735 117,106,079 127,995,700 123,894,420 132,437,654 135,804,383<br />

Vascular access 92,415,361 98,518,056 107,875,730 127,462,988 146,051,643 145,763,103 156,744,281<br />

Peritoneal access 3,369,011 3,017,540 3,063,647 3,414,226 5,278,600 5,516,279 4,958,064<br />

Physician/supplier EPO 1,072,986 1,364,253 1,623,151 1,291,888 1,330,730 1,537,090 1,572,452<br />

Physician/supplier iron 10,678 5,829 32,097 67,500 87,539 85,709 97,223<br />

Immunosuppressive drugs 2,521,560 1,999,166 1,703,275 12,876,963 23,382,266 31,719,410 41,931,093<br />

Durable medical equipment 69,703,420 88,648,935 89,918,082 88,029,345 68,907,080 73,438,373 86,504,218<br />

Physician/supplier radiology 40,656,436 37,049,808 37,779,220 43,981,925 48,829,670 50,418,794 50,955,067<br />

Physician/supplier lab/pathology 105,491,691 126,149,451 148,369,196 170,351,824 193,439,097 205,749,935 211,328,434<br />

Physician/supplier ambulance 43,173,997 54,618,532 60,514,964 77,604,478 180,665,759 187,091,960 197,405,188<br />

Other physician/supplier 314,778,455 176,286,270 178,803,858 207,341,559 130,523,465 138,348,687 199,462,276<br />

~E & M refers to evaluation & management.<br />

Includes all Medicare costs, beginning with the date of first ESRD service.<br />

Medicare hospital pass-through costs for indirect medical education, organ acquisition, etc. are included.


K<br />

MEDICARE COSTS FOR ESRD<br />

Reference section K<br />

Table K.2 K.2 (continued)<br />

Total Medicare costs ($) of reported ESRD patients: by by claim type<br />

period prevalent ESRD patients, all ESRD patients with at least one Medicare claim<br />

period prevalent ESRD patients, all ESRD patients with at least one Medicare claim<br />

1998 1999 2000 2001 2002 2003<br />

Patients 315,771 329,589 346,148 364,445 388,667 395,371<br />

Patient years at risk 263,738 275,457 289,978 305,115 324,715 331,972<br />

Total Medicare 11,200,043,727 11,670,352,828 12,604,402,053 14,200,511,904 15,782,945,154 16,663,400,013<br />

670<br />

Total inpatient ($) 4,428,755,540 4,711,968,805 4,959,859,104 5,527,499,314 6,100,920,415 6,147,474,107<br />

Medical DRG 1,908,531,510 2,104,898,567 2,226,185,483 2,507,750,909 2,723,489,302 2,825,763,063<br />

Surgical DRG 2,159,369,713 2,242,867,126 2,349,173,638 2,567,656,294 2,765,732,943 2,675,771,284<br />

Other DRG 41,332,729 46,720,323 46,566,029 89,278,457 245,773,771 286,518,275<br />

Transplant DRG 178,444,174 177,484,899 184,430,821 199,057,170 195,857,722 195,263,421<br />

Non-transplant pass-throughs 134,496,160 134,223,554 147,968,919 157,837,134 164,591,228 157,932,957<br />

Transplant pass-throughs 6,581,254 5,774,336 5,534,215 5,919,350 5,475,449 6,225,106<br />

Total outpatient ($) 4,050,064,581 4,407,864,980 4,698,473,026 5,288,968,033 5,887,771,025 6,358,802,239<br />

Outpatient hemodialysis 2,166,673,228 2,310,263,752 2,461,511,662 2,659,310,394 2,925,104,213 3,038,749,410<br />

Outpatient peritoneal dialysis 176,747,571 158,923,669 149,748,277 151,408,218 177,959,507 227,188,097<br />

Outpatient other dialysis 440,795 706,922 688,089 630,775 691,532 1,392,820<br />

Outpatient EPO 843,547,988 1,006,329,155 1,082,911,194 1,178,325,134 1,398,823,515 1,555,190,080<br />

Outpatient vitamin D hormones 143,649,641 146,667,738 253,810,610 368,565,475 373,277,139 379,257,724<br />

Outpatient iron 133,383,836 142,480,279 149,721,298 214,238,303 232,679,956 250,428,164<br />

Outpatient other injectables 48,018,334 61,469,241 78,597,372 83,374,224 74,629,839 56,488,404<br />

Radiology 75,688,060 79,625,425 72,043,243 87,098,578 103,686,303 142,865,692<br />

Pharmacy 75,998,134 110,139,721 63,780,390 89,427,286 67,920,001 56,683,976<br />

Ambulance 6,602,116 6,551,460 7,417,256 8,801,182 12,514,852 15,797,131<br />

Laboratory/pathology 103,234,142 101,763,345 104,659,469 114,098,455 115,562,639 126,424,285<br />

Outpatient other 276,080,734 282,944,274 273,584,165 333,690,010 404,921,530 508,336,458<br />

Skilled nursing facility 311,574,599 262,988,294 295,517,964 376,556,028 436,468,776 450,891,930<br />

Home health agency 265,870,051 81,839,375 233,011,604 257,364,011 290,295,195 290,797,909<br />

Hospice 13,638,720 16,698,144 19,767,709 26,507,461 34,791,908 43,211,041<br />

Total physician/supplier ($) 2,130,140,237 2,188,993,229 2,397,772,645 2,723,617,056 3,032,697,837 3,372,222,786<br />

Transplant surgery 17,791,194 16,836,821 17,027,468 18,045,079 18,449,789 19,437,322<br />

Inpatient surgery 130,129,394 122,785,965 135,506,274 145,370,760 148,498,405 158,891,549<br />

Outpatient surgery 89,526,340 88,354,777 100,250,727 111,983,138 121,008,126 135,341,608<br />

~E&M nephrology inpatient 84,452,705 88,417,974 92,655,258 98,884,904 106,689,254 121,075,208<br />

~E&M nephrology outpatient 11,723,356 12,443,393 13,908,713 14,706,759 17,314,885 19,408,274<br />

~E&M non-nephrology inpatient 214,271,012 234,768,378 259,130,889 304,036,171 327,391,205 371,358,195<br />

~E&M non-nephrology outpatient 88,538,001 98,336,057 117,527,048 136,996,956 152,207,795 169,217,333<br />

Dialysis capitation 302,666,249 316,136,662 362,152,427 402,382,945 429,286,434 447,665,703<br />

Inpatient dialysis 106,657,530 103,377,224 96,436,519 104,989,377 100,765,002 99,536,173<br />

Home dialysis 135,810,349 130,227,634 135,986,762 137,818,663 108,143,909 56,739,450<br />

Vascular access 162,743,044 173,720,202 177,194,198 191,939,901 201,365,749 226,315,000<br />

Peritoneal access 4,250,885 3,873,634 3,775,899 3,876,811 3,609,484 3,767,485<br />

Physician/supplier EPO 1,616,545 1,839,456 2,918,648 4,197,859 3,867,431 11,455,997<br />

Physician/supplier iron 57,719 46,667 48,232 70,149 87,675 108,579<br />

Immunosuppressive drugs 47,000,118 47,819,750 75,240,729 113,062,510 153,633,486 198,964,299<br />

Durable medical equipment 89,031,027 93,616,013 83,085,257 91,737,763 114,912,422 133,551,247<br />

Physician/supplier radiology 59,645,989 63,040,628 72,032,101 86,913,327 97,409,493 118,338,480<br />

Physician/supplier lab/pathology 176,005,504 171,949,817 183,765,375 192,415,007 257,895,802 297,155,696<br />

Physician/supplier ambulance 196,695,539 181,587,912 210,602,744 261,064,715 306,319,096 368,425,439<br />

Other physician/supplier 211,527,737 239,814,262 258,527,378 303,124,262 363,842,395 415,469,746<br />

~E & M refers to evaluation & management.<br />

Includes all Medicare costs, beginning with the date of first ESRD service.<br />

Medicare hospital pass-through costs for indirect medical education, organ acquisition, etc. are included.


MEDICARE COSTS FOR ESRD<br />

2005 Annual <strong>Data</strong> ReportK<br />

Table K.3 K.3<br />

Medicare costs ($) for ESRD patients: by payor status & claim type<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

ESRD<br />

ESRD<br />

patients,<br />

patients,<br />

as-treated<br />

as-treated<br />

model<br />

model<br />

1994-1998<br />

All Medicare Primary Payor Medicare Secondary Payor<br />

Patient modality periods 701,482 588,108 113,374<br />

Patient years at risk 1,187,928 1,047,136 140,792<br />

Total Medicare 48,371,771,586 46,319,802,200 2,051,969,385<br />

Total inpatient ($) 19,137,643,826 18,243,312,479 894,331,347<br />

Medical DRG 7,515,804,512 7,189,915,034 325,889,477<br />

Surgical DRG 9,866,620,856 9,439,146,377 427,474,479<br />

Other DRG 145,293,537 138,485,191 6,808,347<br />

Transplant DRG 896,221,001 797,564,198 98,656,803<br />

Non-transplant pass-throughs 674,047,122 642,761,681 31,285,441<br />

Transplant pass-throughs 39,656,798 35,439,998 4,216,800<br />

671<br />

Total outpatient ($) 17,212,995,070 16,587,831,169 625,163,900<br />

Outpatient hemodialysis 9,417,513,501 9,105,319,203 312,194,299<br />

Outpatient peritoneal dialysis 1,083,535,470 1,030,846,792 52,688,678<br />

Outpatient other dialysis 1,712,432 1,647,115 65,318<br />

Outpatient EPO 3,244,137,534 3,132,275,195 111,862,339<br />

Outpatient vitamin D hormones 546,366,974 528,111,134 18,255,840<br />

Outpatient iron 415,196,143 401,259,654 13,936,489<br />

Outpatient other injectables 133,657,546 128,739,472 4,918,074<br />

Radiology 314,584,251 300,478,268 14,105,983<br />

Pharmacy 308,640,937 293,834,209 14,806,728<br />

Ambulance 27,128,778 26,024,660 1,104,119<br />

Laboratory/pathology 502,877,571 474,595,713 28,281,858<br />

Outpatient other 1,217,643,931 1,164,699,755 52,944,177<br />

Skilled nursing facility 1,068,083,428 1,030,048,510 38,034,919<br />

Home health agency 1,460,495,158 1,404,448,005 56,047,153<br />

Hospice 44,578,265 42,461,974 2,116,290<br />

Total physician/supplier ($) 9,447,975,839 9,011,700,063 436,275,776<br />

Transplant surgery 92,469,023 80,239,472 12,229,551<br />

Inpatient surgery 584,475,020 555,031,022 29,443,997<br />

Outpatient surgery 351,259,842 331,359,879 19,899,963<br />

~E&M nephrology inpatient 356,872,148 340,941,586 15,930,562<br />

~E&M nephrology outpatient 52,719,839 48,176,974 4,542,865<br />

~E&M non-nephrology inpatient 841,407,269 804,251,910 37,155,360<br />

~E&M non-nephrology outpatient 344,904,787 325,657,331 19,247,456<br />

Dialysis capitation 1,358,577,137 1,304,623,123 53,954,014<br />

Inpatient dialysis 540,620,900 519,199,477 21,421,423<br />

Home dialysis 643,631,354 609,221,093 34,410,262<br />

Vascular access 836,974,548 803,561,486 33,413,062<br />

Peritoneal access 22,898,426 21,428,810 1,469,616<br />

Physician/supplier EPO 6,607,260 6,140,009 467,251<br />

Physician/supplier iron 379,247 357,710 21,537<br />

Immunosuppressive drugs 154,216,369 138,470,352 15,746,017<br />

Durable medical equipment 396,585,989 379,340,420 17,245,569<br />

Physician/supplier radiology 239,710,723 226,995,289 12,715,434<br />

Physician/supplier lab/pathology 935,761,337 897,312,317 38,449,020<br />

Physician/supplier ambulance 822,003,627 796,089,039 25,914,588<br />

Other physician/supplier 865,900,994 823,302,764 42,598,230<br />

~E & M refers to evaluation & management.<br />

Patients of unknown age are excluded.<br />

The payment values include pro-rated Medicare costs, starting on the date of Medicare entitlement,<br />

as determined by the USRDS payor sequence.<br />

Patients are at risk until death, loss of Medicare entitlement, or the end of the period (12/31/03).<br />

Dialysis modality change or transplant results in a new modality period.


K<br />

MEDICARE COSTS FOR ESRD<br />

Reference section K<br />

Table K.3 K.3 (continued)<br />

Medicare costs ($) for ESRD patients: by payor status & claim type<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

ESRD<br />

ESRD<br />

patients,<br />

patients,<br />

as-treated<br />

as-treated<br />

model<br />

model<br />

1999-2003<br />

All Medicare Primary Payor Medicare Secondary Payor<br />

Patient modality periods 840,272 711,177 129,095<br />

Patient years at risk 1,528,034 1,326,783 201,251<br />

Total Medicare 69,494,175,419 66,616,291,721 2,877,883,698<br />

672<br />

Total inpatient ($) 26,787,922,245 25,592,572,863 1,195,349,382<br />

Medical DRG 12,074,499,057 11,549,205,121 525,293,935<br />

Surgical DRG 12,311,951,432 11,774,706,912 537,244,520<br />

Other DRG 696,203,200 663,865,470 32,337,730<br />

Transplant DRG 932,740,983 868,408,886 64,332,097<br />

Non-transplant pass-throughs 744,294,652 710,145,962 34,148,690<br />

Transplant pass-throughs 28,232,922 26,240,513 1,992,409<br />

Total outpatient ($) 26,241,104,510 25,295,465,436 945,639,074<br />

Outpatient hemodialysis 13,337,669,998 12,881,855,003 455,814,995<br />

Outpatient peritoneal dialysis 855,938,092 822,229,740 33,708,351<br />

Outpatient other dialysis 4,151,312 3,997,969 153,343<br />

Outpatient EPO 6,069,707,715 5,852,604,907 217,102,807<br />

Outpatient vitamin D hormones 1,463,050,327 1,411,814,756 51,235,572<br />

Outpatient iron 967,249,951 934,132,284 33,117,667<br />

Outpatient other injectables 340,720,283 326,730,642 13,989,642<br />

Radiology 455,331,272 436,002,374 19,328,898<br />

Pharmacy 308,945,202 295,404,527 13,540,675<br />

Ambulance 50,280,111 48,095,550 2,184,562<br />

Laboratory/pathology 520,558,320 494,710,010 25,848,310<br />

Outpatient other 1,867,501,926 1,787,887,673 79,614,253<br />

Skilled nursing facility 1,776,207,834 1,702,286,507 73,921,327<br />

Home health agency 1,125,068,121 1,080,956,167 44,111,954<br />

Hospice 119,007,557 112,828,148 6,179,409<br />

Total physician/supplier ($) 13,444,865,152 12,832,182,600 612,682,552<br />

Transplant surgery 88,335,579 80,485,144 7,850,435<br />

Inpatient surgery 638,683,075 606,662,766 32,020,309<br />

Outpatient surgery 490,050,558 463,037,932 27,012,626<br />

~E&M nephrology inpatient 498,135,973 475,378,798 22,757,175<br />

~E&M nephrology outpatient 75,136,437 69,118,434 6,018,003<br />

~E&M non-nephrology inpatient 1,465,363,471 1,399,006,453 66,357,017<br />

~E&M non-nephrology outpatient 656,313,032 620,117,877 36,195,155<br />

Dialysis capitation 1,926,874,012 1,850,051,656 76,822,356<br />

Inpatient dialysis 496,148,425 475,062,128 21,086,298<br />

Home dialysis 560,120,665 536,688,453 23,432,212<br />

Vascular access 1,082,118,065 1,037,100,876 45,017,189<br />

Peritoneal access 18,522,225 17,405,819 1,116,406<br />

Physician/supplier EPO 22,494,432 21,157,201 1,337,231<br />

Physician/supplier iron 341,869 324,838 17,032<br />

Immunosuppressive drugs 578,315,344 540,585,451 37,729,893<br />

Durable medical equipment 505,200,592 483,150,727 22,049,865<br />

Physician/supplier radiology 412,980,242 391,731,775 21,248,466<br />

Physician/supplier lab/pathology 1,082,019,074 1,040,200,202 41,818,872<br />

Physician/supplier ambulance 1,305,232,242 1,257,269,912 47,962,330<br />

Other physician/supplier 1,542,479,840 1,467,646,158 74,833,681<br />

~E & M refers to evaluation & management.<br />

Patients of unknown age are excluded.<br />

The payment values include pro-rated Medicare costs, starting on the date of Medicare entitlement,<br />

as determined by the USRDS payor sequence.<br />

Patients are at risk until death, loss of Medicare entitlement, or the end of the period (12/31/03).<br />

Dialysis modality change or transplant results in a new modality period.


MEDICARE COSTS FOR ESRD<br />

2005 Annual <strong>Data</strong> ReportK<br />

Table K.4 K.4<br />

Per person per year costs: all ESRD patients, with unknowns dropped (model 1) 1)<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

ESRD<br />

ESRD<br />

patients,<br />

patients,<br />

as-treated<br />

as-treated<br />

model,<br />

model,<br />

primary<br />

primary<br />

payor<br />

payor<br />

only<br />

only<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 33,696 40,453 39,043 36,089 39,169 43,267 39,742 39,110 39,646 37,322 39,969 46,526 47,229<br />

5-9 26,216 20,102 22,110 26,453 23,363 25,736 26,693 26,003 21,654 22,747 26,259 27,243 30,764<br />

10-14 23,707 24,668 24,202 26,301 26,558 25,121 25,758 24,543 21,737 21,784 23,991 27,988 31,803<br />

15-19 25,897 25,619 27,279 29,128 29,551 28,314 27,008 29,389 27,437 28,999 31,911 34,803 36,255<br />

20-29 27,848 28,390 29,667 30,729 31,970 33,059 32,702 32,602 33,478 33,611 36,062 38,036 39,533<br />

30-39 28,393 29,871 30,791 32,678 33,866 34,968 35,023 34,262 35,012 35,924 38,403 40,187 40,987<br />

40-49 30,333 31,702 32,553 34,077 36,183 38,204 38,049 37,550 38,216 39,401 42,200 44,283 45,043<br />

50-59 33,362 35,434 36,917 39,237 40,781 43,400 43,725 42,909 43,098 44,424 47,251 49,340 50,169<br />

60-64 36,814 38,938 39,936 42,124 44,447 46,884 47,195 46,974 46,877 48,008 51,327 53,879 55,111<br />

65-69 42,776 45,294 46,471 48,595 50,441 53,382 54,203 53,229 52,487 53,716 56,695 59,705 60,782<br />

70-79 45,353 48,460 49,350 51,449 53,963 57,332 58,464 57,249 56,856 58,638 62,344 64,757 65,597<br />

80+ 46,259 48,694 51,223 53,003 55,597 59,079 60,898 59,529 58,849 60,544 64,679 67,746 69,345<br />

0-19 26,016 25,769 26,754 28,662 28,822 28,392 27,656 28,347 25,888 26,801 29,598 32,900 35,284<br />

20-44 28,615 29,820 30,791 32,377 33,985 35,304 35,259 34,727 35,430 36,117 38,809 40,853 41,694<br />

45-64 33,952 35,884 37,057 39,135 40,912 43,375 43,553 42,997 43,253 44,605 47,503 49,674 50,656<br />

65-74 43,733 46,474 47,559 49,691 51,769 54,829 55,843 54,705 54,089 55,679 58,906 61,405 62,325<br />

75+ 46,093 49,052 50,575 52,529 55,266 58,836 60,174 58,981 58,521 60,102 64,145 67,137 68,386<br />

673<br />

Male 34,165 36,246 37,362 39,396 41,189 43,594 44,184 43,850 44,024 45,353 48,498 50,940 52,215<br />

Female 38,412 40,708 42,078 44,305 46,836 49,624 50,265 49,527 49,588 51,029 54,539 57,239 58,098<br />

White 35,358 37,392 38,493 40,378 42,620 44,989 45,745 45,252 44,980 46,331 49,518 52,007 53,117<br />

Black 38,096 40,657 42,013 44,573 46,478 49,367 49,700 49,054 49,712 51,149 54,877 57,504 58,786<br />

Native American 34,145 34,785 37,860 39,416 41,382 44,339 43,953 42,904 44,614 44,664 46,910 50,536 50,681<br />

Asian 30,871 32,512 34,359 36,096 37,855 40,542 41,650 41,374 42,133 43,402 45,810 48,391 47,812<br />

Other/unknown 33,920 23,679 24,829 41,005 56,204 55,812 53,044 53,933 53,262 56,915 57,880 59,875 58,452<br />

†Hispanic 46,168 46,827 46,475 46,265 47,223 50,382 53,399 54,350<br />

†Non-Hispanic 45,624 46,666 46,469 46,786 48,411 51,923 54,459 55,598<br />

Diabetes 42,421 44,883 46,841 49,239 51,566 55,147 55,727 54,756 54,241 55,927 59,708 62,245 63,150<br />

Hypertension 38,369 40,860 42,000 43,858 45,287 47,378 47,965 47,261 47,749 48,842 52,359 54,949 56,160<br />

Glomerulonephritis 29,510 30,640 31,179 32,785 34,548 35,902 35,843 35,416 35,610 36,135 38,061 39,849 40,528<br />

Other cause 31,549 33,104 33,540 35,209 37,827 39,922 40,340 39,915 40,161 41,595 44,514 46,857 48,007<br />

Unknown cause 33,806 35,436 35,671 37,970 38,662 40,666 41,522 41,415 41,380 42,800 44,290 47,199 47,048<br />

All 36,165 38,346 39,583 41,709 43,841 46,420 47,026 46,497 46,618 47,984 51,288 53,831 54,904<br />

Model 1: As-treated actuarial model.<br />

The standard USRDS as-treated economic model where all costs are attributed to the patients’ modality at the time the costs were incurred.<br />

If a modality changes, then the costs incurred after the change are attributed to the new modality. See economic methods section for further details.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.


K<br />

MEDICARE COSTS FOR ESRD<br />

Reference section K<br />

Table K.5 K.5<br />

Per person per year costs; all dialysis patients, with unknowns dropped (model 1) 1)<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

ESRD<br />

ESRD<br />

patients,<br />

patients,<br />

as-treated<br />

as-treated<br />

model,<br />

model,<br />

primary<br />

primary<br />

payor<br />

payor<br />

only<br />

only<br />

674<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 40,567 61,544 50,956 48,182 58,337 54,396 52,639 52,969 52,842 52,710 56,204 59,522 63,216<br />

5-9 42,751 35,913 41,102 43,996 38,999 46,532 52,743 51,321 44,725 50,343 50,580 48,462 45,706<br />

10-14 37,485 37,440 39,480 42,649 43,335 42,930 42,679 42,983 39,032 40,750 43,719 45,569 48,544<br />

15-19 36,128 35,109 37,403 40,174 42,149 41,624 39,088 43,284 39,690 43,826 46,520 50,283 47,880<br />

20-29 36,284 38,338 39,622 40,960 41,618 43,975 42,837 42,525 44,079 44,328 46,572 48,786 50,662<br />

30-39 36,978 39,113 40,671 43,026 44,380 46,543 46,679 45,887 47,247 48,119 50,929 52,741 53,858<br />

40-49 36,952 39,269 40,526 42,258 44,970 47,542 47,234 47,178 48,519 50,002 53,178 55,701 56,843<br />

50-59 38,337 41,104 43,099 45,885 47,324 50,801 51,204 50,846 51,895 53,210 56,619 58,980 60,184<br />

60-64 40,011 42,860 44,183 46,747 49,275 52,370 52,947 53,205 53,790 55,049 59,129 62,336 63,445<br />

65-69 44,606 47,516 49,249 51,919 54,020 57,635 58,891 58,097 57,707 59,337 63,021 66,623 68,447<br />

70-79 45,889 49,169 50,178 52,419 55,120 58,783 60,065 58,977 58,828 60,898 64,936 67,824 69,142<br />

80+ 46,346 48,793 51,276 53,096 55,704 59,215 61,072 59,722 59,100 60,842 65,043 68,199 69,900<br />

0-19 37,476 37,700 39,343 41,794 43,565 43,514 42,148 44,541 40,818 44,351 47,006 49,765 49,048<br />

20-44 36,741 38,815 40,276 42,241 44,065 46,302 45,982 45,558 46,869 47,751 50,720 52,962 54,167<br />

45-64 38,691 41,441 43,024 45,491 47,422 50,635 50,967 50,855 51,863 53,242 56,741 59,354 60,552<br />

65-74 45,074 48,161 49,612 52,104 54,430 58,012 59,349 58,377 58,120 60,106 63,977 67,090 68,660<br />

75+ 46,297 49,245 50,775 52,804 55,584 59,272 60,696 59,537 59,158 60,900 64,999 68,162 69,665<br />

Male 39,732 42,508 43,912 46,179 48,067 51,222 51,901 51,616 52,130 53,626 57,044 59,858 61,352<br />

Female 42,781 45,643 47,356 49,865 52,514 55,903 56,710 56,075 56,481 58,151 62,184 65,149 66,388<br />

White 41,901 44,776 46,281 48,565 50,987 54,187 55,243 54,816 54,883 56,493 60,118 62,955 64,476<br />

Black 40,552 43,477 45,031 47,689 49,698 53,053 53,424 52,906 53,851 55,346 59,395 62,279 63,744<br />

Native American 37,967 38,609 41,970 43,129 45,955 49,673 49,052 48,129 49,867 50,091 52,419 56,645 56,453<br />

Asian 35,844 37,621 40,506 42,246 44,066 47,496 48,504 48,340 49,677 51,561 53,741 56,675 56,269<br />

Other/unknown 52,289 35,441 38,416 54,386 60,433 57,863 54,004 54,997 54,498 58,170 59,407 61,112 59,253<br />

†Hispanic 53,038 53,500 53,316 53,441 54,614 58,103 61,520 62,634<br />

†Non-Hispanic 53,686 54,255 53,726 54,145 55,813 59,653 62,476 63,935<br />

Diabetes 46,343 49,133 51,220 53,765 56,167 60,257 60,776 59,803 59,464 61,073 65,081 67,632 68,745<br />

Hypertension 41,076 43,919 45,255 47,266 48,877 51,530 52,307 51,726 52,445 53,663 57,317 60,222 61,648<br />

Glomerulonephritis 36,430 38,527 39,734 41,559 43,502 45,682 45,514 45,523 46,430 47,423 50,048 52,603 53,802<br />

Other cause 37,915 40,584 41,562 44,154 47,194 50,045 51,117 50,680 51,689 53,681 57,387 60,413 62,166<br />

Unknown cause 40,894 43,547 43,916 46,499 47,524 50,452 51,052 51,170 51,511 53,642 55,627 59,591 60,043<br />

All 41,232 44,048 45,605 47,988 50,243 53,505 54,236 53,774 54,232 55,797 59,499 62,361 63,723<br />

Model 1: As-treated actuarial model.<br />

The standard USRDS as-treated economic model where all costs are attributed to the patients’ modality at the time the costs were incurred.<br />

If a modality changes, then the costs incurred after the change are attributed to the new modality. See economic methods section for further details.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.


MEDICARE COSTS FOR ESRD<br />

2005 Annual <strong>Data</strong> ReportK<br />

Table K.6 K.6<br />

Per person per year costs; hemodialysis patients, with unknowns dropped (model 1) 1)<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

ESRD<br />

ESRD<br />

patients,<br />

patients,<br />

as-treated<br />

as-treated<br />

model,<br />

model,<br />

primary<br />

primary<br />

payor<br />

payor<br />

only<br />

only<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 47,720 75,584 53,206 63,906 74,968 60,896 64,202 52,785 83,958 81,594 101,539 77,292 56,984<br />

5-9 42,852 38,813 48,759 46,587 48,059 55,026 59,312 56,998 58,401 51,961 62,673 60,997 60,133<br />

10-14 40,608 39,668 41,663 44,965 44,806 46,356 45,520 51,316 44,333 44,951 51,820 53,585 54,655<br />

15-19 36,748 36,468 38,382 40,506 44,226 43,484 40,652 45,571 40,572 45,888 48,648 52,942 50,524<br />

20-29 37,014 39,070 41,034 42,124 42,719 45,493 44,506 43,601 45,304 45,389 48,209 50,512 52,552<br />

30-39 37,796 39,949 41,996 44,341 45,793 48,020 47,885 46,796 48,506 49,252 52,378 54,263 55,536<br />

40-49 37,442 39,849 41,381 43,305 46,031 48,721 48,272 48,230 49,574 51,020 54,276 56,761 58,022<br />

50-59 38,708 41,858 43,860 46,794 48,071 51,620 52,144 51,393 52,668 53,887 57,477 59,883 61,281<br />

60-64 40,587 43,485 45,075 47,623 50,014 53,121 53,627 53,664 54,334 55,478 59,758 63,021 64,370<br />

65-69 44,814 47,906 49,755 52,599 54,626 58,605 59,531 58,532 58,218 59,952 63,312 67,103 69,096<br />

70-79 45,767 49,215 50,477 52,582 55,498 59,215 60,302 59,042 58,944 61,055 64,985 68,060 69,440<br />

80+ 45,916 48,255 50,959 52,822 55,584 59,272 60,863 59,312 58,676 60,459 64,572 67,632 69,428<br />

0-19 38,222 38,536 40,184 42,646 45,876 45,229 43,303 47,433 43,352 46,990 51,224 54,201 51,899<br />

20-44 37,423 39,559 41,445 43,469 45,340 47,761 47,254 46,565 48,080 48,883 52,097 54,436 55,784<br />

45-64 39,173 42,126 43,876 46,424 48,247 51,501 51,864 51,509 52,641 53,917 57,607 60,234 61,616<br />

65-74 45,156 48,421 50,086 52,621 55,001 58,828 59,833 58,683 58,515 60,564 64,233 67,556 69,188<br />

75+ 46,006 48,997 50,705 52,638 55,623 59,363 60,674 59,311 58,918 60,720 64,704 67,885 69,523<br />

675<br />

Male 40,016 42,912 44,601 46,850 48,754 52,024 52,564 52,030 52,604 54,087 57,536 60,407 62,065<br />

Female 43,358 46,420 48,316 50,913 53,623 57,180 57,853 56,938 57,401 59,035 63,112 66,174 67,501<br />

White 42,581 45,617 47,397 49,675 52,184 55,590 56,402 55,655 55,719 57,307 60,951 63,862 65,567<br />

Black 40,734 43,812 45,552 48,266 50,256 53,618 54,006 53,284 54,332 55,782 59,859 62,806 64,346<br />

Native American 38,208 39,019 42,652 43,724 46,095 50,307 49,523 48,508 50,258 50,476 52,875 57,331 56,853<br />

Asian 36,282 38,381 41,299 43,233 45,316 48,912 49,828 49,217 50,566 52,592 54,795 57,806 57,547<br />

Other/unknown 46,798 36,131 38,985 55,332 61,828 60,298 56,127 56,698 56,016 59,413 60,802 62,530 60,108<br />

†Hispanic 54,168 54,523 54,302 54,319 55,571 58,971 62,516 63,651<br />

†Non-Hispanic 54,843 55,216 54,337 54,796 56,429 60,303 63,206 64,813<br />

Diabetes 46,765 49,636 51,852 54,402 56,809 61,053 61,375 60,201 59,894 61,458 65,440 68,069 69,314<br />

Hypertension 41,184 44,193 45,813 47,850 49,481 52,268 52,794 52,070 52,834 54,096 57,693 60,748 62,233<br />

Glomerulonephritis 37,110 39,494 41,005 42,844 44,947 47,187 46,928 46,604 47,581 48,653 51,396 53,977 55,258<br />

Other cause 38,516 41,326 42,549 45,187 48,245 51,151 52,378 51,463 52,748 54,475 58,515 61,597 63,581<br />

Unknown cause 41,259 44,099 44,589 47,161 48,507 51,752 52,121 51,699 51,902 54,317 56,112 60,015 60,988<br />

All 41,667 44,644 46,433 48,849 51,141 54,540 55,130 54,400 54,913 56,451 60,187 63,125 64,614<br />

Model 1: As-treated actuarial model.<br />

The standard USRDS as-treated economic model where all costs are attributed to the patients’ modality at the time the costs were incurred.<br />

If a modality changes, then the costs incurred after the change are attributed to the new modality. See economic methods section for further details.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.


K<br />

MEDICARE COSTS FOR ESRD<br />

Reference section K<br />

Table K.7 K.7<br />

Per person per year costs; CAPD/CCPD patients, with unknowns dropped (model 1) 1)<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

ESRD<br />

ESRD<br />

patients,<br />

patients,<br />

as-treated<br />

as-treated<br />

model,<br />

model,<br />

primary<br />

primary<br />

payor<br />

payor<br />

only<br />

only<br />

676<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 36,312 55,823 48,825 43,960 52,550 51,917 48,466 53,019 44,861 38,105 46,451 54,196 64,467<br />

5-9 41,403 35,374 34,884 43,448 36,762 43,357 48,923 46,145 33,650 46,729 41,384 40,091 38,106<br />

10-14 34,717 34,646 36,133 39,485 41,401 39,189 40,626 37,458 33,493 34,603 33,703 36,534 41,251<br />

15-19 34,011 33,104 34,894 39,269 37,656 38,153 36,331 38,298 37,948 37,915 40,779 42,687 40,084<br />

20-29 32,673 34,815 34,226 36,215 37,787 38,426 36,029 37,341 38,003 38,440 38,420 39,567 40,249<br />

30-39 33,102 35,313 35,464 37,451 38,640 40,394 41,035 40,680 39,652 41,045 41,366 42,560 42,266<br />

40-49 33,680 35,741 35,983 37,129 40,186 41,796 41,242 40,461 40,628 41,889 43,578 45,821 45,724<br />

50-59 34,639 35,895 37,545 39,704 42,515 45,311 44,578 45,595 44,160 45,484 46,300 48,118 47,030<br />

60-64 33,635 36,681 36,808 39,645 42,897 45,701 45,854 46,832 45,168 47,696 48,263 49,761 48,171<br />

65-69 36,032 38,108 39,652 41,401 45,270 46,254 48,747 48,211 46,665 47,000 51,676 52,147 52,506<br />

70-79 36,597 38,473 39,076 41,042 43,463 47,252 48,716 48,268 47,355 49,066 51,133 50,048 50,422<br />

80+ 36,215 36,651 39,204 40,268 43,281 44,682 45,530 44,624 45,333 45,935 47,433 50,375 51,445<br />

0-19 35,568 36,436 37,075 40,498 40,579 41,272 40,759 40,738 37,126 38,160 39,821 42,269 44,217<br />

20-44 33,110 35,147 35,334 36,964 38,929 40,232 39,933 39,943 39,580 40,389 41,414 42,694 42,518<br />

45-64 34,158 36,238 36,973 39,176 42,053 44,703 44,169 44,614 43,543 45,395 46,116 48,079 47,230<br />

65-74 36,201 38,470 39,424 41,343 44,594 46,473 48,980 48,333 47,024 48,117 51,483 50,998 51,858<br />

75+ 36,658 37,338 39,046 40,497 43,032 46,886 47,012 46,745 46,560 47,611 49,613 50,501 50,247<br />

Male 34,167 36,057 36,562 38,456 40,930 43,031 43,386 43,483 42,852 43,794 45,364 46,828 46,515<br />

Female 35,039 37,110 38,064 40,060 42,915 45,181 45,406 45,347 44,150 45,775 47,306 48,232 48,274<br />

White 34,405 36,427 37,241 39,220 41,877 43,815 44,721 44,453 43,596 44,574 46,144 47,296 47,115<br />

Black 35,441 37,667 37,872 39,858 42,700 45,635 44,586 45,162 43,967 45,860 47,705 49,183 49,163<br />

Native American 34,333 34,008 35,910 37,446 43,411 43,579 42,401 41,947 43,091 42,023 45,197 46,098 48,470<br />

Asian 29,626 29,204 33,106 34,339 34,990 38,091 38,479 40,026 39,995 41,861 42,168 42,286 40,875<br />

Other/unknown 74,055 21,086 31,977 42,423 37,170 39,471 38,761 40,875 38,836 45,543 41,560 44,714 45,308<br />

†Hispanic 41,594 42,830 42,122 42,353 41,410 44,005 45,180 45,223<br />

†Non-Hispanic 42,146 42,974 43,677 43,136 44,801 46,593 47,780 47,684<br />

Diabetes 39,013 41,747 43,645 45,665 48,469 51,667 51,985 51,514 50,017 51,783 53,516 54,608 53,834<br />

Hypertension 33,825 35,438 35,789 37,465 40,241 41,661 42,921 42,143 41,792 42,556 44,784 44,840 45,337<br />

Glomerulonephritis 31,776 32,712 32,827 34,785 36,588 38,248 38,087 38,644 38,487 38,780 39,900 41,391 42,071<br />

Other cause 32,410 34,402 34,582 36,579 39,551 41,719 40,875 41,817 40,146 42,543 43,477 45,305 44,929<br />

Unknown cause 34,291 36,069 34,588 37,520 38,351 38,461 38,520 40,040 40,637 40,767 41,649 43,906 41,751<br />

All 34,588 36,563 37,289 39,235 41,896 44,079 44,377 44,405 43,503 44,788 46,336 47,525 47,384<br />

Model 1: As-treated actuarial model.<br />

The standard USRDS as-treated economic model where all costs are attributed to the patients’ modality at the time the costs were incurred.<br />

If a modality changes, then the costs incurred after the change are attributed to the new modality. See economic methods section for further details.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.


MEDICARE COSTS FOR ESRD<br />

2005 Annual <strong>Data</strong> ReportK<br />

Table K.8 K.8<br />

Per person per year costs: by by transplant patients, with unknowns dropped (model 1) 1)<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

ESRD<br />

ESRD<br />

patients,<br />

patients,<br />

as-treated<br />

as-treated<br />

model,<br />

model,<br />

primary<br />

primary<br />

payor<br />

payor<br />

only<br />

only<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 27,930 24,830 29,681 25,201 23,609 33,017 30,413 30,908 30,754 26,987 27,396 36,150 35,005<br />

5-9 17,859 13,316 15,011 18,627 16,263 17,694 16,821 17,601 14,836 14,261 16,589 17,471 22,551<br />

10-14 14,079 16,757 14,816 16,780 16,228 15,288 16,952 15,296 13,534 13,314 14,691 17,974 21,855<br />

15-19 16,045 16,409 17,421 18,274 18,737 16,900 16,014 16,576 16,788 16,338 19,760 20,761 25,020<br />

20-29 16,731 15,819 16,704 16,905 18,426 17,772 18,190 17,907 17,638 17,363 19,701 20,714 21,183<br />

30-39 15,528 16,316 16,335 17,334 17,817 17,626 17,430 16,821 16,681 17,486 19,157 20,359 20,529<br />

40-49 16,523 16,425 16,871 17,730 18,101 19,034 19,107 17,531 16,963 17,700 19,643 20,605 20,538<br />

50-59 16,393 16,619 17,220 18,411 19,774 20,311 20,695 19,534 17,852 19,864 20,895 22,122 21,884<br />

60-64 16,649 16,149 16,901 17,943 19,315 20,214 20,715 19,835 18,947 20,517 21,476 21,989 24,441<br />

65-69 17,403 18,095 17,375 17,687 19,688 19,702 20,426 20,786 19,873 21,113 22,480 24,566 24,528<br />

70-79 14,717 16,037 17,846 18,027 18,366 18,004 19,149 19,820 19,433 21,024 24,129 23,973 24,629<br />

80+ 17,532 17,009 25,654 13,776 17,574 14,166 16,830 14,155 11,355 18,328 19,712 18,534 19,404<br />

0-19 16,748 16,624 17,273 18,472 18,085 17,739 17,522 17,414 16,346 15,772 18,225 20,541 24,533<br />

20-44 16,059 16,247 16,418 17,167 17,988 17,958 18,077 17,180 16,915 17,307 19,254 20,428 20,604<br />

45-64 16,530 16,431 17,237 18,321 19,233 20,021 20,236 19,105 17,887 19,615 20,822 21,759 22,158<br />

65-74 17,031 17,379 17,453 17,885 19,408 19,257 20,140 20,483 19,629 21,305 22,879 24,137 24,525<br />

75+ 11,841 19,527 19,745 15,556 16,858 16,962 17,821 19,111 19,209 18,698 24,766 24,610 23,907<br />

677<br />

Male 15,994 16,064 16,586 17,567 18,436 18,554 18,770 18,127 17,426 18,467 20,465 21,179 21,967<br />

Female 16,809 16,973 17,299 17,990 18,930 19,516 19,852 18,895 18,088 19,396 20,681 22,462 22,398<br />

White 15,481 15,514 16,110 16,730 17,636 18,008 18,139 17,380 16,605 17,664 19,234 20,455 20,909<br />

Black 19,849 20,023 20,134 21,795 22,774 22,884 23,356 22,383 21,640 23,341 25,374 26,411 26,902<br />

Native American 15,744 15,818 17,405 20,912 18,516 18,673 19,065 17,430 18,292 18,106 19,907 19,965 21,475<br />

Asian 14,587 16,273 14,550 14,907 15,055 14,949 16,370 16,355 15,591 15,388 18,045 18,509 17,826<br />

Other/unknown 10,960 9,602 4,480 8,851 15,555 10,424 18,808 16,352 13,786 22,599 14,407 22,904 35,900<br />

†Hispanic 19,312 20,070 19,094 18,373 18,927 20,411 21,460 21,816<br />

†Non-Hispanic 20,382 20,331 19,372 18,466 19,723 21,446 22,587 22,931<br />

Diabetes 21,932 22,253 23,646 24,919 25,735 26,243 26,466 24,793 23,276 25,548 27,598 29,595 29,643<br />

Hypertension 17,811 18,053 18,378 19,260 19,490 19,177 19,533 18,721 18,257 19,171 21,991 22,596 22,867<br />

Glomerulonephritis 13,835 13,820 13,385 14,464 15,444 15,567 16,149 15,288 14,893 15,494 16,585 17,463 17,980<br />

Other cause 14,511 14,285 14,713 14,677 15,857 16,506 16,027 16,092 15,346 16,231 17,479 18,438 19,304<br />

Unknown cause 12,715 12,950 13,552 14,167 14,031 13,708 15,023 14,747 14,626 15,140 16,200 16,766 16,507<br />

All 16,311 16,420 16,868 17,736 18,629 18,932 19,199 18,433 17,691 18,841 20,551 21,698 22,142<br />

Model 1: As-treated actuarial model.<br />

The standard USRDS as-treated economic model where all costs are attributed to the patients’ modality at the time the costs were incurred.<br />

If a modality changes, then the costs incurred after the change are attributed to the new modality. See economic methods section for further details.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.


K<br />

MEDICARE COSTS FOR ESRD<br />

Reference section K<br />

Table K.9 K.9<br />

Per person per year costs: dialysis patients (model 2) 2)<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

ESRD<br />

ESRD<br />

patients,<br />

patients,<br />

primary<br />

primary<br />

payor<br />

payor<br />

only<br />

only<br />

678<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 38,608 54,700 44,301 44,494 51,958 54,681 47,615 43,244 47,081 36,520 48,725 54,086 50,192<br />

5-9 37,933 32,398 39,108 41,553 33,301 43,301 49,441 44,984 37,843 47,750 44,135 47,894 42,826<br />

10-14 35,013 33,659 37,594 39,852 39,017 35,985 37,627 37,676 36,451 38,067 36,429 42,876 45,384<br />

15-19 34,460 33,721 35,381 37,377 39,567 38,813 38,225 41,357 36,939 41,581 43,864 46,879 46,249<br />

20-29 35,013 37,084 38,452 39,925 40,276 42,675 41,839 41,300 42,564 43,223 45,196 47,536 49,322<br />

30-39 35,723 37,565 39,214 41,837 43,428 44,917 45,962 44,905 46,023 46,800 49,774 51,758 52,412<br />

40-49 35,969 37,904 39,207 41,259 43,830 46,446 46,623 46,121 47,139 48,557 52,044 54,955 55,549<br />

50-59 37,384 39,953 41,825 45,139 46,508 49,645 50,727 49,995 50,706 51,939 55,686 58,345 59,157<br />

60-64 38,995 41,514 42,982 45,966 48,704 51,244 52,310 52,586 52,773 54,105 58,490 62,284 62,981<br />

65-69 42,123 44,632 46,029 49,778 52,047 55,185 56,593 56,139 55,966 57,224 61,537 66,050 67,287<br />

70-79 43,524 46,157 46,674 50,286 53,253 56,419 57,571 56,947 57,004 58,749 63,569 67,199 67,764<br />

80+ 44,095 45,832 47,728 50,979 53,710 56,868 58,622 57,954 57,597 58,654 63,643 67,514 68,158<br />

0-19 35,271 35,111 36,945 38,970 40,090 40,009 39,811 41,020 37,564 41,030 42,681 46,642 46,042<br />

20-44 35,450 37,292 38,882 41,175 42,974 44,960 45,345 44,547 45,603 46,491 49,562 52,085 52,840<br />

45-64 37,789 40,247 41,800 44,687 46,640 49,503 50,397 50,037 50,672 52,019 55,868 58,861 59,633<br />

65-74 42,662 45,232 46,216 49,874 52,441 55,588 56,970 56,408 56,355 57,962 62,550 66,487 67,458<br />

75+ 43,945 46,235 47,330 50,837 53,775 56,943 58,198 57,587 57,455 58,756 63,622 67,515 68,034<br />

Male 38,118 40,566 41,797 44,759 46,731 49,687 50,731 50,394 50,763 52,051 55,912 59,262 60,078<br />

Female 41,569 44,001 45,452 48,804 51,561 54,430 55,568 54,972 55,356 56,855 61,455 65,028 65,800<br />

White 40,626 43,020 44,336 47,450 49,928 52,800 54,074 53,708 53,775 55,183 59,402 62,833 63,638<br />

Black 38,964 41,650 42,994 46,327 48,465 51,453 52,344 51,731 52,464 53,772 58,187 61,619 62,626<br />

Native American 36,063 37,156 40,387 42,371 45,486 48,477 48,290 47,278 48,947 49,117 51,613 55,968 55,879<br />

Asian 34,284 35,601 37,871 40,298 42,677 45,526 47,069 46,629 47,861 49,557 52,575 56,040 55,322<br />

Other/unknown 30,117 19,897 21,487 38,569 54,738 54,627 51,417 53,005 52,679 55,986 57,198 59,486 57,286<br />

†Hispanic 51,594 52,383 52,313 52,243 53,246 57,328 61,247 62,321<br />

†Non-Hispanic 52,335 53,214 52,635 52,959 54,415 58,765 62,165 63,063<br />

Diabetes 45,151 47,385 49,094 52,622 55,147 58,593 59,496 58,601 58,219 59,640 64,175 67,385 68,266<br />

Hypertension 39,714 42,258 43,227 46,005 47,760 50,118 51,029 50,560 51,197 52,226 56,401 59,814 60,626<br />

Glomerulonephritis 35,233 37,146 38,406 40,549 42,639 44,540 44,902 44,558 45,307 46,201 49,271 51,958 52,946<br />

Other cause 36,545 38,868 39,815 42,991 46,046 48,580 50,120 49,599 50,415 52,193 56,360 60,172 60,832<br />

Unknown cause 37,429 38,979 39,620 43,615 44,380 48,000 48,945 48,961 49,468 51,221 53,449 58,129 55,292<br />

All 39,816 42,256 43,600 46,752 49,106 52,012 53,092 52,618 52,989 54,359 58,562 61,992 62,767<br />

Model 2: Categorical calendar year model. Patients are classified into four mutually exclusive modality groups, based on calendar year.<br />

Patients are classified into four mutually exclusive modality groups, based on calendar year. If a patient receives a transplant during a calendar year,<br />

they are placed into the transplant event modality and costs are aggregated for the entire time that the patient is alive,<br />

ESRD and Medicare entitled during the calendar year.<br />

Other modalities (dialysis, functioning graft, graft failure) are defined in a similar fashion. See economic methods section for further details.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.


MEDICARE COSTS FOR ESRD<br />

2005 Annual <strong>Data</strong> ReportK<br />

Table K.10 K.10<br />

Per person per year costs: transplant event within the year (model 2) 2)<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

ESRD<br />

ESRD<br />

patients,<br />

patients,<br />

primary<br />

primary<br />

payor<br />

payor<br />

only<br />

only<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 97,476 94,493 90,219 103,916 94,320 108,517 95,046 101,548 94,805 88,070 94,361 108,019 99,816<br />

5-9 97,221 84,173 93,779 95,945 89,344 95,534 101,420 98,394 88,985 92,637 82,365 74,343 85,498<br />

10-14 81,729 85,891 75,200 81,087 93,441 83,445 94,455 79,602 77,614 80,018 87,872 82,081 88,343<br />

15-19 76,790 77,060 82,131 86,907 84,687 85,812 82,531 89,794 79,854 81,078 87,158 90,864 88,380<br />

20-29 76,424 80,803 84,908 86,340 89,240 86,658 89,288 86,738 86,602 83,119 89,645 91,423 91,004<br />

30-39 79,478 83,058 87,441 89,495 93,078 94,353 91,406 87,840 91,018 92,358 92,283 93,789 94,166<br />

40-49 80,756 82,831 85,579 86,729 92,048 92,087 93,413 88,040 89,843 92,565 94,196 96,955 93,673<br />

50-59 81,817 83,344 87,047 90,936 93,796 93,664 95,421 92,091 91,720 95,202 94,374 97,657 95,714<br />

60-64 81,938 85,660 85,813 87,028 93,497 93,382 94,781 94,602 93,634 97,908 98,524 100,140 100,044<br />

65-69 85,746 85,425 89,040 92,410 97,535 98,134 107,760 99,275 97,891 97,818 103,721 103,561 101,613<br />

70-79 81,753 80,902 104,570 92,591 97,043 90,818 100,821 105,033 103,007 103,351 110,251 106,655 103,510<br />

80+ 91,065 93,110 147,155 75,313 104,276 71,019 88,063 77,466 71,440 97,088 118,903 74,185 90,558<br />

0-19 83,258 82,527 83,702 88,078 88,205 89,571 90,346 89,617 81,952 82,802 87,416 88,131 89,491<br />

20-44 78,837 82,318 85,772 87,893 91,900 91,591 91,179 87,260 89,408 89,302 92,427 93,696 93,034<br />

45-64 81,518 83,644 86,973 89,024 92,961 93,158 94,872 91,791 91,685 95,639 94,846 98,292 96,291<br />

65-74 85,246 84,618 91,449 91,974 97,089 96,693 105,416 100,547 99,477 99,323 105,201 103,481 102,296<br />

75+ 74,782 80,531 135,940 109,237 105,403 74,709 114,792 102,328 91,312 102,274 117,859 116,430 100,634<br />

679<br />

Male 80,176 81,663 85,927 88,366 92,066 90,936 93,304 90,157 90,444 92,000 95,150 96,146 94,947<br />

Female 80,677 84,834 87,476 89,005 93,204 94,774 94,648 91,045 91,668 94,355 94,356 98,111 96,494<br />

White 81,013 83,246 87,578 89,377 93,050 93,023 94,637 91,153 89,798 91,548 93,516 96,387 94,431<br />

Black 79,368 83,113 84,771 87,856 92,654 91,539 93,248 90,149 94,550 97,226 98,912 99,429 99,204<br />

Native American 71,913 74,132 77,199 89,952 89,172 88,746 88,975 80,749 83,715 83,478 82,484 86,377 92,797<br />

Asian 77,911 78,910 84,203 81,466 82,456 91,426 86,948 86,433 86,333 86,338 87,882 91,292 87,356<br />

Other/unknown 91,519 52,111 36,657 81,814 108,849 65,912 70,490 62,302 93,584 77,799 88,280 95,586<br />

†Hispanic 90,341 93,388 87,324 87,999 86,423 89,763 90,816 90,716<br />

†Non-Hispanic 92,690 93,750 90,717 91,368 93,961 95,623 98,007 96,472<br />

Diabetes 85,162 91,349 95,104 95,730 100,654 99,552 101,331 96,843 95,263 101,775 102,922 106,540 105,046<br />

Hypertension 80,019 79,691 83,892 85,550 90,176 88,738 92,538 88,029 90,817 91,840 95,320 96,106 94,162<br />

Glomerulonephritis 77,115 79,049 81,392 85,040 87,657 87,969 89,258 86,354 87,321 87,008 88,271 90,735 89,440<br />

Other cause 80,238 82,232 84,563 87,084 90,314 93,191 91,807 89,906 89,661 89,355 92,363 92,827 93,732<br />

Unknown cause 80,035 85,884 92,331 95,104 102,302 93,321 96,265 93,169 94,119 97,128 92,619 96,291 85,280<br />

All 80,380 82,928 86,553 88,618 92,505 92,491 93,845 90,518 90,936 92,959 94,826 96,942 95,567<br />

Model 2: Categorical calendar year model. Patients are classified into four mutually exclusive modality groups, based on calendar year.<br />

Patients are classified into four mutually exclusive modality groups, based on calendar year. If a patient receives a transplant during a calendar year,<br />

they are placed into the transplant event modality and costs are aggregated for the entire time that the patient is alive,<br />

ESRD and Medicare entitled during the calendar year.<br />

Other modalities (dialysis, functioning graft, graft failure) are defined in a similar fashion. See economic methods section for further details.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.


K<br />

MEDICARE COSTS FOR ESRD<br />

Reference section K<br />

Table K.11 K.11<br />

Per person per year costs: functioning graft patients (model 2) 2)<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

ESRD<br />

ESRD<br />

patients,<br />

patients,<br />

primary<br />

primary<br />

payor<br />

payor<br />

only<br />

only<br />

680<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 12,198 12,783 13,032 11,823 13,345 15,643 16,869 14,238 10,258 18,210 13,277 15,588 16,742<br />

5-9 8,271 7,510 6,568 10,563 8,712 7,988 7,614 9,947 9,329 8,738 9,173 11,762 13,474<br />

10-14 7,029 7,922 7,766 7,181 6,026 7,581 8,707 8,055 7,029 7,574 7,942 9,757 11,913<br />

15-19 7,191 7,370 7,028 6,784 8,769 7,856 7,448 7,284 7,709 8,864 10,433 9,954 13,763<br />

20-29 7,300 6,894 6,837 7,481 7,982 7,991 8,604 8,657 8,813 8,379 10,156 10,878 11,571<br />

30-39 8,040 8,509 8,486 9,281 9,350 9,971 10,094 9,708 9,642 9,991 11,303 12,200 12,520<br />

40-49 8,766 9,191 9,341 10,341 10,327 11,283 11,348 10,935 10,399 11,093 12,325 13,265 13,751<br />

50-59 8,841 9,722 10,037 11,113 12,160 12,655 13,192 12,526 11,689 13,144 14,050 14,848 15,373<br />

60-64 9,970 9,756 10,721 11,912 12,289 13,029 14,366 13,909 13,460 14,687 15,681 15,998 18,048<br />

65-69 10,492 11,357 11,543 12,205 13,856 14,017 14,132 14,348 14,470 15,313 16,731 18,159 18,369<br />

70-79 10,814 11,025 12,258 13,458 13,622 13,842 14,610 15,697 15,978 16,562 19,069 19,372 20,159<br />

80+ 10,747 11,746 10,181 9,558 15,945 11,907 16,035 12,556 10,765 15,069 16,552 16,924 17,840<br />

0-19 7,689 7,922 7,576 7,974 8,408 8,282 8,499 8,470 7,958 9,004 9,619 10,533 13,464<br />

20-44 8,001 8,314 8,286 9,032 9,247 9,869 10,151 9,808 9,560 9,944 11,326 12,229 12,661<br />

45-64 9,098 9,553 10,024 11,217 11,727 12,389 12,895 12,413 11,843 13,008 14,030 14,750 15,640<br />

65-74 10,620 11,165 11,762 12,569 13,838 13,820 14,351 14,699 14,754 15,809 17,355 18,465 18,937<br />

75+ 9,926 12,991 11,411 12,341 13,237 15,500 13,914 16,063 17,256 15,779 20,175 19,874 20,332<br />

Male 8,343 8,778 9,053 10,016 10,471 11,207 11,423 11,357 10,982 11,938 13,329 14,120 15,126<br />

Female 8,892 9,310 9,485 10,539 11,098 11,500 12,306 11,847 11,754 12,547 13,944 15,104 15,700<br />

White 8,460 8,819 9,116 10,192 10,546 11,165 11,478 11,236 11,074 11,926 13,246 14,136 15,069<br />

Black 9,361 10,064 10,107 10,869 11,955 12,703 13,368 13,208 12,520 13,777 15,245 16,453 17,166<br />

Native American 8,120 8,465 9,660 10,455 10,917 10,801 11,840 11,486 11,735 12,052 14,552 13,607 13,876<br />

Asian 5,645 6,266 6,305 6,540 6,682 6,547 8,259 8,307 8,343 8,037 10,250 11,184 11,167<br />

Other/unknown 8,010 8,713 3,185 8,662 8,850 3,640 12,701 5,156 4,943 10,560 9,322 12,707 10,623<br />

†Hispanic 11,213 11,157 10,920 10,809 11,545 13,107 13,868 14,628<br />

†Non-Hispanic 11,694 12,205 11,894 11,592 12,567 13,910 14,934 15,734<br />

Diabetes 13,774 14,311 14,828 16,690 17,300 18,140 18,670 17,551 16,611 18,178 19,991 21,345 21,809<br />

Hypertension 8,171 9,222 9,321 9,633 10,144 10,534 11,073 11,018 10,790 11,670 13,650 14,324 15,293<br />

Glomerulonephritis 6,384 6,671 6,639 7,470 7,831 8,338 8,878 8,746 8,679 9,388 10,167 10,970 11,854<br />

Other cause 7,398 7,377 7,631 8,177 8,751 9,223 9,232 9,640 9,570 10,154 11,269 12,104 13,128<br />

Unknown cause 7,374 7,843 8,075 8,711 8,094 8,973 9,332 9,149 9,605 9,501 10,990 11,709 11,529<br />

All 8,557 8,987 9,225 10,220 10,716 11,321 11,771 11,551 11,290 12,182 13,576 14,515 15,357<br />

Model 2: Categorical calendar year model. Patients are classified into four mutually exclusive modality groups, based on calendar year.<br />

Patients are classified into four mutually exclusive modality groups, based on calendar year. If a patient receives a transplant during a calendar year,<br />

they are placed into the transplant event modality and costs are aggregated for the entire time that the patient is alive,<br />

ESRD and Medicare entitled during the calendar year.<br />

Other modalities (dialysis, functioning graft, graft failure) are defined in a similar fashion. See economic methods section for further details.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.


MEDICARE COSTS FOR ESRD<br />

2005 Annual <strong>Data</strong> ReportK<br />

Table K.12 K.12<br />

Per person per year costs: graft failure within the year (model 2) 2)<br />

period<br />

period<br />

prevalent<br />

prevalent<br />

ESRD<br />

ESRD<br />

patients,<br />

patients,<br />

primary<br />

primary<br />

payor<br />

payor<br />

only<br />

only<br />

1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003<br />

0-4 67,902 58,071 85,107 65,344 . 59,837 . 146,176 82,778 . 80,221 71,423 38,588<br />

5-9 48,684 38,173 35,947 61,736 66,306 129,842 97,796 69,343 86,674 80,976 . 51,408 30,568<br />

10-14 40,229 59,264 50,154 53,872 48,036 45,235 64,234 48,846 46,415 39,833 58,190 52,778 65,233<br />

15-19 40,307 41,634 39,734 52,033 48,252 52,387 57,165 46,088 51,365 59,973 53,383 65,270 69,859<br />

20-29 47,423 43,203 47,279 48,273 45,559 57,615 49,312 51,691 53,312 54,085 54,793 63,105 59,358<br />

30-39 45,609 52,573 47,413 51,443 52,482 52,438 56,088 55,214 57,425 54,601 58,090 68,636 64,944<br />

40-49 46,898 51,158 51,203 51,429 54,303 56,576 59,791 58,194 59,717 58,861 65,296 65,160 65,604<br />

50-59 50,414 50,459 50,570 60,348 55,117 64,245 63,804 64,638 65,980 67,336 70,818 76,345 69,464<br />

60-64 52,438 52,847 56,996 59,877 61,354 69,655 72,071 72,336 71,024 72,243 76,853 74,279 88,574<br />

65-69 51,564 63,902 51,607 60,158 69,040 70,091 68,899 79,907 72,995 59,308 78,370 86,798 94,571<br />

70-79 67,330 50,087 57,860 69,651 62,321 98,748 80,769 54,873 62,739 66,248 92,764 83,666 87,579<br />

80+ 43,001 45,125 69,934 61,296 22,440 . . 38,299 52,007 60,836 175,320 126,020 70,941<br />

0-19 41,773 45,899 44,476 53,516 48,303 55,504 61,992 51,060 54,751 57,395 54,685 62,318 64,887<br />

20-44 46,252 49,662 48,197 49,704 50,902 54,724 54,622 55,991 57,106 55,448 57,466 66,367 63,437<br />

45-64 49,824 50,734 51,872 58,447 56,260 62,668 65,374 62,285 64,553 66,048 72,079 72,823 72,289<br />

65-74 56,366 58,851 52,985 63,585 66,782 77,826 73,932 73,018 68,925 61,361 84,394 86,472 92,482<br />

75+ 36,792 56,792 68,843 56,694 52,035 84,110 69,396 55,504 70,997 67,490 94,109 84,793 86,514<br />

681<br />

Male 45,344 49,317 48,262 51,898 51,749 55,733 55,934 57,389 60,657 58,540 66,222 67,148 68,289<br />

Female 50,254 51,532 51,475 55,696 56,029 63,821 65,898 62,343 61,191 63,556 66,302 75,964 74,949<br />

White 48,232 52,318 49,953 55,914 54,994 59,456 59,443 59,865 61,361 59,275 65,954 71,212 70,549<br />

Black 45,446 46,701 49,387 49,971 51,583 59,479 61,762 57,991 60,383 63,309 66,788 71,455 72,346<br />

Native American 52,099 42,320 39,262 53,334 56,057 50,687 70,524 50,267 44,698 52,863 58,672 76,254 81,094<br />

Asian 43,982 47,260 45,788 46,074 34,876 46,614 44,056 68,398 64,649 59,056 69,661 55,584 58,805<br />

Other/unknown . . . . 113,333 . 24,838 187,862 12,635 63,034 . 147,412 .<br />

†Hispanic 56,426 55,512 54,665 61,988 57,136 63,324 66,709 74,318<br />

†Non-Hispanic 58,648 60,039 59,465 60,589 60,645 66,604 71,002 70,306<br />

Diabetes 61,827 64,452 64,023 66,086 67,849 69,813 75,714 71,107 77,036 74,298 80,080 88,941 87,575<br />

Hypertension 43,099 46,010 48,462 53,790 48,059 56,364 60,096 58,419 59,379 57,970 61,885 68,695 72,883<br />

Glomerulonephritis 43,401 45,687 45,700 46,900 50,129 53,009 52,469 52,711 53,282 54,169 58,931 61,429 60,834<br />

Other cause 45,557 49,392 45,892 52,097 51,859 60,549 57,654 56,303 58,076 58,886 67,160 67,402 65,769<br />

Unknown cause 48,018 49,897 49,796 53,301 51,025 51,722 54,091 75,504 57,423 61,526 65,021 68,029 67,508<br />

All 47,270 50,223 49,537 53,497 53,435 59,018 59,995 59,393 60,874 60,602 66,255 70,994 70,930<br />

Model 2: Categorical calendar year model. Patients are classified into four mutually exclusive modality groups, based on calendar year.<br />

Patients are classified into four mutually exclusive modality groups, based on calendar year. If a patient receives a transplant during a calendar year,<br />

they are placed into the transplant event modality and costs are aggregated for the entire time that the patient is alive,<br />

ESRD and Medicare entitled during the calendar year.<br />

Other modalities (dialysis, functioning graft, graft failure) are defined in a similar fashion. See economic methods section for further details.<br />

"." Zero values in this cell.<br />

†CMS began collecting Hispanic ethnicity data in April 1995; cells prior to 1996 have therfore been left blank.


KMEDICARE COSTS FOR ESRD<br />

KMEDICARE COSTS FOR ESRD<br />

Reference section K<br />

Table K.13<br />

Part B Medicare costs ($) per patient YAR: by physician/supplier specialty<br />

period prevalent patients, as-treated model; Medicare primary payor only<br />

ON OUR WEBSITE & CD<br />

Medicare payments ($) per person per year: 1999-2003, by claim type: model<br />

1 (k.a-k.e).<br />

682<br />

1999 2000 2001 2002 2003<br />

All 8,522 8,885 9,588 10,143 10,921<br />

Nephrology 1,940 1,989 2,059 2,187 2,299<br />

Pediatric medicine 785 803 833 936 1,192<br />

Medical supply company 752 776 824 837 722<br />

Laboratory 613 620 611 799 895<br />

Ambulance service supplier 724 799 933 1,114 1,329<br />

Internal medicine 667 699 753 805 859<br />

General surgery 468 456 452 439 452<br />

Radiology (diagnostic and therapeutic) 469 472 502 536 612<br />

Cardiology 313 328 352 372 426<br />

Anesthesiology 255 252 248 235 243<br />

Multispecialty clinic/group practice 223 268 379 134 6<br />

Pharmacy 481 540 669 736 872<br />

Opthalmology 126 135 143 146 158<br />

Vascular surgery 148 149 154 168 187<br />

Thoracic surgery 89 81 81 74 73<br />

General and family practice 122 136 150 175 219<br />

Emergency medicine 125 141 158 180 211<br />

Gastroenterology 98 97 99 98 104<br />

Urology 73 72 76 77 81<br />

Pulmonary disease 97 100 107 121 139<br />

Orthopedic surgery 73 76 82 86 91<br />

Neurology 68 70 78 82 90<br />

Hematology/oncology 66 77 85 107 132<br />

Infectious disease 69 72 80 88 100<br />

Pathology 44 48 50 52 57<br />

Therapeutic services 60 66 70 72 82<br />

Podiatry 48 54 63 68 78<br />

Cardiac surgery 30 30 30 32 37<br />

Dermatology 33 38 41 46 51<br />

Ambulatory surgery center 31 35 38 45 52<br />

Psychiatry (includes neuropsychiatry) 25 24 24 24 25<br />

Obstetrics/gynecology 21 23 24 26 31<br />

Endocrinology 25 26 29 31 35<br />

Plastic and reconstructive surgery 18 19 21 20 21<br />

Otolaryngology 17 18 20 21 23<br />

Geriatric medicine 12 14 17 19 23<br />

Neurosurgery 13 14 15 15 16<br />

Peripheral vascular disease 7 7 9 9 9<br />

Rheumatology 8 8 9 9 10<br />

Optometry 10 13 10 11 12<br />

Home health agency 3 3 1 3 2<br />

Hospital 2 2 2 1 4<br />

Nuclear medicine 5 5 5 6 7<br />

Chiropractic 4 4 5 5 6<br />

Colorectal surgery 3 3 3 3 3<br />

Allergy/immunology 1 1 2 2 2<br />

Other nursing facility 2 1 1 1 1<br />

Maxillofacial and oral surgery 1 1 1 1 1<br />

Skilled nursing facility 1 0 1 1 1<br />

Intermediate care nursing facility 0 0 0 0 0<br />

Other medical care/supplies 12 17 26 26 33<br />

Unknown 32 12 8 12 18<br />

Patients 300,502 314,420 331,323 350,074 359,311<br />

Total years at risk 239,602 251,534 264,872 279,819 290,957<br />

Fertile female patients (age >13) 139,789 145,634 152,619 160,436 163,938<br />

Fertile female years at risk 110,920 115,738 121,428 127,457 132,021<br />

Pediatric patients (age 64) 119,688 124,505 132,037 140,884 144,674<br />

Geriatric years at risk 85,820 90,028 95,365 101,671 106,014<br />

Patients of unknown age are excluded.<br />

The pediatric medicine rate uses pediatric (age 64) years at risk,<br />

& the obstetrics/gynecology rate uses fertile female (age >13) years at risk. All other rates are calculated using total years at risk.


Reference<br />

L<br />

Section<br />

Vascular<br />

access


L<br />

VASCULAR<br />

ACCESS<br />

Reference section L<br />

684<br />

L.1 . 685<br />

Catheter insertions in prevalent hemodialysis patients, per 1,000 patient years,<br />

with unknowns dropped<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

L.2 . 686<br />

Arteriovenous fistula insertions in prevalent hemodialysis patients, per 1,000<br />

patient years, with unknowns dropped<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

L.3 . 687<br />

Graft insertions in prevalent hemodialysis patients, per 1,000 patient years, with<br />

unknowns dropped<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

L.4 . 688<br />

Catheter intervention events: prevalent hemodialysis patients<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

L.5 . 690<br />

Arteriovenous fistula intervention events: prevalent hemodialysis patients<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

L.6 . 692<br />

Graft intervention events: prevalent hemodialysis patients<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

L.7 . 694<br />

Catheter complications: prevalent hemodialysis patients<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

L.8 . 696<br />

Arteriovenous fistula complications: prevalent hemodialysis patients<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

L.9 . 698<br />

Graft complications: prevalent hemodialysis patients<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

L.10 . 700<br />

Peritoneal dialysis complications: prevalent peritoneal dialysis patients<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

L.11 . 702<br />

Catheter insertions in hemodialysis patients, per 1,000 patient years, by ESRD<br />

vintage<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

L.12 . 703<br />

Arteriovenous fistula insertions in hemodialysis patients, per 1,000 patient years,<br />

by ESRD vintage<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

L.13 . 704<br />

Graft insertions in hemodialysis patients, per 1,000 patient years, by ESRD vintage<br />

by age, gender, race, ethnicity, & primary diagnosis


Table L.1 L.1<br />

Catheter insertions in in prevalent hemodialysis patients, per 1,000 patient years, with unknowns dropped<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

VASCULAR<br />

2005 Annual <strong>Data</strong><br />

ACCESSL<br />

Report<br />

1999 2000 2001 2002 2003<br />

0-4 1,152 1,270 2,284 1,259 1,241<br />

5-9 1,155 937 731 691 766<br />

10-14 789 588 659 859 568<br />

15-19 545 621 594 600 636<br />

20-29 571 551 603 575 548<br />

30-39 581 561 562 556 510<br />

40-49 539 526 540 519 483<br />

50-59 528 514 510 501 472<br />

60-64 522 506 493 482 465<br />

65-69 531 530 502 502 482<br />

70-79 528 502 497 483 458<br />

80+ 525 515 495 492 450<br />

0-19 639 647 642 668 642<br />

20-44 566 549 567 555 517<br />

45-64 528 513 509 495 468<br />

65-74 530 519 504 497 474<br />

75+ 525 504 491 482 450<br />

685<br />

Male 476 464 454 441 420<br />

Female 598 579 578 572 535<br />

White 506 490 487 474 456<br />

Black 580 567 557 550 506<br />

Native American 422 415 427 443 410<br />

Asian 406 392 394 384 371<br />

Hispanic 538 524 498 497 474<br />

Non-Hispanic 537 520 517 506 477<br />

Diabetes 597 574 564 552 520<br />

Hypertension 505 489 473 463 430<br />

Glomerulonephritis 461 454 456 431 418<br />

Cystic kidney 434 432 427 426 395<br />

Other urologic 525 482 522 506 489<br />

Other cause 523 518 544 539 513<br />

Unknown cause 508 495 460 479 435<br />

Missing disease 392 578 268 342 18<br />

All 534.5 518.8 512.9 502.2 473.2


L<br />

VASCULAR<br />

686<br />

ACCESS<br />

Reference section L<br />

Table L.2 L.2<br />

Arteriovenous fistula insertions in in prevalent hemodialysis patients, per 1,000 patient years, with unknowns dropped<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1999 2000 2001 2002 2003<br />

0-4 . . . 74.1 0.0<br />

5-9 56.3 36.1 . 30.0 95.8<br />

10-14 141.6 96.3 154.6 251.1 142.1<br />

15-19 83.7 146.9 102.3 149.4 133.4<br />

20-29 92.0 87.7 97.2 94.7 117.2<br />

30-39 84.3 86.1 87.6 95.8 99.4<br />

40-49 74.9 79.7 79.4 84.2 85.6<br />

50-59 62.4 67.7 70.3 72.1 79.8<br />

60-64 54.9 64.6 64.8 71.3 74.2<br />

65-69 61.8 67.3 69.6 76.1 82.6<br />

70-79 62.0 64.3 68.5 75.2 80.2<br />

80+ 58.5 55.3 65.4 70.5 72.2<br />

0-19 90.3 129.3 103.6 159.1 130.5<br />

20-44 83.0 87.2 87.5 93.3 98.5<br />

45-64 62.4 67.9 70.1 73.4 78.8<br />

65-74 61.3 65.7 69.1 74.6 83.2<br />

75+ 61.2 60.2 67.0 74.1 74.3<br />

Male 75.5 78.9 80.5 85.7 89.9<br />

Female 54.2 57.9 62.3 67.5 72.7<br />

White 67.9 70.5 75.5 81.5 86.6<br />

Black 62.8 67.7 68.1 71.9 76.2<br />

Native American 63.0 64.7 85.0 87.3 86.5<br />

Asian 51.8 57.8 56.2 70.3 73.1<br />

Hispanic 60.1 63.7 66.4 71.6 75.5<br />

Non-Hispanic 68.8 71.3 73.7 78.9 83.8<br />

Diabetes 61.6 66.3 70.0 75.0 78.9<br />

Hypertension 65.5 68.6 70.5 77.1 79.4<br />

Glomerulonephritis 68.0 69.5 73.4 75.6 86.5<br />

Cystic kidney 54.3 64.0 65.4 72.1 72.6<br />

Other urologic 79.2 77.6 76.2 83.2 90.5<br />

Other cause 74.9 80.8 84.3 84.6 98.3<br />

Unknown cause 69.7 69.0 73.8 91.6 88.9<br />

Missing disease 30.7 69.0 17.3 15.2 5.9<br />

All 65.3 68.9 71.9 77.2 81.9<br />

"."Zero values in this cell.


Table L.3 L.3<br />

Graft insertions in prevalent hemodialysis patients, per 1,000 patient years, with unknowns dropped<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

VASCULAR<br />

2005 Annual <strong>Data</strong><br />

ACCESSL<br />

Report<br />

1999 2000 2001 2002 2003<br />

0-4 . . . 74.1 .<br />

5-9 56.3 72.1 58.4 120.1 63.9<br />

10-14 50.6 32.1 82.4 57.9 56.8<br />

15-19 131.5 130.1 122.8 142.3 111.2<br />

20-29 173.4 149.4 140.0 134.9 121.5<br />

30-39 181.6 159.5 153.6 138.1 132.9<br />

40-49 177.7 159.8 150.2 140.3 132.5<br />

50-59 176.8 159.7 154.7 142.5 137.2<br />

60-64 172.4 158.2 146.8 148.6 133.2<br />

65-69 182.8 172.0 156.8 149.3 144.0<br />

70-79 172.8 160.6 153.9 148.3 138.4<br />

80+ 152.5 140.0 135.7 132.9 124.5<br />

0-19 109.8 107.5 109.3 124.1 97.0<br />

20-44 177.3 157.8 149.9 138.4 131.8<br />

45-64 176.3 159.3 151.5 143.8 134.7<br />

65-74 177.7 167.1 157.0 150.7 144.5<br />

75+ 163.6 150.1 143.4 138.7 127.8<br />

687<br />

Male 158.0 143.3 133.3 126.8 119.7<br />

Female 191.1 176.2 170.2 162.6 152.8<br />

White 153.6 142.6 135.4 127.1 120.0<br />

Black 202.2 181.8 173.2 167.4 157.3<br />

Native American 127.6 123.5 106.6 107.6 104.8<br />

Asian 156.6 148.9 136.9 130.4 122.2<br />

Hispanic 180.3 164.9 154.1 143.7 134.0<br />

Non-Hispanic 176.0 159.6 151.6 144.6 136.6<br />

Diabetes 193.2 176.2 165.1 157.9 147.2<br />

Hypertension 171.6 157.8 149.1 142.8 133.3<br />

Glomerulonephritis 150.5 135.5 129.8 118.4 113.4<br />

Cystic kidney 139.9 125.9 114.5 101.8 103.7<br />

Other urologic 158.7 156.5 145.7 136.1 132.8<br />

Other cause 154.7 138.9 144.1 136.4 133.9<br />

Unknown cause 158.9 140.9 127.9 126.0 110.3<br />

Missing disease 69.1 69.0 34.6 45.6 0.0<br />

All 173.9 158.9 150.8 143.6 135.1<br />

"."Zero values in this cell.


L<br />

VASCULAR<br />

688<br />

ACCESS<br />

Reference section L<br />

Table L.4 L.4<br />

Catheter intervention events: prevalent hemodialysis patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1999 2000 2001<br />

# pts % RM %RP %DC # pts % RM %RP %DC # pts % RM %RP %DC<br />

0-4 . . . . . . . . . . . .<br />

5-9 . . . . . . . . . . . .<br />

10-14 . . . . . . . . . . . .<br />

15-19 . . . . 3 * * * . . . .<br />

20-29 2 * * * 13 23 46 . 14 7 43 .<br />

30-39 40 13 33 . 48 21 25 6 51 8 25 .<br />

40-49 55 20 24 2 71 11 24 4 81 20 27 4<br />

50-59 80 13 24 4 94 20 35 4 109 16 27 5<br />

60-64 43 16 21 2 56 16 23 5 73 15 15 3<br />

65-69 59 12 24 3 77 8 14 4 68 15 22 3<br />

70-79 149 7 16 1 157 13 25 1 180 13 19 3<br />

80+ 68 9 18 . 80 18 24 3 94 13 17 3<br />

Unknown<br />

0-19 3 * * *<br />

20-44 67 18 27 1 92 21 25 3 104 13 32 2<br />

45-64 153 14 24 3 190 16 31 5 224 16 21 4<br />

65-74 133 8 20 2 152 9 20 3 166 14 21 3<br />

75+ 143 10 17 1 162 17 24 1 176 13 18 3<br />

Male 214 11 22 1 265 17 22 4 268 16 20 3<br />

Female 282 12 20 2 334 13 28 3 402 13 23 3<br />

Unknown<br />

White 264 11 22 2 320 12 22 2 376 15 23 2<br />

Black 205 12 21 2 254 18 30 5 267 13 21 4<br />

Native American 11 9 36 . 7 * * * 10 10 40 .<br />

Asian 10 . . . 14 21 21 . 16 13 19 6<br />

Other/unknown 6 * * * 4 * * * 1 * * *<br />

Hispanic 51 18 29 2 62 13 32 2 65 14 31 3<br />

Non-Hispanic 372 10 20 2 478 15 24 3 566 14 20 3<br />

Diabetes 199 9 20 2 243 14 26 4 267 12 21 3<br />

Hypertension 138 11 19 1 161 13 26 3 184 17 25 3<br />

Glomerulonephritis 62 10 18 2 69 17 23 4 86 14 21 1<br />

Cystic kidney 13 15 23 8 14 21 36 0 16 25 38 6<br />

Other urologic 17 12 24 12 30 13 20 0 22 14 23 14<br />

Other cause 48 21 31 . 58 19 24 3 69 10 16 .<br />

Unknown cause 19 21 32 . 24 17 25 4 26 19 19 .<br />

Missing disease<br />

All 496 11 21 2 599 15 25 3 670 14 22 3<br />

RM: removal; RP: replacement; DC: declot.<br />

<strong>Data</strong> represents prevalent hemodialysis patients who are in the USRDS and CPM databases.<br />

Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


VASCULAR<br />

2005 Annual <strong>Data</strong><br />

ACCESSL<br />

Report<br />

Table L.4 L.4 (continued)<br />

Catheter intervention events: prevalent hemodialysis patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

2002 2003<br />

# pts % RM %RP %DC # pts % RM %RP %DC<br />

0-4 . . . . . . . .<br />

5-9 . . . . . . . .<br />

10-14 . .<br />

15-19 2 * * * 1 * * *<br />

20-29 17 18 12 12 17 18 6 6<br />

30-39 38 24 18 . 42 17 19 2<br />

40-49 74 14 27 7 84 14 27 2<br />

50-59 119 19 23 3 129 13 17 3<br />

60-64 71 10 13 4 53 21 23 9<br />

65-69 85 20 20 . 79 15 23 3<br />

70-79 176 13 21 5 201 15 18 1<br />

80+ 117 15 22 2 101 16 18 2<br />

Unknown<br />

689<br />

0-19 2 * * * 1 * * *<br />

20-44 91 19 22 2 95 16 21 3<br />

45-64 228 15 20 5 230 15 20 4<br />

65-74 173 16 23 3 191 16 20 2<br />

75+ 205 14 20 2 190 14 18 2<br />

Male 286 12 18 2 292 15 20 2<br />

Female 413 18 23 4 415 15 19 3<br />

Unknown<br />

White 387 14 20 3 382 17 19 2<br />

Black 287 16 22 3 296 13 19 4<br />

Native American 13 31 23 8 9 * * *<br />

Asian 9 * * * 20 25 35 .<br />

Other/unknown 3 * * *<br />

Hispanic 52 17 21 6 65 17 18 5<br />

Non-Hispanic 624 16 21 3 611 16 19 2<br />

Diabetes 269 18 25 3 308 14 18 3<br />

Hypertension 201 13 16 3 177 16 21 3<br />

Glomerulonephritis 84 10 13 1 87 17 18 2<br />

Cystic kidney 16 31 56 . 21 10 19 5<br />

Other urologic 28 18 14 7 16 19 31 .<br />

Other cause 73 12 21 5 70 13 17 3<br />

Unknown cause 28 25 29 7 28 21 32 .<br />

Missing disease<br />

All 699 15 21 3 707 15 20 3<br />

RM: removal; RP: replacement; DC: declot.<br />

<strong>Data</strong> represents prevalent hemodialysis patients who are in the USRDS and CPM databases.<br />

Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


L<br />

VASCULAR<br />

690<br />

ACCESS<br />

Reference section L<br />

Table L.5 L.5<br />

Arteriovenous fistula intervention events: prevalent hemodialysis patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1999 2000 2001<br />

# pts % RM %RP %DC # pts % RM %RP %DC # pts % RM %RP %DC<br />

0-4 . . . . . . . . . . . .<br />

5-9 . . . . . . . . . . . .<br />

10-14 . . . . . . . . . . . .<br />

15-19 . . . . 2 * * * 4 * * *<br />

20-29 52 2 . 4 44 . 2 7 53 . . 4<br />

30-39 111 2 1 1 94 . . 2 112 . 1 4<br />

40-49 190 4 4 2 205 . . 4 199 . 1 4<br />

50-59 208 . 1 4 213 . 2 4 238 . 2 3<br />

60-64 102 . 1 3 101 1 2 . 124 . . 2<br />

65-69 150 . 1 3 125 . 3 2 140 . 1 3<br />

70-79 218 . 1 1 234 . 1 2 257 2 2 4<br />

80+ 69 . 1 . 86 . 1 2 112 . 1 2<br />

Unknown<br />

0-19 2 * * *<br />

20-44 248 3 2 2 238 . . 4 4 * * *<br />

45-64 415 1 1 3 419 . 2 3 264 . 1 4<br />

65-74 273 . . 2 254 . 2 2 462 . 1 3<br />

75+ 164 . 2 1 191 1 1 3 277 1 1 4<br />

Male 799 1 2 3 748 . 1 2 838 1 1 3<br />

Female 301 1 1 2 356 1 2 4 401 . 1 3<br />

Unknown<br />

White 612 1 2 2 642 . 2 2 698 1 1 2<br />

Black 398 2 1 4 383 . . 3 448 1 1 5<br />

Native American 41 . . . 35 . 3 3 36 . . 6<br />

Asian 40 3 . . 38 . . 8 46 . . 4<br />

Other/unknown 9 * * * 6 * * * 11 . . .<br />

Hispanic 128 1 1 2 127 1 2 2 142 1 . 6<br />

Non-Hispanic 790 1 1 2 884 . 1 3 1,016 1 1 3<br />

Diabetes 343 1 . 4 319 . 1 3 385 1 1 4<br />

Hypertension 312 1 2 2 323 1 1 2 373 1 1 4<br />

Glomerulonephritis 225 1 2 2 222 . 3 3 230 . 1 3<br />

Cystic kidney 45 2 . 2 42 . 2 . 58 . . 2<br />

Other urologic 38 3 5 . 48 . . 6 38 . . 3<br />

Other cause 95 2 3 1 95 . 2 3 113 1 1 3<br />

Unknown cause 42 . 2 . 55 . . 2 42 . . 2<br />

Missing disease<br />

All 1,100 1 1 2 1,104 . 1 3 1,239 1 1 3<br />

RM: removal; RP: replacement; DC: declot.<br />

<strong>Data</strong> represents prevalent hemodialysis patients who are in the USRDS and CPM databases.<br />

Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


VASCULAR<br />

2005 Annual <strong>Data</strong><br />

ACCESSL<br />

Report<br />

Table L.5 L.5 (continued)<br />

Arteriovenous fistula intervention events: prevalent hemodialysis patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

2002 2003<br />

# pts % RM %RP %DC # pts % RM %RP %DC<br />

0-4 . . . . . . . .<br />

5-9 . . . . . . . .<br />

10-14 . . . . . . . .<br />

15-19 . . . . 2 * * *<br />

20-29 47 . 2 2 49 2 . 6<br />

30-39 139 1 3 8 135 1 1 5<br />

40-49 210 . 2 3 249 1 2 5<br />

50-59 277 1 1 5 337 1 2 5<br />

60-64 143 1 1 4 142 . . 1<br />

65-69 151 1 1 5 159 1 . 2<br />

70-79 283 . . 2 280 1 2 4<br />

80+ 112 1 . 8 155 1 . 3<br />

Unknown<br />

691<br />

0-19 2 * * *<br />

20-44 280 . 3 5 300 1 1 6<br />

45-64 536 1 1 5 612 1 2 4<br />

65-74 289 . . 4 307 1 1 3<br />

75+ 257 . . 4 287 1 1 4<br />

Male 950 . 1 4 1,045 1 1 4<br />

Female 412 1 1 6 463 1 2 5<br />

Unknown<br />

White 773 1 1 4 888 1 1 3<br />

Black 498 . 2 6 511 . 2 5<br />

Native American 33 . . 9 39 3 . 10<br />

Asian 49 2 . 6 53 . . 4<br />

Other/unknown 9 * * * 17 . . 6<br />

Hispanic 178 1 1 3 229 . . 4<br />

Non-Hispanic 1,111 1 1 5 1,225 1 1 4<br />

Diabetes 487 1 1 6 530 1 . 5<br />

Hypertension 405 . 1 4 463 1 2 4<br />

Glomerulonephritis 243 . 2 3 249 1 2 4<br />

Cystic kidney 36 . . . 47 . . 2<br />

Other urologic 39 . . 3 45 . 2 2<br />

Other cause 100 . 1 4 113 2 . 4<br />

Unknown cause 52 . . 10 61 3 2 2<br />

Missing disease<br />

All 1,362 1 1 5 1,508 1 1 4<br />

RM: removal; RP: replacement; DC: declot.<br />

<strong>Data</strong> represents prevalent hemodialysis patients who are in the USRDS and CPM databases.<br />

Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


L<br />

VASCULAR<br />

692<br />

ACCESS<br />

Reference section L<br />

Table L.6 L.6<br />

Graft intervention events: prevalent hemodialysis patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1999 2000 2001<br />

# pts % RM %RP %DC # pts % RM %RP %DC # pts % RM %RP %DC<br />

0-4 . . . . . . . . . . . .<br />

5-9 . . . . . . . . . . . .<br />

10-14 . . . . . . . . .<br />

15-19 . . . . . . . . 1 * * *<br />

20-29 48 . 2 6 58 3 3 16 30 . . 10<br />

30-39 138 1 2 7 122 2 5 4 118 3 4 10<br />

40-49 294 2 4 5 264 3 2 7 267 2 3 12<br />

50-59 409 . 4 5 391 1 3 8 393 1 3 8<br />

60-64 235 2 3 6 269 3 3 6 238 2 3 10<br />

65-69 306 . 3 5 305 1 3 10 288 1 3 13<br />

70-79 607 1 2 6 567 1 1 9 556 2 3 9<br />

80+ 185 1 2 6 213 . 2 11 208 1 2 11<br />

Unknown<br />

0-19 1 * * *<br />

20-44 309 2 3 6 286 3 3 7 251 2 3 10<br />

45-64 815 1 4 6 818 2 3 7 795 2 3 10<br />

65-74 663 1 2 6 631 1 2 11 582 2 3 10<br />

75+ 435 1 2 6 454 1 2 8 470 1 2 11<br />

Male 1,034 1 3 6 1,022 2 3 8 940 2 3 10<br />

Female 1,188 1 3 6 1,167 2 2 9 1,159 1 3 10<br />

Unknown<br />

White 1,048 1 3 6 1,069 1 2 8 1,020 2 2 10<br />

Black 1,034 1 3 6 993 2 3 9 964 1 3 11<br />

Native American 45 2 . 4 35 3 . 11 32 . 3 .<br />

Asian 75 . 5 . 81 . 1 7 66 . 5 12<br />

Other/unknown 20 5 5 . 11 9 9 9 17 . 6 .<br />

Hispanic 239 1 4 6 218 2 4 7 246 2 3 11<br />

Non-Hispanic 1,611 1 2 6 1,758 1 2 9 1,708 1 3 10<br />

Diabetes 906 . 3 7 890 2 2 9 914 1 2 9<br />

Hypertension 662 1 4 6 647 2 2 8 650 1 3 11<br />

Glomerulonephritis 293 2 3 4 294 1 3 9 233 3 3 12<br />

Cystic kidney 54 . . 2 77 . 3 6 51 . . .<br />

Other urologic 58 . 2 3 63 . 5 5 63 2 2 10<br />

Other cause 163 2 3 9 148 3 1 6 118 3 2 12<br />

Unknown cause 85 1 1 2 70 3 3 13 70 1 4 10<br />

Missing disease 1 * * *<br />

All 2,222 1 3 6 2,189 2 2 8 2,099 2 3 10<br />

RM: removal; RP: replacement; DC: declot.<br />

<strong>Data</strong> represents prevalent hemodialysis patients who are in the USRDS and CPM databases.<br />

Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


VASCULAR<br />

2005 Annual <strong>Data</strong><br />

ACCESSL<br />

Report<br />

Table L.6 L.6 (continued)<br />

Graft intervention events: prevalent hemodialysis patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

2002 2003<br />

# pts % RM %RP %DC # pts % RM %RP %DC<br />

0-4 . . . . . . . .<br />

5-9 . . . . . . . .<br />

10-14 . . . . . . . .<br />

15-19 . 1 * * *<br />

20-29 28 . . 18 33 3 3 21<br />

30-39 121 1 1 21 111 3 3 15<br />

40-49 224 2 3 12 238 2 . 13<br />

50-59 371 2 3 9 367 1 2 14<br />

60-64 229 1 1 13 215 1 4 14<br />

65-69 292 1 2 14 273 . 3 14<br />

70-79 529 1 1 13 486 1 2 12<br />

80+ 219 1 . 14 221 2 2 14<br />

Unknown<br />

693<br />

0-19 1 * * *<br />

20-44 253 2 1 18 240 3 2 19<br />

45-64 720 2 2 10 724 1 2 13<br />

65-74 576 1 2 14 526 1 2 13<br />

75+ 464 1 . 13 454 1 2 13<br />

Male 911 2 1 13 897 1 2 14<br />

Female 1,102 1 2 13 1,048 1 2 13<br />

Unknown<br />

White 970 1 1 14 929 1 2 13<br />

Black 929 1 2 12 887 2 2 15<br />

Native American 27 7 . . 39 . . 10<br />

Asian 73 1 4 16 69 . 3 14<br />

Other/unknown 14 . . 21 21 . . 5<br />

Hispanic 254 1 2 14 233 . 2 15<br />

Non-Hispanic 1,670 1 1 13 1,657 1 2 14<br />

Diabetes 886 1 1 13 839 1 2 14<br />

Hypertension 567 1 3 12 593 2 3 13<br />

Glomerulonephritis 259 2 3 15 212 1 . 14<br />

Cystic kidney 61 5 . 5 49 . 4 16<br />

Other urologic 55 . 2 15 52 4 6 8<br />

Other cause 123 2 . 10 144 1 3 11<br />

Unknown cause 62 2 2 16 56 . . 20<br />

Missing disease<br />

All 2,013 1 2 13 1,945 1 2 14<br />

RM: removal; RP: replacement; DC: declot.<br />

<strong>Data</strong> represents prevalent hemodialysis patients who are in the USRDS and CPM databases.<br />

Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


L<br />

VASCULAR<br />

694<br />

ACCESS<br />

Reference section L<br />

Table L.7 L.7<br />

Catheter complications: prevalent hemodialysis patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1999 2000 2001<br />

# pts %H % I % S # pts %H % I % S # pts %H % I % S<br />

0-4 . . . . . . . . . . . .<br />

5-9 . . . . . . . . . . . .<br />

10-14 . . . . . . . . .<br />

15-19 . 3 * * * . . . .<br />

20-29 2 * * * 13 . 8 . 14 7 21 21<br />

30-39 40 5 18 13 48 2 17 17 51 4 6 10<br />

40-49 55 . 18 15 71 3 11 8 81 4 12 11<br />

50-59 80 . 13 23 94 4 12 13 109 3 13 12<br />

60-64 43 . 7 7 56 2 7 9 73 4 12 11<br />

65-69 59 2 15 17 77 . 1 5 68 3 9 21<br />

70-79 149 1 8 9 157 3 6 10 180 4 13 14<br />

80+ 68 6 13 21 80 3 9 13 94 2 13 18<br />

Unknown<br />

0-19 3 * * *<br />

20-44 67 4 16 12 92 2 14 13 104 5 10 10<br />

45-64 153 . 13 17 190 3 10 10 224 3 13 13<br />

65-74 133 2 10 11 152 3 5 10 166 3 11 17<br />

75+ 143 3 12 15 162 2 7 9 176 3 13 16<br />

Male 214 1 15 18 265 2 9 9 268 4 11 13<br />

Female 282 2 10 11 334 3 8 11 402 3 13 15<br />

Unknown<br />

White 264 2 13 14 320 3 7 9 376 4 12 13<br />

Black 205 2 11 14 254 2 10 12 267 3 11 15<br />

Native American 11 . 45 55 7 * * * 10 10 40 50<br />

Asian 10 . . . 14 . 7 . 16 . . .<br />

Other/unknown 6 * * * 4 * * * 1 * * *<br />

Hispanic 51 . 14 18 62 5 11 11 65 5 20 22<br />

Non-Hispanic 372 2 12 14 478 2 8 10 566 4 11 13<br />

Diabetes 199 3 13 18 243 2 10 11 267 4 13 16<br />

Hypertension 138 1 12 12 161 2 6 5 184 3 12 16<br />

Glomerulonephritis 62 . 10 10 69 3 4 12 86 1 10 10<br />

Cystic kidney 13 . 23 . 14 7 14 21 16 . 13 13<br />

Other urologic 17 6 29 18 30 3 13 20 22 9 . .<br />

Other cause 48 2 6 13 58 5 9 10 69 4 9 10<br />

Unknown cause 19 5 11 21 24 . 8 13 26 4 19 15<br />

Missing disease<br />

All 496 2 12 14 599 3 8 10 670 3 12 14<br />

H: IP hospital stay with a diagnosis code of 996.1 "Mechanical complication of vascular device, implant, and graft."<br />

I: IP hospital stay with a diagnosis of a device infection.<br />

S: IP hospital stay with a diagnosis of sepsis.<br />

<strong>Data</strong> represents prevalent hemodialysis patients who are in the USRDS and CPM databases.<br />

Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


VASCULAR<br />

2005 Annual <strong>Data</strong><br />

ACCESSL<br />

Report<br />

Table L.7 L.7 (continued)<br />

Catheter complications: prevalent hemodialysis patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

2002 2003<br />

# pts %H % I % S # pts %H % I % S<br />

0-4 . . . . . . . .<br />

5-9 . . . . . . . .<br />

10-14 . . . . . . . .<br />

15-19 2 * * * 1 * * *<br />

20-29 17 . 12 12 17 . 12 .<br />

30-39 38 3 21 18 42 . 10 10<br />

40-49 74 4 12 9 84 . 19 11<br />

50-59 119 7 17 13 129 2 16 14<br />

60-64 71 . 15 14 53 4 15 11<br />

65-69 85 5 11 9 79 4 10 13<br />

70-79 176 2 15 16 201 3 9 15<br />

80+ 117 2 12 16 101 1 14 15<br />

Unknown<br />

695<br />

0-19 2 * * * 1 * * *<br />

20-44 91 3 15 13 95 . 12 6<br />

45-64 228 4 16 13 230 2 17 13<br />

65-74 173 5 12 12 191 4 9 14<br />

75+ 205 1 14 18 190 2 12 15<br />

Male 286 2 12 13 292 2 14 14<br />

Female 413 4 16 15 415 2 12 12<br />

Unknown<br />

White 387 2 14 14 382 2 11 13<br />

Black 287 5 14 14 296 1 16 14<br />

Native American 13 . 23 8 9 * * *<br />

Asian 9 * * * 20 5 10 15<br />

Other/unknown 3 * * *<br />

Hispanic 52 . 19 15 65 5 11 9<br />

Non-Hispanic 624 3 13 14 611 2 13 14<br />

Diabetes 269 3 17 18 308 3 15 17<br />

Hypertension 201 4 13 12 177 3 12 12<br />

Glomerulonephritis 84 1 14 11 87 . 8 8<br />

Cystic kidney 16 . 13 13 21 . 10 10<br />

Other urologic 28 4 14 11 16 . 6 13<br />

Other cause 73 1 10 10 70 . 10 9<br />

Unknown cause 28 7 11 11 28 . 18 4<br />

Missing disease<br />

All 699 3 14 14 707 2 13 13<br />

H: IP hospital stay with a diagnosis code of 996.1 "Mechanical complication of vascular device, implant, and graft."<br />

I: IP hospital stay with a diagnosis of a device infection.<br />

S: IP hospital stay with a diagnosis of sepsis.<br />

<strong>Data</strong> represents prevalent hemodialysis patients who are in the USRDS and CPM databases.<br />

Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


L<br />

Vascular<br />

696<br />

access<br />

Reference section L<br />

Table L.8<br />

Table<br />

L.8<br />

L.8<br />

by Arteriovenous age, gender, race, fistula by age, gender, race,<br />

ethnicity, complications:<br />

ethnicity, primary<br />

primary<br />

diagnosis prevalent hemodialysis patients<br />

diagnosis<br />

by age, gender, race, ethnicity, & primary diagnosis<br />

1999 2000 2001<br />

1999 2000 2001<br />

pts %H pts %H pts %H # pts %H % I % S # pts %H % I % S # pts %H % I % S<br />

0-4 0-4 . . . . . . . . . . . .<br />

5-9 5-9 . . . . . . . . . . . .<br />

10-14 10-14 . . . . . . . . . . . .<br />

15-19 15-19 . . . . 2 * * * 4<br />

20-29 52 44 53 20-29 52 . . . 44 . 2 . 53 * * *<br />

30-39 111 94 112 30-39 111 . 3 2 94 . 2 2 112 . 2 2<br />

40-49 190 205 199 40-49 190 1 2 3 205 . 1 2 199 . 3 2<br />

50-59 208 213 238 50-59 208 . . 4 213 1 1 4 238 1 1 3<br />

60-64 102 101 124 60-64 102 . . 2 101 . . 2 124 . 1 5<br />

65-69 150 125 140 65-69 150 1 1 5 125 . 2 6 140 . . 5<br />

70-79 218 234 257 70-79 218 1 . 2 234 1 1 6 257 1 2 4<br />

80+ 69 86 112 80+ 69 . 1 7 86 . . 6 112 1 2 5<br />

Unknown<br />

Unknown<br />

0-19 0-19 2 * * *<br />

20-44 248 238 20-44 248 . 2 1 238 . 2 1 4 * * *<br />

45-64 415 419 264 45-64 415 . 1 3 419 1 1 3 264 . 2 2<br />

65-74 273 254 462 65-74 273 1 1 4 254 1 2 5 462 . 1 4<br />

75+ 164 191 277 75+ 164 1 1 4 191 . 1 7 277 1 2 5<br />

Male 799 748 838 Male 799 . 1 3 748 . 1 4 838 . 1 4<br />

Female 301 356 401 Female 301 1 1 5 356 1 2 4 401 1 3 5<br />

Unknown<br />

Unknown<br />

White 612 642 698 White 612 . 1 3 642 . 1 4 698 . 1 4<br />

Black 398 383 448 Black 398 1 . 4 383 1 3 4 448 . 2 5<br />

Native American 41 35 36 Native American 41 . 2 2 35 . . 9 36 . 3 .<br />

Asian 40 38 46 Asian 40 . 5 . 38 . 3 3 46 . . 4<br />

Other/unknown 11 Other/unknown 9 * * * 6 * * * 11 . . .<br />

Hispanic 128 127 142 Hispanic 128 1 1 4 127 1 1 7 142 1 1 5<br />

Non-Hispanic 790 884 1,016 Non-Hispanic 790 . 1 3 884 1 2 3 1,016 . 2 4<br />

Diabetes 343 319 385 Diabetes 343 . 1 5 319 1 1 5 385 1 1 5<br />

Hypertension 312 323 373 Hypertension 312 1 . 3 323 . 2 4 373 1 2 5<br />

Glomerulonephritis 225 222 230 Glomerulonephritis 225 1 2 2 222 . 2 4 230 . 1 4<br />

Cystic kidney 45 42 58 Cystic kidney 45 . . 4 42 . . 2 58 2 . 2<br />

Other urologic 38 48 38 Other urologic 38 . 3 3 48 2 . 4 38 . . .<br />

Other cause 95 95 113 Other cause 95 . . 4 95 . . 1 113 . 1 5<br />

Unknown cause 42 55 42 Unknown cause 42 2 . . 55 . . 2 42 . 2 .<br />

Missing disease<br />

Missing disease<br />

All 1,100 1,104 1,239 All 1,100 1 1 3 1,104 1 1 4 1,239 . 2 4<br />

H: IP hospital stay with diagnosis code of 996.1 "Mechanical complication of vascular device, implant, and graft."<br />

H: IP hospital stay with a diagnosis code of 996.1 "Mechanical complication of vascular device, implant, and graft."<br />

I: IP hospital stay with diagnosis of device infection.<br />

I: IP hospital stay with a diagnosis of a device infection.<br />

S: IP hospital stay with diagnosis of sepsis.<br />

S: IP hospital stay with a diagnosis of sepsis.<br />

<strong>Data</strong> represents prevalent hemodialysis patients who are in the USRDS and CPM databases.<br />

<strong>Data</strong> represents prevalent hemodialysis patients who are in the USRDS and CPM databases.<br />

Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.<br />

Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.<br />

"."Zero values in this cell.


VASCULAR<br />

2005 Annual <strong>Data</strong><br />

ACCESSL<br />

Report<br />

Table L.8 L.8 (continued)<br />

Arteriovenous fistula complications: prevalent hemodialysis patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

2002 2003<br />

# pts %H % I % S # pts %H % I % S<br />

0-4 . . . . . . . .<br />

5-9 . . . . . . . .<br />

10-14 . . . . . . . .<br />

15-19 . . . . 2 * * *<br />

20-29 47 . 2 . 49 2 2 2<br />

30-39 139 . . 1 135 . 3 3<br />

40-49 210 1 1 3 249 . 2 4<br />

50-59 277 . 1 3 337 1 1 3<br />

60-64 143 . 1 4 142 1 . 3<br />

65-69 151 1 2 2 159 2 1 4<br />

70-79 283 . . 5 280 1 1 3<br />

80+ 112 2 1 4 155 . 1 4<br />

Unknown<br />

697<br />

0-19 2 * * *<br />

20-44 280 . 1 2 300 . 2 3<br />

45-64 536 1 1 3 612 1 1 3<br />

65-74 289 . 1 3 307 2 1 3<br />

75+ 257 1 . 6 287 . 1 4<br />

Male 950 1 1 3 1045 1 1 3<br />

Female 412 . 1 3 463 1 2 3<br />

Unknown<br />

White 773 1 . 4 888 1 1 3<br />

Black 498 . 2 3 511 . 2 3<br />

Native American 33 . 3 . 39 3 . 8<br />

Asian 49 2 2 . 53 2 2 .<br />

Other/unknown 9 * * * 17 . . 6<br />

Hispanic 178 1 1 2 229 1 2 4<br />

Non-Hispanic 1,111 . 1 3 1225 1 1 3<br />

Diabetes 487 . 1 4 530 1 1 5<br />

Hypertension 405 . 1 3 463 . 2 3<br />

Glomerulonephritis 243 . 1 2 249 2 1 2<br />

Cystic kidney 36 3 3 8 47 2 . 6<br />

Other urologic 39 . . 3 45 . 2 .<br />

Other cause 100 1 1 1 113 1 3 2<br />

Unknown cause 52 . . 6 61 . . 3<br />

Missing disease<br />

All 1,362 1 1 3 1,508 1 1 3<br />

H: IP hospital stay with a diagnosis code of 996.1 "Mechanical complication of vascular device, implant, and graft."<br />

I: IP hospital stay with a diagnosis of a device infection.<br />

S: IP hospital stay with a diagnosis of sepsis.<br />

<strong>Data</strong> represents prevalent hemodialysis patients who are in the USRDS and CPM databases.<br />

Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


L<br />

VASCULAR<br />

698<br />

ACCESS<br />

Reference section L<br />

Table L.9 L.9<br />

Graft complications: prevalent hemodialysis patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1999 2000 2001<br />

# pts %H % I % S # pts %H % I % S # pts %H % I % S<br />

0-4 . . . . . . . . . . . .<br />

5-9 . . . . . . . . . . . .<br />

10-14 . . . . . . . . . . . .<br />

15-19 . . . . . . . . 1 * * *<br />

20-29 48 2 . . 58 . 7 3 30 . . .<br />

30-39 138 1 2 4 122 1 3 2 118 1 3 5<br />

40-49 294 1 3 4 264 2 3 5 267 1 3 3<br />

50-59 409 1 2 5 391 1 2 3 393 1 3 3<br />

60-64 235 . 3 4 269 1 4 6 238 . 2 6<br />

65-69 306 1 1 4 305 1 1 4 288 . 1 6<br />

70-79 607 1 3 6 567 . 2 6 556 1 3 5<br />

80+ 185 . 3 8 213 1 . 2 208 1 3 5<br />

Unknown . . . . . . . . . . . .<br />

0-19 1 * * *<br />

20-44 309 1 2 3 286 1 4 3 251 1 2 4<br />

45-64 815 1 2 5 818 1 3 5 795 1 2 4<br />

65-74 663 1 2 6 631 1 1 5 582 1 3 7<br />

75+ 435 1 3 6 454 1 1 4 470 1 3 4<br />

Male 1,034 1 3 5 1,022 1 2 4 940 1 3 4<br />

Female 1,188 1 2 5 1,167 1 3 5 1,159 1 2 5<br />

Unknown . . . . . . . . . . . .<br />

White 1,048 1 2 5 1,069 1 2 4 1,020 1 3 4<br />

Black 1,034 1 2 5 993 1 3 4 964 1 2 5<br />

Native American 45 2 9 9 35 3 6 6 32 . 3 13<br />

Asian 75 1 4 3 81 . . 4 66 . 2 .<br />

Other/unknown 20 . 5 . 11 9 . . 17 . . 12<br />

Hispanic 239 1 3 5 218 1 1 3 246 2 3 6<br />

Non-Hispanic 1,611 1 2 5 1,758 1 2 5 1,708 1 2 4<br />

Diabetes 906 1 2 5 890 1 2 5 914 1 2 6<br />

Hypertension 662 1 2 4 647 1 3 4 650 1 3 3<br />

Glomerulonephritis 293 1 3 5 294 1 3 3 233 . 2 5<br />

Cystic kidney 54 . 2 4 77 . . 4 51 . 2 10<br />

Other urologic 58 . 5 7 63 3 . 3 63 3 3 .<br />

Other cause 163 2 4 7 148 . 4 3 118 1 3 5<br />

Unknown cause 85 . 1 4 70 . 1 3 70 1 3 3<br />

Missing disease 1 * * *<br />

All 2,222 1 2 5 2,189 1 2 4 2,099 1 2 5<br />

H: IP hospital stay with a diagnosis code of 996.1 "Mechanical complication of vascular device, implant, and graft."<br />

I: IP hospital stay with a diagnosis of a device infection.<br />

S: IP hospital stay with a diagnosis of sepsis.<br />

<strong>Data</strong> represents prevalent hemodialysis patients who are in the USRDS and CPM databases.<br />

Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


VASCULAR<br />

2005 Annual <strong>Data</strong><br />

ACCESSL<br />

Report<br />

Table L.9 L.9 (continued)<br />

Graft complications: prevalent hemodialysis patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

2002 2003<br />

# pts %H % I % S # pts %H % I % S<br />

0-4 . . . . . . . .<br />

5-9 . . . . . . . .<br />

10-14 . . . . . . . .<br />

15-19 . . . . 1 * * *<br />

20-29 28 . 7 . 33 . 3 3<br />

30-39 121 1 4 2 111 1 6 7<br />

40-49 224 2 2 4 238 . 2 3<br />

50-59 371 . 2 5 367 1 1 2<br />

60-64 229 . 3 2 215 . 4 5<br />

65-69 292 1 3 4 273 1 4 7<br />

70-79 529 1 2 5 486 1 2 5<br />

80+ 219 2 1 7 221 1 4 7<br />

Unknown<br />

699<br />

0-19 1 * * *<br />

20-44 253 2 4 3 240 . 5 5<br />

45-64 720 . 3 4 724 . 2 4<br />

65-74 576 1 2 5 526 1 3 6<br />

75+ 464 2 2 6 454 1 2 6<br />

Male 911 1 2 5 897 1 2 5<br />

Female 1,102 1 2 4 1,048 1 3 5<br />

Unknown<br />

White 970 1 2 5 929 1 2 5<br />

Black 929 1 2 4 887 1 3 4<br />

Native American 27 . 7 11 39 3 3 3<br />

Asian 73 1 . 3 69 1 1 7<br />

Other/unknown 14 . . . 21 . . 5<br />

Hispanic 254 1 2 5 233 . 2 6<br />

Non-Hispanic 1,670 1 2 4 1,657 1 3 5<br />

Diabetes 886 2 2 6 839 1 3 6<br />

Hypertension 567 1 2 5 593 1 3 4<br />

Glomerulonephritis 259 . 3 2 212 1 2 5<br />

Cystic kidney 61 2 2 3 49 . . .<br />

Other urologic 55 . 2 2 52 . . 8<br />

Other cause 123 . 3 3 144 1 3 3<br />

Unknown cause 62 . 3 5 56 2 4 9<br />

Missing disease<br />

All 2,013 1 2 5 1,945 1 3 5<br />

H: IP hospital stay with a diagnosis code of 996.1 "Mechanical complication of vascular device, implant, and graft."<br />

I: IP hospital stay with a diagnosis of a device infection.<br />

S: IP hospital stay with a diagnosis of sepsis.<br />

<strong>Data</strong> represents prevalent hemodialysis patients who are in the USRDS and CPM databases.<br />

Access represents the current access at the time of CPM data collection Includes only patients for whom the access is known.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


L<br />

VASCULAR<br />

700<br />

ACCESS<br />

Reference section L<br />

Table L.10 L.10<br />

Peritoneal dialysis complications: prevalent peritoneal dialysis patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

1999 2000 2001<br />

# pts % I % P % S # pts % I % P % S # pts % I % P % S<br />

0-4 47 17 23 6 45 7 11 . 60 15 20 5<br />

5-9 40 10 15 3 49 24 41 2 58 17 22 5<br />

10-14 108 12 19 1 88 13 20 2 101 13 24 2<br />

15-19 172 11 18 2 175 14 23 2 178 16 20 2<br />

20-29 963 13 21 2 887 13 20 2 898 13 20 3<br />

30-39 2,000 14 20 3 1,931 14 21 4 1,867 13 20 3<br />

40-49 3,097 14 20 3 2,866 13 20 3 2,807 15 21 4<br />

50-59 3,278 14 21 4 3,323 14 20 4 3,264 13 19 5<br />

60-64 1,652 12 19 5 1,541 13 20 5 1,545 12 18 6<br />

65-69 2,067 12 20 5 1,970 13 19 5 1,898 12 19 6<br />

70-79 3,253 11 20 5 3,003 11 19 6 2,885 12 19 5<br />

80+ 762 13 21 6 737 13 19 6 738 10 17 6<br />

Unknown<br />

0-19 367 12 19 2 357 14 24 2 397 15 21 3<br />

20-44 4,387 14 20 3 4,167 14 20 3 4,051 14 20 3<br />

45-64 6,603 13 20 4 6,381 13 20 4 6,330 13 19 5<br />

65-74 4,039 12 20 5 3,782 12 19 5 3,598 12 19 6<br />

75+ 2,043 12 20 6 1,928 13 19 6 1,923 11 19 6<br />

Male 8,787 12 19 4 8,291 12 18 4 8,182 12 18 4<br />

Female 8,652 14 21 4 8,324 14 21 5 8,117 14 21 5<br />

Unknown<br />

White 11,596 12 18 4 11,012 12 18 4 10,736 11 17 5<br />

Black 4,773 16 25 4 4,551 15 24 4 4,494 16 24 5<br />

Native American 245 14 20 2 222 13 18 4 222 16 23 4<br />

Asian 665 12 17 5 676 11 16 5 699 13 16 5<br />

Other/unknown 160 13 21 7 154 14 17 5 148 20 22 7<br />

Hispanic 1,862 15 20 4 1,883 14 20 5 1,938 15 20 5<br />

Non-Hispanic 13,776 12 20 4 13,675 13 20 4 13,734 13 19 5<br />

Diabetes 5,700 14 21 6 5,427 13 20 6 5,304 13 19 7<br />

Hypertension 4,283 13 20 4 4,108 13 20 4 4,086 13 20 4<br />

Glomerulonephritis 3,627 12 19 3 3,346 12 19 3 3,305 12 18 3<br />

Cystic kidney 733 11 18 4 708 11 18 4 666 11 18 3<br />

Other urologic 486 14 19 2 483 15 21 3 488 12 17 5<br />

Other cause 1,885 12 20 4 1,878 14 21 5 1,802 14 20 4<br />

Unknown cause 711 14 22 3 653 13 20 4 636 12 18 4<br />

Missing disease 14 . . . 12 . . 8 12 8 17 8<br />

All 17,439 13 20 4 16,615 13 20 4 16,299 13 19 5<br />

I: IP hospital stay with a diagnosis of a device infection.<br />

P: IP hospital stay with a diagnosis of peritonitis.<br />

S: IP hospital stay with a diagnosis of sepsis.<br />

** PD not merged with CPM data.<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


VASCULAR<br />

2005 Annual <strong>Data</strong><br />

ACCESSL<br />

Report<br />

Table L.10 L.10 (continued)<br />

Peritoneal dialysis complications: prevalent peritoneal dialysis patients<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

2002 2003<br />

# pts % I % P % S # pts % I % P % S<br />

0-4 56 11 25 2 75 13 27 7<br />

5-9 63 10 19 3 75 12 21 1<br />

10-14 106 17 24 . 133 14 22 2<br />

15-19 165 9 27 1 158 12 27 4<br />

20-29 937 11 19 2 895 13 20 3<br />

30-39 1,874 12 21 4 1,912 12 20 3<br />

40-49 2,760 13 20 4 2,826 13 21 5<br />

50-59 3,370 12 20 5 3,459 12 20 5<br />

60-64 1,489 12 20 6 1,559 12 19 5<br />

65-69 1,948 12 21 6 1,874 12 19 6<br />

70-79 2,878 10 17 5 2,974 11 19 6<br />

80+ 824 10 18 8 864 10 18 4<br />

Unknown<br />

701<br />

0-19 390 12 24 1 441 13 24 3<br />

20-44 4,063 13 21 3 4,031 13 20 3<br />

45-64 6,367 12 20 5 6,620 12 20 5<br />

65-74 3,603 11 19 5 3,580 12 19 6<br />

75+ 2,047 10 18 7 2,132 9 19 5<br />

Male 8,283 11 19 4 8,533 11 19 5<br />

Female 8,187 12 21 5 8,271 13 20 5<br />

Unknown<br />

White 10,897 11 18 5 11,078 11 18 5<br />

Black 4,436 14 24 5 4,515 14 23 5<br />

Native American 239 11 26 4 257 13 21 6<br />

Asian 732 11 16 3 763 9 14 5<br />

Other/unknown 166 16 25 6 191 13 22 5<br />

Hispanic 1,929 13 20 5 2,087 13 21 6<br />

Non-Hispanic 14,136 11 20 5 14,437 12 19 5<br />

Diabetes 5,430 12 21 6 5,568 12 20 7<br />

Hypertension 3,949 12 19 4 4,109 11 19 4<br />

Glomerulonephritis 3,290 11 19 4 3,314 11 19 4<br />

Cystic kidney 673 10 16 4 634 11 18 3<br />

Other urologic 546 10 19 6 551 9 16 4<br />

Other cause 1,897 13 22 5 1,954 14 22 4<br />

Unknown cause 675 9 18 3 651 12 19 4<br />

Missing disease 10 10 10 . 23 . . .<br />

All 16,470 12 20 5 16,804 12 20 5<br />

I: IP hospital stay with a diagnosis of a device infection.<br />

P: IP hospital stay with a diagnosis of peritonitis.<br />

S: IP hospital stay with a diagnosis of sepsis.<br />

** PD not merged with CPM data.<br />

"."Zero values in this cell.


L<br />

VASCULAR<br />

702<br />

ACCESS<br />

Reference section L<br />

Table L.11 L.11<br />

Catheter insertions in in hemodialysis patients, per 1,000 patient years, by by ESRD vintage<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

# Patients < 6 mo. 6 mo.-1 yr 1-2 yrs 2-5 yrs 5+ yrs<br />

0-4 21 * * * * .<br />

5-9 47 * * 647 1,064 *<br />

10-14 142 68 408 829 690 663<br />

15-19 531 726 450 719 605 656<br />

20-29 5,171 636 666 577 549 491<br />

30-39 13,461 678 595 570 505 451<br />

40-49 26,702 623 564 503 470 441<br />

50-59 39,535 643 521 487 460 421<br />

60-64 22,417 600 510 468 446 425<br />

65-69 27,478 665 518 468 449 440<br />

70-79 53,652 667 472 438 415 422<br />

80+ 26,378 675 475 430 397 379<br />

0-19 741 693 447 723 651 655<br />

20-44 30,019 658 613 557 514 461<br />

45-64 77,267 623 520 480 452 423<br />

65-74 55,475 672 508 450 435 436<br />

75+ 52,033 665 460 438 402 395<br />

Male 115,287 598 456 408 390 385<br />

Female 100,247 716 571 539 506 486<br />

White 117,636 641 478 448 422 404<br />

Black 84,944 682 579 519 482 464<br />

Native American 3,339 624 462 393 385 369<br />

Asian 7,637 473 390 343 366 357<br />

Other/unknown 1,979 1,066 532 522 460 329<br />

Hispanic 27,111 735 540 493 421 406<br />

Non-Hispanic 183,520 643 506 467 448 444<br />

Diabetes 90,716 687 542 517 480 485<br />

Hypertension 62,994 612 478 404 396 401<br />

Glomerulonephritis 24,940 540 428 444 411 393<br />

Cystic kidney 5,430 457 433 402 403 369<br />

Other urologic 6,035 716 515 472 493 417<br />

Other cause 17,334 770 542 516 465 466<br />

Unknown cause 7,840 608 481 377 411 408<br />

Missing disease 246 . . . 31 .<br />

All 215,535 653 509 469 444 431<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


Table L.12 L.12<br />

Arteriovenous fistula insertions in in hemodialysis patients, per 1,000 patient years, by by ESRD vintage<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

VASCULAR<br />

2005 Annual <strong>Data</strong><br />

ACCESSL<br />

Report<br />

# Patients < 6 mo. 6 mo.-1 yr 1-2 yrs 2-5 yrs 5+ yrs<br />

0-4 21 * * * * .<br />

5-9 47 * * 92 . *<br />

10-14 142 68 58 . 207 232<br />

15-19 531 299 156 90 99 120<br />

20-29 5,171 240 190 109 99 91<br />

30-39 13,461 228 134 97 89 79<br />

40-49 26,702 220 127 73 69 68<br />

50-59 39,535 203 108 70 65 61<br />

60-64 22,417 198 107 63 57 51<br />

65-69 27,478 234 104 73 51 56<br />

70-79 53,652 228 97 70 50 46<br />

80+ 26,378 197 81 58 43 41<br />

0-19 741 216 124 76 114 143<br />

20-44 30,019 228 145 90 86 78<br />

45-64 77,267 204 110 69 62 60<br />

65-74 55,475 236 104 72 51 53<br />

75+ 52,033 207 84 62 45 42<br />

703<br />

Male 115,287 241 115 77 64 65<br />

Female 100,247 189 93 63 52 54<br />

White 117,636 225 103 70 57 64<br />

Black 84,944 208 108 70 59 57<br />

Native American 3,339 179 109 102 71 59<br />

Asian 7,637 152 107 80 52 58<br />

Other/unknown 1,979 262 96 64 79 49<br />

Hispanic 27,111 217 91 66 50 58<br />

Non-Hispanic 183,520 217 107 71 60 61<br />

Diabetes 90,716 201 101 65 55 51<br />

Hypertension 62,994 220 102 66 56 56<br />

Glomerulonephritis 24,940 237 115 90 69 71<br />

Cystic kidney 5,430 173 80 85 60 63<br />

Other urologic 6,035 265 125 82 59 63<br />

Other cause 17,334 263 132 87 69 69<br />

Unknown cause 7,840 247 102 84 68 52<br />

Missing disease 246 18 . . . .<br />

All 215,535 217 105 70 58 60<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


L<br />

VASCULAR<br />

Reference<br />

704<br />

VASCULAR ACCESS<br />

Reference section L<br />

Table L.13 L.13<br />

Graft insertions in hemodialysis patients, per 1,000 patient years, by by ESRD vintage<br />

by<br />

by<br />

age,<br />

age,<br />

gender,<br />

gender,<br />

race,<br />

race,<br />

ethnicity,<br />

ethnicity, &<br />

primary<br />

primary<br />

diagnosis<br />

diagnosis<br />

# Patients < 6 mo. 6 mo.-1 yr 1-2 yrs 2-5 yrs 5+ yrs<br />

0-4 21 * * * * .<br />

5-9 47 * * . 152 *<br />

10-14 142 68 . 69 34 100<br />

15-19 531 43 121 116 169 90<br />

20-29 5,171 168 139 127 126 103<br />

30-39 13,461 191 178 129 122 124<br />

40-49 26,702 198 170 124 124 121<br />

50-59 39,535 246 171 136 119 120<br />

60-64 22,417 240 158 137 114 112<br />

65-69 27,478 296 181 128 109 119<br />

70-79 53,652 271 159 127 109 110<br />

80+ 26,378 250 128 115 95 90<br />

0-19 741 43 87 95 136 94<br />

20-44 30,019 184 167 131 126 120<br />

45-64 77,267 237 167 132 117 118<br />

65-74 55,475 291 172 132 110 119<br />

75+ 52,033 252 141 116 101 94<br />

ON OUR WEBSITE & CD<br />

Vascular access insertions in diabetic hemodialysis patients, per 1,000 patient<br />

years, by ESRD vintage (Table 13.a).<br />

Vascular access insertions in non-diabetic hemodialysis patients, per 1,000<br />

patient years, by ESRD vintage (Table 13.b).<br />

Male 115,287 218 139 109 102 105<br />

Female 100,247 288 185 149 125 127<br />

White 117,636 233 137 110 96 96<br />

Black 84,944 293 206 160 136 132<br />

Native American 3,339 131 135 111 84 110<br />

Asian 7,637 212 136 102 108 119<br />

Other/unknown 1,979 230 182 113 92 76<br />

†Hispanic 27,111 264 155 127 110 114<br />

†Non-Hispanic 183,520 250 162 128 114 118<br />

Diabetes 90,716 266 172 141 118 123<br />

Hypertension 62,994 258 156 117 111 116<br />

Glomerulonephritis 24,940 197 138 114 99 106<br />

Cystic kidney 5,430 177 131 92 97 97<br />

Other urologic 6,035 246 135 125 119 116<br />

Other cause 17,334 242 163 127 114 113<br />

Unknown cause 7,840 174 128 91 94 107<br />

Missing disease 246 . . . . .<br />

All 215,535 251 161 128 113 115<br />

*Values for cells with 10 or fewer patients are suppressed.<br />

"."Zero values in this cell.


Reference<br />

M<br />

Section<br />

Census<br />

populations


MCENSUS POPULATIONS<br />

Reference section M<br />

706<br />

M.1 . 707<br />

U.S. resident population on July 1 from the 2000 census & P-25 total estimates<br />

population in thousands; used in computing incidence and prevalence rates:<br />

standard population for adjustment is 2002<br />

M.2 . 715<br />

Resident population estimates of the U.S.<br />

by gender, race, & Hispanic origin; population in thousands


CENSUS POPULATIONS<br />

2005 Annual <strong>Data</strong> ReportM<br />

Table M.1 M.1<br />

U.S. resident population on July 1 from the 2000 census & P-25 total total estimates<br />

population<br />

population<br />

in<br />

in<br />

thousands;<br />

thousands;<br />

used<br />

used<br />

in<br />

in<br />

computing<br />

computing<br />

incidence<br />

incidence &<br />

prevalence<br />

prevalence<br />

rates:<br />

rates:<br />

standard<br />

standard<br />

population<br />

population<br />

for<br />

for<br />

adjustment<br />

adjustment<br />

is<br />

is<br />

2002<br />

2002<br />

1993 Male Female<br />

Age White Black N Am Asian All White Black N Am Asian All<br />

0-4 7,964,173 1,636,763 115,933 379,953 10,096,822 7,564,224 1,594,969 112,395 360,865 9,632,453<br />

5-9 7,599,008 1,494,226 121,777 330,617 9,545,628 7,211,778 1,454,362 117,437 316,751 9,100,328<br />

10-14 7,657,445 1,464,928 117,766 352,514 9,592,653 7,245,204 1,428,055 114,997 340,494 9,128,750<br />

15-19 7,180,143 1,362,474 101,128 333,971 8,977,716 6,749,044 1,333,625 96,610 316,858 8,496,137<br />

20-24 7,813,730 1,330,099 103,915 414,414 9,662,158 7,448,399 1,385,931 93,962 399,474 9,327,766<br />

25-29 8,300,489 1,294,498 95,333 405,433 10,095,753 8,030,120 1,424,850 91,519 426,651 9,973,140<br />

30-34 9,443,797 1,340,524 97,077 421,855 11,303,253 9,222,821 1,515,266 99,298 442,865 11,280,250<br />

35-39 9,078,471 1,251,011 89,158 386,260 10,804,900 8,985,160 1,425,406 94,406 416,723 10,921,695<br />

40-44 8,040,722 1,027,935 75,209 327,647 9,471,513 8,061,909 1,196,487 80,205 374,841 9,713,442<br />

45-49 6,803,040 750,984 59,227 249,977 7,863,228 6,914,671 890,418 62,650 282,357 8,150,096<br />

50-54 5,427,312 598,040 44,556 188,842 6,258,750 5,617,539 721,123 48,032 205,181 6,591,875<br />

55-59 4,494,319 483,065 34,177 143,721 5,155,282 4,775,768 604,288 36,919 163,996 5,580,971<br />

60-64 4,265,734 430,200 26,615 113,790 4,836,339 4,719,106 558,799 29,941 148,033 5,455,879<br />

65-69 4,041,267 372,476 20,440 92,334 4,526,517 4,860,061 508,224 24,422 124,555 5,517,262<br />

70-74 3,376,362 274,399 14,410 72,133 3,737,304 4,389,209 413,841 18,851 89,635 4,911,536<br />

75-79 2,354,469 181,499 8,339 43,872 2,588,179 3,517,938 312,949 12,723 55,410 3,899,020<br />

80-84 1,367,779 104,893 4,623 25,371 1,502,666 2,526,390 209,363 8,138 29,870 2,773,761<br />

85+ 859,598 73,429 3,233 15,679 951,939 2,279,874 185,336 6,631 21,786 2,493,627<br />

707<br />

All 106,067,858 15,471,443 1,132,916 4,298,383 126,970,600 110,119,215 17,163,292 1,149,136 4,516,345 132,947,988<br />

1994<br />

0-4 7,968,973 1,643,519 115,442 393,827 10,121,761 7,568,646 1,600,475 111,930 374,050 9,655,101<br />

5-9 7,709,288 1,562,683 128,697 339,480 9,740,148 7,317,770 1,519,209 124,302 323,250 9,284,531<br />

10-14 7,761,341 1,484,466 122,509 367,135 9,735,451 7,345,293 1,445,863 119,654 355,025 9,265,835<br />

15-19 7,336,974 1,399,176 105,824 344,805 9,186,779 6,890,176 1,369,387 100,890 328,577 8,689,030<br />

20-24 7,632,587 1,324,916 105,366 425,430 9,488,299 7,275,679 1,384,092 96,101 411,893 9,167,765<br />

25-29 8,146,834 1,272,422 96,617 416,639 9,932,512 7,869,470 1,402,370 91,730 443,483 9,807,053<br />

30-34 9,431,303 1,353,052 99,412 433,316 11,317,083 9,188,494 1,525,942 101,354 457,116 11,272,906<br />

35-39 9,230,293 1,288,294 93,270 402,842 11,014,699 9,121,971 1,466,232 98,081 433,624 11,119,908<br />

40-44 8,228,157 1,069,369 79,387 343,689 9,720,602 8,245,884 1,241,965 84,970 390,838 9,963,657<br />

45-49 7,107,218 804,170 62,972 271,515 8,245,875 7,217,091 950,757 66,705 310,142 8,544,695<br />

50-54 5,641,067 620,865 47,240 201,592 6,510,764 5,832,653 746,753 50,819 221,202 6,851,427<br />

55-59 4,603,963 496,223 35,876 154,158 5,290,220 4,885,586 621,422 38,659 173,079 5,718,746<br />

60-64 4,201,063 431,647 27,432 120,147 4,780,289 4,627,851 557,471 30,773 153,787 5,369,882<br />

65-69 4,030,826 379,632 20,956 96,336 4,527,750 4,809,824 512,818 24,828 132,506 5,479,976<br />

70-74 3,436,461 274,157 15,003 77,517 3,803,138 4,444,626 418,065 19,411 96,825 4,978,927<br />

75-79 2,403,758 185,469 8,497 46,331 2,644,055 3,558,788 315,712 12,983 60,024 3,947,507<br />

80-84 1,413,422 106,617 4,765 27,026 1,551,830 2,578,774 216,334 8,440 33,040 2,836,588<br />

85+ 890,717 75,187 3,290 17,030 986,224 2,351,953 192,250 6,893 23,712 2,574,808<br />

All 107,174,245 15,771,864 1,172,555 4,478,815 128,597,479 111,130,529 17,487,117 1,188,523 4,722,173 134,528,342<br />

1995<br />

0-4 7,895,976 1,630,851 113,756 403,885 10,044,468 7,499,024 1,587,540 110,267 385,206 9,582,037<br />

5-9 7,839,306 1,625,589 136,390 351,857 9,953,142 7,440,124 1,580,199 131,449 333,257 9,485,029<br />

10-14 7,836,074 1,498,977 126,491 379,298 9,840,840 7,418,207 1,458,221 123,573 366,208 9,366,209<br />

15-19 7,526,265 1,446,571 111,624 360,407 9,444,867 7,062,318 1,415,543 106,565 344,705 8,929,131<br />

20-24 7,464,041 1,312,034 105,887 432,319 9,314,281 7,096,032 1,371,957 97,197 420,747 8,985,933<br />

25-29 8,104,812 1,266,751 99,787 435,983 9,907,333 7,815,554 1,396,445 93,572 467,032 9,772,603<br />

30-34 9,315,742 1,355,233 100,863 442,060 11,213,898 9,059,561 1,525,929 102,169 470,630 11,158,289<br />

35-39 9,362,914 1,320,573 97,672 418,394 11,199,553 9,240,473 1,498,690 102,281 450,623 11,292,067<br />

40-44 8,434,726 1,110,268 83,575 360,837 9,989,406 8,445,547 1,286,983 89,671 407,541 10,229,742<br />

45-49 7,434,737 862,486 67,524 293,256 8,658,003 7,539,305 1,016,465 71,302 338,666 8,965,738<br />

50-54 5,845,029 644,015 49,938 216,613 6,755,595 6,035,263 773,262 53,605 238,773 7,100,903<br />

55-59 4,664,849 511,283 37,224 164,940 5,378,296 4,943,182 636,808 40,373 183,639 5,804,002<br />

60-64 4,189,515 435,204 28,526 127,132 4,780,377 4,604,971 561,115 31,873 159,388 5,357,347<br />

65-69 4,031,761 384,701 21,429 101,600 4,539,491 4,753,648 518,375 25,316 139,655 5,436,994<br />

70-74 3,483,264 275,209 15,665 81,528 3,855,666 4,489,681 420,423 19,994 103,839 5,033,937<br />

75-79 2,455,895 191,812 8,698 49,552 2,705,957 3,601,636 321,872 13,314 65,103 4,001,925<br />

80-84 1,469,516 107,115 4,969 29,012 1,610,612 2,638,708 220,133 8,640 36,519 2,904,000<br />

85+ 923,911 77,868 3,357 18,450 1,023,586 2,423,216 200,806 7,216 25,898 2,657,136<br />

All 108,278,333 16,056,540 1,213,375 4,667,123 130,215,371 112,106,450 17,790,766 1,228,377 4,937,429 136,063,022


MCENSUS POPULATIONS<br />

Reference section M<br />

Table M.1 M.1 (continued)<br />

U.S. resident population on July 1 from the 2000 census & P-25 total total estimates<br />

population<br />

population<br />

in<br />

in<br />

thousands;<br />

thousands;<br />

used<br />

used<br />

in<br />

in<br />

computing<br />

computing<br />

incidence<br />

incidence &<br />

prevalence<br />

prevalence<br />

rates:<br />

rates:<br />

standard<br />

standard<br />

population<br />

population<br />

for<br />

for<br />

adjustment<br />

adjustment<br />

is<br />

is<br />

2002<br />

2002<br />

708<br />

1993 All<br />

Age White Black N Am Asian All<br />

0-4 15,528,397 3,231,732 228,328 740,818 19,729,275<br />

5-9 14,810,786 2,948,588 239,214 647,368 18,645,956<br />

10-14 14,902,649 2,892,983 232,763 693,008 18,721,403<br />

15-19 13,929,187 2,696,099 197,738 650,829 17,473,853<br />

20-24 15,262,129 2,716,030 197,877 813,888 18,989,924<br />

25-29 16,330,609 2,719,348 186,852 832,084 20,068,893<br />

30-34 18,666,618 2,855,790 196,375 864,720 22,583,503<br />

35-39 18,063,631 2,676,417 183,564 802,983 21,726,595<br />

40-44 16,102,631 2,224,422 155,414 702,488 19,184,955<br />

45-49 13,717,711 1,641,402 121,877 532,334 16,013,324<br />

50-54 11,044,851 1,319,163 92,588 394,023 12,850,625<br />

55-59 9,270,087 1,087,353 71,096 307,717 10,736,253<br />

60-64 8,984,840 988,999 56,556 261,823 10,292,218<br />

65-69 8,901,328 880,700 44,862 216,889 10,043,779<br />

70-74 7,765,571 688,240 33,261 161,768 8,648,840<br />

75-79 5,872,407 494,448 21,062 99,282 6,487,199<br />

80-84 3,894,169 314,256 12,761 55,241 4,276,427<br />

85+ 3,139,472 258,765 9,864 37,465 3,445,566<br />

All 216,187,073 32,634,735 2,282,052 8,814,728 259,918,588<br />

1994<br />

0-4 15,537,619 3,243,994 227,372 767,877 19,776,862<br />

5-9 15,027,058 3,081,892 252,999 662,730 19,024,679<br />

10-14 15,106,634 2,930,329 242,163 722,160 19,001,286<br />

15-19 14,227,150 2,768,563 206,714 673,382 17,875,809<br />

20-24 14,908,266 2,709,008 201,467 837,323 18,656,064<br />

25-29 16,016,304 2,674,792 188,347 860,122 19,739,565<br />

30-34 18,619,797 2,878,994 200,766 890,432 22,589,989<br />

35-39 18,352,264 2,754,526 191,351 836,466 22,134,607<br />

40-44 16,474,041 2,311,334 164,357 734,527 19,684,259<br />

45-49 14,324,309 1,754,927 129,677 581,657 16,790,570<br />

50-54 11,473,720 1,367,618 98,059 422,794 13,362,191<br />

55-59 9,489,549 1,117,645 74,535 327,237 11,008,966<br />

60-64 8,828,914 989,118 58,205 273,934 10,150,171<br />

65-69 8,840,650 892,450 45,784 228,842 10,007,726<br />

70-74 7,881,087 692,222 34,414 174,342 8,782,065<br />

75-79 5,962,546 501,181 21,480 106,355 6,591,562<br />

80-84 3,992,196 322,951 13,205 60,066 4,388,418<br />

85+ 3,242,670 267,437 10,183 40,742 3,561,032<br />

All 218,304,774 33,258,981 2,361,078 9,200,988 263,125,821<br />

1995<br />

0-4 15,395,000 3,218,391 224,023 789,091 19,626,505<br />

5-9 15,279,430 3,205,788 267,839 685,114 19,438,171<br />

10-14 15,254,281 2,957,198 250,064 745,506 19,207,049<br />

15-19 14,588,583 2,862,114 218,189 705,112 18,373,998<br />

20-24 14,560,073 2,683,991 203,084 853,066 18,300,214<br />

25-29 15,920,366 2,663,196 193,359 903,015 19,679,936<br />

30-34 18,375,303 2,881,162 203,032 912,690 22,372,187<br />

35-39 18,603,387 2,819,263 199,953 869,017 22,491,620<br />

40-44 16,880,273 2,397,251 173,246 768,378 20,219,148<br />

45-49 14,974,042 1,878,951 138,826 631,922 17,623,741<br />

50-54 11,880,292 1,417,277 103,543 455,386 13,856,498<br />

55-59 9,608,031 1,148,091 77,597 348,579 11,182,298<br />

60-64 8,794,486 996,319 60,399 286,520 10,137,724<br />

65-69 8,785,409 903,076 46,745 241,255 9,976,485<br />

70-74 7,972,945 695,632 35,659 185,367 8,889,603<br />

75-79 6,057,531 513,684 22,012 114,655 6,707,882<br />

80-84 4,108,224 327,248 13,609 65,531 4,514,612<br />

85+ 3,347,127 278,674 10,573 44,348 3,680,722<br />

All 220,384,783 33,847,306 2,441,752 9,604,552 266,278,393


CENSUS POPULATIONS<br />

2005 Annual <strong>Data</strong> ReportM<br />

Table M.1 M.1 (continued)<br />

U.S. resident population on July 1 from the 2000 census & P-25 total total estimates<br />

population<br />

population<br />

in<br />

in<br />

thousands;<br />

thousands;<br />

used<br />

used<br />

in<br />

in<br />

computing<br />

computing<br />

incidence<br />

incidence &<br />

prevalence<br />

prevalence<br />

rates:<br />

rates:<br />

standard<br />

standard<br />

population<br />

population<br />

for<br />

for<br />

adjustment<br />

adjustment<br />

is<br />

is<br />

2002<br />

2002<br />

1996 Male Female<br />

Age White Black N Am Asian All White Black N Am Asian All<br />

0-4 7,803,866 1,604,625 116,811 407,721 9,933,023 7,410,480 1,561,290 113,087 390,392 9,475,249<br />

5-9 7,972,130 1,685,189 139,841 371,394 10,168,554 7,568,233 1,637,490 135,344 350,909 9,691,976<br />

10-14 7,913,265 1,525,160 130,601 389,458 9,958,484 7,492,096 1,482,057 127,370 375,102 9,476,625<br />

15-19 7,738,458 1,488,901 118,778 380,800 9,726,937 7,258,062 1,457,078 113,354 364,729 9,193,223<br />

20-24 7,279,709 1,285,788 106,027 434,761 9,106,285 6,900,199 1,346,300 98,308 425,553 8,770,360<br />

25-29 8,156,257 1,278,350 104,447 460,242 9,999,296 7,861,931 1,411,841 97,034 494,038 9,864,844<br />

30-34 9,096,950 1,356,426 102,434 449,791 11,005,601 8,831,484 1,521,561 102,904 483,615 10,939,564<br />

35-39 9,472,201 1,343,487 102,192 433,863 11,351,743 9,338,077 1,523,117 106,601 466,213 11,434,008<br />

40-44 8,641,407 1,153,738 88,141 379,726 10,263,012 8,647,658 1,332,404 94,755 427,683 10,502,500<br />

45-49 7,826,927 931,220 72,187 315,136 9,145,470 7,928,335 1,093,992 76,352 366,377 9,465,056<br />

50-54 5,971,991 662,160 53,233 232,586 6,919,970 6,160,996 793,557 57,059 257,857 7,269,469<br />

55-59 4,787,024 524,591 39,324 176,470 5,527,409 5,063,559 651,727 42,545 195,460 5,953,291<br />

60-64 4,172,998 438,999 29,863 135,450 4,777,310 4,568,631 564,647 33,110 165,588 5,331,976<br />

65-69 4,035,781 387,659 22,220 107,072 4,552,732 4,717,165 521,980 26,150 146,060 5,411,355<br />

70-74 3,466,014 278,315 16,152 85,082 3,845,563 4,459,349 424,268 20,459 110,762 5,014,838<br />

75-79 2,540,487 198,382 9,116 53,738 2,801,723 3,686,120 331,134 13,954 70,757 4,101,965<br />

80-84 1,520,290 107,983 5,198 30,970 1,664,441 2,684,309 222,166 8,915 40,150 2,955,540<br />

85+ 956,830 79,645 3,486 19,970 1,059,931 2,490,781 208,251 7,521 28,408 2,734,961<br />

709<br />

All 109,352,585 16,330,618 1,260,051 4,864,230 131,807,484 113,067,465 18,084,860 1,274,822 5,159,653 137,586,800<br />

1997<br />

0-4 7,730,763 1,584,153 119,118 409,966 9,844,000 7,338,334 1,540,070 115,311 394,956 9,388,671<br />

5-9 8,098,381 1,734,270 143,831 392,135 10,368,617 7,691,675 1,683,850 139,729 370,161 9,885,415<br />

10-14 7,958,434 1,552,144 134,700 398,065 10,043,343 7,537,853 1,506,979 130,730 381,792 9,557,354<br />

15-19 7,922,392 1,522,994 125,288 401,851 9,972,525 7,429,588 1,490,307 119,876 385,395 9,425,166<br />

20-24 7,293,135 1,287,882 108,228 439,901 9,129,146 6,895,088 1,351,027 100,570 434,245 8,780,930<br />

25-29 8,135,517 1,292,134 107,842 484,495 10,019,988 7,829,862 1,426,443 100,111 522,636 9,879,052<br />

30-34 8,852,301 1,341,280 103,725 458,886 10,756,192 8,583,182 1,502,539 103,711 500,299 10,689,731<br />

35-39 9,499,899 1,359,837 106,292 447,597 11,413,625 9,358,777 1,539,982 110,196 481,041 11,489,996<br />

40-44 8,849,785 1,205,684 92,894 400,149 10,548,512 8,845,308 1,383,494 99,618 447,862 10,776,282<br />

45-49 7,801,429 971,899 75,669 331,646 9,180,643 7,899,957 1,139,417 80,357 386,266 9,505,997<br />

50-54 6,547,925 709,292 58,225 253,728 7,569,170 6,729,950 845,302 61,821 284,625 7,921,698<br />

55-59 4,960,293 547,486 41,548 187,275 5,736,602 5,238,352 676,523 44,949 208,661 6,168,485<br />

60-64 4,205,372 445,402 31,250 145,914 4,827,938 4,587,032 570,885 34,280 174,089 5,366,286<br />

65-69 3,992,933 387,403 22,659 112,779 4,515,774 4,632,329 523,011 26,820 151,896 5,334,056<br />

70-74 3,454,388 282,332 16,431 88,807 3,841,958 4,424,261 429,111 20,814 117,900 4,992,086<br />

75-79 2,621,159 204,135 9,650 58,503 2,893,447 3,775,108 338,886 14,625 76,764 4,205,383<br />

80-84 1,564,123 109,734 5,206 32,804 1,711,867 2,721,758 227,041 9,026 43,689 3,001,514<br />

85+ 993,801 81,293 3,595 21,490 1,100,179 2,553,020 213,458 7,780 31,039 2,805,297<br />

All 110,482,030 16,619,354 1,306,151 5,065,991 133,473,526 114,071,434 18,388,325 1,320,324 5,393,316 139,173,399<br />

1998<br />

0-4 7,689,418 1,570,017 122,869 414,689 9,796,993 7,302,203 1,524,897 118,440 402,390 9,347,930<br />

5-9 8,181,024 1,769,019 146,699 407,050 10,503,792 7,764,365 1,714,847 142,801 384,523 10,006,536<br />

10-14 8,021,105 1,590,753 138,733 407,728 10,158,319 7,599,325 1,544,543 134,355 388,639 9,666,862<br />

15-19 8,086,650 1,554,952 132,750 424,385 10,198,737 7,586,393 1,520,323 126,838 407,441 9,640,995<br />

20-24 7,406,255 1,299,133 111,950 448,550 9,265,888 6,986,138 1,366,116 104,300 444,661 8,901,215<br />

25-29 8,070,031 1,293,838 110,633 501,784 9,976,286 7,752,392 1,429,357 103,585 542,024 9,827,358<br />

30-34 8,616,655 1,327,076 105,214 464,763 10,513,708 8,337,467 1,484,415 104,369 512,909 10,439,160<br />

35-39 9,477,303 1,375,264 110,494 463,728 11,426,789 9,332,023 1,554,732 113,680 498,973 11,499,408<br />

40-44 9,036,103 1,253,414 97,984 417,290 10,804,791 9,017,592 1,429,965 104,481 465,328 11,017,366<br />

45-49 7,948,839 1,013,484 80,048 351,616 9,393,987 8,044,479 1,182,721 84,885 408,091 9,720,176<br />

50-54 6,785,086 755,839 62,620 275,634 7,879,179 6,962,250 896,810 66,574 312,881 8,238,515<br />

55-59 5,263,446 568,826 44,229 199,471 6,075,972 5,543,514 699,336 47,890 222,735 6,513,475<br />

60-64 4,298,739 457,289 33,024 156,084 4,945,136 4,674,315 583,948 35,917 182,192 5,476,372<br />

65-69 3,919,470 387,128 23,301 119,052 4,448,951 4,520,361 522,654 27,675 157,624 5,228,314<br />

70-74 3,487,578 287,754 16,705 92,303 3,884,340 4,425,978 436,949 21,240 124,475 5,008,642<br />

75-79 2,673,109 209,450 10,224 64,150 2,956,933 3,826,791 345,305 15,242 83,847 4,271,185<br />

80-84 1,602,731 110,908 5,252 34,387 1,753,278 2,750,898 227,785 9,128 47,170 3,034,981<br />

85+ 1,036,235 83,616 3,801 23,173 1,146,825 2,621,858 221,677 8,106 34,069 2,885,710<br />

All 111,599,777 16,907,760 1,356,530 5,265,837 135,129,904 115,048,342 18,686,380 1,369,506 5,619,972 140,724,200


MCENSUS POPULATIONS<br />

Reference section M<br />

Table M.1 M.1 (continued)<br />

U.S. resident population on July 1 from the 2000 census & P-25 total total estimates<br />

population<br />

population<br />

in<br />

in<br />

thousands;<br />

thousands;<br />

used<br />

used<br />

in<br />

in<br />

computing<br />

computing<br />

incidence<br />

incidence &<br />

prevalence<br />

prevalence<br />

rates:<br />

rates:<br />

standard<br />

standard<br />

population<br />

population<br />

for<br />

for<br />

adjustment<br />

adjustment<br />

is<br />

is<br />

2002<br />

2002<br />

710<br />

1996 All<br />

Age White Black N Am Asian All<br />

0-4 15,214,346 3,165,915 229,898 798,113 19,408,272<br />

5-9 15,540,363 3,322,679 275,185 722,303 19,860,530<br />

10-14 15,405,361 3,007,217 257,971 764,560 19,435,109<br />

15-19 14,996,520 2,945,979 232,132 745,529 18,920,160<br />

20-24 14,179,908 2,632,088 204,335 860,314 17,876,645<br />

25-29 16,018,188 2,690,191 201,481 954,280 19,864,140<br />

30-34 17,928,434 2,877,987 205,338 933,406 21,945,165<br />

35-39 18,810,278 2,866,604 208,793 900,076 22,785,751<br />

40-44 17,289,065 2,486,142 182,896 807,409 20,765,512<br />

45-49 15,755,262 2,025,212 148,539 681,513 18,610,526<br />

50-54 12,132,987 1,455,717 110,292 490,443 14,189,439<br />

55-59 9,850,583 1,176,318 81,869 371,930 11,480,700<br />

60-64 8,741,629 1,003,646 62,973 301,038 10,109,286<br />

65-69 8,752,946 909,639 48,370 253,132 9,964,087<br />

70-74 7,925,363 702,583 36,611 195,844 8,860,401<br />

75-79 6,226,607 529,516 23,070 124,495 6,903,688<br />

80-84 4,204,599 330,149 14,113 71,120 4,619,981<br />

85+ 3,447,611 287,896 11,007 48,378 3,794,892<br />

All 222,420,050 34,415,478 2,534,873 10,023,883 269,394,284<br />

1997<br />

0-4 15,069,097 3,124,223 234,429 804,922 19,232,671<br />

5-9 15,790,056 3,418,120 283,560 762,296 20,254,032<br />

10-14 15,496,287 3,059,123 265,430 779,857 19,600,697<br />

15-19 15,351,980 3,013,301 245,164 787,246 19,397,691<br />

20-24 14,188,223 2,638,909 208,798 874,146 17,910,076<br />

25-29 15,965,379 2,718,577 207,953 1,007,131 19,899,040<br />

30-34 17,435,483 2,843,819 207,436 959,185 21,445,923<br />

35-39 18,858,676 2,899,819 216,488 928,638 22,903,621<br />

40-44 17,695,093 2,589,178 192,512 848,011 21,324,794<br />

45-49 15,701,386 2,111,316 156,026 717,912 18,686,640<br />

50-54 13,277,875 1,554,594 120,046 538,353 15,490,868<br />

55-59 10,198,645 1,224,009 86,497 395,936 11,905,087<br />

60-64 8,792,404 1,016,287 65,530 320,003 10,194,224<br />

65-69 8,625,262 910,414 49,479 264,675 9,849,830<br />

70-74 7,878,649 711,443 37,245 206,707 8,834,044<br />

75-79 6,396,267 543,021 24,275 135,267 7,098,830<br />

80-84 4,285,881 336,775 14,232 76,493 4,713,381<br />

85+ 3,546,821 294,751 11,375 52,529 3,905,476<br />

All 224,553,464 35,007,679 2,626,475 10,459,307 272,646,925<br />

1998<br />

0-4 14,991,621 3,094,914 241,309 817,079 19,144,923<br />

5-9 15,945,389 3,483,866 289,500 791,573 20,510,328<br />

10-14 15,620,430 3,135,296 273,088 796,367 19,825,181<br />

15-19 15,673,043 3,075,275 259,588 831,826 19,839,732<br />

20-24 14,392,393 2,665,249 216,250 893,211 18,167,103<br />

25-29 15,822,423 2,723,195 214,218 1,043,808 19,803,644<br />

30-34 16,954,122 2,811,491 209,583 977,672 20,952,868<br />

35-39 18,809,326 2,929,996 224,174 962,701 22,926,197<br />

40-44 18,053,695 2,683,379 202,465 882,618 21,822,157<br />

45-49 15,993,318 2,196,205 164,933 759,707 19,114,163<br />

50-54 13,747,336 1,652,649 129,194 588,515 16,117,694<br />

55-59 10,806,960 1,268,162 92,119 422,206 12,589,447<br />

60-64 8,973,054 1,041,237 68,941 338,276 10,421,508<br />

65-69 8,439,831 909,782 50,976 276,676 9,677,265<br />

70-74 7,913,556 724,703 37,945 216,778 8,892,982<br />

75-79 6,499,900 554,755 25,466 147,997 7,228,118<br />

80-84 4,353,629 338,693 14,380 81,557 4,788,259<br />

85+ 3,658,093 305,293 11,907 57,242 4,032,535<br />

All 226,648,119 35,594,140 2,726,036 10,885,809 275,854,104


CENSUS POPULATIONS<br />

2005 Annual <strong>Data</strong> ReportM<br />

Table M.1 M.1 (continued)<br />

U.S. resident population on July 1 from the 2000 census & P-25 total total estimates<br />

population<br />

population<br />

in<br />

in<br />

thousands;<br />

thousands;<br />

used<br />

used<br />

in<br />

in<br />

computing<br />

computing<br />

incidence<br />

incidence &<br />

prevalence<br />

prevalence<br />

rates:<br />

rates:<br />

standard<br />

standard<br />

population<br />

population<br />

for<br />

for<br />

adjustment<br />

adjustment<br />

is<br />

is<br />

2002<br />

2002<br />

1999 Male Female<br />

Age White Black N Am Asian All White Black N Am Asian All<br />

0-4 7,672,039 1,571,904 128,050 417,814 9,789,807 7,289,975 1,524,030 123,319 408,413 9,345,737<br />

5-9 8,211,295 1,773,681 147,918 420,948 10,553,842 7,791,071 1,718,506 144,111 398,930 10,052,618<br />

10-14 8,144,247 1,650,063 144,583 418,807 10,357,700 7,717,223 1,600,922 140,084 397,435 9,855,664<br />

15-19 8,174,959 1,567,014 139,002 442,058 10,323,033 7,672,225 1,532,399 132,191 424,754 9,761,569<br />

20-24 7,581,135 1,330,173 117,865 463,641 9,492,814 7,127,585 1,400,773 109,530 460,727 9,098,615<br />

25-29 7,944,134 1,291,042 112,551 531,363 9,879,090 7,606,278 1,427,024 106,468 556,197 9,695,967<br />

30-34 8,447,156 1,308,656 107,912 490,502 10,354,226 8,155,146 1,458,386 105,924 529,667 10,249,123<br />

35-39 9,425,123 1,387,055 114,524 481,693 11,408,395 9,277,734 1,564,410 117,270 514,740 11,474,154<br />

40-44 9,169,012 1,291,354 103,043 435,269 10,998,678 9,135,045 1,468,119 108,927 483,359 11,195,450<br />

45-49 8,151,142 1,060,502 85,195 369,634 9,666,473 8,240,528 1,229,341 90,336 427,529 9,987,734<br />

50-54 7,099,852 811,874 67,122 300,193 8,279,041 7,271,943 957,589 71,341 343,698 8,644,571<br />

55-59 5,470,979 589,866 47,202 211,740 6,319,787 5,754,517 722,150 50,646 237,721 6,765,034<br />

60-64 4,407,170 471,350 34,766 166,190 5,079,476 4,784,689 600,993 37,824 190,223 5,613,729<br />

65-69 3,865,205 385,148 24,113 125,044 4,399,510 4,431,324 519,753 28,606 162,305 5,141,988<br />

70-74 3,485,993 294,812 17,090 96,080 3,893,975 4,386,249 444,367 21,795 131,025 4,983,436<br />

75-79 2,721,384 210,570 10,617 68,814 3,011,385 3,875,879 349,571 15,848 89,923 4,331,221<br />

80-84 1,645,730 114,685 5,413 36,503 1,802,331 2,787,768 231,410 9,395 51,404 3,079,977<br />

85+ 1,079,319 85,342 3,815 24,834 1,193,310 2,686,737 228,287 8,365 37,319 2,960,708<br />

711<br />

All 112,695,874 17,195,091 1,410,781 5,501,127 136,802,873 115,991,916 18,978,030 1,421,980 5,845,369 142,237,295<br />

2000<br />

0-4 7,685,508 1,584,529 134,846 425,574 9,830,457 7,303,354 1,530,817 130,215 417,469 9,381,855<br />

5-9 8,152,580 1,752,987 147,843 434,028 10,487,438 7,736,375 1,698,085 144,500 414,505 9,993,465<br />

10-14 8,266,736 1,702,103 152,621 431,870 10,553,330 7,832,426 1,652,270 147,799 408,097 10,040,592<br />

15-19 8,216,475 1,575,332 146,248 454,292 10,392,347 7,712,405 1,537,246 138,460 435,465 9,823,576<br />

20-24 7,801,689 1,377,286 126,816 483,515 9,789,306 7,315,937 1,446,736 117,937 480,845 9,361,455<br />

25-29 7,797,733 1,274,323 115,912 553,769 9,741,737 7,428,263 1,405,036 109,362 569,036 9,511,697<br />

30-34 8,402,379 1,308,049 113,661 530,842 10,354,931 8,099,679 1,454,915 110,123 554,717 10,219,434<br />

35-39 9,267,789 1,385,321 119,236 502,141 11,274,487 9,118,847 1,560,827 120,892 531,619 11,332,185<br />

40-44 9,283,584 1,325,449 110,294 454,230 11,173,557 9,240,322 1,498,972 115,759 500,696 11,355,749<br />

45-49 8,368,459 1,104,104 92,584 390,722 9,955,869 8,450,087 1,274,008 97,644 448,393 10,270,132<br />

50-54 7,446,638 875,412 74,794 325,841 8,722,685 7,615,196 1,027,023 78,830 376,841 9,097,890<br />

55-59 5,665,213 613,184 51,786 227,030 6,557,213 5,950,632 748,209 55,285 255,300 7,009,426<br />

60-64 4,465,825 483,846 37,957 178,106 5,165,734 4,843,618 613,650 41,036 201,823 5,700,127<br />

65-69 3,854,086 385,855 26,682 132,759 4,399,382 4,405,288 522,917 31,192 169,259 5,128,656<br />

70-74 3,480,420 299,087 19,103 102,656 3,901,266 4,330,054 449,794 23,942 140,000 4,943,790<br />

75-79 2,755,831 212,828 12,447 73,775 3,054,881 3,911,719 353,334 17,541 98,028 4,380,622<br />

80-84 1,685,103 119,864 6,499 40,319 1,851,785 2,820,458 237,031 10,746 57,571 3,125,806<br />

85+ 1,129,929 87,592 4,820 27,794 1,250,135 2,757,352 234,944 9,959 42,586 3,044,841<br />

All 113,725,977 17,467,151 1,494,149 5,769,263 138,456,540 116,872,012 19,245,814 1,501,222 6,102,250 143,721,298<br />

*2001<br />

0-4 7,736,643 1,599,132 128,887 438,635 9,903,297 7,361,972 1,547,089 124,505 427,005 9,460,571<br />

5-9 8,061,095 1,716,185 144,120 441,182 10,362,582 7,647,907 1,661,300 140,584 425,721 9,875,512<br />

10-14 8,354,489 1,745,713 154,292 443,160 10,697,654 7,922,443 1,693,741 149,850 417,847 10,183,881<br />

15-19 8,234,593 1,591,186 147,995 453,298 10,427,072 7,721,189 1,541,225 141,091 431,742 9,835,247<br />

20-24 8,054,392 1,440,869 132,551 497,770 10,125,582 7,538,862 1,496,411 122,677 493,228 9,651,178<br />

25-29 7,676,960 1,263,922 117,089 565,638 9,623,609 7,270,052 1,384,146 109,285 581,804 9,345,287<br />

30-34 8,441,433 1,312,093 114,544 564,964 10,433,034 8,119,426 1,460,737 110,666 590,322 10,281,151<br />

35-39 9,100,492 1,378,208 118,827 522,413 11,119,940 8,920,903 1,550,409 119,095 549,058 11,139,465<br />

40-44 9,379,398 1,346,081 112,738 470,317 11,308,534 9,326,477 1,522,441 117,967 515,288 11,482,173<br />

45-49 8,581,768 1,142,749 95,934 411,365 10,231,816 8,657,322 1,318,857 101,675 469,437 10,547,291<br />

50-54 7,665,713 923,273 78,466 347,010 9,014,462 7,836,715 1,084,072 82,903 403,221 9,406,911<br />

55-59 5,929,034 638,672 54,982 242,615 6,865,303 6,209,945 779,315 58,762 274,251 7,322,273<br />

60-64 4,567,084 490,674 39,733 188,545 5,286,036 4,946,836 624,690 42,819 211,936 5,826,281<br />

65-69 3,848,908 394,485 28,101 140,967 4,412,461 4,385,076 533,650 32,777 176,701 5,128,204<br />

70-74 3,465,957 298,229 20,206 107,267 3,891,659 4,279,293 446,180 24,662 146,719 4,896,854<br />

75-79 2,755,636 215,759 13,226 77,574 3,062,195 3,885,143 360,182 18,274 105,431 4,369,030<br />

80-84 1,754,327 124,715 7,209 44,241 1,930,492 2,899,157 243,480 11,620 62,952 3,217,209<br />

85+ 1,187,342 90,152 5,125 30,226 1,312,845 2,819,984 238,535 10,818 47,442 3,116,779<br />

All 114,795,264 17,712,097 1,514,025 5,987,187 140,008,573 117,748,702 19,486,460 1,520,030 6,330,105 145,085,297<br />

*<strong>Data</strong> from the CDC's Bridged Race <strong>Data</strong>base.


MCENSUS POPULATIONS<br />

Reference section M<br />

Table M.1 M.1 (continued)<br />

U.S. resident population on July 1 from the 2000 census & P-25 total total estimates<br />

population<br />

population<br />

in<br />

in<br />

thousands;<br />

thousands;<br />

used<br />

used<br />

in<br />

in<br />

computing<br />

computing<br />

incidence<br />

incidence &<br />

prevalence<br />

prevalence<br />

rates:<br />

rates:<br />

standard<br />

standard<br />

population<br />

population<br />

for<br />

for<br />

adjustment<br />

adjustment<br />

is<br />

is<br />

2002<br />

2002<br />

712<br />

1999 All<br />

Age White Black N Am Asian All<br />

0-4 14,962,014 3,095,934 251,369 826,227 19,135,544<br />

5-9 16,002,366 3,492,187 292,029 819,878 20,606,460<br />

10-14 15,861,470 3,250,985 284,667 816,242 20,213,364<br />

15-19 15,847,184 3,099,413 271,193 866,812 20,084,602<br />

20-24 14,708,720 2,730,946 227,395 924,368 18,591,429<br />

25-29 15,550,412 2,718,066 219,019 1,087,560 19,575,057<br />

30-34 16,602,302 2,767,042 213,836 1,020,169 20,603,349<br />

35-39 18,702,857 2,951,465 231,794 996,433 22,882,549<br />

40-44 18,304,057 2,759,473 211,970 918,628 22,194,128<br />

45-49 16,391,670 2,289,843 175,531 797,163 19,654,207<br />

50-54 14,371,795 1,769,463 138,463 643,891 16,923,612<br />

55-59 11,225,496 1,312,016 97,848 449,461 13,084,821<br />

60-64 9,191,859 1,072,343 72,590 356,413 10,693,205<br />

65-69 8,296,529 904,901 52,719 287,349 9,541,498<br />

70-74 7,872,242 739,179 38,885 227,105 8,877,411<br />

75-79 6,597,263 560,141 26,465 158,737 7,342,606<br />

80-84 4,433,498 346,095 14,808 87,907 4,882,308<br />

85+ 3,766,056 313,629 12,180 62,153 4,154,018<br />

All 228,687,790 36,173,121 2,832,761 11,346,496 279,040,168<br />

2000<br />

0-4 14,988,862 3,115,346 265,061 843,043 19,212,312<br />

5-9 15,888,955 3,451,072 292,343 848,533 20,480,903<br />

10-14 16,099,162 3,354,373 300,420 839,967 20,593,922<br />

15-19 15,928,880 3,112,578 284,708 889,757 20,215,923<br />

20-24 15,117,626 2,824,022 244,753 964,360 19,150,761<br />

25-29 15,225,996 2,679,359 225,274 1,122,805 19,253,434<br />

30-34 16,502,058 2,762,964 223,784 1,085,559 20,574,365<br />

35-39 18,386,636 2,946,148 240,128 1,033,760 22,606,672<br />

40-44 18,523,906 2,824,421 226,053 954,926 22,529,306<br />

45-49 16,818,546 2,378,112 190,228 839,115 20,226,001<br />

50-54 15,061,834 1,902,435 153,624 702,682 17,820,575<br />

55-59 11,615,845 1,361,393 107,071 482,330 13,566,639<br />

60-64 9,309,443 1,097,496 78,993 379,929 10,865,861<br />

65-69 8,259,374 908,772 57,874 302,018 9,528,038<br />

70-74 7,810,474 748,881 43,045 242,656 8,845,056<br />

75-79 6,667,550 566,162 29,988 171,803 7,435,503<br />

80-84 4,505,561 356,895 17,245 97,890 4,977,591<br />

85+ 3,887,281 322,536 14,779 70,380 4,294,976<br />

All 230,597,989 36,712,965 2,995,371 11,871,513 282,177,838<br />

*2001<br />

0-4 15,098,615 3,146,221 253,392 865,640 19,363,868<br />

5-9 15,709,002 3,377,485 284,704 866,903 20,238,094<br />

10-14 16,276,932 3,439,454 304,142 861,007 20,881,535<br />

15-19 15,955,782 3,132,411 289,086 885,040 20,262,319<br />

20-24 15,593,254 2,937,280 255,228 990,998 19,776,760<br />

25-29 14,947,012 2,648,068 226,374 1,147,442 18,968,896<br />

30-34 16,560,859 2,772,830 225,210 1,155,286 20,714,185<br />

35-39 18,021,395 2,928,617 237,922 1,071,471 22,259,405<br />

40-44 18,705,875 2,868,522 230,705 985,605 22,790,707<br />

45-49 17,239,090 2,461,606 197,609 880,802 20,779,107<br />

50-54 15,502,428 2,007,345 161,369 750,231 18,421,373<br />

55-59 12,138,979 1,417,987 113,744 516,866 14,187,576<br />

60-64 9,513,920 1,115,364 82,552 400,481 11,112,317<br />

65-69 8,233,984 928,135 60,878 317,668 9,540,665<br />

70-74 7,745,250 744,409 44,868 253,986 8,788,513<br />

75-79 6,640,779 575,941 31,500 183,005 7,431,225<br />

80-84 4,653,484 368,195 18,829 107,193 5,147,701<br />

85+ 4,007,326 328,687 15,943 77,668 4,429,624<br />

All 232,543,966 37,198,557 3,034,055 12,317,292 285,093,870<br />

*<strong>Data</strong> from the CDC's Bridged Race <strong>Data</strong>base.


CENSUS POPULATIONS<br />

2005 Annual <strong>Data</strong> ReportM<br />

Table M.1 M.1 (continued)<br />

U.S. resident population on July 1 from the the 2000 census & P-25 P-25 total total estimates<br />

population<br />

population<br />

in<br />

in<br />

thousands;<br />

thousands;<br />

used<br />

used<br />

in<br />

in<br />

computing<br />

computing<br />

incidence<br />

incidence &<br />

prevalence<br />

prevalence<br />

rates:<br />

rates:<br />

standard<br />

standard<br />

population<br />

population<br />

for<br />

for<br />

adjustment<br />

adjustment<br />

is<br />

is<br />

2002<br />

2001<br />

*2002 Male Female<br />

Age White Black N Am Asian All White Black N Am Asian All<br />

0-4 7,816,256 1,619,647 123,011 449,652 10,008,566 7,445,550 1,567,526 119,160 434,734 9,566,970<br />

5-9 7,956,537 1,673,129 140,823 447,955 10,218,444 7,548,940 1,619,993 137,128 435,939 9,742,000<br />

10-14 8,414,121 1,781,594 154,844 454,452 10,805,011 7,981,301 1,728,593 150,851 427,989 10,288,734<br />

15-19 8,253,883 1,610,992 149,519 453,725 10,468,119 7,748,372 1,556,846 143,244 431,085 9,879,547<br />

20-24 8,280,085 1,500,081 138,202 512,299 10,430,667 7,732,926 1,534,207 127,883 504,283 9,899,299<br />

25-29 7,659,199 1,263,507 118,763 571,140 9,612,609 7,214,124 1,376,873 110,037 588,261 9,289,295<br />

30-34 8,453,956 1,323,363 116,299 602,542 10,496,160 8,107,049 1,469,240 111,519 628,619 10,316,427<br />

35-39 8,889,312 1,359,218 116,980 539,100 10,904,610 8,690,385 1,527,836 116,729 565,973 10,900,923<br />

40-44 9,429,375 1,358,995 114,722 489,028 11,392,120 9,360,050 1,539,308 119,490 530,969 11,549,817<br />

45-49 8,762,293 1,183,241 99,598 431,571 10,476,703 8,829,337 1,362,834 105,143 490,074 10,787,388<br />

50-54 7,771,369 962,180 80,921 364,634 9,179,104 7,942,782 1,133,861 86,132 422,813 9,585,588<br />

55-59 6,262,966 670,348 58,895 262,435 7,254,644 6,539,415 816,348 62,958 299,301 7,718,022<br />

60-64 4,773,900 503,964 41,970 198,982 5,518,816 5,163,123 644,385 45,266 224,097 6,076,871<br />

65-69 3,860,892 400,502 29,445 150,476 4,441,315 4,385,302 540,241 33,710 184,537 5,143,790<br />

70-74 3,435,320 299,667 21,088 112,047 3,868,122 4,214,645 446,993 25,784 152,674 4,840,096<br />

75-79 2,763,556 217,854 13,898 81,250 3,076,558 3,860,510 364,699 19,045 112,894 4,357,148<br />

80-84 1,818,576 130,367 7,938 48,443 2,005,324 2,972,542 251,046 12,498 68,703 3,304,789<br />

85+ 1,244,847 92,967 5,536 33,173 1,376,523 2,885,996 243,215 11,753 52,918 3,193,882<br />

713<br />

All 115,846,443 17,951,616 1,532,452 6,202,904 141,533,415 118,622,349 19,724,044 1,538,330 6,555,863 146,440,586<br />

*2003<br />

0-4 7,889,666 1,637,210 117,395 461,144 10,105,415 7,523,300 1,583,938 113,637 442,989 9,663,864<br />

5-9 7,887,082 1,640,152 138,699 453,974 10,119,907 7,487,677 1,587,289 134,828 445,575 9,655,369<br />

10-14 8,435,323 1,804,333 154,547 462,546 10,856,749 8,000,163 1,749,239 150,708 436,502 10,336,612<br />

15-19 8,275,292 1,632,697 150,102 460,589 10,518,680 7,795,394 1,583,322 144,926 436,147 9,959,789<br />

20-24 8,450,770 1,547,308 143,788 522,056 10,663,922 7,862,961 1,556,595 133,130 511,086 10,063,772<br />

25-29 7,784,835 1,289,611 122,223 576,042 9,772,711 7,294,715 1,394,320 112,534 593,674 9,395,243<br />

30-34 8,374,007 1,323,274 117,422 635,072 10,449,775 8,015,352 1,467,416 111,871 660,230 10,254,869<br />

35-39 8,714,212 1,339,996 115,453 556,887 10,726,548 8,478,198 1,503,136 114,337 585,785 10,681,456<br />

40-44 9,414,670 1,365,312 116,429 510,700 11,407,111 9,335,125 1,549,254 120,340 550,760 11,555,479<br />

45-49 8,949,574 1,226,834 103,075 451,396 10,730,879 9,005,159 1,408,560 108,883 507,707 11,030,309<br />

50-54 7,857,280 990,815 83,706 380,976 9,312,777 8,028,569 1,170,892 89,277 441,896 9,730,634<br />

55-59 6,598,781 712,977 63,206 285,760 7,660,724 6,871,244 866,646 67,401 328,035 8,133,326<br />

60-64 4,990,925 518,640 44,131 209,904 5,763,600 5,392,244 664,773 48,008 237,061 6,342,086<br />

65-69 3,928,400 406,144 31,125 159,872 4,525,541 4,445,652 547,197 35,400 192,293 5,220,542<br />

70-74 3,379,699 304,446 22,108 117,567 3,823,820 4,129,856 451,388 26,857 159,040 4,767,141<br />

75-79 2,779,916 219,081 14,860 85,105 3,098,962 3,844,813 368,591 19,940 120,287 4,353,631<br />

80-84 1,857,912 135,452 8,654 53,227 2,055,245 3,013,756 258,504 13,208 75,366 3,360,834<br />

85+ 1,306,751 95,911 6,031 36,231 1,444,924 2,950,147 246,859 12,828 58,709 3,268,543<br />

All 116,875,095 18,190,193 1,552,954 6,419,048 143,037,290 119,474,325 19,957,919 1,558,113 6,783,142 147,773,499<br />

*<strong>Data</strong> from the CDC's Bridged Race <strong>Data</strong>base.


MCENSUS POPULATIONS<br />

Reference section M<br />

Table M.1 M.1 (continued)<br />

U.S. resident population on July 1 from the 2000 census & P-25 total total estimates<br />

population<br />

population<br />

in<br />

in<br />

thousands;<br />

thousands;<br />

used<br />

used<br />

in<br />

in<br />

computing<br />

computing<br />

incidence<br />

incidence &<br />

prevalence<br />

prevalence<br />

rates:<br />

rates:<br />

standard<br />

standard<br />

population<br />

population<br />

for<br />

for<br />

adjustment<br />

adjustment<br />

is<br />

is<br />

2002<br />

2001<br />

714<br />

*2002 All<br />

Age White Black N Am Asian All<br />

0-4 15,261,806 3,187,173 242,171 884,386 19,575,536<br />

5-9 15,505,477 3,293,122 277,951 883,894 19,960,444<br />

10-14 16,395,422 3,510,187 305,695 882,441 21,093,745<br />

15-19 16,002,255 3,167,838 292,763 884,810 20,347,666<br />

20-24 16,013,011 3,034,288 266,085 1,016,582 20,329,966<br />

25-29 14,873,323 2,640,380 228,800 1,159,401 18,901,904<br />

30-34 16,561,005 2,792,603 227,818 1,231,161 20,812,587<br />

35-39 17,579,697 2,887,054 233,709 1,105,073 21,805,533<br />

40-44 18,789,425 2,898,303 234,212 1,019,997 22,941,937<br />

45-49 17,591,630 2,546,075 204,741 921,645 21,264,091<br />

50-54 15,714,151 2,096,041 167,053 787,447 18,764,692<br />

55-59 12,802,381 1,486,696 121,853 561,736 14,972,666<br />

60-64 9,937,023 1,148,349 87,236 423,079 11,595,687<br />

65-69 8,246,194 940,743 63,155 335,013 9,585,105<br />

70-74 7,649,965 746,660 46,872 264,721 8,708,218<br />

75-79 6,624,066 582,553 32,943 194,144 7,433,706<br />

80-84 4,791,118 381,413 20,436 117,146 5,310,113<br />

85+ 4,130,843 336,182 17,289 86,091 4,570,405<br />

All 234,468,792 37,675,660 3,070,782 12,758,767 287,974,001<br />

*2003<br />

0-4 15,412,966 3,221,148 231,032 904,133 19,769,279<br />

5-9 15,374,759 3,227,441 273,527 899,549 19,775,276<br />

10-14 16,435,486 3,553,572 305,255 899,048 21,193,361<br />

15-19 16,070,686 3,216,019 295,028 896,736 20,478,469<br />

20-24 16,313,731 3,103,903 276,918 1,033,142 20,727,694<br />

25-29 15,079,550 2,683,931 234,757 1,169,716 19,167,954<br />

30-34 16,389,359 2,790,690 229,293 1,295,302 20,704,644<br />

35-39 17,192,410 2,843,132 229,790 1,142,672 21,408,004<br />

40-44 18,749,795 2,914,566 236,769 1,061,460 22,962,590<br />

45-49 17,954,733 2,635,394 211,958 959,103 21,761,188<br />

50-54 15,885,849 2,161,707 172,983 822,872 19,043,411<br />

55-59 13,470,025 1,579,623 130,607 613,795 15,794,050<br />

60-64 10,383,169 1,183,413 92,139 446,965 12,105,686<br />

65-69 8,374,052 953,341 66,525 352,165 9,746,083<br />

70-74 7,509,555 755,834 48,965 276,607 8,590,961<br />

75-79 6,624,729 587,672 34,800 205,392 7,452,593<br />

80-84 4,871,668 393,956 21,862 128,593 5,416,079<br />

85+ 4,256,898 342,770 18,859 94,940 4,713,467<br />

All 236,349,420 38,148,112 3,111,067 13,202,190 290,810,789<br />

*<strong>Data</strong> from the CDC's Bridged Race <strong>Data</strong>base.


Table M.2 M.2<br />

Resident population estimates of of the U.S.<br />

by gender, race, & Hispanic origin; population in thousands<br />

by gender, race, & Hispanic origin; population in thousands<br />

July 1, July 1, July 1, July 1, July 1, July 1, July 1,<br />

1990 1991 1992 1993 1994 1995 1996<br />

All races<br />

Population 249,622,814 252,980,941 256,514,224 259,918,588 263,125,821 266,278,393 269,394,284<br />

Percent of total 100.0 100.0 100.0 100.0 100.0 100.0 100.0<br />

Male population 121,713,764 123,416,235 125,247,146 126,970,600 128,597,479 130,215,371 131,807,484<br />

Female population 127,909,050 129,564,706 131,267,078 132,947,988 134,528,342 136,063,022 137,586,800<br />

CENSUS POPULATIONS<br />

2005 Annual <strong>Data</strong> ReportM<br />

White<br />

Black<br />

Population 209,366,661 211,606,011 213,945,622 216,187,073 218,304,774 220,384,783 222,420,050<br />

Percent of total 83.9 83.7 83.4 83.2 83.0 82.8 82.6<br />

Male population 102,493,278 103,658,047 104,902,267 106,067,858 107,174,245 108,278,333 109,352,585<br />

Female population 106,873,383 107,947,964 109,043,355 110,119,215 111,130,529 112,106,450 113,067,465<br />

Population 30,648,345 31,290,743 31,979,982 32,634,735 33,258,981 33,847,306 34,415,478<br />

Percent of total 12.3 12.4 12.5 12.6 12.6 12.7 12.8<br />

Male population 14,502,886 14,809,739 15,154,311 15,471,443 15,771,864 16,056,540 16,330,618<br />

Female population 16,145,459 16,481,004 16,825,671 17,163,292 17,487,117 17,790,766 18,084,860<br />

715<br />

American Indian, Eskimo, and Aleut<br />

Population 2,058,726 2,126,968 2,202,176 2,282,052 2,361,078 2,441,752 2,534,873<br />

Percent of total 0.8 0.8 0.9 0.9 0.9 0.9 0.9<br />

Male population 1,020,993 1,055,180 1,092,909 1,132,916 1,172,555 1,213,375 1,260,051<br />

Female population 1,037,733 1,071,788 1,109,267 1,149,136 1,188,523 1,228,377 1,274,822<br />

Asian and Pacific Islander<br />

Population 7,549,082 7,957,219 8,386,444 8,814,728 9,200,988 9,604,552 10,023,883<br />

Percent of total 3.0 3.2 3.3 3.4 3.5 3.6 3.7<br />

Male population 3,696,607 3,893,269 4,097,659 4,298,383 4,478,815 4,667,123 4,864,230<br />

Female population 3,852,475 4,063,950 4,288,785 4,516,345 4,722,173 4,937,429 5,159,653<br />

Hispanic<br />

Population 22,572,838 23,554,990 24,619,345 25,776,661 26,945,933 28,157,801 29,463,458<br />

Percent of total 9.0 9.3 9.6 9.9 10.2 10.6 10.9<br />

Male population 11,503,986 12,016,949 12,568,506 13,164,148 13,770,495 14,406,194 15,086,059<br />

Female population 11,068,852 11,538,041 12,050,839 12,612,513 13,175,438 13,751,607 14,377,399<br />

Non-Hispanic<br />

Population 227,049,976 229,425,951 231,894,879 234,141,927 236,179,888 238,120,592 239,930,826<br />

Percent of total 91.0 90.7 90.4 90.1 89.8 89.4 89.1<br />

Male population 110,209,778 111,399,286 112,678,640 113,806,452 114,826,984 115,809,177 116,721,425<br />

Female population 116,840,198 118,026,665 119,216,239 120,335,475 121,352,904 122,311,415 123,209,401


MCENSUS POPULATIONS<br />

MReference section M<br />

Table M.2 M.2 (continued)<br />

Resident population estimates of of the U.S.<br />

by gender, race, & Hispanic origin; population in thousands<br />

by gender, race, & Hispanic origin; population in thousands<br />

July 1, July 1, July 1, July 1, July 1, July 1, July 1,<br />

1997 1998 1999 *2000 *2001 *2002 *2003<br />

All races<br />

Population 272,646,925 275,854,104 279,040,168 282,177,838 285,093,870 287,974,001 290,810,789<br />

Percent of total 100.0 100.0 100.0 100.0 100.0 100.0 100.0<br />

Male population 133,473,526 135,129,904 136,802,873 138,456,540 140,008,573 141,533,415 143,037,290<br />

Female population 139,173,399 140,724,200 142,237,295 143,721,298 145,085,297 146,440,586 147,773,499<br />

716<br />

White<br />

Black<br />

Population 224,553,464 226,648,119 228,687,790 230,597,989 232,543,966 234,468,792 236,349,420<br />

Percent of total 82.4 82.2 82.0 81.7 81.6 81.4 81.3<br />

Male population 110,482,030 111,599,777 112,695,874 113,725,977 114,795,264 115,846,443 116,875,095<br />

Female population 114,071,434 115,048,342 115,991,916 116,872,012 117,748,702 118,622,349 119,474,325<br />

Population 35,007,679 35,594,140 36,173,121 36,712,965 37,198,557 37,675,660 38,148,112<br />

Percent of total 12.8 12.9 13.0 13.0 13.1 13.1 13.1<br />

Male population 16,619,354 16,907,760 17,195,091 17,467,151 17,712,097 17,951,616 18,190,193<br />

Female population 18,388,325 18,686,380 18,978,030 19,245,814 19,486,460 19,724,044 19,957,919<br />

American Indian, Eskimo, and Aleut<br />

Population 2,626,475 2,726,036 2,832,761 2,995,371 3,034,055 3,070,782 3,111,067<br />

Percent of total 1.0 1.0 1.0 1.1 1.1 1.1 1.1<br />

Male population 1,306,151 1,356,530 1,410,781 1,494,149 1,514,025 1,532,452 1,552,954<br />

Female population 1,320,324 1,369,506 1,421,980 1,501,222 1,520,030 1,538,330 1,558,113<br />

Asian and Pacific Islander<br />

Population 10,459,307 10,885,809 11,346,496 11,871,513 12,317,292 12,758,767 13,202,190<br />

Percent of total 3.8 4.0 4.1 4.2 4.3 4.4 4.5<br />

Male population 5,065,991 5,265,837 5,501,127 5,769,263 5,987,187 6,202,904 6,419,048<br />

Female population 5,393,316 5,619,972 5,845,369 6,102,250 6,330,105 6,555,863 6,783,142<br />

Hispanic<br />

Population 30,895,896 32,382,865 33,937,795 35,650,138 37,061,639 38,488,299 39,899,063<br />

Percent of total 11.3 11.7 12.2 12.6 13.0 13.4 13.7<br />

Male population 15,833,620 16,612,836 17,436,364 18,347,648 19,096,700 19,851,814 20,599,115<br />

Female population 15,062,276 15,770,029 16,501,431 17,302,490 17,964,939 18,636,485 19,299,948<br />

Non-Hispanic<br />

Population 241,751,029 243,471,239 245,102,373 246,527,700 248,032,231 249,485,702 250,911,726<br />

Percent of total 88.7 88.3 87.8 87.4 87.0 86.6 86.3<br />

Male population 117,639,906 118,517,068 119,366,509 120,108,892 120,911,873 121,681,601 122,438,175<br />

Female population 124,111,123 124,954,171 125,735,864 126,418,808 127,120,358 127,804,101 128,473,551<br />

*<strong>Data</strong> from the CDC's Bridged Race <strong>Data</strong>base.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!